Query 041757
Match_columns 381
No_of_seqs 373 out of 2207
Neff 9.5
Searched_HMMs 46136
Date Fri Mar 29 10:18:23 2013
Command hhsearch -i /work/01045/syshi/csienesis_hhblits_a3m/041757.a3m -d /work/01045/syshi/HHdatabase/Cdd.hhm -o /work/01045/syshi/hhsearch_cdd/041757hhsearch_cdd -cpu 12 -v 0
No Hit Prob E-value P-value Score SS Cols Query HMM Template HMM
1 KOG1187 Serine/threonine prote 100.0 3.9E-49 8.4E-54 369.3 22.4 274 22-327 61-355 (361)
2 KOG0192 Tyrosine kinase specif 100.0 3.9E-49 8.4E-54 367.0 19.4 249 36-332 41-311 (362)
3 KOG0591 NIMA (never in mitosis 100.0 4.1E-50 8.9E-55 344.0 9.6 245 35-323 18-284 (375)
4 KOG0581 Mitogen-activated prot 100.0 2.9E-49 6.3E-54 352.0 14.9 236 36-319 79-334 (364)
5 KOG0575 Polo-like serine/threo 100.0 1.2E-48 2.7E-53 367.0 18.2 231 36-319 18-268 (592)
6 KOG0197 Tyrosine kinases [Sign 100.0 4.3E-48 9.3E-53 359.6 15.0 241 38-327 208-464 (468)
7 KOG0615 Serine/threonine prote 100.0 1.3E-47 2.8E-52 344.2 12.2 237 34-319 170-436 (475)
8 KOG0595 Serine/threonine-prote 100.0 8.4E-47 1.8E-51 339.3 14.3 184 33-237 7-215 (429)
9 KOG0598 Ribosomal protein S6 k 100.0 8.5E-46 1.9E-50 329.8 14.6 184 34-237 23-226 (357)
10 KOG1026 Nerve growth factor re 100.0 7.4E-46 1.6E-50 360.8 13.5 253 36-328 486-766 (774)
11 KOG0198 MEKK and related serin 100.0 3E-45 6.5E-50 331.2 13.4 245 35-324 16-280 (313)
12 KOG0592 3-phosphoinositide-dep 100.0 8.3E-45 1.8E-49 336.3 14.2 237 32-319 69-337 (604)
13 KOG0661 MAPK related serine/th 100.0 6.9E-45 1.5E-49 331.9 12.5 263 32-320 6-291 (538)
14 KOG0593 Predicted protein kina 100.0 2.1E-44 4.5E-49 311.8 14.1 257 36-319 2-283 (396)
15 cd05102 PTKc_VEGFR3 Catalytic 100.0 9.2E-44 2E-48 334.5 17.9 254 35-326 6-336 (338)
16 KOG0600 Cdc2-related protein k 100.0 1.2E-43 2.5E-48 326.2 15.9 261 35-319 116-399 (560)
17 KOG0583 Serine/threonine prote 100.0 2.8E-43 6E-48 330.5 17.7 233 33-318 14-273 (370)
18 KOG1095 Protein tyrosine kinas 100.0 8.4E-44 1.8E-48 358.0 14.9 256 37-335 693-972 (1025)
19 KOG0193 Serine/threonine prote 100.0 5.2E-44 1.1E-48 334.7 11.7 245 36-327 392-656 (678)
20 KOG0597 Serine-threonine prote 100.0 1.7E-43 3.6E-48 328.4 13.2 230 36-319 2-250 (808)
21 KOG0578 p21-activated serine/t 100.0 4.2E-43 9.2E-48 327.3 14.1 234 35-319 272-522 (550)
22 KOG0659 Cdk activating kinase 100.0 1.3E-42 2.7E-47 295.9 15.4 257 36-320 2-281 (318)
23 KOG0194 Protein tyrosine kinas 100.0 7.1E-43 1.5E-47 329.5 13.4 244 37-330 158-426 (474)
24 KOG4721 Serine/threonine prote 100.0 2.9E-43 6.2E-48 326.8 9.6 239 40-330 128-374 (904)
25 PHA02988 hypothetical protein; 100.0 1E-41 2.2E-46 312.6 19.3 252 23-325 9-280 (283)
26 KOG0588 Serine/threonine prote 100.0 1.9E-42 4E-47 327.1 14.7 231 35-319 11-262 (786)
27 KOG0582 Ste20-like serine/thre 100.0 8.1E-42 1.8E-46 309.7 17.8 247 34-319 24-292 (516)
28 KOG0660 Mitogen-activated prot 100.0 3.5E-42 7.6E-47 305.6 15.0 272 30-319 16-309 (359)
29 KOG0616 cAMP-dependent protein 100.0 3.3E-42 7.2E-47 297.4 13.9 180 35-237 43-242 (355)
30 KOG0589 Serine/threonine prote 100.0 1.4E-42 3.1E-47 321.7 12.3 235 36-320 4-258 (426)
31 cd05096 PTKc_DDR1 Catalytic do 100.0 1.4E-41 3.1E-46 314.9 17.3 255 35-322 4-303 (304)
32 KOG0605 NDR and related serine 100.0 5.8E-42 1.3E-46 317.5 14.2 230 34-313 139-435 (550)
33 cd05104 PTKc_Kit Catalytic dom 100.0 1.3E-41 2.8E-46 324.0 16.7 251 35-324 34-374 (375)
34 cd05106 PTKc_CSF-1R Catalytic 100.0 1.4E-41 3E-46 323.6 16.5 253 34-325 36-373 (374)
35 KOG0663 Protein kinase PITSLRE 100.0 1.1E-41 2.5E-46 298.5 14.5 263 35-319 75-360 (419)
36 KOG0196 Tyrosine kinase, EPH ( 100.0 6.2E-43 1.3E-47 335.0 7.1 245 38-331 631-898 (996)
37 KOG2345 Serine/threonine prote 100.0 7.5E-42 1.6E-46 288.4 12.8 258 32-325 17-301 (302)
38 KOG0580 Serine/threonine prote 100.0 2.8E-42 6.1E-47 289.7 9.6 232 35-319 21-272 (281)
39 KOG0611 Predicted serine/threo 100.0 8.3E-42 1.8E-46 306.0 13.2 230 35-319 52-302 (668)
40 cd07859 STKc_TDY_MAPK_plant Ca 100.0 2.5E-41 5.3E-46 317.8 17.1 267 37-319 1-289 (338)
41 cd05612 STKc_PRKX_like Catalyt 100.0 1.7E-41 3.8E-46 312.4 15.3 228 36-319 1-253 (291)
42 cd05571 STKc_PKB Catalytic dom 100.0 2.3E-41 4.9E-46 316.2 16.2 225 42-319 1-250 (323)
43 KOG0585 Ca2+/calmodulin-depend 100.0 2.2E-41 4.8E-46 308.8 15.3 239 35-321 96-373 (576)
44 KOG1989 ARK protein kinase fam 100.0 2.3E-41 5E-46 330.8 16.1 255 34-332 35-319 (738)
45 cd07848 STKc_CDKL5 Catalytic d 100.0 7.7E-41 1.7E-45 307.3 18.5 262 36-319 1-283 (287)
46 cd05064 PTKc_EphR_A10 Catalyti 100.0 6.8E-41 1.5E-45 304.4 17.4 240 35-324 4-265 (266)
47 cd05631 STKc_GRK4 Catalytic do 100.0 8.1E-41 1.8E-45 307.0 17.9 235 37-319 1-260 (285)
48 PTZ00263 protein kinase A cata 100.0 3.1E-41 6.8E-46 316.0 15.4 229 35-319 17-270 (329)
49 KOG4257 Focal adhesion tyrosin 100.0 1.5E-41 3.2E-46 318.3 12.8 235 41-326 394-651 (974)
50 cd05048 PTKc_Ror Catalytic Dom 100.0 1.4E-40 3E-45 304.9 18.1 249 36-324 5-283 (283)
51 cd06649 PKc_MEK2 Catalytic dom 100.0 1.5E-40 3.3E-45 311.7 18.6 182 35-237 4-203 (331)
52 cd05585 STKc_YPK1_like Catalyt 100.0 6.3E-41 1.4E-45 311.7 15.5 222 44-318 1-245 (312)
53 cd05108 PTKc_EGFR Catalytic do 100.0 1.2E-40 2.7E-45 310.3 17.1 244 35-328 6-272 (316)
54 PTZ00426 cAMP-dependent protei 100.0 6.2E-41 1.3E-45 315.1 15.1 229 35-319 29-283 (340)
55 PTZ00267 NIMA-related protein 100.0 1.2E-40 2.6E-45 326.7 17.7 238 36-319 67-322 (478)
56 cd05105 PTKc_PDGFR_alpha Catal 100.0 1.3E-40 2.8E-45 318.6 17.3 253 35-326 36-399 (400)
57 KOG0694 Serine/threonine prote 100.0 7.1E-41 1.5E-45 318.3 15.3 227 34-314 366-613 (694)
58 cd05595 STKc_PKB_beta Catalyti 100.0 1.2E-40 2.6E-45 311.3 16.6 225 42-319 1-250 (323)
59 cd05593 STKc_PKB_gamma Catalyt 100.0 1.4E-40 3.1E-45 311.4 17.0 225 42-319 1-250 (328)
60 cd07869 STKc_PFTAIRE1 Catalyti 100.0 1.7E-40 3.7E-45 307.5 17.0 184 35-238 4-206 (303)
61 KOG0201 Serine/threonine prote 100.0 5.9E-42 1.3E-46 310.3 6.7 234 34-319 11-262 (467)
62 cd05111 PTK_HER3 Pseudokinase 100.0 6.5E-40 1.4E-44 300.1 20.2 244 35-328 6-272 (279)
63 cd05054 PTKc_VEGFR Catalytic d 100.0 2.5E-40 5.4E-45 310.8 17.4 254 35-326 6-335 (337)
64 PHA03212 serine/threonine kina 100.0 4.6E-40 9.9E-45 314.4 19.5 258 35-319 91-375 (391)
65 KOG0658 Glycogen synthase kina 100.0 9E-42 1.9E-46 303.5 7.1 264 36-319 24-305 (364)
66 cd07871 STKc_PCTAIRE3 Catalyti 100.0 3.6E-40 7.9E-45 303.2 17.7 261 36-319 5-284 (288)
67 KOG0033 Ca2+/calmodulin-depend 100.0 3.2E-41 7E-46 284.1 9.7 236 34-319 9-266 (355)
68 cd05093 PTKc_TrkB Catalytic do 100.0 4.1E-40 8.8E-45 302.8 18.0 252 36-327 5-282 (288)
69 cd05094 PTKc_TrkC Catalytic do 100.0 6.4E-40 1.4E-44 301.9 18.9 252 36-327 5-285 (291)
70 cd05080 PTKc_Tyk2_rpt2 Catalyt 100.0 7E-40 1.5E-44 300.4 19.0 250 38-325 6-282 (283)
71 cd05600 STKc_Sid2p_Dbf2p Catal 100.0 3.7E-40 7.9E-45 309.4 17.2 237 36-320 1-257 (333)
72 PTZ00283 serine/threonine prot 100.0 4E-40 8.7E-45 323.4 17.9 248 32-320 28-297 (496)
73 cd05062 PTKc_IGF-1R Catalytic 100.0 5E-40 1.1E-44 300.4 17.1 249 34-322 4-276 (277)
74 cd05584 STKc_p70S6K Catalytic 100.0 4.5E-40 9.7E-45 307.5 17.1 225 42-319 2-255 (323)
75 cd05033 PTKc_EphR Catalytic do 100.0 1.2E-39 2.6E-44 296.0 19.3 240 36-324 4-265 (266)
76 cd05114 PTKc_Tec_Rlk Catalytic 100.0 9.9E-40 2.1E-44 294.9 18.4 236 36-321 4-255 (256)
77 cd05594 STKc_PKB_alpha Catalyt 100.0 2.2E-40 4.7E-45 309.9 14.0 226 42-319 1-251 (325)
78 cd07862 STKc_CDK6 Catalytic do 100.0 9.3E-40 2E-44 300.5 17.6 263 36-319 1-286 (290)
79 cd05035 PTKc_Axl_like Catalyti 100.0 2.2E-39 4.8E-44 295.0 19.9 248 38-324 1-272 (273)
80 cd05614 STKc_MSK2_N N-terminal 100.0 6.3E-40 1.4E-44 307.7 16.5 235 37-319 1-266 (332)
81 cd06650 PKc_MEK1 Catalytic dom 100.0 6.3E-40 1.4E-44 307.7 16.3 182 35-237 4-203 (333)
82 cd05045 PTKc_RET Catalytic dom 100.0 1.7E-39 3.6E-44 299.0 18.8 250 37-326 1-288 (290)
83 cd08228 STKc_Nek6 Catalytic do 100.0 1.4E-39 3E-44 295.6 17.7 245 36-325 2-266 (267)
84 cd05075 PTKc_Axl Catalytic dom 100.0 2.3E-39 4.9E-44 295.0 18.7 248 38-324 1-271 (272)
85 cd05590 STKc_nPKC_eta Catalyti 100.0 7.9E-40 1.7E-44 305.4 15.8 221 42-315 1-242 (320)
86 cd05589 STKc_PKN Catalytic dom 100.0 1.3E-39 2.9E-44 304.5 17.2 228 38-319 1-256 (324)
87 cd05072 PTKc_Lyn Catalytic dom 100.0 2.1E-39 4.6E-44 293.5 18.0 241 35-324 5-261 (261)
88 cd05095 PTKc_DDR2 Catalytic do 100.0 1.6E-39 3.4E-44 300.1 17.3 256 35-323 4-296 (296)
89 cd05049 PTKc_Trk Catalytic dom 100.0 2E-39 4.4E-44 296.6 17.9 249 35-323 4-280 (280)
90 cd05052 PTKc_Abl Catalytic dom 100.0 2.8E-39 6E-44 293.2 18.3 240 36-324 6-262 (263)
91 PF07714 Pkinase_Tyr: Protein 100.0 2.6E-40 5.6E-45 299.4 11.3 234 40-321 3-259 (259)
92 PTZ00036 glycogen synthase kin 100.0 1.7E-39 3.7E-44 315.1 17.6 269 34-319 64-350 (440)
93 cd05591 STKc_nPKC_epsilon Cata 100.0 1.1E-39 2.3E-44 304.6 15.6 225 42-319 1-253 (321)
94 KOG1094 Discoidin domain recep 100.0 1.4E-40 2.9E-45 309.9 9.2 249 35-324 537-804 (807)
95 cd05032 PTKc_InsR_like Catalyt 100.0 1.9E-39 4.2E-44 296.2 16.7 248 35-322 5-276 (277)
96 cd05592 STKc_nPKC_theta_delta 100.0 1.8E-39 3.9E-44 302.4 16.8 224 42-318 1-246 (316)
97 cd05098 PTKc_FGFR1 Catalytic d 100.0 3.3E-39 7.3E-44 299.4 18.3 253 35-327 17-302 (307)
98 cd05587 STKc_cPKC Catalytic do 100.0 1.8E-39 3.9E-44 303.5 16.6 225 37-314 1-246 (324)
99 cd05101 PTKc_FGFR2 Catalytic d 100.0 4.1E-39 8.8E-44 298.4 18.7 253 35-327 14-299 (304)
100 cd05084 PTKc_Fes Catalytic dom 100.0 5.3E-39 1.1E-43 289.4 18.9 232 42-322 1-251 (252)
101 cd05053 PTKc_FGFR Catalytic do 100.0 3.2E-39 6.9E-44 297.4 17.8 251 35-325 11-292 (293)
102 PLN00034 mitogen-activated pro 100.0 2.1E-39 4.5E-44 306.7 16.9 232 35-319 73-327 (353)
103 cd05082 PTKc_Csk Catalytic dom 100.0 4.8E-39 1E-43 290.4 18.4 237 36-324 6-256 (256)
104 cd05088 PTKc_Tie2 Catalytic do 100.0 2.7E-39 5.8E-44 299.5 17.1 251 36-329 7-285 (303)
105 cd05113 PTKc_Btk_Bmx Catalytic 100.0 2.9E-39 6.2E-44 292.0 16.9 237 36-322 4-256 (256)
106 cd05588 STKc_aPKC Catalytic do 100.0 9.7E-40 2.1E-44 305.9 14.2 231 42-319 1-261 (329)
107 cd05570 STKc_PKC Catalytic dom 100.0 1.9E-39 4E-44 302.6 16.0 225 42-319 1-251 (318)
108 cd05109 PTKc_HER2 Catalytic do 100.0 6.7E-39 1.5E-43 293.2 19.4 244 35-328 6-272 (279)
109 cd05618 STKc_aPKC_iota Catalyt 100.0 9.2E-40 2E-44 306.0 14.0 229 42-314 1-250 (329)
110 cd05089 PTKc_Tie1 Catalytic do 100.0 4.8E-39 1E-43 297.0 18.5 250 36-328 2-279 (297)
111 cd05090 PTKc_Ror1 Catalytic do 100.0 3.3E-39 7.2E-44 295.9 17.3 248 36-323 5-282 (283)
112 cd05055 PTKc_PDGFR Catalytic d 100.0 2.4E-39 5.1E-44 299.8 16.3 243 35-324 34-301 (302)
113 cd05097 PTKc_DDR_like Catalyti 100.0 2.7E-39 5.8E-44 298.4 16.5 255 35-322 4-294 (295)
114 cd05605 STKc_GRK4_like Catalyt 100.0 4.1E-39 9E-44 295.7 17.6 235 37-319 1-260 (285)
115 cd05051 PTKc_DDR Catalytic dom 100.0 2.1E-39 4.6E-44 298.9 15.7 255 35-322 4-295 (296)
116 cd05036 PTKc_ALK_LTK Catalytic 100.0 4E-39 8.7E-44 294.4 17.3 245 35-322 5-276 (277)
117 cd05043 PTK_Ryk Pseudokinase d 100.0 6.6E-39 1.4E-43 293.4 18.6 252 35-327 5-279 (280)
118 cd05620 STKc_nPKC_delta Cataly 100.0 2.6E-39 5.6E-44 301.4 16.1 224 42-318 1-246 (316)
119 cd05092 PTKc_TrkA Catalytic do 100.0 4.4E-39 9.6E-44 294.7 17.3 248 35-322 4-279 (280)
120 cd05573 STKc_ROCK_NDR_like Cat 100.0 1.2E-39 2.6E-44 307.9 14.0 235 36-320 1-285 (350)
121 cd07853 STKc_NLK Catalytic dom 100.0 3E-39 6.5E-44 307.7 16.7 261 37-319 1-287 (372)
122 cd05608 STKc_GRK1 Catalytic do 100.0 4.2E-39 9.2E-44 294.9 17.0 231 44-319 1-256 (280)
123 cd05582 STKc_RSK_N N-terminal 100.0 7.9E-40 1.7E-44 305.2 12.3 222 42-316 2-245 (318)
124 cd05619 STKc_nPKC_theta Cataly 100.0 3.9E-39 8.4E-44 300.2 16.8 224 42-318 1-246 (316)
125 cd05103 PTKc_VEGFR2 Catalytic 100.0 4.2E-39 9.1E-44 303.4 17.2 254 35-326 6-341 (343)
126 cd05616 STKc_cPKC_beta Catalyt 100.0 3.1E-39 6.7E-44 301.8 16.1 225 37-314 1-246 (323)
127 cd08224 STKc_Nek6_Nek7 Catalyt 100.0 1.4E-38 3.1E-43 288.8 20.0 245 36-325 2-266 (267)
128 KOG4278 Protein tyrosine kinas 100.0 1.2E-39 2.6E-44 305.3 13.1 239 39-326 270-525 (1157)
129 cd05099 PTKc_FGFR4 Catalytic d 100.0 7.4E-39 1.6E-43 298.1 18.5 254 35-328 11-297 (314)
130 cd05107 PTKc_PDGFR_beta Cataly 100.0 3.8E-39 8.2E-44 308.4 16.9 252 35-325 36-400 (401)
131 cd05068 PTKc_Frk_like Catalyti 100.0 1.3E-38 2.9E-43 288.4 19.6 241 35-324 5-261 (261)
132 cd05626 STKc_LATS2 Catalytic d 100.0 2.7E-39 5.9E-44 308.9 15.9 183 37-237 2-249 (381)
133 cd05148 PTKc_Srm_Brk Catalytic 100.0 6.5E-39 1.4E-43 290.2 17.6 241 34-324 4-261 (261)
134 cd05061 PTKc_InsR Catalytic do 100.0 7.9E-39 1.7E-43 294.2 18.3 252 34-325 4-279 (288)
135 cd05575 STKc_SGK Catalytic dom 100.0 2.1E-39 4.6E-44 302.9 14.6 221 42-315 1-242 (323)
136 cd05081 PTKc_Jak2_Jak3_rpt2 Ca 100.0 7E-39 1.5E-43 293.8 17.8 254 35-324 3-283 (284)
137 cd05607 STKc_GRK7 Catalytic do 100.0 5.2E-39 1.1E-43 293.8 16.8 231 44-321 1-251 (277)
138 cd05091 PTKc_Ror2 Catalytic do 100.0 6E-39 1.3E-43 294.1 16.5 248 36-323 5-282 (283)
139 cd05628 STKc_NDR1 Catalytic do 100.0 4.3E-39 9.2E-44 305.7 16.0 184 36-237 1-237 (363)
140 cd05599 STKc_NDR_like Catalyti 100.0 2.5E-39 5.4E-44 307.4 14.3 184 36-237 1-240 (364)
141 cd05059 PTKc_Tec_like Catalyti 100.0 9.3E-39 2E-43 288.6 17.4 236 36-321 4-255 (256)
142 cd08229 STKc_Nek7 Catalytic do 100.0 6.3E-39 1.4E-43 291.3 16.2 245 36-325 2-266 (267)
143 KOG0594 Protein kinase PCTAIRE 100.0 3E-39 6.4E-44 287.7 13.6 267 36-320 11-302 (323)
144 cd05058 PTKc_Met_Ron Catalytic 100.0 1.8E-38 3.8E-43 287.5 18.7 237 42-326 1-261 (262)
145 cd05602 STKc_SGK1 Catalytic do 100.0 3.3E-39 7.3E-44 301.9 14.4 226 42-320 1-247 (325)
146 cd05071 PTKc_Src Catalytic dom 100.0 2.6E-38 5.7E-43 286.7 19.7 240 35-324 5-260 (262)
147 cd05596 STKc_ROCK Catalytic do 100.0 4.4E-39 9.6E-44 306.0 15.2 237 35-320 42-304 (370)
148 cd06625 STKc_MEKK3_like Cataly 100.0 1.7E-38 3.6E-43 287.8 18.3 236 36-320 2-260 (263)
149 cd05604 STKc_SGK3 Catalytic do 100.0 2.6E-39 5.6E-44 302.6 13.2 227 42-321 1-248 (325)
150 cd08529 STKc_FA2-like Catalyti 100.0 2.6E-38 5.6E-43 285.2 19.3 234 37-320 1-253 (256)
151 cd05601 STKc_CRIK Catalytic do 100.0 1.7E-39 3.6E-44 304.5 11.9 235 36-319 1-262 (330)
152 cd05115 PTKc_Zap-70 Catalytic 100.0 1.7E-38 3.7E-43 287.2 18.1 232 43-324 2-255 (257)
153 cd07876 STKc_JNK2 Catalytic do 100.0 2.2E-38 4.8E-43 300.4 19.7 185 34-237 19-223 (359)
154 cd05629 STKc_NDR_like_fungal C 100.0 3.4E-39 7.4E-44 307.9 14.2 184 36-237 1-249 (377)
155 cd05116 PTKc_Syk Catalytic dom 100.0 1.6E-38 3.4E-43 287.3 17.6 231 43-324 2-255 (257)
156 cd05603 STKc_SGK2 Catalytic do 100.0 4.8E-39 1E-43 300.3 14.6 221 42-315 1-242 (321)
157 cd05110 PTKc_HER4 Catalytic do 100.0 1.4E-38 3E-43 294.8 17.5 244 35-328 6-272 (303)
158 cd07872 STKc_PCTAIRE2 Catalyti 100.0 1.8E-38 3.9E-43 294.8 18.1 261 36-319 6-285 (309)
159 cd05625 STKc_LATS1 Catalytic d 100.0 5.2E-39 1.1E-43 307.2 14.8 183 37-237 2-249 (382)
160 cd07878 STKc_p38beta_MAPK11 Ca 100.0 2.1E-38 4.5E-43 298.7 18.7 265 33-319 12-297 (343)
161 cd05079 PTKc_Jak1_rpt2 Catalyt 100.0 2.1E-38 4.6E-43 290.7 18.2 256 36-324 4-283 (284)
162 cd07868 STKc_CDK8 Catalytic do 100.0 3.8E-38 8.3E-43 293.6 20.1 190 41-238 6-218 (317)
163 PTZ00266 NIMA-related protein 100.0 2E-38 4.4E-43 322.4 19.7 241 35-319 12-294 (1021)
164 cd05065 PTKc_EphR_B Catalytic 100.0 2.6E-38 5.7E-43 287.7 18.5 240 36-324 4-268 (269)
165 cd05042 PTKc_Aatyk Catalytic d 100.0 1.4E-38 3E-43 289.5 16.6 240 42-322 1-268 (269)
166 cd07863 STKc_CDK4 Catalytic do 100.0 2.3E-38 4.9E-43 290.9 18.0 262 37-319 1-284 (288)
167 KOG0599 Phosphorylase kinase g 100.0 2.7E-39 5.8E-44 276.5 10.9 235 35-319 16-282 (411)
168 cd05070 PTKc_Fyn_Yrk Catalytic 100.0 2.9E-38 6.4E-43 285.9 18.4 239 35-323 5-259 (260)
169 cd05087 PTKc_Aatyk1_Aatyk3 Cat 100.0 9.5E-39 2.1E-43 290.7 15.2 240 42-322 1-268 (269)
170 cd05067 PTKc_Lck_Blk Catalytic 100.0 4.3E-38 9.3E-43 284.9 19.2 239 35-323 5-259 (260)
171 cd05598 STKc_LATS Catalytic do 100.0 3.5E-39 7.5E-44 307.8 12.6 184 36-237 1-245 (376)
172 cd05086 PTKc_Aatyk2 Catalytic 100.0 6E-38 1.3E-42 285.3 20.2 239 42-322 1-267 (268)
173 cd05060 PTKc_Syk_like Catalyti 100.0 3.4E-38 7.4E-43 285.0 18.5 233 42-325 1-256 (257)
174 PHA03209 serine/threonine kina 100.0 2.2E-38 4.8E-43 300.0 17.7 182 34-236 64-256 (357)
175 cd08219 STKc_Nek3 Catalytic do 100.0 2E-38 4.3E-43 286.2 16.6 234 37-320 1-252 (255)
176 cd05066 PTKc_EphR_A Catalytic 100.0 2.9E-38 6.3E-43 287.1 17.7 240 36-324 4-266 (267)
177 cd05100 PTKc_FGFR3 Catalytic d 100.0 2.9E-38 6.3E-43 296.6 18.2 253 36-328 12-297 (334)
178 cd05615 STKc_cPKC_alpha Cataly 100.0 1.6E-38 3.4E-43 297.0 16.3 226 37-315 1-247 (323)
179 cd05076 PTK_Tyk2_rpt1 Pseudoki 100.0 2.2E-38 4.8E-43 289.2 16.9 205 61-322 61-274 (274)
180 cd05047 PTKc_Tie Catalytic dom 100.0 2.5E-38 5.5E-43 288.1 17.2 241 42-325 1-269 (270)
181 cd05056 PTKc_FAK Catalytic dom 100.0 5.2E-38 1.1E-42 285.9 19.2 241 36-327 6-268 (270)
182 cd05063 PTKc_EphR_A2 Catalytic 100.0 3.7E-38 8E-43 286.5 18.2 241 35-324 4-267 (268)
183 cd05050 PTKc_Musk Catalytic do 100.0 2.8E-38 6.1E-43 290.5 17.5 249 35-323 4-288 (288)
184 cd05617 STKc_aPKC_zeta Catalyt 100.0 1.6E-38 3.4E-43 297.5 16.0 227 42-315 1-249 (327)
185 cd05621 STKc_ROCK2 Catalytic d 100.0 1.1E-38 2.3E-43 303.2 15.0 184 34-237 41-248 (370)
186 cd05057 PTKc_EGFR_like Catalyt 100.0 4.6E-38 9.9E-43 287.7 18.6 243 35-327 6-271 (279)
187 PHA03207 serine/threonine kina 100.0 1.6E-38 3.4E-43 304.7 16.2 185 35-238 91-289 (392)
188 cd05039 PTKc_Csk_like Catalyti 100.0 5E-38 1.1E-42 283.7 18.5 237 35-324 5-256 (256)
189 PHA03211 serine/threonine kina 100.0 2.9E-38 6.4E-43 306.1 18.1 185 34-236 167-362 (461)
190 cd07874 STKc_JNK3 Catalytic do 100.0 3.3E-38 7.1E-43 298.8 17.8 185 34-237 15-219 (355)
191 cd06615 PKc_MEK Catalytic doma 100.0 5.5E-38 1.2E-42 291.4 18.9 181 36-237 1-199 (308)
192 cd05077 PTK_Jak1_rpt1 Pseudoki 100.0 3.7E-38 8.1E-43 285.8 17.3 223 42-321 1-261 (262)
193 cd05069 PTKc_Yes Catalytic dom 100.0 8.3E-38 1.8E-42 283.1 19.1 238 36-323 6-259 (260)
194 cd06637 STKc_TNIK Catalytic do 100.0 1.6E-38 3.5E-43 289.4 14.5 244 32-319 2-268 (272)
195 cd00192 PTKc Catalytic domain 100.0 7.6E-38 1.6E-42 282.6 18.7 240 42-322 1-262 (262)
196 cd05630 STKc_GRK6 Catalytic do 100.0 5E-38 1.1E-42 288.5 17.6 234 38-319 2-260 (285)
197 cd07875 STKc_JNK1 Catalytic do 100.0 4E-38 8.7E-43 299.2 17.4 185 34-237 22-226 (364)
198 KOG4279 Serine/threonine prote 100.0 4E-39 8.8E-44 305.1 10.2 229 42-319 581-831 (1226)
199 cd05622 STKc_ROCK1 Catalytic d 100.0 2.5E-38 5.5E-43 300.8 15.8 184 34-237 41-248 (371)
200 cd06638 STKc_myosinIIIA Cataly 100.0 5.9E-38 1.3E-42 287.9 17.8 250 30-320 12-283 (286)
201 KOG0596 Dual specificity; seri 100.0 2.7E-38 5.8E-43 293.3 15.4 237 35-319 360-626 (677)
202 cd06646 STKc_MAP4K5 Catalytic 100.0 1.3E-38 2.9E-43 289.2 13.2 239 34-320 7-265 (267)
203 KOG0610 Putative serine/threon 100.0 5.8E-38 1.3E-42 282.5 16.9 237 36-319 77-391 (459)
204 KOG0574 STE20-like serine/thre 100.0 3E-40 6.5E-45 285.8 2.0 233 38-319 35-282 (502)
205 PRK13184 pknD serine/threonine 100.0 4.4E-38 9.4E-43 318.7 18.0 254 36-327 2-293 (932)
206 cd05085 PTKc_Fer Catalytic dom 100.0 8.8E-38 1.9E-42 281.0 17.9 231 42-322 1-249 (250)
207 cd05078 PTK_Jak2_Jak3_rpt1 Pse 100.0 2.9E-38 6.4E-43 285.7 14.6 223 42-321 1-257 (258)
208 KOG0579 Ste20-like serine/thre 100.0 5.3E-39 1.2E-43 301.6 10.0 236 35-319 31-288 (1187)
209 PF00069 Pkinase: Protein kina 100.0 2.4E-38 5.2E-43 286.0 13.9 236 38-319 1-256 (260)
210 cd07867 STKc_CDC2L6 Catalytic 100.0 1E-37 2.2E-42 290.7 18.4 191 40-238 5-218 (317)
211 KOG0032 Ca2+/calmodulin-depend 100.0 1E-37 2.2E-42 292.8 18.4 236 33-319 32-292 (382)
212 PLN00113 leucine-rich repeat r 100.0 1.3E-37 2.8E-42 330.6 21.4 251 36-327 690-954 (968)
213 KOG2052 Activin A type IB rece 100.0 3E-38 6.5E-43 286.4 14.1 285 3-326 184-505 (513)
214 cd05073 PTKc_Hck Catalytic dom 100.0 2E-37 4.2E-42 280.6 19.6 239 35-323 5-259 (260)
215 KOG0584 Serine/threonine prote 100.0 4.1E-38 9E-43 296.8 15.4 231 39-319 43-295 (632)
216 cd06639 STKc_myosinIIIB Cataly 100.0 1.6E-37 3.5E-42 285.9 19.0 254 25-319 11-286 (291)
217 cd08221 STKc_Nek9 Catalytic do 100.0 1.9E-37 4E-42 279.9 18.9 234 37-320 1-253 (256)
218 cd05038 PTKc_Jak_rpt2 Catalyti 100.0 9.5E-38 2E-42 285.9 17.2 256 36-324 4-283 (284)
219 cd06654 STKc_PAK1 Catalytic do 100.0 5.4E-38 1.2E-42 289.9 15.5 238 31-319 15-269 (296)
220 cd05632 STKc_GRK5 Catalytic do 100.0 1.2E-37 2.6E-42 286.0 17.5 234 38-319 2-260 (285)
221 PHA03210 serine/threonine kina 100.0 1.3E-37 2.9E-42 306.4 19.0 261 35-319 147-453 (501)
222 cd05627 STKc_NDR2 Catalytic do 100.0 2.3E-38 5E-43 300.3 13.1 184 36-237 1-237 (360)
223 cd06619 PKc_MKK5 Catalytic dom 100.0 1.7E-37 3.6E-42 284.1 18.3 235 36-320 1-253 (279)
224 cd06645 STKc_MAP4K3 Catalytic 100.0 5.7E-38 1.2E-42 285.1 14.9 238 34-319 7-264 (267)
225 cd05046 PTK_CCK4 Pseudokinase 100.0 1.4E-37 3E-42 283.8 17.4 246 36-322 5-274 (275)
226 cd05040 PTKc_Ack_like Catalyti 100.0 2.1E-37 4.5E-42 279.7 18.3 233 42-322 1-256 (257)
227 cd06643 STKc_SLK Catalytic dom 100.0 1.3E-37 2.8E-42 285.1 17.1 234 37-319 6-261 (282)
228 cd06624 STKc_ASK Catalytic dom 100.0 1.9E-37 4.2E-42 281.8 18.1 241 30-319 2-264 (268)
229 cd07873 STKc_PCTAIRE1 Catalyti 100.0 1.1E-37 2.4E-42 288.4 16.7 261 36-319 6-285 (301)
230 PHA02882 putative serine/threo 100.0 1.4E-37 3.1E-42 286.7 17.4 247 35-321 11-293 (294)
231 cd05044 PTKc_c-ros Catalytic d 100.0 2.6E-37 5.7E-42 281.0 18.8 238 42-322 1-268 (269)
232 cd06644 STKc_STK10_LOK Catalyt 100.0 2.1E-37 4.5E-42 285.3 18.3 237 34-319 10-268 (292)
233 cd05083 PTKc_Chk Catalytic dom 100.0 2.3E-37 5.1E-42 279.1 18.3 234 36-323 6-253 (254)
234 cd06620 PKc_MAPKK_Byr1_like Ca 100.0 1.3E-37 2.9E-42 285.5 16.9 245 36-321 5-267 (284)
235 PTZ00284 protein kinase; Provi 100.0 2.1E-37 4.5E-42 303.5 19.1 182 34-237 127-346 (467)
236 cd05034 PTKc_Src_like Catalyti 100.0 2.2E-37 4.7E-42 280.2 17.7 240 35-323 5-260 (261)
237 cd05597 STKc_DMPK_like Catalyt 100.0 1.1E-37 2.3E-42 292.4 16.1 184 36-237 1-209 (331)
238 cd07849 STKc_ERK1_2_like Catal 100.0 2.1E-37 4.5E-42 291.1 18.0 275 34-325 3-299 (336)
239 KOG4717 Serine/threonine prote 100.0 9.4E-38 2E-42 287.3 15.1 233 34-319 16-269 (864)
240 KOG0577 Serine/threonine prote 100.0 7.7E-39 1.7E-43 298.5 8.1 229 36-319 26-277 (948)
241 cd06613 STKc_MAP4K3_like Catal 100.0 4.1E-37 8.8E-42 278.4 19.2 238 35-319 2-259 (262)
242 cd08223 STKc_Nek4 Catalytic do 100.0 4.8E-37 1E-41 277.2 19.6 234 37-319 1-253 (257)
243 cd06628 STKc_MAPKKK_Byr2_like 100.0 2.6E-37 5.5E-42 280.7 17.8 233 37-319 1-263 (267)
244 cd07847 STKc_CDKL1_4 Catalytic 100.0 3.6E-37 7.8E-42 282.5 19.0 259 36-319 1-282 (286)
245 KOG0667 Dual-specificity tyros 100.0 6.7E-38 1.5E-42 297.7 14.4 258 36-319 186-501 (586)
246 cd05112 PTKc_Itk Catalytic dom 100.0 3E-37 6.5E-42 278.5 18.0 236 36-321 4-255 (256)
247 cd06612 STKc_MST1_2 Catalytic 100.0 1.3E-37 2.9E-42 280.6 15.5 236 35-319 2-252 (256)
248 cd05623 STKc_MRCK_alpha Cataly 100.0 1.3E-37 2.9E-42 291.9 15.7 184 36-237 1-209 (332)
249 cd06621 PKc_MAPKK_Pek1_like Ca 100.0 7.6E-37 1.7E-41 280.9 20.3 247 36-319 1-265 (287)
250 cd07839 STKc_CDK5 Catalytic do 100.0 1.8E-37 3.8E-42 284.4 16.0 260 37-319 1-280 (284)
251 cd07846 STKc_CDKL2_3 Catalytic 100.0 3E-37 6.4E-42 283.1 17.4 260 36-319 1-282 (286)
252 cd06636 STKc_MAP4K4_6 Catalyti 100.0 1.6E-37 3.5E-42 284.5 15.5 247 29-319 9-278 (282)
253 cd08218 STKc_Nek1 Catalytic do 100.0 4E-37 8.7E-42 277.7 17.7 233 37-319 1-252 (256)
254 cd07861 STKc_CDK1_euk Catalyti 100.0 3.5E-37 7.7E-42 282.5 17.6 259 37-319 1-281 (285)
255 cd05624 STKc_MRCK_beta Catalyt 100.0 1.3E-37 2.8E-42 291.8 14.9 184 36-237 1-209 (331)
256 KOG0199 ACK and related non-re 100.0 2.7E-38 5.8E-43 299.8 10.0 243 32-323 106-371 (1039)
257 cd05074 PTKc_Tyro3 Catalytic d 100.0 5.2E-37 1.1E-41 279.6 18.2 248 38-324 1-272 (273)
258 cd05041 PTKc_Fes_like Catalyti 100.0 6.2E-37 1.3E-41 275.6 18.4 232 42-322 1-250 (251)
259 cd05586 STKc_Sck1_like Catalyt 100.0 7.9E-38 1.7E-42 293.2 12.8 224 44-319 1-252 (330)
260 cd06651 STKc_MEKK3 Catalytic d 100.0 7.3E-37 1.6E-41 277.8 18.1 236 36-319 2-260 (266)
261 cd05580 STKc_PKA Catalytic dom 100.0 6.7E-37 1.5E-41 281.7 17.9 227 36-318 1-252 (290)
262 cd06611 STKc_SLK_like Catalyti 100.0 2.6E-37 5.6E-42 282.8 14.9 237 34-319 3-261 (280)
263 cd08528 STKc_Nek10 Catalytic d 100.0 7.2E-37 1.6E-41 278.2 17.6 239 37-322 1-268 (269)
264 cd06640 STKc_MST4 Catalytic do 100.0 1.1E-36 2.3E-41 278.4 18.7 233 35-320 3-253 (277)
265 cd06608 STKc_myosinIII_like Ca 100.0 7.2E-37 1.6E-41 278.5 17.5 246 33-319 3-271 (275)
266 cd05609 STKc_MAST Catalytic do 100.0 8.5E-37 1.8E-41 283.1 18.2 240 36-323 1-273 (305)
267 cd06622 PKc_MAPKK_PBS2_like Ca 100.0 6.1E-37 1.3E-41 281.2 17.1 237 36-319 1-261 (286)
268 cd06655 STKc_PAK2 Catalytic do 100.0 8.3E-37 1.8E-41 281.9 17.8 235 34-319 17-268 (296)
269 cd06629 STKc_MAPKKK_Bck1_like 100.0 8.8E-37 1.9E-41 278.0 17.7 238 37-319 2-268 (272)
270 cd06631 STKc_YSK4 Catalytic do 100.0 6.4E-37 1.4E-41 277.9 16.7 235 37-319 1-261 (265)
271 cd06605 PKc_MAPKK Catalytic do 100.0 3.5E-37 7.6E-42 279.4 14.9 236 36-319 1-256 (265)
272 cd07870 STKc_PFTAIRE2 Catalyti 100.0 1.1E-36 2.3E-41 280.4 18.2 184 34-237 3-205 (291)
273 cd08217 STKc_Nek2 Catalytic do 100.0 1.3E-36 2.7E-41 275.2 18.4 240 37-319 1-261 (265)
274 cd07855 STKc_ERK5 Catalytic do 100.0 8.9E-37 1.9E-41 286.6 17.8 269 34-319 3-293 (334)
275 cd05037 PTK_Jak_rpt1 Pseudokin 100.0 6.7E-37 1.4E-41 276.5 16.3 222 42-321 1-258 (259)
276 cd07844 STKc_PCTAIRE_like Cata 100.0 7.6E-37 1.6E-41 281.3 17.0 182 36-237 5-205 (291)
277 cd07858 STKc_TEY_MAPK_plant Ca 100.0 7.9E-37 1.7E-41 287.2 17.4 273 34-324 3-297 (337)
278 cd08227 PK_STRAD_alpha Pseudok 100.0 6.9E-37 1.5E-41 286.5 16.9 183 40-238 2-212 (327)
279 KOG4645 MAPKKK (MAP kinase kin 100.0 1.8E-38 4E-43 318.7 6.3 237 34-319 1233-1493(1509)
280 cd06642 STKc_STK25-YSK1 Cataly 100.0 3.4E-37 7.3E-42 281.7 14.2 232 36-320 4-253 (277)
281 cd08220 STKc_Nek8 Catalytic do 100.0 1.4E-36 3E-41 274.0 18.0 232 37-319 1-252 (256)
282 cd06656 STKc_PAK3 Catalytic do 100.0 3.6E-37 7.9E-42 284.5 14.4 237 32-319 15-268 (297)
283 KOG0586 Serine/threonine prote 100.0 1.4E-37 3E-42 292.9 11.4 232 34-319 54-305 (596)
284 cd07833 STKc_CDKL Catalytic do 100.0 1.6E-36 3.4E-41 278.5 18.2 260 36-319 1-284 (288)
285 cd06609 STKc_MST3_like Catalyt 100.0 1.2E-36 2.7E-41 277.4 17.3 231 36-319 1-250 (274)
286 smart00219 TyrKc Tyrosine kina 100.0 2.4E-36 5.1E-41 272.5 18.2 234 39-321 2-258 (258)
287 KOG3653 Transforming growth fa 100.0 8.4E-37 1.8E-41 278.9 14.9 260 37-329 211-508 (534)
288 cd06652 STKc_MEKK2 Catalytic d 100.0 2.6E-36 5.6E-41 274.0 18.2 236 36-319 2-260 (265)
289 cd06658 STKc_PAK5 Catalytic do 100.0 5.2E-37 1.1E-41 282.8 13.7 234 35-319 21-271 (292)
290 cd07860 STKc_CDK2_3 Catalytic 100.0 2E-36 4.4E-41 277.4 17.6 258 37-319 1-280 (284)
291 KOG0986 G protein-coupled rece 100.0 5.5E-37 1.2E-41 278.6 13.4 244 23-314 171-435 (591)
292 cd07850 STKc_JNK Catalytic dom 100.0 3.2E-36 7E-41 284.9 19.3 185 34-237 14-218 (353)
293 cd07832 STKc_CCRK Catalytic do 100.0 3.5E-36 7.5E-41 276.0 18.9 258 37-319 1-281 (286)
294 cd06630 STKc_MEKK1 Catalytic d 100.0 2.3E-36 5E-41 274.5 17.4 237 37-319 1-263 (268)
295 cd06610 STKc_OSR1_SPAK Catalyt 100.0 2.7E-36 5.8E-41 273.7 17.6 242 36-319 1-263 (267)
296 cd05578 STKc_Yank1 Catalytic d 100.0 1.7E-36 3.6E-41 274.1 15.6 231 37-318 1-253 (258)
297 cd06623 PKc_MAPKK_plant_like C 100.0 3.9E-36 8.4E-41 272.2 17.9 235 36-319 1-255 (264)
298 cd06607 STKc_TAO Catalytic dom 100.0 7E-36 1.5E-40 277.2 19.6 234 32-320 11-267 (307)
299 cd07852 STKc_MAPK15 Catalytic 100.0 3.4E-36 7.3E-41 283.0 17.6 267 34-320 5-295 (337)
300 cd06632 STKc_MEKK1_plant Catal 100.0 3.7E-36 8E-41 271.4 16.9 231 37-319 1-254 (258)
301 cd05574 STKc_phototropin_like 100.0 1.9E-36 4.1E-41 282.0 15.4 237 36-319 1-288 (316)
302 cd07843 STKc_CDC2L1 Catalytic 100.0 3.5E-36 7.5E-41 277.2 17.0 264 36-319 5-289 (293)
303 KOG0604 MAP kinase-activated p 100.0 1.2E-36 2.7E-41 263.2 12.7 246 34-319 59-321 (400)
304 cd06617 PKc_MKK3_6 Catalytic d 100.0 3.3E-36 7.1E-41 275.8 16.0 236 36-319 1-260 (283)
305 cd06659 STKc_PAK6 Catalytic do 100.0 2.5E-36 5.4E-41 278.9 14.9 234 36-320 21-271 (297)
306 cd07841 STKc_CDK7 Catalytic do 100.0 1.1E-35 2.4E-40 274.5 19.0 256 37-319 1-281 (298)
307 cd07856 STKc_Sty1_Hog1 Catalyt 100.0 8.8E-36 1.9E-40 279.0 18.3 262 32-319 6-287 (328)
308 cd06647 STKc_PAK_I Catalytic d 100.0 4E-36 8.7E-41 277.0 15.7 236 34-320 17-269 (293)
309 KOG4250 TANK binding protein k 100.0 2.9E-36 6.3E-41 287.7 14.9 272 36-326 13-312 (732)
310 cd06641 STKc_MST3 Catalytic do 100.0 1.1E-35 2.4E-40 271.8 18.2 232 36-320 4-253 (277)
311 cd08225 STKc_Nek5 Catalytic do 100.0 5.2E-36 1.1E-40 270.3 15.7 233 37-319 1-253 (257)
312 cd07831 STKc_MOK Catalytic dom 100.0 1.8E-35 4E-40 270.6 19.2 258 38-319 1-278 (282)
313 cd05633 STKc_GRK3 Catalytic do 100.0 6.5E-36 1.4E-40 273.6 16.2 225 43-319 1-254 (279)
314 cd07836 STKc_Pho85 Catalytic d 100.0 2.1E-35 4.5E-40 270.6 19.5 261 37-319 1-280 (284)
315 KOG0200 Fibroblast/platelet-de 100.0 5.4E-36 1.2E-40 299.8 16.5 251 36-326 296-581 (609)
316 KOG0666 Cyclin C-dependent kin 100.0 5.1E-36 1.1E-40 260.7 14.0 193 32-237 20-241 (438)
317 cd06614 STKc_PAK Catalytic dom 100.0 1.1E-35 2.5E-40 272.8 17.2 239 32-319 15-269 (286)
318 cd07842 STKc_CDK8_like Catalyt 100.0 2.3E-35 4.9E-40 274.5 19.3 192 37-240 1-220 (316)
319 KOG1025 Epidermal growth facto 100.0 8.9E-37 1.9E-41 294.0 10.0 242 38-329 698-962 (1177)
320 cd06648 STKc_PAK_II Catalytic 100.0 1.8E-35 3.8E-40 271.6 18.0 233 36-319 19-268 (285)
321 cd06626 STKc_MEKK4 Catalytic d 100.0 2.1E-35 4.6E-40 267.5 18.0 236 37-319 1-260 (264)
322 cd07865 STKc_CDK9 Catalytic do 100.0 1.9E-35 4.2E-40 274.2 18.1 192 33-237 9-225 (310)
323 cd07845 STKc_CDK10 Catalytic d 100.0 2E-35 4.3E-40 274.3 18.0 262 35-319 6-289 (309)
324 cd06917 STKc_NAK1_like Catalyt 100.0 1.4E-35 3E-40 270.8 16.4 230 37-319 2-254 (277)
325 cd07834 STKc_MAPK Catalytic do 100.0 1.8E-35 3.8E-40 277.2 17.4 274 37-326 1-297 (330)
326 cd07837 STKc_CdkB_plant Cataly 100.0 3.2E-35 7E-40 270.9 18.8 266 36-319 1-290 (295)
327 cd07857 STKc_MPK1 Catalytic do 100.0 2.2E-35 4.8E-40 276.9 17.9 266 37-319 1-291 (332)
328 PHA03390 pk1 serine/threonine- 100.0 1.8E-35 3.9E-40 269.0 16.7 233 34-319 12-261 (267)
329 cd06635 STKc_TAO1 Catalytic do 100.0 1.4E-35 3.1E-40 276.4 16.4 237 34-325 23-282 (317)
330 cd05572 STKc_cGK_PKG Catalytic 100.0 2.3E-35 5.1E-40 267.2 17.4 226 44-319 1-251 (262)
331 cd07840 STKc_CDK9_like Catalyt 100.0 4.3E-35 9.2E-40 268.6 18.2 262 38-319 1-283 (287)
332 cd08222 STKc_Nek11 Catalytic d 100.0 3.3E-35 7.2E-40 265.9 17.1 234 37-319 1-256 (260)
333 cd05583 STKc_MSK_N N-terminal 100.0 2.5E-35 5.4E-40 270.9 16.3 239 37-323 1-266 (288)
334 cd05577 STKc_GRK Catalytic dom 100.0 2.4E-35 5.2E-40 269.5 16.1 225 44-316 1-245 (277)
335 cd06616 PKc_MKK4 Catalytic dom 100.0 9E-36 2E-40 273.7 13.1 241 36-319 4-266 (288)
336 cd07835 STKc_CDK1_like Catalyt 100.0 3.9E-35 8.4E-40 268.7 17.1 257 38-319 1-279 (283)
337 cd08530 STKc_CNK2-like Catalyt 100.0 4.4E-35 9.6E-40 264.0 17.1 233 37-319 1-252 (256)
338 cd05118 STKc_CMGC Catalytic do 100.0 7.5E-35 1.6E-39 266.6 18.9 257 38-319 1-279 (283)
339 cd07879 STKc_p38delta_MAPK13 C 100.0 6.1E-35 1.3E-39 275.0 18.7 267 34-325 13-304 (342)
340 KOG1035 eIF-2alpha kinase GCN2 100.0 4.3E-36 9.4E-41 300.3 11.1 241 35-319 478-870 (1351)
341 cd06653 STKc_MEKK3_like_1 Cata 100.0 6.4E-35 1.4E-39 264.7 17.8 236 36-319 2-260 (264)
342 cd06606 STKc_MAPKKK Catalytic 100.0 6.2E-35 1.3E-39 262.9 17.5 237 37-319 1-256 (260)
343 KOG0690 Serine/threonine prote 100.0 4.3E-36 9.3E-41 262.5 9.6 182 36-237 168-369 (516)
344 cd08215 STKc_Nek Catalytic dom 100.0 6.9E-35 1.5E-39 262.6 17.6 235 37-319 1-254 (258)
345 cd07880 STKc_p38gamma_MAPK12 C 100.0 6E-35 1.3E-39 275.1 17.7 264 32-319 11-297 (343)
346 cd05613 STKc_MSK1_N N-terminal 100.0 9E-35 1.9E-39 267.4 18.0 235 37-319 1-267 (290)
347 cd05579 STKc_MAST_like Catalyt 100.0 4E-35 8.6E-40 265.4 15.5 227 44-321 1-255 (265)
348 cd08216 PK_STRAD Pseudokinase 100.0 1.1E-34 2.4E-39 269.9 18.7 240 59-319 42-294 (314)
349 cd06657 STKc_PAK4 Catalytic do 100.0 4.6E-35 1E-39 269.7 15.3 229 40-319 24-269 (292)
350 cd07864 STKc_CDK12 Catalytic d 100.0 9.6E-35 2.1E-39 268.7 17.2 269 34-319 5-298 (302)
351 cd08226 PK_STRAD_beta Pseudoki 100.0 9.3E-35 2E-39 272.2 17.3 265 42-326 4-316 (328)
352 cd07830 STKc_MAK_like Catalyti 100.0 2E-34 4.4E-39 263.9 19.1 258 38-319 1-279 (283)
353 cd07851 STKc_p38 Catalytic dom 100.0 5.6E-35 1.2E-39 275.3 15.8 265 31-319 10-297 (343)
354 cd05122 PKc_STE Catalytic doma 100.0 1.3E-34 2.8E-39 259.7 17.3 233 37-319 1-250 (253)
355 cd05606 STKc_beta_ARK Catalyti 100.0 9E-35 2E-39 265.9 16.5 225 43-319 1-254 (278)
356 cd05611 STKc_Rim15_like Cataly 100.0 4.5E-35 9.8E-40 265.0 14.3 227 42-321 2-249 (260)
357 cd05581 STKc_PDK1 Catalytic do 100.0 6.1E-35 1.3E-39 266.6 15.3 233 36-319 1-276 (280)
358 cd06634 STKc_TAO2 Catalytic do 100.0 5.3E-35 1.1E-39 271.4 14.8 233 34-321 13-268 (308)
359 cd07838 STKc_CDK4_6_like Catal 100.0 4.4E-34 9.6E-39 262.0 20.8 261 38-319 1-283 (287)
360 PLN00009 cyclin-dependent kina 100.0 1.4E-34 3E-39 266.7 17.3 258 36-319 2-283 (294)
361 cd07866 STKc_BUR1 Catalytic do 100.0 1.4E-34 3E-39 268.5 17.5 268 35-319 7-307 (311)
362 cd06627 STKc_Cdc7_like Catalyt 100.0 1.8E-34 4E-39 259.5 17.6 231 37-319 1-250 (254)
363 cd07877 STKc_p38alpha_MAPK14 C 100.0 1.4E-34 3.1E-39 272.7 17.5 270 29-320 10-300 (345)
364 KOG0612 Rho-associated, coiled 100.0 4.2E-35 9.2E-40 291.2 14.0 184 35-237 74-282 (1317)
365 cd06633 STKc_TAO3 Catalytic do 100.0 3E-34 6.5E-39 267.0 18.5 229 36-319 21-272 (313)
366 cd07854 STKc_MAPK4_6 Catalytic 100.0 1.5E-34 3.2E-39 272.4 16.6 266 34-319 3-299 (342)
367 cd07829 STKc_CDK_like Catalyti 100.0 7.3E-34 1.6E-38 259.9 18.1 256 38-319 1-278 (282)
368 PTZ00024 cyclin-dependent prot 100.0 3.7E-34 8E-39 268.9 16.6 259 34-319 6-312 (335)
369 KOG1151 Tousled-like protein k 100.0 2.9E-35 6.3E-40 266.7 8.2 244 34-319 461-740 (775)
370 cd06618 PKc_MKK7 Catalytic dom 100.0 3.1E-34 6.7E-39 264.7 15.1 237 35-320 14-273 (296)
371 KOG0662 Cyclin-dependent kinas 100.0 1.9E-34 4.2E-39 232.7 11.8 259 36-319 2-282 (292)
372 KOG0671 LAMMER dual specificit 100.0 1.7E-34 3.7E-39 257.7 12.1 261 35-319 88-405 (415)
373 cd05123 STKc_AGC Catalytic dom 100.0 8.3E-34 1.8E-38 254.9 16.7 220 44-316 1-240 (250)
374 KOG0587 Traf2- and Nck-interac 100.0 7.5E-34 1.6E-38 276.2 16.3 244 33-319 16-281 (953)
375 KOG0669 Cyclin T-dependent kin 100.0 7.4E-35 1.6E-39 246.7 7.7 268 34-320 15-315 (376)
376 KOG1006 Mitogen-activated prot 100.0 4.7E-36 1E-40 255.7 -0.3 243 36-320 64-327 (361)
377 KOG0603 Ribosomal protein S6 k 100.0 4.7E-34 1E-38 270.4 13.0 228 34-319 320-562 (612)
378 KOG0696 Serine/threonine prote 100.0 7E-34 1.5E-38 255.7 12.1 183 35-237 348-551 (683)
379 KOG0607 MAP kinase-interacting 100.0 9.4E-34 2E-38 247.3 12.2 247 41-319 83-360 (463)
380 cd05610 STKc_MASTL Catalytic d 100.0 3E-33 6.6E-38 283.8 17.6 129 36-182 4-152 (669)
381 KOG0983 Mitogen-activated prot 100.0 1.6E-34 3.5E-39 247.2 6.8 232 39-319 95-348 (391)
382 KOG0614 cGMP-dependent protein 100.0 3.2E-34 6.9E-39 263.7 8.7 226 36-313 420-665 (732)
383 KOG4236 Serine/threonine prote 100.0 2E-34 4.4E-39 266.0 5.1 178 40-237 568-767 (888)
384 cd05576 STKc_RPK118_like Catal 100.0 3.9E-33 8.4E-38 249.1 12.3 210 47-316 4-225 (237)
385 KOG1024 Receptor-like protein 100.0 1.5E-32 3.3E-37 245.6 13.3 252 36-328 284-559 (563)
386 KOG1290 Serine/threonine prote 100.0 3.4E-32 7.3E-37 249.5 15.5 138 12-167 60-221 (590)
387 PLN03225 Serine/threonine-prot 100.0 4.5E-32 9.8E-37 269.0 17.1 267 34-319 130-449 (566)
388 KOG0608 Warts/lats-like serine 100.0 3.4E-32 7.3E-37 256.0 13.3 190 37-244 630-879 (1034)
389 KOG0695 Serine/threonine prote 100.0 5.7E-32 1.2E-36 237.7 12.2 184 36-239 250-454 (593)
390 KOG0668 Casein kinase II, alph 100.0 7.1E-32 1.5E-36 225.6 10.3 261 34-319 36-321 (338)
391 KOG0984 Mitogen-activated prot 100.0 2E-32 4.4E-37 225.5 6.8 187 35-238 45-254 (282)
392 KOG1027 Serine/threonine prote 100.0 1.9E-32 4E-37 265.4 7.6 235 38-319 511-766 (903)
393 smart00220 S_TKc Serine/Threon 100.0 1.6E-30 3.4E-35 231.6 16.2 210 60-319 31-240 (244)
394 KOG1345 Serine/threonine kinas 100.0 2.1E-31 4.6E-36 227.9 9.4 262 12-323 2-287 (378)
395 KOG0664 Nemo-like MAPK-related 100.0 2.5E-32 5.4E-37 233.9 3.8 185 38-237 55-259 (449)
396 PLN03224 probable serine/threo 100.0 2.4E-30 5.3E-35 251.0 17.0 262 34-319 143-499 (507)
397 KOG1152 Signal transduction se 100.0 3.4E-31 7.4E-36 247.1 8.3 181 36-238 561-771 (772)
398 KOG0665 Jun-N-terminal kinase 100.0 2.6E-30 5.7E-35 226.0 8.8 240 57-319 56-309 (369)
399 KOG1167 Serine/threonine prote 100.0 1.2E-28 2.7E-33 223.0 11.3 265 34-319 34-380 (418)
400 PLN00181 protein SPA1-RELATED; 100.0 8.1E-29 1.7E-33 257.1 10.9 203 70-319 26-264 (793)
401 smart00750 KIND kinase non-cat 100.0 6.6E-28 1.4E-32 205.2 13.7 169 106-326 1-171 (176)
402 cd00180 PKc Catalytic domain o 100.0 3E-27 6.6E-32 205.3 16.9 194 44-320 1-214 (215)
403 KOG0576 Mitogen-activated prot 99.9 5.1E-29 1.1E-33 236.1 4.8 239 33-319 12-270 (829)
404 KOG0670 U4/U6-associated splic 99.9 4E-28 8.7E-33 224.2 9.7 184 34-237 430-636 (752)
405 smart00221 STYKc Protein kinas 99.9 1.6E-26 3.5E-31 203.7 15.1 181 38-237 1-201 (225)
406 KOG1164 Casein kinase (serine/ 99.9 8.2E-24 1.8E-28 197.2 17.8 248 37-328 19-301 (322)
407 KOG0590 Checkpoint kinase and 99.9 3.2E-25 6.9E-30 219.8 6.9 238 39-319 321-584 (601)
408 KOG1165 Casein kinase (serine/ 99.9 1.8E-23 3.9E-28 184.2 16.5 266 33-341 25-316 (449)
409 KOG1163 Casein kinase (serine/ 99.9 4.8E-24 1E-28 180.1 11.8 270 28-342 7-302 (341)
410 PRK09188 serine/threonine prot 99.9 1.5E-23 3.2E-28 195.6 13.4 152 32-211 14-195 (365)
411 KOG1023 Natriuretic peptide re 99.9 3.1E-23 6.6E-28 197.0 8.8 221 70-328 1-228 (484)
412 COG0515 SPS1 Serine/threonine 99.9 1.6E-21 3.6E-26 180.6 18.7 247 38-320 2-275 (384)
413 KOG0195 Integrin-linked kinase 99.9 7.1E-23 1.5E-27 175.9 6.0 213 59-325 230-447 (448)
414 PRK10359 lipopolysaccharide co 99.8 2.7E-21 5.9E-26 168.2 7.7 162 33-230 28-216 (232)
415 KOG0603 Ribosomal protein S6 k 99.8 2.2E-21 4.8E-26 184.7 4.5 169 43-237 1-192 (612)
416 KOG4158 BRPK/PTEN-induced prot 99.8 6.4E-20 1.4E-24 165.5 12.1 202 74-321 274-511 (598)
417 PRK12274 serine/threonine prot 99.8 8.2E-20 1.8E-24 155.7 11.9 174 39-241 5-212 (218)
418 KOG1240 Protein kinase contain 99.8 1.2E-20 2.5E-25 188.6 6.5 255 11-320 1-291 (1431)
419 PRK10345 hypothetical protein; 99.8 6.7E-19 1.5E-23 152.7 11.7 125 39-181 5-156 (210)
420 cd05147 RIO1_euk RIO kinase fa 99.8 3.2E-19 6.9E-24 153.1 8.7 99 65-184 68-167 (190)
421 cd05145 RIO1_like RIO kinase f 99.8 2.2E-18 4.8E-23 148.3 10.8 102 64-186 67-169 (190)
422 KOG1033 eIF-2alpha kinase PEK/ 99.8 1.1E-19 2.3E-24 170.1 1.3 126 93-231 328-457 (516)
423 KOG1166 Mitotic checkpoint ser 99.8 2.4E-18 5.2E-23 174.7 9.9 183 35-235 697-902 (974)
424 PF14531 Kinase-like: Kinase-l 99.7 8.2E-19 1.8E-23 157.2 4.4 227 36-311 12-288 (288)
425 KOG0606 Microtubule-associated 99.7 2E-18 4.4E-23 172.5 4.6 164 34-237 81-259 (1205)
426 PRK09605 bifunctional UGMP fam 99.7 7.7E-17 1.7E-21 160.3 11.6 122 35-183 332-476 (535)
427 PRK14879 serine/threonine prot 99.7 2.7E-16 5.8E-21 137.7 10.0 119 42-183 2-143 (211)
428 smart00090 RIO RIO-like kinase 99.7 2.9E-16 6.2E-21 139.4 10.1 125 37-184 29-198 (237)
429 KOG0590 Checkpoint kinase and 99.6 1.7E-17 3.7E-22 164.9 -0.2 242 35-319 19-285 (601)
430 TIGR03724 arch_bud32 Kae1-asso 99.6 5.1E-16 1.1E-20 134.6 8.9 115 43-183 1-138 (199)
431 cd05144 RIO2_C RIO kinase fami 99.6 2E-15 4.4E-20 130.8 10.4 121 37-185 16-176 (198)
432 KOG1266 Protein kinase [Signal 99.5 5.5E-15 1.2E-19 130.9 6.1 160 68-234 119-280 (458)
433 PRK01723 3-deoxy-D-manno-octul 99.5 8.9E-14 1.9E-18 123.7 10.5 104 61-183 85-191 (239)
434 cd05120 APH_ChoK_like Aminogly 99.5 3.1E-13 6.6E-18 111.1 10.2 122 40-183 2-138 (155)
435 cd05119 RIO RIO kinase family, 99.5 2.3E-13 5E-18 116.7 9.0 75 96-185 90-165 (187)
436 KOG0601 Cyclin-dependent kinas 99.3 1.7E-12 3.7E-17 124.2 7.7 180 38-236 116-327 (524)
437 KOG1243 Protein kinase [Genera 99.3 3.2E-11 6.9E-16 116.8 13.2 167 42-234 32-201 (690)
438 KOG0601 Cyclin-dependent kinas 99.2 2.1E-11 4.5E-16 116.8 4.3 179 35-235 264-465 (524)
439 KOG0606 Microtubule-associated 99.1 3.2E-11 6.8E-16 121.7 3.8 186 35-238 803-1037(1205)
440 TIGR01982 UbiB 2-polyprenylphe 99.1 2.6E-10 5.6E-15 110.3 10.0 104 63-185 200-308 (437)
441 cd05151 ChoK Choline Kinase (C 99.1 3.3E-10 7.2E-15 95.4 6.9 96 61-182 37-135 (170)
442 cd05146 RIO3_euk RIO kinase fa 99.0 9.7E-10 2.1E-14 93.9 9.0 99 64-185 74-175 (197)
443 COG3642 Mn2+-dependent serine/ 99.0 1.1E-09 2.5E-14 90.6 9.0 96 59-182 42-139 (204)
444 KOG3087 Serine/threonine prote 99.0 5.5E-09 1.2E-13 86.2 9.7 125 40-182 11-164 (229)
445 PRK04750 ubiB putative ubiquin 98.9 1.2E-09 2.7E-14 107.0 7.0 80 93-186 233-316 (537)
446 KOG2137 Protein kinase [Signal 98.8 1.1E-09 2.4E-14 106.7 2.1 152 136-318 104-263 (700)
447 COG4248 Uncharacterized protei 98.8 2.2E-07 4.7E-12 86.1 16.1 265 40-329 15-305 (637)
448 PF01163 RIO1: RIO1 family; I 98.8 3E-08 6.5E-13 84.4 9.0 102 59-185 51-157 (188)
449 PRK15123 lipopolysaccharide co 98.8 4.2E-08 9.1E-13 88.4 9.5 110 62-182 74-193 (268)
450 cd05154 ACAD10_11_like Acyl-Co 98.8 6.7E-08 1.5E-12 84.8 10.7 110 60-182 39-205 (223)
451 KOG3741 Poly(A) ribonuclease s 98.8 3E-07 6.5E-12 87.2 15.2 148 65-235 322-475 (655)
452 PF06293 Kdo: Lipopolysacchari 98.7 8.5E-08 1.8E-12 83.5 9.5 111 59-183 54-170 (206)
453 PRK09902 hypothetical protein; 98.6 6.8E-07 1.5E-11 76.7 11.0 112 59-182 62-178 (216)
454 COG0478 RIO-like serine/threon 98.4 8.1E-07 1.7E-11 78.3 8.4 118 38-182 93-250 (304)
455 KOG0576 Mitogen-activated prot 98.4 1.3E-07 2.9E-12 91.6 1.7 170 41-235 247-429 (829)
456 PF06176 WaaY: Lipopolysacchar 98.3 4.9E-06 1.1E-10 71.8 10.3 127 34-182 29-182 (229)
457 PF12260 PIP49_C: Protein-kina 98.3 4E-05 8.7E-10 65.4 15.0 105 64-184 7-112 (188)
458 TIGR02172 Fb_sc_TIGR02172 Fibr 98.0 5.1E-05 1.1E-09 66.9 11.0 61 42-107 7-80 (226)
459 KOG1035 eIF-2alpha kinase GCN2 98.0 1.6E-05 3.5E-10 82.4 7.6 200 62-321 228-435 (1351)
460 KOG1235 Predicted unusual prot 97.9 3.6E-05 7.8E-10 75.3 7.5 80 93-186 274-357 (538)
461 PF10707 YrbL-PhoP_reg: PhoP r 97.8 0.00035 7.6E-09 60.0 11.5 99 59-180 54-169 (199)
462 COG0661 AarF Predicted unusual 97.7 9E-05 1.9E-09 72.7 8.1 106 63-186 208-317 (517)
463 COG1718 RIO1 Serine/threonine 97.6 0.00048 1E-08 60.4 9.8 99 64-185 116-217 (268)
464 cd05155 APH_ChoK_like_1 Unchar 97.6 0.00064 1.4E-08 60.4 10.6 31 152-182 163-193 (235)
465 cd05150 APH Aminoglycoside 3'- 97.6 0.00049 1.1E-08 61.4 9.7 31 152-182 162-192 (244)
466 PF01636 APH: Phosphotransfera 97.6 0.00033 7.2E-09 61.7 8.2 67 42-110 3-84 (239)
467 PLN02876 acyl-CoA dehydrogenas 97.5 0.00088 1.9E-08 70.5 12.3 46 61-108 83-131 (822)
468 COG2112 Predicted Ser/Thr prot 97.4 0.00055 1.2E-08 56.9 7.3 122 32-182 18-154 (201)
469 KOG1826 Ras GTPase activating 97.3 2.9E-05 6.2E-10 82.6 -2.2 165 61-236 1274-1440(2724)
470 PRK10593 hypothetical protein; 96.9 0.011 2.4E-07 54.5 11.5 67 40-108 18-100 (297)
471 KOG1093 Predicted protein kina 96.8 0.0078 1.7E-07 58.2 9.5 48 61-113 27-74 (725)
472 KOG2268 Serine/threonine prote 96.7 0.0053 1.2E-07 56.0 6.7 117 38-182 94-250 (465)
473 PRK09550 mtnK methylthioribose 96.5 0.02 4.2E-07 54.8 10.2 30 152-182 222-251 (401)
474 PF13095 FTA2: Kinetochore Sim 96.4 0.032 7E-07 47.8 9.9 116 35-181 36-206 (207)
475 TIGR02721 ycfN_thiK thiamine k 96.3 0.0091 2E-07 53.7 6.3 29 153-182 146-174 (256)
476 PF07387 Seadorna_VP7: Seadorn 96.1 0.024 5.3E-07 49.0 7.1 124 59-232 101-224 (308)
477 COG3173 Predicted aminoglycosi 95.7 0.057 1.2E-06 49.9 8.4 32 152-183 197-228 (321)
478 COG5072 ALK1 Serine/threonine 95.4 0.069 1.5E-06 49.8 7.7 74 92-183 297-370 (488)
479 PLN02756 S-methyl-5-thioribose 94.6 0.42 9.1E-06 45.8 10.9 30 152-182 229-258 (418)
480 PRK05231 homoserine kinase; Pr 93.9 0.1 2.2E-06 48.5 5.4 31 152-182 186-216 (319)
481 PF00560 LRR_1: Leucine Rich R 93.9 0.035 7.6E-07 29.1 1.3 21 5-26 2-22 (22)
482 PHA03111 Ser/Thr kinase; Provi 93.8 0.077 1.7E-06 48.7 4.1 38 131-168 279-317 (444)
483 COG3001 Uncharacterized protei 93.8 0.38 8.2E-06 42.1 8.0 48 57-109 49-99 (286)
484 cd05156 ChoK_euk Choline Kinas 93.7 0.14 3E-06 47.2 5.8 31 152-182 178-212 (302)
485 PF05445 Pox_ser-thr_kin: Poxv 93.2 0.1 2.2E-06 48.3 3.9 55 131-185 275-348 (434)
486 cd05157 ETNK_euk Ethanolamine 93.1 0.14 2.9E-06 45.2 4.6 31 152-182 169-200 (235)
487 TIGR00938 thrB_alt homoserine 92.9 0.2 4.3E-06 46.4 5.5 31 152-182 186-216 (307)
488 cd05153 HomoserineK_II Homoser 92.6 0.079 1.7E-06 48.6 2.4 31 152-182 174-204 (296)
489 COG2334 Putative homoserine ki 92.6 0.25 5.3E-06 46.1 5.6 144 35-182 39-227 (331)
490 PF12799 LRR_4: Leucine Rich r 92.3 0.071 1.5E-06 33.6 1.2 33 5-38 3-35 (44)
491 KOG2270 Serine/threonine prote 92.3 0.48 1E-05 44.5 6.9 102 63-184 213-314 (520)
492 PRK10271 thiK thiamine kinase; 92.2 0.1 2.2E-06 44.3 2.4 29 153-182 77-105 (188)
493 TIGR02906 spore_CotS spore coa 91.7 0.34 7.5E-06 44.7 5.6 30 152-182 186-215 (313)
494 COG0510 ycfN Thiamine kinase a 90.8 0.44 9.6E-06 43.1 5.1 46 136-182 137-182 (269)
495 PF01633 Choline_kinase: Choli 90.6 0.17 3.6E-06 44.0 2.1 30 153-182 143-173 (211)
496 PTZ00384 choline kinase; Provi 90.6 1.1 2.3E-05 42.9 7.8 28 153-181 227-254 (383)
497 PF03881 Fructosamin_kin: Fruc 90.3 0.73 1.6E-05 42.2 6.1 44 58-106 51-97 (288)
498 cd05152 MPH2' Macrolide 2'-Pho 89.8 0.23 4.9E-06 45.3 2.4 30 153-182 185-215 (276)
499 smart00587 CHK ZnF_C4 abd HLH 89.8 0.25 5.3E-06 42.5 2.5 31 152-182 119-154 (196)
500 TIGR02904 spore_ysxE spore coa 89.5 0.5 1.1E-05 43.7 4.6 31 152-182 195-225 (309)
No 1
>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=3.9e-49 Score=369.32 Aligned_cols=274 Identities=35% Similarity=0.592 Sum_probs=225.2
Q ss_pred ccccccchhhhhccccccccceecCCCceEEEecc---------------ccc-HHHHHHHHHHHHccCCCcccceeeee
Q 041757 22 EVGKLKNLEILDVSRNMLEENLISAGTFGFSHLRR---------------QGA-FKSFIAECKALRNIRHRNLIKVLTAC 85 (381)
Q Consensus 22 ~~~~~~~l~~~~~~~~~~~~~~lG~G~fg~V~~~~---------------~~~-~~~~~~E~~~l~~l~h~nIv~~~~~~ 85 (381)
.+..+..-++..+|++|...++||+|+||.||++. ... .++|.+|+.++.+++|||+|+++|+|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 45567778889999999999999999999998743 122 56799999999999999999999999
Q ss_pred ccccccCCc-eEEEEEEcccCCCHHHhhccccCCcccccCCC-cccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCC
Q 041757 86 LGVDYQGND-FKALVYEFMHNRSLKEWLYPISKEDETYKRPR-NLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPS 163 (381)
Q Consensus 86 ~~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~ 163 (381)
.+ .+ ..+||+||+++|+|.++|+. ... .++|..+++|+.++|+||+|||..+...||||||||+
T Consensus 141 ~e-----~~~~~~LVYEym~nGsL~d~L~~---------~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKss 206 (361)
T KOG1187|consen 141 LE-----GGEHRLLVYEYMPNGSLEDHLHG---------KKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSS 206 (361)
T ss_pred ec-----CCceEEEEEEccCCCCHHHHhCC---------CCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHH
Confidence 74 33 68999999999999999974 222 8899999999999999999999887778999999999
Q ss_pred CeeeCCCCCeEEeecccceecCC-CCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccc-c
Q 041757 164 NVLLDDDMTARVGDFGLARFLPP-TRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMF-E 241 (381)
Q Consensus 164 Nill~~~~~~kl~Dfg~~~~~~~-~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~-~ 241 (381)
|||+|.++.+||+|||+|+.... ....... ..||.+|+|||+......+.|+|||||||++.|++||+.|.+... .
T Consensus 207 NILLD~~~~aKlsDFGLa~~~~~~~~~~~~~--~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~ 284 (361)
T KOG1187|consen 207 NILLDEDFNAKLSDFGLAKLGPEGDTSVSTT--VMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPR 284 (361)
T ss_pred HeeECCCCCEEccCccCcccCCccccceeee--cCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCc
Confidence 99999999999999999976654 2221111 059999999999998899999999999999999999999876443 3
Q ss_pred CCCcHHHHHHHHhhc-hHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041757 242 GDMNLHKFAKMALSN-HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE 320 (381)
Q Consensus 242 ~~~~~~~~~~~~~~~-~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~ 320 (381)
+...+..|.+..+.. .+.+++|+.+...... .......+..++.+|++.+|.+||+|.+|+++
T Consensus 285 ~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~----------------~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~ 348 (361)
T KOG1187|consen 285 GELSLVEWAKPLLEEGKLREIVDPRLKEGEYP----------------DEKEVKKLAELALRCLRPDPKERPTMSQVVKE 348 (361)
T ss_pred ccccHHHHHHHHHHCcchhheeCCCccCCCCC----------------hHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHH
Confidence 344567776655555 5788888776521110 11567789999999999999999999999999
Q ss_pred HHHhhhh
Q 041757 321 LQSIKNT 327 (381)
Q Consensus 321 L~~i~~~ 327 (381)
|+.+...
T Consensus 349 L~~~~~~ 355 (361)
T KOG1187|consen 349 LEGILSL 355 (361)
T ss_pred HHhhccc
Confidence 9665443
No 2
>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]
Probab=100.00 E-value=3.9e-49 Score=366.95 Aligned_cols=249 Identities=31% Similarity=0.437 Sum_probs=198.8
Q ss_pred ccccccceecCCCceEEEecccc------------------cHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757 36 RNMLEENLISAGTFGFSHLRRQG------------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA 97 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~~------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~ 97 (381)
......+.||.|+||+||.+.-. ..+.|.+|+.+|.+++|||||+++|+|.. .....+
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~----~~~~~~ 116 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTS----PPGSLC 116 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC----CCCceE
Confidence 34455667999999999764311 14599999999999999999999999864 122689
Q ss_pred EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCC-ceeeccCCCCeeeCCCC-CeEE
Q 041757 98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPV-TAHCVLKPSNVLLDDDM-TARV 175 (381)
Q Consensus 98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~-ivHrDlkp~Nill~~~~-~~kl 175 (381)
|||||+++|+|.++++. .....+++..++.++.||++||.||| +.+ ||||||||+|||++.++ ++||
T Consensus 117 iVtEy~~~GsL~~~l~~--------~~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI 185 (362)
T KOG0192|consen 117 IVTEYMPGGSLSVLLHK--------KRKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKI 185 (362)
T ss_pred EEEEeCCCCcHHHHHhh--------cccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEE
Confidence 99999999999999963 13678999999999999999999999 456 99999999999999997 9999
Q ss_pred eecccceecCCCCCcccccCccCccceeCCCCcC--CCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH
Q 041757 176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGV--GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA 253 (381)
Q Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~ 253 (381)
+|||+++....... ......||+.|||||++. ...|+.|+||||||+++|||+||+.||..... ......
T Consensus 186 ~DFGlsr~~~~~~~--~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-----~~~~~~- 257 (362)
T KOG0192|consen 186 ADFGLSREKVISKT--SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-----VQVASA- 257 (362)
T ss_pred CCCccceeeccccc--cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-----HHHHHH-
Confidence 99999987765431 112256999999999999 56899999999999999999999999863322 111111
Q ss_pred hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhcCCCC
Q 041757 254 LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLLGPK 332 (381)
Q Consensus 254 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~~~~~~ 332 (381)
++.... ++.++..++..+..++.+||+.||..||++.+++..|+.+........
T Consensus 258 -------v~~~~~------------------Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~~~ 311 (362)
T KOG0192|consen 258 -------VVVGGL------------------RPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISSAG 311 (362)
T ss_pred -------HHhcCC------------------CCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcccC
Confidence 111000 111233588899999999999999999999999999999988776543
No 3
>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=4.1e-50 Score=343.99 Aligned_cols=245 Identities=23% Similarity=0.336 Sum_probs=198.5
Q ss_pred cccccccceecCCCceEEEecc-------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757 35 SRNMLEENLISAGTFGFSHLRR-------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF 95 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~-------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~ 95 (381)
-.+|.+.++||+|.||.||++. ....+...+|+.+|++|+|||||+++++.+ .++...
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f---~~~~ev 94 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSF---IEDNEV 94 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhh---hccchh
Confidence 3568999999999999998864 345678889999999999999999999643 244556
Q ss_pred EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCC--ceeeccCCCCeeeCCCCCe
Q 041757 96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPV--TAHCVLKPSNVLLDDDMTA 173 (381)
Q Consensus 96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~--ivHrDlkp~Nill~~~~~~ 173 (381)
++||||||..|||...++..+ +..+.+++..++.++.|++.||.++|... .+ |+||||||.||+++.+|.+
T Consensus 95 lnivmE~c~~GDLsqmIk~~K------~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvv 167 (375)
T KOG0591|consen 95 LNIVMELCDAGDLSQMIKHFK------KQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVV 167 (375)
T ss_pred hHHHHHhhcccCHHHHHHHHH------hccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCce
Confidence 899999999999999996554 55778999999999999999999999521 34 9999999999999999999
Q ss_pred EEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH
Q 041757 174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA 253 (381)
Q Consensus 174 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~ 253 (381)
||+|||+++.+........ +.+|||.||+||.+.+..|+.+|||||+||++|||+.-++||. ++ ++..+
T Consensus 168 KLGDfGL~r~l~s~~tfA~--S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~----g~-n~~~L---- 236 (375)
T KOG0591|consen 168 KLGDFGLGRFLSSKTTFAH--SLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFY----GD-NLLSL---- 236 (375)
T ss_pred eeccchhHhHhcchhHHHH--hhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcc----cc-cHHHH----
Confidence 9999999998876544333 3789999999999999999999999999999999999999975 22 33222
Q ss_pred hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHH-HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 041757 254 LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINII-RECVISMVRIGVACSMESPQDRMKMTNVVHELQS 323 (381)
Q Consensus 254 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~ 323 (381)
..+.-..+.. +.+ ...+.++..|+..|+..||+.||+...++..+.+
T Consensus 237 --------~~KI~qgd~~---------------~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 237 --------CKKIEQGDYP---------------PLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred --------HHHHHcCCCC---------------CCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 2222211111 012 4677889999999999999999997655555543
No 4
>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]
Probab=100.00 E-value=2.9e-49 Score=352.05 Aligned_cols=236 Identities=22% Similarity=0.315 Sum_probs=195.7
Q ss_pred ccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc-eE
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND-FK 96 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~-~~ 96 (381)
.+....+.||+|..|+|+++.+ ...+++.+|++++++.+||+||++||.|+. +. ..
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~-----~~~~i 153 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYS-----NGEEI 153 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe-----CCceE
Confidence 3566779999999999988653 346788999999999999999999999753 44 69
Q ss_pred EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757 97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG 176 (381)
Q Consensus 97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~ 176 (381)
.|+||||.+|+|++++ ...+++++.....++.++++||.|||+ ..+||||||||+|||++..|.+||+
T Consensus 154 sI~mEYMDgGSLd~~~----------k~~g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKic 221 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDIL----------KRVGRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKIC 221 (364)
T ss_pred EeehhhcCCCCHHHHH----------hhcCCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEec
Confidence 9999999999999999 445789999999999999999999995 2599999999999999999999999
Q ss_pred ecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhc
Q 041757 177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSN 256 (381)
Q Consensus 177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~ 256 (381)
|||.++.+..... .+++||..|||||.+.+..|+.++||||||++++|+.+|+.||.........
T Consensus 222 DFGVS~~lvnS~a----~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~----------- 286 (364)
T KOG0581|consen 222 DFGVSGILVNSIA----NTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLD----------- 286 (364)
T ss_pred cccccHHhhhhhc----ccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCC-----------
Confidence 9999998776622 2378999999999999999999999999999999999999997633111122
Q ss_pred hHHHHHhhhhccCchhhhhcccchhhhhHHHHHH-HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 257 HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIR-ECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 257 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
.-+++.......+.. .+. .+.+++..++..||++||.+|||+.|+++
T Consensus 287 -~~~Ll~~Iv~~ppP~---------------lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 287 -IFELLCAIVDEPPPR---------------LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred -HHHHHHHHhcCCCCC---------------CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 233344333322211 123 37788999999999999999999999986
No 5
>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=1.2e-48 Score=367.03 Aligned_cols=231 Identities=23% Similarity=0.346 Sum_probs=200.6
Q ss_pred ccccccceecCCCceEEEecc--------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757 36 RNMLEENLISAGTFGFSHLRR--------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF 95 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~--------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~ 95 (381)
..|..+++||+|||+.||.++ ....+...+|+++.++|+|||||+++++ |++.++
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~-----FEDs~n 92 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHF-----FEDSNN 92 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeE-----eecCCc
Confidence 569999999999999998765 3456788899999999999999999999 678999
Q ss_pred EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757 96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV 175 (381)
Q Consensus 96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl 175 (381)
+|||+|+|+.++|..++ ++.+.+++.+++.++.||+.||.||| +.+|+|||||..|++++++..+||
T Consensus 93 VYivLELC~~~sL~el~----------Krrk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKI 159 (592)
T KOG0575|consen 93 VYIVLELCHRGSLMELL----------KRRKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKI 159 (592)
T ss_pred eEEEEEecCCccHHHHH----------HhcCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEe
Confidence 99999999999999999 56788999999999999999999999 669999999999999999999999
Q ss_pred eecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhh
Q 041757 176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALS 255 (381)
Q Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 255 (381)
+|||+|..+..+...... .+|||.|.|||++....++..+||||+||++|.|+.|++||+ .
T Consensus 160 gDFGLAt~le~~~Erk~T--lCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFe-----------------t 220 (592)
T KOG0575|consen 160 GDFGLATQLEYDGERKKT--LCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFE-----------------T 220 (592)
T ss_pred cccceeeeecCcccccce--ecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcc-----------------c
Confidence 999999988765433332 689999999999999999999999999999999999999986 2
Q ss_pred chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
..+++..++....+... |.....+..+|+.++|+.||.+|||+++|+.
T Consensus 221 k~vkety~~Ik~~~Y~~----------------P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 221 KTVKETYNKIKLNEYSM----------------PSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred chHHHHHHHHHhcCccc----------------ccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 23444444443333321 3456677889999999999999999999995
No 6
>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]
Probab=100.00 E-value=4.3e-48 Score=359.60 Aligned_cols=241 Identities=26% Similarity=0.407 Sum_probs=197.0
Q ss_pred ccccceecCCCceEEEecc---------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEc
Q 041757 38 MLEENLISAGTFGFSHLRR---------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEF 102 (381)
Q Consensus 38 ~~~~~~lG~G~fg~V~~~~---------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~ 102 (381)
+...+.||+|-||.|++.+ ....+.|.+|+++|++|+|+|||+++++|.. ++.++|||||
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~-----~~piyIVtE~ 282 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTK-----QEPIYIVTEY 282 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEec-----CCceEEEEEe
Confidence 4456899999999997754 2345789999999999999999999999864 4579999999
Q ss_pred ccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccce
Q 041757 103 MHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR 182 (381)
Q Consensus 103 ~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~ 182 (381)
|+.|+|.++|.. .....+...+.+.++.|||+|++||. ++++|||||..+|||++++..+||+|||+|+
T Consensus 283 m~~GsLl~yLr~--------~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr 351 (468)
T KOG0197|consen 283 MPKGSLLDYLRT--------REGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLAR 351 (468)
T ss_pred cccCcHHHHhhh--------cCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEccccccc
Confidence 999999999963 24677889999999999999999999 7799999999999999999999999999999
Q ss_pred ecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchHHHH
Q 041757 183 FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHVKDI 261 (381)
Q Consensus 183 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (381)
...++... ......-++.|.|||.+....|+.|||||||||+||||+| |+.|+..+. + .++
T Consensus 352 ~~~d~~Y~-~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms----n-------------~ev 413 (468)
T KOG0197|consen 352 LIGDDEYT-ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS----N-------------EEV 413 (468)
T ss_pred ccCCCcee-ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC----H-------------HHH
Confidence 55544432 2222345789999999999999999999999999999998 888854221 1 111
Q ss_pred HhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 041757 262 VDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT 327 (381)
Q Consensus 262 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~ 327 (381)
+...- ...+.+.|..||..+.++|..||+.+|++|||+..+...|+.+...
T Consensus 414 ~~~le---------------~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 414 LELLE---------------RGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred HHHHh---------------ccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 11100 0112223568999999999999999999999999999999887653
No 7
>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=1.3e-47 Score=344.24 Aligned_cols=237 Identities=18% Similarity=0.250 Sum_probs=188.8
Q ss_pred ccccccccceecCCCceEEEeccc------------------------ccHHHHHHHHHHHHccCCCcccceeeeecccc
Q 041757 34 VSRNMLEENLISAGTFGFSHLRRQ------------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVD 89 (381)
Q Consensus 34 ~~~~~~~~~~lG~G~fg~V~~~~~------------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 89 (381)
..+.|.+.+.||+|+||.|.++.+ .......+|+++|++|+|||||+++++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~----- 244 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDF----- 244 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeee-----
Confidence 346688889999999999966431 112234689999999999999999999
Q ss_pred ccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCC
Q 041757 90 YQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD 169 (381)
Q Consensus 90 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~ 169 (381)
+...+..|+||||+.||+|.+++ ...+.+.+.....++.|++.|+.||| +.||+||||||+|||+..
T Consensus 245 f~~~ds~YmVlE~v~GGeLfd~v----------v~nk~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~ 311 (475)
T KOG0615|consen 245 FEVPDSSYMVLEYVEGGELFDKV----------VANKYLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSN 311 (475)
T ss_pred eecCCceEEEEEEecCccHHHHH----------HhccccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEecc
Confidence 55677889999999999999999 56778888888999999999999999 779999999999999976
Q ss_pred C---CCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCcc---CcccchhhhhHHHHHHHhCCCCCCccccCC
Q 041757 170 D---MTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEV---STIGDVYSYGILLLELMIREKPSDIMFEGD 243 (381)
Q Consensus 170 ~---~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~---~~~sDiwSlG~il~el~tg~~Pf~~~~~~~ 243 (381)
+ ..+||+|||+|+......... ..+||+.|.|||++.+..+ ..++||||+||+||-+++|.+||.......
T Consensus 312 ~~e~~llKItDFGlAK~~g~~sfm~---TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~ 388 (475)
T KOG0615|consen 312 DAEDCLLKITDFGLAKVSGEGSFMK---TLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP 388 (475)
T ss_pred CCcceEEEecccchhhccccceehh---hhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc
Confidence 6 689999999999877443332 3789999999999987543 457899999999999999999987444332
Q ss_pred CcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 244 MNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
.-..++....+.- .+........+..+++.+||..||++|||+.|+++
T Consensus 389 sl~eQI~~G~y~f----------------------------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 389 SLKEQILKGRYAF----------------------------GPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred cHHHHHhcCcccc----------------------------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 2222221111110 01113466778899999999999999999999986
No 8
>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]
Probab=100.00 E-value=8.4e-47 Score=339.25 Aligned_cols=184 Identities=28% Similarity=0.481 Sum_probs=163.9
Q ss_pred hccccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757 33 DVSRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN 93 (381)
Q Consensus 33 ~~~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 93 (381)
..-++|...+.||+|+||+||+++. ..++.+.+|+.+|+.++|||||++++++ ...
T Consensus 7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~-----~~~ 81 (429)
T KOG0595|consen 7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCI-----EDD 81 (429)
T ss_pred cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEE-----ecC
Confidence 3467899999999999999998752 2456678899999999999999999995 457
Q ss_pred ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCC---
Q 041757 94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDD--- 170 (381)
Q Consensus 94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~--- 170 (381)
++.|||||||.||||.+|+ ...+.+++..+..++.||+.||++|| +++||||||||+|||++..
T Consensus 82 ~~i~lVMEyC~gGDLs~yi----------~~~~~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~ 148 (429)
T KOG0595|consen 82 DFIYLVMEYCNGGDLSDYI----------RRRGRLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARN 148 (429)
T ss_pred CeEEEEEEeCCCCCHHHHH----------HHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCC
Confidence 8999999999999999999 45668999999999999999999999 7799999999999999765
Q ss_pred ---CCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCC
Q 041757 171 ---MTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSD 237 (381)
Q Consensus 171 ---~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~ 237 (381)
-.+||+|||+|+.+....... ..+|++.|||||++....|+.|+|+||+|+++|++++|+.||+
T Consensus 149 ~~~~~LKIADFGfAR~L~~~~~a~---tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~ 215 (429)
T KOG0595|consen 149 DTSPVLKIADFGFARFLQPGSMAE---TLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFD 215 (429)
T ss_pred CCCceEEecccchhhhCCchhHHH---HhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcc
Confidence 468999999999887554433 2679999999999999999999999999999999999999986
No 9
>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]
Probab=100.00 E-value=8.5e-46 Score=329.80 Aligned_cols=184 Identities=27% Similarity=0.357 Sum_probs=166.1
Q ss_pred ccccccccceecCCCceEEEecc--------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757 34 VSRNMLEENLISAGTFGFSHLRR--------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN 93 (381)
Q Consensus 34 ~~~~~~~~~~lG~G~fg~V~~~~--------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 93 (381)
.-++|...++||+|+||+|+.++ ....+...+|..+|.+++||.||+++.. +++.
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ys-----FQt~ 97 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYS-----FQTE 97 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEe-----cccC
Confidence 35789999999999999997765 2346677889999999999999999988 7889
Q ss_pred ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757 94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA 173 (381)
Q Consensus 94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~ 173 (381)
+.+|+|+||+.||.|..+| .+...+++..+.-++.+|+.||.||| +++||||||||+|||+|.+|++
T Consensus 98 ~kLylVld~~~GGeLf~hL----------~~eg~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi 164 (357)
T KOG0598|consen 98 EKLYLVLDYLNGGELFYHL----------QREGRFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHI 164 (357)
T ss_pred CeEEEEEeccCCccHHHHH----------HhcCCcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcE
Confidence 9999999999999999999 56788999999999999999999999 7799999999999999999999
Q ss_pred EEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCC
Q 041757 174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSD 237 (381)
Q Consensus 174 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~ 237 (381)
+|+|||+++........+. .++||+.|||||++.+..|+..+|+||+|+++|||++|.+||.
T Consensus 165 ~LtDFgL~k~~~~~~~~t~--tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~ 226 (357)
T KOG0598|consen 165 KLTDFGLCKEDLKDGDATR--TFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFY 226 (357)
T ss_pred EEeccccchhcccCCCccc--cccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCc
Confidence 9999999986554433333 2789999999999999999999999999999999999999975
No 10
>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]
Probab=100.00 E-value=7.4e-46 Score=360.76 Aligned_cols=253 Identities=23% Similarity=0.390 Sum_probs=206.5
Q ss_pred ccccccceecCCCceEEEecc-----------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccC
Q 041757 36 RNMLEENLISAGTFGFSHLRR-----------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQG 92 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~-----------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 92 (381)
.+-...+.||+|+||+||+++ ....++|.+|+++|..|+|||||+++|+|..
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~----- 560 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE----- 560 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc-----
Confidence 445556889999999997754 2367899999999999999999999999864
Q ss_pred CceEEEEEEcccCCCHHHhhccccCCcccccC----CCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeC
Q 041757 93 NDFKALVYEFMHNRSLKEWLYPISKEDETYKR----PRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLD 168 (381)
Q Consensus 93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~ 168 (381)
++..++|+|||..|||.+||..........-. +..++..+.+.|+.|||.|+.||- +..+|||||..+|+||.
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVg 637 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVG 637 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceec
Confidence 78899999999999999999755443222212 445999999999999999999999 66999999999999999
Q ss_pred CCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHH
Q 041757 169 DDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLH 247 (381)
Q Consensus 169 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~ 247 (381)
++..|||+|||+++.+-...+......-.-+++|||||.+..++|+++||||||||+|||+++ |+.||......+
T Consensus 638 e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E---- 713 (774)
T KOG1026|consen 638 ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE---- 713 (774)
T ss_pred cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH----
Confidence 999999999999998777666554433335789999999999999999999999999999997 899975222110
Q ss_pred HHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 041757 248 KFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT 327 (381)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~ 327 (381)
.+..+-+..+ .+.++.||.++.+||..||+.+|.+||+++||-..|+.....
T Consensus 714 ---------VIe~i~~g~l-------------------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 714 ---------VIECIRAGQL-------------------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred ---------HHHHHHcCCc-------------------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 0111111111 122568999999999999999999999999999999998765
Q ss_pred c
Q 041757 328 L 328 (381)
Q Consensus 328 ~ 328 (381)
.
T Consensus 766 s 766 (774)
T KOG1026|consen 766 S 766 (774)
T ss_pred C
Confidence 4
No 11
>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=3e-45 Score=331.22 Aligned_cols=245 Identities=21% Similarity=0.296 Sum_probs=189.4
Q ss_pred cccccccceecCCCceEEEeccccc-----------------HHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757 35 SRNMLEENLISAGTFGFSHLRRQGA-----------------FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA 97 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~~~~-----------------~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~ 97 (381)
..++..++.||+|+||+||++.... .+.+.+|+.+|.+|+|||||+++|.... ......+
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~---~~~~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSS---RENDEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCcccc---ccCeeeE
Confidence 4668889999999999998865321 5568999999999999999999997322 1113689
Q ss_pred EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCC-CCCeEEe
Q 041757 98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD-DMTARVG 176 (381)
Q Consensus 98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~-~~~~kl~ 176 (381)
+.|||+++|+|.+++.. ....+++..+..+..||++||.||| +++||||||||+|||++. ++.+||+
T Consensus 93 i~mEy~~~GsL~~~~~~---------~g~~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~Kla 160 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKR---------YGGKLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLA 160 (313)
T ss_pred eeeeccCCCcHHHHHHH---------cCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEec
Confidence 99999999999999953 1227999999999999999999999 779999999999999999 7999999
Q ss_pred ecccceecCCC-CCcccccCccCccceeCCCCcCCC-ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHh
Q 041757 177 DFGLARFLPPT-RTQTSSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMAL 254 (381)
Q Consensus 177 Dfg~~~~~~~~-~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 254 (381)
|||+++..... ..........||+.|||||++... ....++|||||||++.||+||+.||... ............
T Consensus 161 DFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~---~~~~~~~~~ig~ 237 (313)
T KOG0198|consen 161 DFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF---FEEAEALLLIGR 237 (313)
T ss_pred cCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh---cchHHHHHHHhc
Confidence 99999876641 111222346799999999999853 3445999999999999999999998633 111111111111
Q ss_pred hchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 041757 255 SNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSI 324 (381)
Q Consensus 255 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i 324 (381)
.... +.++...+.+..+++.+|+..||++|||+.++++.--..
T Consensus 238 ~~~~---------------------------P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~ 280 (313)
T KOG0198|consen 238 EDSL---------------------------PEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLK 280 (313)
T ss_pred cCCC---------------------------CCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhh
Confidence 1100 012445677888999999999999999999999855433
No 12
>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]
Probab=100.00 E-value=8.3e-45 Score=336.27 Aligned_cols=237 Identities=22% Similarity=0.339 Sum_probs=196.3
Q ss_pred hhccccccccceecCCCceEEEecc--------------------cccHHHHHHHHHHHHcc-CCCcccceeeeeccccc
Q 041757 32 LDVSRNMLEENLISAGTFGFSHLRR--------------------QGAFKSFIAECKALRNI-RHRNLIKVLTACLGVDY 90 (381)
Q Consensus 32 ~~~~~~~~~~~~lG~G~fg~V~~~~--------------------~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~ 90 (381)
.....+|..++.||.|+|++|++++ +..++....|-.+|.+| .||.|+++|.. +
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~T-----F 143 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFT-----F 143 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEE-----e
Confidence 3346789999999999999997765 33455566799999999 69999999988 6
Q ss_pred cCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCC
Q 041757 91 QGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDD 170 (381)
Q Consensus 91 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~ 170 (381)
++...+|+|+||+++|+|.++| .+.+.+++..++.++.+|+.||+||| +.|||||||||+|||+|++
T Consensus 144 QD~~sLYFvLe~A~nGdll~~i----------~K~Gsfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~d 210 (604)
T KOG0592|consen 144 QDEESLYFVLEYAPNGDLLDLI----------KKYGSFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKD 210 (604)
T ss_pred ecccceEEEEEecCCCcHHHHH----------HHhCcchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCC
Confidence 7799999999999999999999 56788999999999999999999999 6799999999999999999
Q ss_pred CCeEEeecccceecCCCCCc---------ccc--cCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCcc
Q 041757 171 MTARVGDFGLARFLPPTRTQ---------TSS--IDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIM 239 (381)
Q Consensus 171 ~~~kl~Dfg~~~~~~~~~~~---------~~~--~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~ 239 (381)
+++||+|||.|+.+...... ... ..++||..|.+||+|.....+..+|||+|||++|.|+.|++||.
T Consensus 211 mhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFr-- 288 (604)
T KOG0592|consen 211 GHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFR-- 288 (604)
T ss_pred CcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCc--
Confidence 99999999999988754222 111 45889999999999999999999999999999999999999975
Q ss_pred ccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 240 FEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
+...+.-+ .+.+..+. .+++..++.+.+|+.+.|..||.+|+|..+|.+
T Consensus 289 --a~NeyliF-------------qkI~~l~y----------------~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 289 --AANEYLIF-------------QKIQALDY----------------EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred --cccHHHHH-------------HHHHHhcc----------------cCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence 22222211 11111111 123456677888899999999999999988865
No 13
>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=6.9e-45 Score=331.94 Aligned_cols=263 Identities=21% Similarity=0.266 Sum_probs=201.2
Q ss_pred hhccccccccceecCCCceEEEecccc------cHHHH------------HHHHHHHHccC-CCcccceeeeeccccccC
Q 041757 32 LDVSRNMLEENLISAGTFGFSHLRRQG------AFKSF------------IAECKALRNIR-HRNLIKVLTACLGVDYQG 92 (381)
Q Consensus 32 ~~~~~~~~~~~~lG~G~fg~V~~~~~~------~~~~~------------~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~ 92 (381)
....++|...++||.|+||.||+++.. +++.. +||++.|++|+ |||||++.+++.+ .
T Consensus 6 ~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d----~ 81 (538)
T KOG0661|consen 6 VIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRD----N 81 (538)
T ss_pred hhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhc----c
Confidence 345688999999999999999998632 12221 47999999998 9999999999643 2
Q ss_pred CceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCC
Q 041757 93 NDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT 172 (381)
Q Consensus 93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~ 172 (381)
...+++|||||+. +|.++++ .+.+.+++..+..|+.||+.||+|+| ..|+.|||+||+|||+.....
T Consensus 82 ~~~L~fVfE~Md~-NLYqLmK---------~R~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~ 148 (538)
T KOG0661|consen 82 DRILYFVFEFMDC-NLYQLMK---------DRNRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDV 148 (538)
T ss_pred CceEeeeHHhhhh-hHHHHHh---------hcCCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccce
Confidence 3389999999965 9999997 45788999999999999999999999 669999999999999998899
Q ss_pred eEEeecccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHH
Q 041757 173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAK 251 (381)
Q Consensus 173 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~ 251 (381)
+||+|||+|+.+......+. ++.|..|+|||++.. ..|+.+.||||+|||++|+.+-++. |+|...++++.+
T Consensus 149 iKiaDFGLARev~SkpPYTe---YVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPL----FPG~sE~Dqi~K 221 (538)
T KOG0661|consen 149 IKIADFGLAREVRSKPPYTE---YVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPL----FPGASEIDQIYK 221 (538)
T ss_pred eEecccccccccccCCCcch---hhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhccc----CCCCcHHHHHHH
Confidence 99999999998876655543 678999999998664 6789999999999999999998887 566666666555
Q ss_pred HH---hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041757 252 MA---LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE 320 (381)
Q Consensus 252 ~~---~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~ 320 (381)
.. ..+...++...... ....-+...+..........+.+..+.++++.+|+.+||.+|||+.+.++.
T Consensus 222 Ic~VLGtP~~~~~~eg~~L--a~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 222 ICEVLGTPDKDSWPEGYNL--ASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHhCCCccccchhHHHH--HHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 43 12211111110000 000001111122222334445688899999999999999999999999873
No 14
>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]
Probab=100.00 E-value=2.1e-44 Score=311.84 Aligned_cols=257 Identities=19% Similarity=0.295 Sum_probs=193.6
Q ss_pred ccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK 96 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~ 96 (381)
+.|+...++|+|+||+|++.+. ...+-.++|+++|++|+|+|+|.++.+ +......
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEV-----Frrkrkl 76 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEV-----FRRKRKL 76 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHH-----HHhccee
Confidence 3577788999999999987652 134556899999999999999999999 5568899
Q ss_pred EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757 97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG 176 (381)
Q Consensus 97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~ 176 (381)
+||+|||+. ++.+-|. ..+..++...+..++.|++.|+.|+| +.++|||||||+|||++.++.+||+
T Consensus 77 hLVFE~~dh-TvL~eLe---------~~p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLC 143 (396)
T KOG0593|consen 77 HLVFEYCDH-TVLHELE---------RYPNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLC 143 (396)
T ss_pred EEEeeecch-HHHHHHH---------hccCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEec
Confidence 999999977 5555553 45677899999999999999999999 6699999999999999999999999
Q ss_pred ecccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH--
Q 041757 177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA-- 253 (381)
Q Consensus 177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~-- 253 (381)
|||+|+.+..+..... .++.|.+|+|||.+.+ ..|+..+||||+||++.||++|.+-| ++...+.++....
T Consensus 144 DFGFAR~L~~pgd~YT--DYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~----PG~SDiDQLy~I~kt 217 (396)
T KOG0593|consen 144 DFGFARTLSAPGDNYT--DYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLW----PGRSDIDQLYLIRKT 217 (396)
T ss_pred cchhhHhhcCCcchhh--hhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCC----CCcchHHHHHHHHHH
Confidence 9999998875444333 3679999999999988 67999999999999999999999985 4555444443322
Q ss_pred hhc---hHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 254 LSN---HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 254 ~~~---~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
+.+ ....++..-- .-..+...........+.-.+....-+++++..|++.||++|++.+|++.
T Consensus 218 LG~L~prhq~iF~~N~---~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 218 LGNLIPRHQSIFSSNP---FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred HcccCHHHHHHhccCC---ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 111 1111111100 00000011111122222223455568899999999999999999999984
No 15
>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3. Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V
Probab=100.00 E-value=9.2e-44 Score=334.48 Aligned_cols=254 Identities=22% Similarity=0.316 Sum_probs=192.6
Q ss_pred cccccccceecCCCceEEEeccc-----------------------ccHHHHHHHHHHHHcc-CCCcccceeeeeccccc
Q 041757 35 SRNMLEENLISAGTFGFSHLRRQ-----------------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVDY 90 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~~-----------------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~ 90 (381)
.++|...++||+|+||.||++.. ...+.+.+|+.++..+ +||||++++++|.
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~---- 81 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACT---- 81 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEec----
Confidence 46799999999999999987631 1235688999999999 8999999999864
Q ss_pred cCCceEEEEEEcccCCCHHHhhccccCCcc--------------------------------------------------
Q 041757 91 QGNDFKALVYEFMHNRSLKEWLYPISKEDE-------------------------------------------------- 120 (381)
Q Consensus 91 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~-------------------------------------------------- 120 (381)
......++||||+++|+|.+++........
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 234568999999999999999864221000
Q ss_pred --cccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccceecCCCCCcccccCccC
Q 041757 121 --TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKG 198 (381)
Q Consensus 121 --~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g 198 (381)
.......+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++...............+
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~ 238 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCC
Confidence 0001235788899999999999999999 66999999999999999999999999999986644332222222346
Q ss_pred ccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcc
Q 041757 199 SIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRG 277 (381)
Q Consensus 199 t~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 277 (381)
++.|+|||++.+..++.++|||||||++|||++ |..||...... ..+... +.+....
T Consensus 239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~----~~~~~~--------~~~~~~~---------- 296 (338)
T cd05102 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN----EEFCQR--------LKDGTRM---------- 296 (338)
T ss_pred CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc----HHHHHH--------HhcCCCC----------
Confidence 788999999998899999999999999999997 99997532111 111110 0000000
Q ss_pred cchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 041757 278 DQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKN 326 (381)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~ 326 (381)
..+..++..+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus 297 ---------~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 297 ---------RAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred ---------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0012445678999999999999999999999999998765
No 16
>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=1.2e-43 Score=326.15 Aligned_cols=261 Identities=22% Similarity=0.265 Sum_probs=198.5
Q ss_pred cccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757 35 SRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF 95 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~ 95 (381)
.+.|+..++||+|+||.||+++. +...-..+||.+|++|.||||+++.+..++ .....
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~---~~~~s 192 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTS---KLSGS 192 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEe---cCCce
Confidence 35688899999999999999762 344567899999999999999999999654 33678
Q ss_pred EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757 96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV 175 (381)
Q Consensus 96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl 175 (381)
+|||+|||+. ||..++. ...-.+++.++..++.|++.||+|+| ..+|+|||||.+|||||.+|.+||
T Consensus 193 iYlVFeYMdh-DL~GLl~---------~p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKi 259 (560)
T KOG0600|consen 193 IYLVFEYMDH-DLSGLLS---------SPGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKI 259 (560)
T ss_pred EEEEEecccc-hhhhhhc---------CCCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEe
Confidence 9999999976 9999985 44668999999999999999999999 779999999999999999999999
Q ss_pred eecccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHH---HHHH
Q 041757 176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLH---KFAK 251 (381)
Q Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~---~~~~ 251 (381)
+|||+|+++....... .+..+-|..|+|||.+.+ ..|+.++|+||.||||.||++|++.|. +...+. .+.+
T Consensus 260 aDFGLAr~y~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~----G~tEveQl~kIfk 334 (560)
T KOG0600|consen 260 ADFGLARFYTPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQ----GRTEVEQLHKIFK 334 (560)
T ss_pred ccccceeeccCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcC----CccHHHHHHHHHH
Confidence 9999999877655432 233568999999999887 469999999999999999999999854 443333 3333
Q ss_pred HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 252 MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 252 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
...++.-.. ... ..-|.-..+.................+...++|+..+|..||++|.|+.++++
T Consensus 335 lcGSP~e~~-W~~--~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 335 LCGSPTEDY-WPV--SKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred HhCCCChhc-ccc--ccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 333322111 110 00011011111111111122224556678899999999999999999999886
No 17
>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=2.8e-43 Score=330.53 Aligned_cols=233 Identities=23% Similarity=0.296 Sum_probs=189.4
Q ss_pred hccccccccceecCCCceEEEeccc----------------------ccHHHHHHHHHHHHccC-CCcccceeeeecccc
Q 041757 33 DVSRNMLEENLISAGTFGFSHLRRQ----------------------GAFKSFIAECKALRNIR-HRNLIKVLTACLGVD 89 (381)
Q Consensus 33 ~~~~~~~~~~~lG~G~fg~V~~~~~----------------------~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~ 89 (381)
...++|..++.||+|+||+|+++.. ...+...+|+.+++.++ ||||++++.+
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev----- 88 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEV----- 88 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEE-----
Confidence 3567899999999999999977642 12345567999999999 9999999999
Q ss_pred ccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCC
Q 041757 90 YQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD 169 (381)
Q Consensus 90 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~ 169 (381)
+......++|||||.+|+|.+++ ....++.+..+..++.|++.|++||| +.+|+||||||+|||++.
T Consensus 89 ~~t~~~~~ivmEy~~gGdL~~~i----------~~~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~ 155 (370)
T KOG0583|consen 89 FATPTKIYIVMEYCSGGDLFDYI----------VNKGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDG 155 (370)
T ss_pred EecCCeEEEEEEecCCccHHHHH----------HHcCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecC
Confidence 55677799999999999999999 44778999999999999999999999 679999999999999999
Q ss_pred C-CCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCc-cC-cccchhhhhHHHHHHHhCCCCCCccccCCCcH
Q 041757 170 D-MTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNE-VS-TIGDVYSYGILLLELMIREKPSDIMFEGDMNL 246 (381)
Q Consensus 170 ~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~-~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~ 246 (381)
+ +.+||+|||++...... .......+||+.|+|||++.+.. |+ .++||||+||+||.|++|..||+. .+.
T Consensus 156 ~~~~~Kl~DFG~s~~~~~~--~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d-----~~~ 228 (370)
T KOG0583|consen 156 NEGNLKLSDFGLSAISPGE--DGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD-----SNV 228 (370)
T ss_pred CCCCEEEeccccccccCCC--CCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC-----ccH
Confidence 9 99999999999887411 11222368999999999999977 85 789999999999999999999873 111
Q ss_pred HHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHH-HHHHHHHHHhccCCCCCCCCCHHHHH
Q 041757 247 HKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIREC-VISMVRIGVACSMESPQDRMKMTNVV 318 (381)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~l~~~cl~~dP~~RPs~~~vl 318 (381)
... ..+...... .++... ..++..++.+|+..||.+|+|+.+++
T Consensus 229 ~~l------------~~ki~~~~~----------------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 229 PNL------------YRKIRKGEF----------------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred HHH------------HHHHhcCCc----------------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 111 111111100 112233 67889999999999999999999999
No 18
>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]
Probab=100.00 E-value=8.4e-44 Score=358.03 Aligned_cols=256 Identities=23% Similarity=0.378 Sum_probs=207.8
Q ss_pred cccccceecCCCceEEEecc-----------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757 37 NMLEENLISAGTFGFSHLRR-----------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN 93 (381)
Q Consensus 37 ~~~~~~~lG~G~fg~V~~~~-----------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 93 (381)
+-...+.||+|.||.||.+. ...+..|.+|..+|++++|||||+++|+|.. .
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~-----~ 767 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD-----S 767 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC-----C
Confidence 34456899999999997743 3467889999999999999999999999864 6
Q ss_pred ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757 94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA 173 (381)
Q Consensus 94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~ 173 (381)
...+|++|||++|||..||+..+... .....++..+.+.++.|||+|+.||+ .+++|||||..+|+|++....+
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~---~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~V 841 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAP---FQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVV 841 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhccccc---CCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcE
Confidence 77899999999999999997544322 22677999999999999999999999 7799999999999999999999
Q ss_pred EEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHH
Q 041757 174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKM 252 (381)
Q Consensus 174 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~ 252 (381)
||+|||+|+.+....+........-+..|||||.+....|+.|+|||||||++||++| |..||.. ..+...+..
T Consensus 842 KIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~----~~n~~v~~~- 916 (1025)
T KOG1095|consen 842 KIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPS----RSNFEVLLD- 916 (1025)
T ss_pred EEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCC----cchHHHHHH-
Confidence 9999999996655554443332234689999999999999999999999999999998 8888642 222211110
Q ss_pred HhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhcCCCC
Q 041757 253 ALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLLGPK 332 (381)
Q Consensus 253 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~~~~~~ 332 (381)
+.. .++.+.+..|+..+.++|..||+.+|++||++..+++++.++........
T Consensus 917 --------~~~-------------------ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~ 969 (1025)
T KOG1095|consen 917 --------VLE-------------------GGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTI 969 (1025)
T ss_pred --------HHh-------------------CCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCc
Confidence 111 01223356899999999999999999999999999999999988776654
Q ss_pred Ccc
Q 041757 333 NLA 335 (381)
Q Consensus 333 ~~~ 335 (381)
...
T Consensus 970 ~~~ 972 (1025)
T KOG1095|consen 970 YGP 972 (1025)
T ss_pred ccc
Confidence 433
No 19
>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]
Probab=100.00 E-value=5.2e-44 Score=334.74 Aligned_cols=245 Identities=26% Similarity=0.409 Sum_probs=197.5
Q ss_pred ccccccceecCCCceEEEecc----------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEE
Q 041757 36 RNMLEENLISAGTFGFSHLRR----------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALV 99 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~----------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv 99 (381)
+....+..||+|.||+||+++ ....+.|.+|+.++++-+|.||+-+.|+|. +....||
T Consensus 392 ~ev~l~~rIGsGsFGtV~Rg~whGdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~------~p~~AIi 465 (678)
T KOG0193|consen 392 EEVLLGERIGSGSFGTVYRGRWHGDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACM------NPPLAII 465 (678)
T ss_pred HHhhccceeccccccceeecccccceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhc------CCceeee
Confidence 445567999999999998865 346789999999999999999999999975 3344999
Q ss_pred EEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecc
Q 041757 100 YEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179 (381)
Q Consensus 100 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg 179 (381)
+-+|+|.+|+.+|+ .....+...+.+.|+.||+.|+.||| .++|||||||..||++.++++|||+|||
T Consensus 466 TqwCeGsSLY~hlH---------v~etkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFG 533 (678)
T KOG0193|consen 466 TQWCEGSSLYTHLH---------VQETKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFG 533 (678)
T ss_pred ehhccCchhhhhcc---------chhhhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEeccc
Confidence 99999999999998 45578999999999999999999999 8899999999999999999999999999
Q ss_pred cceecCCCCCcccccCccCccceeCCCCcCC---CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhc
Q 041757 180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGVG---NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSN 256 (381)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~ 256 (381)
++..-..-..........|.+.|||||+++. .+|++.|||||||+|+|||++|..||.... -+++..+..+.
T Consensus 534 Latvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~-----~dqIifmVGrG 608 (678)
T KOG0193|consen 534 LATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQN-----RDQIIFMVGRG 608 (678)
T ss_pred ceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCC-----hhheEEEeccc
Confidence 9865433222222223568999999998874 569999999999999999999999986221 12222221111
Q ss_pred h-HHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 041757 257 H-VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT 327 (381)
Q Consensus 257 ~-~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~ 327 (381)
. ..++. .....|++++.+|+..||..++++||.+.+|+..|+.+..+
T Consensus 609 ~l~pd~s------------------------~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 609 YLMPDLS------------------------KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred ccCccch------------------------hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 1 11111 11347888999999999999999999999999999888765
No 20
>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]
Probab=100.00 E-value=1.7e-43 Score=328.36 Aligned_cols=230 Identities=27% Similarity=0.396 Sum_probs=195.2
Q ss_pred ccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK 96 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~ 96 (381)
++|-+.+.||+|+||+||+++. ...+.+.+|+++++.|+|||||.++++ +++..+.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~es-----fEt~~~~ 76 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLES-----FETSAHL 76 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHh-----hcccceE
Confidence 4677888999999999998762 245668899999999999999999999 6789999
Q ss_pred EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757 97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG 176 (381)
Q Consensus 97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~ 176 (381)
|+|+|||.| +|..+| .....++++.+..++.|++.||.||| +.+|+|||+||+|||++.++.+|++
T Consensus 77 ~vVte~a~g-~L~~il----------~~d~~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~Klc 142 (808)
T KOG0597|consen 77 WVVTEYAVG-DLFTIL----------EQDGKLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLC 142 (808)
T ss_pred EEEehhhhh-hHHHHH----------HhccCCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeec
Confidence 999999977 999999 56788999999999999999999999 6699999999999999999999999
Q ss_pred ecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhc
Q 041757 177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSN 256 (381)
Q Consensus 177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~ 256 (381)
|||+|+.+.....- ...+.||+.|||||.+.+..|+..+|+||+||++||+++|++||. ..
T Consensus 143 dFg~Ar~m~~~t~v--ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~-----------------a~ 203 (808)
T KOG0597|consen 143 DFGLARAMSTNTSV--LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFY-----------------AR 203 (808)
T ss_pred hhhhhhhcccCcee--eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCch-----------------HH
Confidence 99999987664332 223679999999999999999999999999999999999999974 22
Q ss_pred hHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 257 HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 257 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
.+..++..++..+.. .+......+..++...+..||..|.|..+++.
T Consensus 204 si~~Lv~~I~~d~v~----------------~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 204 SITQLVKSILKDPVK----------------PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred HHHHHHHHHhcCCCC----------------CcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 233344433322211 13356678888999999999999999999985
No 21
>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=4.2e-43 Score=327.27 Aligned_cols=234 Identities=20% Similarity=0.278 Sum_probs=193.9
Q ss_pred cccccccceecCCCceEEEecc-----------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757 35 SRNMLEENLISAGTFGFSHLRR-----------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA 97 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~-----------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~ 97 (381)
...|..-.+||+|+.|.||.+. +...+..++|+.+|+..+|+|||.+++.+.. .+.+|
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv-----~deLW 346 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLV-----GDELW 346 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcc-----cceeE
Confidence 4557778999999999998765 3456778899999999999999999999653 57899
Q ss_pred EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757 98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD 177 (381)
Q Consensus 98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D 177 (381)
+||||++||+|.+.+. ...+++.++..|+++++.||+||| ..+|+|||||.+|||++.+|.+||+|
T Consensus 347 VVMEym~ggsLTDvVt-----------~~~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltD 412 (550)
T KOG0578|consen 347 VVMEYMEGGSLTDVVT-----------KTRMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTD 412 (550)
T ss_pred EEEeecCCCchhhhhh-----------cccccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEee
Confidence 9999999999999983 455999999999999999999999 77999999999999999999999999
Q ss_pred cccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhch
Q 041757 178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH 257 (381)
Q Consensus 178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~ 257 (381)
||++..+........ ..+||+.|||||++....|++++||||||++++||+-|++||-+ +..+..+....-...
T Consensus 413 FGFcaqi~~~~~KR~--TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln----E~PlrAlyLIa~ng~ 486 (550)
T KOG0578|consen 413 FGFCAQISEEQSKRS--TMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN----ENPLRALYLIATNGT 486 (550)
T ss_pred eeeeeccccccCccc--cccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC----CChHHHHHHHhhcCC
Confidence 999988876654333 36799999999999999999999999999999999999999732 223222222111110
Q ss_pred HHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
+ ....+......+.+++.+||..|+++||++.++|+
T Consensus 487 ------------P--------------~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 487 ------------P--------------KLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred ------------C--------------CcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 0 00113456678899999999999999999999996
No 22
>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]
Probab=100.00 E-value=1.3e-42 Score=295.86 Aligned_cols=257 Identities=22% Similarity=0.315 Sum_probs=199.6
Q ss_pred ccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK 96 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~ 96 (381)
+.|...++||+|.||.||++++ +.....++|++.|+.++|+||+.++++ +...+..
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~-----F~~~~~l 76 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDV-----FPHKSNL 76 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhh-----ccCCCce
Confidence 4688899999999999988752 234578899999999999999999999 5668889
Q ss_pred EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757 97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG 176 (381)
Q Consensus 97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~ 176 (381)
.||+||++. ||+..++ .+...++..++..++.++++|++||| .+.|+||||||.|+|++.+|.+||+
T Consensus 77 ~lVfEfm~t-dLe~vIk---------d~~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiA 143 (318)
T KOG0659|consen 77 SLVFEFMPT-DLEVVIK---------DKNIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIA 143 (318)
T ss_pred EEEEEeccc-cHHHHhc---------ccccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEee
Confidence 999999976 9999997 46678999999999999999999999 6699999999999999999999999
Q ss_pred ecccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH--
Q 041757 177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA-- 253 (381)
Q Consensus 177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~-- 253 (381)
|||+++.+......... .+-|..|+|||.+.| ..|+..+||||.||++.||+.|.+- +.++..++++....
T Consensus 144 DFGLAr~f~~p~~~~~~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~----fpG~sDidQL~~If~~ 217 (318)
T KOG0659|consen 144 DFGLARFFGSPNRIQTH--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPF----FPGDSDIDQLSKIFRA 217 (318)
T ss_pred cccchhccCCCCccccc--ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCC----CCCCchHHHHHHHHHH
Confidence 99999988766544333 257999999998887 4699999999999999999998876 56776666654433
Q ss_pred -hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041757 254 -LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE 320 (381)
Q Consensus 254 -~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~ 320 (381)
..+.....-+-.-..+..+...... .........+..+.++++..+|.+||.+|+|++|+++.
T Consensus 218 LGTP~~~~WP~~~~lpdY~~~~~~P~----~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 218 LGTPTPDQWPEMTSLPDYVKIQQFPK----PPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cCCCCcccCccccccccHHHHhcCCC----CccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 1211111111111111111110000 00111334566778999999999999999999999873
No 23
>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]
Probab=100.00 E-value=7.1e-43 Score=329.55 Aligned_cols=244 Identities=24% Similarity=0.372 Sum_probs=192.9
Q ss_pred cccccceecCCCceEEEecc------------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccC
Q 041757 37 NMLEENLISAGTFGFSHLRR------------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQG 92 (381)
Q Consensus 37 ~~~~~~~lG~G~fg~V~~~~------------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 92 (381)
+-...++||+|+||.|+.++ ...+.+|++|+++|++++|||||++||++. .
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~-----~ 232 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV-----L 232 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc-----C
Confidence 33445999999999995532 235678999999999999999999999965 4
Q ss_pred CceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCC
Q 041757 93 NDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT 172 (381)
Q Consensus 93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~ 172 (381)
...++||||+|.||+|.++|. +....++..+...++.+.+.||+||| +++++||||..+|+|++.++.
T Consensus 233 ~~Pl~ivmEl~~gGsL~~~L~---------k~~~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~ 300 (474)
T KOG0194|consen 233 EEPLMLVMELCNGGSLDDYLK---------KNKKSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGV 300 (474)
T ss_pred CCccEEEEEecCCCcHHHHHH---------hCCCCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCe
Confidence 788999999999999999995 33346999999999999999999999 789999999999999999999
Q ss_pred eEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHH
Q 041757 173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAK 251 (381)
Q Consensus 173 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~ 251 (381)
+||+|||+++.-... ........-++.|+|||.+....|+.++|||||||++||+++ |..||.... ...
T Consensus 301 vKISDFGLs~~~~~~--~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~----~~~---- 370 (474)
T KOG0194|consen 301 VKISDFGLSRAGSQY--VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMK----NYE---- 370 (474)
T ss_pred EEeCccccccCCcce--eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCC----HHH----
Confidence 999999998754411 111111235789999999999999999999999999999998 888965221 111
Q ss_pred HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 041757 252 MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLLG 330 (381)
Q Consensus 252 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~~~~ 330 (381)
+........ .+...+...+..+..++.+||..||++||||.++.+.|+.+......
T Consensus 371 ---------v~~kI~~~~--------------~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 371 ---------VKAKIVKNG--------------YRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred ---------HHHHHHhcC--------------ccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 111110000 00011235667888888899999999999999999999999876543
No 24
>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]
Probab=100.00 E-value=2.9e-43 Score=326.80 Aligned_cols=239 Identities=24% Similarity=0.359 Sum_probs=195.7
Q ss_pred ccceecCCCceEEEeccc----ccHHH----HHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEcccCCCHHHh
Q 041757 40 EENLISAGTFGFSHLRRQ----GAFKS----FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEW 111 (381)
Q Consensus 40 ~~~~lG~G~fg~V~~~~~----~~~~~----~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~ 111 (381)
..+-||.|+-|.|++.+- .+++. -..+|+-|++|+||||+.|.|+|.. ...++||||||..|.|..+
T Consensus 128 ELeWlGSGaQGAVF~Grl~netVAVKKV~elkETdIKHLRkLkH~NII~FkGVCtq-----sPcyCIiMEfCa~GqL~~V 202 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLHNETVAVKKVRELKETDIKHLRKLKHPNIITFKGVCTQ-----SPCYCIIMEFCAQGQLYEV 202 (904)
T ss_pred hhhhhccCcccceeeeeccCceehhHHHhhhhhhhHHHHHhccCcceeeEeeeecC-----CceeEEeeeccccccHHHH
Confidence 358899999999988652 22222 2347888999999999999999975 6788999999999999999
Q ss_pred hccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccceecCCCCCcc
Q 041757 112 LYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQT 191 (381)
Q Consensus 112 l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 191 (381)
| +....++......|..+||.|+.||| ...|||||||.-||||..+..+||+|||-++...+. .
T Consensus 203 L----------ka~~~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---S 266 (904)
T KOG4721|consen 203 L----------KAGRPITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK---S 266 (904)
T ss_pred H----------hccCccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhhhh---h
Confidence 9 56788999999999999999999999 669999999999999999999999999999876554 2
Q ss_pred cccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHHHHhhhhccCch
Q 041757 192 SSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDE 271 (381)
Q Consensus 192 ~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 271 (381)
....++||..|||||++...+.+.|+||||||||||||+||..||.+.-.. .+++...++.+
T Consensus 267 TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss-----AIIwGVGsNsL------------- 328 (904)
T KOG4721|consen 267 TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS-----AIIWGVGSNSL------------- 328 (904)
T ss_pred hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh-----eeEEeccCCcc-------------
Confidence 233478999999999999999999999999999999999999998633211 11111111111
Q ss_pred hhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 041757 272 KLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLLG 330 (381)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~~~~ 330 (381)
-...+..|++.+.-|+++||+..|..||++.+++..|+-...++..
T Consensus 329 -------------~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pell~ 374 (904)
T KOG4721|consen 329 -------------HLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPELLS 374 (904)
T ss_pred -------------cccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHHhc
Confidence 1122568999999999999999999999999999999866555543
No 25
>PHA02988 hypothetical protein; Provisional
Probab=100.00 E-value=1e-41 Score=312.64 Aligned_cols=252 Identities=19% Similarity=0.261 Sum_probs=192.2
Q ss_pred cccccchhhhhccccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeee
Q 041757 23 VGKLKNLEILDVSRNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTA 84 (381)
Q Consensus 23 ~~~~~~l~~~~~~~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~ 84 (381)
+.+++.+...++ +......||+|++|.||++.. ...+.|.+|+.+|.+++||||++++++
T Consensus 9 ~~~~~~i~~~~i--~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~ 86 (283)
T PHA02988 9 INDIKCIESDDI--DKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGF 86 (283)
T ss_pred cCcceecCHHHc--CCCCCeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeee
Confidence 444555444444 233336799999999977541 114677899999999999999999999
Q ss_pred eccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCC
Q 041757 85 CLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSN 164 (381)
Q Consensus 85 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~N 164 (381)
+.+. .......++||||+++|+|.+++. ....+++...+.++.|++.||.|||.. .+++||||||+|
T Consensus 87 ~~~~-~~~~~~~~lv~Ey~~~g~L~~~l~----------~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~n 153 (283)
T PHA02988 87 IIDI-VDDLPRLSLILEYCTRGYLREVLD----------KEKDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVS 153 (283)
T ss_pred EEec-ccCCCceEEEEEeCCCCcHHHHHh----------hCCCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhh
Confidence 7531 123457899999999999999994 345688899999999999999999942 378899999999
Q ss_pred eeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCC--CccCcccchhhhhHHHHHHHhCCCCCCccccC
Q 041757 165 VLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG--NEVSTIGDVYSYGILLLELMIREKPSDIMFEG 242 (381)
Q Consensus 165 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~ 242 (381)
|+++.++.+||+|||+++....... ...|+..|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 154 ill~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~-- 226 (283)
T PHA02988 154 FLVTENYKLKIICHGLEKILSSPPF-----KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT-- 226 (283)
T ss_pred EEECCCCcEEEcccchHhhhccccc-----cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC--
Confidence 9999999999999999986543322 2358899999999876 679999999999999999999999986321
Q ss_pred CCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 041757 243 DMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQ 322 (381)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~ 322 (381)
.... .......... ...+..++..+.+++.+||+.||++|||+.++++.|+
T Consensus 227 ---~~~~------------~~~i~~~~~~--------------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~ 277 (283)
T PHA02988 227 ---TKEI------------YDLIINKNNS--------------LKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLS 277 (283)
T ss_pred ---HHHH------------HHHHHhcCCC--------------CCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHH
Confidence 1111 1111100000 0011245678899999999999999999999999999
Q ss_pred Hhh
Q 041757 323 SIK 325 (381)
Q Consensus 323 ~i~ 325 (381)
.+.
T Consensus 278 ~~~ 280 (283)
T PHA02988 278 LYK 280 (283)
T ss_pred HHH
Confidence 875
No 26
>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=1.9e-42 Score=327.06 Aligned_cols=231 Identities=21% Similarity=0.306 Sum_probs=196.7
Q ss_pred cccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757 35 SRNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND 94 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~ 94 (381)
.+-|+.++-||.|+-|.|.++++ .......+|+.+|+-+.||||+++|++ ++++.
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydV-----we~~~ 85 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDV-----WENKQ 85 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeee-----eccCc
Confidence 35588999999999999977662 234567889999999999999999999 77899
Q ss_pred eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757 95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR 174 (381)
Q Consensus 95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k 174 (381)
++|+|.||+++|-|.+++ ...+.+++.++.+++.||+.|+.|+| ..+|+||||||+|+|++..+.+|
T Consensus 86 ~lylvlEyv~gGELFdyl----------v~kG~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIK 152 (786)
T KOG0588|consen 86 HLYLVLEYVPGGELFDYL----------VRKGPLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIK 152 (786)
T ss_pred eEEEEEEecCCchhHHHH----------HhhCCCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEe
Confidence 999999999999999999 67889999999999999999999999 66999999999999999999999
Q ss_pred EeecccceecCCCCCcccccCccCccceeCCCCcCCCcc-CcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH
Q 041757 175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEV-STIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA 253 (381)
Q Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~ 253 (381)
|+|||+|..-..+..... .||++.|+|||++.+.+| +.++||||.|||||.|+||+.||+ +.+
T Consensus 153 IADFGMAsLe~~gklLeT---SCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd-----DdN-------- 216 (786)
T KOG0588|consen 153 IADFGMASLEVPGKLLET---SCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD-----DDN-------- 216 (786)
T ss_pred eeccceeecccCCccccc---cCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC-----Ccc--------
Confidence 999999986555444333 579999999999999988 578999999999999999999986 222
Q ss_pred hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 254 LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 254 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
++.++.+.-.+ ...++.+.+.+..+|+.+|+..||+.|.|+.||++
T Consensus 217 ----ir~LLlKV~~G----------------~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~k 262 (786)
T KOG0588|consen 217 ----IRVLLLKVQRG----------------VFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILK 262 (786)
T ss_pred ----HHHHHHHHHcC----------------cccCCCcCCHHHHHHHHHHhccCccccccHHHHhh
Confidence 23333322222 12335677889999999999999999999999987
No 27
>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=8.1e-42 Score=309.72 Aligned_cols=247 Identities=21% Similarity=0.278 Sum_probs=192.9
Q ss_pred ccccccccceecCCCceEEEecc------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757 34 VSRNMLEENLISAGTFGFSHLRR------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF 95 (381)
Q Consensus 34 ~~~~~~~~~~lG~G~fg~V~~~~------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~ 95 (381)
-.+.|+...+||.|.-++||++. +.....+.+|+..|+.++||||++++..|+ .+..
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFv-----v~~~ 98 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFV-----VDSE 98 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEE-----ecce
Confidence 46789999999999999998865 234678899999999999999999999965 4888
Q ss_pred EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757 96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV 175 (381)
Q Consensus 96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl 175 (381)
+|+||.||.+|++.+.++. .-+..+++..+..|+.++++||.||| ..|.||||||+.||||+.+|.+||
T Consensus 99 LWvVmpfMa~GS~ldIik~--------~~~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkL 167 (516)
T KOG0582|consen 99 LWVVMPFMAGGSLLDIIKT--------YYPDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKL 167 (516)
T ss_pred eEEeehhhcCCcHHHHHHH--------HccccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEE
Confidence 9999999999999999964 23456999999999999999999999 669999999999999999999999
Q ss_pred eecccceecCCCCCc-ccc-cCccCccceeCCCCcCC--CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHH
Q 041757 176 GDFGLARFLPPTRTQ-TSS-IDVKGSIGYIAPEYGVG--NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAK 251 (381)
Q Consensus 176 ~Dfg~~~~~~~~~~~-~~~-~~~~gt~~y~aPE~l~~--~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~ 251 (381)
+|||.+..+...... ... ..++||+.|||||++.. ..|+.|+||||||++..|+.+|..||...-+. +...
T Consensus 168 adFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm-----kvLl 242 (516)
T KOG0582|consen 168 ADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM-----KVLL 242 (516)
T ss_pred cCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH-----HHHH
Confidence 999988766554321 111 34679999999999654 46999999999999999999999998633221 1111
Q ss_pred HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 252 MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 252 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
..+.+. .|..... ....+........+.+++..||..||.+|||++++++
T Consensus 243 ~tLqn~-----------pp~~~t~-------~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 243 LTLQND-----------PPTLLTS-------GLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred HHhcCC-----------CCCcccc-------cCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 111111 1100000 0000112345558888999999999999999999986
No 28
>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=3.5e-42 Score=305.63 Aligned_cols=272 Identities=22% Similarity=0.294 Sum_probs=202.7
Q ss_pred hhhhccccccccceecCCCceEEEecc-------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccc
Q 041757 30 EILDVSRNMLEENLISAGTFGFSHLRR-------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDY 90 (381)
Q Consensus 30 ~~~~~~~~~~~~~~lG~G~fg~V~~~~-------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 90 (381)
+...+...|...+.||+|+||.|..+. ....++..+|+++|+.++|+||+.+++++.....
T Consensus 16 ~~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~ 95 (359)
T KOG0660|consen 16 ELFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSR 95 (359)
T ss_pred eEEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccc
Confidence 445566777778999999999995533 2245677889999999999999999999776444
Q ss_pred cCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCC
Q 041757 91 QGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDD 170 (381)
Q Consensus 91 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~ 170 (381)
..-+..|+|+|+| +-||.+.+ +....++...+..++.|++.||.|+| +.+|+||||||+|++++.+
T Consensus 96 ~~f~DvYiV~elM-etDL~~ii----------k~~~~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~ 161 (359)
T KOG0660|consen 96 DKFNDVYLVFELM-ETDLHQII----------KSQQDLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNAD 161 (359)
T ss_pred cccceeEEehhHH-hhHHHHHH----------HcCccccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccC
Confidence 5677889999999 55999999 45566999999999999999999999 7799999999999999999
Q ss_pred CCeEEeecccceecCCCCCcccccCccCccceeCCCCcC-CCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHH
Q 041757 171 MTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGV-GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKF 249 (381)
Q Consensus 171 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~ 249 (381)
..+||+|||+|+...........+..+.|..|+|||.+. ...|+.+.||||.|||+.||++|++-| .|.....++
T Consensus 162 c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplF----pG~d~v~Ql 237 (359)
T KOG0660|consen 162 CDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLF----PGKDYVHQL 237 (359)
T ss_pred CCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCC----CCCchHHHH
Confidence 999999999999886543233334577899999999765 578999999999999999999999985 444443333
Q ss_pred HHH--HhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 250 AKM--ALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 250 ~~~--~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
... ..+..-.+.+...-.......+...............+...+..++|+.+||..||.+|+|++|+++
T Consensus 238 ~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 238 QLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 221 1111112222211111111111111122222223334567778999999999999999999999986
No 29
>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]
Probab=100.00 E-value=3.3e-42 Score=297.41 Aligned_cols=180 Identities=24% Similarity=0.366 Sum_probs=163.5
Q ss_pred cccccccceecCCCceEEEecc--------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757 35 SRNMLEENLISAGTFGFSHLRR--------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND 94 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~--------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~ 94 (381)
-++|...+.||.|+||+|.+++ ...++...+|..+|+.+.||.++++++. +.+..
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t-----~~d~~ 117 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGT-----FKDNS 117 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEe-----eccCC
Confidence 4678889999999999997765 2356677889999999999999999998 45689
Q ss_pred eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757 95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR 174 (381)
Q Consensus 95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k 174 (381)
+.++||||.+||.|..++ .+.+++++..++-++.||+.||+||| +.+|++|||||+|||+|.+|.+|
T Consensus 118 ~lymvmeyv~GGElFS~L----------rk~~rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iK 184 (355)
T KOG0616|consen 118 NLYMVMEYVPGGELFSYL----------RKSGRFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIK 184 (355)
T ss_pred eEEEEEeccCCccHHHHH----------HhcCCCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEE
Confidence 999999999999999999 56788999999999999999999999 77999999999999999999999
Q ss_pred EeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCC
Q 041757 175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSD 237 (381)
Q Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~ 237 (381)
|+|||+|+.+.... ...+||+.|+|||++....|+.++|.|||||++|||+.|.+||.
T Consensus 185 itDFGFAK~v~~rT-----~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~ 242 (355)
T KOG0616|consen 185 ITDFGFAKRVSGRT-----WTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFY 242 (355)
T ss_pred EEeccceEEecCcE-----EEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCc
Confidence 99999999876542 12689999999999999999999999999999999999999975
No 30
>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=1.4e-42 Score=321.69 Aligned_cols=235 Identities=21% Similarity=0.284 Sum_probs=195.1
Q ss_pred ccccccceecCCCceEEEecc-------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce-
Q 041757 36 RNMLEENLISAGTFGFSHLRR-------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF- 95 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~-------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~- 95 (381)
++|...+++|+|+||.+++.+ ....+...+|+.+++++.|||||.+++.++ .++.
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~-----~~~~~ 78 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFE-----EDGQL 78 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchh-----cCCce
Confidence 678899999999999986544 223457889999999999999999999953 3555
Q ss_pred EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757 96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV 175 (381)
Q Consensus 96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl 175 (381)
.+|||+||+||++.+.+.. .+...++++.+..++.|++.|+.||| ...|+|||||+.||+++.+..+||
T Consensus 79 l~Ivm~Y~eGg~l~~~i~~--------~k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkL 147 (426)
T KOG0589|consen 79 LCIVMEYCEGGDLAQLIKE--------QKGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKL 147 (426)
T ss_pred EEEEEeecCCCCHHHHHHH--------HhhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceee
Confidence 9999999999999999964 33567899999999999999999999 669999999999999999999999
Q ss_pred eecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhh
Q 041757 176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALS 255 (381)
Q Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 255 (381)
+|||+|+.+........ .++||+.||+||.+.+.+|+.|+|||||||++|||++-+++|..
T Consensus 148 gDfGlaK~l~~~~~~a~--tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a----------------- 208 (426)
T KOG0589|consen 148 GDFGLAKILNPEDSLAS--TVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKA----------------- 208 (426)
T ss_pred cchhhhhhcCCchhhhh--eecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCc-----------------
Confidence 99999999877653222 36799999999999999999999999999999999999999751
Q ss_pred chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041757 256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE 320 (381)
Q Consensus 256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~ 320 (381)
.++..++.+...... .+.+.....++..++..|+..+|+.||++.+++.+
T Consensus 209 ~~m~~Li~ki~~~~~---------------~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 209 SNMSELILKINRGLY---------------SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred cchHHHHHHHhhccC---------------CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 122223322221110 11234677889999999999999999999999976
No 31
>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1. Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k
Probab=100.00 E-value=1.4e-41 Score=314.85 Aligned_cols=255 Identities=21% Similarity=0.346 Sum_probs=188.3
Q ss_pred cccccccceecCCCceEEEecc----------------------------------cccHHHHHHHHHHHHccCCCcccc
Q 041757 35 SRNMLEENLISAGTFGFSHLRR----------------------------------QGAFKSFIAECKALRNIRHRNLIK 80 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~----------------------------------~~~~~~~~~E~~~l~~l~h~nIv~ 80 (381)
.++|...++||+|+||.||++. ......|.+|+++|.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3578889999999999998753 112457889999999999999999
Q ss_pred eeeeeccccccCCceEEEEEEcccCCCHHHhhccccCCccc---------ccCCCcccHHHHHHHHHHHHHHHHHhhcCC
Q 041757 81 VLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDET---------YKRPRNLNLLRRLNIAIDVASALNYLHHDC 151 (381)
Q Consensus 81 ~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~---------~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ 151 (381)
+++++. ..+..++||||+++|+|.+++......... ......+++..++.++.|++.||.|||
T Consensus 84 ~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH--- 155 (304)
T cd05096 84 LLGVCV-----DEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS--- 155 (304)
T ss_pred EEEEEe-----cCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---
Confidence 999964 356789999999999999998532211000 112245788899999999999999999
Q ss_pred CCCceeeccCCCCeeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh
Q 041757 152 QPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI 231 (381)
Q Consensus 152 ~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t 231 (381)
+.+|+||||||+||+++.++.+||+|||+++.+.............++..|+|||++....++.++||||||+++|||++
T Consensus 156 ~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~ 235 (304)
T cd05096 156 SLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235 (304)
T ss_pred HCCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHH
Confidence 66999999999999999999999999999986644332222222346788999999988889999999999999999987
Q ss_pred --CCCCCCccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCC
Q 041757 232 --REKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQ 309 (381)
Q Consensus 232 --g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~ 309 (381)
+..||..... ...... ............ ....++.++..+.+++.+||+.||.
T Consensus 236 ~~~~~p~~~~~~-----~~~~~~-----~~~~~~~~~~~~---------------~~~~~~~~~~~~~~li~~cl~~~p~ 290 (304)
T cd05096 236 LCKEQPYGELTD-----EQVIEN-----AGEFFRDQGRQV---------------YLFRPPPCPQGLYELMLQCWSRDCR 290 (304)
T ss_pred ccCCCCCCcCCH-----HHHHHH-----HHHHhhhccccc---------------cccCCCCCCHHHHHHHHHHccCCch
Confidence 5567642211 111000 000000000000 0000124567899999999999999
Q ss_pred CCCCHHHHHHHHH
Q 041757 310 DRMKMTNVVHELQ 322 (381)
Q Consensus 310 ~RPs~~~vl~~L~ 322 (381)
+|||+.+|.+.|+
T Consensus 291 ~RPs~~~i~~~l~ 303 (304)
T cd05096 291 ERPSFSDIHAFLT 303 (304)
T ss_pred hCcCHHHHHHHHh
Confidence 9999999998875
No 32
>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]
Probab=100.00 E-value=5.8e-42 Score=317.47 Aligned_cols=230 Identities=20% Similarity=0.276 Sum_probs=186.4
Q ss_pred ccccccccceecCCCceEEEecc--------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757 34 VSRNMLEENLISAGTFGFSHLRR--------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN 93 (381)
Q Consensus 34 ~~~~~~~~~~lG~G~fg~V~~~~--------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 93 (381)
..++|...++||+|+||.||+++ .+.++....|-.+|....+|.||++|.. |++.
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYs-----FQD~ 213 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYS-----FQDK 213 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEE-----ecCC
Confidence 35789999999999999999876 3467788899999999999999999988 6789
Q ss_pred ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757 94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA 173 (381)
Q Consensus 94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~ 173 (381)
+++||||||++|||+..+| .+...|++..+..++.+++.|++.+| +.|+|||||||+|+|||..|++
T Consensus 214 ~~LYLiMEylPGGD~mTLL----------~~~~~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHi 280 (550)
T KOG0605|consen 214 EYLYLIMEYLPGGDMMTLL----------MRKDTLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHI 280 (550)
T ss_pred CeeEEEEEecCCccHHHHH----------HhcCcCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCE
Confidence 9999999999999999999 57788999999999999999999999 7799999999999999999999
Q ss_pred EEeecccceecCCC---------------------CCcc------------------------cccCccCccceeCCCCc
Q 041757 174 RVGDFGLARFLPPT---------------------RTQT------------------------SSIDVKGSIGYIAPEYG 208 (381)
Q Consensus 174 kl~Dfg~~~~~~~~---------------------~~~~------------------------~~~~~~gt~~y~aPE~l 208 (381)
||+|||++..+... .... ...+.+|||-|+|||++
T Consensus 281 KLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVl 360 (550)
T KOG0605|consen 281 KLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVL 360 (550)
T ss_pred eeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHH
Confidence 99999998543220 0000 01136799999999999
Q ss_pred CCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHHHHhhh--hccCchhhhhcccchhhhhHH
Q 041757 209 VGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSI--LLNDDEKLVVRGDQKQTQAKI 286 (381)
Q Consensus 209 ~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--l~~~~~~~~~~~~~~~~~~~~ 286 (381)
.+..|+..+|+||||||+|||+.|.+||. ++.....+.+. +... +....
T Consensus 361 l~kgY~~~cDwWSLG~ImyEmLvGyPPF~----s~tp~~T~rkI---------~nwr~~l~fP~---------------- 411 (550)
T KOG0605|consen 361 LGKGYGKECDWWSLGCIMYEMLVGYPPFC----SETPQETYRKI---------VNWRETLKFPE---------------- 411 (550)
T ss_pred hcCCCCccccHHHHHHHHHHHHhCCCCCC----CCCHHHHHHHH---------HHHhhhccCCC----------------
Confidence 99999999999999999999999999975 22222222111 1110 11111
Q ss_pred HHHHHHHHHHHHHHHhccCCCCCCCCC
Q 041757 287 NIIRECVISMVRIGVACSMESPQDRMK 313 (381)
Q Consensus 287 ~~~~~~~~~l~~l~~~cl~~dP~~RPs 313 (381)
...+..+..+||.+|+. ||++|.-
T Consensus 412 --~~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 412 --EVDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred --cCcccHHHHHHHHHHhc-CHHHhcC
Confidence 12344688899999998 9999975
No 33
>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit. Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce
Probab=100.00 E-value=1.3e-41 Score=324.00 Aligned_cols=251 Identities=22% Similarity=0.252 Sum_probs=189.5
Q ss_pred cccccccceecCCCceEEEecc-----------------------cccHHHHHHHHHHHHcc-CCCcccceeeeeccccc
Q 041757 35 SRNMLEENLISAGTFGFSHLRR-----------------------QGAFKSFIAECKALRNI-RHRNLIKVLTACLGVDY 90 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~-----------------------~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~ 90 (381)
.++|..+++||+|+||.||++. ....+.+.+|+++|..+ +||||++++++|.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~---- 109 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT---- 109 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec----
Confidence 4579999999999999997652 11235688999999999 7999999999964
Q ss_pred cCCceEEEEEEcccCCCHHHhhccccCCcc--------------------------------------------------
Q 041757 91 QGNDFKALVYEFMHNRSLKEWLYPISKEDE-------------------------------------------------- 120 (381)
Q Consensus 91 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~-------------------------------------------------- 120 (381)
.....++|||||++|+|.+++........
T Consensus 110 -~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 110 -VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred -cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 46778999999999999999854221000
Q ss_pred ---------------cccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccceecC
Q 041757 121 ---------------TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLP 185 (381)
Q Consensus 121 ---------------~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~ 185 (381)
.......+++..++.++.||+.||.||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~ 265 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIR 265 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceecc
Confidence 0001235788899999999999999999 6699999999999999999999999999998765
Q ss_pred CCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchHHHHHhh
Q 041757 186 PTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHVKDIVDS 264 (381)
Q Consensus 186 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (381)
............++..|+|||++.+..++.++|||||||++|||++ |..||...... ..+.. .+..
T Consensus 266 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~----~~~~~---------~~~~ 332 (375)
T cd05104 266 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD----SKFYK---------MIKE 332 (375)
T ss_pred CcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch----HHHHH---------HHHh
Confidence 4433222222335678999999999999999999999999999998 88887532111 11111 1110
Q ss_pred hhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 041757 265 ILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSI 324 (381)
Q Consensus 265 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i 324 (381)
..... .+...+.++.+++.+||+.||++|||+.+|++.|++.
T Consensus 333 ~~~~~------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 333 GYRML------------------SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CccCC------------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 00000 0112345788999999999999999999999999863
No 34
>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor. Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti
Probab=100.00 E-value=1.4e-41 Score=323.63 Aligned_cols=253 Identities=22% Similarity=0.292 Sum_probs=191.0
Q ss_pred ccccccccceecCCCceEEEeccc-----------------------ccHHHHHHHHHHHHcc-CCCcccceeeeecccc
Q 041757 34 VSRNMLEENLISAGTFGFSHLRRQ-----------------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVD 89 (381)
Q Consensus 34 ~~~~~~~~~~lG~G~fg~V~~~~~-----------------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~ 89 (381)
..++|...+.||+|+||.||++.. ...+.+.+|+++++.+ +|+||++++++|.
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~--- 112 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT--- 112 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEec---
Confidence 456899999999999999986431 1235678999999999 7999999999954
Q ss_pred ccCCceEEEEEEcccCCCHHHhhccccCC---------------------------------------------------
Q 041757 90 YQGNDFKALVYEFMHNRSLKEWLYPISKE--------------------------------------------------- 118 (381)
Q Consensus 90 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~--------------------------------------------------- 118 (381)
.....++|||||++|+|.+++......
T Consensus 113 --~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (374)
T cd05106 113 --HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS 190 (374)
T ss_pred --CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence 467889999999999999998532100
Q ss_pred ---------cccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccceecCCCCC
Q 041757 119 ---------DETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRT 189 (381)
Q Consensus 119 ---------~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 189 (381)
.........+++..++.++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~ 267 (374)
T cd05106 191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN 267 (374)
T ss_pred ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc
Confidence 000011245788999999999999999999 66999999999999999999999999999986654332
Q ss_pred cccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchHHHHHhhhhcc
Q 041757 190 QTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLN 268 (381)
Q Consensus 190 ~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 268 (381)
........++..|+|||++.+..++.++|||||||++|||++ |+.||....... .+. ..+......
T Consensus 268 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~~------------~~~~~~~~~ 334 (374)
T cd05106 268 YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KFY------------KMVKRGYQM 334 (374)
T ss_pred eeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HHH------------HHHHcccCc
Confidence 222222335678999999988899999999999999999997 999986322111 000 111100000
Q ss_pred CchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 041757 269 DDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIK 325 (381)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~ 325 (381)
. .+...+.++.+++.+||+.||.+|||+.+|++.|+++.
T Consensus 335 ~------------------~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 335 S------------------RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred c------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 0 01123467889999999999999999999999998864
No 35
>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]
Probab=100.00 E-value=1.1e-41 Score=298.49 Aligned_cols=263 Identities=20% Similarity=0.215 Sum_probs=193.5
Q ss_pred cccccccceecCCCceEEEeccccc-------------------HHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757 35 SRNMLEENLISAGTFGFSHLRRQGA-------------------FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF 95 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~~~~-------------------~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~ 95 (381)
-++|...++|++|+||.||.++... --..++|+.+|.+++|||||.+-.+.++ .+-+.
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG---~~~d~ 151 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVG---SNMDK 151 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEec---cccce
Confidence 4678889999999999999987432 2245789999999999999999999764 45666
Q ss_pred EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757 96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV 175 (381)
Q Consensus 96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl 175 (381)
+|+|||||+. ||..++. .-..++...++..+..|+++|++||| ...|+||||||+|+|++..|.+||
T Consensus 152 iy~VMe~~Eh-DLksl~d---------~m~q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKi 218 (419)
T KOG0663|consen 152 IYIVMEYVEH-DLKSLME---------TMKQPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKI 218 (419)
T ss_pred eeeeHHHHHh-hHHHHHH---------hccCCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEe
Confidence 9999999976 9999996 34568999999999999999999999 559999999999999999999999
Q ss_pred eecccceecCCCCCcccccCccCccceeCCCCcCCC-ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH-
Q 041757 176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA- 253 (381)
Q Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~- 253 (381)
+|||+|+.+........ ..+-|..|+|||.+.+. .|+++.|+||+|||+.|++++++.| .+...+.++.+..
T Consensus 219 aDFGLAR~ygsp~k~~T--~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf----~G~sE~dQl~~If~ 292 (419)
T KOG0663|consen 219 ADFGLAREYGSPLKPYT--PLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLF----PGKSEIDQLDKIFK 292 (419)
T ss_pred cccchhhhhcCCcccCc--ceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCC----CCCchHHHHHHHHH
Confidence 99999998877643332 35689999999998874 5999999999999999999999985 4444444332221
Q ss_pred -hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHH-HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 254 -LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRE-CVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 254 -~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
+......+....-.....+......+.....+..+... ....-.+|+...+.+||.+|.|++|.++
T Consensus 293 llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 293 LLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred HhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 11111111100000000000111111111111111111 3456788899999999999999999886
No 36
>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]
Probab=100.00 E-value=6.2e-43 Score=335.01 Aligned_cols=245 Identities=24% Similarity=0.384 Sum_probs=204.2
Q ss_pred ccccceecCCCceEEEecc---------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757 38 MLEENLISAGTFGFSHLRR---------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK 96 (381)
Q Consensus 38 ~~~~~~lG~G~fg~V~~~~---------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~ 96 (381)
..++++||.|.||.|+..+ ..+...|+.|+.||.+++||||+++.|+ .......
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGV-----VTks~Pv 705 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGV-----VTKSKPV 705 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEE-----EecCcee
Confidence 4567999999999996543 4567899999999999999999999999 4558889
Q ss_pred EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757 97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG 176 (381)
Q Consensus 97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~ 176 (381)
+||+|||++|+|+.||+ ...+.++..+...+++.|+.|+.||- .+++|||||..+|||++.+-.+|++
T Consensus 706 MIiTEyMENGsLDsFLR---------~~DGqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILVNsnLvCKVs 773 (996)
T KOG0196|consen 706 MIITEYMENGSLDSFLR---------QNDGQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILVNSNLVCKVS 773 (996)
T ss_pred EEEhhhhhCCcHHHHHh---------hcCCceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheeeccceEEEec
Confidence 99999999999999997 45677999999999999999999999 7799999999999999999999999
Q ss_pred ecccceecCCCCC-cccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHh
Q 041757 177 DFGLARFLPPTRT-QTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMAL 254 (381)
Q Consensus 177 Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~ 254 (381)
|||+++.+.++.. ........-+++|.|||.+...+++.+|||||||++|||+++ |..||..+...+
T Consensus 774 DFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd----------- 842 (996)
T KOG0196|consen 774 DFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD----------- 842 (996)
T ss_pred cccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH-----------
Confidence 9999998866552 222222334689999999999999999999999999999886 999976443211
Q ss_pred hchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhcCCC
Q 041757 255 SNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLLGP 331 (381)
Q Consensus 255 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~~~~~ 331 (381)
.++.+-+. .+.+.|.+|+..|.+||+.||++|-.+||++.||+..|+++......-
T Consensus 843 --VIkaIe~g-------------------yRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SL 898 (996)
T KOG0196|consen 843 --VIKAIEQG-------------------YRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSL 898 (996)
T ss_pred --HHHHHHhc-------------------cCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhh
Confidence 11111111 122235689999999999999999999999999999999998765443
No 37
>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]
Probab=100.00 E-value=7.5e-42 Score=288.40 Aligned_cols=258 Identities=19% Similarity=0.266 Sum_probs=202.5
Q ss_pred hhccccccccceecCCCceEEEecc-----------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757 32 LDVSRNMLEENLISAGTFGFSHLRR-----------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND 94 (381)
Q Consensus 32 ~~~~~~~~~~~~lG~G~fg~V~~~~-----------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~ 94 (381)
..-.++|.+.+.||+|||+.|++++ ....+..++|++..++++||||++++++++........
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 3346789999999999999998876 24677889999999999999999999998754344567
Q ss_pred eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757 95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR 174 (381)
Q Consensus 95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k 174 (381)
..||+++|...|+|.+.+.... .+...+++.+.+.|+.++++||.+||+. ...+.||||||.|||+.+.+.++
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k------~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~v 169 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLK------IKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPV 169 (302)
T ss_pred eEEEEeehhccccHHHHHHHHh------hcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceE
Confidence 7999999999999999996543 3456799999999999999999999966 44599999999999999999999
Q ss_pred EeecccceecCCCCCccc-------ccCccCccceeCCCCcC---CCccCcccchhhhhHHHHHHHhCCCCCCccccCCC
Q 041757 175 VGDFGLARFLPPTRTQTS-------SIDVKGSIGYIAPEYGV---GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDM 244 (381)
Q Consensus 175 l~Dfg~~~~~~~~~~~~~-------~~~~~gt~~y~aPE~l~---~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~ 244 (381)
|.|||.+........... ...-..|..|+|||.+. +...++++|||||||++|+|+.|..||+..+..+.
T Consensus 170 l~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg 249 (302)
T KOG2345|consen 170 LMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG 249 (302)
T ss_pred EEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC
Confidence 999999876553221111 11234789999999876 34578999999999999999999999986654332
Q ss_pred cHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 041757 245 NLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSI 324 (381)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i 324 (381)
++.-. +....+.. |+ ....+..+.+++..|++.||.+||++.+++..++.+
T Consensus 250 SlaLA-----------v~n~q~s~-P~-----------------~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 250 SLALA-----------VQNAQISI-PN-----------------SSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred eEEEe-----------eecccccc-CC-----------------CCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 21110 00000000 00 012667899999999999999999999999998876
Q ss_pred h
Q 041757 325 K 325 (381)
Q Consensus 325 ~ 325 (381)
.
T Consensus 301 i 301 (302)
T KOG2345|consen 301 I 301 (302)
T ss_pred c
Confidence 3
No 38
>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=2.8e-42 Score=289.67 Aligned_cols=232 Identities=21% Similarity=0.320 Sum_probs=193.7
Q ss_pred cccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757 35 SRNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND 94 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~ 94 (381)
-++|.+++.||+|.||.||+++. +...++.+|+++.+.|+||||+++|++ +.+..
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~-----fhd~~ 95 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGY-----FHDSK 95 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhh-----eeccc
Confidence 47899999999999999999762 234677899999999999999999999 55688
Q ss_pred eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757 95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR 174 (381)
Q Consensus 95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k 174 (381)
..||++||.++|.|...|.. .....+++.....+..|+|.||.|+| .++|+||||||+|+|++..+.+|
T Consensus 96 riyLilEya~~gel~k~L~~--------~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lk 164 (281)
T KOG0580|consen 96 RIYLILEYAPRGELYKDLQE--------GRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELK 164 (281)
T ss_pred eeEEEEEecCCchHHHHHHh--------cccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCee
Confidence 99999999999999999953 24567889999999999999999999 77999999999999999999999
Q ss_pred EeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHh
Q 041757 175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMAL 254 (381)
Q Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 254 (381)
|+|||.+...+.+...+ .+||.-|.+||+..+..++..+|+|++|++.||++.|.+||..... +..+..+...
T Consensus 165 iAdfGwsV~~p~~kR~t----lcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~-~etYkrI~k~-- 237 (281)
T KOG0580|consen 165 IADFGWSVHAPSNKRKT----LCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH-SETYKRIRKV-- 237 (281)
T ss_pred ccCCCceeecCCCCcee----eecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh-HHHHHHHHHc--
Confidence 99999998766333332 6799999999999999999999999999999999999999874431 1111111111
Q ss_pred hchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 255 SNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 255 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
-.. ++...+....+++.+|+..+|.+|.+..|++.
T Consensus 238 -----------~~~-------------------~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 238 -----------DLK-------------------FPSTISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred -----------ccc-------------------CCcccChhHHHHHHHHhccCccccccHHHHhh
Confidence 000 12355668889999999999999999999875
No 39
>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=8.3e-42 Score=305.97 Aligned_cols=230 Identities=21% Similarity=0.300 Sum_probs=191.1
Q ss_pred cccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757 35 SRNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND 94 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~ 94 (381)
...|++.+.||+|+||.|.++.. ...-...+|+++|+.|+||||+.+|.+ |++.+
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEV-----FENkd 126 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEV-----FENKD 126 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhh-----hcCCc
Confidence 46688899999999999966542 234456789999999999999999999 78899
Q ss_pred eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757 95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR 174 (381)
Q Consensus 95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k 174 (381)
.+.|||||..+|.|++|+ ...+.+++.++..+++||..|+.|+| +.+++|||||.+|||+|.++.+|
T Consensus 127 KIvivMEYaS~GeLYDYi----------Ser~~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiK 193 (668)
T KOG0611|consen 127 KIVIVMEYASGGELYDYI----------SERGSLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIK 193 (668)
T ss_pred eEEEEEEecCCccHHHHH----------HHhccccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCee
Confidence 999999999999999999 56788999999999999999999999 67999999999999999999999
Q ss_pred EeecccceecCCCCCcccccCccCccceeCCCCcCCCcc-CcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH
Q 041757 175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEV-STIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA 253 (381)
Q Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~ 253 (381)
|+|||++-.+....... .++|++.|.+||++.+.+| ++.+|-|||||+||.|+.|..||+..
T Consensus 194 IADFGLSNly~~~kfLq---TFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~-------------- 256 (668)
T KOG0611|consen 194 IADFGLSNLYADKKFLQ---TFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR-------------- 256 (668)
T ss_pred eeccchhhhhccccHHH---HhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc--------------
Confidence 99999998776655443 3789999999999999988 57899999999999999999998621
Q ss_pred hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 254 LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 254 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
+.+.++..+-...+. -++.+....-|++.||..||+.|.|+.+|..
T Consensus 257 ---Dhk~lvrQIs~GaYr-----------------EP~~PSdA~gLIRwmLmVNP~RRATieDiAs 302 (668)
T KOG0611|consen 257 ---DHKRLVRQISRGAYR-----------------EPETPSDASGLIRWMLMVNPERRATIEDIAS 302 (668)
T ss_pred ---hHHHHHHHhhccccc-----------------CCCCCchHHHHHHHHHhcCcccchhHHHHhh
Confidence 112222222211111 0233446677888999999999999999875
No 40
>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants. Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos
Probab=100.00 E-value=2.5e-41 Score=317.79 Aligned_cols=267 Identities=18% Similarity=0.201 Sum_probs=184.7
Q ss_pred cccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757 37 NMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA 97 (381)
Q Consensus 37 ~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~ 97 (381)
.|...++||+|+||.||++.. .....+.+|++++++++||||+++++++...+.......+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 478889999999999987641 1234578999999999999999999987643333345689
Q ss_pred EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757 98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD 177 (381)
Q Consensus 98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D 177 (381)
+|||||. ++|.+++. ....+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|
T Consensus 81 lv~e~~~-~~L~~~l~----------~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~D 146 (338)
T cd07859 81 VVFELME-SDLHQVIK----------ANDDLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICD 146 (338)
T ss_pred EEEecCC-CCHHHHHH----------hcccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEcc
Confidence 9999995 69999883 4456899999999999999999999 66999999999999999999999999
Q ss_pred cccceecCCCCCc-ccccCccCccceeCCCCcCC--CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHh
Q 041757 178 FGLARFLPPTRTQ-TSSIDVKGSIGYIAPEYGVG--NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMAL 254 (381)
Q Consensus 178 fg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~--~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 254 (381)
||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ...........
T Consensus 147 fg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~--~~~~~~~~~~~ 224 (338)
T cd07859 147 FGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV--VHQLDLITDLL 224 (338)
T ss_pred CccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCCh--HHHHHHHHHHh
Confidence 9999765332211 11123568999999998865 6789999999999999999999999853211 00001111111
Q ss_pred hchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 255 SNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 255 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
.....+.............................+.....+.+++.+||+.||++|||+.++++
T Consensus 225 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 225 GTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred CCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 11101111100000000000000000000000001123457789999999999999999999996
No 41
>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt
Probab=100.00 E-value=1.7e-41 Score=312.38 Aligned_cols=228 Identities=22% Similarity=0.290 Sum_probs=182.7
Q ss_pred ccccccceecCCCceEEEecccc--------------------cHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757 36 RNMLEENLISAGTFGFSHLRRQG--------------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF 95 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~~--------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~ 95 (381)
++|...+.||+|+||.||++... ..+.+.+|+.++++++||||++++++ +.+...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~-----~~~~~~ 75 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWT-----EHDQRF 75 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhh-----hccCCe
Confidence 46888999999999999876521 23457789999999999999999988 455788
Q ss_pred EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757 96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV 175 (381)
Q Consensus 96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl 175 (381)
.++||||+++|+|.+++. ....+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||
T Consensus 76 ~~lv~e~~~~~~L~~~~~----------~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl 142 (291)
T cd05612 76 LYMLMEYVPGGELFSYLR----------NSGRFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKL 142 (291)
T ss_pred EEEEEeCCCCCCHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEE
Confidence 999999999999999993 4556889999999999999999999 679999999999999999999999
Q ss_pred eecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhh
Q 041757 176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALS 255 (381)
Q Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 255 (381)
+|||+++....... ...|++.|+|||++.+..++.++|||||||++|+|++|+.||.... . ...
T Consensus 143 ~Dfg~~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~----~-~~~------ 206 (291)
T cd05612 143 TDFGFAKKLRDRTW-----TLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN----P-FGI------ 206 (291)
T ss_pred EecCcchhccCCcc-----cccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----H-HHH------
Confidence 99999976543221 2458999999999999889999999999999999999999985221 1 111
Q ss_pred chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 041757 256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMK-----MTNVVH 319 (381)
Q Consensus 256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~~vl~ 319 (381)
......... .++......+.+++.+||+.||.+||+ +.++++
T Consensus 207 ------~~~i~~~~~----------------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 207 ------YEKILAGKL----------------EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred ------HHHHHhCCc----------------CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 111110000 001233457889999999999999995 777764
No 42
>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be
Probab=100.00 E-value=2.3e-41 Score=316.23 Aligned_cols=225 Identities=24% Similarity=0.310 Sum_probs=178.8
Q ss_pred ceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEE
Q 041757 42 NLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYE 101 (381)
Q Consensus 42 ~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e 101 (381)
++||+|+||.||++.. .....+.+|+.++++++||||+++++++ ...+..++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSF-----QTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----EcCCEEEEEEe
Confidence 4699999999987642 1234677899999999999999999984 45788999999
Q ss_pred cccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccc
Q 041757 102 FMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLA 181 (381)
Q Consensus 102 ~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~ 181 (381)
|+++|+|.+++. ....+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 76 ~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a 142 (323)
T cd05571 76 YANGGELFFHLS----------RERVFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLC 142 (323)
T ss_pred CCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCC
Confidence 999999999983 4567899999999999999999999 679999999999999999999999999998
Q ss_pred eecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHHH
Q 041757 182 RFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDI 261 (381)
Q Consensus 182 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (381)
+........ .....||+.|+|||++.+..++.++|||||||++|||++|..||... .....
T Consensus 143 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~-----~~~~~------------ 203 (323)
T cd05571 143 KEGISDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-----DHEKL------------ 203 (323)
T ss_pred cccccCCCc--ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCC-----CHHHH------------
Confidence 754322211 12256999999999999999999999999999999999999998521 11111
Q ss_pred HhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 041757 262 VDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRM-----KMTNVVH 319 (381)
Q Consensus 262 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~~vl~ 319 (381)
......... .++.....++.+++.+||+.||++|| ++.++++
T Consensus 204 ~~~~~~~~~----------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 204 FELILMEEI----------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred HHHHHcCCC----------------CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 111110000 01123456788999999999999999 7888875
No 43
>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=2.2e-41 Score=308.82 Aligned_cols=239 Identities=22% Similarity=0.271 Sum_probs=185.2
Q ss_pred cccccccceecCCCceEEEeccc-------------------------------ccHHHHHHHHHHHHccCCCcccceee
Q 041757 35 SRNMLEENLISAGTFGFSHLRRQ-------------------------------GAFKSFIAECKALRNIRHRNLIKVLT 83 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~~-------------------------------~~~~~~~~E~~~l~~l~h~nIv~~~~ 83 (381)
-++|..++.||+|.||.|.++.. ...+...+|+.+|++++|||||+++.
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 46799999999999999966541 13468889999999999999999999
Q ss_pred eeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCc-ccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCC
Q 041757 84 ACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRN-LNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKP 162 (381)
Q Consensus 84 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~-l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp 162 (381)
+.- ....+.+|||+|||..|.+...- .... +++.+++.+++++..||+||| .++||||||||
T Consensus 176 vLD---DP~s~~~YlVley~s~G~v~w~p-----------~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKP 238 (576)
T KOG0585|consen 176 VLD---DPESDKLYLVLEYCSKGEVKWCP-----------PDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKP 238 (576)
T ss_pred eec---CcccCceEEEEEeccCCccccCC-----------CCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccch
Confidence 943 35678899999999998876432 2333 999999999999999999999 77999999999
Q ss_pred CCeeeCCCCCeEEeecccceecCCCCC---cccccCccCccceeCCCCcCCCc----cCcccchhhhhHHHHHHHhCCCC
Q 041757 163 SNVLLDDDMTARVGDFGLARFLPPTRT---QTSSIDVKGSIGYIAPEYGVGNE----VSTIGDVYSYGILLLELMIREKP 235 (381)
Q Consensus 163 ~Nill~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~gt~~y~aPE~l~~~~----~~~~sDiwSlG~il~el~tg~~P 235 (381)
+|+|++++|++||+|||.+........ .......+||+.|+|||...+.. -+.+.||||+||+||.++.|+.|
T Consensus 239 sNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~P 318 (576)
T KOG0585|consen 239 SNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLP 318 (576)
T ss_pred hheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCC
Confidence 999999999999999999987643311 11112357999999999887632 35678999999999999999999
Q ss_pred CCccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHH
Q 041757 236 SDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMT 315 (381)
Q Consensus 236 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 315 (381)
|-. + ...++.+++....-.- +..++....+.+|+.++|.+||+.|.+..
T Consensus 319 F~~----~-------------~~~~l~~KIvn~pL~f--------------P~~pe~~e~~kDli~~lL~KdP~~Ri~l~ 367 (576)
T KOG0585|consen 319 FFD----D-------------FELELFDKIVNDPLEF--------------PENPEINEDLKDLIKRLLEKDPEQRITLP 367 (576)
T ss_pred ccc----c-------------hHHHHHHHHhcCcccC--------------CCcccccHHHHHHHHHHhhcChhheeehh
Confidence 742 1 1223333332211100 00124567888999999999999999999
Q ss_pred HHHHHH
Q 041757 316 NVVHEL 321 (381)
Q Consensus 316 ~vl~~L 321 (381)
+|....
T Consensus 368 ~ik~Hp 373 (576)
T KOG0585|consen 368 DIKLHP 373 (576)
T ss_pred hheecc
Confidence 987543
No 44
>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]
Probab=100.00 E-value=2.3e-41 Score=330.76 Aligned_cols=255 Identities=20% Similarity=0.225 Sum_probs=198.7
Q ss_pred ccccccccceecCCCceEEEecc-----------------cccHHHHHHHHHHHHccC-CCcccceeeeecc-ccccC-C
Q 041757 34 VSRNMLEENLISAGTFGFSHLRR-----------------QGAFKSFIAECKALRNIR-HRNLIKVLTACLG-VDYQG-N 93 (381)
Q Consensus 34 ~~~~~~~~~~lG~G~fg~V~~~~-----------------~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~-~~~~~-~ 93 (381)
...+..++++|.+|||+.||++. ....+...+|+++|++|+ |+|||.+++.... ....+ .
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 45667888999999999999875 235677889999999997 9999999994322 11122 3
Q ss_pred ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757 94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA 173 (381)
Q Consensus 94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~ 173 (381)
-.++|.||||.||.|-+++.. .....|++.++++|+.|+|+|+.+||.. +..|||||||-+||||+.++..
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~--------Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~ 185 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNT--------RLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNY 185 (738)
T ss_pred eEEEeehhhccCCcHHHHHHH--------HHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCE
Confidence 567899999999999999964 2345599999999999999999999977 7789999999999999999999
Q ss_pred EEeecccceecCCCCCcccc-------cCccCccceeCCCCc---CCCccCcccchhhhhHHHHHHHhCCCCCCccccCC
Q 041757 174 RVGDFGLARFLPPTRTQTSS-------IDVKGSIGYIAPEYG---VGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD 243 (381)
Q Consensus 174 kl~Dfg~~~~~~~~~~~~~~-------~~~~gt~~y~aPE~l---~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~ 243 (381)
||||||.+............ .....|+.|+|||++ .+..+++|+|||||||+||.|+....||+....-
T Consensus 186 KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l- 264 (738)
T KOG1989|consen 186 KLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL- 264 (738)
T ss_pred EeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce-
Confidence 99999998643332211111 113368999999975 4678999999999999999999999998622110
Q ss_pred CcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 041757 244 MNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQS 323 (381)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~ 323 (381)
.+++. .+ ..+..+.+...+.+||..||+.||.+||++.+|++.+..
T Consensus 265 ----------------aIlng----~Y--------------~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~ 310 (738)
T KOG1989|consen 265 ----------------AILNG----NY--------------SFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE 310 (738)
T ss_pred ----------------eEEec----cc--------------cCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence 01110 00 001124678899999999999999999999999999999
Q ss_pred hhhhcCCCC
Q 041757 324 IKNTLLGPK 332 (381)
Q Consensus 324 i~~~~~~~~ 332 (381)
+........
T Consensus 311 l~~~~~~~~ 319 (738)
T KOG1989|consen 311 LANKPCPIP 319 (738)
T ss_pred HhcCCCCcc
Confidence 987655433
No 45
>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes
Probab=100.00 E-value=7.7e-41 Score=307.27 Aligned_cols=262 Identities=18% Similarity=0.214 Sum_probs=186.9
Q ss_pred ccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK 96 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~ 96 (381)
++|...+.||+|+||.||++.. ...+.+.+|+.+++.++||||+++++++ ...+..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 75 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAF-----RRRGKL 75 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhE-----ecCCEE
Confidence 4688999999999999987542 1245678999999999999999999984 457789
Q ss_pred EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757 97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG 176 (381)
Q Consensus 97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~ 176 (381)
++||||++++.+..+. .....+++..+..++.|++.||.||| ..+|+||||||+||+++.++.+||+
T Consensus 76 ~lv~e~~~~~~l~~~~----------~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~ 142 (287)
T cd07848 76 YLVFEYVEKNMLELLE----------EMPNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLC 142 (287)
T ss_pred EEEEecCCCCHHHHHH----------hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEe
Confidence 9999999987776554 23456889999999999999999999 6699999999999999999999999
Q ss_pred ecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhc
Q 041757 177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSN 256 (381)
Q Consensus 177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~ 256 (381)
|||++.......... .....|++.|+|||++.+..++.++|||||||++|||++|+.||......+ ....... ....
T Consensus 143 Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~-~~~~~~~-~~~~ 219 (287)
T cd07848 143 DFGFARNLSEGSNAN-YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEID-QLFTIQK-VLGP 219 (287)
T ss_pred eccCccccccccccc-ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH-hhCC
Confidence 999998764432211 112468999999999998889999999999999999999999985321111 0011100 0000
Q ss_pred hHHHHHhhhhccCchh--hhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 257 HVKDIVDSILLNDDEK--LVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 257 ~~~~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
...+..... ..++.. ....................+..+.+++.+||+.||++|||+.++++
T Consensus 220 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 220 LPAEQMKLF-YSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred CCHHHHHhh-hccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000111000 000000 00000000000011112235668999999999999999999999875
No 46
>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor
Probab=100.00 E-value=6.8e-41 Score=304.38 Aligned_cols=240 Identities=22% Similarity=0.314 Sum_probs=187.9
Q ss_pred cccccccceecCCCceEEEeccc---------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757 35 SRNMLEENLISAGTFGFSHLRRQ---------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN 93 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~~---------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 93 (381)
.++|...+.||+|+||.||++.. .....|.+|+.++.+++||||+++++++. ..
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~ 78 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVIT-----RG 78 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEe-----cC
Confidence 35688999999999999976521 12356889999999999999999999953 46
Q ss_pred ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757 94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA 173 (381)
Q Consensus 94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~ 173 (381)
+..++||||+++|+|.+++. .....+++..++.++.|++.||+||| +.+++||||||+||+++.++.+
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~---------~~~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~ 146 (266)
T cd05064 79 NTMMIVTEYMSNGALDSFLR---------KHEGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVC 146 (266)
T ss_pred CCcEEEEEeCCCCcHHHHHH---------hCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcE
Confidence 78999999999999999985 22356899999999999999999999 6699999999999999999999
Q ss_pred EEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHH
Q 041757 174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKM 252 (381)
Q Consensus 174 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~ 252 (381)
+++|||.+.......... .....++..|+|||++.+..++.++|||||||++||+++ |..||..... .....
T Consensus 147 ~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~-----~~~~~- 219 (266)
T cd05064 147 KISGFRRLQEDKSEAIYT-TMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG-----QDVIK- 219 (266)
T ss_pred EECCCcccccccccchhc-ccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH-----HHHHH-
Confidence 999999876543222111 111335678999999998899999999999999999875 9999853211 11100
Q ss_pred HhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 041757 253 ALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSI 324 (381)
Q Consensus 253 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i 324 (381)
.+.+.... ..+..++..+.+++.+||+.+|.+||++.+|++.|.++
T Consensus 220 -------~~~~~~~~-------------------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 220 -------AVEDGFRL-------------------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -------HHHCCCCC-------------------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 01000000 01234667899999999999999999999999998764
No 47
>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i
Probab=100.00 E-value=8.1e-41 Score=307.01 Aligned_cols=235 Identities=22% Similarity=0.282 Sum_probs=182.3
Q ss_pred cccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757 37 NMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK 96 (381)
Q Consensus 37 ~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~ 96 (381)
+|...+.||+|+||.||++.. .....+.+|+.++.+++|+||+++++++ ...+..
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~-----~~~~~~ 75 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAY-----ETKDAL 75 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEE-----ccCCeE
Confidence 477889999999999977541 1123577899999999999999999985 446789
Q ss_pred EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757 97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG 176 (381)
Q Consensus 97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~ 176 (381)
++||||+++|+|..++.. .....+++..++.++.|++.||.||| +.+|+||||||+||+++.++.+||+
T Consensus 76 ~lv~e~~~~g~L~~~~~~--------~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~ 144 (285)
T cd05631 76 CLVLTIMNGGDLKFHIYN--------MGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRIS 144 (285)
T ss_pred EEEEEecCCCcHHHHHHh--------hCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEe
Confidence 999999999999988742 12346889999999999999999999 7799999999999999999999999
Q ss_pred ecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhc
Q 041757 177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSN 256 (381)
Q Consensus 177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~ 256 (381)
|||++.......... ...||..|+|||++.+..++.++|||||||++|||++|+.||....... ....
T Consensus 145 Dfg~~~~~~~~~~~~---~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-~~~~-------- 212 (285)
T cd05631 145 DLGLAVQIPEGETVR---GRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV-KREE-------- 212 (285)
T ss_pred eCCCcEEcCCCCeec---CCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch-hHHH--------
Confidence 999998764332221 2458999999999999999999999999999999999999986322110 0000
Q ss_pred hHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 041757 257 HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMK-----MTNVVH 319 (381)
Q Consensus 257 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~~vl~ 319 (381)
+...+.... ...+...+..+.+++.+||+.||.+||+ +.++++
T Consensus 213 -----~~~~~~~~~---------------~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 213 -----VDRRVKEDQ---------------EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred -----HHHHhhccc---------------ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 110000000 0001234567889999999999999997 677775
No 48
>PTZ00263 protein kinase A catalytic subunit; Provisional
Probab=100.00 E-value=3.1e-41 Score=316.05 Aligned_cols=229 Identities=18% Similarity=0.220 Sum_probs=183.4
Q ss_pred cccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757 35 SRNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND 94 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~ 94 (381)
-++|...+.||+|+||.||++.. ...+.+.+|+.++++++||||+++++++ ...+
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~ 91 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSF-----QDEN 91 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----EcCC
Confidence 36789999999999999987642 1235678899999999999999999984 4578
Q ss_pred eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757 95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR 174 (381)
Q Consensus 95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k 174 (381)
..++||||+++|+|.+++. ....+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+|
T Consensus 92 ~~~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~k 158 (329)
T PTZ00263 92 RVYFLLEFVVGGELFTHLR----------KAGRFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVK 158 (329)
T ss_pred EEEEEEcCCCCChHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEE
Confidence 8999999999999999994 4556888999999999999999999 67999999999999999999999
Q ss_pred EeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHh
Q 041757 175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMAL 254 (381)
Q Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 254 (381)
|+|||+++....... ...||+.|+|||++.+..++.++|||||||++|+|++|..||... ..... ..
T Consensus 159 l~Dfg~~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~----~~~~~-~~--- 225 (329)
T PTZ00263 159 VTDFGFAKKVPDRTF-----TLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDD----TPFRI-YE--- 225 (329)
T ss_pred EeeccCceEcCCCcc-----eecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCC----CHHHH-HH---
Confidence 999999987644322 245899999999999989999999999999999999999997521 11111 11
Q ss_pred hchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 041757 255 SNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMK-----MTNVVH 319 (381)
Q Consensus 255 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~~vl~ 319 (381)
.+... ... .+......+.+++.+||+.||.+||+ +.+++.
T Consensus 226 -----~i~~~----~~~----------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 226 -----KILAG----RLK----------------FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred -----HHhcC----CcC----------------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 01110 000 01123456788999999999999997 577664
No 49
>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]
Probab=100.00 E-value=1.5e-41 Score=318.34 Aligned_cols=235 Identities=23% Similarity=0.356 Sum_probs=200.5
Q ss_pred cceecCCCceEEEecc----------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEE
Q 041757 41 ENLISAGTFGFSHLRR----------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKAL 98 (381)
Q Consensus 41 ~~~lG~G~fg~V~~~~----------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~l 98 (381)
.++||.|-||.||.+. ....+.|+.|..+|++++|||||+++|+|. ....||
T Consensus 394 ~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~------e~P~Wi 467 (974)
T KOG4257|consen 394 KRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCV------EQPMWI 467 (974)
T ss_pred HHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeee------ccceeE
Confidence 4899999999997642 235788999999999999999999999986 567899
Q ss_pred EEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeec
Q 041757 99 VYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDF 178 (381)
Q Consensus 99 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df 178 (381)
|||+++.|.|..||. .....++......++.||+.||+||| ++++|||||..+|||+.....+||+||
T Consensus 468 vmEL~~~GELr~yLq---------~nk~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDF 535 (974)
T KOG4257|consen 468 VMELAPLGELREYLQ---------QNKDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADF 535 (974)
T ss_pred EEecccchhHHHHHH---------hccccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeeccc
Confidence 999999999999997 45677999999999999999999999 789999999999999999999999999
Q ss_pred ccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhch
Q 041757 179 GLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNH 257 (381)
Q Consensus 179 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 257 (381)
|+++.+........+. ..-++.|||||.+....++.+||||-|||.+||++. |..||......+.
T Consensus 536 GLSR~~ed~~yYkaS~-~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV------------- 601 (974)
T KOG4257|consen 536 GLSRYLEDDAYYKASR-GKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV------------- 601 (974)
T ss_pred chhhhccccchhhccc-cccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce-------------
Confidence 9999998877666553 446789999999999999999999999999999875 9999864332221
Q ss_pred HHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 041757 258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKN 326 (381)
Q Consensus 258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~ 326 (381)
+.. .....+.+.+++|++.+..|+.+||.+||.+||.+.++...|+.+..
T Consensus 602 ----I~~---------------iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 602 ----IGH---------------IENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred ----EEE---------------ecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 110 01112334567999999999999999999999999999999988765
No 50
>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors. Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer
Probab=100.00 E-value=1.4e-40 Score=304.85 Aligned_cols=249 Identities=20% Similarity=0.336 Sum_probs=191.7
Q ss_pred ccccccceecCCCceEEEeccc-----------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccC
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ-----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQG 92 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~-----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 92 (381)
.+|+..+.||+|+||.||++.. .....|.+|+.++.+++||||+++++++. .
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~-----~ 79 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCT-----K 79 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEc-----C
Confidence 4678889999999999986531 12356889999999999999999999953 4
Q ss_pred CceEEEEEEcccCCCHHHhhccccCCccc------ccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCee
Q 041757 93 NDFKALVYEFMHNRSLKEWLYPISKEDET------YKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVL 166 (381)
Q Consensus 93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~------~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nil 166 (381)
....+++|||+++|+|.+++......... ......+++..++.++.|++.||.||| ..+++||||||+||+
T Consensus 80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil 156 (283)
T cd05048 80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCL 156 (283)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEE
Confidence 67789999999999999999643211100 011256888999999999999999999 669999999999999
Q ss_pred eCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCc
Q 041757 167 LDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMN 245 (381)
Q Consensus 167 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~ 245 (381)
+++++.++|+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 157 ~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~---- 232 (283)
T cd05048 157 VGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN---- 232 (283)
T ss_pred EcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH----
Confidence 99999999999999986544332222222446888999999988889999999999999999998 9999753211
Q ss_pred HHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 041757 246 LHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSI 324 (381)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i 324 (381)
.. +......... ...+..++.++.+++.+||+.||.+||++.+|++.|+++
T Consensus 233 -~~------------~~~~i~~~~~---------------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 233 -QE------------VIEMIRSRQL---------------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred -HH------------HHHHHHcCCc---------------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 11 1111000000 001235678899999999999999999999999999763
No 51
>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2. Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst
Probab=100.00 E-value=1.5e-40 Score=311.70 Aligned_cols=182 Identities=23% Similarity=0.303 Sum_probs=157.8
Q ss_pred cccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757 35 SRNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK 96 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~ 96 (381)
.++|...+.||+|+||.||++.. ...+.+.+|+++|++++||||+++++++. ..+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 78 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGEI 78 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-----ECCEE
Confidence 57899999999999999977542 12457889999999999999999999954 46789
Q ss_pred EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757 97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG 176 (381)
Q Consensus 97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~ 176 (381)
++||||+++|+|.+++. ....+++..+..++.|++.||.|||+. .+|+||||||+||+++.++.+||+
T Consensus 79 ~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~ 146 (331)
T cd06649 79 SICMEHMDGGSLDQVLK----------EAKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLC 146 (331)
T ss_pred EEEeecCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEc
Confidence 99999999999999994 445688999999999999999999942 269999999999999999999999
Q ss_pred ecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCC
Q 041757 177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSD 237 (381)
Q Consensus 177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~ 237 (381)
|||++........ ....|+..|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 147 Dfg~~~~~~~~~~----~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 203 (331)
T cd06649 147 DFGVSGQLIDSMA----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIP 203 (331)
T ss_pred cCccccccccccc----ccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 9999876543322 12458999999999999899999999999999999999999985
No 52
>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl
Probab=100.00 E-value=6.3e-41 Score=311.74 Aligned_cols=222 Identities=22% Similarity=0.272 Sum_probs=175.3
Q ss_pred ecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEcc
Q 041757 44 ISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFM 103 (381)
Q Consensus 44 lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~~ 103 (381)
||+|+||.||++.. .....+.+|+.++.+++||||+++++++ ...+..++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSF-----QSPEKLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEE-----ecCCeEEEEEcCC
Confidence 79999999987642 1235677899999999999999999984 4577899999999
Q ss_pred cCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccccee
Q 041757 104 HNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARF 183 (381)
Q Consensus 104 ~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~ 183 (381)
++|+|.+++. ....+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 76 ~~g~L~~~l~----------~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~ 142 (312)
T cd05585 76 NGGELFHHLQ----------REGRFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKL 142 (312)
T ss_pred CCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECccccc
Confidence 9999999994 4456899999999999999999999 67999999999999999999999999999875
Q ss_pred cCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHHHHh
Q 041757 184 LPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVD 263 (381)
Q Consensus 184 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (381)
....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||... ..... ..
T Consensus 143 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~-----~~~~~------------~~ 203 (312)
T cd05585 143 NMKDDDK--TNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDE-----NVNEM------------YR 203 (312)
T ss_pred CccCCCc--cccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCC-----CHHHH------------HH
Confidence 4332221 12256899999999999999999999999999999999999998521 11111 11
Q ss_pred hhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCH---HHHH
Q 041757 264 SILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKM---TNVV 318 (381)
Q Consensus 264 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~---~~vl 318 (381)
..+.... ..+......+.+++.+||+.||.+||++ .+++
T Consensus 204 ~~~~~~~----------------~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 204 KILQEPL----------------RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred HHHcCCC----------------CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 1111100 0112345678899999999999999864 4554
No 53
>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor. Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor
Probab=100.00 E-value=1.2e-40 Score=310.31 Aligned_cols=244 Identities=23% Similarity=0.324 Sum_probs=191.2
Q ss_pred cccccccceecCCCceEEEeccc----------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccC
Q 041757 35 SRNMLEENLISAGTFGFSHLRRQ----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQG 92 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~~----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 92 (381)
..+|+..+.||+|+||.||++.. ...+.+.+|+.+++.++||||++++++|..
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~----- 80 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT----- 80 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC-----
Confidence 35699999999999999987531 124578889999999999999999999752
Q ss_pred CceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCC
Q 041757 93 NDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT 172 (381)
Q Consensus 93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~ 172 (381)
...++|+||+++|+|.+++. .....+++..++.++.|++.||+||| +.+|+||||||+||+++.++.
T Consensus 81 -~~~~~v~e~~~~g~l~~~l~---------~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~ 147 (316)
T cd05108 81 -STVQLITQLMPFGCLLDYVR---------EHKDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQH 147 (316)
T ss_pred -CCceeeeecCCCCCHHHHHH---------hccccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCc
Confidence 34679999999999999985 23446888899999999999999999 679999999999999999999
Q ss_pred eEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHH
Q 041757 173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAK 251 (381)
Q Consensus 173 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~ 251 (381)
+||+|||+++...............++..|+|||++.+..++.++||||||+++||+++ |..||... ....+.
T Consensus 148 ~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~-----~~~~~~- 221 (316)
T cd05108 148 VKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-----PASEIS- 221 (316)
T ss_pred EEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC-----CHHHHH-
Confidence 99999999987654433222222335678999999999899999999999999999998 99997522 111111
Q ss_pred HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhc
Q 041757 252 MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTL 328 (381)
Q Consensus 252 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~~ 328 (381)
..+..... .+ .+..++.++.+++.+||..||++|||+.+++..+..+....
T Consensus 222 --------~~~~~~~~-~~-----------------~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 222 --------SILEKGER-LP-----------------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred --------HHHhCCCC-CC-----------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 11110000 00 01234557889999999999999999999999999887654
No 54
>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional
Probab=100.00 E-value=6.2e-41 Score=315.08 Aligned_cols=229 Identities=21% Similarity=0.250 Sum_probs=183.6
Q ss_pred cccccccceecCCCceEEEeccc---------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757 35 SRNMLEENLISAGTFGFSHLRRQ---------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN 93 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~~---------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 93 (381)
.++|...+.||+|+||.||++.. ...+.+.+|+.+++.++||||+++++++ .+.
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~ 103 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSF-----KDE 103 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEE-----EeC
Confidence 46799999999999999987641 1234577899999999999999999995 457
Q ss_pred ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757 94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA 173 (381)
Q Consensus 94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~ 173 (381)
...++||||+++|+|.+++. ....+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+
T Consensus 104 ~~~~lv~Ey~~~g~L~~~i~----------~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~i 170 (340)
T PTZ00426 104 SYLYLVLEFVIGGEFFTFLR----------RNKRFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFI 170 (340)
T ss_pred CEEEEEEeCCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCE
Confidence 78999999999999999993 4557899999999999999999999 7799999999999999999999
Q ss_pred EEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH
Q 041757 174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA 253 (381)
Q Consensus 174 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~ 253 (381)
||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|..||... .... ...
T Consensus 171 kL~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~----~~~~-~~~-- 238 (340)
T PTZ00426 171 KMTDFGFAKVVDTRT-----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYAN----EPLL-IYQ-- 238 (340)
T ss_pred EEecCCCCeecCCCc-----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCC----CHHH-HHH--
Confidence 999999998764322 1246999999999999888999999999999999999999998522 1111 000
Q ss_pred hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 041757 254 LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRM-----KMTNVVH 319 (381)
Q Consensus 254 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~~vl~ 319 (381)
.+...... .+......+.+++.+|++.||++|+ ++.++++
T Consensus 239 ------~i~~~~~~--------------------~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 239 ------KILEGIIY--------------------FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred ------HHhcCCCC--------------------CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 11111000 0112345678899999999999995 7887765
No 55
>PTZ00267 NIMA-related protein kinase; Provisional
Probab=100.00 E-value=1.2e-40 Score=326.70 Aligned_cols=238 Identities=17% Similarity=0.202 Sum_probs=188.1
Q ss_pred ccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA 97 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~ 97 (381)
..|...+.||+|+||.||++.. .....+.+|+.+|+.++|||||++++++ ...+..+
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~-----~~~~~~~ 141 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDF-----KSDDKLL 141 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEE-----EECCEEE
Confidence 3488999999999999987642 1234577899999999999999999995 4477899
Q ss_pred EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757 98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD 177 (381)
Q Consensus 98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D 177 (381)
+||||+++|+|.+++.... .....+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|
T Consensus 142 lv~E~~~gg~L~~~l~~~~------~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~D 212 (478)
T PTZ00267 142 LIMEYGSGGDLNKQIKQRL------KEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGD 212 (478)
T ss_pred EEEECCCCCCHHHHHHHHH------hccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEe
Confidence 9999999999999885321 23456889999999999999999999 66999999999999999999999999
Q ss_pred cccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhch
Q 041757 178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH 257 (381)
Q Consensus 178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~ 257 (381)
||+++..............+||+.|+|||++.+..++.++|||||||++|||++|+.||.... .
T Consensus 213 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~-----~----------- 276 (478)
T PTZ00267 213 FGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS-----Q----------- 276 (478)
T ss_pred CcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC-----H-----------
Confidence 999987655433222233569999999999999899999999999999999999999975211 1
Q ss_pred HHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
.+++...+..... ..+..++..+.+++.+||+.||++||++.+++.
T Consensus 277 -~~~~~~~~~~~~~---------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 277 -REIMQQVLYGKYD---------------PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred -HHHHHHHHhCCCC---------------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 1111111111100 001234567899999999999999999999874
No 56
>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha. Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-
Probab=100.00 E-value=1.3e-40 Score=318.56 Aligned_cols=253 Identities=22% Similarity=0.296 Sum_probs=192.7
Q ss_pred cccccccceecCCCceEEEeccc-----------------------ccHHHHHHHHHHHHccC-CCcccceeeeeccccc
Q 041757 35 SRNMLEENLISAGTFGFSHLRRQ-----------------------GAFKSFIAECKALRNIR-HRNLIKVLTACLGVDY 90 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~~-----------------------~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~ 90 (381)
.+.|.++++||+|+||.||.+.. ...+.+.+|+++|+++. ||||++++++|.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~---- 111 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT---- 111 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc----
Confidence 56788999999999999976431 12457889999999996 999999999964
Q ss_pred cCCceEEEEEEcccCCCHHHhhccccCCcc--------------------------------------------------
Q 041757 91 QGNDFKALVYEFMHNRSLKEWLYPISKEDE-------------------------------------------------- 120 (381)
Q Consensus 91 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~-------------------------------------------------- 120 (381)
.....++|||||++|+|.+++........
T Consensus 112 -~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 112 -KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred -cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 46789999999999999999854211000
Q ss_pred ------------------------------------cccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCC
Q 041757 121 ------------------------------------TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSN 164 (381)
Q Consensus 121 ------------------------------------~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~N 164 (381)
.......+++..++.++.|++.||.||| ..+|+||||||+|
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~N 267 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARN 267 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHh
Confidence 0001234788889999999999999999 6699999999999
Q ss_pred eeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCC
Q 041757 165 VLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGD 243 (381)
Q Consensus 165 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~ 243 (381)
|+++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 268 ill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~ 347 (400)
T cd05105 268 VLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS 347 (400)
T ss_pred EEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence 9999999999999999987654333222223446788999999988889999999999999999997 999975332111
Q ss_pred CcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 041757 244 MNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQS 323 (381)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~ 323 (381)
... ..+..... . ..+..++..+.+++.+||+.||++|||+.+|.+.|++
T Consensus 348 ----~~~---------~~~~~~~~--~----------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~ 396 (400)
T cd05105 348 ----TFY---------NKIKSGYR--M----------------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVES 396 (400)
T ss_pred ----HHH---------HHHhcCCC--C----------------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHH
Confidence 000 00000000 0 0122456788999999999999999999999999998
Q ss_pred hhh
Q 041757 324 IKN 326 (381)
Q Consensus 324 i~~ 326 (381)
+.+
T Consensus 397 l~~ 399 (400)
T cd05105 397 LLP 399 (400)
T ss_pred HcC
Confidence 753
No 57
>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=7.1e-41 Score=318.33 Aligned_cols=227 Identities=21% Similarity=0.313 Sum_probs=191.6
Q ss_pred ccccccccceecCCCceEEEecc--------------------cccHHHHHHHHHHHHccC-CCcccceeeeeccccccC
Q 041757 34 VSRNMLEENLISAGTFGFSHLRR--------------------QGAFKSFIAECKALRNIR-HRNLIKVLTACLGVDYQG 92 (381)
Q Consensus 34 ~~~~~~~~~~lG~G~fg~V~~~~--------------------~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~ 92 (381)
.-++|...++||+|.||+|.++. ...++..+.|.+++.... ||.+++++.. +++
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~-----fQT 440 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSC-----FQT 440 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccc-----ccc
Confidence 35789999999999999996654 457888999999999885 9999999999 788
Q ss_pred CceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCC
Q 041757 93 NDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT 172 (381)
Q Consensus 93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~ 172 (381)
.+++|.||||+.|||+..+. ....+++..+.-++..++.||.||| +++||+||||.+|||+|..|.
T Consensus 441 ~~~l~fvmey~~Ggdm~~~~-----------~~~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh 506 (694)
T KOG0694|consen 441 KEHLFFVMEYVAGGDLMHHI-----------HTDVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGH 506 (694)
T ss_pred CCeEEEEEEecCCCcEEEEE-----------ecccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCc
Confidence 99999999999999954443 4578999999999999999999999 669999999999999999999
Q ss_pred eEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHH
Q 041757 173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM 252 (381)
Q Consensus 173 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~ 252 (381)
+||+|||+++........ ...++||+.|||||++.+..|+.++|.|||||+||||+.|+.||. ++
T Consensus 507 ~kiADFGlcKe~m~~g~~--TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~----gd--------- 571 (694)
T KOG0694|consen 507 VKIADFGLCKEGMGQGDR--TSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFP----GD--------- 571 (694)
T ss_pred EEecccccccccCCCCCc--cccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCC----CC---------
Confidence 999999999865433332 234899999999999999999999999999999999999999975 22
Q ss_pred HhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCH
Q 041757 253 ALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKM 314 (381)
Q Consensus 253 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 314 (381)
+-.++++.++.-++. .|..++.+.+.|+.+.+..+|++|.-+
T Consensus 572 ----dEee~FdsI~~d~~~----------------yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 572 ----DEEEVFDSIVNDEVR----------------YPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ----CHHHHHHHHhcCCCC----------------CCCcccHHHHHHHHHHhccCcccccCC
Confidence 123455555544332 145677889999999999999999765
No 58
>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in
Probab=100.00 E-value=1.2e-40 Score=311.33 Aligned_cols=225 Identities=24% Similarity=0.307 Sum_probs=177.7
Q ss_pred ceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEE
Q 041757 42 NLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYE 101 (381)
Q Consensus 42 ~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e 101 (381)
++||+|+||.||++.. .....+.+|+++++.++||||+++++++ ...+..++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCEEEEEEe
Confidence 4699999999987542 1234567899999999999999999984 45778999999
Q ss_pred cccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccc
Q 041757 102 FMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLA 181 (381)
Q Consensus 102 ~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~ 181 (381)
|+++|+|..++. ....+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 76 ~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~ 142 (323)
T cd05595 76 YANGGELFFHLS----------RERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLC 142 (323)
T ss_pred CCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHh
Confidence 999999999883 4557899999999999999999999 669999999999999999999999999998
Q ss_pred eecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHHH
Q 041757 182 RFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDI 261 (381)
Q Consensus 182 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (381)
+........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ... .
T Consensus 143 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~-----~~~------------~ 203 (323)
T cd05595 143 KEGISDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----HER------------L 203 (323)
T ss_pred ccccCCCCc--cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCC-----HHH------------H
Confidence 753322211 112568999999999999899999999999999999999999985221 111 1
Q ss_pred HhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 041757 262 VDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRM-----KMTNVVH 319 (381)
Q Consensus 262 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~~vl~ 319 (381)
.......... .+...+..+.+++.+||+.||.+|| ++.++++
T Consensus 204 ~~~~~~~~~~----------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 204 FELILMEEIR----------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred HHHHhcCCCC----------------CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 1111100000 0123456788999999999999998 7888875
No 59
>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate
Probab=100.00 E-value=1.4e-40 Score=311.41 Aligned_cols=225 Identities=25% Similarity=0.321 Sum_probs=178.7
Q ss_pred ceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEE
Q 041757 42 NLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYE 101 (381)
Q Consensus 42 ~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e 101 (381)
++||+|+||.||++.. .....+.+|+++++.++||||+++++++ ...+..++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSF-----QTKDRLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCEEEEEEe
Confidence 4699999999987642 2345678899999999999999999884 55788999999
Q ss_pred cccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccc
Q 041757 102 FMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLA 181 (381)
Q Consensus 102 ~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~ 181 (381)
|+++|+|..++. ....+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 76 y~~~g~L~~~l~----------~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~ 142 (328)
T cd05593 76 YVNGGELFFHLS----------RERVFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLC 142 (328)
T ss_pred CCCCCCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCC
Confidence 999999999883 4557899999999999999999999 679999999999999999999999999998
Q ss_pred eecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHHH
Q 041757 182 RFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDI 261 (381)
Q Consensus 182 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (381)
+........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ....
T Consensus 143 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~-----~~~~------------ 203 (328)
T cd05593 143 KEGITDAAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----HEKL------------ 203 (328)
T ss_pred ccCCCcccc--cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC-----HHHH------------
Confidence 754322211 122568999999999998899999999999999999999999985221 1111
Q ss_pred HhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 041757 262 VDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRM-----KMTNVVH 319 (381)
Q Consensus 262 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~~vl~ 319 (381)
......... .++.....++.+++.+||..||.+|| ++.++++
T Consensus 204 ~~~~~~~~~----------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 204 FELILMEDI----------------KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred HHHhccCCc----------------cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 111110000 00123455788899999999999997 8888875
No 60
>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase. Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an
Probab=100.00 E-value=1.7e-40 Score=307.53 Aligned_cols=184 Identities=22% Similarity=0.327 Sum_probs=154.2
Q ss_pred cccccccceecCCCceEEEecccc------------------cHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757 35 SRNMLEENLISAGTFGFSHLRRQG------------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK 96 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~~~------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~ 96 (381)
.++|...+.||+|+||.||++... ....+.+|+.+++.++||||+++++++ .+....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~ 78 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII-----HTKETL 78 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEE-----ecCCeE
Confidence 578999999999999999876521 124578899999999999999999994 457789
Q ss_pred EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757 97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG 176 (381)
Q Consensus 97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~ 176 (381)
++||||+. ++|.+++. .....+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+
T Consensus 79 ~lv~e~~~-~~l~~~~~---------~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~ 145 (303)
T cd07869 79 TLVFEYVH-TDLCQYMD---------KHPGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLA 145 (303)
T ss_pred EEEEECCC-cCHHHHHH---------hCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEC
Confidence 99999995 68888874 23456888999999999999999999 6699999999999999999999999
Q ss_pred ecccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCc
Q 041757 177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDI 238 (381)
Q Consensus 177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~ 238 (381)
|||++.......... ....+++.|+|||++.+ ..++.++|||||||++|+|++|..||..
T Consensus 146 Dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 206 (303)
T cd07869 146 DFGLARAKSVPSHTY--SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPG 206 (303)
T ss_pred CCCcceeccCCCccC--CCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999987654322211 12458999999998765 4588999999999999999999999863
No 61
>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=5.9e-42 Score=310.33 Aligned_cols=234 Identities=21% Similarity=0.252 Sum_probs=191.6
Q ss_pred ccccccccceecCCCceEEEecc------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757 34 VSRNMLEENLISAGTFGFSHLRR------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF 95 (381)
Q Consensus 34 ~~~~~~~~~~lG~G~fg~V~~~~------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~ 95 (381)
....|...+.||+|+||.||++. ...++...+|+.+|.+++++||.++|+.++ .+..
T Consensus 11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl-----~g~~ 85 (467)
T KOG0201|consen 11 PELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYL-----KGTK 85 (467)
T ss_pred cccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhhee-----eccc
Confidence 44567777999999999998865 335677888999999999999999999955 4778
Q ss_pred EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757 96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV 175 (381)
Q Consensus 96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl 175 (381)
++++||||.||++.+.+ .....+.+..+..++++++.||.||| ..+.+|||||+.|||+..+|.+||
T Consensus 86 LwiiMey~~gGsv~~lL----------~~~~~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl 152 (467)
T KOG0201|consen 86 LWIIMEYCGGGSVLDLL----------KSGNILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKL 152 (467)
T ss_pred HHHHHHHhcCcchhhhh----------ccCCCCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEE
Confidence 99999999999999999 34555588888889999999999999 669999999999999999999999
Q ss_pred eecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhh
Q 041757 176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALS 255 (381)
Q Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 255 (381)
+|||.+..+....... ..++||+.|||||++....|+.|+||||||++.+||.+|.+|+....+....+ . +.
T Consensus 153 ~DfgVa~ql~~~~~rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf-l-----Ip 224 (467)
T KOG0201|consen 153 ADFGVAGQLTNTVKRR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF-L-----IP 224 (467)
T ss_pred Eecceeeeeechhhcc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE-e-----cc
Confidence 9999998887765554 23789999999999999999999999999999999999999976433211000 0 00
Q ss_pred chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
.. .| + .....+.+.+.+++..||..||+.||++.++++
T Consensus 225 k~-----------~P------------P---~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 225 KS-----------AP------------P---RLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred CC-----------CC------------C---ccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 00 00 0 001145667889999999999999999999985
No 62
>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3. Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r
Probab=100.00 E-value=6.5e-40 Score=300.06 Aligned_cols=244 Identities=23% Similarity=0.342 Sum_probs=189.7
Q ss_pred cccccccceecCCCceEEEeccc----------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccC
Q 041757 35 SRNMLEENLISAGTFGFSHLRRQ----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQG 92 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~~----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 92 (381)
.++|...+.||+|+||+||++.. .....+..|+..+.+++||||+++++++.
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~------ 79 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP------ 79 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC------
Confidence 35788889999999999987541 12345677888899999999999999853
Q ss_pred CceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCC
Q 041757 93 NDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT 172 (381)
Q Consensus 93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~ 172 (381)
....++++||+++|+|.+++. .....+++..+..++.|++.||.||| ..+++||||||+||+++.++.
T Consensus 80 ~~~~~~i~e~~~~gsL~~~l~---------~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~ 147 (279)
T cd05111 80 GASLQLVTQLSPLGSLLDHVR---------QHRDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSI 147 (279)
T ss_pred CCccEEEEEeCCCCcHHHHHH---------hcccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCc
Confidence 345689999999999999995 23456899999999999999999999 669999999999999999999
Q ss_pred eEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHH
Q 041757 173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAK 251 (381)
Q Consensus 173 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~ 251 (381)
+||+|||+++...............++..|+|||++.+..++.++||||||+++||+++ |..||..... ..
T Consensus 148 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-----~~--- 219 (279)
T cd05111 148 VQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP-----HE--- 219 (279)
T ss_pred EEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH-----HH---
Confidence 99999999987654332222222457788999999988889999999999999999998 9999752211 00
Q ss_pred HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhc
Q 041757 252 MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTL 328 (381)
Q Consensus 252 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~~ 328 (381)
..+++........ +..++..+.+++.+||..||++|||+.++++.|..+.+..
T Consensus 220 ------~~~~~~~~~~~~~------------------~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~ 272 (279)
T cd05111 220 ------VPDLLEKGERLAQ------------------PQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272 (279)
T ss_pred ------HHHHHHCCCcCCC------------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence 1111111000000 1124456788999999999999999999999999887643
No 63
>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors. Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto
Probab=100.00 E-value=2.5e-40 Score=310.77 Aligned_cols=254 Identities=21% Similarity=0.293 Sum_probs=192.1
Q ss_pred cccccccceecCCCceEEEeccc-----------------------ccHHHHHHHHHHHHcc-CCCcccceeeeeccccc
Q 041757 35 SRNMLEENLISAGTFGFSHLRRQ-----------------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVDY 90 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~~-----------------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~ 90 (381)
.++|++.++||+|+||.||++.. ...+.+.+|+.++.++ +|+||++++++|.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~---- 81 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACT---- 81 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEe----
Confidence 35799999999999999987631 1234577899999999 7999999999874
Q ss_pred cCCceEEEEEEcccCCCHHHhhccccCCcc--------------------------------------------------
Q 041757 91 QGNDFKALVYEFMHNRSLKEWLYPISKEDE-------------------------------------------------- 120 (381)
Q Consensus 91 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~-------------------------------------------------- 120 (381)
......+++|||+++++|.+++........
T Consensus 82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 345678999999999999999854221000
Q ss_pred -cccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccceecCCCCCcccccCccCc
Q 041757 121 -TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGS 199 (381)
Q Consensus 121 -~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt 199 (381)
.......+++..+..++.|++.||.||| ..+|+||||||+||+++.++.++|+|||++..+.............++
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~ 238 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCC
Confidence 0001236789999999999999999999 669999999999999999999999999999876543322222224467
Q ss_pred cceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhccc
Q 041757 200 IGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGD 278 (381)
Q Consensus 200 ~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 278 (381)
..|+|||++.+..++.++|||||||++|||++ |..||...... ..+. ..+......
T Consensus 239 ~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~----~~~~---------~~~~~~~~~---------- 295 (337)
T cd05054 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID----EEFC---------RRLKEGTRM---------- 295 (337)
T ss_pred ccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc----HHHH---------HHHhccCCC----------
Confidence 88999999999999999999999999999998 99997532111 0110 000000000
Q ss_pred chhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 041757 279 QKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKN 326 (381)
Q Consensus 279 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~ 326 (381)
..+.....++.+++.+||+.+|++||++.+|++.|+.+..
T Consensus 296 --------~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 296 --------RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred --------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0012345678999999999999999999999999998754
No 64
>PHA03212 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=4.6e-40 Score=314.43 Aligned_cols=258 Identities=19% Similarity=0.229 Sum_probs=186.4
Q ss_pred cccccccceecCCCceEEEeccc-----------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEcc
Q 041757 35 SRNMLEENLISAGTFGFSHLRRQ-----------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFM 103 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~~-----------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~~ 103 (381)
..+|...++||+|+||.||++.. .....+.+|+++|++++||||+++++++ ......++|||++
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~~~lv~e~~ 165 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRGGTATEAHILRAINHPSIIQLKGTF-----TYNKFTCLILPRY 165 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhhhhhHHHHHHHHhCCCCCCCCEeEEE-----EECCeeEEEEecC
Confidence 46799999999999999988653 2345678999999999999999999985 4477889999999
Q ss_pred cCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccccee
Q 041757 104 HNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARF 183 (381)
Q Consensus 104 ~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~ 183 (381)
. ++|..++. ....+++..++.++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 166 ~-~~L~~~l~----------~~~~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~ 231 (391)
T PHA03212 166 K-TDLYCYLA----------AKRNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACF 231 (391)
T ss_pred C-CCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCcccc
Confidence 5 68988883 4456889999999999999999999 66999999999999999999999999999975
Q ss_pred cCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCcccc--CCC----cHHHHHHHHhh--
Q 041757 184 LPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFE--GDM----NLHKFAKMALS-- 255 (381)
Q Consensus 184 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~--~~~----~~~~~~~~~~~-- 255 (381)
....... ......||+.|+|||++.+..++.++|||||||++|||++|..||-.... +.. .+.........
T Consensus 232 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p 310 (391)
T PHA03212 232 PVDINAN-KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHP 310 (391)
T ss_pred ccccccc-ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCCh
Confidence 4322111 11225699999999999998999999999999999999999988632211 111 11111111000
Q ss_pred ----c----hHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 256 ----N----HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 256 ----~----~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
. .+............. ..... .........+.++.+++.+||+.||.+|||+.|+++
T Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~--~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 311 NEFPIDAQANLDEIYIGLAKKSSR-----KPGSR--PLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred hhcCcchhHHHHHHHHHHHhccCC-----CCCCC--CCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0 001111000000000 00000 001112245668899999999999999999999985
No 65
>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]
Probab=100.00 E-value=9e-42 Score=303.54 Aligned_cols=264 Identities=21% Similarity=0.250 Sum_probs=193.1
Q ss_pred ccccccceecCCCceEEEecccc-------------cHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEc
Q 041757 36 RNMLEENLISAGTFGFSHLRRQG-------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEF 102 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~~-------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~ 102 (381)
-.|...+++|.|+||.||.+.-. ..+---+|+++|+.++|||||++..++......+.-...+||||
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVley 103 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEY 103 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHh
Confidence 35778899999999999886521 11222369999999999999999988775322223356689999
Q ss_pred ccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCC-CCeEEeecccc
Q 041757 103 MHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDD-MTARVGDFGLA 181 (381)
Q Consensus 103 ~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~-~~~kl~Dfg~~ 181 (381)
++. +|.++++... .....++...+.-+..||.+||+||| ..+|+||||||+|+|+|.+ |.+||+|||.|
T Consensus 104 mP~-tL~~~~r~~~------~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSA 173 (364)
T KOG0658|consen 104 MPE-TLYRVIRHYT------RANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSA 173 (364)
T ss_pred chH-HHHHHHHHHh------hcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcc
Confidence 987 9999995332 34577888889999999999999999 6799999999999999976 89999999999
Q ss_pred eecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHH---HHHHhhch
Q 041757 182 RFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKF---AKMALSNH 257 (381)
Q Consensus 182 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~---~~~~~~~~ 257 (381)
+.+..+....+ +..|..|+|||.+.+ ..|+.+.||||.|||+.||+-|++.| .|+....++ .+....+.
T Consensus 174 K~L~~~epniS---YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plF----pG~s~~dQL~eIik~lG~Pt 246 (364)
T KOG0658|consen 174 KVLVKGEPNIS---YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLF----PGDSSVDQLVEIIKVLGTPT 246 (364)
T ss_pred eeeccCCCcee---EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCccc----CCCCHHHHHHHHHHHhCCCC
Confidence 98876655433 568999999998887 57999999999999999999999985 444443333 33333333
Q ss_pred HHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
. +-+..+... ....... .-....+..-.....+++.++++.+++.++|.+|.++.|++.
T Consensus 247 ~-e~I~~mn~~-y~~~~~p-~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 247 R-EDIKSMNPN-YTEFKFP-QIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred H-HHHhhcCcc-cccccCc-ccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 2 223322211 0000000 000011111123456778999999999999999999999985
No 66
>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase. Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament
Probab=100.00 E-value=3.6e-40 Score=303.15 Aligned_cols=261 Identities=20% Similarity=0.261 Sum_probs=183.2
Q ss_pred ccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA 97 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~ 97 (381)
++|...++||.|+||.||++.. .....+.+|+.++++++||||+++++++ ......+
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~~ 79 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII-----HTERCLT 79 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEE-----cCCCeEE
Confidence 5688899999999999987641 1234678999999999999999999994 4577899
Q ss_pred EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757 98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD 177 (381)
Q Consensus 98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D 177 (381)
+||||+++ +|.+++. .....+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|
T Consensus 80 lv~e~~~~-~l~~~l~---------~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~D 146 (288)
T cd07871 80 LVFEYLDS-DLKQYLD---------NCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLAD 146 (288)
T ss_pred EEEeCCCc-CHHHHHH---------hcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECc
Confidence 99999975 9999884 23345788999999999999999999 67999999999999999999999999
Q ss_pred cccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhc
Q 041757 178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSN 256 (381)
Q Consensus 178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~ 256 (381)
||+++......... ....+++.|+|||++.+ ..++.++||||+||++|+|++|+.||......+ .+..... ....
T Consensus 147 fG~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~-~~~~~~~-~~~~ 222 (288)
T cd07871 147 FGLARAKSVPTKTY--SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKE-ELHLIFR-LLGT 222 (288)
T ss_pred CcceeeccCCCccc--cCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH-HhCC
Confidence 99997654332211 12457999999998865 568999999999999999999999985321110 0111111 1111
Q ss_pred hHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 257 HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 257 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
...+..........-. .....................+..+++.+|+..||.+|||+.|+++
T Consensus 223 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 223 PTEETWPGITSNEEFR-SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred CChHHhhccccchhhh-ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 1111111100000000 0000000000000111223456789999999999999999999974
No 67
>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]
Probab=100.00 E-value=3.2e-41 Score=284.09 Aligned_cols=236 Identities=19% Similarity=0.251 Sum_probs=187.2
Q ss_pred ccccccccceecCCCceEEEec-------------------ccccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757 34 VSRNMLEENLISAGTFGFSHLR-------------------RQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND 94 (381)
Q Consensus 34 ~~~~~~~~~~lG~G~fg~V~~~-------------------~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~ 94 (381)
.+++|+..++||+|.|+.|+.. .....+.+.+|+++.+.|+|||||++.+. .....
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~t-----i~~~~ 83 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS-----IQEES 83 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhh-----hcccc
Confidence 4788999999999999999442 13356778899999999999999999998 66788
Q ss_pred eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCC---CC
Q 041757 95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD---DM 171 (381)
Q Consensus 95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~---~~ 171 (381)
+.|+|+|++.|++|..-+ .....+++..+-.++.||+++|.|+| ..+|||||+||+|+++.. ..
T Consensus 84 ~~ylvFe~m~G~dl~~eI----------V~R~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A 150 (355)
T KOG0033|consen 84 FHYLVFDLVTGGELFEDI----------VAREFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGA 150 (355)
T ss_pred eeEEEEecccchHHHHHH----------HHHHHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCC
Confidence 999999999999998766 34466788999999999999999999 669999999999999954 33
Q ss_pred CeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHH
Q 041757 172 TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAK 251 (381)
Q Consensus 172 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~ 251 (381)
-+||+|||++..+... ......+|||.|||||++...+|+..+|||+.||+||-|+.|.+||...
T Consensus 151 ~vKL~~FGvAi~l~~g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~------------ 215 (355)
T KOG0033|consen 151 AVKLADFGLAIEVNDG---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE------------ 215 (355)
T ss_pred ceeecccceEEEeCCc---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCc------------
Confidence 6899999999988732 2233467999999999999999999999999999999999999997521
Q ss_pred HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 252 MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 252 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
...++....+....+-.. +..+...++..+|+++||..||.+|.|+.|.++
T Consensus 216 -----~~~rlye~I~~g~yd~~~------------~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 216 -----DQHRLYEQIKAGAYDYPS------------PEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred -----cHHHHHHHHhccccCCCC------------cccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 122222222222211000 002345556778888999999999999888764
No 68
>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly
Probab=100.00 E-value=4.1e-40 Score=302.78 Aligned_cols=252 Identities=23% Similarity=0.394 Sum_probs=193.7
Q ss_pred ccccccceecCCCceEEEeccc----------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN 93 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 93 (381)
++|.+.+.||+|+||.||++.. ...+.+.+|+.++++++||||+++++++. ..
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 79 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV-----EG 79 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----cC
Confidence 5788999999999999987541 12456889999999999999999999954 46
Q ss_pred ceEEEEEEcccCCCHHHhhccccCCcc---cccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCC
Q 041757 94 DFKALVYEFMHNRSLKEWLYPISKEDE---TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDD 170 (381)
Q Consensus 94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~---~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~ 170 (381)
+..++||||+++++|.+++........ .......+++..++.++.|++.||+||| +.+++||||||+||+++++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~ 156 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGEN 156 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccC
Confidence 788999999999999999853221100 0012345899999999999999999999 6699999999999999999
Q ss_pred CCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHH
Q 041757 171 MTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKF 249 (381)
Q Consensus 171 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~ 249 (381)
+.+||+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||..... .
T Consensus 157 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~-----~-- 229 (288)
T cd05093 157 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-----N-- 229 (288)
T ss_pred CcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----H--
Confidence 9999999999986544332222222345778999999998889999999999999999998 8999752211 1
Q ss_pred HHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 041757 250 AKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT 327 (381)
Q Consensus 250 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~ 327 (381)
+.+......... ..+..++.++.+++.+||+.||.+|||+.+|++.|+++.+.
T Consensus 230 ----------~~~~~i~~~~~~---------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 230 ----------EVIECITQGRVL---------------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred ----------HHHHHHHcCCcC---------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 111111100000 00113445789999999999999999999999999998765
No 69
>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n
Probab=100.00 E-value=6.4e-40 Score=301.93 Aligned_cols=252 Identities=23% Similarity=0.399 Sum_probs=193.8
Q ss_pred ccccccceecCCCceEEEeccc----------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN 93 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 93 (381)
++|...+.||+|+||.||++.. ...+.+.+|+.++++++|+||+++++++ ...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~ 79 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVC-----GDG 79 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEE-----ccC
Confidence 5678889999999999987631 1235788999999999999999999995 446
Q ss_pred ceEEEEEEcccCCCHHHhhccccCCc------ccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeee
Q 041757 94 DFKALVYEFMHNRSLKEWLYPISKED------ETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLL 167 (381)
Q Consensus 94 ~~~~lv~e~~~~g~L~~~l~~~~~~~------~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill 167 (381)
...++||||+++++|.+++....... ........+++..++.++.|++.||+||| ..+|+||||||+||++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~ 156 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLV 156 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEE
Confidence 77899999999999999996422100 00012345889999999999999999999 6699999999999999
Q ss_pred CCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcH
Q 041757 168 DDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNL 246 (381)
Q Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~ 246 (381)
+.++.++|+|||++................++..|+|||++.+..++.++||||||+++|||++ |..||.....
T Consensus 157 ~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~----- 231 (291)
T cd05094 157 GANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN----- 231 (291)
T ss_pred ccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----
Confidence 9999999999999976544332222222446788999999998899999999999999999998 9999752211
Q ss_pred HHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 041757 247 HKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKN 326 (381)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~ 326 (381)
.. .++........ ..+..++..+.+++.+||+.||++|||+.+|++.|+++.+
T Consensus 232 ~~------------~~~~~~~~~~~---------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 232 TE------------VIECITQGRVL---------------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HH------------HHHHHhCCCCC---------------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 00 11111100000 0012345678899999999999999999999999999976
Q ss_pred h
Q 041757 327 T 327 (381)
Q Consensus 327 ~ 327 (381)
.
T Consensus 285 ~ 285 (291)
T cd05094 285 A 285 (291)
T ss_pred h
Confidence 4
No 70
>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign
Probab=100.00 E-value=7e-40 Score=300.36 Aligned_cols=250 Identities=23% Similarity=0.333 Sum_probs=188.4
Q ss_pred ccccceecCCCceEEEecc----------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757 38 MLEENLISAGTFGFSHLRR----------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF 95 (381)
Q Consensus 38 ~~~~~~lG~G~fg~V~~~~----------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~ 95 (381)
|...+.||+|+||+||++. ......+.+|++++++++||||+++++++.. .....
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~ 82 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSE---QGGKG 82 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCCce
Confidence 4788999999999996521 0134578899999999999999999998653 33556
Q ss_pred EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757 96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV 175 (381)
Q Consensus 96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl 175 (381)
.++||||+++++|.+++. ...+++..++.++.|++.||.||| +.+++||||||+||+++.++.++|
T Consensus 83 ~~lv~e~~~~~~l~~~~~-----------~~~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l 148 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLP-----------KHKLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKI 148 (283)
T ss_pred EEEEecCCCCCCHHHHHH-----------HcCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEE
Confidence 899999999999999984 235899999999999999999999 669999999999999999999999
Q ss_pred eecccceecCCCCCccc-ccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHh
Q 041757 176 GDFGLARFLPPTRTQTS-SIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMAL 254 (381)
Q Consensus 176 ~Dfg~~~~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 254 (381)
+|||+++.......... .....++..|+|||.+.+..++.++||||||+++|||++|..||...... +........
T Consensus 149 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~---~~~~~~~~~ 225 (283)
T cd05080 149 GDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK---FEEMIGPKQ 225 (283)
T ss_pred eecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch---hhhhhcccc
Confidence 99999987654322111 11123567799999998888999999999999999999999997532111 111110000
Q ss_pred h----chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 041757 255 S----NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIK 325 (381)
Q Consensus 255 ~----~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~ 325 (381)
. ..+.+.++..... ..+..++..+.+++.+||+.||++|||+.++++.|+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 226 GQMTVVRLIELLERGMRL------------------PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred cccchhhhhhhhhcCCCC------------------CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 0 0011111111000 011245678999999999999999999999999998874
No 71
>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.
Probab=100.00 E-value=3.7e-40 Score=309.39 Aligned_cols=237 Identities=18% Similarity=0.188 Sum_probs=185.6
Q ss_pred ccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF 95 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~ 95 (381)
++|...++||+|+||.||++.. ...+.+.+|++++..++||||+++++++ ...+.
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~-----~~~~~ 75 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAF-----QDDEY 75 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEE-----EcCCE
Confidence 4688999999999999987642 1335678899999999999999999984 45778
Q ss_pred EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757 96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV 175 (381)
Q Consensus 96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl 175 (381)
.++||||+++|+|.+++. ....+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||
T Consensus 76 ~~lv~e~~~g~~L~~~l~----------~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL 142 (333)
T cd05600 76 LYLAMEYVPGGDFRTLLN----------NLGVLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKL 142 (333)
T ss_pred EEEEEeCCCCCCHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEE
Confidence 999999999999999993 4556889999999999999999999 669999999999999999999999
Q ss_pred eecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhh
Q 041757 176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALS 255 (381)
Q Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 255 (381)
+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|..||.... . .........
T Consensus 143 ~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~----~-~~~~~~i~~ 212 (333)
T cd05600 143 TDFGLSKGIVTY-----ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGST----P-NETWENLKY 212 (333)
T ss_pred EeCcCCcccccc-----cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCC----H-HHHHHHHHh
Confidence 999999765431 122568999999999999899999999999999999999999985221 1 111000000
Q ss_pred chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041757 256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE 320 (381)
Q Consensus 256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~ 320 (381)
. ...+. .+.. .......+.++.+++.+||..+|.+||++.++++.
T Consensus 213 -----~-~~~~~-~~~~-------------~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 213 -----W-KETLQ-RPVY-------------DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred -----c-ccccc-CCCC-------------CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0 00000 0000 00001345678899999999999999999999864
No 72
>PTZ00283 serine/threonine protein kinase; Provisional
Probab=100.00 E-value=4e-40 Score=323.45 Aligned_cols=248 Identities=20% Similarity=0.256 Sum_probs=191.7
Q ss_pred hhccccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccc--
Q 041757 32 LDVSRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDY-- 90 (381)
Q Consensus 32 ~~~~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~-- 90 (381)
....++|.+.++||+|+||+||+++. .....+.+|+.++..++|+||++++..+...+.
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 34568999999999999999987642 234567889999999999999998877543111
Q ss_pred -cCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCC
Q 041757 91 -QGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD 169 (381)
Q Consensus 91 -~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~ 169 (381)
......++||||+++|+|.+++.... .....+++..+..++.|++.||.||| +.+|+||||||+|||++.
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~------~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~ 178 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRA------KTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCS 178 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhh------ccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeC
Confidence 11224689999999999999985321 23456889999999999999999999 679999999999999999
Q ss_pred CCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHH
Q 041757 170 DMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKF 249 (381)
Q Consensus 170 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~ 249 (381)
++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||... ...
T Consensus 179 ~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~-----~~~-- 251 (496)
T PTZ00283 179 NGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE-----NME-- 251 (496)
T ss_pred CCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC-----CHH--
Confidence 9999999999998765433222223356999999999999999999999999999999999999998521 111
Q ss_pred HHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041757 250 AKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE 320 (381)
Q Consensus 250 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~ 320 (381)
+++...+..... ..+...+.++.+++.+||+.||.+||++.++++.
T Consensus 252 ----------~~~~~~~~~~~~---------------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 252 ----------EVMHKTLAGRYD---------------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred ----------HHHHHHhcCCCC---------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 111111111100 0123456678999999999999999999999863
No 73
>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor. Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh
Probab=100.00 E-value=5e-40 Score=300.36 Aligned_cols=249 Identities=19% Similarity=0.324 Sum_probs=188.4
Q ss_pred ccccccccceecCCCceEEEeccc-----------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccc
Q 041757 34 VSRNMLEENLISAGTFGFSHLRRQ-----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDY 90 (381)
Q Consensus 34 ~~~~~~~~~~lG~G~fg~V~~~~~-----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 90 (381)
.+++|+..+.||+|+||.||.+.. .....+.+|+.+++.++||||+++++++
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~----- 78 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV----- 78 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-----
Confidence 467899999999999999986320 1234578999999999999999999995
Q ss_pred cCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCC
Q 041757 91 QGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDD 170 (381)
Q Consensus 91 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~ 170 (381)
......++||||+++|+|.+++...............+++..++.++.|++.||.||| +.+++||||||+||+++++
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~ 155 (277)
T cd05062 79 SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAED 155 (277)
T ss_pred cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCC
Confidence 4467889999999999999998643211111111234678889999999999999999 6699999999999999999
Q ss_pred CCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHH
Q 041757 171 MTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKF 249 (381)
Q Consensus 171 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~ 249 (381)
+.++|+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||.... ....
T Consensus 156 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~-----~~~~ 230 (277)
T cd05062 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS-----NEQV 230 (277)
T ss_pred CCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC-----HHHH
Confidence 9999999999876544332222222345788999999988889999999999999999999 788874221 1111
Q ss_pred HHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 041757 250 AKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQ 322 (381)
Q Consensus 250 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~ 322 (381)
... +....... .+..++..+.+++.+||+.||++|||+.++++.|+
T Consensus 231 ~~~--------~~~~~~~~-------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 231 LRF--------VMEGGLLD-------------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHH--------HHcCCcCC-------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 110 00000000 01234567899999999999999999999999886
No 74
>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase. Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in
Probab=100.00 E-value=4.5e-40 Score=307.46 Aligned_cols=225 Identities=22% Similarity=0.229 Sum_probs=177.1
Q ss_pred ceecCCCceEEEeccc------------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757 42 NLISAGTFGFSHLRRQ------------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA 97 (381)
Q Consensus 42 ~~lG~G~fg~V~~~~~------------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~ 97 (381)
++||+|+||.||+++. .....+.+|+.+|+.++||||+++++++ ..++..+
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~~~ 76 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAF-----QTGGKLY 76 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEE-----ecCCeEE
Confidence 6799999999987542 1123467899999999999999999984 4577899
Q ss_pred EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757 98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD 177 (381)
Q Consensus 98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D 177 (381)
+||||+++|+|.+++. ....+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|
T Consensus 77 lv~e~~~~~~L~~~~~----------~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~D 143 (323)
T cd05584 77 LILEYLSGGELFMHLE----------REGIFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTD 143 (323)
T ss_pred EEEeCCCCchHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEee
Confidence 9999999999999983 4556788889999999999999999 67999999999999999999999999
Q ss_pred cccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhch
Q 041757 178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH 257 (381)
Q Consensus 178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~ 257 (381)
||+++......... ....||+.|+|||++.+..++.++|||||||++|||++|+.||.... . ....
T Consensus 144 fg~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~----~-~~~~------- 209 (323)
T cd05584 144 FGLCKESIHEGTVT--HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN----R-KKTI------- 209 (323)
T ss_pred CcCCeecccCCCcc--cccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC----H-HHHH-------
Confidence 99987543322211 12468999999999998889999999999999999999999985221 1 1111
Q ss_pred HHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 041757 258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRM-----KMTNVVH 319 (381)
Q Consensus 258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~~vl~ 319 (381)
..+...... .+......+.+++.+||+.||++|| ++.++++
T Consensus 210 -~~~~~~~~~--------------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 210 -DKILKGKLN--------------------LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred -HHHHcCCCC--------------------CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 111111000 0123455788999999999999999 7887765
No 75
>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment
Probab=100.00 E-value=1.2e-39 Score=296.01 Aligned_cols=240 Identities=22% Similarity=0.356 Sum_probs=189.4
Q ss_pred ccccccceecCCCceEEEeccc---------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ---------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND 94 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~---------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~ 94 (381)
++|...+.||+|+||+||++.. .....|.+|+.++++++||||+++++.+ ...+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 78 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVV-----TKSR 78 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEE-----ecCC
Confidence 5788999999999999987531 1245788899999999999999999984 4467
Q ss_pred eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757 95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR 174 (381)
Q Consensus 95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k 174 (381)
..++||||+++++|.+++.. ....+++..++.++.|++.||.||| +.+|+||||||+||+++.++.++
T Consensus 79 ~~~iv~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~ 146 (266)
T cd05033 79 PVMIITEYMENGSLDKFLRE---------NDGKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCK 146 (266)
T ss_pred ceEEEEEcCCCCCHHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEE
Confidence 78999999999999999852 2346889999999999999999999 67999999999999999999999
Q ss_pred EeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHH
Q 041757 175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMA 253 (381)
Q Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~ 253 (381)
|+|||+++...............++..|+|||.+.+..++.++||||||+++|++++ |..||..... ..
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~-----~~----- 216 (266)
T cd05033 147 VSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN-----QD----- 216 (266)
T ss_pred ECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH-----HH-----
Confidence 999999987753222211112335678999999998899999999999999999998 9999742211 00
Q ss_pred hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 041757 254 LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSI 324 (381)
Q Consensus 254 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i 324 (381)
+.+....... .+.+..++..+.+++.+||+.+|++||++.+|++.|+++
T Consensus 217 -------~~~~~~~~~~---------------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 217 -------VIKAVEDGYR---------------LPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -------HHHHHHcCCC---------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1111000000 000124556789999999999999999999999999875
No 76
>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h
Probab=100.00 E-value=9.9e-40 Score=294.91 Aligned_cols=236 Identities=23% Similarity=0.371 Sum_probs=184.3
Q ss_pred ccccccceecCCCceEEEeccc---------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEE
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ---------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVY 100 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~---------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~ 100 (381)
++|...+.||+|+||.||++.. .....+.+|+.++++++||||+++++++. .....++||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~iv~ 78 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT-----QQKPLYIVT 78 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEc-----cCCCEEEEE
Confidence 4577889999999999987542 12467889999999999999999999953 467789999
Q ss_pred EcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccc
Q 041757 101 EFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180 (381)
Q Consensus 101 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 180 (381)
||+++|+|.+++.. ....+++..++.++.|++.||.||| +.+++||||||+||+++.++.+||+|||.
T Consensus 79 e~~~~~~L~~~~~~---------~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~ 146 (256)
T cd05114 79 EFMENGCLLNYLRQ---------RQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGM 146 (256)
T ss_pred EcCCCCcHHHHHHh---------CccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCC
Confidence 99999999999852 2345889999999999999999999 66999999999999999999999999999
Q ss_pred ceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchHH
Q 041757 181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHVK 259 (381)
Q Consensus 181 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 259 (381)
++......... .....++..|+|||++.+..++.++||||||+++||+++ |+.||.... . ......
T Consensus 147 ~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~----~-~~~~~~------- 213 (256)
T cd05114 147 TRYVLDDEYTS-SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS----N-YEVVEM------- 213 (256)
T ss_pred ccccCCCceec-cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC----H-HHHHHH-------
Confidence 87654332221 112335678999999988889999999999999999999 899975221 1 111110
Q ss_pred HHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 041757 260 DIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHEL 321 (381)
Q Consensus 260 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L 321 (381)
+........ +...+..+.+++.+||..+|.+|||+.++++.|
T Consensus 214 -i~~~~~~~~-------------------~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 214 -ISRGFRLYR-------------------PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred -HHCCCCCCC-------------------CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 000000000 112345789999999999999999999999876
No 77
>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien
Probab=100.00 E-value=2.2e-40 Score=309.88 Aligned_cols=226 Identities=24% Similarity=0.299 Sum_probs=177.5
Q ss_pred ceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEE
Q 041757 42 NLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYE 101 (381)
Q Consensus 42 ~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e 101 (381)
+.||+|+||.||++.. .....+.+|+++++.++||||+++++++ ......++|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~-----~~~~~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-----QTHDRLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEE-----EcCCEEEEEEe
Confidence 4699999999987542 1235667899999999999999999884 45778999999
Q ss_pred cccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccc
Q 041757 102 FMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLA 181 (381)
Q Consensus 102 ~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~ 181 (381)
|+++|+|..++ .....+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||++
T Consensus 76 ~~~~~~L~~~l----------~~~~~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~~ 143 (325)
T cd05594 76 YANGGELFFHL----------SRERVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLC 143 (325)
T ss_pred CCCCCcHHHHH----------HhcCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCCC
Confidence 99999999988 3455789999999999999999999931 59999999999999999999999999998
Q ss_pred eecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHHH
Q 041757 182 RFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDI 261 (381)
Q Consensus 182 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (381)
+......... ....||+.|+|||++.+..++.++|||||||++|||++|..||.... ......
T Consensus 144 ~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~-----~~~~~~---------- 206 (325)
T cd05594 144 KEGIKDGATM--KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----HEKLFE---------- 206 (325)
T ss_pred eecCCCCccc--ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCC-----HHHHHH----------
Confidence 7543322211 12459999999999998899999999999999999999999985211 111111
Q ss_pred HhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 041757 262 VDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRM-----KMTNVVH 319 (381)
Q Consensus 262 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~~vl~ 319 (381)
........ .+.....++.+++.+||+.||.+|+ ++.++++
T Consensus 207 --~i~~~~~~----------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 207 --LILMEEIR----------------FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred --HHhcCCCC----------------CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 10000000 0123455788899999999999997 8888875
No 78
>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla
Probab=100.00 E-value=9.3e-40 Score=300.51 Aligned_cols=263 Identities=20% Similarity=0.244 Sum_probs=185.3
Q ss_pred ccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHcc---CCCcccceeeeeccccccC
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNI---RHRNLIKVLTACLGVDYQG 92 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l---~h~nIv~~~~~~~~~~~~~ 92 (381)
++|...+.||+|+||.||++.. .....+.+|+.+++.+ +||||++++++|.......
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 3688899999999999988642 0123567788887766 6999999999976433344
Q ss_pred CceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCC
Q 041757 93 NDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT 172 (381)
Q Consensus 93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~ 172 (381)
....++||||+. ++|.+++.. .....+++..+..++.|++.||.||| +.+|+||||||+||+++.++.
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~--------~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~ 148 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDK--------VPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQ 148 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHh--------CCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCC
Confidence 667899999996 599999853 22345889999999999999999999 679999999999999999999
Q ss_pred eEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHH
Q 041757 173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM 252 (381)
Q Consensus 173 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~ 252 (381)
+||+|||+++........ ....||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .+......
T Consensus 149 ~kl~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~-~~~~i~~~ 224 (290)
T cd07862 149 IKLADFGLARIYSFQMAL---TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDV 224 (290)
T ss_pred EEEccccceEeccCCccc---ccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHH
Confidence 999999999876543211 22458999999999988889999999999999999999999976321110 01111100
Q ss_pred HhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 253 ALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 253 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
.......+.... ... +.. ..............+.....+.+++.+||+.||++|||+.++++
T Consensus 225 ~~~~~~~~~~~~-~~~-~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 225 IGLPGEEDWPRD-VAL-PRQ---AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hCCCChhhchhh-hcc-cch---hccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000000000000 000 000 00000001111122345567889999999999999999999985
No 79
>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu
Probab=100.00 E-value=2.2e-39 Score=295.01 Aligned_cols=248 Identities=22% Similarity=0.360 Sum_probs=189.0
Q ss_pred ccccceecCCCceEEEeccc----------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccc-cCCc
Q 041757 38 MLEENLISAGTFGFSHLRRQ----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDY-QGND 94 (381)
Q Consensus 38 ~~~~~~lG~G~fg~V~~~~~----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~-~~~~ 94 (381)
|...+.||+|+||.||.+.. .....+.+|++.++.++||||+++++++..... ....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 56778999999999986531 123578899999999999999999998764221 2234
Q ss_pred eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757 95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR 174 (381)
Q Consensus 95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k 174 (381)
..++||||+++|+|..++...... .....+++..+..++.|++.||.||| ..+++||||||+||++++++.+|
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~----~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~k 153 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLG----GLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVC 153 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhcc----CCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEE
Confidence 579999999999999998532211 12346899999999999999999999 66999999999999999999999
Q ss_pred EeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHH
Q 041757 175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMA 253 (381)
Q Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~ 253 (381)
|+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.... . ..
T Consensus 154 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~----~-~~----- 223 (273)
T cd05035 154 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE----N-HE----- 223 (273)
T ss_pred ECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC----H-HH-----
Confidence 999999987654433222212235678999999988889999999999999999999 888874221 1 01
Q ss_pred hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 041757 254 LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSI 324 (381)
Q Consensus 254 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i 324 (381)
+.+........ ..+..++..+.+++.+||+.||.+|||+.++++.|+++
T Consensus 224 -------~~~~~~~~~~~---------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 224 -------IYDYLRHGNRL---------------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred -------HHHHHHcCCCC---------------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11111100000 01224566899999999999999999999999999876
No 80
>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2. Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph
Probab=100.00 E-value=6.3e-40 Score=307.66 Aligned_cols=235 Identities=21% Similarity=0.261 Sum_probs=181.0
Q ss_pred cccccceecCCCceEEEeccc------------------------ccHHHHHHHHHHHHccC-CCcccceeeeecccccc
Q 041757 37 NMLEENLISAGTFGFSHLRRQ------------------------GAFKSFIAECKALRNIR-HRNLIKVLTACLGVDYQ 91 (381)
Q Consensus 37 ~~~~~~~lG~G~fg~V~~~~~------------------------~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~ 91 (381)
+|...++||+|+||.||+++. ...+.+.+|+.++..++ |+||++++++ +.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~-----~~ 75 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYA-----FQ 75 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEE-----Ee
Confidence 578899999999999987542 11245678999999995 9999999988 45
Q ss_pred CCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC
Q 041757 92 GNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM 171 (381)
Q Consensus 92 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~ 171 (381)
.....++||||+++|+|.+++. ....+++..+..++.|++.||.||| +.+|+||||||+|||++.++
T Consensus 76 ~~~~~~lv~e~~~~g~L~~~l~----------~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~ 142 (332)
T cd05614 76 TEAKLHLILDYVSGGEMFTHLY----------QRDNFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEG 142 (332)
T ss_pred cCCEEEEEEeCCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCC
Confidence 5778999999999999999983 4456899999999999999999999 66999999999999999999
Q ss_pred CeEEeecccceecCCCCCcccccCccCccceeCCCCcCCC-ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHH
Q 041757 172 TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFA 250 (381)
Q Consensus 172 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~ 250 (381)
.+||+|||+++......... .....||+.|+|||++.+. .++.++|||||||++|||++|..||....... ....+
T Consensus 143 ~~kl~DfG~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~~~- 219 (332)
T cd05614 143 HVVLTDFGLSKEFLSEEKER-TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN-TQSEV- 219 (332)
T ss_pred CEEEeeCcCCccccccCCCc-cccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC-CHHHH-
Confidence 99999999997654332221 1125699999999998865 47889999999999999999999985322111 11111
Q ss_pred HHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 041757 251 KMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRM-----KMTNVVH 319 (381)
Q Consensus 251 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~~vl~ 319 (381)
........+. .+...+..+.+++.+||+.||++|| ++.++++
T Consensus 220 -----------~~~~~~~~~~----------------~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 220 -----------SRRILKCDPP----------------FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred -----------HHHHhcCCCC----------------CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 1111111110 0123455778899999999999999 6667764
No 81
>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1. Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst
Probab=100.00 E-value=6.3e-40 Score=307.68 Aligned_cols=182 Identities=22% Similarity=0.302 Sum_probs=157.1
Q ss_pred cccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757 35 SRNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK 96 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~ 96 (381)
.++|...++||+|+||.||++.. ...+.+.+|++++++++||||++++++|. ..+..
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 78 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGEI 78 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEE-----ECCEE
Confidence 57899999999999999987542 12356889999999999999999999964 46789
Q ss_pred EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757 97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG 176 (381)
Q Consensus 97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~ 176 (381)
++||||+++|+|.+++. ....+++..+..++.|++.||.|||+. .+++||||||+||+++.++.+||+
T Consensus 79 ~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~ 146 (333)
T cd06650 79 SICMEHMDGGSLDQVLK----------KAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLC 146 (333)
T ss_pred EEEEecCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEe
Confidence 99999999999999994 345688899999999999999999942 379999999999999999999999
Q ss_pred ecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCC
Q 041757 177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSD 237 (381)
Q Consensus 177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~ 237 (381)
|||++........ ....|+..|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus 147 Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~ 203 (333)
T cd06650 147 DFGVSGQLIDSMA----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIP 203 (333)
T ss_pred eCCcchhhhhhcc----ccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 9999875533221 12458999999999998889999999999999999999999986
No 82
>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein. Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi
Probab=100.00 E-value=1.7e-39 Score=298.96 Aligned_cols=250 Identities=20% Similarity=0.334 Sum_probs=191.2
Q ss_pred cccccceecCCCceEEEeccc-----------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757 37 NMLEENLISAGTFGFSHLRRQ-----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN 93 (381)
Q Consensus 37 ~~~~~~~lG~G~fg~V~~~~~-----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 93 (381)
+|...++||+|+||.||++.. .....+.+|+.+++.++||||+++++.|. ..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~ 75 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACS-----QD 75 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEe-----cC
Confidence 467789999999999987531 12356889999999999999999999854 46
Q ss_pred ceEEEEEEcccCCCHHHhhccccCCcc--------------cccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeec
Q 041757 94 DFKALVYEFMHNRSLKEWLYPISKEDE--------------TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCV 159 (381)
Q Consensus 94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~--------------~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrD 159 (381)
+..++||||+.+|+|.+++........ .......+++..++.++.|++.||.||| +.+++|||
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~d 152 (290)
T cd05045 76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRD 152 (290)
T ss_pred CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhh
Confidence 678999999999999999864321110 0012346889999999999999999999 66999999
Q ss_pred cCCCCeeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCc
Q 041757 160 LKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDI 238 (381)
Q Consensus 160 lkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~ 238 (381)
|||+||++++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||..
T Consensus 153 ikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 232 (290)
T cd05045 153 LAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 232 (290)
T ss_pred hhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence 999999999999999999999976543332211222346778999999888889999999999999999998 9999752
Q ss_pred cccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 041757 239 MFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVV 318 (381)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl 318 (381)
.. ...+ .+.+....... .+..++.++.+++.+||+.+|.+||++.+++
T Consensus 233 ~~-----~~~~---------~~~~~~~~~~~------------------~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~ 280 (290)
T cd05045 233 IA-----PERL---------FNLLKTGYRME------------------RPENCSEEMYNLMLTCWKQEPDKRPTFADIS 280 (290)
T ss_pred CC-----HHHH---------HHHHhCCCCCC------------------CCCCCCHHHHHHHHHHccCCcccCCCHHHHH
Confidence 21 1111 11111111000 0123456788999999999999999999999
Q ss_pred HHHHHhhh
Q 041757 319 HELQSIKN 326 (381)
Q Consensus 319 ~~L~~i~~ 326 (381)
+.|+++..
T Consensus 281 ~~l~~~~~ 288 (290)
T cd05045 281 KELEKMMV 288 (290)
T ss_pred HHHHHHHh
Confidence 99998864
No 83
>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase
Probab=100.00 E-value=1.4e-39 Score=295.58 Aligned_cols=245 Identities=21% Similarity=0.279 Sum_probs=191.6
Q ss_pred ccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF 95 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~ 95 (381)
++|...++||+|+||.||++.. .....+.+|+++++.++||||+++++++. ..+.
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 76 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFI-----EDNE 76 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEE-----ECCe
Confidence 5788999999999999987642 12346888999999999999999999854 4678
Q ss_pred EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757 96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV 175 (381)
Q Consensus 96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl 175 (381)
.++||||+++|+|.+++.... .....+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l 147 (267)
T cd08228 77 LNIVLELADAGDLSQMIKYFK------KQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKL 147 (267)
T ss_pred EEEEEEecCCCcHHHHHHHhh------hccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEE
Confidence 899999999999999885322 23345788999999999999999999 669999999999999999999999
Q ss_pred eecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhh
Q 041757 176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALS 255 (381)
Q Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 255 (381)
+|||++.......... ....+++.|+|||.+.+..++.++||||||+++|||++|..||.... .....+...
T Consensus 148 ~d~g~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~---~~~~~~~~~--- 219 (267)
T cd08228 148 GDLGLGRFFSSKTTAA--HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK---MNLFSLCQK--- 219 (267)
T ss_pred CccccceeccchhHHH--hcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccc---ccHHHHHHH---
Confidence 9999988765432211 12458889999999988889999999999999999999999974221 111111111
Q ss_pred chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 041757 256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIK 325 (381)
Q Consensus 256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~ 325 (381)
+.... .+. ......+..+.+++.+||..+|++||++.+|++.++++.
T Consensus 220 ------~~~~~--~~~---------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 220 ------IEQCD--YPP---------------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred ------HhcCC--CCC---------------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 00000 000 001245567899999999999999999999999998864
No 84
>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl. Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor
Probab=100.00 E-value=2.3e-39 Score=294.99 Aligned_cols=248 Identities=20% Similarity=0.334 Sum_probs=186.4
Q ss_pred ccccceecCCCceEEEecc---------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccc-cCCce
Q 041757 38 MLEENLISAGTFGFSHLRR---------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDY-QGNDF 95 (381)
Q Consensus 38 ~~~~~~lG~G~fg~V~~~~---------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~-~~~~~ 95 (381)
+..+++||+|+||.||++. ....+.+.+|+++++.++|+||+++++++..... .....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3467889999999998653 1234678889999999999999999998754211 12345
Q ss_pred EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757 96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV 175 (381)
Q Consensus 96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl 175 (381)
.++||||+++|+|.+++...... .....+++..+..++.|++.||.||| ..+|+||||||+||+++.++.+||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~----~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl 153 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLG----DCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCV 153 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhccc----CCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEE
Confidence 78999999999999987421110 22345889999999999999999999 669999999999999999999999
Q ss_pred eecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHh
Q 041757 176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMAL 254 (381)
Q Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~ 254 (381)
+|||+++...............+++.|+|||++.+..++.++||||||+++||+++ |+.||.... . .....
T Consensus 154 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~----~-~~~~~--- 225 (272)
T cd05075 154 ADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE----N-SEIYD--- 225 (272)
T ss_pred CCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC----H-HHHHH---
Confidence 99999987654332211112346778999999998889999999999999999999 788875211 1 11110
Q ss_pred hchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 041757 255 SNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSI 324 (381)
Q Consensus 255 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i 324 (381)
.+. ..... ..+..++..+.+++.+||+.||++|||+.++++.|+++
T Consensus 226 ------~~~---~~~~~---------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 226 ------YLR---QGNRL---------------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred ------HHH---cCCCC---------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 000 00000 00123456788999999999999999999999999875
No 85
>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal
Probab=100.00 E-value=7.9e-40 Score=305.39 Aligned_cols=221 Identities=24% Similarity=0.260 Sum_probs=173.9
Q ss_pred ceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHcc-CCCcccceeeeeccccccCCceEEEEE
Q 041757 42 NLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVY 100 (381)
Q Consensus 42 ~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~~~~~lv~ 100 (381)
++||+|+||.||+++. ...+.+.+|..++..+ +||||+++++++ ...+..++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~-----~~~~~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCF-----QTPDRLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEE-----EcCCEEEEEE
Confidence 4699999999987641 1235567888888877 699999999984 4577899999
Q ss_pred EcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccc
Q 041757 101 EFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180 (381)
Q Consensus 101 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 180 (381)
||+++|+|.+++. ....+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 76 Ey~~~g~L~~~i~----------~~~~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~ 142 (320)
T cd05590 76 EFVNGGDLMFHIQ----------KSRRFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGM 142 (320)
T ss_pred cCCCCchHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCC
Confidence 9999999999983 4557899999999999999999999 67999999999999999999999999999
Q ss_pred ceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHH
Q 041757 181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKD 260 (381)
Q Consensus 181 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 260 (381)
++........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ...
T Consensus 143 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~-----~~~------------ 203 (320)
T cd05590 143 CKEGIFNGKT--TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN-----EDD------------ 203 (320)
T ss_pred CeecCcCCCc--ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC-----HHH------------
Confidence 8754322221 122468999999999998899999999999999999999999985221 111
Q ss_pred HHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHH
Q 041757 261 IVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMT 315 (381)
Q Consensus 261 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 315 (381)
+.......... .+...+.++.+++.+||+.||.+||++.
T Consensus 204 ~~~~i~~~~~~----------------~~~~~~~~~~~li~~~L~~dP~~R~~~~ 242 (320)
T cd05590 204 LFEAILNDEVV----------------YPTWLSQDAVDILKAFMTKNPTMRLGSL 242 (320)
T ss_pred HHHHHhcCCCC----------------CCCCCCHHHHHHHHHHcccCHHHCCCCC
Confidence 11111111100 0112455788999999999999999983
No 86
>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N. Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved
Probab=100.00 E-value=1.3e-39 Score=304.46 Aligned_cols=228 Identities=21% Similarity=0.271 Sum_probs=176.0
Q ss_pred ccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHH---HccCCCcccceeeeeccccccCCc
Q 041757 38 MLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKAL---RNIRHRNLIKVLTACLGVDYQGND 94 (381)
Q Consensus 38 ~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l---~~l~h~nIv~~~~~~~~~~~~~~~ 94 (381)
|...++||+|+||.||++.. ...+.+.+|++++ +.++||||+++++++ ...+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~-----~~~~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACF-----QTED 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEE-----EcCC
Confidence 56778999999999987642 1234566676655 466799999999984 4578
Q ss_pred eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757 95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR 174 (381)
Q Consensus 95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k 174 (381)
..++||||+++|+|..++. ...+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+|
T Consensus 76 ~~~lv~E~~~~~~L~~~~~-----------~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~k 141 (324)
T cd05589 76 HVCFVMEYAAGGDLMMHIH-----------TDVFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVK 141 (324)
T ss_pred EEEEEEcCCCCCcHHHHhh-----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEE
Confidence 8999999999999998873 246899999999999999999999 67999999999999999999999
Q ss_pred EeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHh
Q 041757 175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMAL 254 (381)
Q Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 254 (381)
|+|||+++........ .....|++.|+|||++.+..++.++|||||||++|||++|+.||.... . .
T Consensus 142 L~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~----~-~------- 207 (324)
T cd05589 142 IADFGLCKEGMGFGDR--TSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD----E-E------- 207 (324)
T ss_pred eCcccCCccCCCCCCc--ccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC----H-H-------
Confidence 9999998754322221 122568999999999999899999999999999999999999985221 1 1
Q ss_pred hchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 041757 255 SNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMK-----MTNVVH 319 (381)
Q Consensus 255 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~~vl~ 319 (381)
++.......... .+...+..+.+++.+||+.||.+||+ +.++++
T Consensus 208 -----~~~~~i~~~~~~----------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 208 -----EVFDSIVNDEVR----------------YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred -----HHHHHHHhCCCC----------------CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 111111111100 01234567889999999999999994 556554
No 87
>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn. Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa
Probab=100.00 E-value=2.1e-39 Score=293.52 Aligned_cols=241 Identities=20% Similarity=0.331 Sum_probs=189.1
Q ss_pred cccccccceecCCCceEEEeccc---------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEE
Q 041757 35 SRNMLEENLISAGTFGFSHLRRQ---------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALV 99 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~~---------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv 99 (381)
-++|+..++||+|+||.||++.. ...+.+.+|+.+++.++|+||+++++.+ ......++|
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv 79 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV-----TKEEPIYII 79 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEE-----cCCCCcEEE
Confidence 36788899999999999987541 1346788999999999999999999984 446778999
Q ss_pred EEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecc
Q 041757 100 YEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179 (381)
Q Consensus 100 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg 179 (381)
|||+++++|.+++.. .....+++..++.++.|++.||+||| ..+++||||||+||+++.++.++|+|||
T Consensus 80 ~e~~~~~~L~~~l~~--------~~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg 148 (261)
T cd05072 80 TEYMAKGSLLDFLKS--------DEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFG 148 (261)
T ss_pred EecCCCCcHHHHHHH--------hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCc
Confidence 999999999999853 22456788889999999999999999 6699999999999999999999999999
Q ss_pred cceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchH
Q 041757 180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHV 258 (381)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 258 (381)
++.......... .....++..|+|||++.+..++.++|||||||++|+|++ |..||..... ......
T Consensus 149 ~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~-----~~~~~~------ 216 (261)
T cd05072 149 LARVIEDNEYTA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN-----SDVMSA------ 216 (261)
T ss_pred cceecCCCceec-cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH-----HHHHHH------
Confidence 998765433211 112346778999999988889999999999999999998 9999752211 000000
Q ss_pred HHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 041757 259 KDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSI 324 (381)
Q Consensus 259 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i 324 (381)
+..... .+ ....++.++.+++.+||+.+|++||++.++.+.|+++
T Consensus 217 ---~~~~~~-~~-----------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 217 ---LQRGYR-MP-----------------RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred ---HHcCCC-CC-----------------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 000000 00 0123456788999999999999999999999999753
No 88
>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2. Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit
Probab=100.00 E-value=1.6e-39 Score=300.07 Aligned_cols=256 Identities=19% Similarity=0.318 Sum_probs=189.2
Q ss_pred cccccccceecCCCceEEEecc----------------------------------cccHHHHHHHHHHHHccCCCcccc
Q 041757 35 SRNMLEENLISAGTFGFSHLRR----------------------------------QGAFKSFIAECKALRNIRHRNLIK 80 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~----------------------------------~~~~~~~~~E~~~l~~l~h~nIv~ 80 (381)
.++|+..++||+|+||.||++. ....+.+.+|+++++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 3578999999999999999752 112357889999999999999999
Q ss_pred eeeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcc-cccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeec
Q 041757 81 VLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE-TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCV 159 (381)
Q Consensus 81 ~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~-~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrD 159 (381)
+++++. ..+..++||||+++|+|.+++........ .......+++..+..++.|++.||+||| +.+++|||
T Consensus 84 ~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~d 155 (296)
T cd05095 84 LLAVCI-----TSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRD 155 (296)
T ss_pred EEEEEe-----cCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeeccc
Confidence 999954 46678999999999999999864321111 0122345788899999999999999999 66999999
Q ss_pred cCCCCeeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh--CCCCCC
Q 041757 160 LKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI--REKPSD 237 (381)
Q Consensus 160 lkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t--g~~Pf~ 237 (381)
|||+||+++.++.++|+|||+++.+.............+++.|+|||+..+..++.++|||||||++|||++ |..||.
T Consensus 156 lkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~ 235 (296)
T cd05095 156 LATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYS 235 (296)
T ss_pred CChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcc
Confidence 999999999999999999999976544322221112335678999998888889999999999999999998 778875
Q ss_pred ccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHH
Q 041757 238 IMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNV 317 (381)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v 317 (381)
.... ...... ............. ...+..++..+.+++.+||+.||.+|||+.+|
T Consensus 236 ~~~~-----~~~~~~-----~~~~~~~~~~~~~---------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i 290 (296)
T cd05095 236 QLSD-----EQVIEN-----TGEFFRDQGRQVY---------------LPKPALCPDSLYKLMLSCWRRNAKERPSFQEI 290 (296)
T ss_pred ccCh-----HHHHHH-----HHHHHhhcccccc---------------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHH
Confidence 2211 111110 0000100000000 00012355788999999999999999999999
Q ss_pred HHHHHH
Q 041757 318 VHELQS 323 (381)
Q Consensus 318 l~~L~~ 323 (381)
++.|++
T Consensus 291 ~~~l~~ 296 (296)
T cd05095 291 HATLLE 296 (296)
T ss_pred HHHHhC
Confidence 998863
No 89
>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt
Probab=100.00 E-value=2e-39 Score=296.57 Aligned_cols=249 Identities=24% Similarity=0.392 Sum_probs=190.9
Q ss_pred cccccccceecCCCceEEEeccc-----------------------ccHHHHHHHHHHHHccCCCcccceeeeecccccc
Q 041757 35 SRNMLEENLISAGTFGFSHLRRQ-----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQ 91 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~~-----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 91 (381)
.++|...+.||+|+||.||++.. ...+.+.+|+++|+.++|+||+++++++.
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----- 78 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCT----- 78 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEe-----
Confidence 35688889999999999987531 13467899999999999999999999954
Q ss_pred CCceEEEEEEcccCCCHHHhhccccCCcc----cccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeee
Q 041757 92 GNDFKALVYEFMHNRSLKEWLYPISKEDE----TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLL 167 (381)
Q Consensus 92 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~----~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill 167 (381)
.....++||||+++++|.+++........ .......+++..+..++.|++.|+.||| +.+++||||||+||++
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili 155 (280)
T cd05049 79 EGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLV 155 (280)
T ss_pred cCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEE
Confidence 46789999999999999999964321100 0123456889999999999999999999 6699999999999999
Q ss_pred CCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcH
Q 041757 168 DDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNL 246 (381)
Q Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~ 246 (381)
+.++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |..||.....
T Consensus 156 ~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~----- 230 (280)
T cd05049 156 GYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN----- 230 (280)
T ss_pred cCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH-----
Confidence 9999999999999976544332222222346788999999999999999999999999999998 9999752211
Q ss_pred HHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 041757 247 HKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQS 323 (381)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~ 323 (381)
.. .++........ ..+...+..+.+++.+||..||++||++.||++.|++
T Consensus 231 ~~------------~~~~~~~~~~~---------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 231 EE------------VIECITQGRLL---------------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HH------------HHHHHHcCCcC---------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 11 11110000000 0012355678999999999999999999999998863
No 90
>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase. Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays
Probab=100.00 E-value=2.8e-39 Score=293.22 Aligned_cols=240 Identities=22% Similarity=0.359 Sum_probs=188.2
Q ss_pred ccccccceecCCCceEEEeccc----------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEE
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ----------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALV 99 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~----------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv 99 (381)
.+|...++||+|+||.||++.. .....+.+|+++++.++|+||+++++++. ..+..++|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv 80 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPPFYII 80 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEc-----CCCCcEEE
Confidence 4578889999999999977531 13467899999999999999999999954 46678999
Q ss_pred EEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecc
Q 041757 100 YEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179 (381)
Q Consensus 100 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg 179 (381)
|||+++++|.+++.. .....+++..++.++.|++.||.||| ..+++||||||+||+++.++.+||+|||
T Consensus 81 ~e~~~~~~L~~~~~~--------~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~ 149 (263)
T cd05052 81 TEFMTYGNLLDYLRE--------CNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFG 149 (263)
T ss_pred EEeCCCCcHHHHHHh--------CCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCc
Confidence 999999999999853 22346888999999999999999999 6699999999999999999999999999
Q ss_pred cceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchH
Q 041757 180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHV 258 (381)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 258 (381)
++........... ....++..|+|||.+.+..++.++|||||||++|||++ |..||... ........
T Consensus 150 ~~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~-----~~~~~~~~------ 217 (263)
T cd05052 150 LSRLMTGDTYTAH-AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-----DLSQVYEL------ 217 (263)
T ss_pred cccccccceeecc-CCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHH------
Confidence 9987654322211 11224668999999988899999999999999999998 89997421 11111111
Q ss_pred HHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 041757 259 KDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSI 324 (381)
Q Consensus 259 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i 324 (381)
+...... ..+..++..+.+++.+||..||++|||+.++++.|+++
T Consensus 218 ---~~~~~~~------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 218 ---LEKGYRM------------------ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred ---HHCCCCC------------------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 1000000 00123556889999999999999999999999999875
No 91
>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity. Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....
Probab=100.00 E-value=2.6e-40 Score=299.44 Aligned_cols=234 Identities=29% Similarity=0.456 Sum_probs=177.7
Q ss_pred ccceecCCCceEEEeccc----------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757 40 EENLISAGTFGFSHLRRQ----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA 97 (381)
Q Consensus 40 ~~~~lG~G~fg~V~~~~~----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~ 97 (381)
..+.||.|.||.|+.+.. ...+.|.+|++.+++++||||++++|+|. ..+..+
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~-----~~~~~~ 77 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCI-----ENEPLF 77 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEE-----SSSSEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccc-----cccccc
Confidence 457899999999976431 13678999999999999999999999975 355589
Q ss_pred EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757 98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD 177 (381)
Q Consensus 98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D 177 (381)
+|||||++|+|.++|.. .....+++..+..++.||+.||.||| +.+++|+||+++||+++.++.+||+|
T Consensus 78 lv~e~~~~g~L~~~L~~--------~~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~ 146 (259)
T PF07714_consen 78 LVMEYCPGGSLDDYLKS--------KNKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSD 146 (259)
T ss_dssp EEEE--TTEBHHHHHHH--------TCTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEES
T ss_pred ccccccccccccccccc--------cccccccccccccccccccccccccc---cccccccccccccccccccccccccc
Confidence 99999999999999963 12467899999999999999999999 55899999999999999999999999
Q ss_pred cccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhc
Q 041757 178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSN 256 (381)
Q Consensus 178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~ 256 (381)
||++....................|+|||.+....++.++||||||+++||+++ |+.||... ....+...
T Consensus 147 f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~-----~~~~~~~~---- 217 (259)
T PF07714_consen 147 FGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY-----DNEEIIEK---- 217 (259)
T ss_dssp TTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS-----CHHHHHHH----
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-----cccccccc----
Confidence 999988743333222223447889999999998889999999999999999999 67886422 11111111
Q ss_pred hHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 041757 257 HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHEL 321 (381)
Q Consensus 257 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L 321 (381)
+.+.... ..+..++..+.+++.+||+.||++|||+.++++.|
T Consensus 218 ----~~~~~~~-------------------~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 218 ----LKQGQRL-------------------PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ----HHTTEET-------------------TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ----ccccccc-------------------eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1000000 01224567889999999999999999999999876
No 92
>PTZ00036 glycogen synthase kinase; Provisional
Probab=100.00 E-value=1.7e-39 Score=315.14 Aligned_cols=269 Identities=19% Similarity=0.208 Sum_probs=184.8
Q ss_pred ccccccccceecCCCceEEEecccc-------------cHHHHHHHHHHHHccCCCcccceeeeeccccc---cCCceEE
Q 041757 34 VSRNMLEENLISAGTFGFSHLRRQG-------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDY---QGNDFKA 97 (381)
Q Consensus 34 ~~~~~~~~~~lG~G~fg~V~~~~~~-------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~---~~~~~~~ 97 (381)
..++|...++||+|+||.||++... ......+|+.+|+.++||||+++++++....+ ....+.+
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~ 143 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLN 143 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEE
Confidence 3567999999999999999876421 12344579999999999999999887643211 2234577
Q ss_pred EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC-CeEEe
Q 041757 98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM-TARVG 176 (381)
Q Consensus 98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~-~~kl~ 176 (381)
+||||+++ +|.+++.... .....+++..++.++.|++.||.||| +.+|+||||||+|||++.++ .+||+
T Consensus 144 lvmE~~~~-~l~~~~~~~~------~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~ 213 (440)
T PTZ00036 144 VVMEFIPQ-TVHKYMKHYA------RNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLC 213 (440)
T ss_pred EEEecCCc-cHHHHHHHHh------hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeee
Confidence 99999975 7877764221 23457899999999999999999999 67999999999999998654 79999
Q ss_pred ecccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhh
Q 041757 177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALS 255 (381)
Q Consensus 177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 255 (381)
|||+++.+....... ...||+.|+|||++.+ ..++.++|||||||++|||++|.+||...... ..+.........
T Consensus 214 DFGla~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~-~~~~~i~~~~~~ 289 (440)
T PTZ00036 214 DFGSAKNLLAGQRSV---SYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV-DQLVRIIQVLGT 289 (440)
T ss_pred ccccchhccCCCCcc---cCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCC
Confidence 999998665433222 2458999999998776 46899999999999999999999997532111 011111111111
Q ss_pred chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
.....+ ..+ ....... .............++...+.++.+++.+||..||.+|||+.|+++
T Consensus 290 p~~~~~-~~~-~~~~~~~-~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 290 PTEDQL-KEM-NPNYADI-KFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred CCHHHH-HHh-chhhhcc-cCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 111111 000 0000000 000000011111222345568999999999999999999999984
No 93
>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to
Probab=100.00 E-value=1.1e-39 Score=304.64 Aligned_cols=225 Identities=24% Similarity=0.278 Sum_probs=176.0
Q ss_pred ceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHcc-CCCcccceeeeeccccccCCceEEEEE
Q 041757 42 NLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVY 100 (381)
Q Consensus 42 ~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~~~~~lv~ 100 (381)
++||+|+||.||++.. ...+.+..|.+++..+ +||||+++++++ ...+..++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~-----~~~~~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCF-----QTKDRLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCeEEEEE
Confidence 4699999999987641 1234567899999876 799999999994 4577899999
Q ss_pred EcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccc
Q 041757 101 EFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180 (381)
Q Consensus 101 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 180 (381)
||+++|+|..++. ....+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 76 E~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~ 142 (321)
T cd05591 76 EYVNGGDLMFQIQ----------RSRKFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGM 142 (321)
T ss_pred eCCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeeccc
Confidence 9999999999883 4556889999999999999999999 66999999999999999999999999999
Q ss_pred ceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHH
Q 041757 181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKD 260 (381)
Q Consensus 181 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 260 (381)
+.......... ....||+.|+|||++.+..++.++|||||||++|||++|+.||.... . . +
T Consensus 143 ~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~----~-~------------~ 203 (321)
T cd05591 143 CKEGILNGVTT--TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN----E-D------------D 203 (321)
T ss_pred ceecccCCccc--cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC----H-H------------H
Confidence 87643322211 22468999999999998899999999999999999999999985221 1 1 1
Q ss_pred HHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCC-------CHHHHHH
Q 041757 261 IVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRM-------KMTNVVH 319 (381)
Q Consensus 261 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-------s~~~vl~ 319 (381)
.+......... .+.....++.+++.+||+.||++|| ++.++++
T Consensus 204 ~~~~i~~~~~~----------------~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 204 LFESILHDDVL----------------YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred HHHHHHcCCCC----------------CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 11111111100 0112345788999999999999999 6677764
No 94
>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]
Probab=100.00 E-value=1.4e-40 Score=309.93 Aligned_cols=249 Identities=22% Similarity=0.358 Sum_probs=197.6
Q ss_pred cccccccceecCCCceEEEecc-----------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757 35 SRNMLEENLISAGTFGFSHLRR-----------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA 97 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~-----------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~ 97 (381)
.......++||+|-||.|.+.. ....++|.+|+++|.+|+|||||+++|+|+. ++.++
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~-----DePic 611 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQ-----DDPLC 611 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeec-----CCchH
Confidence 3455667999999999996643 3456899999999999999999999999975 67889
Q ss_pred EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757 98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD 177 (381)
Q Consensus 98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D 177 (381)
+|+||+++|+|.+|+.... ...+.-....+|+.||+.||+||. +.++|||||.+.|+|+++++++||+|
T Consensus 612 mI~EYmEnGDLnqFl~ahe--------apt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiad 680 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHE--------LPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIAD 680 (807)
T ss_pred HHHHHHhcCcHHHHHHhcc--------CcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecC
Confidence 9999999999999996421 122455566789999999999999 77999999999999999999999999
Q ss_pred cccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh--CCCCCCccccCCCcHHHHHHHHhh
Q 041757 178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI--REKPSDIMFEGDMNLHKFAKMALS 255 (381)
Q Consensus 178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t--g~~Pf~~~~~~~~~~~~~~~~~~~ 255 (381)
||+++-+-...........+-+++|||||.+.-++++++||||+||+++||+++ ...||....... .-
T Consensus 681 fgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~----------vv 750 (807)
T KOG1094|consen 681 FGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ----------VV 750 (807)
T ss_pred cccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH----------HH
Confidence 999997777666655555667899999999999999999999999999999864 788875332211 11
Q ss_pred chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 041757 256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSI 324 (381)
Q Consensus 256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i 324 (381)
++..++++. .+... -...++-|+..+.++|.+||..|-.+|||++++...|++.
T Consensus 751 en~~~~~~~----~~~~~-----------~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 751 ENAGEFFRD----QGRQV-----------VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred HhhhhhcCC----CCcce-----------eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 111111111 00000 0122467899999999999999999999999999988764
No 95
>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological
Probab=100.00 E-value=1.9e-39 Score=296.24 Aligned_cols=248 Identities=21% Similarity=0.323 Sum_probs=189.3
Q ss_pred cccccccceecCCCceEEEeccc-----------------------ccHHHHHHHHHHHHccCCCcccceeeeecccccc
Q 041757 35 SRNMLEENLISAGTFGFSHLRRQ-----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQ 91 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~~-----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 91 (381)
.++|...+.||+|+||.||++.. .....+.+|+.+++.++||||+++++++.
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~----- 79 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVS----- 79 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEc-----
Confidence 35788899999999999986431 12346889999999999999999999954
Q ss_pred CCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC
Q 041757 92 GNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM 171 (381)
Q Consensus 92 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~ 171 (381)
.....++||||+++|+|.+++...............+++..++.++.|++.||.||| +.+++||||||+||+++.++
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~ 156 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDL 156 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCC
Confidence 467889999999999999999643221111012335788899999999999999999 67999999999999999999
Q ss_pred CeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHH
Q 041757 172 TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFA 250 (381)
Q Consensus 172 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~ 250 (381)
.+||+|||+++.+.............++..|+|||.+.+..++.++|||||||++||+++ |..||.... .....
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~-----~~~~~ 231 (277)
T cd05032 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS-----NEEVL 231 (277)
T ss_pred CEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC-----HHHHH
Confidence 999999999886654432222222446789999999988889999999999999999998 898874211 11111
Q ss_pred HHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 041757 251 KMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQ 322 (381)
Q Consensus 251 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~ 322 (381)
.. +...... ..+..++..+.+++.+||+.+|++|||+.++++.|+
T Consensus 232 ~~--------~~~~~~~-------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 232 KF--------VIDGGHL-------------------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred HH--------HhcCCCC-------------------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 10 0000000 001234668899999999999999999999999886
No 96
>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp
Probab=100.00 E-value=1.8e-39 Score=302.44 Aligned_cols=224 Identities=22% Similarity=0.294 Sum_probs=173.4
Q ss_pred ceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHcc-CCCcccceeeeeccccccCCceEEEEE
Q 041757 42 NLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVY 100 (381)
Q Consensus 42 ~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~~~~~lv~ 100 (381)
++||+|+||.||++.. ...+.+..|..++..+ +||||+++++++ ......++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTF-----QTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence 4699999999987642 1233456677777654 799999999984 4577899999
Q ss_pred EcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccc
Q 041757 101 EFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180 (381)
Q Consensus 101 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 180 (381)
||+++|+|..++. ....+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 76 e~~~gg~L~~~~~----------~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~ 142 (316)
T cd05592 76 EYLNGGDLMFHIQ----------SSGRFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGM 142 (316)
T ss_pred cCCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcC
Confidence 9999999999983 4456899999999999999999999 66999999999999999999999999999
Q ss_pred ceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHH
Q 041757 181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKD 260 (381)
Q Consensus 181 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 260 (381)
++........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||.... . ...
T Consensus 143 a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~----~-~~~----------- 204 (316)
T cd05592 143 CKENMNGEGK--ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED----E-DEL----------- 204 (316)
T ss_pred CeECCCCCCc--cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC----H-HHH-----------
Confidence 9765332211 122568999999999999899999999999999999999999985221 1 111
Q ss_pred HHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHH-HHH
Q 041757 261 IVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMT-NVV 318 (381)
Q Consensus 261 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-~vl 318 (381)
........+. .+.....++.+++.+||+.||.+||++. +++
T Consensus 205 -~~~i~~~~~~----------------~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 205 -FDSILNDRPH----------------FPRWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred -HHHHHcCCCC----------------CCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 1111110000 0123445678899999999999999875 443
No 97
>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=100.00 E-value=3.3e-39 Score=299.44 Aligned_cols=253 Identities=21% Similarity=0.348 Sum_probs=191.9
Q ss_pred cccccccceecCCCceEEEeccc-------------------------ccHHHHHHHHHHHHcc-CCCcccceeeeeccc
Q 041757 35 SRNMLEENLISAGTFGFSHLRRQ-------------------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGV 88 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~~-------------------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~ 88 (381)
.++|.+++.||+|+||.||++.. .....+.+|+.+++.+ +||||+++++++.
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~-- 94 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT-- 94 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe--
Confidence 36799999999999999986531 1234678899999999 7999999999964
Q ss_pred cccCCceEEEEEEcccCCCHHHhhccccCCcc------cccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCC
Q 041757 89 DYQGNDFKALVYEFMHNRSLKEWLYPISKEDE------TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKP 162 (381)
Q Consensus 89 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp 162 (381)
.....++||||+++|+|.+++........ .......+++.+++.++.|++.||+||| +.+++||||||
T Consensus 95 ---~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp 168 (307)
T cd05098 95 ---QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAA 168 (307)
T ss_pred ---cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccH
Confidence 46678999999999999999964321100 0012235889999999999999999999 66999999999
Q ss_pred CCeeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCcccc
Q 041757 163 SNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFE 241 (381)
Q Consensus 163 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~ 241 (381)
+||+++.++.+||+|||.++...............++..|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus 169 ~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~-- 246 (307)
T cd05098 169 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-- 246 (307)
T ss_pred HheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC--
Confidence 999999999999999999876643322211111234578999999988889999999999999999998 88886421
Q ss_pred CCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 041757 242 GDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHEL 321 (381)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L 321 (381)
........ +..... ...+..++.++.+++.+||+.+|.+|||+.+|++.|
T Consensus 247 ---~~~~~~~~---------~~~~~~------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l 296 (307)
T cd05098 247 ---PVEELFKL---------LKEGHR------------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 296 (307)
T ss_pred ---CHHHHHHH---------HHcCCC------------------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 11111111 110000 001124556888999999999999999999999999
Q ss_pred HHhhhh
Q 041757 322 QSIKNT 327 (381)
Q Consensus 322 ~~i~~~ 327 (381)
+++...
T Consensus 297 ~~~~~~ 302 (307)
T cd05098 297 DRILAL 302 (307)
T ss_pred HHHHHH
Confidence 998765
No 98
>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C. Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory
Probab=100.00 E-value=1.8e-39 Score=303.51 Aligned_cols=225 Identities=20% Similarity=0.227 Sum_probs=175.7
Q ss_pred cccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCC-cccceeeeeccccccCCce
Q 041757 37 NMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHR-NLIKVLTACLGVDYQGNDF 95 (381)
Q Consensus 37 ~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~-nIv~~~~~~~~~~~~~~~~ 95 (381)
+|...+.||+|+||.||++.. ...+.+..|.+++..+.|+ +|+++++++ ...+.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QTMDR 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEE-----EcCCE
Confidence 578889999999999987642 2345677899999999765 578888874 45778
Q ss_pred EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757 96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV 175 (381)
Q Consensus 96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl 175 (381)
.++||||+++|+|.+++. ....+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||
T Consensus 76 ~~lv~E~~~~g~L~~~~~----------~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL 142 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQ----------QVGKFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKI 142 (324)
T ss_pred EEEEEcCCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEE
Confidence 999999999999999983 4456889999999999999999999 679999999999999999999999
Q ss_pred eecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhh
Q 041757 176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALS 255 (381)
Q Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 255 (381)
+|||+++........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||.... . ..
T Consensus 143 ~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~----~-~~------- 208 (324)
T cd05587 143 ADFGMCKENIFGGKT--TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED----E-DE------- 208 (324)
T ss_pred eecCcceecCCCCCc--eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC----H-HH-------
Confidence 999998753222211 112468999999999999899999999999999999999999985221 1 11
Q ss_pred chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCH
Q 041757 256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKM 314 (381)
Q Consensus 256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 314 (381)
.+......... .+......+.+++.+||+.||.+|++.
T Consensus 209 -----~~~~i~~~~~~----------------~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 209 -----LFQSIMEHNVS----------------YPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred -----HHHHHHcCCCC----------------CCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 11111110000 011344578899999999999999986
No 99
>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=100.00 E-value=4.1e-39 Score=298.42 Aligned_cols=253 Identities=19% Similarity=0.352 Sum_probs=193.2
Q ss_pred cccccccceecCCCceEEEecc-------------------------cccHHHHHHHHHHHHcc-CCCcccceeeeeccc
Q 041757 35 SRNMLEENLISAGTFGFSHLRR-------------------------QGAFKSFIAECKALRNI-RHRNLIKVLTACLGV 88 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~-------------------------~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~ 88 (381)
.++|...+.||+|+||.||++. ....+.+.+|+.+++.+ +||||+++++.+.
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~-- 91 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT-- 91 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe--
Confidence 5778899999999999998663 11235678899999999 7999999999953
Q ss_pred cccCCceEEEEEEcccCCCHHHhhccccCCcccc------cCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCC
Q 041757 89 DYQGNDFKALVYEFMHNRSLKEWLYPISKEDETY------KRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKP 162 (381)
Q Consensus 89 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp 162 (381)
.....++||||+++|+|.+++.......... .....+++..++.++.|++.||.||| +.+++||||||
T Consensus 92 ---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp 165 (304)
T cd05101 92 ---QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAA 165 (304)
T ss_pred ---cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeeccccc
Confidence 4678899999999999999996432110000 11245788899999999999999999 66999999999
Q ss_pred CCeeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCcccc
Q 041757 163 SNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFE 241 (381)
Q Consensus 163 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~ 241 (381)
+||+++.++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|++++ |..||...
T Consensus 166 ~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-- 243 (304)
T cd05101 166 RNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-- 243 (304)
T ss_pred ceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC--
Confidence 999999999999999999987654332222222346778999999988889999999999999999998 77886421
Q ss_pred CCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 041757 242 GDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHEL 321 (381)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L 321 (381)
........ ...... ...+..++..+.+++.+||+.+|.+|||+.++++.|
T Consensus 244 ---~~~~~~~~------------~~~~~~---------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l 293 (304)
T cd05101 244 ---PVEELFKL------------LKEGHR---------------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDL 293 (304)
T ss_pred ---CHHHHHHH------------HHcCCc---------------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHH
Confidence 11111111 100000 000124566888999999999999999999999999
Q ss_pred HHhhhh
Q 041757 322 QSIKNT 327 (381)
Q Consensus 322 ~~i~~~ 327 (381)
+++...
T Consensus 294 ~~~~~~ 299 (304)
T cd05101 294 DRILTL 299 (304)
T ss_pred HHHHHh
Confidence 988654
No 100
>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes. Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular
Probab=100.00 E-value=5.3e-39 Score=289.39 Aligned_cols=232 Identities=21% Similarity=0.308 Sum_probs=179.6
Q ss_pred ceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEcc
Q 041757 42 NLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFM 103 (381)
Q Consensus 42 ~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~~ 103 (381)
++||+|+||.||++.. .....+.+|++++++++||||++++++|. .....++||||+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~ 75 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT-----QKQPIYIVMELV 75 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-----CCCCeEEEEeec
Confidence 4699999999987531 12456899999999999999999999964 467789999999
Q ss_pred cCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccccee
Q 041757 104 HNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARF 183 (381)
Q Consensus 104 ~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~ 183 (381)
++++|.+++. .....+++..++.++.|++.||.||| +.+++||||||+||+++.++.+||+|||++..
T Consensus 76 ~~~~L~~~~~---------~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 143 (252)
T cd05084 76 QGGDFLTFLR---------TEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSRE 143 (252)
T ss_pred cCCcHHHHHH---------hCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcc
Confidence 9999999984 22345889999999999999999999 66999999999999999999999999999876
Q ss_pred cCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchHHHHH
Q 041757 184 LPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHVKDIV 262 (381)
Q Consensus 184 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (381)
..............++..|+|||.+.+..++.++||||||+++||+++ |..||..... . .....+
T Consensus 144 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~-----~---------~~~~~~ 209 (252)
T cd05084 144 EEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN-----Q---------QTREAI 209 (252)
T ss_pred cccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH-----H---------HHHHHH
Confidence 543221111111123567999999988889999999999999999998 8888752211 0 011111
Q ss_pred hhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 041757 263 DSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQ 322 (381)
Q Consensus 263 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~ 322 (381)
...... ..+..++..+.+++.+||+.+|++|||+.++++.|+
T Consensus 210 ~~~~~~------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 210 EQGVRL------------------PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HcCCCC------------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 110000 011234568899999999999999999999999886
No 101
>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,
Probab=100.00 E-value=3.2e-39 Score=297.42 Aligned_cols=251 Identities=20% Similarity=0.337 Sum_probs=192.1
Q ss_pred cccccccceecCCCceEEEeccc-----------------------ccHHHHHHHHHHHHcc-CCCcccceeeeeccccc
Q 041757 35 SRNMLEENLISAGTFGFSHLRRQ-----------------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVDY 90 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~~-----------------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~ 90 (381)
.++|...+.||+|+||.||++.. .....+.+|+.++.++ +|+||+++++++.
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~---- 86 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT---- 86 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc----
Confidence 46788899999999999987531 1234688899999999 7999999999954
Q ss_pred cCCceEEEEEEcccCCCHHHhhccccCCcc------cccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCC
Q 041757 91 QGNDFKALVYEFMHNRSLKEWLYPISKEDE------TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSN 164 (381)
Q Consensus 91 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~N 164 (381)
..+..++||||+++|+|.+++........ .......+++..++.++.|++.||+||| ..+|+||||||+|
T Consensus 87 -~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~N 162 (293)
T cd05053 87 -QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARN 162 (293)
T ss_pred -CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceee
Confidence 46778999999999999999964321100 0022456889999999999999999999 6699999999999
Q ss_pred eeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCC
Q 041757 165 VLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGD 243 (381)
Q Consensus 165 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~ 243 (381)
|+++.++.+||+|||+++.+.............++..|+|||++.+..++.++|||||||++||+++ |..||....
T Consensus 163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--- 239 (293)
T cd05053 163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP--- 239 (293)
T ss_pred EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC---
Confidence 9999999999999999987655432222222335678999999988889999999999999999997 888874211
Q ss_pred CcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 041757 244 MNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQS 323 (381)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~ 323 (381)
...... .+..... + ..+..++..+.+++.+||..||.+|||+.++++.|++
T Consensus 240 --~~~~~~---------~~~~~~~--~----------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~ 290 (293)
T cd05053 240 --VEELFK---------LLKEGYR--M----------------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDR 290 (293)
T ss_pred --HHHHHH---------HHHcCCc--C----------------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHH
Confidence 111111 0100000 0 0012345678899999999999999999999999988
Q ss_pred hh
Q 041757 324 IK 325 (381)
Q Consensus 324 i~ 325 (381)
+.
T Consensus 291 ~~ 292 (293)
T cd05053 291 ML 292 (293)
T ss_pred hh
Confidence 74
No 102
>PLN00034 mitogen-activated protein kinase kinase; Provisional
Probab=100.00 E-value=2.1e-39 Score=306.69 Aligned_cols=232 Identities=21% Similarity=0.293 Sum_probs=177.5
Q ss_pred cccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757 35 SRNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK 96 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~ 96 (381)
..+|...++||+|+||.||++.. .....+.+|+++++.++|+||+++++++ ...+..
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 147 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF-----DHNGEI 147 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEe-----ccCCeE
Confidence 35677889999999999987642 1245688999999999999999999994 457789
Q ss_pred EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757 97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG 176 (381)
Q Consensus 97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~ 176 (381)
++||||+++|+|.... ...+..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+
T Consensus 148 ~lv~e~~~~~~L~~~~--------------~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~ 210 (353)
T PLN00034 148 QVLLEFMDGGSLEGTH--------------IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIA 210 (353)
T ss_pred EEEEecCCCCcccccc--------------cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEc
Confidence 9999999999986532 2456677889999999999999 6699999999999999999999999
Q ss_pred ecccceecCCCCCcccccCccCccceeCCCCcCC-----CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHH
Q 041757 177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-----NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAK 251 (381)
Q Consensus 177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~ 251 (381)
|||+++.+....... ....||..|+|||++.. ...+.++|||||||++|||++|+.||..... ..+.....
T Consensus 211 DfG~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~--~~~~~~~~ 286 (353)
T PLN00034 211 DFGVSRILAQTMDPC--NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ--GDWASLMC 286 (353)
T ss_pred ccccceecccccccc--cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--ccHHHHHH
Confidence 999998765432211 12468999999998753 2345689999999999999999999862211 11111111
Q ss_pred HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 252 MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 252 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
....... ...+..+..++.+++.+||+.||++|||+.|+++
T Consensus 287 ------------~~~~~~~---------------~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 287 ------------AICMSQP---------------PEAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred ------------HHhccCC---------------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000000 0001245567899999999999999999999987
No 103
>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase. Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re
Probab=100.00 E-value=4.8e-39 Score=290.43 Aligned_cols=237 Identities=25% Similarity=0.353 Sum_probs=187.1
Q ss_pred ccccccceecCCCceEEEecc-------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEc
Q 041757 36 RNMLEENLISAGTFGFSHLRR-------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEF 102 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~-------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~ 102 (381)
++|...+.||+|+||.||++. ....+.+.+|+.++++++|+||+++++++. ......++||||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~~lv~e~ 81 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLYIVTEY 81 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEE----cCCCceEEEEEC
Confidence 578888999999999998753 223567899999999999999999999753 345678999999
Q ss_pred ccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccce
Q 041757 103 MHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR 182 (381)
Q Consensus 103 ~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~ 182 (381)
+++++|.+++.. .....+++..++.++.|++.||+||| ..+++||||||+||+++.++.+||+|||++.
T Consensus 82 ~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~ 150 (256)
T cd05082 82 MAKGSLVDYLRS--------RGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTK 150 (256)
T ss_pred CCCCcHHHHHHh--------cCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccce
Confidence 999999999853 12335788999999999999999999 6699999999999999999999999999987
Q ss_pred ecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchHHHH
Q 041757 183 FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHVKDI 261 (381)
Q Consensus 183 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (381)
....... ...++..|+|||++.+..++.++|||||||++|+|++ |+.||... ........
T Consensus 151 ~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~-----~~~~~~~~--------- 211 (256)
T cd05082 151 EASSTQD-----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-----PLKDVVPR--------- 211 (256)
T ss_pred eccccCC-----CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHH---------
Confidence 6543221 1235678999999988889999999999999999997 99997421 11111111
Q ss_pred HhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 041757 262 VDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSI 324 (381)
Q Consensus 262 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i 324 (381)
...... ...+..++..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 212 ---~~~~~~---------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 212 ---VEKGYK---------------MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred ---HhcCCC---------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 000000 001124566888999999999999999999999998764
No 104
>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2. Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A
Probab=100.00 E-value=2.7e-39 Score=299.53 Aligned_cols=251 Identities=22% Similarity=0.317 Sum_probs=189.3
Q ss_pred ccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHcc-CCCcccceeeeeccccccCCc
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGND 94 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~~ 94 (381)
++|...+.||+|+||.||++.. .....+.+|++++.++ +|+||+++++++ ...+
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~-----~~~~ 81 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EHRG 81 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEE-----CCCC
Confidence 5788889999999999988741 1234678899999999 799999999995 4467
Q ss_pred eEEEEEEcccCCCHHHhhccccCCccc------ccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeC
Q 041757 95 FKALVYEFMHNRSLKEWLYPISKEDET------YKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLD 168 (381)
Q Consensus 95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~------~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~ 168 (381)
..++||||+++++|.+++......... ......+++..++.++.|++.||+||| +.+++||||||+||+++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~ 158 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVG 158 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEec
Confidence 899999999999999999643211000 012236889999999999999999999 67999999999999999
Q ss_pred CCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHH
Q 041757 169 DDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLH 247 (381)
Q Consensus 169 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~ 247 (381)
.++.+||+|||++......... ....++..|+|||++.+..++.++|||||||++|||+| |..||..... .
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-----~ 230 (303)
T cd05088 159 ENYVAKIADFGLSRGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-----A 230 (303)
T ss_pred CCCcEEeCccccCcccchhhhc---ccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh-----H
Confidence 9999999999998643211111 11224667999999988889999999999999999998 9999752211 1
Q ss_pred HHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 041757 248 KFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT 327 (381)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~ 327 (381)
.. .+....... ...+...+..+.+++.+||+.+|++||++.++++.|.++...
T Consensus 231 ~~------------~~~~~~~~~---------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 231 EL------------YEKLPQGYR---------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred HH------------HHHHhcCCc---------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 11 110000000 000112445788999999999999999999999999988665
Q ss_pred cC
Q 041757 328 LL 329 (381)
Q Consensus 328 ~~ 329 (381)
..
T Consensus 284 ~~ 285 (303)
T cd05088 284 RK 285 (303)
T ss_pred hh
Confidence 43
No 105
>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome. Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds
Probab=100.00 E-value=2.9e-39 Score=292.04 Aligned_cols=237 Identities=21% Similarity=0.340 Sum_probs=185.1
Q ss_pred ccccccceecCCCceEEEeccc---------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEE
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ---------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVY 100 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~---------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~ 100 (381)
++|...+.||+|+||.||+++. .....+.+|+.++++++||||+++++++. .....++||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~ 78 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT-----KQRPIYIVT 78 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEc-----cCCCcEEEE
Confidence 4678889999999999977641 12457899999999999999999999954 356789999
Q ss_pred EcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccc
Q 041757 101 EFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180 (381)
Q Consensus 101 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 180 (381)
||+.+|+|.+++.. ....+++..++.++.|++.||.||| +.+++|+||||+||+++.++.+||+|||.
T Consensus 79 e~~~~~~l~~~i~~---------~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~ 146 (256)
T cd05113 79 EYMSNGCLLNYLRE---------HGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGL 146 (256)
T ss_pred EcCCCCcHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCcc
Confidence 99999999999852 2336899999999999999999999 67999999999999999999999999999
Q ss_pred ceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchHH
Q 041757 181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHVK 259 (381)
Q Consensus 181 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 259 (381)
++......... .....++..|+|||++.+..++.++||||||+++|+|++ |..||..... ..
T Consensus 147 ~~~~~~~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-----~~----------- 209 (256)
T cd05113 147 SRYVLDDEYTS-SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN-----SE----------- 209 (256)
T ss_pred ceecCCCceee-cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH-----HH-----------
Confidence 88665433221 112335678999999988889999999999999999998 9999752211 00
Q ss_pred HHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 041757 260 DIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQ 322 (381)
Q Consensus 260 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~ 322 (381)
+.......... ..+...+..+.+++.+||+.||.+|||+.++++.|+
T Consensus 210 -~~~~~~~~~~~---------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 210 -TVEKVSQGLRL---------------YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred -HHHHHhcCCCC---------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 11111100000 001123567899999999999999999999998763
No 106
>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C. Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl
Probab=100.00 E-value=9.7e-40 Score=305.93 Aligned_cols=231 Identities=22% Similarity=0.278 Sum_probs=176.9
Q ss_pred ceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHcc-CCCcccceeeeeccccccCCceEEEEE
Q 041757 42 NLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVY 100 (381)
Q Consensus 42 ~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~~~~~lv~ 100 (381)
++||+|+||.||++.. ...+.+.+|..++..+ +||||+++++++ ......++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~-----~~~~~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCF-----QTESRLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEE-----EcCCEEEEEE
Confidence 4799999999987642 1234577899999998 699999999984 4577899999
Q ss_pred EcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccc
Q 041757 101 EFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180 (381)
Q Consensus 101 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 180 (381)
|||++|+|..++. ....+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 76 e~~~~g~L~~~~~----------~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~ 142 (329)
T cd05588 76 EFVSGGDLMFHMQ----------RQRKLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGM 142 (329)
T ss_pred eCCCCCCHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCcc
Confidence 9999999999883 4567999999999999999999999 77999999999999999999999999999
Q ss_pred ceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCC---cHHHHHHHHhhch
Q 041757 181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDM---NLHKFAKMALSNH 257 (381)
Q Consensus 181 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~---~~~~~~~~~~~~~ 257 (381)
++........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.||+.....+. ....+..
T Consensus 143 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~------ 214 (329)
T cd05588 143 CKEGIRPGDT--TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLF------ 214 (329)
T ss_pred ccccccCCCc--cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHH------
Confidence 8753222211 1125689999999999999999999999999999999999999863221110 0001000
Q ss_pred HHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCC------HHHHHH
Q 041757 258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMK------MTNVVH 319 (381)
Q Consensus 258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs------~~~vl~ 319 (381)
..+... .. ..+...+..+.+++.+||+.||.+||+ +.++++
T Consensus 215 -~~~~~~----~~----------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 215 -QVILEK----QI----------------RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred -HHHHcC----CC----------------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 000110 00 011234557889999999999999998 556653
No 107
>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C. Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re
Probab=100.00 E-value=1.9e-39 Score=302.62 Aligned_cols=225 Identities=22% Similarity=0.251 Sum_probs=177.3
Q ss_pred ceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHcc-CCCcccceeeeeccccccCCceEEEEE
Q 041757 42 NLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVY 100 (381)
Q Consensus 42 ~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~~~~~lv~ 100 (381)
++||+|+||+||++.. .....+.+|.+++..+ +||||+++++++ ...+..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~-----~~~~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCF-----QTKDRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence 4699999999987642 1234567899999888 699999999984 4577899999
Q ss_pred EcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccc
Q 041757 101 EFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180 (381)
Q Consensus 101 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 180 (381)
||+++|+|..++. ....+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 76 e~~~~~~L~~~~~----------~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 142 (318)
T cd05570 76 EYVNGGDLMFHIQ----------RSGRFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGM 142 (318)
T ss_pred cCCCCCCHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCC
Confidence 9999999999883 4557899999999999999999999 67999999999999999999999999999
Q ss_pred ceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHH
Q 041757 181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKD 260 (381)
Q Consensus 181 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 260 (381)
++......... ....|++.|+|||++.+..++.++|||||||++|+|++|+.||.... .....
T Consensus 143 ~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~-----~~~~~---------- 205 (318)
T cd05570 143 CKEGILGGVTT--STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD-----EDELF---------- 205 (318)
T ss_pred CeecCcCCCcc--cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC-----HHHHH----------
Confidence 87533222211 12458999999999999999999999999999999999999985221 11111
Q ss_pred HHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHH
Q 041757 261 IVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKM-----TNVVH 319 (381)
Q Consensus 261 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~~vl~ 319 (381)
......... .+...+..+.+++.+||+.||.+|||+ .++++
T Consensus 206 --~~i~~~~~~----------------~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 206 --QSILEDEVR----------------YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred --HHHHcCCCC----------------CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 111100000 012345678899999999999999999 77764
No 108
>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2. Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve
Probab=100.00 E-value=6.7e-39 Score=293.22 Aligned_cols=244 Identities=23% Similarity=0.326 Sum_probs=190.4
Q ss_pred cccccccceecCCCceEEEeccc----------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccC
Q 041757 35 SRNMLEENLISAGTFGFSHLRRQ----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQG 92 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~~----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 92 (381)
.++|...++||.|+||+||++.. ...+.+.+|+.+++.++||||+++++++.
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~------ 79 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICL------ 79 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEc------
Confidence 56788899999999999987531 12456788999999999999999999964
Q ss_pred CceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCC
Q 041757 93 NDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT 172 (381)
Q Consensus 93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~ 172 (381)
....++++||+++|+|.+++. .....+++..++.++.|++.||.||| +.+++||||||+||++++++.
T Consensus 80 ~~~~~l~~~~~~~g~l~~~l~---------~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~ 147 (279)
T cd05109 80 TSTVQLVTQLMPYGCLLDYVR---------ENKDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNH 147 (279)
T ss_pred CCCcEEEEEcCCCCCHHHHHh---------hccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCc
Confidence 234679999999999999985 22456899999999999999999999 679999999999999999999
Q ss_pred eEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHH
Q 041757 173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAK 251 (381)
Q Consensus 173 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~ 251 (381)
+||+|||+++...............+++.|+|||.+.+..++.++|||||||++||+++ |..||..... ..
T Consensus 148 ~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----~~--- 219 (279)
T cd05109 148 VKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA-----RE--- 219 (279)
T ss_pred EEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----HH---
Confidence 99999999987754332222212235678999999988889999999999999999998 8999752211 00
Q ss_pred HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhc
Q 041757 252 MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTL 328 (381)
Q Consensus 252 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~~ 328 (381)
....+....... .+..++..+.+++.+||+.||++||++.++++.|+.+....
T Consensus 220 ------~~~~~~~~~~~~------------------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 220 ------IPDLLEKGERLP------------------QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred ------HHHHHHCCCcCC------------------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 111111100000 01235567889999999999999999999999998775543
No 109
>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota. Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o
Probab=100.00 E-value=9.2e-40 Score=306.04 Aligned_cols=229 Identities=23% Similarity=0.273 Sum_probs=173.9
Q ss_pred ceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHcc-CCCcccceeeeeccccccCCceEEEEE
Q 041757 42 NLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVY 100 (381)
Q Consensus 42 ~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~~~~~lv~ 100 (381)
++||+|+||.||++.. .....+.+|+.++.++ +||||+++++++ ...+..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QTESRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEE-----EeCCEEEEEE
Confidence 4699999999987641 1234567888888877 799999999984 4577899999
Q ss_pred EcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccc
Q 041757 101 EFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180 (381)
Q Consensus 101 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 180 (381)
||+++|+|..++. ....+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 76 E~~~~~~L~~~~~----------~~~~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~ 142 (329)
T cd05618 76 EYVNGGDLMFHMQ----------RQRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGM 142 (329)
T ss_pred eCCCCCCHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCc
Confidence 9999999998883 4567899999999999999999999 66999999999999999999999999999
Q ss_pred ceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHH
Q 041757 181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKD 260 (381)
Q Consensus 181 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 260 (381)
++......... ....||+.|+|||++.+..++.++|||||||++|||++|+.||............. ...
T Consensus 143 ~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~--------~~~ 212 (329)
T cd05618 143 CKEGLRPGDTT--STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT--------EDY 212 (329)
T ss_pred cccccCCCCcc--ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCccccc--------HHH
Confidence 87543222111 22568999999999999999999999999999999999999986322111110000 000
Q ss_pred HHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCH
Q 041757 261 IVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKM 314 (381)
Q Consensus 261 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 314 (381)
+......... ..+......+.+++.+||+.||.+||++
T Consensus 213 ~~~~i~~~~~----------------~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 213 LFQVILEKQI----------------RIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred HHHHHhcCCC----------------CCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 0000010000 0122345578899999999999999984
No 110
>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1. Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.
Probab=100.00 E-value=4.8e-39 Score=297.00 Aligned_cols=250 Identities=22% Similarity=0.311 Sum_probs=189.1
Q ss_pred ccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHcc-CCCcccceeeeeccccccCCc
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGND 94 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~~ 94 (381)
++|...++||+|+||.||++.. ...+.+.+|+.++.++ +||||+++++++ ....
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~-----~~~~ 76 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGAC-----ENRG 76 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEE-----ccCC
Confidence 5788899999999999987531 1235688899999999 699999999985 3466
Q ss_pred eEEEEEEcccCCCHHHhhccccCCcc------cccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeC
Q 041757 95 FKALVYEFMHNRSLKEWLYPISKEDE------TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLD 168 (381)
Q Consensus 95 ~~~lv~e~~~~g~L~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~ 168 (381)
..++||||+++++|.+++........ .......+++..++.++.|++.||+||| +.+++||||||+||+++
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~ 153 (297)
T cd05089 77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVG 153 (297)
T ss_pred cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEEC
Confidence 78999999999999999954221100 0012245889999999999999999999 66999999999999999
Q ss_pred CCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHH
Q 041757 169 DDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLH 247 (381)
Q Consensus 169 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~ 247 (381)
.++.+||+|||++.......... ....+..|+|||++.+..++.++|||||||++|||++ |..||..... .
T Consensus 154 ~~~~~kl~dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~-----~ 225 (297)
T cd05089 154 ENLASKIADFGLSRGEEVYVKKT---MGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC-----A 225 (297)
T ss_pred CCCeEEECCcCCCccccceeccC---CCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-----H
Confidence 99999999999986432211111 1123567999999988889999999999999999997 9999752211 1
Q ss_pred HHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 041757 248 KFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT 327 (381)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~ 327 (381)
..... +... .... .+..++..+.+++.+||+.+|.+|||+.++++.|+.+...
T Consensus 226 ~~~~~--------~~~~-~~~~------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~ 278 (297)
T cd05089 226 ELYEK--------LPQG-YRME------------------KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA 278 (297)
T ss_pred HHHHH--------HhcC-CCCC------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 11110 0000 0000 0123556788999999999999999999999999988766
Q ss_pred c
Q 041757 328 L 328 (381)
Q Consensus 328 ~ 328 (381)
.
T Consensus 279 ~ 279 (297)
T cd05089 279 R 279 (297)
T ss_pred h
Confidence 5
No 111
>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1. Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly
Probab=100.00 E-value=3.3e-39 Score=295.86 Aligned_cols=248 Identities=21% Similarity=0.311 Sum_probs=188.0
Q ss_pred ccccccceecCCCceEEEeccc----------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN 93 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 93 (381)
++|+..+.||+|+||.||++.. .....+.+|+.+++.++||||+++++++ ...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~ 79 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVV-----TQE 79 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEE-----ecC
Confidence 5678889999999999987531 1235688999999999999999999984 446
Q ss_pred ceEEEEEEcccCCCHHHhhccccCCc-------ccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCee
Q 041757 94 DFKALVYEFMHNRSLKEWLYPISKED-------ETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVL 166 (381)
Q Consensus 94 ~~~~lv~e~~~~g~L~~~l~~~~~~~-------~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nil 166 (381)
...++||||+++++|.+++....... ........+++..++.++.|++.||.||| +.+++||||||+||+
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nil 156 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNIL 156 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEE
Confidence 78899999999999999984321100 00011345788999999999999999999 669999999999999
Q ss_pred eCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCc
Q 041757 167 LDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMN 245 (381)
Q Consensus 167 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~ 245 (381)
++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.... .
T Consensus 157 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~----~ 232 (283)
T cd05090 157 IGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS----N 232 (283)
T ss_pred EcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC----H
Confidence 99999999999999987644332222222346778999999988889999999999999999998 988974211 0
Q ss_pred HHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 041757 246 LHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQS 323 (381)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~ 323 (381)
...... +...... ..+..++..+.+++.+||+.||.+||++.+|.+.|..
T Consensus 233 -~~~~~~---------~~~~~~~------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 233 -QEVIEM---------VRKRQLL------------------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred -HHHHHH---------HHcCCcC------------------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 111111 1000000 0012345678899999999999999999999998864
No 112
>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors. Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept
Probab=100.00 E-value=2.4e-39 Score=299.76 Aligned_cols=243 Identities=23% Similarity=0.297 Sum_probs=188.7
Q ss_pred cccccccceecCCCceEEEeccc-----------------------ccHHHHHHHHHHHHcc-CCCcccceeeeeccccc
Q 041757 35 SRNMLEENLISAGTFGFSHLRRQ-----------------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVDY 90 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~~-----------------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~ 90 (381)
.++|...+.||+|+||.||++.. ...+.+.+|+++++++ +||||+++++++.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~---- 109 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACT---- 109 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEe----
Confidence 46799999999999999976531 1234688999999999 7999999999954
Q ss_pred cCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCC
Q 041757 91 QGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDD 170 (381)
Q Consensus 91 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~ 170 (381)
..+..++||||+++|+|.+++.. .....+++.++..++.|++.||.||| +.+++|+||||+||+++.+
T Consensus 110 -~~~~~~lv~e~~~~~~L~~~i~~--------~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~ 177 (302)
T cd05055 110 -IGGPILVITEYCCYGDLLNFLRR--------KRESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHG 177 (302)
T ss_pred -cCCceEEEEEcCCCCcHHHHHHh--------CCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCC
Confidence 46678999999999999999953 12234899999999999999999999 6699999999999999999
Q ss_pred CCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHH
Q 041757 171 MTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKF 249 (381)
Q Consensus 171 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~ 249 (381)
+.++|+|||+++...............++..|+|||++.+..++.++|||||||++||+++ |..||...... ..+
T Consensus 178 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~----~~~ 253 (302)
T cd05055 178 KIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD----SKF 253 (302)
T ss_pred CeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch----HHH
Confidence 9999999999986654332211122346788999999998889999999999999999998 99997532111 010
Q ss_pred HHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 041757 250 AKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSI 324 (381)
Q Consensus 250 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i 324 (381)
...+....... .+...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 254 ---------~~~~~~~~~~~------------------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 254 ---------YKLIKEGYRMA------------------QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ---------HHHHHcCCcCC------------------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 11111100000 0112345788999999999999999999999999874
No 113
>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including
Probab=100.00 E-value=2.7e-39 Score=298.36 Aligned_cols=255 Identities=21% Similarity=0.330 Sum_probs=186.9
Q ss_pred cccccccceecCCCceEEEeccc--------------------------------ccHHHHHHHHHHHHccCCCccccee
Q 041757 35 SRNMLEENLISAGTFGFSHLRRQ--------------------------------GAFKSFIAECKALRNIRHRNLIKVL 82 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~~--------------------------------~~~~~~~~E~~~l~~l~h~nIv~~~ 82 (381)
.++|...++||+|+||.||++.. .....|.+|++++++++|+||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 46789999999999999986431 1234688899999999999999999
Q ss_pred eeeccccccCCceEEEEEEcccCCCHHHhhccccCC--cccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeecc
Q 041757 83 TACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKE--DETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVL 160 (381)
Q Consensus 83 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~--~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDl 160 (381)
+++. .....++||||+++++|.+++...... .........+++..++.++.|++.||.||| +.+++||||
T Consensus 84 ~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dl 155 (295)
T cd05097 84 GVCV-----SDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDL 155 (295)
T ss_pred EEEc-----CCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeecccc
Confidence 9954 467889999999999999998532100 000011234688899999999999999999 669999999
Q ss_pred CCCCeeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh--CCCCCCc
Q 041757 161 KPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI--REKPSDI 238 (381)
Q Consensus 161 kp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t--g~~Pf~~ 238 (381)
||+||+++.++.+||+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||..
T Consensus 156 kp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~ 235 (295)
T cd05097 156 ATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235 (295)
T ss_pred ChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence 99999999999999999999976544332222222345778999999988889999999999999999998 5667642
Q ss_pred cccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 041757 239 MFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVV 318 (381)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl 318 (381)
... ...... .............. ..+...+..+.+++.+||+.||++|||+.+|+
T Consensus 236 ~~~-----~~~~~~-----~~~~~~~~~~~~~~---------------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~ 290 (295)
T cd05097 236 LSD-----EQVIEN-----TGEFFRNQGRQIYL---------------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIH 290 (295)
T ss_pred cCh-----HHHHHH-----HHHhhhhccccccC---------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHH
Confidence 111 111000 00000000000000 00113456899999999999999999999999
Q ss_pred HHHH
Q 041757 319 HELQ 322 (381)
Q Consensus 319 ~~L~ 322 (381)
+.|+
T Consensus 291 ~~l~ 294 (295)
T cd05097 291 HFLR 294 (295)
T ss_pred HHHh
Confidence 9886
No 114
>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,
Probab=100.00 E-value=4.1e-39 Score=295.68 Aligned_cols=235 Identities=22% Similarity=0.258 Sum_probs=181.9
Q ss_pred cccccceecCCCceEEEecccc--------------------cHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757 37 NMLEENLISAGTFGFSHLRRQG--------------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK 96 (381)
Q Consensus 37 ~~~~~~~lG~G~fg~V~~~~~~--------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~ 96 (381)
+|+..++||+|+||.||++... ....+.+|+.+++.++||||+++++++ ...+..
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 75 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ETKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeee-----cCCCeE
Confidence 4778899999999999775421 123467899999999999999999984 446789
Q ss_pred EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757 97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG 176 (381)
Q Consensus 97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~ 176 (381)
++||||+++|+|.+++.. .....+++..+..++.|++.||.||| +.+++||||||+||++++++.++|+
T Consensus 76 ~lv~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~ 144 (285)
T cd05605 76 CLVLTLMNGGDLKFHIYN--------MGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRIS 144 (285)
T ss_pred EEEEeccCCCcHHHHHHh--------cCcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEe
Confidence 999999999999988842 12346899999999999999999999 6699999999999999999999999
Q ss_pred ecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhc
Q 041757 177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSN 256 (381)
Q Consensus 177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~ 256 (381)
|||++.......... ...|++.|+|||++.+..++.++|||||||++||+++|+.||...... .....+
T Consensus 145 Dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~-~~~~~~------- 213 (285)
T cd05605 145 DLGLAVEIPEGETIR---GRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK-VKREEV------- 213 (285)
T ss_pred eCCCceecCCCCccc---cccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh-hHHHHH-------
Confidence 999998764332221 245899999999998888999999999999999999999998632110 000000
Q ss_pred hHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 041757 257 HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRM-----KMTNVVH 319 (381)
Q Consensus 257 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~~vl~ 319 (381)
...+.... . ..+...+..+.+++.+||+.||.+|| ++.++++
T Consensus 214 --~~~~~~~~---~----------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 214 --ERRVKEDQ---E----------------EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred --HHHhhhcc---c----------------ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 00000000 0 00123556788999999999999999 6777754
No 115
>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors. Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke
Probab=100.00 E-value=2.1e-39 Score=298.92 Aligned_cols=255 Identities=22% Similarity=0.337 Sum_probs=189.6
Q ss_pred cccccccceecCCCceEEEeccc----------------------------------ccHHHHHHHHHHHHccCCCcccc
Q 041757 35 SRNMLEENLISAGTFGFSHLRRQ----------------------------------GAFKSFIAECKALRNIRHRNLIK 80 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~~----------------------------------~~~~~~~~E~~~l~~l~h~nIv~ 80 (381)
..+|...+.||+|+||.||++.. ...+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 46788999999999999986321 23567889999999999999999
Q ss_pred eeeeeccccccCCceEEEEEEcccCCCHHHhhccccCCccc-ccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeec
Q 041757 81 VLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDET-YKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCV 159 (381)
Q Consensus 81 ~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~-~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrD 159 (381)
+++++. .....++||||+++++|.+++......... ......+++..++.++.|++.||.||| +.+++|||
T Consensus 84 ~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~d 155 (296)
T cd05051 84 LLGVCT-----VDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRD 155 (296)
T ss_pred EEEEEe-----cCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccc
Confidence 999954 457889999999999999999543211000 112236899999999999999999999 66999999
Q ss_pred cCCCCeeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh--CCCCCC
Q 041757 160 LKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI--REKPSD 237 (381)
Q Consensus 160 lkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t--g~~Pf~ 237 (381)
|||+||+++.++.++|+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 156 lkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~ 235 (296)
T cd05051 156 LATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYE 235 (296)
T ss_pred cchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCC
Confidence 999999999999999999999986654433222223456788999999988889999999999999999998 677764
Q ss_pred ccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHH
Q 041757 238 IMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNV 317 (381)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v 317 (381)
.... ..... .... ........ .....+..++.++.+++.+||+.||.+|||+.+|
T Consensus 236 ~~~~-----~~~~~--------~~~~-~~~~~~~~-----------~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el 290 (296)
T cd05051 236 HLTD-----QQVIE--------NAGH-FFRDDGRQ-----------IYLPRPPNCPKDIYELMLECWRRDEEDRPTFREI 290 (296)
T ss_pred CcCh-----HHHHH--------HHHh-cccccccc-----------ccCCCccCCCHHHHHHHHHHhccChhcCCCHHHH
Confidence 2211 00000 0000 00000000 0000012345689999999999999999999999
Q ss_pred HHHHH
Q 041757 318 VHELQ 322 (381)
Q Consensus 318 l~~L~ 322 (381)
++.|+
T Consensus 291 ~~~L~ 295 (296)
T cd05051 291 HLFLQ 295 (296)
T ss_pred HHHhc
Confidence 99885
No 116
>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase. Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well
Probab=100.00 E-value=4e-39 Score=294.44 Aligned_cols=245 Identities=21% Similarity=0.285 Sum_probs=186.5
Q ss_pred cccccccceecCCCceEEEecccc-----------------------cHHHHHHHHHHHHccCCCcccceeeeecccccc
Q 041757 35 SRNMLEENLISAGTFGFSHLRRQG-----------------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQ 91 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~~~-----------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 91 (381)
.++|...+.||+|+||.||++... ....|.+|+.+++.++|+||+++++++.
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----- 79 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSF----- 79 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----
Confidence 467899999999999999865321 2346889999999999999999999854
Q ss_pred CCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC
Q 041757 92 GNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM 171 (381)
Q Consensus 92 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~ 171 (381)
.....++||||+++++|.+++....... .....+++..++.++.||+.||+||| +.+++||||||+||+++.++
T Consensus 80 ~~~~~~lv~e~~~g~~L~~~i~~~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~ 153 (277)
T cd05036 80 ERLPRFILLELMAGGDLKSFLRENRPRP---ERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKG 153 (277)
T ss_pred cCCCcEEEEecCCCCCHHHHHHHhCCCC---CCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccC
Confidence 3567799999999999999996432111 12236899999999999999999999 66999999999999998654
Q ss_pred ---CeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHH
Q 041757 172 ---TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLH 247 (381)
Q Consensus 172 ---~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~ 247 (381)
.+||+|||+++................+..|+|||++.+..++.++|||||||++|||++ |..||..... .
T Consensus 154 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~-----~ 228 (277)
T cd05036 154 PGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN-----Q 228 (277)
T ss_pred CCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----H
Confidence 689999999987643322211111234578999999988889999999999999999997 9999752211 1
Q ss_pred HHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 041757 248 KFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQ 322 (381)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~ 322 (381)
.... .+...... ..+..++..+.+++.+||+.+|++|||+.+|++.|+
T Consensus 229 ~~~~---------~~~~~~~~------------------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 229 EVME---------FVTGGGRL------------------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHHH---------HHHcCCcC------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1111 11100000 001234568899999999999999999999999885
No 117
>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase). Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It
Probab=100.00 E-value=6.6e-39 Score=293.36 Aligned_cols=252 Identities=21% Similarity=0.345 Sum_probs=194.0
Q ss_pred cccccccceecCCCceEEEecccc----------------------cHHHHHHHHHHHHccCCCcccceeeeeccccccC
Q 041757 35 SRNMLEENLISAGTFGFSHLRRQG----------------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQG 92 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~~~----------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 92 (381)
.++|...++||+|+||.||.+... ..+.+.+|+.+++.++|+||+++++++.. .
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~----~ 80 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIE----D 80 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec----C
Confidence 567889999999999999876421 24668899999999999999999998643 3
Q ss_pred CceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCC
Q 041757 93 NDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT 172 (381)
Q Consensus 93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~ 172 (381)
....++++||+++++|.+++....... ......+++..++.++.|++.||.||| +.+++||||||+||+++.++.
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~--~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~ 155 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGE--ANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQ 155 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccc--cccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCc
Confidence 567899999999999999985422110 012256899999999999999999999 669999999999999999999
Q ss_pred eEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHH
Q 041757 173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAK 251 (381)
Q Consensus 173 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~ 251 (381)
+||+|||+++.+.............++..|+|||++.+..++.++||||||+++||+++ |+.||... .. ..+..
T Consensus 156 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~----~~-~~~~~ 230 (280)
T cd05043 156 VKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEI----DP-FEMAA 230 (280)
T ss_pred EEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcC----CH-HHHHH
Confidence 99999999986644332211112346778999999988889999999999999999999 99997522 11 11111
Q ss_pred HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 041757 252 MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT 327 (381)
Q Consensus 252 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~ 327 (381)
.+..... .. ....++..+.+++.+||+.||++|||+.++++.|+.+.+.
T Consensus 231 ---------~~~~~~~--~~----------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 231 ---------YLKDGYR--LA----------------QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred ---------HHHcCCC--CC----------------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 0000000 00 0123456789999999999999999999999999988654
No 118
>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I
Probab=100.00 E-value=2.6e-39 Score=301.38 Aligned_cols=224 Identities=22% Similarity=0.282 Sum_probs=173.6
Q ss_pred ceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHcc-CCCcccceeeeeccccccCCceEEEEE
Q 041757 42 NLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVY 100 (381)
Q Consensus 42 ~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~~~~~lv~ 100 (381)
++||+|+||.||++.. ...+.+..|..++..+ +||||+++++++ ...+..++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTF-----QTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEE-----EeCCEEEEEE
Confidence 4799999999987642 1234566788888765 899999999984 4578899999
Q ss_pred EcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccc
Q 041757 101 EFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180 (381)
Q Consensus 101 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 180 (381)
||+++|+|..++. ....+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 76 E~~~~g~L~~~i~----------~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~ 142 (316)
T cd05620 76 EFLNGGDLMFHIQ----------DKGRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGM 142 (316)
T ss_pred CCCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCC
Confidence 9999999999983 4456889999999999999999999 67999999999999999999999999999
Q ss_pred ceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHH
Q 041757 181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKD 260 (381)
Q Consensus 181 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 260 (381)
++........ .....||+.|+|||++.+..++.++|||||||++|||++|..||.... . ...
T Consensus 143 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~----~-~~~----------- 204 (316)
T cd05620 143 CKENVFGDNR--ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD----E-DEL----------- 204 (316)
T ss_pred CeecccCCCc--eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC----H-HHH-----------
Confidence 8753222111 123568999999999999999999999999999999999999985221 1 111
Q ss_pred HHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHH-HHH
Q 041757 261 IVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMT-NVV 318 (381)
Q Consensus 261 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-~vl 318 (381)
........+. .+.....++.+++.+||+.||++||++. +++
T Consensus 205 -~~~~~~~~~~----------------~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 205 -FESIRVDTPH----------------YPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred -HHHHHhCCCC----------------CCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 1111000000 0112345678899999999999999985 554
No 119
>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory
Probab=100.00 E-value=4.4e-39 Score=294.68 Aligned_cols=248 Identities=23% Similarity=0.380 Sum_probs=188.7
Q ss_pred cccccccceecCCCceEEEecc----------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccC
Q 041757 35 SRNMLEENLISAGTFGFSHLRR----------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQG 92 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~----------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 92 (381)
.++|...++||+|+||.||++. ....+.+.+|+++++.++|+||+++++++. .
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~ 78 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCT-----E 78 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEe-----c
Confidence 3567788999999999998753 112457889999999999999999999853 4
Q ss_pred CceEEEEEEcccCCCHHHhhccccCCc-----ccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeee
Q 041757 93 NDFKALVYEFMHNRSLKEWLYPISKED-----ETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLL 167 (381)
Q Consensus 93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~-----~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill 167 (381)
....++||||+++++|.+++....... ........+++..++.++.|++.||+||| +.+++||||||+||++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~ 155 (280)
T cd05092 79 GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLV 155 (280)
T ss_pred CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEE
Confidence 677899999999999999986432110 00011245889999999999999999999 6699999999999999
Q ss_pred CCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcH
Q 041757 168 DDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNL 246 (381)
Q Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~ 246 (381)
++++.+||+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 156 ~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---- 231 (280)
T cd05092 156 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT---- 231 (280)
T ss_pred cCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH----
Confidence 9999999999999976544322221222335788999999998899999999999999999998 89997522110
Q ss_pred HHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 041757 247 HKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQ 322 (381)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~ 322 (381)
+.+......... ..+..++..+.+++.+||+.||.+||++.+|++.|+
T Consensus 232 -------------~~~~~~~~~~~~---------------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 232 -------------EAIECITQGREL---------------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred -------------HHHHHHHcCccC---------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 001111000000 001245567889999999999999999999999886
No 120
>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the
Probab=100.00 E-value=1.2e-39 Score=307.88 Aligned_cols=235 Identities=21% Similarity=0.271 Sum_probs=185.8
Q ss_pred ccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF 95 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~ 95 (381)
++|...+.||+|+||+||++.. .....+.+|++++..++||||+++++++ .+.+.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSF-----QDEEH 75 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhe-----ecCCe
Confidence 4688999999999999987652 2345678899999999999999999884 55788
Q ss_pred EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757 96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV 175 (381)
Q Consensus 96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl 175 (381)
.++||||+++++|.+++. ....+++..+..++.|++.||.||| ..+|+||||||+||+++.++.+||
T Consensus 76 ~~lv~e~~~~~~L~~~l~----------~~~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL 142 (350)
T cd05573 76 LYLVMEYMPGGDLMNLLI----------RKDVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKL 142 (350)
T ss_pred EEEEEcCCCCCCHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEe
Confidence 999999999999999994 3467899999999999999999999 679999999999999999999999
Q ss_pred eecccceecCCCC---------------------------CcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHH
Q 041757 176 GDFGLARFLPPTR---------------------------TQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLE 228 (381)
Q Consensus 176 ~Dfg~~~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~e 228 (381)
+|||++....... .........||+.|+|||++.+..++.++|||||||++||
T Consensus 143 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~e 222 (350)
T cd05573 143 ADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYE 222 (350)
T ss_pred ecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhh
Confidence 9999998665433 0011123568999999999999999999999999999999
Q ss_pred HHhCCCCCCccccCCCcHHHHHHHHhhchHHHHHh--hhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCC
Q 041757 229 LMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVD--SILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSME 306 (381)
Q Consensus 229 l~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~ 306 (381)
|++|+.||.... ....+ ..+.. ..+.... ....+..+.+++.+|+.
T Consensus 223 ll~g~~Pf~~~~----~~~~~---------~~i~~~~~~~~~p~------------------~~~~~~~~~~li~~ll~- 270 (350)
T cd05573 223 MLYGFPPFYSDT----LQETY---------NKIINWKESLRFPP------------------DPPVSPEAIDLICRLLC- 270 (350)
T ss_pred hccCCCCCCCCC----HHHHH---------HHHhccCCcccCCC------------------CCCCCHHHHHHHHHHcc-
Confidence 999999985221 11110 01111 0000000 01245678899999997
Q ss_pred CCCCCCC-HHHHHHH
Q 041757 307 SPQDRMK-MTNVVHE 320 (381)
Q Consensus 307 dP~~RPs-~~~vl~~ 320 (381)
||.+||+ +.++++.
T Consensus 271 dp~~R~~s~~~ll~h 285 (350)
T cd05573 271 DPEDRLGSFEEIKSH 285 (350)
T ss_pred ChhhcCCCHHHHhcC
Confidence 9999999 9999863
No 121
>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase. Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription
Probab=100.00 E-value=3e-39 Score=307.73 Aligned_cols=261 Identities=19% Similarity=0.247 Sum_probs=184.1
Q ss_pred cccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757 37 NMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA 97 (381)
Q Consensus 37 ~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~ 97 (381)
+|+..++||+|+||.||++.. ...+.+.+|+++++.++|+||+++++++...+.......+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478889999999999987652 1235688999999999999999999996542222223789
Q ss_pred EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757 98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD 177 (381)
Q Consensus 98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D 177 (381)
+||||+. ++|.+++ .....+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|
T Consensus 81 lv~e~~~-~~l~~~~----------~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~D 146 (372)
T cd07853 81 VVTELMQ-SDLHKII----------VSPQPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICD 146 (372)
T ss_pred EEeeccc-cCHHHHH----------hcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEecc
Confidence 9999996 5888887 34567899999999999999999999 67999999999999999999999999
Q ss_pred cccceecCCCCCcccccCccCccceeCCCCcCCC-ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhc
Q 041757 178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSN 256 (381)
Q Consensus 178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~ 256 (381)
||+++......... .....+++.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+..+.......
T Consensus 147 fg~a~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~g~~ 224 (372)
T cd07853 147 FGLARVEEPDESKH-MTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI-QQLDLITDLLGTP 224 (372)
T ss_pred ccceeecccCcccc-CCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH-HHHHHHHHHcCCC
Confidence 99998654332211 1224578999999998774 4789999999999999999999998532211 0111111111111
Q ss_pred hHHHHHhh------hhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 257 HVKDIVDS------ILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 257 ~~~~~~~~------~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
...++... .+...+.. ................++.+++.+||+.||.+|||+.++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 225 SLEAMRSACEGARAHILRGPHK------PPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred CHHHHHHhhHHHHHHHHhCCCC------CCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 11111000 00000000 00000000111233567889999999999999999999986
No 122
>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g
Probab=100.00 E-value=4.2e-39 Score=294.86 Aligned_cols=231 Identities=23% Similarity=0.301 Sum_probs=177.3
Q ss_pred ecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEcc
Q 041757 44 ISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFM 103 (381)
Q Consensus 44 lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~~ 103 (381)
||+|+||+||++.. ...+.+..|+++++.++|+||+++++++ ......++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAF-----QTKTDLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEE-----cCCCeEEEEEeCC
Confidence 79999999987531 1234567899999999999999999884 4577899999999
Q ss_pred cCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccccee
Q 041757 104 HNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARF 183 (381)
Q Consensus 104 ~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~ 183 (381)
++|+|..++.... .....+++..++.++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++..
T Consensus 76 ~~g~L~~~~~~~~------~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 146 (280)
T cd05608 76 NGGDLRYHIYNVD------EENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVE 146 (280)
T ss_pred CCCCHHHHHHhcc------ccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCcccee
Confidence 9999998874321 23456899999999999999999999 67999999999999999999999999999986
Q ss_pred cCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHHHHh
Q 041757 184 LPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVD 263 (381)
Q Consensus 184 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (381)
........ ....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .. ..+..
T Consensus 147 ~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~------------~~~~~ 211 (280)
T cd05608 147 LKDGQSKT--KGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-EN------------KELKQ 211 (280)
T ss_pred cCCCCccc--cccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch-hH------------HHHHH
Confidence 65433221 12468999999999999999999999999999999999999986321110 00 01111
Q ss_pred hhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 041757 264 SILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRM-----KMTNVVH 319 (381)
Q Consensus 264 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~~vl~ 319 (381)
....... ..+...+..+.+++.+||+.||++|| ++.++++
T Consensus 212 ~~~~~~~----------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 212 RILNDSV----------------TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred hhcccCC----------------CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 1110000 01124556788999999999999999 5566664
No 123
>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase. Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate
Probab=100.00 E-value=7.9e-40 Score=305.17 Aligned_cols=222 Identities=21% Similarity=0.243 Sum_probs=175.5
Q ss_pred ceecCCCceEEEeccc----------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEE
Q 041757 42 NLISAGTFGFSHLRRQ----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALV 99 (381)
Q Consensus 42 ~~lG~G~fg~V~~~~~----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv 99 (381)
+.||+|+||.||+++. .....+.+|++++++++||||+++++++ ......++|
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~~lv 76 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAF-----QTEGKLYLI 76 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEE-----EcCCEEEEE
Confidence 5799999999986532 1234567899999999999999999984 457789999
Q ss_pred EEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecc
Q 041757 100 YEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179 (381)
Q Consensus 100 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg 179 (381)
|||+++|+|.+++. ....+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||
T Consensus 77 ~e~~~~~~L~~~l~----------~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg 143 (318)
T cd05582 77 LDFLRGGDLFTRLS----------KEVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFG 143 (318)
T ss_pred EcCCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeecc
Confidence 99999999999983 4556899999999999999999999 6799999999999999999999999999
Q ss_pred cceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHH
Q 041757 180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVK 259 (381)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 259 (381)
+++........ .....|++.|+|||++.+..++.++|||||||++|||++|+.||.... . ...
T Consensus 144 ~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~----~-~~~---------- 206 (318)
T cd05582 144 LSKESIDHEKK--AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD----R-KET---------- 206 (318)
T ss_pred CCcccCCCCCc--eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC----H-HHH----------
Confidence 98765433221 122568999999999998889999999999999999999999985221 1 111
Q ss_pred HHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 041757 260 DIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTN 316 (381)
Q Consensus 260 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~ 316 (381)
......... ..+...+..+.+++.+||+.||++||++.+
T Consensus 207 --~~~i~~~~~----------------~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 207 --MTMILKAKL----------------GMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred --HHHHHcCCC----------------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 111110000 001234567889999999999999999655
No 124
>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in
Probab=100.00 E-value=3.9e-39 Score=300.15 Aligned_cols=224 Identities=23% Similarity=0.313 Sum_probs=173.9
Q ss_pred ceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHcc-CCCcccceeeeeccccccCCceEEEEE
Q 041757 42 NLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVY 100 (381)
Q Consensus 42 ~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~~~~~lv~ 100 (381)
+.||+|+||.||++.. ...+.+..|..++..+ +||||+++++++ .+.+..++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTF-----QTKENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEE-----EeCCEEEEEE
Confidence 4699999999987642 1234566788888764 899999999994 4577899999
Q ss_pred EcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccc
Q 041757 101 EFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180 (381)
Q Consensus 101 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 180 (381)
||+++|+|.+++. ....+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 76 ey~~~g~L~~~l~----------~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~ 142 (316)
T cd05619 76 EYLNGGDLMFHIQ----------SCHKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGM 142 (316)
T ss_pred eCCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCc
Confidence 9999999999983 4456889999999999999999999 66999999999999999999999999999
Q ss_pred ceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHH
Q 041757 181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKD 260 (381)
Q Consensus 181 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 260 (381)
++......... ....||+.|+|||++.+..++.++|||||||++|||++|..||.... ....
T Consensus 143 ~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~-----~~~~----------- 204 (316)
T cd05619 143 CKENMLGDAKT--CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD-----EEEL----------- 204 (316)
T ss_pred ceECCCCCCce--eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC-----HHHH-----------
Confidence 87543222111 12468999999999999899999999999999999999999985221 1111
Q ss_pred HHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHH-HHH
Q 041757 261 IVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMT-NVV 318 (381)
Q Consensus 261 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-~vl 318 (381)
........+. .+.....++.+++.+||+.||.+||++. ++.
T Consensus 205 -~~~i~~~~~~----------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 205 -FQSIRMDNPC----------------YPRWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred -HHHHHhCCCC----------------CCccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 1110000000 0112345678899999999999999997 554
No 125
>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2. Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp
Probab=100.00 E-value=4.2e-39 Score=303.38 Aligned_cols=254 Identities=20% Similarity=0.292 Sum_probs=189.0
Q ss_pred cccccccceecCCCceEEEeccc-----------------------ccHHHHHHHHHHHHcc-CCCcccceeeeeccccc
Q 041757 35 SRNMLEENLISAGTFGFSHLRRQ-----------------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVDY 90 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~~-----------------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~ 90 (381)
.++|...+.||+|+||.||++.. .....+.+|+.++.++ +||||++++++|..
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~--- 82 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK--- 82 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeec---
Confidence 46799999999999999987631 1235678899999999 68999999998642
Q ss_pred cCCceEEEEEEcccCCCHHHhhccccCCccc-------------------------------------------------
Q 041757 91 QGNDFKALVYEFMHNRSLKEWLYPISKEDET------------------------------------------------- 121 (381)
Q Consensus 91 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~------------------------------------------------- 121 (381)
.....++|||||++|+|.+++.........
T Consensus 83 -~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 83 -PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred -CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 345779999999999999998542110000
Q ss_pred --------ccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccceecCCCCCcccc
Q 041757 122 --------YKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSS 193 (381)
Q Consensus 122 --------~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 193 (381)
......+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++............
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 238 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK 238 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhc
Confidence 000134688889999999999999999 679999999999999999999999999999865433222222
Q ss_pred cCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchHHHHHhhhhccCchh
Q 041757 194 IDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEK 272 (381)
Q Consensus 194 ~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 272 (381)
....++..|+|||++.+..++.++||||||+++|++++ |..||...... ...... +........
T Consensus 239 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----~~~~~~--------~~~~~~~~~--- 303 (343)
T cd05103 239 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID----EEFCRR--------LKEGTRMRA--- 303 (343)
T ss_pred CCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc----HHHHHH--------HhccCCCCC---
Confidence 22335678999999988889999999999999999997 89997532110 011000 000000000
Q ss_pred hhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 041757 273 LVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKN 326 (381)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~ 326 (381)
+.....++.+++.+||+.||.+|||+.+|++.|+.+.+
T Consensus 304 ----------------~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 304 ----------------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred ----------------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 11233468899999999999999999999999998864
No 126
>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta. Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and
Probab=100.00 E-value=3.1e-39 Score=301.82 Aligned_cols=225 Identities=20% Similarity=0.225 Sum_probs=176.1
Q ss_pred cccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHcc-CCCcccceeeeeccccccCCce
Q 041757 37 NMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDF 95 (381)
Q Consensus 37 ~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~~~ 95 (381)
+|...++||+|+||.||++.. ...+.+..|..++..+ +|++|+++++++ ...+.
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCF-----QTMDR 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEE-----ecCCE
Confidence 578889999999999987641 1223466788888877 489999999884 45778
Q ss_pred EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757 96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV 175 (381)
Q Consensus 96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl 175 (381)
.++||||+++|+|.+++. ....+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||
T Consensus 76 ~~lv~E~~~~g~L~~~~~----------~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL 142 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQ----------QVGRFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKI 142 (323)
T ss_pred EEEEEcCCCCCCHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEE
Confidence 999999999999999983 4456889999999999999999999 669999999999999999999999
Q ss_pred eecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhh
Q 041757 176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALS 255 (381)
Q Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 255 (381)
+|||+++........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||.... . ...
T Consensus 143 ~DfG~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~----~-~~~------ 209 (323)
T cd05616 143 ADFGMCKENMWDGVT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED----E-DEL------ 209 (323)
T ss_pred ccCCCceecCCCCCc--cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC----H-HHH------
Confidence 999999754322211 112568999999999999999999999999999999999999985221 1 111
Q ss_pred chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCH
Q 041757 256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKM 314 (381)
Q Consensus 256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 314 (381)
.......... .+.....++.+++.+|++.||.+|++.
T Consensus 210 ------~~~i~~~~~~----------------~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 210 ------FQSIMEHNVA----------------YPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred ------HHHHHhCCCC----------------CCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 1111110000 012345578889999999999999985
No 127
>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a
Probab=100.00 E-value=1.4e-38 Score=288.76 Aligned_cols=245 Identities=23% Similarity=0.295 Sum_probs=192.3
Q ss_pred ccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF 95 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~ 95 (381)
++|...+.||+|+||.||++.. ...+.+.+|++++++++|+||+++++.+. ..+.
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~-----~~~~ 76 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFI-----ENNE 76 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeee-----cCCe
Confidence 6789999999999999977542 12567889999999999999999999954 4678
Q ss_pred EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757 96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV 175 (381)
Q Consensus 96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl 175 (381)
.++||||+++|+|.+++.... .....+++..++.++.+++.||.||| +.+++||||+|+||+++.++.++|
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l 147 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHFK------KQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKL 147 (267)
T ss_pred EEEEEecCCCCCHHHHHHHhc------ccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEE
Confidence 899999999999999985321 23456889999999999999999999 669999999999999999999999
Q ss_pred eecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhh
Q 041757 176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALS 255 (381)
Q Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 255 (381)
+|||++.......... ....++..|+|||.+.+..++.++||||||+++|+|++|..||... .......
T Consensus 148 ~d~~~~~~~~~~~~~~--~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~---~~~~~~~------ 216 (267)
T cd08224 148 GDLGLGRFFSSKTTAA--HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD---KMNLYSL------ 216 (267)
T ss_pred eccceeeeccCCCccc--ceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccC---CccHHHH------
Confidence 9999987654432211 1245888999999998888999999999999999999999997422 1111111
Q ss_pred chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 041757 256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIK 325 (381)
Q Consensus 256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~ 325 (381)
.+......... ......+..+.+++.+||..+|++|||+.+|++.|+++.
T Consensus 217 ------~~~~~~~~~~~--------------~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 217 ------CKKIEKCDYPP--------------LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred ------HhhhhcCCCCC--------------CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 11110000000 001245567889999999999999999999999998874
No 128
>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.2e-39 Score=305.34 Aligned_cols=239 Identities=23% Similarity=0.374 Sum_probs=195.5
Q ss_pred cccceecCCCceEEEecc----------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEc
Q 041757 39 LEENLISAGTFGFSHLRR----------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEF 102 (381)
Q Consensus 39 ~~~~~lG~G~fg~V~~~~----------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~ 102 (381)
....+||-|.||.||... ...+++|++|+.+|+.++|||+|+++|+|.. +..+|||+||
T Consensus 270 tMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~-----EpPFYIiTEf 344 (1157)
T KOG4278|consen 270 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTH-----EPPFYIITEF 344 (1157)
T ss_pred eeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhcc-----CCCeEEEEec
Confidence 345899999999996532 3467899999999999999999999999874 7788999999
Q ss_pred ccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccce
Q 041757 103 MHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR 182 (381)
Q Consensus 103 ~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~ 182 (381)
|.+|+|.+||++ .....++....+.++.||+.|++||. .+++|||||..+|+|+.++..+|++|||+++
T Consensus 345 M~yGNLLdYLRe--------cnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsR 413 (1157)
T KOG4278|consen 345 MCYGNLLDYLRE--------CNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSR 413 (1157)
T ss_pred ccCccHHHHHHH--------hchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhh
Confidence 999999999964 23445677778899999999999999 7899999999999999999999999999999
Q ss_pred ecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchHHHH
Q 041757 183 FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHVKDI 261 (381)
Q Consensus 183 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (381)
.+..+.+.... ...-++.|.|||.+..+.++.|+|||+|||+|||+.| |..||. + ..+.+ ..++
T Consensus 414 lMtgDTYTAHA-GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYP----G-idlSq---------VY~L 478 (1157)
T KOG4278|consen 414 LMTGDTYTAHA-GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYP----G-IDLSQ---------VYGL 478 (1157)
T ss_pred hhcCCceeccc-CccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCC----C-ccHHH---------HHHH
Confidence 98876554332 2334788999999999999999999999999999987 888853 2 11111 1222
Q ss_pred HhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 041757 262 VDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKN 326 (381)
Q Consensus 262 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~ 326 (381)
+.+- .+.+.+..|++.+.+||+.||+++|.+||++.|+-+.++.+..
T Consensus 479 LEkg------------------yRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 479 LEKG------------------YRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred Hhcc------------------ccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 2211 1112256899999999999999999999999999999887644
No 129
>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=100.00 E-value=7.4e-39 Score=298.10 Aligned_cols=254 Identities=20% Similarity=0.341 Sum_probs=192.6
Q ss_pred cccccccceecCCCceEEEeccc-------------------------ccHHHHHHHHHHHHcc-CCCcccceeeeeccc
Q 041757 35 SRNMLEENLISAGTFGFSHLRRQ-------------------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGV 88 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~~-------------------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~ 88 (381)
.++|.++++||+|+||.||++.. .....+.+|+++++++ +||||++++++|.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-- 88 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT-- 88 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc--
Confidence 36788999999999999987531 1235678899999999 5999999999954
Q ss_pred cccCCceEEEEEEcccCCCHHHhhccccCCcc------cccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCC
Q 041757 89 DYQGNDFKALVYEFMHNRSLKEWLYPISKEDE------TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKP 162 (381)
Q Consensus 89 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp 162 (381)
.....++||||+++|+|.+++........ .......+++..+..++.|++.||.||| +.+++||||||
T Consensus 89 ---~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp 162 (314)
T cd05099 89 ---QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAA 162 (314)
T ss_pred ---cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccc
Confidence 36678999999999999999964321000 0012345889999999999999999999 66999999999
Q ss_pred CCeeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCcccc
Q 041757 163 SNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFE 241 (381)
Q Consensus 163 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~ 241 (381)
+||+++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|++++ |..||...
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~-- 240 (314)
T cd05099 163 RNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI-- 240 (314)
T ss_pred eeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCC--
Confidence 999999999999999999986654322221111234568999999988889999999999999999999 88887422
Q ss_pred CCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 041757 242 GDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHEL 321 (381)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L 321 (381)
........ +. .... ...+..++.++.+++.+||+.||++|||+.++++.|
T Consensus 241 ---~~~~~~~~---------~~---~~~~---------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l 290 (314)
T cd05099 241 ---PVEELFKL---------LR---EGHR---------------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEAL 290 (314)
T ss_pred ---CHHHHHHH---------HH---cCCC---------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 11111111 00 0000 000124456788999999999999999999999999
Q ss_pred HHhhhhc
Q 041757 322 QSIKNTL 328 (381)
Q Consensus 322 ~~i~~~~ 328 (381)
.++....
T Consensus 291 ~~~~~~~ 297 (314)
T cd05099 291 DKVLAAV 297 (314)
T ss_pred HHHHHHh
Confidence 9987654
No 130
>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta. Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D
Probab=100.00 E-value=3.8e-39 Score=308.39 Aligned_cols=252 Identities=20% Similarity=0.272 Sum_probs=190.4
Q ss_pred cccccccceecCCCceEEEeccc-----------------------ccHHHHHHHHHHHHccC-CCcccceeeeeccccc
Q 041757 35 SRNMLEENLISAGTFGFSHLRRQ-----------------------GAFKSFIAECKALRNIR-HRNLIKVLTACLGVDY 90 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~~-----------------------~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~ 90 (381)
.++|..+++||+|+||.||++.. ...+.+.+|+++|.++. ||||++++++|.
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~---- 111 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT---- 111 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc----
Confidence 45688889999999999987641 12347889999999997 999999999964
Q ss_pred cCCceEEEEEEcccCCCHHHhhccccCCc---------------------------------------------------
Q 041757 91 QGNDFKALVYEFMHNRSLKEWLYPISKED--------------------------------------------------- 119 (381)
Q Consensus 91 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~--------------------------------------------------- 119 (381)
.....++|||||++|+|.++++......
T Consensus 112 -~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 112 -KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred -cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 3567899999999999999996432100
Q ss_pred -------------------------------------ccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCC
Q 041757 120 -------------------------------------ETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKP 162 (381)
Q Consensus 120 -------------------------------------~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp 162 (381)
........+++..++.++.|++.||.||| ..+++||||||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp 267 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAA 267 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCc
Confidence 00011234677888999999999999999 67999999999
Q ss_pred CCeeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCcccc
Q 041757 163 SNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFE 241 (381)
Q Consensus 163 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~ 241 (381)
+||+++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~- 346 (401)
T cd05107 268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP- 346 (401)
T ss_pred ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC-
Confidence 999999999999999999986543322222222346788999999988889999999999999999998 888975221
Q ss_pred CCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 041757 242 GDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHEL 321 (381)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L 321 (381)
...... ..+..-... ..+..++..+.+++.+||+.+|.+||++.+|++.|
T Consensus 347 ---~~~~~~---------~~~~~~~~~------------------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 396 (401)
T cd05107 347 ---MNEQFY---------NAIKRGYRM------------------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLV 396 (401)
T ss_pred ---chHHHH---------HHHHcCCCC------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 111100 111100000 00123456889999999999999999999999999
Q ss_pred HHhh
Q 041757 322 QSIK 325 (381)
Q Consensus 322 ~~i~ 325 (381)
+++.
T Consensus 397 ~~~~ 400 (401)
T cd05107 397 GDLL 400 (401)
T ss_pred HHHh
Confidence 8864
No 131
>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a
Probab=100.00 E-value=1.3e-38 Score=288.36 Aligned_cols=241 Identities=29% Similarity=0.378 Sum_probs=188.8
Q ss_pred cccccccceecCCCceEEEeccc---------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEE
Q 041757 35 SRNMLEENLISAGTFGFSHLRRQ---------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALV 99 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~~---------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv 99 (381)
.++|...+.||+|+||.||++.. ...+.+.+|+.++++++||||+++++++ ...+..++|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv 79 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVC-----TLEEPIYIV 79 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEE-----ecCCCeeee
Confidence 46688899999999999987531 1346789999999999999999999985 346778999
Q ss_pred EEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecc
Q 041757 100 YEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179 (381)
Q Consensus 100 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg 179 (381)
|||+++++|.+++.. .....+++..+..++.|++.||.||| ..+++||||||+||+++.++.+||+|||
T Consensus 80 ~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg 148 (261)
T cd05068 80 TELMKYGSLLEYLQG--------GAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFG 148 (261)
T ss_pred eecccCCcHHHHHhc--------cCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcc
Confidence 999999999999953 12346889999999999999999999 6699999999999999999999999999
Q ss_pred cceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchH
Q 041757 180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHV 258 (381)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 258 (381)
+++.......... .....+..|+|||++.+..++.++||||||+++|||++ |+.||.... ....+
T Consensus 149 ~~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~----~~~~~--------- 214 (261)
T cd05068 149 LARVIKEDIYEAR-EGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT----NAEVL--------- 214 (261)
T ss_pred eEEEccCCccccc-CCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC----HHHHH---------
Confidence 9987764322211 11223467999999998899999999999999999999 999975221 10000
Q ss_pred HHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 041757 259 KDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSI 324 (381)
Q Consensus 259 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i 324 (381)
..+...... ..+...+..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus 215 -~~~~~~~~~------------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 215 -QQVDQGYRM------------------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred -HHHHcCCCC------------------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 001000000 00123456789999999999999999999999999753
No 132
>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2. Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po
Probab=100.00 E-value=2.7e-39 Score=308.90 Aligned_cols=183 Identities=21% Similarity=0.297 Sum_probs=155.2
Q ss_pred cccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757 37 NMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK 96 (381)
Q Consensus 37 ~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~ 96 (381)
+|...++||+|+||+||++.. ...+.+.+|++++++++||||+++++++ .+.+..
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~-----~~~~~~ 76 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSF-----QDKDNL 76 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEE-----ecCCEE
Confidence 578889999999999987642 1235678899999999999999999995 457789
Q ss_pred EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757 97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG 176 (381)
Q Consensus 97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~ 176 (381)
++|||||++|+|.+++. ....+++..+..++.|++.||.||| ..+|+||||||+|||++.++.+||+
T Consensus 77 ~lv~E~~~gg~L~~~l~----------~~~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~ 143 (381)
T cd05626 77 YFVMDYIPGGDMMSLLI----------RMEVFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLT 143 (381)
T ss_pred EEEEecCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEe
Confidence 99999999999999983 4456889999999999999999999 6799999999999999999999999
Q ss_pred ecccceecCCCCC---------------------------------------------cccccCccCccceeCCCCcCCC
Q 041757 177 DFGLARFLPPTRT---------------------------------------------QTSSIDVKGSIGYIAPEYGVGN 211 (381)
Q Consensus 177 Dfg~~~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~l~~~ 211 (381)
|||+++....... .......+||+.|+|||++.+.
T Consensus 144 DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~ 223 (381)
T cd05626 144 DFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK 223 (381)
T ss_pred eCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCC
Confidence 9999764321000 0001124699999999999988
Q ss_pred ccCcccchhhhhHHHHHHHhCCCCCC
Q 041757 212 EVSTIGDVYSYGILLLELMIREKPSD 237 (381)
Q Consensus 212 ~~~~~sDiwSlG~il~el~tg~~Pf~ 237 (381)
.++.++|||||||++|||++|..||.
T Consensus 224 ~~~~~~DiwSlG~il~elltG~~Pf~ 249 (381)
T cd05626 224 GYTQLCDWWSVGVILFEMLVGQPPFL 249 (381)
T ss_pred CCCCccceeehhhHHHHHHhCCCCCc
Confidence 89999999999999999999999985
No 133
>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk. Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom
Probab=100.00 E-value=6.5e-39 Score=290.20 Aligned_cols=241 Identities=28% Similarity=0.431 Sum_probs=191.6
Q ss_pred ccccccccceecCCCceEEEeccc----------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757 34 VSRNMLEENLISAGTFGFSHLRRQ----------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA 97 (381)
Q Consensus 34 ~~~~~~~~~~lG~G~fg~V~~~~~----------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~ 97 (381)
...+|...++||.|+||.||++.. .....+.+|+.+++.++|+||+++++++ ......+
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 78 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVC-----SVGEPVY 78 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeE-----ecCCCeE
Confidence 356789999999999999987642 1356788999999999999999999985 4467889
Q ss_pred EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757 98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD 177 (381)
Q Consensus 98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D 177 (381)
+||||+++++|.+++.. .....+++..+..++.|++.||.||| +.+++|+||||+||++++++.+||+|
T Consensus 79 lv~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d 147 (261)
T cd05148 79 IITELMEKGSLLAFLRS--------PEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVAD 147 (261)
T ss_pred EEEeecccCCHHHHHhc--------CCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEcc
Confidence 99999999999999953 23456889999999999999999999 66999999999999999999999999
Q ss_pred cccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhc
Q 041757 178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSN 256 (381)
Q Consensus 178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~ 256 (381)
||.+........... ...++..|+|||.+....++.++||||||+++|+|++ |+.||.... . .
T Consensus 148 ~g~~~~~~~~~~~~~--~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~----~-~--------- 211 (261)
T cd05148 148 FGLARLIKEDVYLSS--DKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN----N-H--------- 211 (261)
T ss_pred ccchhhcCCcccccc--CCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC----H-H---------
Confidence 999987654332222 2346778999999988889999999999999999998 899975221 0 0
Q ss_pred hHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 041757 257 HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSI 324 (381)
Q Consensus 257 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i 324 (381)
+.+....... ....+..++..+.+++.+||..||.+|||+.++++.|+.+
T Consensus 212 ---~~~~~~~~~~---------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 212 ---EVYDQITAGY---------------RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred ---HHHHHHHhCC---------------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 0111000000 0001124566889999999999999999999999999864
No 134
>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor. Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta
Probab=100.00 E-value=7.9e-39 Score=294.19 Aligned_cols=252 Identities=19% Similarity=0.286 Sum_probs=190.5
Q ss_pred ccccccccceecCCCceEEEeccc-----------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccc
Q 041757 34 VSRNMLEENLISAGTFGFSHLRRQ-----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDY 90 (381)
Q Consensus 34 ~~~~~~~~~~lG~G~fg~V~~~~~-----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 90 (381)
..++|.+.++||+|+||.||++.. .....+.+|+.+++.++||||+++++++
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~----- 78 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVV----- 78 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-----
Confidence 357899999999999999986420 1234578899999999999999999985
Q ss_pred cCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCC
Q 041757 91 QGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDD 170 (381)
Q Consensus 91 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~ 170 (381)
......++||||+++|+|.+++...............++...+..++.|++.||.||| +.+|+||||||+||+++.+
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~ 155 (288)
T cd05061 79 SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHD 155 (288)
T ss_pred cCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCC
Confidence 3466789999999999999999643221111112344567788999999999999999 6799999999999999999
Q ss_pred CCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHH
Q 041757 171 MTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKF 249 (381)
Q Consensus 171 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~ 249 (381)
+.++|+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.... ...
T Consensus 156 ~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~-----~~~- 229 (288)
T cd05061 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS-----NEQ- 229 (288)
T ss_pred CcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC-----HHH-
Confidence 9999999999886544332222222345778999999988889999999999999999998 788875211 111
Q ss_pred HHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 041757 250 AKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIK 325 (381)
Q Consensus 250 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~ 325 (381)
+.+........ ..+..++..+.+++.+||+.||.+|||+.++++.|++..
T Consensus 230 -----------~~~~~~~~~~~---------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 230 -----------VLKFVMDGGYL---------------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred -----------HHHHHHcCCCC---------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 11111100000 001234568999999999999999999999999988764
No 135
>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr
Probab=100.00 E-value=2.1e-39 Score=302.95 Aligned_cols=221 Identities=24% Similarity=0.286 Sum_probs=171.4
Q ss_pred ceecCCCceEEEecccc--------------------cHHHHHHHHH-HHHccCCCcccceeeeeccccccCCceEEEEE
Q 041757 42 NLISAGTFGFSHLRRQG--------------------AFKSFIAECK-ALRNIRHRNLIKVLTACLGVDYQGNDFKALVY 100 (381)
Q Consensus 42 ~~lG~G~fg~V~~~~~~--------------------~~~~~~~E~~-~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~ 100 (381)
++||+|+||+||++... ..+.+.+|.. +++.++||||+++++++ ...+..++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~-----~~~~~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTADKLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEE-----EeCCEEEEEE
Confidence 46999999999876421 1233445554 45778999999999984 4577899999
Q ss_pred EcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccc
Q 041757 101 EFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180 (381)
Q Consensus 101 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 180 (381)
||+++|+|..++. ....+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 76 e~~~~g~L~~~l~----------~~~~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~ 142 (323)
T cd05575 76 DYVNGGELFFHLQ----------RERSFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGL 142 (323)
T ss_pred cCCCCCCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCC
Confidence 9999999999983 4557889999999999999999999 66999999999999999999999999999
Q ss_pred ceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHH
Q 041757 181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKD 260 (381)
Q Consensus 181 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 260 (381)
++........ .....||+.|+|||++.+..++.++|||||||++|||++|..||... ... +
T Consensus 143 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~-----~~~------------~ 203 (323)
T cd05575 143 CKEGIEHSKT--TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR-----DTA------------E 203 (323)
T ss_pred CcccccCCCc--cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCC-----CHH------------H
Confidence 8754322221 12256899999999999989999999999999999999999998522 111 1
Q ss_pred HHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHH
Q 041757 261 IVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMT 315 (381)
Q Consensus 261 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 315 (381)
+.+..+..... .....+..+.+++.+||+.||.+||++.
T Consensus 204 ~~~~i~~~~~~----------------~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 204 MYDNILNKPLR----------------LKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred HHHHHHcCCCC----------------CCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 11111111100 0123456788999999999999999985
No 136
>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3. Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th
Probab=100.00 E-value=7e-39 Score=293.81 Aligned_cols=254 Identities=24% Similarity=0.400 Sum_probs=189.0
Q ss_pred cccccccceecCCCceEEEecc---------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757 35 SRNMLEENLISAGTFGFSHLRR---------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN 93 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~---------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 93 (381)
..+|+..+.||+|+||.||.+. ....+.+.+|++++++++||||+++++++.. .+.
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~ 79 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYS---AGR 79 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEcc---CCC
Confidence 4578889999999999998753 1124578899999999999999999998653 335
Q ss_pred ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757 94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA 173 (381)
Q Consensus 94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~ 173 (381)
...++||||+++|+|.+++.. ....+++..++.++.|++.||.||| ..+++||||||+||+++.++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~---------~~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~ 147 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQK---------HRERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRV 147 (284)
T ss_pred CceEEEEEecCCCCHHHHHHh---------cCcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeE
Confidence 568999999999999999852 2345889999999999999999999 6699999999999999999999
Q ss_pred EEeecccceecCCCCCccc-ccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHH
Q 041757 174 RVGDFGLARFLPPTRTQTS-SIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM 252 (381)
Q Consensus 174 kl~Dfg~~~~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~ 252 (381)
||+|||++........... .....++..|+|||++.+..++.++||||||+++|||++|..|+..... .+...
T Consensus 148 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~------~~~~~ 221 (284)
T cd05081 148 KIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA------EFMRM 221 (284)
T ss_pred EECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch------hhhhh
Confidence 9999999987654332111 1112245569999999888899999999999999999998877532110 00000
Q ss_pred Hhhc-----hHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 041757 253 ALSN-----HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSI 324 (381)
Q Consensus 253 ~~~~-----~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i 324 (381)
.... ....+.+. +.... ....+..++..+.+++.+||..+|++|||+.+|++.|+++
T Consensus 222 ~~~~~~~~~~~~~~~~~-~~~~~--------------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 222 MGNDKQGQMIVYHLIEL-LKNNG--------------RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred cccccccccchHHHHHH-HhcCC--------------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0000 00011100 00000 0001124556799999999999999999999999999876
No 137
>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr
Probab=100.00 E-value=5.2e-39 Score=293.81 Aligned_cols=231 Identities=22% Similarity=0.257 Sum_probs=177.0
Q ss_pred ecCCCceEEEecccc--------------------cHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEcc
Q 041757 44 ISAGTFGFSHLRRQG--------------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFM 103 (381)
Q Consensus 44 lG~G~fg~V~~~~~~--------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~~ 103 (381)
||+|+||.||++... ..+.+..|++++++++||||+++++++ ....+.++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~-----~~~~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAF-----ESKTHLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEE-----ecCCeEEEEEecC
Confidence 799999999875421 123456799999999999999999884 4577899999999
Q ss_pred cCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccccee
Q 041757 104 HNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARF 183 (381)
Q Consensus 104 ~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~ 183 (381)
++++|.+++.. .....+++..+..++.|++.||+||| +.+|+||||||+||+++.++.++|+|||++..
T Consensus 76 ~g~~L~~~~~~--------~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~ 144 (277)
T cd05607 76 NGGDLKYHIYN--------VGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVE 144 (277)
T ss_pred CCCCHHHHHHh--------ccccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeee
Confidence 99999988842 22345888899999999999999999 67999999999999999999999999999987
Q ss_pred cCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHHHHh
Q 041757 184 LPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVD 263 (381)
Q Consensus 184 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (381)
........ ...|+..|+|||++.+..++.++|||||||++|||++|..||...... .... ++..
T Consensus 145 ~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~-~~~~------------~~~~ 208 (277)
T cd05607 145 LKDGKTIT---QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK-VAKE------------ELKR 208 (277)
T ss_pred cCCCceee---ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch-hhHH------------HHHH
Confidence 65433221 245899999999999888999999999999999999999998532111 0101 1111
Q ss_pred hhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 041757 264 SILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHEL 321 (381)
Q Consensus 264 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L 321 (381)
..+...... .....+.++.+++.+||+.||.+||++.|+++.+
T Consensus 209 ~~~~~~~~~---------------~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 209 RTLEDEVKF---------------EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred Hhhcccccc---------------ccccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 111000000 0113455788999999999999999998876444
No 138
>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2. Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly
Probab=100.00 E-value=6e-39 Score=294.10 Aligned_cols=248 Identities=18% Similarity=0.249 Sum_probs=187.7
Q ss_pred ccccccceecCCCceEEEeccc-----------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccC
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ-----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQG 92 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~-----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 92 (381)
.+|...+.||+|+||.||++.. ...+.+.+|+.++..++||||+++++++. .
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~-----~ 79 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVT-----K 79 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----C
Confidence 3477788999999999987631 12356888999999999999999999954 4
Q ss_pred CceEEEEEEcccCCCHHHhhccccCC------cccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCee
Q 041757 93 NDFKALVYEFMHNRSLKEWLYPISKE------DETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVL 166 (381)
Q Consensus 93 ~~~~~lv~e~~~~g~L~~~l~~~~~~------~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nil 166 (381)
....++++||+.+++|.+++...... .........+++..++.++.|++.||.||| +.+|+||||||+||+
T Consensus 80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil 156 (283)
T cd05091 80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVL 156 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheE
Confidence 66789999999999999998422100 000012345788899999999999999999 669999999999999
Q ss_pred eCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCc
Q 041757 167 LDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMN 245 (381)
Q Consensus 167 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~ 245 (381)
+++++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||.... .
T Consensus 157 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~----~ 232 (283)
T cd05091 157 VFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS----N 232 (283)
T ss_pred ecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC----H
Confidence 99999999999999886654332222222346789999999988889999999999999999998 888865211 1
Q ss_pred HHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 041757 246 LHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQS 323 (381)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~ 323 (381)
.. +.......... ..+..++..+.+++.+||+.+|.+||++.+|+..|+.
T Consensus 233 -~~------------~~~~i~~~~~~---------------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 233 -QD------------VIEMIRNRQVL---------------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred -HH------------HHHHHHcCCcC---------------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 11 11111111000 0123466778999999999999999999999999864
No 139
>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1. Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus
Probab=100.00 E-value=4.3e-39 Score=305.66 Aligned_cols=184 Identities=23% Similarity=0.304 Sum_probs=157.6
Q ss_pred ccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF 95 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~ 95 (381)
++|+..++||+|+||+||++.. .....+.+|+.++.+++|+||+++++.+ .+...
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~-----~~~~~ 75 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSF-----QDKLN 75 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCCe
Confidence 4788999999999999987642 1234577899999999999999999984 55788
Q ss_pred EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757 96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV 175 (381)
Q Consensus 96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl 175 (381)
.++|||||++|+|.+++. ....+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||
T Consensus 76 ~~lv~E~~~gg~L~~~l~----------~~~~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL 142 (363)
T cd05628 76 LYLIMEFLPGGDMMTLLM----------KKDTLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKL 142 (363)
T ss_pred EEEEEcCCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEE
Confidence 999999999999999994 4567899999999999999999999 679999999999999999999999
Q ss_pred eecccceecCCCCCc---------------------------------ccccCccCccceeCCCCcCCCccCcccchhhh
Q 041757 176 GDFGLARFLPPTRTQ---------------------------------TSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSY 222 (381)
Q Consensus 176 ~Dfg~~~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSl 222 (381)
+|||+++........ ......+||+.|+|||++.+..++.++|||||
T Consensus 143 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSl 222 (363)
T cd05628 143 SDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSL 222 (363)
T ss_pred eeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhh
Confidence 999998765321100 00113569999999999999999999999999
Q ss_pred hHHHHHHHhCCCCCC
Q 041757 223 GILLLELMIREKPSD 237 (381)
Q Consensus 223 G~il~el~tg~~Pf~ 237 (381)
||++|||++|+.||.
T Consensus 223 Gvil~ell~G~~Pf~ 237 (363)
T cd05628 223 GVIMYEMLIGYPPFC 237 (363)
T ss_pred HHHHHHHHhCCCCCC
Confidence 999999999999985
No 140
>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica
Probab=100.00 E-value=2.5e-39 Score=307.44 Aligned_cols=184 Identities=21% Similarity=0.306 Sum_probs=157.2
Q ss_pred ccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF 95 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~ 95 (381)
++|...++||+|+||+||++.. .....+.+|+.+|..++||||+++++++ .+...
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~ 75 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSF-----QDENY 75 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCe
Confidence 4788999999999999987642 1234567899999999999999999994 55788
Q ss_pred EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757 96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV 175 (381)
Q Consensus 96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl 175 (381)
.++|||||++|+|.+++. ....+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||
T Consensus 76 ~~lv~E~~~~g~L~~~l~----------~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl 142 (364)
T cd05599 76 LYLIMEYLPGGDMMTLLM----------KKDTFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKL 142 (364)
T ss_pred EEEEECCCCCcHHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEE
Confidence 999999999999999984 4456899999999999999999999 669999999999999999999999
Q ss_pred eecccceecCCCCCcc------------------------------------cccCccCccceeCCCCcCCCccCcccch
Q 041757 176 GDFGLARFLPPTRTQT------------------------------------SSIDVKGSIGYIAPEYGVGNEVSTIGDV 219 (381)
Q Consensus 176 ~Dfg~~~~~~~~~~~~------------------------------------~~~~~~gt~~y~aPE~l~~~~~~~~sDi 219 (381)
+|||++..+....... .....+||+.|+|||++.+..++.++||
T Consensus 143 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 222 (364)
T cd05599 143 SDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDW 222 (364)
T ss_pred eecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeee
Confidence 9999987653321100 0012459999999999998899999999
Q ss_pred hhhhHHHHHHHhCCCCCC
Q 041757 220 YSYGILLLELMIREKPSD 237 (381)
Q Consensus 220 wSlG~il~el~tg~~Pf~ 237 (381)
|||||++|||++|..||.
T Consensus 223 wSlG~il~el~~G~~Pf~ 240 (364)
T cd05599 223 WSLGVIMYEMLVGYPPFC 240 (364)
T ss_pred ecchhHHHHhhcCCCCCC
Confidence 999999999999999985
No 141
>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows
Probab=100.00 E-value=9.3e-39 Score=288.61 Aligned_cols=236 Identities=25% Similarity=0.366 Sum_probs=184.1
Q ss_pred ccccccceecCCCceEEEeccc---------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEE
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ---------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVY 100 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~---------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~ 100 (381)
.+|...+.||+|+||.||++.. .....+.+|++++++++||||+++++++ ......++||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv~ 78 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC-----TKQRPIFIVT 78 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEE-----cCCCceEEEE
Confidence 3577889999999999987531 1235788999999999999999999985 4467889999
Q ss_pred EcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccc
Q 041757 101 EFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180 (381)
Q Consensus 101 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 180 (381)
||+++++|.+++.. ....+++..++.++.|++.||.||| +.+++||||||+||+++.++.+||+|||+
T Consensus 79 e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~ 146 (256)
T cd05059 79 EYMANGCLLNYLRE---------RKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGL 146 (256)
T ss_pred ecCCCCCHHHHHHh---------cccCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCccc
Confidence 99999999999852 2346889999999999999999999 66999999999999999999999999999
Q ss_pred ceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchHH
Q 041757 181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHVK 259 (381)
Q Consensus 181 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 259 (381)
++.......... ....++..|+|||.+.+..++.++||||||+++|++++ |..||...... .....
T Consensus 147 ~~~~~~~~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~~~~------- 213 (256)
T cd05059 147 ARYVLDDQYTSS-QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS-----EVVES------- 213 (256)
T ss_pred ceeccccccccc-CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH-----HHHHH-------
Confidence 986643322111 11224567999999998899999999999999999999 89997522110 00000
Q ss_pred HHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 041757 260 DIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHEL 321 (381)
Q Consensus 260 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L 321 (381)
+..... . ..+..++..+.+++.+||..+|++|||+.++++.|
T Consensus 214 --~~~~~~--~----------------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 214 --VSAGYR--L----------------YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred --HHcCCc--C----------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 000000 0 00123566899999999999999999999999876
No 142
>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.
Probab=100.00 E-value=6.3e-39 Score=291.27 Aligned_cols=245 Identities=23% Similarity=0.278 Sum_probs=191.2
Q ss_pred ccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF 95 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~ 95 (381)
++|...+.||+|+||.||++.. .....+.+|+.+++.++|+||+++++++. ..+.
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~ 76 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI-----EDNE 76 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeE-----eCCe
Confidence 4788889999999999987541 12357888999999999999999999854 4678
Q ss_pred EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757 96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV 175 (381)
Q Consensus 96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl 175 (381)
.+++|||+++++|.+++.... .....+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l 147 (267)
T cd08229 77 LNIVLELADAGDLSRMIKHFK------KQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKL 147 (267)
T ss_pred EEEEEEecCCCCHHHHHHHhh------ccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEE
Confidence 899999999999999985321 23456899999999999999999999 669999999999999999999999
Q ss_pred eecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhh
Q 041757 176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALS 255 (381)
Q Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 255 (381)
+|||++.......... ....++..|+|||++.+..++.++||||||+++|+|++|..||.... .......
T Consensus 148 ~dfg~~~~~~~~~~~~--~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~~~----- 217 (267)
T cd08229 148 GDLGLGRFFSSKTTAA--HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK---MNLYSLC----- 217 (267)
T ss_pred CcchhhhccccCCccc--ccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCccccc---chHHHHh-----
Confidence 9999987664433221 12458899999999988889999999999999999999999975221 1111111
Q ss_pred chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 041757 256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIK 325 (381)
Q Consensus 256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~ 325 (381)
.......... ......+..+.+++.+||..||.+|||+.+|++.++++.
T Consensus 218 -------~~~~~~~~~~--------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 218 -------KKIEQCDYPP--------------LPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred -------hhhhcCCCCC--------------CCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 1100000000 001235567889999999999999999999999998764
No 143
>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]
Probab=100.00 E-value=3e-39 Score=287.70 Aligned_cols=267 Identities=21% Similarity=0.284 Sum_probs=189.2
Q ss_pred ccccccceecCCCceEEEecc-------------------cccHHHHHHHHHHHHccCCCc-ccceeeeecccc-ccCCc
Q 041757 36 RNMLEENLISAGTFGFSHLRR-------------------QGAFKSFIAECKALRNIRHRN-LIKVLTACLGVD-YQGND 94 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~-------------------~~~~~~~~~E~~~l~~l~h~n-Iv~~~~~~~~~~-~~~~~ 94 (381)
..|...++||+|+||+||+++ ++.....++|+.+|++|+|+| ||++++++.... .....
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 457777889999999998865 124456789999999999999 999999976421 12234
Q ss_pred eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757 95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR 174 (381)
Q Consensus 95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k 174 (381)
..++|+||+.. +|..++..... ....++...+..++.||+.||+||| +.+|+||||||+|||++++|.+|
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~------~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lK 160 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPK------KPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLK 160 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccc------cccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEe
Confidence 78899999965 99999964321 1146777899999999999999999 66999999999999999999999
Q ss_pred EeecccceecCCCCCcccccCccCccceeCCCCcCCC-ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH
Q 041757 175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA 253 (381)
Q Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~ 253 (381)
|+|||+|+....+.... ...++|..|+|||++.+. .|+...||||+||+++||++++.-| .++..........
T Consensus 161 laDFGlAra~~ip~~~y--t~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LF----pG~se~~ql~~If 234 (323)
T KOG0594|consen 161 LADFGLARAFSIPMRTY--TPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLF----PGDSEIDQLFRIF 234 (323)
T ss_pred eeccchHHHhcCCcccc--cccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCC----CCCcHHHHHHHHH
Confidence 99999999665443322 235689999999999886 7999999999999999999998875 4444433332221
Q ss_pred h---hchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041757 254 L---SNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE 320 (381)
Q Consensus 254 ~---~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~ 320 (381)
. .+.....-.-....+... .+ .............+.......+++..|++.+|.+|.|+..+++.
T Consensus 235 ~~lGtP~e~~Wp~v~~~~~~k~-~f-~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 235 RLLGTPNEKDWPGVSSLPDYKA-PF-PKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred HHcCCCCccCCCCccccccccc-cC-cCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 1 110000000000000000 00 00000111111112222478999999999999999999999875
No 144
>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron. Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca
Probab=100.00 E-value=1.8e-38 Score=287.54 Aligned_cols=237 Identities=23% Similarity=0.369 Sum_probs=179.2
Q ss_pred ceecCCCceEEEeccc---------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEE
Q 041757 42 NLISAGTFGFSHLRRQ---------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVY 100 (381)
Q Consensus 42 ~~lG~G~fg~V~~~~~---------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~ 100 (381)
+.||+|+||.||++.. ...+.+.+|+.+++.++||||+++++++.. .+...++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLP----SEGSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeec----CCCCcEEEE
Confidence 4689999999986431 124577889999999999999999998642 345678999
Q ss_pred EcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccc
Q 041757 101 EFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180 (381)
Q Consensus 101 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 180 (381)
||+.+|+|.+++.. ....+++..++.++.|++.||.||| ..+++||||||+||+++.++.+||+|||+
T Consensus 77 e~~~~~~L~~~~~~---------~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~ 144 (262)
T cd05058 77 PYMKHGDLRNFIRS---------ETHNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGL 144 (262)
T ss_pred ecCCCCCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccc
Confidence 99999999999952 2344677788899999999999999 66999999999999999999999999999
Q ss_pred ceecCCCCCc--ccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhC-CCCCCccccCCCcHHHHHHHHhhch
Q 041757 181 ARFLPPTRTQ--TSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIR-EKPSDIMFEGDMNLHKFAKMALSNH 257 (381)
Q Consensus 181 ~~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg-~~Pf~~~~~~~~~~~~~~~~~~~~~ 257 (381)
++........ .......++..|+|||.+.+..++.++||||||+++|||++| .+||... .. ...
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~----~~-~~~-------- 211 (262)
T cd05058 145 ARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV----DS-FDI-------- 211 (262)
T ss_pred cccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC----CH-HHH--------
Confidence 9765432211 111123467789999999888899999999999999999995 5554321 11 111
Q ss_pred HHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 041757 258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKN 326 (381)
Q Consensus 258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~ 326 (381)
.......... ..+...+..+.+++.+||..+|++||++.+|++.|+++..
T Consensus 212 ----~~~~~~~~~~---------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 212 ----TVYLLQGRRL---------------LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred ----HHHHhcCCCC---------------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 1111100000 0011345678899999999999999999999999998754
No 145
>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt
Probab=100.00 E-value=3.3e-39 Score=301.85 Aligned_cols=226 Identities=24% Similarity=0.266 Sum_probs=172.6
Q ss_pred ceecCCCceEEEecccc--------------------cHHHHHHHHH-HHHccCCCcccceeeeeccccccCCceEEEEE
Q 041757 42 NLISAGTFGFSHLRRQG--------------------AFKSFIAECK-ALRNIRHRNLIKVLTACLGVDYQGNDFKALVY 100 (381)
Q Consensus 42 ~~lG~G~fg~V~~~~~~--------------------~~~~~~~E~~-~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~ 100 (381)
+.||+|+||+||++... ....+.+|.. +++.++||||+++++++ ...+..++||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~-----~~~~~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-----QTADKLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEE-----EcCCeEEEEE
Confidence 46999999999876421 1123344444 46778999999999984 4577899999
Q ss_pred EcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccc
Q 041757 101 EFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180 (381)
Q Consensus 101 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 180 (381)
||+++|+|.+++. ....+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 76 e~~~~~~L~~~~~----------~~~~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~ 142 (325)
T cd05602 76 DYINGGELFYHLQ----------RERCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGL 142 (325)
T ss_pred eCCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCC
Confidence 9999999999983 4456788889999999999999999 67999999999999999999999999999
Q ss_pred ceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHH
Q 041757 181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKD 260 (381)
Q Consensus 181 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 260 (381)
++........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||.... . ..... .
T Consensus 143 a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~----~-~~~~~--------~ 207 (325)
T cd05602 143 CKENIEHNGT--TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN----T-AEMYD--------N 207 (325)
T ss_pred CcccccCCCC--cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC----H-HHHHH--------H
Confidence 8754332221 122569999999999999999999999999999999999999985221 1 11111 1
Q ss_pred HHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041757 261 IVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE 320 (381)
Q Consensus 261 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~ 320 (381)
+...... ..+..+..+.+++.+||+.||.+||++.+.+..
T Consensus 208 i~~~~~~--------------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (325)
T cd05602 208 ILNKPLQ--------------------LKPNITNSARHLLEGLLQKDRTKRLGAKDDFME 247 (325)
T ss_pred HHhCCcC--------------------CCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence 1111000 012345678889999999999999998755443
No 146
>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src. Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo
Probab=100.00 E-value=2.6e-38 Score=286.73 Aligned_cols=240 Identities=23% Similarity=0.383 Sum_probs=188.3
Q ss_pred cccccccceecCCCceEEEeccc---------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEE
Q 041757 35 SRNMLEENLISAGTFGFSHLRRQ---------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALV 99 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~~---------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv 99 (381)
..+|.+.++||+|+||.||++.. ...+.+.+|+++++.++||||+++++.+. ....++|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~------~~~~~lv 78 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS------EEPIYIV 78 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC------CCCcEEE
Confidence 45689999999999999987642 12467899999999999999999998742 3457999
Q ss_pred EEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecc
Q 041757 100 YEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179 (381)
Q Consensus 100 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg 179 (381)
|||+++|+|.+++.. .....+++..++.++.|++.||+||| +.+++||||||+||++++++.++|+|||
T Consensus 79 ~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg 147 (262)
T cd05071 79 TEYMSKGSLLDFLKG--------EMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFG 147 (262)
T ss_pred EEcCCCCcHHHHHhh--------ccccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCC
Confidence 999999999999953 12345788999999999999999999 6799999999999999999999999999
Q ss_pred cceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchH
Q 041757 180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHV 258 (381)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 258 (381)
.++.......... ....++..|+|||+..+..++.++||||||+++|++++ |..||..... .
T Consensus 148 ~~~~~~~~~~~~~-~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~----~------------ 210 (262)
T cd05071 148 LARLIEDNEYTAR-QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----R------------ 210 (262)
T ss_pred ceeeccccccccc-cCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh----H------------
Confidence 9987654432211 12346778999999988889999999999999999999 8888753211 0
Q ss_pred HHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 041757 259 KDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSI 324 (381)
Q Consensus 259 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i 324 (381)
+.......... ......++..+.+++.+||+.||++||++.++++.|+..
T Consensus 211 -~~~~~~~~~~~---------------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 211 -EVLDQVERGYR---------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred -HHHHHHhcCCC---------------CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 00111000000 000134567889999999999999999999999999865
No 147
>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase. Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in
Probab=100.00 E-value=4.4e-39 Score=306.05 Aligned_cols=237 Identities=19% Similarity=0.196 Sum_probs=182.7
Q ss_pred cccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757 35 SRNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND 94 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~ 94 (381)
.++|...++||+|+||.||+++. ...+.+.+|+.+++.++||||+++++++ .+..
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~-----~~~~ 116 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAF-----QDDK 116 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCC
Confidence 57899999999999999987642 1224467899999999999999999884 5578
Q ss_pred eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757 95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR 174 (381)
Q Consensus 95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k 174 (381)
..++||||+++|+|.+++. ...+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+|
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~-----------~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~k 182 (370)
T cd05596 117 YLYMVMEYMPGGDLVNLMS-----------NYDIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLK 182 (370)
T ss_pred EEEEEEcCCCCCcHHHHHH-----------hcCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEE
Confidence 8999999999999999984 234788889999999999999999 67999999999999999999999
Q ss_pred EeecccceecCCCCCcccccCccCccceeCCCCcCCC----ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHH
Q 041757 175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGN----EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFA 250 (381)
Q Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~ 250 (381)
|+|||++........... ....||+.|+|||++.+. .++.++|||||||++|||++|+.||... .....+
T Consensus 183 L~DfG~~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~----~~~~~~- 256 (370)
T cd05596 183 LADFGTCMKMDANGMVRC-DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD----SLVGTY- 256 (370)
T ss_pred EEeccceeeccCCCcccC-CCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCC----CHHHHH-
Confidence 999999987654322111 125699999999988653 4789999999999999999999998522 111111
Q ss_pred HHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 041757 251 KMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQD--RMKMTNVVHE 320 (381)
Q Consensus 251 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~~vl~~ 320 (381)
..+......... +.....+..+.+++.+|+..+|.+ |||+.++++.
T Consensus 257 --------~~i~~~~~~~~~----------------~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 257 --------SKIMDHKNSLTF----------------PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred --------HHHHcCCCcCCC----------------CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 111110000000 001134567888999999999987 9999999763
No 148
>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t
Probab=100.00 E-value=1.7e-38 Score=287.78 Aligned_cols=236 Identities=19% Similarity=0.281 Sum_probs=185.7
Q ss_pred ccccccceecCCCceEEEeccc----------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN 93 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 93 (381)
++|...++||+|+||.||.+.. ...+.+.+|++++++++||||+++++++ ...
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~ 76 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCL-----RDD 76 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ccC
Confidence 5799999999999999987531 1235678899999999999999999995 446
Q ss_pred ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757 94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA 173 (381)
Q Consensus 94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~ 173 (381)
...++|+||+++++|.+++. ....+++..+..++.|++.||.||| ..+++||||+|+||+++.++.+
T Consensus 77 ~~~~~v~e~~~~~~l~~~~~----------~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~ 143 (263)
T cd06625 77 ETLSIFMEYMPGGSVKDQLK----------AYGALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNV 143 (263)
T ss_pred CeEEEEEEECCCCcHHHHHH----------HhCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCE
Confidence 78999999999999999984 3456888999999999999999999 6699999999999999999999
Q ss_pred EEeecccceecCCCCCccc-ccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHH
Q 041757 174 RVGDFGLARFLPPTRTQTS-SIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM 252 (381)
Q Consensus 174 kl~Dfg~~~~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~ 252 (381)
+|+|||+++.......... .....++..|+|||++.+..++.++||||||+++||+++|+.||... .........
T Consensus 144 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~----~~~~~~~~~ 219 (263)
T cd06625 144 KLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEF----EAMAAIFKI 219 (263)
T ss_pred EEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCcccc----chHHHHHHH
Confidence 9999999976543222111 01245788999999999988999999999999999999999997522 111111110
Q ss_pred HhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041757 253 ALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE 320 (381)
Q Consensus 253 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~ 320 (381)
.... . . ...+......+.+++.+||..+|.+|||+.++++.
T Consensus 220 ~~~~---------~--~----------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 220 ATQP---------T--N----------------PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred hccC---------C--C----------------CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 0000 0 0 00122455678899999999999999999999863
No 149
>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,
Probab=100.00 E-value=2.6e-39 Score=302.62 Aligned_cols=227 Identities=25% Similarity=0.286 Sum_probs=173.6
Q ss_pred ceecCCCceEEEeccc--------------------ccHHHHHHHHH-HHHccCCCcccceeeeeccccccCCceEEEEE
Q 041757 42 NLISAGTFGFSHLRRQ--------------------GAFKSFIAECK-ALRNIRHRNLIKVLTACLGVDYQGNDFKALVY 100 (381)
Q Consensus 42 ~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~-~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~ 100 (381)
++||+|+||+||++.. .....+.+|.. +++.++||||+++++++ ...+..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~-----~~~~~~~lv~ 75 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTTEKLYFVL 75 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEE-----ecCCEEEEEE
Confidence 4699999999987642 12234455655 46778999999999884 4577899999
Q ss_pred EcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccc
Q 041757 101 EFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180 (381)
Q Consensus 101 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 180 (381)
||+++|+|..++ .....+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 76 e~~~~~~L~~~l----------~~~~~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~ 142 (325)
T cd05604 76 DFVNGGELFFHL----------QRERSFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGL 142 (325)
T ss_pred cCCCCCCHHHHH----------HHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCC
Confidence 999999999888 34567899999999999999999999 67999999999999999999999999999
Q ss_pred ceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHH
Q 041757 181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKD 260 (381)
Q Consensus 181 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 260 (381)
++........ .....||+.|+|||++.+..++.++|||||||++|||++|..||... . ...
T Consensus 143 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~----~-~~~------------ 203 (325)
T cd05604 143 CKEGIAQSDT--TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCR----D-VAE------------ 203 (325)
T ss_pred cccCCCCCCC--cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCC----C-HHH------------
Confidence 8754322211 12256999999999999999999999999999999999999998521 1 111
Q ss_pred HHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 041757 261 IVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHEL 321 (381)
Q Consensus 261 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L 321 (381)
+.+..+..... ..+.....+.+++.+|++.||.+||++.+.++.+
T Consensus 204 ~~~~~~~~~~~----------------~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i 248 (325)
T cd05604 204 MYDNILHKPLV----------------LRPGASLTAWSILEELLEKDRQRRLGAKEDFLEI 248 (325)
T ss_pred HHHHHHcCCcc----------------CCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHH
Confidence 11111111000 0112345678899999999999999986544433
No 150
>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains. Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc
Probab=100.00 E-value=2.6e-38 Score=285.25 Aligned_cols=234 Identities=20% Similarity=0.269 Sum_probs=186.5
Q ss_pred cccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757 37 NMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA 97 (381)
Q Consensus 37 ~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~ 97 (381)
+|...+.||+|+||.||++.. .....+.+|++++++++||||+++++++. ..+..+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFL-----DKGKLN 75 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeec-----cCCEEE
Confidence 477889999999999987631 24567889999999999999999999954 467899
Q ss_pred EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757 98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD 177 (381)
Q Consensus 98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D 177 (381)
+||||+++++|.+++.. .....+++..++.++.|++.||.||| ..+++|+||||+||+++.++.++|+|
T Consensus 76 lv~e~~~~~~L~~~l~~--------~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~d 144 (256)
T cd08529 76 IVMEYAENGDLHKLLKM--------QRGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGD 144 (256)
T ss_pred EEEEeCCCCcHHHHHHH--------hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcc
Confidence 99999999999999953 12456889999999999999999999 66999999999999999999999999
Q ss_pred cccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhch
Q 041757 178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH 257 (381)
Q Consensus 178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~ 257 (381)
||+++......... ....|++.|+|||++.+..++.++||||||+++|+|++|+.||..... ...
T Consensus 145 f~~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~-------- 209 (256)
T cd08529 145 LGVAKLLSDNTNFA--NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ-----GAL-------- 209 (256)
T ss_pred cccceeccCccchh--hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-----HHH--------
Confidence 99998765443221 124588999999999988899999999999999999999999853221 110
Q ss_pred HHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041757 258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE 320 (381)
Q Consensus 258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~ 320 (381)
.......... ......+..+.+++.+||+.+|++||++.++++.
T Consensus 210 ----~~~~~~~~~~---------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 210 ----ILKIIRGVFP---------------PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ----HHHHHcCCCC---------------CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1110000000 0112455678999999999999999999999863
No 151
>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase. Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor
Probab=100.00 E-value=1.7e-39 Score=304.54 Aligned_cols=235 Identities=20% Similarity=0.222 Sum_probs=182.4
Q ss_pred ccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF 95 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~ 95 (381)
++|...++||+|+||.||++.. ...+.+.+|+.+++.++|+||+++++++ .....
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~-----~~~~~ 75 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAF-----QDKDN 75 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCe
Confidence 4788999999999999987541 1345677899999999999999999984 45778
Q ss_pred EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757 96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV 175 (381)
Q Consensus 96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl 175 (381)
.++||||+++|+|.+++.. ....+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||
T Consensus 76 ~~lv~e~~~~~~L~~~l~~---------~~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL 143 (330)
T cd05601 76 LYLVMEYQPGGDLLSLLNR---------YEDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKL 143 (330)
T ss_pred EEEEECCCCCCCHHHHHHH---------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEe
Confidence 9999999999999999952 2357899999999999999999999 679999999999999999999999
Q ss_pred eecccceecCCCCCcccccCccCccceeCCCCcC------CCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHH
Q 041757 176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGV------GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKF 249 (381)
Q Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~------~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~ 249 (381)
+|||++.......... .....||+.|+|||++. ...++.++|||||||++|||++|+.||... .....+
T Consensus 144 ~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~----~~~~~~ 218 (330)
T cd05601 144 ADFGSAARLTANKMVN-SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG----TSAKTY 218 (330)
T ss_pred ccCCCCeECCCCCcee-eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCC----CHHHHH
Confidence 9999998765443221 11245899999999886 456789999999999999999999998522 111111
Q ss_pred HHHHhhchHHHHHhhh-hccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 250 AKMALSNHVKDIVDSI-LLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 250 ~~~~~~~~~~~~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
..+.... ....+. ....+..+.+++..|+. +|.+|||+.++++
T Consensus 219 ---------~~i~~~~~~~~~~~-----------------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 219 ---------NNIMNFQRFLKFPE-----------------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred ---------HHHHcCCCccCCCC-----------------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 1111100 000000 01245567888899997 9999999999875
No 152
>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa. Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho
Probab=100.00 E-value=1.7e-38 Score=287.20 Aligned_cols=232 Identities=20% Similarity=0.308 Sum_probs=180.1
Q ss_pred eecCCCceEEEecc--------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEc
Q 041757 43 LISAGTFGFSHLRR--------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEF 102 (381)
Q Consensus 43 ~lG~G~fg~V~~~~--------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~ 102 (381)
.||+|+||.||++. ....+.+.+|+.++++++||||+++++++. ....++||||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~------~~~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE------AEALMLVMEM 75 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc------CCCeEEEEEe
Confidence 38999999998642 112356889999999999999999999853 3467999999
Q ss_pred ccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccce
Q 041757 103 MHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR 182 (381)
Q Consensus 103 ~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~ 182 (381)
+++++|.+++. .....+++..++.++.|++.||.||| ..+++||||||+||+++.++.+||+|||++.
T Consensus 76 ~~~~~L~~~l~---------~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~ 143 (257)
T cd05115 76 ASGGPLNKFLS---------GKKDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSK 143 (257)
T ss_pred CCCCCHHHHHH---------hCCCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccc
Confidence 99999999985 23456899999999999999999999 6699999999999999999999999999997
Q ss_pred ecCCCCCcc-cccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchHHH
Q 041757 183 FLPPTRTQT-SSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHVKD 260 (381)
Q Consensus 183 ~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 260 (381)
......... ......++..|+|||++....++.++||||||+++||+++ |..||...... .. ..
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-----~~---------~~ 209 (257)
T cd05115 144 ALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP-----EV---------MS 209 (257)
T ss_pred cccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH-----HH---------HH
Confidence 654432211 1111224578999999988889999999999999999996 99997532110 00 01
Q ss_pred HHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 041757 261 IVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSI 324 (381)
Q Consensus 261 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i 324 (381)
.+...... ..+..++.++.+++.+||..||++||++.+|.+.|+.+
T Consensus 210 ~~~~~~~~------------------~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 210 FIEQGKRL------------------DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred HHHCCCCC------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 11110000 01224567888999999999999999999999998764
No 153
>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn
Probab=100.00 E-value=2.2e-38 Score=300.38 Aligned_cols=185 Identities=24% Similarity=0.233 Sum_probs=153.6
Q ss_pred ccccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeecccc-ccCC
Q 041757 34 VSRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVD-YQGN 93 (381)
Q Consensus 34 ~~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~-~~~~ 93 (381)
..++|...+.||+|+||.||++.. .....+.+|+.+++.++||||+++++++.... ....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 458899999999999999977642 23456788999999999999999999865311 1223
Q ss_pred ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757 94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA 173 (381)
Q Consensus 94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~ 173 (381)
...++||||+.+ +|.+.+. ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~------------~~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~ 162 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH------------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTL 162 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh------------ccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCE
Confidence 457999999965 6766662 23778889999999999999999 6699999999999999999999
Q ss_pred EEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCC
Q 041757 174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSD 237 (381)
Q Consensus 174 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~ 237 (381)
||+|||+++........ ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus 163 kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~ 223 (359)
T cd07876 163 KILDFGLARTACTNFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQ 223 (359)
T ss_pred EEecCCCccccccCccC---CCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 99999999765433221 12458999999999999999999999999999999999999986
No 154
>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of
Probab=100.00 E-value=3.4e-39 Score=307.88 Aligned_cols=184 Identities=21% Similarity=0.277 Sum_probs=155.6
Q ss_pred ccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF 95 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~ 95 (381)
++|...++||+|+||.||++.. ...+.+.+|++++++++||||+++++++ .+...
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~ 75 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSF-----QDAQY 75 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCe
Confidence 4788899999999999987542 1235677899999999999999999994 45788
Q ss_pred EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757 96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV 175 (381)
Q Consensus 96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl 175 (381)
.|+||||+++|+|.+++. ....+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||
T Consensus 76 ~~lv~E~~~gg~L~~~l~----------~~~~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl 142 (377)
T cd05629 76 LYLIMEFLPGGDLMTMLI----------KYDTFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKL 142 (377)
T ss_pred eEEEEeCCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEE
Confidence 999999999999999993 4456889999999999999999999 679999999999999999999999
Q ss_pred eecccceecCCCCC------------cc---------------------------------cccCccCccceeCCCCcCC
Q 041757 176 GDFGLARFLPPTRT------------QT---------------------------------SSIDVKGSIGYIAPEYGVG 210 (381)
Q Consensus 176 ~Dfg~~~~~~~~~~------------~~---------------------------------~~~~~~gt~~y~aPE~l~~ 210 (381)
+|||+++....... .. .....+||+.|+|||++.+
T Consensus 143 ~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 222 (377)
T cd05629 143 SDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ 222 (377)
T ss_pred eecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc
Confidence 99999864321100 00 0012469999999999999
Q ss_pred CccCcccchhhhhHHHHHHHhCCCCCC
Q 041757 211 NEVSTIGDVYSYGILLLELMIREKPSD 237 (381)
Q Consensus 211 ~~~~~~sDiwSlG~il~el~tg~~Pf~ 237 (381)
..++.++|||||||++|||++|..||.
T Consensus 223 ~~~~~~~DiwSlGvil~elltG~~Pf~ 249 (377)
T cd05629 223 QGYGQECDWWSLGAIMFECLIGWPPFC 249 (377)
T ss_pred CCCCCceeeEecchhhhhhhcCCCCCC
Confidence 899999999999999999999999985
No 155
>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase. Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio
Probab=100.00 E-value=1.6e-38 Score=287.25 Aligned_cols=231 Identities=20% Similarity=0.294 Sum_probs=180.5
Q ss_pred eecCCCceEEEecc---------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEE
Q 041757 43 LISAGTFGFSHLRR---------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYE 101 (381)
Q Consensus 43 ~lG~G~fg~V~~~~---------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e 101 (381)
.||+|+||.||++. ....+.+.+|+.+++.++||||+++++++. .+..++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~~~~lv~e 75 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE------AESWMLVME 75 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc------CCCcEEEEe
Confidence 58999999998752 112457889999999999999999999853 345689999
Q ss_pred cccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccc
Q 041757 102 FMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLA 181 (381)
Q Consensus 102 ~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~ 181 (381)
|+++|+|.+++. ....+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++
T Consensus 76 ~~~~~~L~~~l~----------~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~ 142 (257)
T cd05116 76 LAELGPLNKFLQ----------KNKHVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLS 142 (257)
T ss_pred cCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccc
Confidence 999999999993 3456889999999999999999999 679999999999999999999999999999
Q ss_pred eecCCCCCcc-cccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchHH
Q 041757 182 RFLPPTRTQT-SSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHVK 259 (381)
Q Consensus 182 ~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 259 (381)
.......... ......++..|+|||.+....++.++|||||||++|||++ |..||..... ....
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----~~~~--------- 208 (257)
T cd05116 143 KALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG-----NEVT--------- 208 (257)
T ss_pred cccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-----HHHH---------
Confidence 8765443211 1111234678999999988889999999999999999998 9999853211 1111
Q ss_pred HHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 041757 260 DIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSI 324 (381)
Q Consensus 260 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i 324 (381)
+.+...... ..+..++.++.+++.+||+.||++||++.+|.+.|++.
T Consensus 209 ~~i~~~~~~------------------~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 209 QMIESGERM------------------ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred HHHHCCCCC------------------CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 111110000 01124566789999999999999999999999999753
No 156
>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.
Probab=100.00 E-value=4.8e-39 Score=300.28 Aligned_cols=221 Identities=24% Similarity=0.283 Sum_probs=170.4
Q ss_pred ceecCCCceEEEecccc--------------------cHHHHHHHHH-HHHccCCCcccceeeeeccccccCCceEEEEE
Q 041757 42 NLISAGTFGFSHLRRQG--------------------AFKSFIAECK-ALRNIRHRNLIKVLTACLGVDYQGNDFKALVY 100 (381)
Q Consensus 42 ~~lG~G~fg~V~~~~~~--------------------~~~~~~~E~~-~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~ 100 (381)
++||+|+||.||+++.. ....+.+|.. +++.++||||+++++++ .+.+..++||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~-----~~~~~~~lv~ 75 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSF-----QTAEKLYFVL 75 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCEEEEEE
Confidence 47999999999886521 1233455554 57889999999999884 4577899999
Q ss_pred EcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccc
Q 041757 101 EFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180 (381)
Q Consensus 101 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 180 (381)
||+++|+|..++. ....+++..+..++.||+.||.||| ..+|+||||||+||+++.++.+||+|||+
T Consensus 76 e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 142 (321)
T cd05603 76 DYVNGGELFFHLQ----------RERCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGL 142 (321)
T ss_pred cCCCCCCHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCC
Confidence 9999999998883 4556888999999999999999999 66999999999999999999999999999
Q ss_pred ceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHH
Q 041757 181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKD 260 (381)
Q Consensus 181 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 260 (381)
++........ .....||+.|+|||++.+..++.++|||||||++|||++|..||... .....
T Consensus 143 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~-----~~~~~----------- 204 (321)
T cd05603 143 CKEGVEPEET--TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR-----DVSQM----------- 204 (321)
T ss_pred CccCCCCCCc--cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCC-----CHHHH-----------
Confidence 8753222211 12256899999999999888999999999999999999999998521 11111
Q ss_pred HHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHH
Q 041757 261 IVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMT 315 (381)
Q Consensus 261 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 315 (381)
.+....... ..+......+.+++.+||+.||.+||++.
T Consensus 205 -~~~i~~~~~----------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 205 -YDNILHKPL----------------QLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred -HHHHhcCCC----------------CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 111111000 00123445788999999999999999864
No 157
>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4. Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin
Probab=100.00 E-value=1.4e-38 Score=294.77 Aligned_cols=244 Identities=23% Similarity=0.335 Sum_probs=189.4
Q ss_pred cccccccceecCCCceEEEeccc----------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccC
Q 041757 35 SRNMLEENLISAGTFGFSHLRRQ----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQG 92 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~~----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 92 (381)
..+|...+.||+|+||.||++.. .....+.+|+.+++.++||||++++++|..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~----- 80 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS----- 80 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC-----
Confidence 46778889999999999987531 112367889999999999999999998642
Q ss_pred CceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCC
Q 041757 93 NDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT 172 (381)
Q Consensus 93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~ 172 (381)
...++++||+++|+|.+++. .....+++..++.++.|++.||.||| +.+|+||||||+||+++.++.
T Consensus 81 -~~~~~v~e~~~~g~l~~~~~---------~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~ 147 (303)
T cd05110 81 -PTIQLVTQLMPHGCLLDYVH---------EHKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNH 147 (303)
T ss_pred -CCceeeehhcCCCCHHHHHH---------hcccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCc
Confidence 34579999999999999985 23446888999999999999999999 669999999999999999999
Q ss_pred eEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHH
Q 041757 173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAK 251 (381)
Q Consensus 173 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~ 251 (381)
+||+|||+++...............++..|+|||++.+..++.++||||||+++||+++ |..||.... ....
T Consensus 148 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~-----~~~~-- 220 (303)
T cd05110 148 VKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP-----TREI-- 220 (303)
T ss_pred eEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC-----HHHH--
Confidence 99999999987654332222222345778999999988889999999999999999997 889975221 1111
Q ss_pred HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhc
Q 041757 252 MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTL 328 (381)
Q Consensus 252 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~~ 328 (381)
.+++...... + .+..++..+.+++.+||..+|++||++.++++.|+.+.+..
T Consensus 221 -------~~~~~~~~~~-~-----------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 221 -------PDLLEKGERL-P-----------------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred -------HHHHHCCCCC-C-----------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 1111110000 0 01134457889999999999999999999999999886654
No 158
>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase. Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play
Probab=100.00 E-value=1.8e-38 Score=294.81 Aligned_cols=261 Identities=20% Similarity=0.262 Sum_probs=183.5
Q ss_pred ccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA 97 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~ 97 (381)
++|...++||+|+||.||++.. .....+.+|+.++++++||||+++++++ ...+..+
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~ 80 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV-----HTDKSLT 80 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEE-----eeCCeEE
Confidence 5688899999999999987541 1234678899999999999999999995 4467899
Q ss_pred EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757 98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD 177 (381)
Q Consensus 98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D 177 (381)
+||||+++ +|.+++. .....+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|
T Consensus 81 lv~e~~~~-~l~~~~~---------~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~D 147 (309)
T cd07872 81 LVFEYLDK-DLKQYMD---------DCGNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLAD 147 (309)
T ss_pred EEEeCCCC-CHHHHHH---------hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECc
Confidence 99999975 8888874 23445788999999999999999999 66999999999999999999999999
Q ss_pred cccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhc
Q 041757 178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSN 256 (381)
Q Consensus 178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~ 256 (381)
||+++......... ....+++.|+|||++.+ ..++.++|||||||++|+|++|+.||......+ ........ ...
T Consensus 148 fg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~-~~~~~~~~-~~~ 223 (309)
T cd07872 148 FGLARAKSVPTKTY--SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED-ELHLIFRL-LGT 223 (309)
T ss_pred cccceecCCCcccc--ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHH-hCC
Confidence 99997654332211 12357899999998765 468899999999999999999999985322111 11111111 111
Q ss_pred hHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 257 HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 257 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
...+.............. ...................++.+++.+|++.||.+|||+.|+++
T Consensus 224 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 224 PTEETWPGISSNDEFKNY-NFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred CCHHHHhhhcchhhhhhh-hcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 111111110000000000 00000000001112234567889999999999999999999986
No 159
>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1. Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an
Probab=100.00 E-value=5.2e-39 Score=307.17 Aligned_cols=183 Identities=21% Similarity=0.298 Sum_probs=154.9
Q ss_pred cccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757 37 NMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK 96 (381)
Q Consensus 37 ~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~ 96 (381)
.|...++||+|+||.||++.. .....+.+|++++++++||||+++++.+ .+.+..
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~-----~~~~~~ 76 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSF-----QDKDNL 76 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEE-----EeCCEE
Confidence 588899999999999988652 1234678899999999999999999995 457789
Q ss_pred EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757 97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG 176 (381)
Q Consensus 97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~ 176 (381)
++|||||++|+|.+++. ....+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+
T Consensus 77 ~lv~E~~~gg~L~~~l~----------~~~~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~ 143 (382)
T cd05625 77 YFVMDYIPGGDMMSLLI----------RMGIFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLT 143 (382)
T ss_pred EEEEeCCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEe
Confidence 99999999999999984 3456888999999999999999999 6799999999999999999999999
Q ss_pred ecccceecCCCCC---------------------------------------------cccccCccCccceeCCCCcCCC
Q 041757 177 DFGLARFLPPTRT---------------------------------------------QTSSIDVKGSIGYIAPEYGVGN 211 (381)
Q Consensus 177 Dfg~~~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~l~~~ 211 (381)
|||++........ .......+||+.|+|||++.+.
T Consensus 144 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~ 223 (382)
T cd05625 144 DFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT 223 (382)
T ss_pred ECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC
Confidence 9999753311000 0001124689999999999999
Q ss_pred ccCcccchhhhhHHHHHHHhCCCCCC
Q 041757 212 EVSTIGDVYSYGILLLELMIREKPSD 237 (381)
Q Consensus 212 ~~~~~sDiwSlG~il~el~tg~~Pf~ 237 (381)
.++.++|||||||++|||++|+.||.
T Consensus 224 ~~~~~~DiwSlGvil~elltG~~Pf~ 249 (382)
T cd05625 224 GYTQLCDWWSVGVILYEMLVGQPPFL 249 (382)
T ss_pred CCCCeeeEEechHHHHHHHhCCCCCC
Confidence 99999999999999999999999985
No 160
>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is
Probab=100.00 E-value=2.1e-38 Score=298.69 Aligned_cols=265 Identities=18% Similarity=0.198 Sum_probs=183.7
Q ss_pred hccccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeecccc-ccC
Q 041757 33 DVSRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVD-YQG 92 (381)
Q Consensus 33 ~~~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~-~~~ 92 (381)
.+.++|...+.||.|+||.||++.. ...+.+.+|+++|++++||||+++++++.... ...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 4567899999999999999987641 12345778999999999999999999865311 122
Q ss_pred CceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCC
Q 041757 93 NDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT 172 (381)
Q Consensus 93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~ 172 (381)
....++++|++ +++|.+++. ...+++..+..++.|++.||.||| +.+|+||||||+||+++.++.
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~-----------~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~ 156 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVK-----------CQKLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCE 156 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCC
Confidence 34578999988 779988873 345899999999999999999999 669999999999999999999
Q ss_pred eEEeecccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHH
Q 041757 173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAK 251 (381)
Q Consensus 173 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~ 251 (381)
+||+|||+++...... ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...... ..+..+..
T Consensus 157 ~kl~Dfg~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~ 230 (343)
T cd07878 157 LRILDFGLARQADDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI-DQLKRIME 230 (343)
T ss_pred EEEcCCccceecCCCc-----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHH
Confidence 9999999998654322 12458999999999876 56899999999999999999999998522110 00111111
Q ss_pred HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 252 MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 252 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
. ......+...................................+.+++.+|++.||.+|||+.++++
T Consensus 231 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 231 V-VGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred H-hCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 000111111110000000000000000000000011123345789999999999999999999996
No 161
>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1. Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a
Probab=100.00 E-value=2.1e-38 Score=290.72 Aligned_cols=256 Identities=23% Similarity=0.385 Sum_probs=188.6
Q ss_pred ccccccceecCCCceEEEecc----------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757 36 RNMLEENLISAGTFGFSHLRR----------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN 93 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~----------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 93 (381)
+.|.+.++||+|+||.||+++ ......+.+|+++++.++||||+++++++.. .+.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~ 80 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE---DGG 80 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEec---CCC
Confidence 557888999999999998653 1123578899999999999999999998653 224
Q ss_pred ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757 94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA 173 (381)
Q Consensus 94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~ 173 (381)
...++||||+++++|.+++.. ....+++..+..++.|++.||.||| +.+++||||||+||+++.++.+
T Consensus 81 ~~~~lv~e~~~g~~L~~~l~~---------~~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~ 148 (284)
T cd05079 81 NGIKLIMEFLPSGSLKEYLPR---------NKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQV 148 (284)
T ss_pred CceEEEEEccCCCCHHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCE
Confidence 678999999999999999842 2345899999999999999999999 6699999999999999999999
Q ss_pred EEeecccceecCCCCCc-ccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHH
Q 041757 174 RVGDFGLARFLPPTRTQ-TSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM 252 (381)
Q Consensus 174 kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~ 252 (381)
+|+|||+++........ .......++..|+|||++.+..++.++||||||+++||++++..|+..... ........
T Consensus 149 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~---~~~~~~~~ 225 (284)
T cd05079 149 KIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMT---LFLKMIGP 225 (284)
T ss_pred EECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccc---hhhhhccc
Confidence 99999999876543221 111124467789999999888899999999999999999998776432111 00000000
Q ss_pred Hhhc-hHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 041757 253 ALSN-HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSI 324 (381)
Q Consensus 253 ~~~~-~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i 324 (381)
.... .....+....... ..+.+..++..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 226 THGQMTVTRLVRVLEEGK---------------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred ccccccHHHHHHHHHcCc---------------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0000 0000110000000 0001123567899999999999999999999999999876
No 162
>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p
Probab=100.00 E-value=3.8e-38 Score=293.59 Aligned_cols=190 Identities=21% Similarity=0.303 Sum_probs=150.6
Q ss_pred cceecCCCceEEEecccc-----------------cHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEcc
Q 041757 41 ENLISAGTFGFSHLRRQG-----------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFM 103 (381)
Q Consensus 41 ~~~lG~G~fg~V~~~~~~-----------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~~ 103 (381)
+++||+|+||+||++... ....+.+|+++|++++||||+++++++.. ......++||||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~~lv~e~~ 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLS---HADRKVWLLFDYA 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEec---CCCcEEEEEEecc
Confidence 578999999999887521 23467899999999999999999998653 3456789999999
Q ss_pred cCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeee----CCCCCeEEeecc
Q 041757 104 HNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLL----DDDMTARVGDFG 179 (381)
Q Consensus 104 ~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill----~~~~~~kl~Dfg 179 (381)
. ++|.+++........ ......+++..+..++.|++.||.||| +.+|+||||||+|||+ +.++.+||+|||
T Consensus 83 ~-~~l~~~~~~~~~~~~-~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07868 83 E-HDLWHIIKFHRASKA-NKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred C-CCHHHHHHhcccccc-cCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence 5 588888743221110 022346899999999999999999999 6699999999999999 456789999999
Q ss_pred cceecCCCCCc-ccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCc
Q 041757 180 LARFLPPTRTQ-TSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDI 238 (381)
Q Consensus 180 ~~~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~ 238 (381)
+++........ .......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||..
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred ceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 99876543221 11223568999999999876 4589999999999999999999999864
No 163
>PTZ00266 NIMA-related protein kinase; Provisional
Probab=100.00 E-value=2e-38 Score=322.38 Aligned_cols=241 Identities=19% Similarity=0.248 Sum_probs=184.2
Q ss_pred cccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757 35 SRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF 95 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~ 95 (381)
.++|.+.++||.|+||+||++.. .....|..|+.+|++|+|||||++++++.. .....
T Consensus 12 l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~d---e~~~~ 88 (1021)
T PTZ00266 12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLN---KANQK 88 (1021)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEe---cCCCE
Confidence 46899999999999999987642 234678899999999999999999998653 34567
Q ss_pred EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCC----CCCceeeccCCCCeeeCC--
Q 041757 96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDC----QPVTAHCVLKPSNVLLDD-- 169 (381)
Q Consensus 96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~----~~~ivHrDlkp~Nill~~-- 169 (381)
.||||||+++|+|.++|.... .....+++..++.|+.||+.||.|||... ..+||||||||+|||++.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~------~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~ 162 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCY------KMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGI 162 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHh------hccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCc
Confidence 899999999999999985321 12356899999999999999999999531 146999999999999954
Q ss_pred ---------------CCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCC--CccCcccchhhhhHHHHHHHhC
Q 041757 170 ---------------DMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG--NEVSTIGDVYSYGILLLELMIR 232 (381)
Q Consensus 170 ---------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~sDiwSlG~il~el~tg 232 (381)
.+.+||+|||++..+....... ...||+.|+|||++.+ ..++.++|||||||++|||++|
T Consensus 163 ~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~---s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTG 239 (1021)
T PTZ00266 163 RHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAH---SCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG 239 (1021)
T ss_pred cccccccccccccCCCCceEEccCCcccccccccccc---ccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHC
Confidence 2358999999998664432221 2468999999998864 4588999999999999999999
Q ss_pred CCCCCccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCC
Q 041757 233 EKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRM 312 (381)
Q Consensus 233 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 312 (381)
..||.. ......+.... . . .+.. .....+.++.+|+..||..+|.+||
T Consensus 240 k~PF~~----~~~~~qli~~l---------k---~-~p~l---------------pi~~~S~eL~dLI~~~L~~dPeeRP 287 (1021)
T PTZ00266 240 KTPFHK----ANNFSQLISEL---------K---R-GPDL---------------PIKGKSKELNILIKNLLNLSAKERP 287 (1021)
T ss_pred CCCCCc----CCcHHHHHHHH---------h---c-CCCC---------------CcCCCCHHHHHHHHHHhcCChhHCc
Confidence 999852 11222111110 0 0 0000 0012356788999999999999999
Q ss_pred CHHHHHH
Q 041757 313 KMTNVVH 319 (381)
Q Consensus 313 s~~~vl~ 319 (381)
++.+++.
T Consensus 288 Sa~QlL~ 294 (1021)
T PTZ00266 288 SALQCLG 294 (1021)
T ss_pred CHHHHhc
Confidence 9999984
No 164
>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr
Probab=100.00 E-value=2.6e-38 Score=287.71 Aligned_cols=240 Identities=23% Similarity=0.375 Sum_probs=186.3
Q ss_pred ccccccceecCCCceEEEeccc---------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ---------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND 94 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~---------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~ 94 (381)
..|...+.||+|+||.||++.. ...+.|.+|+.++++++||||+++++++ ....
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~~~ 78 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----TKSR 78 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEE-----CCCC
Confidence 3578889999999999986431 1345788999999999999999999994 4577
Q ss_pred eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757 95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR 174 (381)
Q Consensus 95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k 174 (381)
..++||||+++++|.+++. .....+++..++.++.|++.||.||| +.+++|+||||+||+++.++.+|
T Consensus 79 ~~~lv~e~~~~~~L~~~l~---------~~~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~k 146 (269)
T cd05065 79 PVMIITEFMENGALDSFLR---------QNDGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCK 146 (269)
T ss_pred ceEEEEecCCCCcHHHHHh---------hCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEE
Confidence 8899999999999999985 23456889999999999999999999 66999999999999999999999
Q ss_pred EeecccceecCCCCCccccc---CccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHH
Q 041757 175 VGDFGLARFLPPTRTQTSSI---DVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFA 250 (381)
Q Consensus 175 l~Dfg~~~~~~~~~~~~~~~---~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~ 250 (381)
|+|||++............. ....+..|+|||++.+..++.++|||||||++||+++ |..||..... ....
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~-----~~~~ 221 (269)
T cd05065 147 VSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-----QDVI 221 (269)
T ss_pred ECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH-----HHHH
Confidence 99999987665432211111 1112457999999998899999999999999999886 9999752211 1110
Q ss_pred HHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 041757 251 KMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSI 324 (381)
Q Consensus 251 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i 324 (381)
.. +..... . +.+..++..+.+++.+||..+|.+||++.+|+..|+++
T Consensus 222 ~~---------i~~~~~-~-----------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 222 NA---------IEQDYR-L-----------------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred HH---------HHcCCc-C-----------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 000000 0 00124566788999999999999999999999998865
No 165
>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases. Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina
Probab=100.00 E-value=1.4e-38 Score=289.54 Aligned_cols=240 Identities=21% Similarity=0.262 Sum_probs=173.3
Q ss_pred ceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEE
Q 041757 42 NLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYE 101 (381)
Q Consensus 42 ~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e 101 (381)
+.||+|+||.||++.. .....+.+|+.+++.++|+||+++++.+. .....++|||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~-----~~~~~~lv~e 75 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCI-----ESIPYLLVLE 75 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEEC-----CCCceEEEEE
Confidence 3699999999987521 12346789999999999999999999854 4677899999
Q ss_pred cccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccc
Q 041757 102 FMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLA 181 (381)
Q Consensus 102 ~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~ 181 (381)
|+++|+|.+++..... ......++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 76 ~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~ 147 (269)
T cd05042 76 FCPLGDLKNYLRSNRG-----MVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLA 147 (269)
T ss_pred eCCCCcHHHHHHhccc-----cccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccc
Confidence 9999999999954221 11233567788899999999999999 669999999999999999999999999998
Q ss_pred eecCCCCCcccccCccCccceeCCCCcCC-------CccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHH
Q 041757 182 RFLPPTRTQTSSIDVKGSIGYIAPEYGVG-------NEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMA 253 (381)
Q Consensus 182 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-------~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~ 253 (381)
................+++.|+|||++.. ..++.++|||||||++|||++ |..||.... ........
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~----~~~~~~~~- 222 (269)
T cd05042 148 LEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLS----DEQVLKQV- 222 (269)
T ss_pred cccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCC----HHHHHHHH-
Confidence 75433322111122346778999998642 356889999999999999999 778864221 11111000
Q ss_pred hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 041757 254 LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQ 322 (381)
Q Consensus 254 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~ 322 (381)
.......+.. + ......+..+.+++..|| .||++|||+.+|++.|.
T Consensus 223 ~~~~~~~~~~------~----------------~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 223 VREQDIKLPK------P----------------QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred hhccCccCCC------C----------------cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 0000000000 0 011234556777888999 59999999999999873
No 166
>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou
Probab=100.00 E-value=2.3e-38 Score=290.93 Aligned_cols=262 Identities=20% Similarity=0.228 Sum_probs=183.8
Q ss_pred cccccceecCCCceEEEecccc-------------------cHHHHHHHHHHHHcc---CCCcccceeeeeccccccCCc
Q 041757 37 NMLEENLISAGTFGFSHLRRQG-------------------AFKSFIAECKALRNI---RHRNLIKVLTACLGVDYQGND 94 (381)
Q Consensus 37 ~~~~~~~lG~G~fg~V~~~~~~-------------------~~~~~~~E~~~l~~l---~h~nIv~~~~~~~~~~~~~~~ 94 (381)
+|...+.||+|+||+||++... ....+.+|+.+++.+ +||||+++++++.........
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788899999999999886421 123567788887766 699999999987653334456
Q ss_pred eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757 95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR 174 (381)
Q Consensus 95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k 174 (381)
..++||||+.+ +|.+++.. .....+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+|
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~--------~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~k 148 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDK--------VPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVK 148 (288)
T ss_pred eEEEEEccccc-CHHHHHHh--------cCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEE
Confidence 78999999975 89888853 12345899999999999999999999 66999999999999999999999
Q ss_pred EeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHh
Q 041757 175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMAL 254 (381)
Q Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 254 (381)
|+|||+++......... ...+|..|+|||++.+..++.++|||||||++|+|++|.+||...... ..+........
T Consensus 149 l~dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~-~~~~~~~~~~~ 224 (288)
T cd07863 149 LADFGLARIYSCQMALT---PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-DQLGKIFDLIG 224 (288)
T ss_pred ECccCccccccCcccCC---CccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH-HHHHHHHHHhC
Confidence 99999998665332221 245899999999998889999999999999999999999997522111 00111111000
Q ss_pred hchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 255 SNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 255 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
........ ..... +.. ..............+.....+.+++.+|++.||++|||+.+++.
T Consensus 225 ~~~~~~~~-~~~~~-~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 225 LPPEDDWP-RDVTL-PRG---AFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred CCChhhCc-ccccc-ccc---ccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000000 00000 000 00000001111222345567889999999999999999999874
No 167
>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]
Probab=100.00 E-value=2.7e-39 Score=276.48 Aligned_cols=235 Identities=21% Similarity=0.294 Sum_probs=187.2
Q ss_pred cccccccceecCCCceEEEec-----------c--------------cccHHHHHHHHHHHHccC-CCcccceeeeeccc
Q 041757 35 SRNMLEENLISAGTFGFSHLR-----------R--------------QGAFKSFIAECKALRNIR-HRNLIKVLTACLGV 88 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~-----------~--------------~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~ 88 (381)
..+|...+.||+|..++|... + ....+.-.+|+.+|+++. ||+|+++.++
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~---- 91 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV---- 91 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee----
Confidence 356777889999999888221 0 123455678999999996 9999999999
Q ss_pred cccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeC
Q 041757 89 DYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLD 168 (381)
Q Consensus 89 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~ 168 (381)
++++.+.++|+|.|+.|.|.++| ...-.+++....+|+.|+.+|+.||| ..+||||||||+|||++
T Consensus 92 -yes~sF~FlVFdl~prGELFDyL----------ts~VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILld 157 (411)
T KOG0599|consen 92 -YESDAFVFLVFDLMPRGELFDYL----------TSKVTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLD 157 (411)
T ss_pred -ccCcchhhhhhhhcccchHHHHh----------hhheeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeec
Confidence 67799999999999999999999 56678999999999999999999999 77999999999999999
Q ss_pred CCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcC------CCccCcccchhhhhHHHHHHHhCCCCCCccccC
Q 041757 169 DDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGV------GNEVSTIGDVYSYGILLLELMIREKPSDIMFEG 242 (381)
Q Consensus 169 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~------~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~ 242 (381)
++..+||+|||++..+..+..... .+|||+|.|||.+. ...|+..+|+||.||++|.++.|.+||....
T Consensus 158 dn~~i~isDFGFa~~l~~GekLre---lCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk-- 232 (411)
T KOG0599|consen 158 DNMNIKISDFGFACQLEPGEKLRE---LCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK-- 232 (411)
T ss_pred cccceEEeccceeeccCCchhHHH---hcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH--
Confidence 999999999999998877665443 67999999999875 2458899999999999999999999984110
Q ss_pred CCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 243 DMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
++. .+.-.+.+.. +...+...+......+|+.+||+.||.+|.|+.|++.
T Consensus 233 -----Qml----------MLR~ImeGky------------qF~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 233 -----QML----------MLRMIMEGKY------------QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred -----HHH----------HHHHHHhccc------------ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 000 0011111111 0111113466677889999999999999999999985
No 168
>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk. Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r
Probab=100.00 E-value=2.9e-38 Score=285.93 Aligned_cols=239 Identities=24% Similarity=0.399 Sum_probs=186.4
Q ss_pred cccccccceecCCCceEEEeccc---------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEE
Q 041757 35 SRNMLEENLISAGTFGFSHLRRQ---------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALV 99 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~~---------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv 99 (381)
.++|.+.++||+|+||.||++.. ...+.+.+|+.++++++|+||+++++++. ....++|
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~------~~~~~lv 78 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS------EEPIYIV 78 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC------CCCcEEE
Confidence 35788899999999999987541 13467899999999999999999998842 3457899
Q ss_pred EEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecc
Q 041757 100 YEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179 (381)
Q Consensus 100 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg 179 (381)
|||+++++|.+++.. .....+++..++.++.|++.||.||| +.+++||||||+||++++++.++|+|||
T Consensus 79 ~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg 147 (260)
T cd05070 79 TEYMSKGSLLDFLKD--------GEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFG 147 (260)
T ss_pred EEecCCCcHHHHHHh--------cCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCce
Confidence 999999999999853 12345889999999999999999999 6699999999999999999999999999
Q ss_pred cceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchH
Q 041757 180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHV 258 (381)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 258 (381)
++.......... .....++..|+|||++.+..++.++||||||+++|++++ |..||.... .. .
T Consensus 148 ~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~----~~-~---------- 211 (260)
T cd05070 148 LARLIEDNEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN----NR-E---------- 211 (260)
T ss_pred eeeeccCccccc-ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC----HH-H----------
Confidence 998765433211 111235678999999988889999999999999999999 888975221 10 0
Q ss_pred HHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 041757 259 KDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQS 323 (381)
Q Consensus 259 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~ 323 (381)
..+....... ...+...+..+.+++.+||..+|.+|||+.++.+.|++
T Consensus 212 --~~~~~~~~~~---------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 212 --VLEQVERGYR---------------MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred --HHHHHHcCCC---------------CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1111100000 00012345678999999999999999999999998875
No 169
>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3. Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells
Probab=100.00 E-value=9.5e-39 Score=290.66 Aligned_cols=240 Identities=22% Similarity=0.262 Sum_probs=173.7
Q ss_pred ceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEE
Q 041757 42 NLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYE 101 (381)
Q Consensus 42 ~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e 101 (381)
+.||+|+||.||++.. .....+.+|+.++++++||||+++++++. .....++|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e 75 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCT-----EVTPYLLVME 75 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----CCCCcEEEEE
Confidence 3699999999987530 12246888999999999999999999854 4567899999
Q ss_pred cccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccc
Q 041757 102 FMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLA 181 (381)
Q Consensus 102 ~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~ 181 (381)
|+++|+|.+++..... ......++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++
T Consensus 76 ~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~ 147 (269)
T cd05087 76 FCPLGDLKGYLRSCRK-----AELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLS 147 (269)
T ss_pred CCCCCcHHHHHHHhhh-----cccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCcccc
Confidence 9999999999953211 11234567778889999999999999 669999999999999999999999999998
Q ss_pred eecCCCCCcccccCccCccceeCCCCcCCC-------ccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHH
Q 041757 182 RFLPPTRTQTSSIDVKGSIGYIAPEYGVGN-------EVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMA 253 (381)
Q Consensus 182 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-------~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~ 253 (381)
+...............++..|+|||++.+. .++.++||||||+++|||++ |..||...... ... ...
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~----~~~-~~~ 222 (269)
T cd05087 148 HNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE----QVL-TYT 222 (269)
T ss_pred ccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH----HHH-HHH
Confidence 755433322222224578889999987642 35789999999999999996 99998532111 000 000
Q ss_pred hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 041757 254 LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQ 322 (381)
Q Consensus 254 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~ 322 (381)
.......+ ..+. ........+.+++.+|| .+|++|||+.+|+..|+
T Consensus 223 ~~~~~~~~------~~~~----------------~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 223 VREQQLKL------PKPR----------------LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred hhcccCCC------CCCc----------------cCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 00000000 0000 00123346778888999 68999999999998774
No 170
>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk. Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr
Probab=100.00 E-value=4.3e-38 Score=284.86 Aligned_cols=239 Identities=21% Similarity=0.340 Sum_probs=188.0
Q ss_pred cccccccceecCCCceEEEeccc---------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEE
Q 041757 35 SRNMLEENLISAGTFGFSHLRRQ---------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALV 99 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~~---------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv 99 (381)
.++|...++||+|+||.||++.. .....+.+|+.++++++|+||+++++++. ....++|
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~~v 78 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT------QEPIYII 78 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc------cCCcEEE
Confidence 56788899999999999987542 23468899999999999999999998742 4568999
Q ss_pred EEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecc
Q 041757 100 YEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179 (381)
Q Consensus 100 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg 179 (381)
|||+++++|.+++.. .....+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||
T Consensus 79 ~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg 147 (260)
T cd05067 79 TEYMENGSLVDFLKT--------PEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFG 147 (260)
T ss_pred EEcCCCCCHHHHHHh--------cCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCc
Confidence 999999999999853 23456888999999999999999999 6799999999999999999999999999
Q ss_pred cceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchH
Q 041757 180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHV 258 (381)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 258 (381)
++.......... .....++..|+|||++.+..++.++||||||+++||+++ |+.||..... ......
T Consensus 148 ~~~~~~~~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----~~~~~~------ 215 (260)
T cd05067 148 LARLIEDNEYTA-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN-----PEVIQN------ 215 (260)
T ss_pred ceeecCCCCccc-ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh-----HHHHHH------
Confidence 998765332211 112346778999999988889999999999999999999 9999852211 010000
Q ss_pred HHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 041757 259 KDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQS 323 (381)
Q Consensus 259 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~ 323 (381)
+...... ..+...+.++.+++.+||+.+|++|||+++++..|+.
T Consensus 216 ---~~~~~~~------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 216 ---LERGYRM------------------PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ---HHcCCCC------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 0000000 0012345579999999999999999999999999875
No 171
>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor. Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.
Probab=100.00 E-value=3.5e-39 Score=307.78 Aligned_cols=184 Identities=22% Similarity=0.298 Sum_probs=155.6
Q ss_pred ccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF 95 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~ 95 (381)
.+|...+.||+|+||.||+++. .....+.+|+++|++++|+||+++++.+ .+.+.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~ 75 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSF-----QDKDN 75 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCE
Confidence 3688999999999999988652 1234577899999999999999999984 55789
Q ss_pred EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757 96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV 175 (381)
Q Consensus 96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl 175 (381)
.++|||||++|+|.+++. ....+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||
T Consensus 76 ~~lv~E~~~~g~L~~~i~----------~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL 142 (376)
T cd05598 76 LYFVMDYIPGGDMMSLLI----------RLGIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKL 142 (376)
T ss_pred EEEEEeCCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEE
Confidence 999999999999999994 4456888999999999999999999 679999999999999999999999
Q ss_pred eecccceecCCCC-----------------------------------------CcccccCccCccceeCCCCcCCCccC
Q 041757 176 GDFGLARFLPPTR-----------------------------------------TQTSSIDVKGSIGYIAPEYGVGNEVS 214 (381)
Q Consensus 176 ~Dfg~~~~~~~~~-----------------------------------------~~~~~~~~~gt~~y~aPE~l~~~~~~ 214 (381)
+|||++..+.... .........||+.|+|||++.+..++
T Consensus 143 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 222 (376)
T cd05598 143 TDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT 222 (376)
T ss_pred EeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCC
Confidence 9999975331000 00001124699999999999999999
Q ss_pred cccchhhhhHHHHHHHhCCCCCC
Q 041757 215 TIGDVYSYGILLLELMIREKPSD 237 (381)
Q Consensus 215 ~~sDiwSlG~il~el~tg~~Pf~ 237 (381)
.++|||||||++|||++|+.||.
T Consensus 223 ~~~DiwSlGvilyell~G~~Pf~ 245 (376)
T cd05598 223 QLCDWWSVGVILYEMLVGQPPFL 245 (376)
T ss_pred cceeeeeccceeeehhhCCCCCC
Confidence 99999999999999999999985
No 172
>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2. Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage
Probab=100.00 E-value=6e-38 Score=285.34 Aligned_cols=239 Identities=22% Similarity=0.293 Sum_probs=172.6
Q ss_pred ceecCCCceEEEecc--------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEE
Q 041757 42 NLISAGTFGFSHLRR--------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYE 101 (381)
Q Consensus 42 ~~lG~G~fg~V~~~~--------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e 101 (381)
+.||+|+||.||++. ....+.+.+|+.+++.++||||+++++.|. .....++|||
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~-----~~~~~~lv~e 75 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCV-----EAIPYLLVFE 75 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEec-----CCCccEEEEe
Confidence 359999999998753 113467899999999999999999999964 4667899999
Q ss_pred cccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccc
Q 041757 102 FMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLA 181 (381)
Q Consensus 102 ~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~ 181 (381)
|+++|+|.+++.... ......+...+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++
T Consensus 76 ~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~ 146 (268)
T cd05086 76 YCELGDLKSYLSQEQ------WHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIG 146 (268)
T ss_pred cCCCCcHHHHHHhhh------cccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccc
Confidence 999999999995321 11234667778899999999999999 669999999999999999999999999998
Q ss_pred eecCCCCCcccccCccCccceeCCCCcCC-------CccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHH
Q 041757 182 RFLPPTRTQTSSIDVKGSIGYIAPEYGVG-------NEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMA 253 (381)
Q Consensus 182 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-------~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~ 253 (381)
................++..|+|||++.. ..++.++||||||+++|||++ |..||... ... ......
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~----~~~-~~~~~~ 221 (268)
T cd05086 147 PSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHL----SDR-EVLNHV 221 (268)
T ss_pred cccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC----CHH-HHHHHH
Confidence 64332222122223457889999998753 245789999999999999997 56676421 111 111111
Q ss_pred hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 041757 254 LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQ 322 (381)
Q Consensus 254 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~ 322 (381)
.......+.++.+ .......+.+++..|| .+|++||++.+|++.|.
T Consensus 222 ~~~~~~~~~~~~~----------------------~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 222 IKDQQVKLFKPQL----------------------ELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred HhhcccccCCCcc----------------------CCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 1110000111000 1123456777888999 68999999999998773
No 173
>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi
Probab=100.00 E-value=3.4e-38 Score=285.02 Aligned_cols=233 Identities=23% Similarity=0.338 Sum_probs=181.8
Q ss_pred ceecCCCceEEEecc---------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEE
Q 041757 42 NLISAGTFGFSHLRR---------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVY 100 (381)
Q Consensus 42 ~~lG~G~fg~V~~~~---------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~ 100 (381)
++||+|+||.||++. ....+.+.+|+.+++.+.|+||+++++++. .+..++||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~~~~~~v~ 74 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK------GEPLMLVM 74 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc------CCceEEEE
Confidence 479999999997652 013457889999999999999999999853 34579999
Q ss_pred EcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccc
Q 041757 101 EFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180 (381)
Q Consensus 101 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 180 (381)
||+++|+|.+++. ....+++..++.++.|++.||.||| ..+++|+||||+||+++.++.+||+|||+
T Consensus 75 e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~ 141 (257)
T cd05060 75 ELAPLGPLLKYLK----------KRREIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGM 141 (257)
T ss_pred EeCCCCcHHHHHH----------hCCCCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccc
Confidence 9999999999994 3347899999999999999999999 66999999999999999999999999999
Q ss_pred ceecCCCCCcc-cccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchH
Q 041757 181 ARFLPPTRTQT-SSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHV 258 (381)
Q Consensus 181 ~~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 258 (381)
++......... ......++..|+|||.+.+..++.++||||||+++|++++ |..||..... ......
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~-----~~~~~~------ 210 (257)
T cd05060 142 SRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG-----AEVIAM------ 210 (257)
T ss_pred cceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH-----HHHHHH------
Confidence 98664433211 1111224568999999988889999999999999999998 9999753211 111110
Q ss_pred HHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 041757 259 KDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIK 325 (381)
Q Consensus 259 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~ 325 (381)
+... .. ...+..++..+.+++.+||..+|.+||++.++++.|+++.
T Consensus 211 ---~~~~---~~---------------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 211 ---LESG---ER---------------LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred ---HHcC---Cc---------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 0000 00 0001245568899999999999999999999999998764
No 174
>PHA03209 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=2.2e-38 Score=299.96 Aligned_cols=182 Identities=22% Similarity=0.337 Sum_probs=153.5
Q ss_pred ccccccccceecCCCceEEEecccc-----------cHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEc
Q 041757 34 VSRNMLEENLISAGTFGFSHLRRQG-----------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEF 102 (381)
Q Consensus 34 ~~~~~~~~~~lG~G~fg~V~~~~~~-----------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~ 102 (381)
...+|.+.+.||+|+||.||++... .......|+.++++++||||+++++++. .....++||||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~ 138 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTLV-----SGAITCMVLPH 138 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccccHHHHHHHHhCCCCCCcChhheEE-----eCCeeEEEEEc
Confidence 4567999999999999999887632 2334567999999999999999999954 46778999999
Q ss_pred ccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccce
Q 041757 103 MHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR 182 (381)
Q Consensus 103 ~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~ 182 (381)
+. ++|.+++. .....+++..++.++.|++.||.||| ..+|+||||||+|||++.++.+||+|||+++
T Consensus 139 ~~-~~l~~~l~---------~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~ 205 (357)
T PHA03209 139 YS-SDLYTYLT---------KRSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQ 205 (357)
T ss_pred cC-CcHHHHHH---------hccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCcccc
Confidence 95 68988884 33456899999999999999999999 6699999999999999999999999999987
Q ss_pred ecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCC
Q 041757 183 FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPS 236 (381)
Q Consensus 183 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf 236 (381)
........ ....||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 206 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 206 FPVVAPAF---LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ccccCccc---ccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 54332221 1245899999999999989999999999999999999865553
No 175
>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati
Probab=100.00 E-value=2e-38 Score=286.16 Aligned_cols=234 Identities=17% Similarity=0.255 Sum_probs=184.7
Q ss_pred cccccceecCCCceEEEecc------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEE
Q 041757 37 NMLEENLISAGTFGFSHLRR------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKAL 98 (381)
Q Consensus 37 ~~~~~~~lG~G~fg~V~~~~------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~l 98 (381)
+|...++||.|+||.||++. ....+.+.+|+.+++.++|+||+++++.+ ......++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 75 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF-----EADGHLYI 75 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EECCEEEE
Confidence 47788999999999997653 12346788899999999999999999984 45788999
Q ss_pred EEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeec
Q 041757 99 VYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDF 178 (381)
Q Consensus 99 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df 178 (381)
||||+++|+|.+++.. .....+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+||
T Consensus 76 v~e~~~~~~l~~~~~~--------~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~df 144 (255)
T cd08219 76 VMEYCDGGDLMQKIKL--------QRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDF 144 (255)
T ss_pred EEeeCCCCcHHHHHHh--------ccCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEccc
Confidence 9999999999998853 23445789999999999999999999 679999999999999999999999999
Q ss_pred ccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchH
Q 041757 179 GLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHV 258 (381)
Q Consensus 179 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 258 (381)
|.+.......... ....|++.|+|||++.+..++.++||||||+++|+|++|..||... .......
T Consensus 145 g~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~-----~~~~~~~------- 210 (255)
T cd08219 145 GSARLLTSPGAYA--CTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN-----SWKNLIL------- 210 (255)
T ss_pred Ccceeeccccccc--ccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCC-----CHHHHHH-------
Confidence 9998665433221 1245889999999998888999999999999999999999998521 1111111
Q ss_pred HHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041757 259 KDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE 320 (381)
Q Consensus 259 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~ 320 (381)
........ ..+...+..+.+++.+||+.||++|||+.+++..
T Consensus 211 -----~~~~~~~~---------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 211 -----KVCQGSYK---------------PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -----HHhcCCCC---------------CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 00000000 0012344568899999999999999999999864
No 176
>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul
Probab=100.00 E-value=2.9e-38 Score=287.14 Aligned_cols=240 Identities=24% Similarity=0.375 Sum_probs=187.2
Q ss_pred ccccccceecCCCceEEEeccc---------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ---------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND 94 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~---------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~ 94 (381)
.+|.+.+.||+|+||.||++.. ...+.+.+|+.++++++||||+++++++ ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 78 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----TKSK 78 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCC
Confidence 5788899999999999976431 1245788999999999999999999995 3467
Q ss_pred eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757 95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR 174 (381)
Q Consensus 95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k 174 (381)
..++||||+++++|.+++.. ....+++.+++.++.|++.||.||| +.+++||||||+||+++.++.++
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~---------~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~ 146 (267)
T cd05066 79 PVMIVTEYMENGSLDAFLRK---------HDGQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCK 146 (267)
T ss_pred ccEEEEEcCCCCCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEE
Confidence 88999999999999999952 2346788999999999999999999 67999999999999999999999
Q ss_pred EeecccceecCCCCCccc-ccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHH
Q 041757 175 VGDFGLARFLPPTRTQTS-SIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKM 252 (381)
Q Consensus 175 l~Dfg~~~~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~ 252 (381)
|+|||++........... .....++..|+|||++.+..++.++||||||+++||+++ |..||...... .
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~-----~---- 217 (267)
T cd05066 147 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ-----D---- 217 (267)
T ss_pred eCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH-----H----
Confidence 999999987654322111 111223568999999998889999999999999999886 99997522110 0
Q ss_pred HhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 041757 253 ALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSI 324 (381)
Q Consensus 253 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i 324 (381)
.......... .+.+..++..+.+++.+||+.+|.+||++.++++.|+++
T Consensus 218 --------~~~~~~~~~~---------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 218 --------VIKAIEEGYR---------------LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred --------HHHHHhCCCc---------------CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 1111000000 000123456788999999999999999999999999875
No 177
>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=100.00 E-value=2.9e-38 Score=296.63 Aligned_cols=253 Identities=21% Similarity=0.339 Sum_probs=192.3
Q ss_pred ccccccceecCCCceEEEeccc-------------------------ccHHHHHHHHHHHHcc-CCCcccceeeeecccc
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ-------------------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVD 89 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~-------------------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~ 89 (381)
.+|.+++.||+|+||.||++.. ...+.+.+|+++++++ +||||++++++|.
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~--- 88 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT--- 88 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc---
Confidence 4688899999999999987631 1245788999999999 7999999999964
Q ss_pred ccCCceEEEEEEcccCCCHHHhhccccCCcc------cccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCC
Q 041757 90 YQGNDFKALVYEFMHNRSLKEWLYPISKEDE------TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPS 163 (381)
Q Consensus 90 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~ 163 (381)
.....+++|||+++|+|.+++........ .......+++..++.++.|++.||.||| ..+++||||||+
T Consensus 89 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~ 163 (334)
T cd05100 89 --QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAAR 163 (334)
T ss_pred --cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccc
Confidence 36678999999999999999964221000 0012345788899999999999999999 669999999999
Q ss_pred CeeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccC
Q 041757 164 NVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEG 242 (381)
Q Consensus 164 Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~ 242 (381)
||+++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||...
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~--- 240 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI--- 240 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC---
Confidence 99999999999999999987654332222222335678999999999899999999999999999998 88887421
Q ss_pred CCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 041757 243 DMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQ 322 (381)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~ 322 (381)
........... .... ..+..++..+.+++.+||+.+|.+|||+.++++.|+
T Consensus 241 --~~~~~~~~~~~--------~~~~-------------------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~ 291 (334)
T cd05100 241 --PVEELFKLLKE--------GHRM-------------------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLD 291 (334)
T ss_pred --CHHHHHHHHHc--------CCCC-------------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence 11111111100 0000 001234567889999999999999999999999999
Q ss_pred Hhhhhc
Q 041757 323 SIKNTL 328 (381)
Q Consensus 323 ~i~~~~ 328 (381)
++...-
T Consensus 292 ~~~~~~ 297 (334)
T cd05100 292 RVLTVT 297 (334)
T ss_pred HHhhhc
Confidence 987543
No 178
>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha. Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a
Probab=100.00 E-value=1.6e-38 Score=296.99 Aligned_cols=226 Identities=20% Similarity=0.243 Sum_probs=176.0
Q ss_pred cccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccC-CCcccceeeeeccccccCCce
Q 041757 37 NMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIR-HRNLIKVLTACLGVDYQGNDF 95 (381)
Q Consensus 37 ~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~~~~ 95 (381)
+|...++||+|+||.||++.. ...+.+..|..++..+. |++|+++++++ ...+.
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCF-----QTVDR 75 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEE-----ecCCE
Confidence 467778999999999987641 12345778999998886 57788888874 45778
Q ss_pred EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757 96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV 175 (381)
Q Consensus 96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl 175 (381)
.++||||+++|+|.+++. ....+++..++.++.|++.||.||| +.+|+||||||+||+++.++.+||
T Consensus 76 ~~lv~Ey~~~g~L~~~i~----------~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL 142 (323)
T cd05615 76 LYFVMEYVNGGDLMYHIQ----------QVGKFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKI 142 (323)
T ss_pred EEEEEcCCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEE
Confidence 999999999999999983 4567899999999999999999999 679999999999999999999999
Q ss_pred eecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhh
Q 041757 176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALS 255 (381)
Q Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 255 (381)
+|||+++........ .....||+.|+|||++.+..++.++|||||||++|||++|..||..... ..
T Consensus 143 ~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-----~~------- 208 (323)
T cd05615 143 ADFGMCKEHMVDGVT--TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-----DE------- 208 (323)
T ss_pred eccccccccCCCCcc--ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH-----HH-------
Confidence 999998754332221 1124589999999999988899999999999999999999999853211 11
Q ss_pred chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHH
Q 041757 256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMT 315 (381)
Q Consensus 256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 315 (381)
++...+..... .+...+.++.+++.+||+.||.+|++..
T Consensus 209 -----~~~~i~~~~~~----------------~p~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 209 -----LFQSIMEHNVS----------------YPKSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred -----HHHHHHhCCCC----------------CCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 11111111100 0123445778899999999999999853
No 179
>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt
Probab=100.00 E-value=2.2e-38 Score=289.17 Aligned_cols=205 Identities=22% Similarity=0.287 Sum_probs=158.7
Q ss_pred HHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHH
Q 041757 61 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDV 140 (381)
Q Consensus 61 ~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi 140 (381)
..|.+|+.+++.++||||++++++|.. ....++||||+++|+|..++. .....+++..+..++.|+
T Consensus 61 ~~~~~~~~~~~~l~h~niv~~~~~~~~-----~~~~~lv~ey~~~g~L~~~l~---------~~~~~~~~~~~~~i~~qi 126 (274)
T cd05076 61 LAFFETASLMSQVSHIHLAFVHGVCVR-----GSENIMVEEFVEHGPLDVCLR---------KEKGRVPVAWKITVAQQL 126 (274)
T ss_pred HHHHHHHHHHhcCCCCCeeeEEEEEEe-----CCceEEEEecCCCCcHHHHHH---------hcCCCCCHHHHHHHHHHH
Confidence 467889999999999999999999653 667899999999999999984 234568899999999999
Q ss_pred HHHHHHhhcCCCCCceeeccCCCCeeeCCCC-------CeEEeecccceecCCCCCcccccCccCccceeCCCCcCC-Cc
Q 041757 141 ASALNYLHHDCQPVTAHCVLKPSNVLLDDDM-------TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NE 212 (381)
Q Consensus 141 ~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~-------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~ 212 (381)
+.||+||| +.+|+||||||+||+++..+ .+|++|||++........ ..++..|+|||.+.+ ..
T Consensus 127 ~~~l~~lH---~~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~~~------~~~~~~~~aPe~~~~~~~ 197 (274)
T cd05076 127 ASALSYLE---DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREE------RVERIPWIAPECVPGGNS 197 (274)
T ss_pred HHHHHHHH---cCCccCCCCCcccEEEeccCcccCccceeeecCCccccccccccc------cccCCcccCchhhcCCCC
Confidence 99999999 67999999999999997543 479999998764322211 247888999998875 56
Q ss_pred cCcccchhhhhHHHHHHH-hCCCCCCccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHH
Q 041757 213 VSTIGDVYSYGILLLELM-IREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRE 291 (381)
Q Consensus 213 ~~~~sDiwSlG~il~el~-tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (381)
++.++||||||+++||++ +|..||....... .......... . +..
T Consensus 198 ~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--------------~~~~~~~~~~-~-------------------~~~ 243 (274)
T cd05076 198 LSTAADKWSFGTTLLEICFDGEVPLKERTPSE--------------KERFYEKKHR-L-------------------PEP 243 (274)
T ss_pred CCcHHHHHHHHHHHHHHHhCCCCCccccChHH--------------HHHHHHhccC-C-------------------CCC
Confidence 899999999999999985 6899975321110 0011111000 0 011
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 041757 292 CVISMVRIGVACSMESPQDRMKMTNVVHELQ 322 (381)
Q Consensus 292 ~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~ 322 (381)
....+.+++.+||+.+|++|||+.+|++.|+
T Consensus 244 ~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 244 SCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 2246888999999999999999999998873
No 180
>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l
Probab=100.00 E-value=2.5e-38 Score=288.10 Aligned_cols=241 Identities=23% Similarity=0.330 Sum_probs=180.5
Q ss_pred ceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHcc-CCCcccceeeeeccccccCCceEEEEE
Q 041757 42 NLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVY 100 (381)
Q Consensus 42 ~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~~~~~lv~ 100 (381)
++||+|+||.||++.. ...+.+.+|++++.++ +||||+++++++. ..+..++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-----~~~~~~lv~ 75 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HRGYLYLAI 75 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEe-----cCCCceEEE
Confidence 4699999999977531 1235678899999999 7999999999954 466789999
Q ss_pred EcccCCCHHHhhccccCCcc------cccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757 101 EFMHNRSLKEWLYPISKEDE------TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR 174 (381)
Q Consensus 101 e~~~~g~L~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k 174 (381)
||+++|+|.+++........ .......+++..++.++.|++.||+||| +.+++||||||+||+++.++.+|
T Consensus 76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~k 152 (270)
T cd05047 76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAK 152 (270)
T ss_pred EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEE
Confidence 99999999999964321100 0012235789999999999999999999 66999999999999999999999
Q ss_pred EeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHH
Q 041757 175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMA 253 (381)
Q Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~ 253 (381)
|+|||++........ ......+..|+|||++....++.++||||||+++|||++ |..||.... ...
T Consensus 153 l~dfgl~~~~~~~~~---~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~-----~~~----- 219 (270)
T cd05047 153 IADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-----CAE----- 219 (270)
T ss_pred ECCCCCccccchhhh---ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC-----HHH-----
Confidence 999999853221111 111224567999999988889999999999999999997 999975221 111
Q ss_pred hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 041757 254 LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIK 325 (381)
Q Consensus 254 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~ 325 (381)
.......... ...+..++.++.+++.+||+.||.+|||+.+++..|+++.
T Consensus 220 -------~~~~~~~~~~---------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 220 -------LYEKLPQGYR---------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred -------HHHHHhCCCC---------------CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 1111000000 0001234457889999999999999999999999998874
No 181
>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase. Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions
Probab=100.00 E-value=5.2e-38 Score=285.91 Aligned_cols=241 Identities=21% Similarity=0.326 Sum_probs=188.7
Q ss_pred ccccccceecCCCceEEEeccc---------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ---------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND 94 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~---------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~ 94 (381)
++|...++||+|+||.||++.. ...+.+.+|+.++++++||||+++++++. ..
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~------~~ 79 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVIT------EN 79 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEc------CC
Confidence 4578889999999999987531 13457889999999999999999999853 34
Q ss_pred eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757 95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR 174 (381)
Q Consensus 95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k 174 (381)
..++||||+++|+|.+++.. ....+++..++.++.|++.||.||| +.+++||||||+||+++.++.+|
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~ 147 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQV---------NKYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVK 147 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHh---------CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeE
Confidence 56899999999999999952 2345899999999999999999999 66999999999999999999999
Q ss_pred EeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHH
Q 041757 175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMA 253 (381)
Q Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~ 253 (381)
|+|||+++........... ...++..|+|||.+....++.++||||||+++||+++ |..||...... .....
T Consensus 148 l~d~g~~~~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~----~~~~~-- 220 (270)
T cd05056 148 LGDFGLSRYLEDESYYKAS-KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN----DVIGR-- 220 (270)
T ss_pred EccCceeeecccccceecC-CCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH----HHHHH--
Confidence 9999999876554322111 1234568999999988889999999999999999986 99997532111 11100
Q ss_pred hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 041757 254 LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT 327 (381)
Q Consensus 254 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~ 327 (381)
...... ...+..++..+.+++.+||..+|.+|||+.+++..|+++..+
T Consensus 221 -----------~~~~~~---------------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 221 -----------IENGER---------------LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred -----------HHcCCc---------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 000000 001224566889999999999999999999999999988654
No 182
>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored
Probab=100.00 E-value=3.7e-38 Score=286.50 Aligned_cols=241 Identities=22% Similarity=0.365 Sum_probs=188.0
Q ss_pred cccccccceecCCCceEEEeccc---------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757 35 SRNMLEENLISAGTFGFSHLRRQ---------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN 93 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~~---------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 93 (381)
.++|...+.||+|+||.||++.. ...+.+.+|++++++++|+||+++++++ ...
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~ 78 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVV-----TKF 78 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----ccC
Confidence 35788889999999999986531 1245688899999999999999999995 446
Q ss_pred ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757 94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA 173 (381)
Q Consensus 94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~ 173 (381)
+..++||||+++++|.+++. .....+++..+..++.|++.||.||| +.+++||||||+||+++.++.+
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~---------~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~ 146 (268)
T cd05063 79 KPAMIITEYMENGALDKYLR---------DHDGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLEC 146 (268)
T ss_pred CCcEEEEEcCCCCCHHHHHH---------hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcE
Confidence 77899999999999999985 23456889999999999999999999 6699999999999999999999
Q ss_pred EEeecccceecCCCCCcccc-cCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHH
Q 041757 174 RVGDFGLARFLPPTRTQTSS-IDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAK 251 (381)
Q Consensus 174 kl~Dfg~~~~~~~~~~~~~~-~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~ 251 (381)
||+|||++............ .....+..|+|||++.+..++.++|||||||++||+++ |..||..... .....
T Consensus 147 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-----~~~~~ 221 (268)
T cd05063 147 KVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-----HEVMK 221 (268)
T ss_pred EECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-----HHHHH
Confidence 99999999866543222111 11223567999999988889999999999999999997 9999752211 11111
Q ss_pred HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 041757 252 MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSI 324 (381)
Q Consensus 252 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i 324 (381)
. +.... ..+ ....++.++.+++.+||..+|++||++.+|++.|+++
T Consensus 222 ~---------i~~~~-~~~-----------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 222 A---------INDGF-RLP-----------------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred H---------HhcCC-CCC-----------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 00000 000 0123556789999999999999999999999999876
No 183
>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase. Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M
Probab=100.00 E-value=2.8e-38 Score=290.47 Aligned_cols=249 Identities=25% Similarity=0.353 Sum_probs=189.0
Q ss_pred cccccccceecCCCceEEEeccc-----------------------ccHHHHHHHHHHHHccCCCcccceeeeecccccc
Q 041757 35 SRNMLEENLISAGTFGFSHLRRQ-----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQ 91 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~~-----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 91 (381)
.++|...+.||+|+||.||++.. ...+.+.+|+.++++++||||+++++++.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~----- 78 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCA----- 78 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEc-----
Confidence 46789999999999999987541 12456888999999999999999999854
Q ss_pred CCceEEEEEEcccCCCHHHhhccccCCccc------------ccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeec
Q 041757 92 GNDFKALVYEFMHNRSLKEWLYPISKEDET------------YKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCV 159 (381)
Q Consensus 92 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~------------~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrD 159 (381)
.....++||||+++|+|.+++......... ......+++..++.++.|++.||.||| ..+++|||
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~d 155 (288)
T cd05050 79 VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRD 155 (288)
T ss_pred CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeeccc
Confidence 466789999999999999999643211100 011235788999999999999999999 66999999
Q ss_pred cCCCCeeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCc
Q 041757 160 LKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDI 238 (381)
Q Consensus 160 lkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~ 238 (381)
|||+||+++.++.++|+|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||..
T Consensus 156 l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~ 235 (288)
T cd05050 156 LATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG 235 (288)
T ss_pred ccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999876544332221212235678999999988889999999999999999997 8888642
Q ss_pred cccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 041757 239 MFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVV 318 (381)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl 318 (381)
... ..... .+.+..... .+..++.++.+++.+||+.||.+|||+.|++
T Consensus 236 ~~~-----~~~~~--------~~~~~~~~~-------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~ 283 (288)
T cd05050 236 MAH-----EEVIY--------YVRDGNVLS-------------------CPDNCPLELYNLMRLCWSKLPSDRPSFASIN 283 (288)
T ss_pred CCH-----HHHHH--------HHhcCCCCC-------------------CCCCCCHHHHHHHHHHcccCcccCCCHHHHH
Confidence 211 11111 000000000 0123456889999999999999999999999
Q ss_pred HHHHH
Q 041757 319 HELQS 323 (381)
Q Consensus 319 ~~L~~ 323 (381)
+.|++
T Consensus 284 ~~l~~ 288 (288)
T cd05050 284 RILQR 288 (288)
T ss_pred HHhhC
Confidence 98863
No 184
>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta. Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways
Probab=100.00 E-value=1.6e-38 Score=297.54 Aligned_cols=227 Identities=24% Similarity=0.286 Sum_probs=174.5
Q ss_pred ceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHcc-CCCcccceeeeeccccccCCceEEEEE
Q 041757 42 NLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVY 100 (381)
Q Consensus 42 ~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~~~~~lv~ 100 (381)
++||+|+||.||++.. ...+.+.+|+.++.++ +||||+++++++ ...+..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCF-----QTTSRLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEE-----EeCCEEEEEE
Confidence 4799999999987641 1234577899999988 599999999984 4577899999
Q ss_pred EcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccc
Q 041757 101 EFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180 (381)
Q Consensus 101 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 180 (381)
||+++|+|..++. ....+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 76 e~~~~~~L~~~~~----------~~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~ 142 (327)
T cd05617 76 EYVNGGDLMFHMQ----------RQRKLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGM 142 (327)
T ss_pred eCCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEecccc
Confidence 9999999999883 4457899999999999999999999 67999999999999999999999999999
Q ss_pred ceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCC-CcHHHHHHHHhhchHH
Q 041757 181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD-MNLHKFAKMALSNHVK 259 (381)
Q Consensus 181 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~ 259 (381)
++......... ....||+.|+|||++.+..++.++|||||||++|||++|..||....... ........
T Consensus 143 ~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~-------- 212 (327)
T cd05617 143 CKEGLGPGDTT--STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLF-------- 212 (327)
T ss_pred ceeccCCCCce--ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHH--------
Confidence 87533222111 12568999999999999999999999999999999999999986332211 11111100
Q ss_pred HHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHH
Q 041757 260 DIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMT 315 (381)
Q Consensus 260 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 315 (381)
........ ..+...+..+.+++.+||+.||.+||++.
T Consensus 213 ---~~~~~~~~----------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 213 ---QVILEKPI----------------RIPRFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred ---HHHHhCCC----------------CCCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 00000000 01123445678899999999999999853
No 185
>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2. Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found
Probab=100.00 E-value=1.1e-38 Score=303.18 Aligned_cols=184 Identities=22% Similarity=0.285 Sum_probs=156.3
Q ss_pred ccccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757 34 VSRNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN 93 (381)
Q Consensus 34 ~~~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 93 (381)
..++|...++||+|+||.||++.. .....+.+|+.+++.++||||+++++++ .+.
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~~~ 115 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAF-----QDD 115 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcC
Confidence 357899999999999999987642 1234577899999999999999999984 557
Q ss_pred ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757 94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA 173 (381)
Q Consensus 94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~ 173 (381)
...++|||||++|+|.+++. ...+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~-----------~~~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~ 181 (370)
T cd05621 116 KYLYMVMEYMPGGDLVNLMS-----------NYDVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHL 181 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHH-----------hcCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCE
Confidence 88999999999999999984 234788899999999999999999 6799999999999999999999
Q ss_pred EEeecccceecCCCCCcccccCccCccceeCCCCcCCCc----cCcccchhhhhHHHHHHHhCCCCCC
Q 041757 174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNE----VSTIGDVYSYGILLLELMIREKPSD 237 (381)
Q Consensus 174 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~----~~~~sDiwSlG~il~el~tg~~Pf~ 237 (381)
||+|||++........... ....||+.|+|||++.+.. ++.++|||||||++|||++|..||.
T Consensus 182 kL~DFG~a~~~~~~~~~~~-~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~ 248 (370)
T cd05621 182 KLADFGTCMKMDETGMVRC-DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFY 248 (370)
T ss_pred EEEecccceecccCCceec-ccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCC
Confidence 9999999987654332111 2356999999999987543 7889999999999999999999985
No 186
>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea
Probab=100.00 E-value=4.6e-38 Score=287.71 Aligned_cols=243 Identities=21% Similarity=0.343 Sum_probs=190.1
Q ss_pred cccccccceecCCCceEEEeccc----------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccC
Q 041757 35 SRNMLEENLISAGTFGFSHLRRQ----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQG 92 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~~----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 92 (381)
..+|...+.||+|+||.||++.. .....+.+|+.++++++||||++++++|..
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 80 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS----- 80 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-----
Confidence 46788889999999999987531 123578899999999999999999999642
Q ss_pred CceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCC
Q 041757 93 NDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT 172 (381)
Q Consensus 93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~ 172 (381)
...++||||+++|+|.+++. .....+++..++.++.|++.||+||| +.+++||||||+||+++.++.
T Consensus 81 -~~~~~v~e~~~~g~L~~~l~---------~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~ 147 (279)
T cd05057 81 -SQVQLITQLMPLGCLLDYVR---------NHKDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQH 147 (279)
T ss_pred -CceEEEEecCCCCcHHHHHH---------hccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCe
Confidence 57899999999999999985 23445899999999999999999999 669999999999999999999
Q ss_pred eEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHH
Q 041757 173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAK 251 (381)
Q Consensus 173 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~ 251 (381)
+||+|||.++...............++..|+|||.+....++.++||||||+++||+++ |+.||.... ...+..
T Consensus 148 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-----~~~~~~ 222 (279)
T cd05057 148 VKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP-----AVEIPD 222 (279)
T ss_pred EEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHH
Confidence 99999999987654332221111224678999999988889999999999999999998 999975221 111111
Q ss_pred HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 041757 252 MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT 327 (381)
Q Consensus 252 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~ 327 (381)
.+.. .... ..+..+...+.+++.+||..||.+||++.++++.|+++.+.
T Consensus 223 ---------~~~~---~~~~---------------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 223 ---------LLEK---GERL---------------PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred ---------HHhC---CCCC---------------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 1110 0000 00112445688899999999999999999999999998654
No 187
>PHA03207 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=1.6e-38 Score=304.66 Aligned_cols=185 Identities=22% Similarity=0.260 Sum_probs=158.1
Q ss_pred cccccccceecCCCceEEEecccc--------------cHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEE
Q 041757 35 SRNMLEENLISAGTFGFSHLRRQG--------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVY 100 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~~~--------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~ 100 (381)
..+|...+.||+|+||.||++... ....+.+|+++|++++||||+++++++ ......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAY-----RWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccccHHHHHHHHHhcCCCCccceeeeE-----eeCCEEEEEe
Confidence 456999999999999999876311 123457899999999999999999984 4577899999
Q ss_pred EcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccc
Q 041757 101 EFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180 (381)
Q Consensus 101 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 180 (381)
|++. ++|.+++ .....+++..++.++.|++.||.||| ..+|+||||||+|||++.++.++|+|||+
T Consensus 166 e~~~-~~l~~~l----------~~~~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~ 231 (392)
T PHA03207 166 PKYK-CDLFTYV----------DRSGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGA 231 (392)
T ss_pred hhcC-CCHHHHH----------HhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCcc
Confidence 9995 6899888 34567899999999999999999999 66999999999999999999999999999
Q ss_pred ceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCc
Q 041757 181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDI 238 (381)
Q Consensus 181 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~ 238 (381)
+................||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 232 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~ 289 (392)
T PHA03207 232 ACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFG 289 (392)
T ss_pred ccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 9876554333333345699999999999999999999999999999999999999853
No 188
>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk
Probab=100.00 E-value=5e-38 Score=283.71 Aligned_cols=237 Identities=27% Similarity=0.393 Sum_probs=188.4
Q ss_pred cccccccceecCCCceEEEeccc--------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEE
Q 041757 35 SRNMLEENLISAGTFGFSHLRRQ--------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVY 100 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~~--------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~ 100 (381)
.++|...+.||.|+||.||.+.. ...+++.+|+.+++.++|+||+++++++. .....++||
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~v~ 79 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVL-----QGNPLYIVT 79 (256)
T ss_pred hhhccceeeeecCCCceEEEEEecCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEc-----CCCCeEEEE
Confidence 46788899999999999987542 13568899999999999999999999954 477889999
Q ss_pred EcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccc
Q 041757 101 EFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180 (381)
Q Consensus 101 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 180 (381)
||+++++|.+++.. .....+++..+..++.|++.||.||| ..+++|+||||+||+++.++.+||+|||.
T Consensus 80 e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~ 148 (256)
T cd05039 80 EYMAKGSLVDYLRS--------RGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGL 148 (256)
T ss_pred EecCCCcHHHHHHh--------cCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEccccc
Confidence 99999999999953 12236899999999999999999999 66999999999999999999999999999
Q ss_pred ceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchHH
Q 041757 181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHVK 259 (381)
Q Consensus 181 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 259 (381)
++....... ....+..|+|||++....++.++||||||+++|++++ |..||.... ......
T Consensus 149 ~~~~~~~~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-----~~~~~~-------- 210 (256)
T cd05039 149 AKEASQGQD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-----LKDVVP-------- 210 (256)
T ss_pred ccccccccc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH--------
Confidence 987643222 1235678999999988889999999999999999997 999975221 111100
Q ss_pred HHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 041757 260 DIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSI 324 (381)
Q Consensus 260 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i 324 (381)
.+..... . ..+...+..+.+++.+||..+|++|||+.++++.|+++
T Consensus 211 -~~~~~~~--~----------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 211 -HVEKGYR--M----------------EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred -HHhcCCC--C----------------CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 0000000 0 00123456889999999999999999999999999764
No 189
>PHA03211 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=2.9e-38 Score=306.07 Aligned_cols=185 Identities=22% Similarity=0.329 Sum_probs=157.0
Q ss_pred ccccccccceecCCCceEEEecccc-----------cHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEc
Q 041757 34 VSRNMLEENLISAGTFGFSHLRRQG-----------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEF 102 (381)
Q Consensus 34 ~~~~~~~~~~lG~G~fg~V~~~~~~-----------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~ 102 (381)
...+|.+.+.||+|+||.||++... ....+.+|+++|++++|+|||++++++. ..+..++|||+
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~~~~~~E~~iL~~L~HpnIv~l~~~~~-----~~~~~~lv~e~ 241 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYASSVHEARLLRRLSHPAVLALLDVRV-----VGGLTCLVLPK 241 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccccCHHHHHHHHHHCCCCCCCcEEEEEE-----ECCEEEEEEEc
Confidence 3557999999999999999887632 2345778999999999999999999854 36788999999
Q ss_pred ccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccce
Q 041757 103 MHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR 182 (381)
Q Consensus 103 ~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~ 182 (381)
+. ++|.+++. .....+++..++.++.|++.||.||| ..+|+||||||+|||++.++.+||+|||+++
T Consensus 242 ~~-~~L~~~l~---------~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~ 308 (461)
T PHA03211 242 YR-SDLYTYLG---------ARLRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAAC 308 (461)
T ss_pred cC-CCHHHHHH---------hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCce
Confidence 95 68988884 23346899999999999999999999 6699999999999999999999999999998
Q ss_pred ecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCC
Q 041757 183 FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPS 236 (381)
Q Consensus 183 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf 236 (381)
...............||+.|+|||++.+..++.++|||||||++|||++|..|+
T Consensus 309 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 309 FARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred ecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 765433222222356999999999999999999999999999999999988764
No 190
>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok
Probab=100.00 E-value=3.3e-38 Score=298.77 Aligned_cols=185 Identities=23% Similarity=0.242 Sum_probs=154.5
Q ss_pred ccccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeecccc-ccCC
Q 041757 34 VSRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVD-YQGN 93 (381)
Q Consensus 34 ~~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~-~~~~ 93 (381)
..++|...+.||+|+||.||.+.. ...+.+.+|+.+++.++||||+++++++.... ....
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 468899999999999999977531 13456788999999999999999999865321 1233
Q ss_pred ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757 94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA 173 (381)
Q Consensus 94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~ 173 (381)
...++||||+.+ +|.+.+. ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~------------~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~ 158 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ------------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTL 158 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh------------hcCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCE
Confidence 567999999965 6777662 24788889999999999999999 6799999999999999999999
Q ss_pred EEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCC
Q 041757 174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSD 237 (381)
Q Consensus 174 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~ 237 (381)
||+|||+++......... ...||..|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus 159 kl~Dfg~~~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 219 (355)
T cd07874 159 KILDFGLARTAGTSFMMT---PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP 219 (355)
T ss_pred EEeeCcccccCCCccccC---CccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 999999998654432221 2458999999999999899999999999999999999999985
No 191
>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase. Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down
Probab=100.00 E-value=5.5e-38 Score=291.44 Aligned_cols=181 Identities=23% Similarity=0.297 Sum_probs=155.7
Q ss_pred ccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA 97 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~ 97 (381)
++|...+.||+|+||.||++.. .....+.+|++++++++||||+++++++. ..+..+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 75 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFY-----SDGEIS 75 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----eCCEEE
Confidence 4688999999999999977541 12356889999999999999999999954 477899
Q ss_pred EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757 98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD 177 (381)
Q Consensus 98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D 177 (381)
+||||+++++|.+++. ....+++..+..++.|++.||.|||+. .+++||||||+||+++.++.+||+|
T Consensus 76 lv~ey~~~~~L~~~l~----------~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~d 143 (308)
T cd06615 76 ICMEHMDGGSLDQVLK----------KAGRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCD 143 (308)
T ss_pred EEeeccCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEcc
Confidence 9999999999999994 345688999999999999999999941 4899999999999999999999999
Q ss_pred cccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCC
Q 041757 178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSD 237 (381)
Q Consensus 178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~ 237 (381)
||++........ ....++..|+|||++.+..++.++||||||+++|+|++|+.||.
T Consensus 144 fg~~~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~ 199 (308)
T cd06615 144 FGVSGQLIDSMA----NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIP 199 (308)
T ss_pred CCCccccccccc----ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCC
Confidence 999876543222 12458899999999988889999999999999999999999975
No 192
>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1. Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom
Probab=100.00 E-value=3.7e-38 Score=285.80 Aligned_cols=223 Identities=18% Similarity=0.278 Sum_probs=171.6
Q ss_pred ceecCCCceEEEeccc-----------------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccC
Q 041757 42 NLISAGTFGFSHLRRQ-----------------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQG 92 (381)
Q Consensus 42 ~~lG~G~fg~V~~~~~-----------------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 92 (381)
+.||+|+||.||++.. .....|.+|+.++..++||||+++++++. .
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~-----~ 75 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCV-----R 75 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEe-----c
Confidence 4689999999987641 12346778999999999999999999964 3
Q ss_pred CceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCC
Q 041757 93 NDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT 172 (381)
Q Consensus 93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~ 172 (381)
....++||||+++|+|..++. .....+++..++.++.||+.||+||| +.+|+||||||+||+++.++.
T Consensus 76 ~~~~~lv~e~~~~~~l~~~~~---------~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~ 143 (262)
T cd05077 76 DVENIMVEEFVEFGPLDLFMH---------RKSDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGI 143 (262)
T ss_pred CCCCEEEEecccCCCHHHHHH---------hcCCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCc
Confidence 567799999999999999884 23456899999999999999999999 779999999999999986654
Q ss_pred -------eEEeecccceecCCCCCcccccCccCccceeCCCCcC-CCccCcccchhhhhHHHHHHH-hCCCCCCccccCC
Q 041757 173 -------ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGV-GNEVSTIGDVYSYGILLLELM-IREKPSDIMFEGD 243 (381)
Q Consensus 173 -------~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~sDiwSlG~il~el~-tg~~Pf~~~~~~~ 243 (381)
++++|||++....... ...++..|+|||.+. +..++.++|||||||++|||+ +|..||....
T Consensus 144 ~~~~~~~~~l~d~g~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~--- 214 (262)
T cd05077 144 DGECGPFIKLSDPGIPITVLSRQ------ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT--- 214 (262)
T ss_pred cCCCCceeEeCCCCCCccccCcc------cccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc---
Confidence 8999999986543221 134788999999886 466899999999999999998 5888864221
Q ss_pred CcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 041757 244 MNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHEL 321 (381)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L 321 (381)
.... ..+....... ......++.+++.+||+.||.+||++.+|++.+
T Consensus 215 --~~~~---------~~~~~~~~~~--------------------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 215 --LAEK---------ERFYEGQCML--------------------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred --hhHH---------HHHHhcCccC--------------------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 0000 0000000000 011235678999999999999999999999876
No 193
>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes. Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an
Probab=100.00 E-value=8.3e-38 Score=283.06 Aligned_cols=238 Identities=22% Similarity=0.368 Sum_probs=185.8
Q ss_pred ccccccceecCCCceEEEeccc---------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEE
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ---------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVY 100 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~---------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~ 100 (381)
++|...+.||+|+||.||++.. ...+.+.+|++++++++|+|++++++++. ....++||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~~v~ 79 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS------EEPIYIVT 79 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc------CCCcEEEE
Confidence 5688889999999999987641 12357889999999999999999998842 34578999
Q ss_pred EcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccc
Q 041757 101 EFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180 (381)
Q Consensus 101 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 180 (381)
||+++++|.+++.. .....+++..+..++.|++.||.||| +.+++|+||||+||++++++.++|+|||+
T Consensus 80 e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~ 148 (260)
T cd05069 80 EFMGKGSLLDFLKE--------GDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGL 148 (260)
T ss_pred EcCCCCCHHHHHhh--------CCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCcc
Confidence 99999999999953 12345788999999999999999999 66999999999999999999999999999
Q ss_pred ceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchHH
Q 041757 181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHVK 259 (381)
Q Consensus 181 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 259 (381)
+.......... .....++..|+|||+..+..++.++||||||+++||+++ |..||..... ...
T Consensus 149 ~~~~~~~~~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~----------- 212 (260)
T cd05069 149 ARLIEDNEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN----REV----------- 212 (260)
T ss_pred ceEccCCcccc-cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH----HHH-----------
Confidence 98764432211 112336778999999988889999999999999999999 8999753211 000
Q ss_pred HHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 041757 260 DIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQS 323 (381)
Q Consensus 260 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~ 323 (381)
......... ...+...+..+.+++.+||+.||.+||++.+|++.|++
T Consensus 213 --~~~~~~~~~---------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 213 --LEQVERGYR---------------MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred --HHHHHcCCC---------------CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 000000000 00012445678999999999999999999999999875
No 194
>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase. Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ
Probab=100.00 E-value=1.6e-38 Score=289.40 Aligned_cols=244 Identities=20% Similarity=0.215 Sum_probs=186.0
Q ss_pred hhccccccccceecCCCceEEEeccc----------------ccHHHHHHHHHHHHcc-CCCcccceeeeecccccc-CC
Q 041757 32 LDVSRNMLEENLISAGTFGFSHLRRQ----------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQ-GN 93 (381)
Q Consensus 32 ~~~~~~~~~~~~lG~G~fg~V~~~~~----------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~-~~ 93 (381)
.++++.|...+.||+|+||.||++.. .....+.+|+.++.++ +|+||+++++++...... ..
T Consensus 2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 2 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred CChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 35678899999999999999987642 2346788999999999 699999999997642211 23
Q ss_pred ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757 94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA 173 (381)
Q Consensus 94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~ 173 (381)
...++||||+++++|.+++.. .....+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~--------~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~ 150 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKN--------TKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEV 150 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHh--------ccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCE
Confidence 568999999999999999853 12346889999999999999999999 6699999999999999999999
Q ss_pred EEeecccceecCCCCCcccccCccCccceeCCCCcC-----CCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHH
Q 041757 174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGV-----GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHK 248 (381)
Q Consensus 174 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~ 248 (381)
+|+|||++......... .....|+..|+|||++. +..++.++|||||||++|||++|..||.... ....
T Consensus 151 ~l~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~----~~~~ 224 (272)
T cd06637 151 KLVDFGVSAQLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH----PMRA 224 (272)
T ss_pred EEccCCCceeccccccc--CCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccC----HHHH
Confidence 99999999865432211 12245899999999886 3457889999999999999999999975221 1111
Q ss_pred HHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 249 FAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 249 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
.... .. .+... .....++..+.+++.+||..||.+|||+.++++
T Consensus 225 ~~~~---------~~-----~~~~~-------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 225 LFLI---------PR-----NPAPR-------------LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred HHHH---------hc-----CCCCC-------------CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 0000 00 00000 001134457889999999999999999999875
No 195
>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan
Probab=100.00 E-value=7.6e-38 Score=282.61 Aligned_cols=240 Identities=23% Similarity=0.365 Sum_probs=186.1
Q ss_pred ceecCCCceEEEecccc---------------------cHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEE
Q 041757 42 NLISAGTFGFSHLRRQG---------------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVY 100 (381)
Q Consensus 42 ~~lG~G~fg~V~~~~~~---------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~ 100 (381)
++||+|+||.||.+... ..+.+.+|++.+..++|+||+++++++. .....++||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~lv~ 75 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCT-----EEEPLYLVL 75 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeec-----CCCceEEEE
Confidence 46999999999776432 1578889999999999999999999954 477899999
Q ss_pred EcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccc
Q 041757 101 EFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180 (381)
Q Consensus 101 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 180 (381)
||+++++|.+++....... .......+++..++.++.|++.||.||| +.+++||||||+||+++.++.+||+|||.
T Consensus 76 e~~~~~~L~~~l~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~ 151 (262)
T cd00192 76 EYMEGGDLLDYLRKSRPVF-PSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGL 151 (262)
T ss_pred EeccCCcHHHHHhhccccc-cccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccc
Confidence 9999999999995321000 0001367899999999999999999999 67999999999999999999999999999
Q ss_pred ceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchHH
Q 041757 181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHVK 259 (381)
Q Consensus 181 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 259 (381)
+................++..|+|||.+....++.++||||||+++|+|++ |..||.... ....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-----~~~~---------- 216 (262)
T cd00192 152 SRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS-----NEEV---------- 216 (262)
T ss_pred ccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC-----HHHH----------
Confidence 987765432222223457889999999988889999999999999999999 699976331 1111
Q ss_pred HHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 041757 260 DIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQ 322 (381)
Q Consensus 260 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~ 322 (381)
........ ....+..++.++.+++.+||..||.+|||+.++++.|+
T Consensus 217 --~~~~~~~~---------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 217 --LEYLRKGY---------------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred --HHHHHcCC---------------CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11111000 00012344678999999999999999999999998763
No 196
>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as
Probab=100.00 E-value=5e-38 Score=288.52 Aligned_cols=234 Identities=22% Similarity=0.293 Sum_probs=181.3
Q ss_pred ccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757 38 MLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA 97 (381)
Q Consensus 38 ~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~ 97 (381)
|+..++||+|+||.||++.. .....+.+|+.++++++|+||+.+++.+ ...+..+
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~ 76 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAY-----ETKDALC 76 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEE-----ecCCEEE
Confidence 67778999999999976431 1124567899999999999999999985 4467899
Q ss_pred EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757 98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD 177 (381)
Q Consensus 98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D 177 (381)
+||||+++++|.+++.. .....+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|
T Consensus 77 lv~e~~~g~~L~~~l~~--------~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~D 145 (285)
T cd05630 77 LVLTLMNGGDLKFHIYH--------MGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISD 145 (285)
T ss_pred EEEEecCCCcHHHHHHH--------hcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEee
Confidence 99999999999998842 22345889999999999999999999 67999999999999999999999999
Q ss_pred cccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhch
Q 041757 178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH 257 (381)
Q Consensus 178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~ 257 (381)
||++.......... ...|+..|+|||++.+..++.++||||||+++|+|++|..||....... ....
T Consensus 146 fg~~~~~~~~~~~~---~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~-~~~~--------- 212 (285)
T cd05630 146 LGLAVHVPEGQTIK---GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-KREE--------- 212 (285)
T ss_pred ccceeecCCCcccc---CCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc-hHHH---------
Confidence 99987654332211 2358999999999998899999999999999999999999986322110 0000
Q ss_pred HHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 041757 258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMK-----MTNVVH 319 (381)
Q Consensus 258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~~vl~ 319 (381)
...+...... ..+......+.+++.+||+.||++||| +.++++
T Consensus 213 ~~~~~~~~~~-------------------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 213 VERLVKEVQE-------------------EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred HHhhhhhhhh-------------------hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 0011110000 001234556889999999999999999 778876
No 197
>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn
Probab=100.00 E-value=4e-38 Score=299.15 Aligned_cols=185 Identities=22% Similarity=0.228 Sum_probs=154.5
Q ss_pred ccccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeecccc-ccCC
Q 041757 34 VSRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVD-YQGN 93 (381)
Q Consensus 34 ~~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~-~~~~ 93 (381)
..++|...+.||+|+||.||.+.. ...+.+.+|+.+++.++||||+++++++.... ....
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 468899999999999999976531 23456788999999999999999999865311 1234
Q ss_pred ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757 94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA 173 (381)
Q Consensus 94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~ 173 (381)
...++||||+++ +|.+++. ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~------------~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~ 165 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ------------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTL 165 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH------------hcCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcE
Confidence 567999999965 7877772 23778889999999999999999 6699999999999999999999
Q ss_pred EEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCC
Q 041757 174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSD 237 (381)
Q Consensus 174 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~ 237 (381)
||+|||+++........ ....+|..|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus 166 kL~DfG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~ 226 (364)
T cd07875 166 KILDFGLARTAGTSFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFP 226 (364)
T ss_pred EEEeCCCccccCCCCcc---cCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCC
Confidence 99999999865443221 12458999999999999999999999999999999999999985
No 198
>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=4e-39 Score=305.09 Aligned_cols=229 Identities=21% Similarity=0.288 Sum_probs=183.9
Q ss_pred ceecCCCceEEEeccc-----------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEccc
Q 041757 42 NLISAGTFGFSHLRRQ-----------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMH 104 (381)
Q Consensus 42 ~~lG~G~fg~V~~~~~-----------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~~~ 104 (381)
-+||+|+||+||-++. ...+-+..|+.+.++|+|.|||+++|.| ..+++.-|.||-.+
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~-----senGf~kIFMEqVP 655 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSV-----SENGFFKIFMEQVP 655 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhcc-----CCCCeEEEEeecCC
Confidence 5899999999988762 2455678899999999999999999994 45778999999999
Q ss_pred CCCHHHhhccccCCcccccCCCcc--cHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeC-CCCCeEEeecccc
Q 041757 105 NRSLKEWLYPISKEDETYKRPRNL--NLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLD-DDMTARVGDFGLA 181 (381)
Q Consensus 105 ~g~L~~~l~~~~~~~~~~~~~~~l--~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~-~~~~~kl~Dfg~~ 181 (381)
||+|.++|. .+-+++ ++..+--+..||++||.||| ...|||||||-+|+|++ -.|.+||+|||-+
T Consensus 656 GGSLSsLLr---------skWGPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTs 723 (1226)
T KOG4279|consen 656 GGSLSSLLR---------SKWGPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTS 723 (1226)
T ss_pred CCcHHHHHH---------hccCCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccc
Confidence 999999995 334455 78888889999999999999 56999999999999996 5789999999999
Q ss_pred eecCCCCCcccccCccCccceeCCCCcCCC--ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHH
Q 041757 182 RFLPPTRTQTSSIDVKGSIGYIAPEYGVGN--EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVK 259 (381)
Q Consensus 182 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 259 (381)
+.+..-...+. .+.||..|||||++..+ .|+.++|||||||++.||.||++||.... .....+.+.
T Consensus 724 KRLAginP~TE--TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elg---spqAAMFkV------- 791 (1226)
T KOG4279|consen 724 KRLAGINPCTE--TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELG---SPQAAMFKV------- 791 (1226)
T ss_pred hhhccCCcccc--ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecC---ChhHhhhhh-------
Confidence 87755433322 36699999999998864 58999999999999999999999985322 111111111
Q ss_pred HHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 260 DIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 260 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
.+....| ++|.+...+...++++|+.+||.+||++.++++
T Consensus 792 ----GmyKvHP----------------~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 792 ----GMYKVHP----------------PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred ----cceecCC----------------CCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 1111111 235677888999999999999999999999986
No 199
>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1. Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an
Probab=100.00 E-value=2.5e-38 Score=300.84 Aligned_cols=184 Identities=21% Similarity=0.267 Sum_probs=156.2
Q ss_pred ccccccccceecCCCceEEEecccc--------------------cHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757 34 VSRNMLEENLISAGTFGFSHLRRQG--------------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN 93 (381)
Q Consensus 34 ~~~~~~~~~~lG~G~fg~V~~~~~~--------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 93 (381)
..++|...+.||+|+||.||++... ..+.+.+|+.+++.++||||+++++++ .+.
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~~~ 115 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-----QDD 115 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EcC
Confidence 3588999999999999999876421 234467899999999999999999984 457
Q ss_pred ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757 94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA 173 (381)
Q Consensus 94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~ 173 (381)
...++|||||++|+|.+++. ...+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~-----------~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~i 181 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMS-----------NYDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHL 181 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHH-----------hcCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCE
Confidence 88999999999999999984 234788889999999999999999 6799999999999999999999
Q ss_pred EEeecccceecCCCCCcccccCccCccceeCCCCcCCC----ccCcccchhhhhHHHHHHHhCCCCCC
Q 041757 174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGN----EVSTIGDVYSYGILLLELMIREKPSD 237 (381)
Q Consensus 174 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~~~~sDiwSlG~il~el~tg~~Pf~ 237 (381)
||+|||+++.......... ....||+.|+|||++.+. .++.++|||||||++|||++|..||.
T Consensus 182 kL~DfG~a~~~~~~~~~~~-~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~ 248 (371)
T cd05622 182 KLADFGTCMKMNKEGMVRC-DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 248 (371)
T ss_pred EEEeCCceeEcCcCCcccc-cCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCC
Confidence 9999999987654332211 225699999999998754 37899999999999999999999985
No 200
>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin. Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear
Probab=100.00 E-value=5.9e-38 Score=287.85 Aligned_cols=250 Identities=21% Similarity=0.209 Sum_probs=189.4
Q ss_pred hhhhccccccccceecCCCceEEEeccc----------------ccHHHHHHHHHHHHcc-CCCcccceeeeeccccccC
Q 041757 30 EILDVSRNMLEENLISAGTFGFSHLRRQ----------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQG 92 (381)
Q Consensus 30 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~----------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~ 92 (381)
.+.+..++|...+.||+|+||.||++.. .....+.+|+.+++.+ +||||+++++++.......
T Consensus 12 ~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 91 (286)
T cd06638 12 SFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN 91 (286)
T ss_pred cCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence 3445789999999999999999987531 1235678899999999 6999999999876533455
Q ss_pred CceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCC
Q 041757 93 NDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT 172 (381)
Q Consensus 93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~ 172 (381)
....++||||+++++|.+++.... .....+++..+..++.|++.||.||| +.+++||||||+||+++.++.
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~ 162 (286)
T cd06638 92 GDQLWLVLELCNGGSVTDLVKGFL------KRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGG 162 (286)
T ss_pred CCeEEEEEeecCCCCHHHHHHHhh------ccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCC
Confidence 678999999999999999874221 23456888999999999999999999 669999999999999999999
Q ss_pred eEEeecccceecCCCCCcccccCccCccceeCCCCcCC-----CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHH
Q 041757 173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-----NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLH 247 (381)
Q Consensus 173 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~ 247 (381)
+||+|||+++......... ....|++.|+|||++.. ..++.++|||||||++|||++|+.||.... ...
T Consensus 163 ~kl~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~----~~~ 236 (286)
T cd06638 163 VKLVDFGVSAQLTSTRLRR--NTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLH----PMR 236 (286)
T ss_pred EEEccCCceeecccCCCcc--ccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCc----hhH
Confidence 9999999998765432221 12458999999998753 447889999999999999999999975221 111
Q ss_pred HHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041757 248 KFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE 320 (381)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~ 320 (381)
.... .... ..+. ...+..+...+.+++.+||+.||++|||+.+|++.
T Consensus 237 ~~~~---------~~~~---~~~~--------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 237 ALFK---------IPRN---PPPT--------------LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred HHhh---------cccc---CCCc--------------ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 1100 0000 0000 00011234568899999999999999999999874
No 201
>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=2.7e-38 Score=293.29 Aligned_cols=237 Identities=20% Similarity=0.255 Sum_probs=182.0
Q ss_pred cccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccC-CCcccceeeeeccccccCCce
Q 041757 35 SRNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIR-HRNLIKVLTACLGVDYQGNDF 95 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~~~~ 95 (381)
.+.|++.++||+||.+.||++.. .....|.+|+..|.+|+ |.+||++|+|- -.+++
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYE-----v~d~~ 434 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYE-----VTDGY 434 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeee-----ccCce
Confidence 45699999999999999988753 34567899999999996 99999999994 45889
Q ss_pred EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757 96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV 175 (381)
Q Consensus 96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl 175 (381)
+|+||||= ..||..+|.. ....++.-.+..+..|++.++.++| ..||||.||||.|+|+-. |.+||
T Consensus 435 lYmvmE~G-d~DL~kiL~k---------~~~~~~~~~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlVk-G~LKL 500 (677)
T KOG0596|consen 435 LYMVMECG-DIDLNKILKK---------KKSIDPDWFLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLVK-GRLKL 500 (677)
T ss_pred EEEEeecc-cccHHHHHHh---------ccCCCchHHHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEEe-eeEEe
Confidence 99999965 5699999963 2333443478889999999999999 669999999999999864 68999
Q ss_pred eecccceecCCCCCcccccCccCccceeCCCCcCCCc-----------cCcccchhhhhHHHHHHHhCCCCCCccccCCC
Q 041757 176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNE-----------VSTIGDVYSYGILLLELMIREKPSDIMFEGDM 244 (381)
Q Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-----------~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~ 244 (381)
+|||.|..+..+.........+||+.||+||.+.... .+.+|||||+|||||+|+.|+.||....
T Consensus 501 IDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~---- 576 (677)
T KOG0596|consen 501 IDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII---- 576 (677)
T ss_pred eeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH----
Confidence 9999999888776655555678999999999876432 5688999999999999999999975110
Q ss_pred cHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 245 NLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
+. +. .+..+.+ |...+.... . ....+++++|..||..||.+|||..++++
T Consensus 577 n~--~a------Kl~aI~~------P~~~Iefp~---------~--~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 577 NQ--IA------KLHAITD------PNHEIEFPD---------I--PENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred HH--HH------HHHhhcC------CCccccccC---------C--CCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 00 00 0111111 110000000 0 11123899999999999999999999986
No 202
>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated
Probab=100.00 E-value=1.3e-38 Score=289.23 Aligned_cols=239 Identities=18% Similarity=0.236 Sum_probs=183.1
Q ss_pred ccccccccceecCCCceEEEeccc-----------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757 34 VSRNMLEENLISAGTFGFSHLRRQ-----------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK 96 (381)
Q Consensus 34 ~~~~~~~~~~lG~G~fg~V~~~~~-----------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~ 96 (381)
..++|...+.||+|+||.||++.. .....+.+|+.++++++||||+++++++. .....
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~-----~~~~~ 81 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL-----SREKL 81 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEE-----eCCEE
Confidence 356799999999999999987641 13446778999999999999999999954 46788
Q ss_pred EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757 97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG 176 (381)
Q Consensus 97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~ 176 (381)
++||||+++++|.+++. ....+++..+..++.|++.||.||| ..+|+||||||+||+++.++.++|+
T Consensus 82 ~iv~e~~~~~~L~~~~~----------~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~ 148 (267)
T cd06646 82 WICMEYCGGGSLQDIYH----------VTGPLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLA 148 (267)
T ss_pred EEEEeCCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEC
Confidence 99999999999999984 3456889999999999999999999 6699999999999999999999999
Q ss_pred ecccceecCCCCCcccccCccCccceeCCCCcC---CCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH
Q 041757 177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGV---GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA 253 (381)
Q Consensus 177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~ 253 (381)
|||++.......... ....++..|+|||.+. ...++.++|||||||++|||++|+.||....... ....
T Consensus 149 dfg~~~~~~~~~~~~--~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~----~~~~-- 220 (267)
T cd06646 149 DFGVAAKITATIAKR--KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR----ALFL-- 220 (267)
T ss_pred cCccceeeccccccc--CccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhh----hhee--
Confidence 999998664332111 1245889999999874 3457889999999999999999999974221100 0000
Q ss_pred hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041757 254 LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE 320 (381)
Q Consensus 254 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~ 320 (381)
+...... +.. .......+..+.+++.+||..+|++|||+.++++.
T Consensus 221 -------~~~~~~~--~~~-------------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 221 -------MSKSNFQ--PPK-------------LKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred -------eecCCCC--CCC-------------CccccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 0000000 000 00011334678899999999999999999999864
No 203
>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=5.8e-38 Score=282.47 Aligned_cols=237 Identities=22% Similarity=0.286 Sum_probs=189.6
Q ss_pred ccccccceecCCCceEEEecc--------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757 36 RNMLEENLISAGTFGFSHLRR--------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF 95 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~--------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~ 95 (381)
+.|+..+.||.|.-|+||+++ .....+...|.+||+.++||.++.+|+. ++..++
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~-----fet~~~ 151 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYAS-----FETDKY 151 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhe-----eeccce
Confidence 457788999999999999876 2345667779999999999999999999 677999
Q ss_pred EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757 96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV 175 (381)
Q Consensus 96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl 175 (381)
.++|||||+||+|..+++. .....+++..++-++.+++-||+||| -.|||.|||||+||||.++|++-|
T Consensus 152 ~cl~meyCpGGdL~~Lrqk--------Qp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIML 220 (459)
T KOG0610|consen 152 SCLVMEYCPGGDLHSLRQK--------QPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIML 220 (459)
T ss_pred eEEEEecCCCccHHHHHhh--------CCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEe
Confidence 9999999999999999865 45678999999999999999999999 889999999999999999999999
Q ss_pred eecccceecCCC--------------------------------C-C---------------------cccccCccCccc
Q 041757 176 GDFGLARFLPPT--------------------------------R-T---------------------QTSSIDVKGSIG 201 (381)
Q Consensus 176 ~Dfg~~~~~~~~--------------------------------~-~---------------------~~~~~~~~gt~~ 201 (381)
+||.++...... . . .....+++||-.
T Consensus 221 sDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThE 300 (459)
T KOG0610|consen 221 SDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHE 300 (459)
T ss_pred eeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccc
Confidence 999987543210 0 0 011124779999
Q ss_pred eeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchh
Q 041757 202 YIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQ 281 (381)
Q Consensus 202 y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 281 (381)
|.|||++.+...+.++|+|+|||++|||+.|..||. +..+-.- +.+++.+-+....
T Consensus 301 YlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFK----G~~~~~T---------l~NIv~~~l~Fp~----------- 356 (459)
T KOG0610|consen 301 YLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFK----GSNNKET---------LRNIVGQPLKFPE----------- 356 (459)
T ss_pred cccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcC----CCCchhh---------HHHHhcCCCcCCC-----------
Confidence 999999999999999999999999999999999975 3332222 2222222111110
Q ss_pred hhhHHHHHHHHHHHHHHHHHhccCCCCCCCCC----HHHHHH
Q 041757 282 TQAKINIIRECVISMVRIGVACSMESPQDRMK----MTNVVH 319 (381)
Q Consensus 282 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs----~~~vl~ 319 (381)
.++....+.+||.+.|.+||.+|.- +.||-+
T Consensus 357 -------~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 357 -------EPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred -------CCcchhHHHHHHHHHhccChhhhhccccchHHhhc
Confidence 1245567889999999999999988 666653
No 204
>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]
Probab=100.00 E-value=3e-40 Score=285.82 Aligned_cols=233 Identities=19% Similarity=0.259 Sum_probs=193.4
Q ss_pred ccccceecCCCceEEEecc---------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEc
Q 041757 38 MLEENLISAGTFGFSHLRR---------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEF 102 (381)
Q Consensus 38 ~~~~~~lG~G~fg~V~~~~---------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~ 102 (381)
|.+..+||+|+||.|+++- ....++.++|+.+|++.+.|+||++||.++ .+..+|+||||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYF-----K~sDLWIVMEY 109 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYF-----KHSDLWIVMEY 109 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhc-----cCCceEeehhh
Confidence 7778999999999996643 456789999999999999999999999964 36778999999
Q ss_pred ccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccce
Q 041757 103 MHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR 182 (381)
Q Consensus 103 ~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~ 182 (381)
|..|++.+.++ -+...+++.++..++...+.||+||| ...-+|||||..|||++.+|.+||+|||.+.
T Consensus 110 CGAGSiSDI~R---------~R~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAG 177 (502)
T KOG0574|consen 110 CGAGSISDIMR---------ARRKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAG 177 (502)
T ss_pred cCCCcHHHHHH---------HhcCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccc
Confidence 99999999996 46778999999999999999999999 6688999999999999999999999999998
Q ss_pred ecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHHHH
Q 041757 183 FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIV 262 (381)
Q Consensus 183 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (381)
.+.+...... .+.||+.|||||++..-.|+.++||||||++..||..|++||....+....+
T Consensus 178 QLTDTMAKRN--TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF---------------- 239 (502)
T KOG0574|consen 178 QLTDTMAKRN--TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF---------------- 239 (502)
T ss_pred hhhhhHHhhC--ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE----------------
Confidence 8776544333 2679999999999999999999999999999999999999986432211000
Q ss_pred hhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 263 DSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 263 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
.....++.....+.....++.+++++||-.+|++|-|+.++++
T Consensus 240 --------------MIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 240 --------------MIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred --------------eccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 0000011111225567788999999999999999999998876
No 205
>PRK13184 pknD serine/threonine-protein kinase; Reviewed
Probab=100.00 E-value=4.4e-38 Score=318.71 Aligned_cols=254 Identities=20% Similarity=0.251 Sum_probs=189.8
Q ss_pred ccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF 95 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~ 95 (381)
++|...++||+|+||.||++.. ...++|.+|++++++++||||+++++++. +.+.
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~-----d~~~ 76 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICS-----DGDP 76 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe-----eCCE
Confidence 5788999999999999988641 12457899999999999999999999953 4678
Q ss_pred EEEEEEcccCCCHHHhhccccCCc-ccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757 96 KALVYEFMHNRSLKEWLYPISKED-ETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR 174 (381)
Q Consensus 96 ~~lv~e~~~~g~L~~~l~~~~~~~-~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k 174 (381)
.++||||++||+|.+++....... ........++...++.++.|++.||+||| +.+|+||||||+||+++.++.+|
T Consensus 77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vK 153 (932)
T PRK13184 77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVV 153 (932)
T ss_pred EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEE
Confidence 899999999999999985321110 00011234667788999999999999999 66999999999999999999999
Q ss_pred EeecccceecCCCCC----------------cccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCc
Q 041757 175 VGDFGLARFLPPTRT----------------QTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDI 238 (381)
Q Consensus 175 l~Dfg~~~~~~~~~~----------------~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~ 238 (381)
|+|||+++....... .......+||+.|+|||++.+..++.++|||||||++|||++|..||..
T Consensus 154 LiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~ 233 (932)
T PRK13184 154 ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR 233 (932)
T ss_pred EEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 999999987622110 0111124699999999999999999999999999999999999999853
Q ss_pred cccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCC-CHHHH
Q 041757 239 MFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRM-KMTNV 317 (381)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~~v 317 (381)
...... ........+.. .......+..+.+++.+||+.||++|| ++.++
T Consensus 234 ~~~~ki-----------------~~~~~i~~P~~-------------~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeL 283 (932)
T PRK13184 234 KKGRKI-----------------SYRDVILSPIE-------------VAPYREIPPFLSQIAMKALAVDPAERYSSVQEL 283 (932)
T ss_pred cchhhh-----------------hhhhhccChhh-------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 111000 00000000000 000124556788899999999999995 67778
Q ss_pred HHHHHHhhhh
Q 041757 318 VHELQSIKNT 327 (381)
Q Consensus 318 l~~L~~i~~~ 327 (381)
++.|+.....
T Consensus 284 l~~Le~~lq~ 293 (932)
T PRK13184 284 KQDLEPHLQG 293 (932)
T ss_pred HHHHHHHHhc
Confidence 8888877654
No 206
>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer. Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c
Probab=100.00 E-value=8.8e-38 Score=280.99 Aligned_cols=231 Identities=23% Similarity=0.319 Sum_probs=179.2
Q ss_pred ceecCCCceEEEeccc-----------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEccc
Q 041757 42 NLISAGTFGFSHLRRQ-----------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMH 104 (381)
Q Consensus 42 ~~lG~G~fg~V~~~~~-----------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~~~ 104 (381)
++||+|+||.||++.. .....+.+|+++++.++||||+++++++. .....++||||++
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~~ 75 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT-----QRQPIYIVMELVP 75 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEe-----cCCccEEEEECCC
Confidence 4699999999987541 12346889999999999999999999954 4667899999999
Q ss_pred CCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccceec
Q 041757 105 NRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFL 184 (381)
Q Consensus 105 ~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~ 184 (381)
+++|.+++.. ....+++..++.++.|++.||.||| ..+++||||||+||+++.++.+||+|||++...
T Consensus 76 ~~~L~~~~~~---------~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 143 (250)
T cd05085 76 GGDFLSFLRK---------KKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQE 143 (250)
T ss_pred CCcHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceec
Confidence 9999999842 2345789999999999999999999 669999999999999999999999999998765
Q ss_pred CCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchHHHHHh
Q 041757 185 PPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHVKDIVD 263 (381)
Q Consensus 185 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (381)
........ ....++..|+|||++.+..++.++||||||+++|++++ |..||..... ...... +.
T Consensus 144 ~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~-----~~~~~~---------~~ 208 (250)
T cd05085 144 DDGIYSSS-GLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN-----QQAREQ---------VE 208 (250)
T ss_pred cccccccC-CCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH-----HHHHHH---------HH
Confidence 43322111 11234677999999988889999999999999999998 9999752211 111000 00
Q ss_pred hhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 041757 264 SILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQ 322 (381)
Q Consensus 264 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~ 322 (381)
..... ..+..++..+.+++.+||+.+|++||++.++++.|.
T Consensus 209 ~~~~~------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 209 KGYRM------------------SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred cCCCC------------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 00000 001234568899999999999999999999999874
No 207
>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3. Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity
Probab=100.00 E-value=2.9e-38 Score=285.72 Aligned_cols=223 Identities=20% Similarity=0.293 Sum_probs=171.4
Q ss_pred ceecCCCceEEEeccc------------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757 42 NLISAGTFGFSHLRRQ------------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA 97 (381)
Q Consensus 42 ~~lG~G~fg~V~~~~~------------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~ 97 (381)
+.||.|+||.||++.. ...+.+.+|+.+++.++||||+++++++. .....+
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~-----~~~~~~ 75 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCV-----CGDESI 75 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEE-----eCCCcE
Confidence 4699999999988642 12346778999999999999999999964 356789
Q ss_pred EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCC-----
Q 041757 98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT----- 172 (381)
Q Consensus 98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~----- 172 (381)
+||||+++|+|.+++.. ....+++..++.++.|++.||+||| +.+|+||||||+||+++.++.
T Consensus 76 lv~e~~~~g~L~~~l~~---------~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~ 143 (258)
T cd05078 76 MVQEYVKFGSLDTYLKK---------NKNLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGN 143 (258)
T ss_pred EEEecCCCCcHHHHHhc---------CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCC
Confidence 99999999999999952 2346889999999999999999999 779999999999999987664
Q ss_pred ---eEEeecccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCC-CCCCccccCCCcHH
Q 041757 173 ---ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIRE-KPSDIMFEGDMNLH 247 (381)
Q Consensus 173 ---~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~-~Pf~~~~~~~~~~~ 247 (381)
++++|||++....... ...+++.|+|||++.+ ..++.++||||||+++||+++|. .||... ....
T Consensus 144 ~~~~~l~d~g~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~----~~~~ 213 (258)
T cd05078 144 PPFIKLSDPGISITVLPKE------ILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSAL----DSQK 213 (258)
T ss_pred CceEEecccccccccCCch------hccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhc----cHHH
Confidence 6999999886543221 1347889999999887 45789999999999999999985 554311 1000
Q ss_pred HHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 041757 248 KFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHEL 321 (381)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L 321 (381)
. ..+..... ..+.....++.+++.+||+.||++|||+.++++.|
T Consensus 214 ~----------~~~~~~~~--------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 214 K----------LQFYEDRH--------------------QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred H----------HHHHHccc--------------------cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 0 00000000 00112335688999999999999999999999886
No 208
>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=5.3e-39 Score=301.56 Aligned_cols=236 Identities=22% Similarity=0.268 Sum_probs=189.0
Q ss_pred cccccccceecCCCceEEEeccc-----------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757 35 SRNMLEENLISAGTFGFSHLRRQ-----------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA 97 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~~-----------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~ 97 (381)
.+-|.+...||.|+||.||++.. ...+.|+-|++||..+.||+||++++.|+ ..+.+|
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy-----~enkLw 105 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYY-----FENKLW 105 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHh-----ccCceE
Confidence 45577888999999999988753 34678889999999999999999999954 477899
Q ss_pred EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757 98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD 177 (381)
Q Consensus 98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D 177 (381)
|..|||.||-++..+. .-...+++.++..+++|++.||.||| +.+|||||||..|||++-+|.++|+|
T Consensus 106 iliEFC~GGAVDaiml---------EL~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLAD 173 (1187)
T KOG0579|consen 106 ILIEFCGGGAVDAIML---------ELGRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLAD 173 (1187)
T ss_pred EEEeecCCchHhHHHH---------HhccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeec
Confidence 9999999999999886 35678999999999999999999999 77999999999999999999999999
Q ss_pred cccceecCCCCCcccccCccCccceeCCCCc-----CCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHH
Q 041757 178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYG-----VGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM 252 (381)
Q Consensus 178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l-----~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~ 252 (381)
||.+........... .+.|||.|||||+. ...+|+.++||||||++|.||..+.+|.. .-..+..+.+.
T Consensus 174 FGVSAKn~~t~qkRD--sFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHh----elnpMRVllKi 247 (1187)
T KOG0579|consen 174 FGVSAKNKSTRQKRD--SFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHH----ELNPMRVLLKI 247 (1187)
T ss_pred ccccccchhHHhhhc--cccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcc----ccchHHHHHHH
Confidence 999865444332222 37799999999974 45789999999999999999999999943 11222222222
Q ss_pred HhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 253 ALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 253 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
..++. .- ...+......+.+++.+||..||..||++.++++
T Consensus 248 aKSeP-PT-------------------------LlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 248 AKSEP-PT-------------------------LLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred hhcCC-Cc-------------------------ccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 11111 00 0113356667889999999999999999999985
No 209
>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity. Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....
Probab=100.00 E-value=2.4e-38 Score=285.99 Aligned_cols=236 Identities=24% Similarity=0.343 Sum_probs=181.4
Q ss_pred ccccceecCCCceEEEecccc-------------------cHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEE
Q 041757 38 MLEENLISAGTFGFSHLRRQG-------------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKAL 98 (381)
Q Consensus 38 ~~~~~~lG~G~fg~V~~~~~~-------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~l 98 (381)
|+..+.||+|+||+||+++.. ......+|+.++++++||||+++++++. .....++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~~ 75 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQ-----DDNYLYI 75 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEE-----ESSEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccc-----ccccccc
Confidence 667899999999999886521 1223456999999999999999999954 4788899
Q ss_pred EEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeec
Q 041757 99 VYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDF 178 (381)
Q Consensus 99 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df 178 (381)
||||+.+++|.+++. ....+++..++.++.|++.||.+|| +.+++|+||||+||+++.++.++|+||
T Consensus 76 v~~~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Df 142 (260)
T PF00069_consen 76 VMEYCPGGSLQDYLQ----------KNKPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDF 142 (260)
T ss_dssp EEEEETTEBHHHHHH----------HHSSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSG
T ss_pred ccccccccccccccc----------ccccccccccccccccccccccccc---ccccccccccccccccccccccccccc
Confidence 999999999999993 4567899999999999999999999 669999999999999999999999999
Q ss_pred ccceecCCCCCcccccCccCccceeCCCCcC-CCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhch
Q 041757 179 GLARFLPPTRTQTSSIDVKGSIGYIAPEYGV-GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH 257 (381)
Q Consensus 179 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~ 257 (381)
|.+........ ......++..|+|||++. +..++.++||||+|+++|+|++|..||.... ..............
T Consensus 143 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~--~~~~~~~~~~~~~~- 217 (260)
T PF00069_consen 143 GSSVKLSENNE--NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESN--SDDQLEIIEKILKR- 217 (260)
T ss_dssp TTTEESTSTTS--EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSS--HHHHHHHHHHHHHT-
T ss_pred ccccccccccc--cccccccccccccccccccccccccccccccccccccccccccccccccc--chhhhhhhhhcccc-
Confidence 99986522211 222355899999999988 7889999999999999999999999986330 00000000000000
Q ss_pred HHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
....... ........+.+++.+||+.||++|||+.++++
T Consensus 218 --~~~~~~~---------------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 218 --PLPSSSQ---------------------QSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp --HHHHHTT---------------------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred --ccccccc---------------------ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000 00111368999999999999999999999975
No 210
>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6. Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as
Probab=100.00 E-value=1e-37 Score=290.68 Aligned_cols=191 Identities=21% Similarity=0.312 Sum_probs=150.7
Q ss_pred ccceecCCCceEEEecccc-----------------cHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEc
Q 041757 40 EENLISAGTFGFSHLRRQG-----------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEF 102 (381)
Q Consensus 40 ~~~~lG~G~fg~V~~~~~~-----------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~ 102 (381)
.+.+||+|+||.||++... ....+.+|++++++++||||+++++++.. ......++||||
T Consensus 5 ~g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~~lv~e~ 81 (317)
T cd07867 5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLS---HSDRKVWLLFDY 81 (317)
T ss_pred eceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEec---cCCCeEEEEEee
Confidence 4578999999999887521 23467899999999999999999998753 346678999999
Q ss_pred ccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeee----CCCCCeEEeec
Q 041757 103 MHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLL----DDDMTARVGDF 178 (381)
Q Consensus 103 ~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill----~~~~~~kl~Df 178 (381)
+.+ +|.+++........ ......+++..+..++.|++.||.||| +.+|+||||||+||++ +.++.+||+||
T Consensus 82 ~~~-~l~~~~~~~~~~~~-~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07867 82 AEH-DLWHIIKFHRASKA-NKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred eCC-cHHHHHHhhhcccc-CCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence 865 88887742211100 022345889999999999999999999 6799999999999999 55678999999
Q ss_pred ccceecCCCCCc-ccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCc
Q 041757 179 GLARFLPPTRTQ-TSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDI 238 (381)
Q Consensus 179 g~~~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~ 238 (381)
|+++........ .......+|+.|+|||++.+ ..++.++|||||||++|||+||+.||..
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred cceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 999876543221 11122458999999999876 4589999999999999999999999863
No 211
>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]
Probab=100.00 E-value=1e-37 Score=292.82 Aligned_cols=236 Identities=22% Similarity=0.277 Sum_probs=190.8
Q ss_pred hccccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccC-CCcccceeeeecccccc
Q 041757 33 DVSRNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIR-HRNLIKVLTACLGVDYQ 91 (381)
Q Consensus 33 ~~~~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~ 91 (381)
.....|..++.||+|.||.||.+.. .....+.+|+.+|+++. |||||.++++ ++
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~-----~e 106 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDA-----FE 106 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEE-----EE
Confidence 3567799999999999999977542 13468899999999998 9999999999 56
Q ss_pred CCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCC-
Q 041757 92 GNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDD- 170 (381)
Q Consensus 92 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~- 170 (381)
+....++|||+|.||.|.+.+.. . .+++..+..++.|++.++.||| ..||+||||||+|+|+...
T Consensus 107 ~~~~~~lvmEL~~GGeLfd~i~~----------~-~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~ 172 (382)
T KOG0032|consen 107 DPDSVYLVMELCEGGELFDRIVK----------K-HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKD 172 (382)
T ss_pred cCCeEEEEEEecCCchHHHHHHH----------c-cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeecccc
Confidence 68899999999999999999942 2 3999999999999999999999 6799999999999999543
Q ss_pred ---CCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHH
Q 041757 171 ---MTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLH 247 (381)
Q Consensus 171 ---~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~ 247 (381)
+.+|++|||++......... ...+||+.|+|||++....|+..+||||+||++|.|++|.+||.... ...
T Consensus 173 ~~~~~ik~~DFGla~~~~~~~~~---~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~----~~~ 245 (382)
T KOG0032|consen 173 EGSGRIKLIDFGLAKFIKPGERL---HTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGET----EFE 245 (382)
T ss_pred CCCCcEEEeeCCCceEccCCceE---eeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCC----hhH
Confidence 47999999999988762222 23679999999999999999999999999999999999999975322 211
Q ss_pred HHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 248 KFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
... .+........ ..........+.+++.+++..||.+|+|+.++++
T Consensus 246 ~~~---------~i~~~~~~f~----------------~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 246 IFL---------AILRGDFDFT----------------SEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred HHH---------HHHcCCCCCC----------------CCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 111 1111100000 0112355678888999999999999999999998
No 212
>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional
Probab=100.00 E-value=1.3e-37 Score=330.58 Aligned_cols=251 Identities=24% Similarity=0.428 Sum_probs=193.8
Q ss_pred ccccccceecCCCceEEEecccc-------------cHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEc
Q 041757 36 RNMLEENLISAGTFGFSHLRRQG-------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEF 102 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~~-------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~ 102 (381)
..|...++||+|+||.||++... ......+|++.+++++|||||+++++|.. ....++||||
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~~-----~~~~~lv~Ey 764 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRS-----EKGAYLIHEY 764 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEEc-----CCCCEEEEeC
Confidence 34566789999999999987521 11223467999999999999999999753 5678999999
Q ss_pred ccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccce
Q 041757 103 MHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR 182 (381)
Q Consensus 103 ~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~ 182 (381)
+++|+|.++++ .+++..+..++.|++.||+|||...+.+|+||||||+||+++.++..++. ||...
T Consensus 765 ~~~g~L~~~l~-------------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~ 830 (968)
T PLN00113 765 IEGKNLSEVLR-------------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPG 830 (968)
T ss_pred CCCCcHHHHHh-------------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccc
Confidence 99999999993 27888999999999999999997666799999999999999998888775 66554
Q ss_pred ecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhch-HHHH
Q 041757 183 FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH-VKDI 261 (381)
Q Consensus 183 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~-~~~~ 261 (381)
..... ....+|+.|+|||++.+..++.++|||||||++|||++|+.||+...........+........ ....
T Consensus 831 ~~~~~------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 904 (968)
T PLN00113 831 LLCTD------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMW 904 (968)
T ss_pred ccccC------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhhe
Confidence 32211 1135789999999999999999999999999999999999999755555555555554433221 2223
Q ss_pred HhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 041757 262 VDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT 327 (381)
Q Consensus 262 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~ 327 (381)
+++.+.... .....+..++.+++.+||+.||++||||.+|++.|+++.+.
T Consensus 905 ~~~~~~~~~----------------~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 905 IDPSIRGDV----------------SVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred eCccccCCC----------------CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 332221111 11235566889999999999999999999999999988664
No 213
>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=3e-38 Score=286.40 Aligned_cols=285 Identities=22% Similarity=0.298 Sum_probs=225.0
Q ss_pred CceEeEEccCCccccccccccccccchhhhhccccccccceecCCCceEEEecc------------cccHHHHHHHHHHH
Q 041757 3 SLLIALDVSGNKLTGSLHIEVGKLKNLEILDVSRNMLEENLISAGTFGFSHLRR------------QGAFKSFIAECKAL 70 (381)
Q Consensus 3 ~~~~~l~~~~n~~~g~~~~~~~~~~~l~~~~~~~~~~~~~~lG~G~fg~V~~~~------------~~~~~~~~~E~~~l 70 (381)
+|...|+.+....||+ .++.|....+.+.....+.||+|.||.||.++ ....+++.+|.++.
T Consensus 184 tl~Dll~~~~tSGSGS------GlplLVQRTiarqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srdE~SWfrEtEIY 257 (513)
T KOG2052|consen 184 TLKDLLDDLETSGSGS------GLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRDERSWFRETEIY 257 (513)
T ss_pred cHHHHHHhhccCCCCC------CchhHhHHhhhheeEEEEEecCccccceeeccccCCceEEEEecccchhhhhhHHHHH
Confidence 3444555566666666 78899999999999999999999999998765 34568899999999
Q ss_pred Hc--cCCCcccceeeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhh
Q 041757 71 RN--IRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLH 148 (381)
Q Consensus 71 ~~--l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH 148 (381)
+. |+|+||+.|++.-... -..-..+|||++|-+.|||.+||. ...++....++++..+|.||+|||
T Consensus 258 qTvmLRHENILgFIaaD~~~-~gs~TQLwLvTdYHe~GSL~DyL~-----------r~tv~~~~ml~LalS~AsGLaHLH 325 (513)
T KOG2052|consen 258 QTVMLRHENILGFIAADNKD-NGSWTQLWLVTDYHEHGSLYDYLN-----------RNTVTTEGMLKLALSIASGLAHLH 325 (513)
T ss_pred HHHHhccchhhhhhhccccC-CCceEEEEEeeecccCCcHHHHHh-----------hccCCHHHHHHHHHHHhhhHHHHH
Confidence 85 5899999999884321 133567899999999999999994 367899999999999999999999
Q ss_pred c-----CCCCCceeeccCCCCeeeCCCCCeEEeecccceecCCCCC--cccccCccCccceeCCCCcCCCc----c--Cc
Q 041757 149 H-----DCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRT--QTSSIDVKGSIGYIAPEYGVGNE----V--ST 215 (381)
Q Consensus 149 ~-----~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~----~--~~ 215 (381)
- ..++.|.|||||..|||+.+++.+.|+|+|+|........ .......+||-+|||||++.... + -.
T Consensus 326 ~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk 405 (513)
T KOG2052|consen 326 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYK 405 (513)
T ss_pred HHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhh
Confidence 3 3367899999999999999999999999999987665421 22223467999999999987532 2 13
Q ss_pred ccchhhhhHHHHHHHhC----------CCCCCccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhH
Q 041757 216 IGDVYSYGILLLELMIR----------EKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAK 285 (381)
Q Consensus 216 ~sDiwSlG~il~el~tg----------~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 285 (381)
.+||||||.|+||+..+ +.||....+.+.+++.+.+......++-.+.....
T Consensus 406 ~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~------------------ 467 (513)
T KOG2052|consen 406 RADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWK------------------ 467 (513)
T ss_pred HHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccc------------------
Confidence 57999999999999753 67898888888888877665443332222221111
Q ss_pred HHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 041757 286 INIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKN 326 (381)
Q Consensus 286 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~ 326 (381)
..++...+.++|..||..+|..|-|+--+-+.|.++.+
T Consensus 468 ---s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 468 ---SDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred ---cCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 23677889999999999999999999999999998875
No 214
>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase. Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa
Probab=100.00 E-value=2e-37 Score=280.60 Aligned_cols=239 Identities=22% Similarity=0.356 Sum_probs=186.6
Q ss_pred cccccccceecCCCceEEEeccc---------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEE
Q 041757 35 SRNMLEENLISAGTFGFSHLRRQ---------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALV 99 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~~---------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv 99 (381)
.++|...++||+|+||.||++.. ...+.+.+|+++++.++|+||+++++.+. . ...+++
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~-~~~~~v 78 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-----K-EPIYII 78 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEc-----C-CCeEEE
Confidence 46789999999999999987541 13467889999999999999999998843 3 567999
Q ss_pred EEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecc
Q 041757 100 YEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179 (381)
Q Consensus 100 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg 179 (381)
|||+++++|.+++.. .....+++..++.++.|++.||.||| ..+++||||||+||+++.++.+||+|||
T Consensus 79 ~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~ 147 (260)
T cd05073 79 TEFMAKGSLLDFLKS--------DEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFG 147 (260)
T ss_pred EEeCCCCcHHHHHHh--------CCccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCc
Confidence 999999999999953 12345788889999999999999999 6699999999999999999999999999
Q ss_pred cceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchH
Q 041757 180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHV 258 (381)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 258 (381)
.+.......... .....++..|+|||++....++.++||||||+++|++++ |..||.... . .....
T Consensus 148 ~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~----~-~~~~~------- 214 (260)
T cd05073 148 LARVIEDNEYTA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS----N-PEVIR------- 214 (260)
T ss_pred ceeeccCCCccc-ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC----H-HHHHH-------
Confidence 997664432211 111335678999999988889999999999999999999 899975221 1 01000
Q ss_pred HHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 041757 259 KDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQS 323 (381)
Q Consensus 259 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~ 323 (381)
.+..... . ..+...+.++.+++.+||+.+|++||++.++++.|+.
T Consensus 215 --~~~~~~~--~----------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 215 --ALERGYR--M----------------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred --HHhCCCC--C----------------CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0000000 0 0012345678899999999999999999999999875
No 215
>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=4.1e-38 Score=296.79 Aligned_cols=231 Identities=20% Similarity=0.350 Sum_probs=192.5
Q ss_pred cccceecCCCceEEEeccc---------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757 39 LEENLISAGTFGFSHLRRQ---------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA 97 (381)
Q Consensus 39 ~~~~~lG~G~fg~V~~~~~---------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~ 97 (381)
+...+||+|+|=+||++-. ...++|..|+.+|+.|+|||||++|..+.+ ..+....
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d---~~n~~in 119 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVD---TDNKTIN 119 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheec---CCCceee
Confidence 3467899999999998742 234789999999999999999999999775 3346788
Q ss_pred EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCC-CCCeEEe
Q 041757 98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD-DMTARVG 176 (381)
Q Consensus 98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~-~~~~kl~ 176 (381)
+|+|++..|+|..|+ ++.+.++...+..|++||++||.|||++ .++|||||||-+||+|++ .|.|||+
T Consensus 120 ~iTEL~TSGtLr~Y~----------kk~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIG 188 (632)
T KOG0584|consen 120 FITELFTSGTLREYR----------KKHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIG 188 (632)
T ss_pred eeeecccCCcHHHHH----------HHhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeec
Confidence 999999999999999 5677889999999999999999999998 889999999999999976 5799999
Q ss_pred ecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhc
Q 041757 177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSN 256 (381)
Q Consensus 177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~ 256 (381)
|+|+|.......... +.|||.|||||+.. ..|+..+||||||+.+.||+|+..|| ....+-..+.+...++
T Consensus 189 DLGLAtl~r~s~aks----vIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPY----sEC~n~AQIYKKV~SG 259 (632)
T KOG0584|consen 189 DLGLATLLRKSHAKS----VIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPY----SECTNPAQIYKKVTSG 259 (632)
T ss_pred chhHHHHhhccccce----eccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCCh----hhhCCHHHHHHHHHcC
Confidence 999998776544332 67999999999886 68999999999999999999999995 4556666666665555
Q ss_pred hHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 257 HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 257 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
...+-+.+. --+++.+++.+|+.. .++|||+.|+|.
T Consensus 260 iKP~sl~kV--------------------------~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 260 IKPAALSKV--------------------------KDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred CCHHHhhcc--------------------------CCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 433333321 123677888899999 999999999986
No 216
>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin. Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre
Probab=100.00 E-value=1.6e-37 Score=285.86 Aligned_cols=254 Identities=21% Similarity=0.187 Sum_probs=191.5
Q ss_pred cccchhhhhccccccccceecCCCceEEEeccc----------------ccHHHHHHHHHHHHcc-CCCcccceeeeecc
Q 041757 25 KLKNLEILDVSRNMLEENLISAGTFGFSHLRRQ----------------GAFKSFIAECKALRNI-RHRNLIKVLTACLG 87 (381)
Q Consensus 25 ~~~~l~~~~~~~~~~~~~~lG~G~fg~V~~~~~----------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~ 87 (381)
.+.-.++.+.+++|...+.||+|+||.||++.. .....+.+|+.++.++ +||||+++++++..
T Consensus 11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 344455666789999999999999999987542 1235677899999999 79999999999765
Q ss_pred ccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeee
Q 041757 88 VDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLL 167 (381)
Q Consensus 88 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill 167 (381)
.+.......++||||+++++|.+++.... .....+++..++.++.|++.||.||| ..+++||||||+||++
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~------~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili 161 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLL------ICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILL 161 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhh------hcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEE
Confidence 33334467899999999999999885321 23456889999999999999999999 6699999999999999
Q ss_pred CCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCC-----ccCcccchhhhhHHHHHHHhCCCCCCccccC
Q 041757 168 DDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGN-----EVSTIGDVYSYGILLLELMIREKPSDIMFEG 242 (381)
Q Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~ 242 (381)
+.++.+||+|||++........... ...|+..|+|||++... .++.++|||||||++|||++|+.||.....
T Consensus 162 ~~~~~~kl~dfg~~~~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~- 238 (291)
T cd06639 162 TTEGGVKLVDFGVSAQLTSTRLRRN--TSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP- 238 (291)
T ss_pred cCCCCEEEeecccchhccccccccc--CccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH-
Confidence 9999999999999876554322211 24588999999987643 368899999999999999999999753211
Q ss_pred CCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 243 DMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
....... .. ..... ...+......+.+++.+||+.+|++||++.++++
T Consensus 239 ---~~~~~~~---------~~----~~~~~-------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 239 ---VKTLFKI---------PR----NPPPT-------------LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred ---HHHHHHH---------hc----CCCCC-------------CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1111100 00 00000 0001233456889999999999999999999986
No 217
>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa
Probab=100.00 E-value=1.9e-37 Score=279.87 Aligned_cols=234 Identities=18% Similarity=0.307 Sum_probs=185.3
Q ss_pred cccccceecCCCceEEEecc-------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757 37 NMLEENLISAGTFGFSHLRR-------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA 97 (381)
Q Consensus 37 ~~~~~~~lG~G~fg~V~~~~-------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~ 97 (381)
+|+..++||.|+||.|+.++ ....+.+.+|++++++++|+||+++++++ ......+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHF-----MDDNTLL 75 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEE-----ecCCeEE
Confidence 57888999999999875543 12346788999999999999999999995 4477899
Q ss_pred EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757 98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD 177 (381)
Q Consensus 98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D 177 (381)
++|||+++++|.+++.. .....+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.+||+|
T Consensus 76 ~~~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d 144 (256)
T cd08221 76 IEMEYANGGTLYDKIVR--------QKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGD 144 (256)
T ss_pred EEEEecCCCcHHHHHHh--------ccccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECc
Confidence 99999999999999953 12456889999999999999999999 66999999999999999999999999
Q ss_pred cccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhch
Q 041757 178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH 257 (381)
Q Consensus 178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~ 257 (381)
||++......... .....+++.|+|||++.+..++.++||||||+++|+|++|..||... .. .
T Consensus 145 ~~~~~~~~~~~~~--~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~----~~-~---------- 207 (256)
T cd08221 145 FGISKILGSEYSM--AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT----NP-L---------- 207 (256)
T ss_pred CcceEEccccccc--ccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCC----CH-H----------
Confidence 9999876544321 12245899999999998888899999999999999999999997521 11 1
Q ss_pred HHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041757 258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE 320 (381)
Q Consensus 258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~ 320 (381)
+........... ......+..+.+++.+||+.+|.+||++.++++.
T Consensus 208 --~~~~~~~~~~~~---------------~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 208 --NLVVKIVQGNYT---------------PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred --HHHHHHHcCCCC---------------CCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 111111111000 0012345678899999999999999999999875
No 218
>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases. Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut
Probab=100.00 E-value=9.5e-38 Score=285.92 Aligned_cols=256 Identities=23% Similarity=0.341 Sum_probs=191.1
Q ss_pred ccccccceecCCCceEEEeccc--------------------c--cHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ--------------------G--AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN 93 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~--------------------~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 93 (381)
+.|...+.||+|+||.||++.. . ..+.|.+|+++++.++|+||+++++++.. ...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~---~~~ 80 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEK---PGG 80 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeec---CCC
Confidence 5677789999999999987641 1 25678999999999999999999998642 336
Q ss_pred ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757 94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA 173 (381)
Q Consensus 94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~ 173 (381)
...++||||+++++|.+++.. ....+++..+..++.|++.||.||| ..+++|+||||+||+++.++.+
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~---------~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~ 148 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQR---------HRDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLV 148 (284)
T ss_pred CceEEEEecCCCCCHHHHHHh---------CccccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCE
Confidence 678999999999999999952 2336899999999999999999999 6699999999999999999999
Q ss_pred EEeecccceecCCCCCc-ccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHH
Q 041757 174 RVGDFGLARFLPPTRTQ-TSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM 252 (381)
Q Consensus 174 kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~ 252 (381)
+|+|||.+......... .......++..|+|||.+.+..++.++||||||+++|||++|..||................
T Consensus 149 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~ 228 (284)
T cd05038 149 KISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQG 228 (284)
T ss_pred EEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccc
Confidence 99999999877633221 11111235667999999988889999999999999999999999975322211000000000
Q ss_pred -HhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 041757 253 -ALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSI 324 (381)
Q Consensus 253 -~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i 324 (381)
.....+.+.+...... ..+..++.++.+++.+||+.+|.+|||+.+|+++|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 229 QMIVTRLLELLKEGERL------------------PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred cccHHHHHHHHHcCCcC------------------CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 0000011111110000 00124557899999999999999999999999999876
No 219
>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding
Probab=100.00 E-value=5.4e-38 Score=289.86 Aligned_cols=238 Identities=19% Similarity=0.231 Sum_probs=186.7
Q ss_pred hhhccccccccceecCCCceEEEeccc-----------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757 31 ILDVSRNMLEENLISAGTFGFSHLRRQ-----------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN 93 (381)
Q Consensus 31 ~~~~~~~~~~~~~lG~G~fg~V~~~~~-----------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 93 (381)
+.+...+|...+.||.|+||.||++.. ...+.+.+|+.+++.++|+||+++++.+. ..
T Consensus 15 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~-----~~ 89 (296)
T cd06654 15 VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VG 89 (296)
T ss_pred cCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEE-----eC
Confidence 344567899999999999999987641 23467889999999999999999999854 46
Q ss_pred ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757 94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA 173 (381)
Q Consensus 94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~ 173 (381)
...++||||+++++|.+++. ...+++.++..++.|++.||.||| ..+|+||||||+||+++.++.+
T Consensus 90 ~~~~lv~e~~~~~~L~~~~~-----------~~~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~ 155 (296)
T cd06654 90 DELWVVMEYLAGGSLTDVVT-----------ETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSV 155 (296)
T ss_pred CEEEEeecccCCCCHHHHHH-----------hcCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCE
Confidence 78999999999999999984 234788899999999999999999 6699999999999999999999
Q ss_pred EEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH
Q 041757 174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA 253 (381)
Q Consensus 174 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~ 253 (381)
+|+|||++.......... ....+++.|+|||.+.+..++.++|||||||++|+|++|+.||..... ...+....
T Consensus 156 kl~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~----~~~~~~~~ 229 (296)
T cd06654 156 KLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP----LRALYLIA 229 (296)
T ss_pred EECccccchhcccccccc--CcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH----HHhHHHHh
Confidence 999999987654332211 123588999999999888899999999999999999999999852211 11110000
Q ss_pred hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 254 LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 254 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
....+. ...+...+..+.+++.+||..||++|||+.+++.
T Consensus 230 ------------~~~~~~--------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 230 ------------TNGTPE--------------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred ------------cCCCCC--------------CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 000000 0001234567888999999999999999999997
No 220
>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with
Probab=100.00 E-value=1.2e-37 Score=286.00 Aligned_cols=234 Identities=23% Similarity=0.278 Sum_probs=179.4
Q ss_pred ccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757 38 MLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA 97 (381)
Q Consensus 38 ~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~ 97 (381)
|...++||+|+||+||++.. .....+.+|+++|++++|+||+.+++.+ ...+..+
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~ 76 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAY-----ETKDALC 76 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEE-----ecCCEEE
Confidence 56678899999999977542 1123467899999999999999999884 4577899
Q ss_pred EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757 98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD 177 (381)
Q Consensus 98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D 177 (381)
+||||+++++|.+++.. .....+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|
T Consensus 77 lv~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~D 145 (285)
T cd05632 77 LVLTIMNGGDLKFHIYN--------MGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISD 145 (285)
T ss_pred EEEEeccCccHHHHHHH--------hcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEec
Confidence 99999999999988852 22346899999999999999999999 77999999999999999999999999
Q ss_pred cccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhch
Q 041757 178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH 257 (381)
Q Consensus 178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~ 257 (381)
||++......... ....|+..|+|||++.+..++.++||||||+++|++++|..||....... ....
T Consensus 146 fg~~~~~~~~~~~---~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~-~~~~--------- 212 (285)
T cd05632 146 LGLAVKIPEGESI---RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV-KREE--------- 212 (285)
T ss_pred CCcceecCCCCcc---cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH-HHHH---------
Confidence 9998765433221 12458999999999988889999999999999999999999985221100 0000
Q ss_pred HHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 041757 258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMK-----MTNVVH 319 (381)
Q Consensus 258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~~vl~ 319 (381)
+......... ......+..+.+++.+||+.||++||+ +.+++.
T Consensus 213 ----~~~~~~~~~~---------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 213 ----VDRRVLETEE---------------VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred ----HHHhhhcccc---------------ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 0000000000 001234556788999999999999999 555554
No 221
>PHA03210 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=1.3e-37 Score=306.37 Aligned_cols=261 Identities=18% Similarity=0.159 Sum_probs=180.9
Q ss_pred cccccccceecCCCceEEEeccc-----------------------------------ccHHHHHHHHHHHHccCCCccc
Q 041757 35 SRNMLEENLISAGTFGFSHLRRQ-----------------------------------GAFKSFIAECKALRNIRHRNLI 79 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~~-----------------------------------~~~~~~~~E~~~l~~l~h~nIv 79 (381)
.++|.+.++||+|+||+||++.. .....+.+|+.+|++++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 46899999999999999996421 1234577899999999999999
Q ss_pred ceeeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeec
Q 041757 80 KVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCV 159 (381)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrD 159 (381)
++++++ ...+..++|+|++. ++|.+++..... ..........+..++.|++.||.||| +.+|||||
T Consensus 227 ~l~~~~-----~~~~~~~lv~e~~~-~~l~~~l~~~~~-----~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrD 292 (501)
T PHA03210 227 KIEEIL-----RSEANTYMITQKYD-FDLYSFMYDEAF-----DWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRD 292 (501)
T ss_pred cEeEEE-----EECCeeEEEEeccc-cCHHHHHhhccc-----cccccccHHHHHHHHHHHHHHHHHHH---hCCeecCC
Confidence 999995 44678899999995 578887742211 11223345677889999999999999 67999999
Q ss_pred cCCCCeeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCcc
Q 041757 160 LKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIM 239 (381)
Q Consensus 160 lkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~ 239 (381)
|||+|||++.++.+||+|||+++.+....... .....||..|+|||++.+..++.++|||||||++|||++|..++...
T Consensus 293 LKP~NILl~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~ 371 (501)
T PHA03210 293 IKLENIFLNCDGKIVLGDFGTAMPFEKEREAF-DYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGD 371 (501)
T ss_pred CCHHHEEECCCCCEEEEeCCCceecCcccccc-cccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccC
Confidence 99999999999999999999998765433222 12256999999999999999999999999999999999987653211
Q ss_pred ccCCCcHHHHHHHHh---------hchHHHHHhhhhccCchhhhhcccchhhhhHHHHH--HHHHHHHHHHHHhccCCCC
Q 041757 240 FEGDMNLHKFAKMAL---------SNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINII--RECVISMVRIGVACSMESP 308 (381)
Q Consensus 240 ~~~~~~~~~~~~~~~---------~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~l~~~cl~~dP 308 (381)
... .....+..... ......+.+........ .......... ...+.++.+++.+|++.||
T Consensus 372 ~~~-~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~--------~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP 442 (501)
T PHA03210 372 GGG-KPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEID--------HAGHSVPPLIRNLGLPADFEYPLVKMLTFDW 442 (501)
T ss_pred CCC-CHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcc--------cCccchhhHHHhcCCChHHHHHHHHHhccCc
Confidence 111 11111111110 00001111100000000 0000000000 1234567788999999999
Q ss_pred CCCCCHHHHHH
Q 041757 309 QDRMKMTNVVH 319 (381)
Q Consensus 309 ~~RPs~~~vl~ 319 (381)
.+|||+.|++.
T Consensus 443 ~~Rpsa~elL~ 453 (501)
T PHA03210 443 HLRPGAAELLA 453 (501)
T ss_pred ccCcCHHHHhh
Confidence 99999999986
No 222
>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2. Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul
Probab=100.00 E-value=2.3e-38 Score=300.32 Aligned_cols=184 Identities=23% Similarity=0.316 Sum_probs=157.1
Q ss_pred ccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF 95 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~ 95 (381)
++|...+.||+|+||.||++.. .....+.+|+.++.+++||||+++++. +.+...
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~-----~~~~~~ 75 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYS-----FQDKRN 75 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEE-----EEcCCE
Confidence 4688899999999999987542 123567789999999999999999998 455788
Q ss_pred EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757 96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV 175 (381)
Q Consensus 96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl 175 (381)
.++|||||++|+|.+++. ....+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||
T Consensus 76 ~~lv~E~~~gg~L~~~l~----------~~~~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL 142 (360)
T cd05627 76 LYLIMEFLPGGDMMTLLM----------KKDTLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKL 142 (360)
T ss_pred EEEEEeCCCCccHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEE
Confidence 999999999999999993 4566899999999999999999999 779999999999999999999999
Q ss_pred eecccceecCCCCCc---------------------------------ccccCccCccceeCCCCcCCCccCcccchhhh
Q 041757 176 GDFGLARFLPPTRTQ---------------------------------TSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSY 222 (381)
Q Consensus 176 ~Dfg~~~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSl 222 (381)
+|||++......... ......+||+.|+|||++.+..++.++|||||
T Consensus 143 ~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSl 222 (360)
T cd05627 143 SDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSL 222 (360)
T ss_pred eeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccc
Confidence 999998754321100 00112469999999999999999999999999
Q ss_pred hHHHHHHHhCCCCCC
Q 041757 223 GILLLELMIREKPSD 237 (381)
Q Consensus 223 G~il~el~tg~~Pf~ 237 (381)
||++|||++|..||.
T Consensus 223 Gvilyel~tG~~Pf~ 237 (360)
T cd05627 223 GVIMYEMLIGYPPFC 237 (360)
T ss_pred cceeeecccCCCCCC
Confidence 999999999999985
No 223
>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5. Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p
Probab=100.00 E-value=1.7e-37 Score=284.09 Aligned_cols=235 Identities=22% Similarity=0.295 Sum_probs=180.7
Q ss_pred ccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA 97 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~ 97 (381)
++|...++||+|+||.||++.. ...+.+.+|++++++++||||+++++.+. ..+..+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 75 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFF-----VENRIS 75 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEE-----ECCEEE
Confidence 3577889999999999987641 12356889999999999999999999964 367789
Q ss_pred EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757 98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD 177 (381)
Q Consensus 98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D 177 (381)
+||||+++++|..+. .+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.++|+|
T Consensus 76 lv~e~~~~~~l~~~~--------------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~d 138 (279)
T cd06619 76 ICTEFMDGGSLDVYR--------------KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCD 138 (279)
T ss_pred EEEecCCCCChHHhh--------------cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEee
Confidence 999999999996543 3567788899999999999999 66999999999999999999999999
Q ss_pred cccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhch
Q 041757 178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH 257 (381)
Q Consensus 178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~ 257 (381)
||++......... ...|+..|+|||++.+..++.++||||||+++|+|++|+.||............
T Consensus 139 fg~~~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~--------- 205 (279)
T cd06619 139 FGVSTQLVNSIAK----TYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMP--------- 205 (279)
T ss_pred CCcceeccccccc----CCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccch---------
Confidence 9999765433221 246899999999999889999999999999999999999998643322211100
Q ss_pred HHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041757 258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE 320 (381)
Q Consensus 258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~ 320 (381)
...........+... .......++.+++.+||+.||++||++.++++.
T Consensus 206 -~~~~~~~~~~~~~~~--------------~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 206 -LQLLQCIVDEDPPVL--------------PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred -HHHHHHHhccCCCCC--------------CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 000111000000000 001234568899999999999999999999863
No 224
>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated
Probab=100.00 E-value=5.7e-38 Score=285.09 Aligned_cols=238 Identities=18% Similarity=0.224 Sum_probs=182.6
Q ss_pred ccccccccceecCCCceEEEeccc-----------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757 34 VSRNMLEENLISAGTFGFSHLRRQ-----------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK 96 (381)
Q Consensus 34 ~~~~~~~~~~lG~G~fg~V~~~~~-----------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~ 96 (381)
..++|...++||+|+||.||.+.. .....+.+|+.+++.++||||+++++.+ ...+..
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~-----~~~~~~ 81 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSY-----LRRDKL 81 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEE-----EeCCEE
Confidence 356899999999999999987642 1234577899999999999999999985 447788
Q ss_pred EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757 97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG 176 (381)
Q Consensus 97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~ 176 (381)
++||||+++++|.+++. ....+++.+++.++.|++.||.||| ..+++|+||||+||+++.++.++|+
T Consensus 82 ~lv~e~~~~~~L~~~~~----------~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~ 148 (267)
T cd06645 82 WICMEFCGGGSLQDIYH----------VTGPLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLA 148 (267)
T ss_pred EEEEeccCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEC
Confidence 99999999999999983 4457899999999999999999999 6699999999999999999999999
Q ss_pred ecccceecCCCCCcccccCccCccceeCCCCcC---CCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH
Q 041757 177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGV---GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA 253 (381)
Q Consensus 177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~ 253 (381)
|||++......... .....|+..|+|||++. ...++.++|||||||++|+|++|..||...... .......
T Consensus 149 dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~----~~~~~~~ 222 (267)
T cd06645 149 DFGVSAQITATIAK--RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM----RALFLMT 222 (267)
T ss_pred cceeeeEccCcccc--cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccch----hhHHhhh
Confidence 99998765433221 12245899999999874 455889999999999999999999997422111 0000000
Q ss_pred hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 254 LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 254 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
......... ......+..+.+++.+||..+|++|||+.+|++
T Consensus 223 ---------~~~~~~~~~---------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 223 ---------KSNFQPPKL---------------KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred ---------ccCCCCCcc---------------cccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 000000000 000123446788999999999999999999875
No 225
>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4. Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s
Probab=100.00 E-value=1.4e-37 Score=283.80 Aligned_cols=246 Identities=20% Similarity=0.335 Sum_probs=186.7
Q ss_pred ccccccceecCCCceEEEeccc-----------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccC
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ-----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQG 92 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~-----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 92 (381)
.+|...+.||+|+||.||+++. ...+.+.+|++++++++|+||+++++++ ..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~ 79 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLC-----RE 79 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEE-----CC
Confidence 5788889999999999987651 0245789999999999999999999985 44
Q ss_pred CceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCC
Q 041757 93 NDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT 172 (381)
Q Consensus 93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~ 172 (381)
....++||||+++|+|.+++........ ......+++..+..++.|++.||.||| +.+|+||||||+||+++.++.
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~-~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~ 155 (275)
T cd05046 80 AEPHYMILEYTDLGDLKQFLRATKSKDE-KLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQRE 155 (275)
T ss_pred CCcceEEEEecCCCcHHHHHHhcccccc-cccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCc
Confidence 6778999999999999999953221000 011236899999999999999999999 669999999999999999999
Q ss_pred eEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHH
Q 041757 173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAK 251 (381)
Q Consensus 173 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~ 251 (381)
++++|||++.......... .....++..|+|||.+.+..++.++||||||+++|++++ |..||..... ..+..
T Consensus 156 ~~l~~~~~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~-----~~~~~ 229 (275)
T cd05046 156 VKVSLLSLSKDVYNSEYYK-LRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD-----EEVLN 229 (275)
T ss_pred EEEcccccccccCcccccc-cCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch-----HHHHH
Confidence 9999999987543322211 112346778999999988888999999999999999998 7888742211 11111
Q ss_pred HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 041757 252 MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQ 322 (381)
Q Consensus 252 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~ 322 (381)
.... ..... .....++..+.+++.+||+.+|.+|||+.+++..|.
T Consensus 230 ~~~~--------~~~~~------------------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 230 RLQA--------GKLEL------------------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HHHc--------CCcCC------------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 0000 00000 001234568899999999999999999999999875
No 226
>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase. Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and
Probab=100.00 E-value=2.1e-37 Score=279.69 Aligned_cols=233 Identities=23% Similarity=0.332 Sum_probs=181.4
Q ss_pred ceecCCCceEEEeccc---------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEE
Q 041757 42 NLISAGTFGFSHLRRQ---------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVY 100 (381)
Q Consensus 42 ~~lG~G~fg~V~~~~~---------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~ 100 (381)
++||+|+||.||++.. ...+.+.+|+.++++++||||+++++.+. . ...++||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~-~~~~~v~ 74 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVL-----T-HPLMMVT 74 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEc-----C-CeEEEEE
Confidence 4689999999987531 23567889999999999999999999853 3 6789999
Q ss_pred EcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccc
Q 041757 101 EFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180 (381)
Q Consensus 101 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 180 (381)
||+++++|.+++... ....+++..++.++.|++.||.||| ..+++|+||||+||+++.++.+||+|||+
T Consensus 75 e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~ 143 (257)
T cd05040 75 ELAPLGSLLDRLRKD--------ALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGL 143 (257)
T ss_pred EecCCCcHHHHHHhc--------ccccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccc
Confidence 999999999999531 1146899999999999999999999 67999999999999999999999999999
Q ss_pred ceecCCCCCc-ccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchH
Q 041757 181 ARFLPPTRTQ-TSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHV 258 (381)
Q Consensus 181 ~~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 258 (381)
++........ .......++..|+|||++.+..++.++||||||+++|+|++ |..||..... ......
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----~~~~~~------ 212 (257)
T cd05040 144 MRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG-----SQILKK------ 212 (257)
T ss_pred cccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHH------
Confidence 9876543221 11112447789999999988889999999999999999998 9999752211 111110
Q ss_pred HHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 041757 259 KDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQ 322 (381)
Q Consensus 259 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~ 322 (381)
+ ...... . ..+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus 213 --~-~~~~~~-~----------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 213 --I-DKEGER-L----------------ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred --H-HhcCCc-C----------------CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 0 000000 0 001234567889999999999999999999999874
No 227
>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase. Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.
Probab=100.00 E-value=1.3e-37 Score=285.12 Aligned_cols=234 Identities=20% Similarity=0.250 Sum_probs=180.3
Q ss_pred cccccceecCCCceEEEeccc-----------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEE
Q 041757 37 NMLEENLISAGTFGFSHLRRQ-----------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALV 99 (381)
Q Consensus 37 ~~~~~~~lG~G~fg~V~~~~~-----------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv 99 (381)
.|...+.||.|+||.||++.. ...+.+.+|+++++.++||||+++++.+. ..+..++|
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-----~~~~~~~v 80 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY-----YENNLWIL 80 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEe-----eCCEEEEE
Confidence 367788999999999977541 23567889999999999999999999964 36788999
Q ss_pred EEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecc
Q 041757 100 YEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179 (381)
Q Consensus 100 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg 179 (381)
|||+++++|..++. .....+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||
T Consensus 81 ~e~~~~~~l~~~~~---------~~~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg 148 (282)
T cd06643 81 IEFCAGGAVDAVML---------ELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFG 148 (282)
T ss_pred EEecCCCcHHHHHH---------hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEcccc
Confidence 99999999999874 23456899999999999999999999 6699999999999999999999999999
Q ss_pred cceecCCCCCcccccCccCccceeCCCCcC-----CCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHh
Q 041757 180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGV-----GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMAL 254 (381)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 254 (381)
++.......... ....++..|+|||++. +..++.++|||||||++|||++|+.||.... ........
T Consensus 149 ~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~----~~~~~~~~-- 220 (282)
T cd06643 149 VSAKNTRTIQRR--DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN----PMRVLLKI-- 220 (282)
T ss_pred cccccccccccc--ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC----HHHHHHHH--
Confidence 987654322211 1245899999999874 3457889999999999999999999975221 11111100
Q ss_pred hchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 255 SNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 255 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
....+.. ...+...+..+.+++.+||+.||.+||++.++++
T Consensus 221 -----------~~~~~~~-------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 221 -----------AKSEPPT-------------LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred -----------hhcCCCC-------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000000 0001234567889999999999999999998864
No 228
>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase. Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina
Probab=100.00 E-value=1.9e-37 Score=281.83 Aligned_cols=241 Identities=20% Similarity=0.261 Sum_probs=182.7
Q ss_pred hhhhccccccccceecCCCceEEEeccc-----------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccC
Q 041757 30 EILDVSRNMLEENLISAGTFGFSHLRRQ-----------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQG 92 (381)
Q Consensus 30 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~-----------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 92 (381)
+....++++....+||+|+||.||++.. ...+.+.+|+.+++.++|+||+++++++. .
T Consensus 2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~ 76 (268)
T cd06624 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS-----E 76 (268)
T ss_pred CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeec-----c
Confidence 3445567777778999999999987641 13457889999999999999999999954 4
Q ss_pred CceEEEEEEcccCCCHHHhhccccCCcccccCCCcc--cHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCC-
Q 041757 93 NDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNL--NLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD- 169 (381)
Q Consensus 93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l--~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~- 169 (381)
.+..++|+||+++++|.+++.. ....+ ++..+..++.|++.||+||| ..+|+||||||+||+++.
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~ 144 (268)
T cd06624 77 NGFFKIFMEQVPGGSLSALLRS---------KWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTY 144 (268)
T ss_pred CCEEEEEEecCCCCCHHHHHHH---------hcccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCC
Confidence 6789999999999999999852 22334 77888899999999999999 669999999999999976
Q ss_pred CCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCc--cCcccchhhhhHHHHHHHhCCCCCCccccCCCcHH
Q 041757 170 DMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNE--VSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLH 247 (381)
Q Consensus 170 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~ 247 (381)
++.++|+|||.+.......... ....++..|+|||++.... ++.++||||||+++|+|++|..||....... .
T Consensus 145 ~~~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~---~ 219 (268)
T cd06624 145 SGVVKISDFGTSKRLAGINPCT--ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ---A 219 (268)
T ss_pred CCeEEEecchhheecccCCCcc--ccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh---h
Confidence 6789999999987654322211 1234789999999986643 7899999999999999999999975221100 0
Q ss_pred HHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 248 KFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
..... ......+ ..+......+.+++.+||+.+|.+|||+.+++.
T Consensus 220 ~~~~~-----------~~~~~~~----------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 220 AMFKV-----------GMFKIHP----------------EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred hHhhh-----------hhhccCC----------------CCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 00000 0000000 012245567889999999999999999999875
No 229
>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase. Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl
Probab=100.00 E-value=1.1e-37 Score=288.40 Aligned_cols=261 Identities=19% Similarity=0.235 Sum_probs=183.1
Q ss_pred ccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA 97 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~ 97 (381)
++|...++||.|+||.||++.. .....+.+|+.+++.++||||+++++++ ......+
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~-----~~~~~~~ 80 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII-----HTEKSLT 80 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEE-----ecCCeEE
Confidence 5688899999999999987642 1234678899999999999999999995 4577899
Q ss_pred EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757 98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD 177 (381)
Q Consensus 98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D 177 (381)
+||||+. ++|.+++. .....+++..+..++.|++.||.||| +.+++|+||||+||+++.++.+||+|
T Consensus 81 lv~e~~~-~~l~~~l~---------~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~d 147 (301)
T cd07873 81 LVFEYLD-KDLKQYLD---------DCGNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLAD 147 (301)
T ss_pred EEEeccc-cCHHHHHH---------hcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECc
Confidence 9999997 59998885 23446788999999999999999999 66999999999999999999999999
Q ss_pred cccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhc
Q 041757 178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSN 256 (381)
Q Consensus 178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~ 256 (381)
||++.......... ....+++.|+|||++.+ ..++.++|||||||++|+|++|+.||...... ............
T Consensus 148 fg~~~~~~~~~~~~--~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~--~~~~~~~~~~~~ 223 (301)
T cd07873 148 FGLARAKSIPTKTY--SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE--EQLHFIFRILGT 223 (301)
T ss_pred CcchhccCCCCCcc--cccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHcCC
Confidence 99987654332211 12347889999998765 45788999999999999999999998532110 001111111111
Q ss_pred hHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 257 HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 257 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
.........+...... ...................+..+.+++.+|++.||.+|||+.++++
T Consensus 224 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 224 PTEETWPGILSNEEFK-SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred CChhhchhhhcccccc-ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 1111111111000000 0000000000001111234557889999999999999999999986
No 230
>PHA02882 putative serine/threonine kinase; Provisional
Probab=100.00 E-value=1.4e-37 Score=286.74 Aligned_cols=247 Identities=19% Similarity=0.185 Sum_probs=176.5
Q ss_pred cccccccceecCCCceEEEecccccH-------------------------------HHHHHHHHHHHccCCCcccceee
Q 041757 35 SRNMLEENLISAGTFGFSHLRRQGAF-------------------------------KSFIAECKALRNIRHRNLIKVLT 83 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~~~~~-------------------------------~~~~~E~~~l~~l~h~nIv~~~~ 83 (381)
.+.|.+.++||+|+||+||++..... .....+...+..+.|+||+++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 46899999999999999988652110 11122334456678999999998
Q ss_pred eeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCC
Q 041757 84 ACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPS 163 (381)
Q Consensus 84 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~ 163 (381)
++... .......++++|++.. ++.+.+. .....++..+..++.|++.||.||| +.+|+||||||+
T Consensus 91 ~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~----------~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~ 155 (294)
T PHA02882 91 CGSFK-RCRMYYRFILLEKLVE-NTKEIFK----------RIKCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPE 155 (294)
T ss_pred eeeEe-cCCceEEEEEEehhcc-CHHHHHH----------hhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHH
Confidence 75421 1112355788888744 6766663 2233567788999999999999999 679999999999
Q ss_pred CeeeCCCCCeEEeecccceecCCCCCc-----ccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCc
Q 041757 164 NVLLDDDMTARVGDFGLARFLPPTRTQ-----TSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDI 238 (381)
Q Consensus 164 Nill~~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~ 238 (381)
|||++.++.++|+|||+++........ .......||+.|+|||+..+..++.++|||||||++|||++|+.||..
T Consensus 156 Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~ 235 (294)
T PHA02882 156 NIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKG 235 (294)
T ss_pred HEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCc
Confidence 999999999999999999876432211 111124699999999999999999999999999999999999999864
Q ss_pred cccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 041757 239 MFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVV 318 (381)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl 318 (381)
.......... .. .+++........ ....++..+.+++..||..+|++||++.+++
T Consensus 236 ~~~~~~~~~~-~~-------~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~ 290 (294)
T PHA02882 236 FGHNGNLIHA-AK-------CDFIKRLHEGKI-----------------KIKNANKFIYDFIECVTKLSYEEKPDYDALI 290 (294)
T ss_pred cccchHHHHH-hH-------HHHHHHhhhhhh-----------------ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHH
Confidence 3221111111 00 111111111000 0124567899999999999999999999999
Q ss_pred HHH
Q 041757 319 HEL 321 (381)
Q Consensus 319 ~~L 321 (381)
+.|
T Consensus 291 ~~~ 293 (294)
T PHA02882 291 KIF 293 (294)
T ss_pred Hhh
Confidence 876
No 231
>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros. Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male
Probab=100.00 E-value=2.6e-37 Score=280.96 Aligned_cols=238 Identities=26% Similarity=0.394 Sum_probs=181.6
Q ss_pred ceecCCCceEEEeccc------------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757 42 NLISAGTFGFSHLRRQ------------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA 97 (381)
Q Consensus 42 ~~lG~G~fg~V~~~~~------------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~ 97 (381)
+.||+|+||.||+++. .....+.+|+.+++.++||||+++++++. .....+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCL-----LNEPQY 75 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeec-----CCCCeE
Confidence 4699999999986541 13456788999999999999999999954 466789
Q ss_pred EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC-----C
Q 041757 98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM-----T 172 (381)
Q Consensus 98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~-----~ 172 (381)
+||||+++++|.+++....... .....+++..++.++.|++.||.||| +.+++|+||||+||+++.++ .
T Consensus 76 ~v~e~~~~~~L~~~l~~~~~~~---~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~ 149 (269)
T cd05044 76 IIMELMEGGDLLSYLRDARVER---FGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRV 149 (269)
T ss_pred EEEeccCCCcHHHHHHHhhhcc---cCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcc
Confidence 9999999999999996422110 02345788999999999999999999 67999999999999999877 8
Q ss_pred eEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHH
Q 041757 173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAK 251 (381)
Q Consensus 173 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~ 251 (381)
++|+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||... .... ...
T Consensus 150 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~----~~~~-~~~ 224 (269)
T cd05044 150 VKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL----NNQE-VLQ 224 (269)
T ss_pred eEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCccc----CHHH-HHH
Confidence 99999999976544322222222345788999999998899999999999999999998 99997522 1111 000
Q ss_pred HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 041757 252 MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQ 322 (381)
Q Consensus 252 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~ 322 (381)
. +.... ....+...+..+.+++.+||..+|.+||++.++++.|+
T Consensus 225 ~---------~~~~~------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 225 H---------VTAGG------------------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred H---------HhcCC------------------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 0 00000 00012245667899999999999999999999999886
No 232
>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase. Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.
Probab=100.00 E-value=2.1e-37 Score=285.27 Aligned_cols=237 Identities=20% Similarity=0.241 Sum_probs=182.8
Q ss_pred ccccccccceecCCCceEEEeccc-----------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757 34 VSRNMLEENLISAGTFGFSHLRRQ-----------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK 96 (381)
Q Consensus 34 ~~~~~~~~~~lG~G~fg~V~~~~~-----------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~ 96 (381)
..++|.+.++||.|+||.||+++. ...+.+.+|+.+++.++||||+++++.+. .....
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 84 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY-----WDGKL 84 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEE-----eCCeE
Confidence 457899999999999999987642 23467888999999999999999999854 46789
Q ss_pred EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757 97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG 176 (381)
Q Consensus 97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~ 176 (381)
++||||+++++|..++. .....+++..+..++.|++.||.||| ..+++||||||+||+++.++.++|+
T Consensus 85 ~lv~e~~~~~~l~~~~~---------~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~ 152 (292)
T cd06644 85 WIMIEFCPGGAVDAIML---------ELDRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLA 152 (292)
T ss_pred EEEEecCCCCcHHHHHH---------hhcCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEc
Confidence 99999999999998874 23456899999999999999999999 6699999999999999999999999
Q ss_pred ecccceecCCCCCcccccCccCccceeCCCCcC-----CCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHH
Q 041757 177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGV-----GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAK 251 (381)
Q Consensus 177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~ 251 (381)
|||++.......... ....++..|+|||++. ...++.++|||||||++|+|++|..||.... .......
T Consensus 153 dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~----~~~~~~~ 226 (292)
T cd06644 153 DFGVSAKNVKTLQRR--DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN----PMRVLLK 226 (292)
T ss_pred cCccceecccccccc--ceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc----HHHHHHH
Confidence 999987543322111 1245788999999875 3456889999999999999999999975221 1111000
Q ss_pred HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 252 MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 252 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
........ ...+...+.++.+++.+||+.||++||++.++++
T Consensus 227 -------------~~~~~~~~-------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 227 -------------IAKSEPPT-------------LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred -------------HhcCCCcc-------------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000000 0001234457888999999999999999999976
No 233
>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase. Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki
Probab=100.00 E-value=2.3e-37 Score=279.05 Aligned_cols=234 Identities=24% Similarity=0.390 Sum_probs=183.6
Q ss_pred ccccccceecCCCceEEEeccc-------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEc
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ-------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEF 102 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~-------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~ 102 (381)
++|...+.||+|+||.||.+.. ...+.+.+|+.+++.++||||+++++++. .+..++||||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~------~~~~~~v~e~ 79 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVIL------HNGLYIVMEL 79 (254)
T ss_pred HHceeeeeeccCCCCceEecccCCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEc------CCCcEEEEEC
Confidence 5688899999999999977541 23457889999999999999999999853 2346899999
Q ss_pred ccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccce
Q 041757 103 MHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR 182 (381)
Q Consensus 103 ~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~ 182 (381)
+++++|.+++.. .....+++..++.++.|++.||.||| +.+++||||||+||+++.++.+||+|||++.
T Consensus 80 ~~~~~L~~~l~~--------~~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~ 148 (254)
T cd05083 80 MSKGNLVNFLRT--------RGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLAR 148 (254)
T ss_pred CCCCCHHHHHHh--------cCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccce
Confidence 999999999953 12345788999999999999999999 6699999999999999999999999999987
Q ss_pred ecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchHHHH
Q 041757 183 FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHVKDI 261 (381)
Q Consensus 183 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (381)
........ ...+..|+|||++.+..++.++||||||+++|+|++ |..||.... ..... ..
T Consensus 149 ~~~~~~~~-----~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-----~~~~~---------~~ 209 (254)
T cd05083 149 VGSMGVDN-----SKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS-----LKEVK---------EC 209 (254)
T ss_pred eccccCCC-----CCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC-----HHHHH---------HH
Confidence 65432111 234678999999988889999999999999999998 999975221 11111 11
Q ss_pred HhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 041757 262 VDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQS 323 (381)
Q Consensus 262 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~ 323 (381)
+.......+ +..++..+.+++.+||+.+|++||++.++++.|+.
T Consensus 210 ~~~~~~~~~------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 210 VEKGYRMEP------------------PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred HhCCCCCCC------------------CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 111000000 12345678899999999999999999999998863
No 234
>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include
Probab=100.00 E-value=1.3e-37 Score=285.46 Aligned_cols=245 Identities=20% Similarity=0.261 Sum_probs=188.1
Q ss_pred ccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA 97 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~ 97 (381)
++|+..++||+|+||+||++.. ...+.+.+|+++++.++||||+++++.+. .....+
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 79 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFL-----NENNIC 79 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEe-----cCCEEE
Confidence 5788889999999999987541 23467889999999999999999999954 467899
Q ss_pred EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757 98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD 177 (381)
Q Consensus 98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D 177 (381)
+||||+++++|.+++. ....+++..+..++.+++.||.|||+ ..+++||||+|+||+++.++.++|+|
T Consensus 80 lv~e~~~~~~L~~~~~----------~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d 147 (284)
T cd06620 80 MCMEFMDCGSLDRIYK----------KGGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCD 147 (284)
T ss_pred EEEecCCCCCHHHHHH----------hccCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEcc
Confidence 9999999999999983 34568899999999999999999994 24899999999999999999999999
Q ss_pred cccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhch
Q 041757 178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH 257 (381)
Q Consensus 178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~ 257 (381)
||++......... ...|+..|+|||++.+..++.++|||||||++|++++|..||......... . .....
T Consensus 148 ~gl~~~~~~~~~~----~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~--~----~~~~~ 217 (284)
T cd06620 148 FGVSGELINSIAD----TFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDG--Q----DDPMG 217 (284)
T ss_pred CCcccchhhhccC----ccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhh--h----hhhhH
Confidence 9998654322211 245899999999998888999999999999999999999998744322110 0 00001
Q ss_pred HHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 041757 258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHEL 321 (381)
Q Consensus 258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L 321 (381)
+.+.+...+...+.. ......+..+.+++.+||+.||++|||+.++++..
T Consensus 218 ~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 218 ILDLLQQIVQEPPPR--------------LPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred HHHHHHHHhhccCCC--------------CCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 112222221111100 00112556788999999999999999999999864
No 235
>PTZ00284 protein kinase; Provisional
Probab=100.00 E-value=2.1e-37 Score=303.46 Aligned_cols=182 Identities=20% Similarity=0.269 Sum_probs=148.0
Q ss_pred ccccccccceecCCCceEEEecccc----------------cHHHHHHHHHHHHccCCC------cccceeeeecccccc
Q 041757 34 VSRNMLEENLISAGTFGFSHLRRQG----------------AFKSFIAECKALRNIRHR------NLIKVLTACLGVDYQ 91 (381)
Q Consensus 34 ~~~~~~~~~~lG~G~fg~V~~~~~~----------------~~~~~~~E~~~l~~l~h~------nIv~~~~~~~~~~~~ 91 (381)
..++|.+.++||+|+||+||++... ....+..|++++..++|. +++++++++. .
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~----~ 202 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ----N 202 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE----c
Confidence 3578999999999999999887421 123456788888887654 4788887753 2
Q ss_pred CCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC
Q 041757 92 GNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM 171 (381)
Q Consensus 92 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~ 171 (381)
...+.++|||++ +++|.+++. ....+++..+..++.||+.||.|||+. .+||||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~----------~~~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~ 269 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIM----------KHGPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSD 269 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCC
Confidence 346789999998 779999883 445789999999999999999999931 4999999999999998665
Q ss_pred ----------------CeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCC
Q 041757 172 ----------------TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235 (381)
Q Consensus 172 ----------------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~P 235 (381)
.+||+|||.+...... ....+||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 270 ~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~p 344 (467)
T PTZ00284 270 TVVDPVTNRALPPDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLL 344 (467)
T ss_pred cccccccccccCCCCceEEECCCCccccCccc-----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 4999999987543221 1235699999999999999999999999999999999999999
Q ss_pred CC
Q 041757 236 SD 237 (381)
Q Consensus 236 f~ 237 (381)
|.
T Consensus 345 f~ 346 (467)
T PTZ00284 345 YD 346 (467)
T ss_pred CC
Confidence 85
No 236
>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t
Probab=100.00 E-value=2.2e-37 Score=280.25 Aligned_cols=240 Identities=23% Similarity=0.395 Sum_probs=188.2
Q ss_pred cccccccceecCCCceEEEecc---------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEE
Q 041757 35 SRNMLEENLISAGTFGFSHLRR---------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALV 99 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~---------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv 99 (381)
.++|.+.++||.|+||.||++. ....+.+.+|+.++++++|+||+++++++ ......++|
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~~v 79 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVC-----SEEEPIYIV 79 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeee-----ecCCceEEE
Confidence 5788999999999999998753 12346789999999999999999999984 446778999
Q ss_pred EEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecc
Q 041757 100 YEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179 (381)
Q Consensus 100 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg 179 (381)
|||+++++|.+++.. .....+++..+..++.|++.|+.||| ..+++|+||||+||+++.++.+||+|||
T Consensus 80 ~e~~~~~~L~~~i~~--------~~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g 148 (261)
T cd05034 80 TEYMSKGSLLDFLKS--------GEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFG 148 (261)
T ss_pred EeccCCCCHHHHHhc--------cccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccc
Confidence 999999999999953 22346889999999999999999999 6699999999999999999999999999
Q ss_pred cceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchH
Q 041757 180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHV 258 (381)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 258 (381)
++........... ....++..|+|||.+.+..++.++||||||+++|++++ |+.||... ... ....
T Consensus 149 ~~~~~~~~~~~~~-~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~----~~~-~~~~------- 215 (261)
T cd05034 149 LARLIEDDEYTAR-EGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM----TNR-EVLE------- 215 (261)
T ss_pred cceeccchhhhhh-hccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC----CHH-HHHH-------
Confidence 9987654221111 11235678999999988889999999999999999998 99997422 110 1000
Q ss_pred HHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 041757 259 KDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQS 323 (381)
Q Consensus 259 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~ 323 (381)
.+........ +...+..+.+++.+||..+|.+||++.++.+.|+.
T Consensus 216 -~~~~~~~~~~-------------------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 216 -QVERGYRMPR-------------------PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -HHHcCCCCCC-------------------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0000000000 12335678999999999999999999999998875
No 237
>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,
Probab=100.00 E-value=1.1e-37 Score=292.38 Aligned_cols=184 Identities=25% Similarity=0.253 Sum_probs=155.4
Q ss_pred ccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF 95 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~ 95 (381)
++|...+.||+|+||.||+++. ...+.+.+|+.++..++|+||+++++++ .+.++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAF-----QDENN 75 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEE-----ecCCe
Confidence 4788999999999999987542 1234578899999999999999999984 45788
Q ss_pred EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757 96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV 175 (381)
Q Consensus 96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl 175 (381)
.++||||+++|+|.+++. .....+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||
T Consensus 76 ~~lv~e~~~g~~L~~~l~---------~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl 143 (331)
T cd05597 76 LYLVMDYYVGGDLLTLLS---------KFEDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRL 143 (331)
T ss_pred EEEEEecCCCCcHHHHHH---------HhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEE
Confidence 999999999999999994 22456889999999999999999999 779999999999999999999999
Q ss_pred eecccceecCCCCCcccccCccCccceeCCCCcCC-----CccCcccchhhhhHHHHHHHhCCCCCC
Q 041757 176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-----NEVSTIGDVYSYGILLLELMIREKPSD 237 (381)
Q Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~sDiwSlG~il~el~tg~~Pf~ 237 (381)
+|||++........... ....||+.|+|||++.. ..++.++|||||||++|+|++|+.||.
T Consensus 144 ~Dfg~~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~ 209 (331)
T cd05597 144 ADFGSCLRLLADGTVQS-NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFY 209 (331)
T ss_pred EECCceeecCCCCCccc-cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCC
Confidence 99999876654332211 11358999999999863 457889999999999999999999975
No 238
>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase
Probab=100.00 E-value=2.1e-37 Score=291.10 Aligned_cols=275 Identities=19% Similarity=0.231 Sum_probs=190.8
Q ss_pred ccccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757 34 VSRNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF 95 (381)
Q Consensus 34 ~~~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~ 95 (381)
+.++|...++||+|+||.||.+.. .....+.+|+.++++++|+||+++++++...++.....
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 568899999999999999987631 13356788999999999999999999876544445567
Q ss_pred EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757 96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV 175 (381)
Q Consensus 96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl 175 (381)
.++|+||+.+ +|.+++. ...+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||
T Consensus 83 ~~lv~e~~~~-~l~~~~~-----------~~~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl 147 (336)
T cd07849 83 VYIVQELMET-DLYKLIK-----------TQHLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKI 147 (336)
T ss_pred EEEEehhccc-CHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEE
Confidence 8999999964 8888773 346889999999999999999999 669999999999999999999999
Q ss_pred eecccceecCCCCCcc-cccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH
Q 041757 176 GDFGLARFLPPTRTQT-SSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA 253 (381)
Q Consensus 176 ~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~ 253 (381)
+|||++.......... ......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||..... ..........
T Consensus 148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~--~~~~~~~~~~ 225 (336)
T cd07849 148 CDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY--LHQLNLILGV 225 (336)
T ss_pred CcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHH
Confidence 9999998764432211 1122458899999998654 5688999999999999999999999752110 0000001111
Q ss_pred hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH--HHHhh
Q 041757 254 LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE--LQSIK 325 (381)
Q Consensus 254 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~--L~~i~ 325 (381)
......+.............................+....++.+++.+||+.||++|||+.++++. ++...
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 226 LGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred cCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 1111111111111100000000000000000011122345678999999999999999999999985 54443
No 239
>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=9.4e-38 Score=287.27 Aligned_cols=233 Identities=20% Similarity=0.325 Sum_probs=191.8
Q ss_pred ccccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757 34 VSRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND 94 (381)
Q Consensus 34 ~~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~ 94 (381)
+.+=|..++.||+|.|+.|.+++. .....+++|++.|+-++|||||++|.+ ..+..
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEV-----iDTQT 90 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEV-----IDTQT 90 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeeh-----hcccc
Confidence 455688889999999999977652 234678899999999999999999999 66788
Q ss_pred eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeee-CCCCCe
Q 041757 95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLL-DDDMTA 173 (381)
Q Consensus 95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill-~~~~~~ 173 (381)
.+|||+|+-.+|+|.+||- +....+.+..+..++.||..|+.|+| +..+|||||||+|+++ ..-|.+
T Consensus 91 KlyLiLELGD~GDl~DyIm---------KHe~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlV 158 (864)
T KOG4717|consen 91 KLYLILELGDGGDLFDYIM---------KHEEGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLV 158 (864)
T ss_pred eEEEEEEecCCchHHHHHH---------hhhccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCce
Confidence 8999999999999999996 56678999999999999999999999 7899999999999977 456899
Q ss_pred EEeecccceecCCCCCcccccCccCccceeCCCCcCCCccC-cccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHH
Q 041757 174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVS-TIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM 252 (381)
Q Consensus 174 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~ 252 (381)
||.|||++-.+........ .+|+..|.|||++.+..|+ +++||||||||||-|++|+.||....+.+.
T Consensus 159 KLTDFGFSNkf~PG~kL~T---sCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET-------- 227 (864)
T KOG4717|consen 159 KLTDFGFSNKFQPGKKLTT---SCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET-------- 227 (864)
T ss_pred EeeeccccccCCCcchhhc---ccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh--------
Confidence 9999999977665544333 6799999999999999986 678999999999999999999874433221
Q ss_pred HhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 253 ALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 253 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
+.-++|. .+. .+.....++.+|+.+||..||.+|.+.++|..
T Consensus 228 -----LTmImDC----KYt----------------vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 228 -----LTMIMDC----KYT----------------VPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred -----hhhhhcc----ccc----------------CchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 1112221 111 13466778889999999999999999998875
No 240
>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=7.7e-39 Score=298.54 Aligned_cols=229 Identities=24% Similarity=0.318 Sum_probs=182.4
Q ss_pred ccccccceecCCCceEEEecc--------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757 36 RNMLEENLISAGTFGFSHLRR--------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF 95 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~--------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~ 95 (381)
.-|...+.||.|+||.||.++ ....+.+++|+++|++++|||+|.+-|+|. .+..
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyL-----re~T 100 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYL-----REHT 100 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceee-----ccch
Confidence 447788999999999998875 235678899999999999999999999954 4777
Q ss_pred EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757 96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV 175 (381)
Q Consensus 96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl 175 (381)
.|||||||- |+-.+++. ....++.+.++..|+.+.+.||+||| +.+.||||||..|||+++.|.|||
T Consensus 101 aWLVMEYCl-GSAsDlle---------VhkKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKL 167 (948)
T KOG0577|consen 101 AWLVMEYCL-GSASDLLE---------VHKKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKL 167 (948)
T ss_pred HHHHHHHHh-ccHHHHHH---------HHhccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeee
Confidence 899999995 58888886 34677999999999999999999999 669999999999999999999999
Q ss_pred eecccceecCCCCCcccccCccCccceeCCCCcCC---CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHH
Q 041757 176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG---NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM 252 (381)
Q Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~ 252 (381)
+|||.|..+.... +++|||.|||||++.. +.|+.++||||||+++.||..+++|.-++.. +..+...
T Consensus 168 aDFGSAsi~~PAn------sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA----MSALYHI 237 (948)
T KOG0577|consen 168 ADFGSASIMAPAN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA----MSALYHI 237 (948)
T ss_pred ccccchhhcCchh------cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH----HHHHHHH
Confidence 9999987654322 3789999999998764 5799999999999999999999999532211 1111100
Q ss_pred HhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 253 ALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 253 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
.-. ..|.- ...+....+..++..||+.-|.+|||..+++.
T Consensus 238 AQN------------esPtL---------------qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 238 AQN------------ESPTL---------------QSNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred Hhc------------CCCCC---------------CCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 000 00000 01255667788888999999999999988765
No 241
>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ
Probab=100.00 E-value=4.1e-37 Score=278.39 Aligned_cols=238 Identities=21% Similarity=0.271 Sum_probs=185.7
Q ss_pred cccccccceecCCCceEEEeccc-----------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757 35 SRNMLEENLISAGTFGFSHLRRQ-----------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA 97 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~~-----------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~ 97 (381)
.++|...+.||.|+||.||++.. ...+.+.+|+.++++++||||+++++++ ......+
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~ 76 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSY-----LRRDKLW 76 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEE-----EeCCEEE
Confidence 46889999999999999987642 1356789999999999999999999984 4477899
Q ss_pred EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757 98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD 177 (381)
Q Consensus 98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D 177 (381)
++|||+++++|.+++.. ....+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.+||+|
T Consensus 77 l~~e~~~~~~l~~~~~~---------~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d 144 (262)
T cd06613 77 IVMEYCGGGSLQDIYQV---------TRGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLAD 144 (262)
T ss_pred EEEeCCCCCcHHHHHHh---------hccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECc
Confidence 99999999999999842 2256889999999999999999999 66999999999999999999999999
Q ss_pred cccceecCCCCCcccccCccCccceeCCCCcCCC---ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHh
Q 041757 178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGN---EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMAL 254 (381)
Q Consensus 178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~---~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 254 (381)
||++.......... ....++..|+|||.+.+. .++.++||||||+++|+|++|+.||.... ........
T Consensus 145 ~g~~~~~~~~~~~~--~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~----~~~~~~~~-- 216 (262)
T cd06613 145 FGVSAQLTATIAKR--KSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLH----PMRALFLI-- 216 (262)
T ss_pred cccchhhhhhhhcc--ccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCC----HHHHHHHH--
Confidence 99987654432111 124578899999998776 78999999999999999999999975221 11110000
Q ss_pred hchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 255 SNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 255 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
..... .+.. .......+.++.+++.+||..+|.+|||+.+|+.
T Consensus 217 -------~~~~~--~~~~-------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 217 -------SKSNF--PPPK-------------LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred -------HhccC--CCcc-------------ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000 0000 0001244567899999999999999999999875
No 242
>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.
Probab=100.00 E-value=4.8e-37 Score=277.23 Aligned_cols=234 Identities=19% Similarity=0.279 Sum_probs=183.5
Q ss_pred cccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757 37 NMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA 97 (381)
Q Consensus 37 ~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~ 97 (381)
+|...+.||.|+||.||++.. ...+.+.+|++++++++|+|++++++.+. ......+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~~ 76 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWE----GEDGLLY 76 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeec----CCCCEEE
Confidence 478889999999999976541 12356788999999999999999998742 2345689
Q ss_pred EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757 98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD 177 (381)
Q Consensus 98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D 177 (381)
+||||+++++|.+++.. .....+++.++..++.|++.|+.+|| +.+++|+||||+||+++.++.++|+|
T Consensus 77 lv~e~~~~~~l~~~l~~--------~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~d 145 (257)
T cd08223 77 IVMGFCEGGDLYHKLKE--------QKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGD 145 (257)
T ss_pred EEecccCCCcHHHHHHH--------hcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEec
Confidence 99999999999999953 22345899999999999999999999 66999999999999999999999999
Q ss_pred cccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhch
Q 041757 178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH 257 (381)
Q Consensus 178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~ 257 (381)
||++......... .....+++.|+|||++.+..++.++||||||+++|++++|+.||... ........
T Consensus 146 f~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~-----~~~~~~~~----- 213 (257)
T cd08223 146 LGIARVLENQCDM--ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK-----DMNSLVYR----- 213 (257)
T ss_pred ccceEEecccCCc--cccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC-----CHHHHHHH-----
Confidence 9999876443221 11245889999999999988999999999999999999999997521 11111111
Q ss_pred HHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
+....+. ..+...+..+.+++.+||+.||++|||+.++++
T Consensus 214 ---~~~~~~~-------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 214 ---IIEGKLP-------------------PMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred ---HHhcCCC-------------------CCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 1110000 001245567889999999999999999999986
No 243
>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate
Probab=100.00 E-value=2.6e-37 Score=280.72 Aligned_cols=233 Identities=20% Similarity=0.309 Sum_probs=182.8
Q ss_pred cccccceecCCCceEEEecccc--------------------------cHHHHHHHHHHHHccCCCcccceeeeeccccc
Q 041757 37 NMLEENLISAGTFGFSHLRRQG--------------------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDY 90 (381)
Q Consensus 37 ~~~~~~~lG~G~fg~V~~~~~~--------------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 90 (381)
.|..+..||.|+||.||.+... ..+.+.+|+.++++++||||+++++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~----- 75 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSS----- 75 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----
Confidence 3667889999999999876411 124678899999999999999999995
Q ss_pred cCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCC
Q 041757 91 QGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDD 170 (381)
Q Consensus 91 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~ 170 (381)
......++||||+++++|.+++. ....+++..+..++.|++.||.||| +.+++||||+|+||+++.+
T Consensus 76 ~~~~~~~lv~e~~~~~~L~~~l~----------~~~~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~ 142 (267)
T cd06628 76 LDADHLNIFLEYVPGGSVAALLN----------NYGAFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNK 142 (267)
T ss_pred EeCCccEEEEEecCCCCHHHHHH----------hccCccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCC
Confidence 44678899999999999999993 4456888899999999999999999 6699999999999999999
Q ss_pred CCeEEeecccceecCCCCCcc----cccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcH
Q 041757 171 MTARVGDFGLARFLPPTRTQT----SSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNL 246 (381)
Q Consensus 171 ~~~kl~Dfg~~~~~~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~ 246 (381)
+.++|+|||.++......... ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||... ...
T Consensus 143 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~----~~~ 218 (267)
T cd06628 143 GGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC----TQL 218 (267)
T ss_pred CCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCc----cHH
Confidence 999999999998765322111 111235788999999998888999999999999999999999998522 111
Q ss_pred HHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 247 HKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
.... ..... ..+ ..+...+..+.+++.+||+.||.+||++.++++
T Consensus 219 ~~~~---------~~~~~---~~~----------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 219 QAIF---------KIGEN---ASP----------------EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred HHHH---------HHhcc---CCC----------------cCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 1110 00000 000 011245567889999999999999999999986
No 244
>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio
Probab=100.00 E-value=3.6e-37 Score=282.46 Aligned_cols=259 Identities=21% Similarity=0.272 Sum_probs=184.7
Q ss_pred ccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK 96 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~ 96 (381)
++|...+.||+|+||.||++.. ...+.+.+|+.++++++|+||+++++++ ......
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~ 75 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVF-----RRKRKL 75 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEE-----eeCCEE
Confidence 4688889999999999988642 1234578999999999999999999995 447788
Q ss_pred EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757 97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG 176 (381)
Q Consensus 97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~ 176 (381)
++||||+++++|..++ .....+++..++.++.|++.||.||| ..+++||||||+||+++.++.++|+
T Consensus 76 ~~v~e~~~~~~l~~~~----------~~~~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~ 142 (286)
T cd07847 76 HLVFEYCDHTVLNELE----------KNPRGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLC 142 (286)
T ss_pred EEEEeccCccHHHHHH----------hCCCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEEC
Confidence 9999999999888877 34456899999999999999999999 6699999999999999999999999
Q ss_pred ecccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhh
Q 041757 177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALS 255 (381)
Q Consensus 177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 255 (381)
|||++.......... ....++..|+|||++.+ ..++.++||||||+++|+|++|..||......+ ....... ...
T Consensus 143 dfg~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~-~~~~~~~-~~~ 218 (286)
T cd07847 143 DFGFARILTGPGDDY--TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVD-QLYLIRK-TLG 218 (286)
T ss_pred ccccceecCCCcccc--cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHH-HhC
Confidence 999998765543211 12347889999998876 457899999999999999999999985322111 0111110 000
Q ss_pred ch---HHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 256 NH---VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 256 ~~---~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
.. ..+..+.. ........................+..+.+++.+||+.||++|||+.+++.
T Consensus 219 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 219 DLIPRHQQIFSTN---QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred CCChHHhhhcccc---cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00 00000000 000000000000000001112234567899999999999999999999875
No 245
>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]
Probab=100.00 E-value=6.7e-38 Score=297.68 Aligned_cols=258 Identities=23% Similarity=0.301 Sum_probs=188.6
Q ss_pred ccccccceecCCCceEEEecc----------------cccHHHHHHHHHHHHccC-C-----CcccceeeeeccccccCC
Q 041757 36 RNMLEENLISAGTFGFSHLRR----------------QGAFKSFIAECKALRNIR-H-----RNLIKVLTACLGVDYQGN 93 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~----------------~~~~~~~~~E~~~l~~l~-h-----~nIv~~~~~~~~~~~~~~ 93 (381)
..|.+.++||+|+||.|-++. .....+-..|+.+|..|+ | -|+|+++++ +...
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~-----F~fr 260 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDY-----FYFR 260 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeec-----cccc
Confidence 368889999999999995443 123345566999999997 4 389999999 4558
Q ss_pred ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC--
Q 041757 94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM-- 171 (381)
Q Consensus 94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~-- 171 (381)
++.|||+|.+.. +|.++++. ++...++...++.++.||+.||.+|| +.+|||+||||+|||+...+
T Consensus 261 ~HlciVfELL~~-NLYellK~--------n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~ 328 (586)
T KOG0667|consen 261 NHLCIVFELLST-NLYELLKN--------NKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRS 328 (586)
T ss_pred cceeeeehhhhh-hHHHHHHh--------cCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcC
Confidence 999999999954 99999975 45667999999999999999999999 67999999999999996543
Q ss_pred CeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHH
Q 041757 172 TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAK 251 (381)
Q Consensus 172 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~ 251 (381)
.+||+|||.|......... +..+..|+|||++.+.+|+.+.||||||||++||++|.+. |.++.....+..
T Consensus 329 ~vKVIDFGSSc~~~q~vyt-----YiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PL----fpG~ne~DQl~~ 399 (586)
T KOG0667|consen 329 RIKVIDFGSSCFESQRVYT-----YIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPL----FPGDNEYDQLAR 399 (586)
T ss_pred ceeEEecccccccCCccee-----eeeccccccchhhccCCCCCccceeehhhhHHhHhcCccc----cCCCCHHHHHHH
Confidence 7999999999887665542 5578999999999999999999999999999999999776 556655555444
Q ss_pred HHh--hch----------HHHHHhhh-------hccCc-------hhhh----hcccchhh----hhHHHHHHHHHHHHH
Q 041757 252 MAL--SNH----------VKDIVDSI-------LLNDD-------EKLV----VRGDQKQT----QAKINIIRECVISMV 297 (381)
Q Consensus 252 ~~~--~~~----------~~~~~~~~-------l~~~~-------~~~~----~~~~~~~~----~~~~~~~~~~~~~l~ 297 (381)
..- ... ...++++. ...+. .... .......+ ..........-..++
T Consensus 400 I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~ 479 (586)
T KOG0667|consen 400 IIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFI 479 (586)
T ss_pred HHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHH
Confidence 321 100 11112220 00000 0000 00000011 011111123445789
Q ss_pred HHHHhccCCCCCCCCCHHHHHH
Q 041757 298 RIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 298 ~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
+++.+|+.+||.+|+|..++++
T Consensus 480 dflk~~L~~dP~~R~tp~qal~ 501 (586)
T KOG0667|consen 480 DFLKRCLEWDPAERITPAQALN 501 (586)
T ss_pred HHHHHHhccCchhcCCHHHHhc
Confidence 9999999999999999999986
No 246
>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase. Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ
Probab=100.00 E-value=3e-37 Score=278.53 Aligned_cols=236 Identities=24% Similarity=0.392 Sum_probs=183.8
Q ss_pred ccccccceecCCCceEEEeccc---------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEE
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ---------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVY 100 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~---------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~ 100 (381)
.+|...+.||.|+||.||++.. .....|.+|++++++++||||+++++++ ......++||
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~v~ 78 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVC-----TERSPICLVF 78 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEE-----ccCCceEEEE
Confidence 3577789999999999987531 1246789999999999999999999984 4467789999
Q ss_pred EcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccc
Q 041757 101 EFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180 (381)
Q Consensus 101 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 180 (381)
||+++++|.+++. .....+++..+..++.|++.|+.||| +.+++||||||+||+++.++.++|+|||.
T Consensus 79 e~~~~~~L~~~~~---------~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~ 146 (256)
T cd05112 79 EFMEHGCLSDYLR---------AQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGM 146 (256)
T ss_pred EcCCCCcHHHHHH---------hCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcc
Confidence 9999999999985 23345788999999999999999999 66999999999999999999999999999
Q ss_pred ceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchHH
Q 041757 181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHVK 259 (381)
Q Consensus 181 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 259 (381)
+........... ....++..|+|||++.+..++.++||||||+++||+++ |..||..... .
T Consensus 147 ~~~~~~~~~~~~-~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-----~------------ 208 (256)
T cd05112 147 TRFVLDDQYTSS-TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN-----S------------ 208 (256)
T ss_pred eeecccCccccc-CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH-----H------------
Confidence 876544322111 11235678999999988889999999999999999998 9999752211 1
Q ss_pred HHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 041757 260 DIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHEL 321 (381)
Q Consensus 260 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L 321 (381)
+++........ . ..+...+..+.+++.+||+.+|++|||+.++++.|
T Consensus 209 ~~~~~~~~~~~-~--------------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 209 EVVETINAGFR-L--------------YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred HHHHHHhCCCC-C--------------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 11111100000 0 00112346789999999999999999999999876
No 247
>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a
Probab=100.00 E-value=1.3e-37 Score=280.64 Aligned_cols=236 Identities=17% Similarity=0.220 Sum_probs=187.4
Q ss_pred cccccccceecCCCceEEEecccc---------------cHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEE
Q 041757 35 SRNMLEENLISAGTFGFSHLRRQG---------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALV 99 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~~~---------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv 99 (381)
.++|...++||.|+||.||++... ..+.+.+|++++++++|+||+++++++. .....+++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~l~ 76 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYF-----KNTDLWIV 76 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeee-----cCCcEEEE
Confidence 468999999999999999876521 2567999999999999999999999954 46789999
Q ss_pred EEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecc
Q 041757 100 YEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179 (381)
Q Consensus 100 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg 179 (381)
+||+++++|.+++. .....+++..+..++.|++.||.||| ..+++|+||+|+||+++.++.++|+|||
T Consensus 77 ~e~~~~~~L~~~l~---------~~~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg 144 (256)
T cd06612 77 MEYCGAGSVSDIMK---------ITNKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFG 144 (256)
T ss_pred EecCCCCcHHHHHH---------hCccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccc
Confidence 99999999999984 23456899999999999999999999 6699999999999999999999999999
Q ss_pred cceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHH
Q 041757 180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVK 259 (381)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 259 (381)
++.......... ....++..|+|||++.+..++.++||||||+++|+|++|+.||....... ...
T Consensus 145 ~~~~~~~~~~~~--~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~----~~~--------- 209 (256)
T cd06612 145 VSGQLTDTMAKR--NTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR----AIF--------- 209 (256)
T ss_pred cchhcccCcccc--ccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh----hhh---------
Confidence 998765433211 12347889999999988889999999999999999999999986321110 000
Q ss_pred HHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 260 DIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 260 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
. +....... ...+......+.+++.+||+.||.+|||+.+|++
T Consensus 210 ~-~~~~~~~~----------------~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 210 M-IPNKPPPT----------------LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred h-hccCCCCC----------------CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 0 00000000 0002234567889999999999999999999985
No 248
>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha. Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw
Probab=100.00 E-value=1.3e-37 Score=291.87 Aligned_cols=184 Identities=23% Similarity=0.233 Sum_probs=154.5
Q ss_pred ccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF 95 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~ 95 (381)
++|...++||+|+||.||++.. .....+.+|+.++..++|+||+++++++ .+...
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAF-----QDENN 75 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEE-----ecCCE
Confidence 4788899999999999987542 1223477899999999999999999984 45788
Q ss_pred EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757 96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV 175 (381)
Q Consensus 96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl 175 (381)
.++||||+++|+|.+++.. ....+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||
T Consensus 76 ~~lv~ey~~~g~L~~~l~~---------~~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL 143 (332)
T cd05623 76 LYLVMDYYVGGDLLTLLSK---------FEDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRL 143 (332)
T ss_pred EEEEEeccCCCcHHHHHHH---------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEE
Confidence 9999999999999999952 2456889999999999999999999 679999999999999999999999
Q ss_pred eecccceecCCCCCcccccCccCccceeCCCCcC-----CCccCcccchhhhhHHHHHHHhCCCCCC
Q 041757 176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGV-----GNEVSTIGDVYSYGILLLELMIREKPSD 237 (381)
Q Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDiwSlG~il~el~tg~~Pf~ 237 (381)
+|||++........... ....||+.|+|||++. ...++.++|||||||++|||++|+.||.
T Consensus 144 ~DfG~a~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~ 209 (332)
T cd05623 144 ADFGSCLKLMEDGTVQS-SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY 209 (332)
T ss_pred eecchheecccCCccee-cccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCC
Confidence 99999876543322211 1246999999999886 3457899999999999999999999985
No 249
>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases. Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include
Probab=100.00 E-value=7.6e-37 Score=280.88 Aligned_cols=247 Identities=21% Similarity=0.230 Sum_probs=186.2
Q ss_pred ccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA 97 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~ 97 (381)
++|...+.||.|+||.||++.. .....+.+|++++++++||||+++++++.. ......+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~~~ 77 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLD---ESSSSIG 77 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEc---cCCCeEE
Confidence 4688889999999999977542 134678999999999999999999998753 3355789
Q ss_pred EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757 98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD 177 (381)
Q Consensus 98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D 177 (381)
+||||+++++|.+++.... .....+++..+..++.|++.||.||| ..+++|+||+|+||+++.++.++|+|
T Consensus 78 lv~e~~~~~~L~~~l~~~~------~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d 148 (287)
T cd06621 78 IAMEYCEGGSLDSIYKKVK------KRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCD 148 (287)
T ss_pred EEEEecCCCCHHHHHHHHH------hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEee
Confidence 9999999999999874321 23456888999999999999999999 66999999999999999999999999
Q ss_pred cccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhch
Q 041757 178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH 257 (381)
Q Consensus 178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~ 257 (381)
||++......... ...++..|+|||.+.+..++.++||||||+++|+|++|..||.....................
T Consensus 149 fg~~~~~~~~~~~----~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 224 (287)
T cd06621 149 FGVSGELVNSLAG----TFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP 224 (287)
T ss_pred ccccccccccccc----cccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCC
Confidence 9998755432221 234788999999998889999999999999999999999998644221111111111100000
Q ss_pred HHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
... +...+. .....+..+.+++.+||+.+|.+|||+.|+++
T Consensus 225 ~~~-----~~~~~~----------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 225 NPE-----LKDEPG----------------NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred chh-----hccCCC----------------CCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 000 000000 00123457889999999999999999999987
No 250
>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also
Probab=100.00 E-value=1.8e-37 Score=284.41 Aligned_cols=260 Identities=17% Similarity=0.215 Sum_probs=180.8
Q ss_pred cccccceecCCCceEEEecccc-------------------cHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757 37 NMLEENLISAGTFGFSHLRRQG-------------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA 97 (381)
Q Consensus 37 ~~~~~~~lG~G~fg~V~~~~~~-------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~ 97 (381)
+|...+.||+|+||.||++... ....+.+|+.++++++||||++++++ +.+....+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~-----~~~~~~~~ 75 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV-----LHSDKKLT 75 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHH-----hccCCceE
Confidence 4778899999999999876421 12457789999999999999999999 45577899
Q ss_pred EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757 98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD 177 (381)
Q Consensus 98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D 177 (381)
+|+||+. ++|.+++. .....+++..++.++.||+.||.||| ..+++||||||+||+++.++.+||+|
T Consensus 76 lv~e~~~-~~l~~~~~---------~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d 142 (284)
T cd07839 76 LVFEYCD-QDLKKYFD---------SCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLAD 142 (284)
T ss_pred EEEecCC-CCHHHHHH---------hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECc
Confidence 9999996 58888874 23456899999999999999999999 66999999999999999999999999
Q ss_pred cccceecCCCCCcccccCccCccceeCCCCcCCC-ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhc
Q 041757 178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSN 256 (381)
Q Consensus 178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~ 256 (381)
||+++......... ....++..|+|||++.+. .++.++|||||||++|+|++|..||.........+..........
T Consensus 143 fg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~ 220 (284)
T cd07839 143 FGLARAFGIPVRCY--SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP 220 (284)
T ss_pred cchhhccCCCCCCc--CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCC
Confidence 99998654332211 123478899999988764 478999999999999999999999632211111111111000000
Q ss_pred hHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 257 HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 257 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
. .+.... +...+....... ...........+.....+.+++.+||+.||.+|||+.++++
T Consensus 221 ~-~~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 221 T-EESWPG-VSKLPDYKPYPM-YPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred C-hHHhHH-hhhcccccccCC-CCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0 000000 000000000000 00000001112235567889999999999999999999875
No 251
>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI
Probab=100.00 E-value=3e-37 Score=283.12 Aligned_cols=260 Identities=19% Similarity=0.277 Sum_probs=185.0
Q ss_pred ccccccceecCCCceEEEecccc-------------------cHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757 36 RNMLEENLISAGTFGFSHLRRQG-------------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK 96 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~~-------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~ 96 (381)
++|...++||+|+||.||++... ..+.+.+|+++++.++||||+++++++ ......
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 75 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF-----RRKKRL 75 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhc-----ccCCeE
Confidence 46888899999999999875421 234678899999999999999999995 457789
Q ss_pred EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757 97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG 176 (381)
Q Consensus 97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~ 176 (381)
++||||+++++|..+.. ....+++..++.++.|++.||.||| +.+++|+||+|+||++++++.++|+
T Consensus 76 ~lv~e~~~~~~l~~~~~----------~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~ 142 (286)
T cd07846 76 YLVFEFVDHTVLDDLEK----------YPNGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLC 142 (286)
T ss_pred EEEEecCCccHHHHHHh----------ccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEE
Confidence 99999999999988773 3445899999999999999999999 6699999999999999999999999
Q ss_pred ecccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHh-
Q 041757 177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMAL- 254 (381)
Q Consensus 177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~- 254 (381)
|||++.......... ....++..|+|||++.+ ..++.++||||||+++|||++|+.||... .....+.....
T Consensus 143 dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~----~~~~~~~~~~~~ 216 (286)
T cd07846 143 DFGFARTLAAPGEVY--TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGD----SDIDQLYHIIKC 216 (286)
T ss_pred eeeeeeeccCCcccc--CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCC----chHHHHHHHHHH
Confidence 999998765433221 12457889999998875 44788999999999999999999987522 22111111100
Q ss_pred hchHHHHHhhhhccCchh-hhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 255 SNHVKDIVDSILLNDDEK-LVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 255 ~~~~~~~~~~~l~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
...+...........+.. .................+..+..+.+++.+||+.+|++||++.++++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 217 LGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000000000000000000 00000000000011112345678999999999999999999999875
No 252
>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea
Probab=100.00 E-value=1.6e-37 Score=284.49 Aligned_cols=247 Identities=19% Similarity=0.203 Sum_probs=187.2
Q ss_pred hhhhhccccccccceecCCCceEEEeccc----------------ccHHHHHHHHHHHHcc-CCCcccceeeeeccccc-
Q 041757 29 LEILDVSRNMLEENLISAGTFGFSHLRRQ----------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVDY- 90 (381)
Q Consensus 29 l~~~~~~~~~~~~~~lG~G~fg~V~~~~~----------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~- 90 (381)
.+.....+.|...++||.|+||.||++.. .....+..|+.+++++ +|+||+++++++.....
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 88 (282)
T cd06636 9 SALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPP 88 (282)
T ss_pred hhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhccccc
Confidence 34455678899999999999999987542 2345778899999999 69999999999753211
Q ss_pred cCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCC
Q 041757 91 QGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDD 170 (381)
Q Consensus 91 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~ 170 (381)
......+++|||+++|+|.+++.. .....+++..+..++.|++.||.||| +.+++|+||+|+||+++.+
T Consensus 89 ~~~~~~~iv~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~ 157 (282)
T cd06636 89 GHDDQLWLVMEFCGAGSVTDLVKN--------TKGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTEN 157 (282)
T ss_pred CCCCEEEEEEEeCCCCcHHHHHHH--------ccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCC
Confidence 235688999999999999999853 12345788889999999999999999 6699999999999999999
Q ss_pred CCeEEeecccceecCCCCCcccccCccCccceeCCCCcC-----CCccCcccchhhhhHHHHHHHhCCCCCCccccCCCc
Q 041757 171 MTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGV-----GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMN 245 (381)
Q Consensus 171 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~ 245 (381)
+.++|+|||++......... .....|+..|+|||.+. ...++.++|||||||++|||++|..||.....
T Consensus 158 ~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~---- 231 (282)
T cd06636 158 AEVKLVDFGVSAQLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP---- 231 (282)
T ss_pred CCEEEeeCcchhhhhccccC--CCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCH----
Confidence 99999999998765432211 11245899999999876 34578899999999999999999999852211
Q ss_pred HHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 246 LHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
...... .... . .+. .....++..+.+++.+||+.||.+|||+.++++
T Consensus 232 ~~~~~~---------~~~~-~--~~~---------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 232 MRALFL---------IPRN-P--PPK---------------LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred Hhhhhh---------HhhC-C--CCC---------------CcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 110000 0000 0 000 001235568899999999999999999999875
No 253
>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti
Probab=100.00 E-value=4e-37 Score=277.68 Aligned_cols=233 Identities=20% Similarity=0.292 Sum_probs=185.0
Q ss_pred cccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757 37 NMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA 97 (381)
Q Consensus 37 ~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~ 97 (381)
+|+..++||+|+||.||++.. ...+.+.+|+.++++++||||+++++++ ...+..+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF-----EENGNLY 75 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeee-----cCCCeEE
Confidence 478889999999999976431 2335788999999999999999999984 4577899
Q ss_pred EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757 98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD 177 (381)
Q Consensus 98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D 177 (381)
+||||+++++|.+++.. .....+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|
T Consensus 76 lv~e~~~~~~l~~~~~~--------~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d 144 (256)
T cd08218 76 IVMDYCEGGDLYKKINA--------QRGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGD 144 (256)
T ss_pred EEEecCCCCcHHHHHHh--------ccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEee
Confidence 99999999999999853 12345788999999999999999999 66999999999999999999999999
Q ss_pred cccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhch
Q 041757 178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH 257 (381)
Q Consensus 178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~ 257 (381)
||++.......... ....|++.|+|||++.+..++.++|||||||++|++++|..||... .
T Consensus 145 ~~~~~~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~----~------------- 205 (256)
T cd08218 145 FGIARVLNSTVELA--RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG----N------------- 205 (256)
T ss_pred ccceeecCcchhhh--hhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC----C-------------
Confidence 99998665433221 1235788999999998888999999999999999999999997521 1
Q ss_pred HHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
..+.+...+..... ..+...+.++.+++.+||+.+|.+||++.+|++
T Consensus 206 ~~~~~~~~~~~~~~---------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 206 MKNLVLKIIRGSYP---------------PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred HHHHHHHHhcCCCC---------------CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 11111111111100 012245667899999999999999999999986
No 254
>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2
Probab=100.00 E-value=3.5e-37 Score=282.48 Aligned_cols=259 Identities=19% Similarity=0.259 Sum_probs=181.4
Q ss_pred cccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757 37 NMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA 97 (381)
Q Consensus 37 ~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~ 97 (381)
+|...+.||+|+||.||++.. ...+.+.+|+.++++++||||+++++++. .+...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLM-----QESRLY 75 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEe-----eCCeEE
Confidence 477889999999999988642 12356889999999999999999999954 477899
Q ss_pred EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757 98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD 177 (381)
Q Consensus 98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D 177 (381)
+||||++ ++|.+++... .....+++..+..++.|++.||.||| ..+++||||||+||+++.++.+||+|
T Consensus 76 ~v~e~~~-~~l~~~~~~~-------~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~d 144 (285)
T cd07861 76 LIFEFLS-MDLKKYLDSL-------PKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLAD 144 (285)
T ss_pred EEEecCC-CCHHHHHhcC-------CCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECc
Confidence 9999997 6898888532 12356899999999999999999999 66999999999999999999999999
Q ss_pred cccceecCCCCCcccccCccCccceeCCCCcCCC-ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH--h
Q 041757 178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA--L 254 (381)
Q Consensus 178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~--~ 254 (381)
||++.......... ....+++.|+|||++.+. .++.++||||||+++|+|++|+.||... .......... .
T Consensus 145 fg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~----~~~~~~~~~~~~~ 218 (285)
T cd07861 145 FGLARAFGIPVRVY--THEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGD----SEIDQLFRIFRIL 218 (285)
T ss_pred ccceeecCCCcccc--cCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCC----CHHHHHHHHHHHh
Confidence 99987654332111 113468899999987654 5788999999999999999999997532 1111111100 0
Q ss_pred hchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 255 SNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 255 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
..................... ...............+.++.+++.+||..||.+|||+.+|++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 219 GTPTEDVWPGVTSLPDYKNTF--PKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred CCCChhhhhcchhhHHHHhhc--cccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000000000000000000 000000000111234567889999999999999999999875
No 255
>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta. Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.
Probab=100.00 E-value=1.3e-37 Score=291.82 Aligned_cols=184 Identities=23% Similarity=0.248 Sum_probs=155.8
Q ss_pred ccccccceecCCCceEEEecccc--------------------cHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757 36 RNMLEENLISAGTFGFSHLRRQG--------------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF 95 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~~--------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~ 95 (381)
++|...+.||+|+||.||+++.. ....+.+|+.++..++|+||+++++++ .+.+.
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~-----~~~~~ 75 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAF-----QDENY 75 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCE
Confidence 47889999999999999876521 223467899999999999999999984 45788
Q ss_pred EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757 96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV 175 (381)
Q Consensus 96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl 175 (381)
.++||||+++|+|.+++.. ....+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||
T Consensus 76 ~~lv~Ey~~gg~L~~~l~~---------~~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl 143 (331)
T cd05624 76 LYLVMDYYVGGDLLTLLSK---------FEDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRL 143 (331)
T ss_pred EEEEEeCCCCCcHHHHHHH---------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEE
Confidence 9999999999999999952 2456889999999999999999999 679999999999999999999999
Q ss_pred eecccceecCCCCCcccccCccCccceeCCCCcCC-----CccCcccchhhhhHHHHHHHhCCCCCC
Q 041757 176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-----NEVSTIGDVYSYGILLLELMIREKPSD 237 (381)
Q Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~sDiwSlG~il~el~tg~~Pf~ 237 (381)
+|||+++.......... ....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 144 ~DfG~a~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~ 209 (331)
T cd05624 144 ADFGSCLKMNQDGTVQS-SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY 209 (331)
T ss_pred EeccceeeccCCCceee-ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCcc
Confidence 99999987654332221 12458999999998875 457889999999999999999999985
No 256
>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]
Probab=100.00 E-value=2.7e-38 Score=299.84 Aligned_cols=243 Identities=23% Similarity=0.337 Sum_probs=193.9
Q ss_pred hhccccccccceecCCCceEEEecc---------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccc
Q 041757 32 LDVSRNMLEENLISAGTFGFSHLRR---------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDY 90 (381)
Q Consensus 32 ~~~~~~~~~~~~lG~G~fg~V~~~~---------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 90 (381)
+...+.....++||+|.||.|+.+. .....+|++|+.+|.+|+|+|+|++||+..
T Consensus 106 lIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl---- 181 (1039)
T KOG0199|consen 106 LIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVL---- 181 (1039)
T ss_pred eccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeec----
Confidence 3444556667899999999996643 226789999999999999999999999954
Q ss_pred cCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCC
Q 041757 91 QGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDD 170 (381)
Q Consensus 91 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~ 170 (381)
.....+|||+++.|+|.+.|+. .....|.......++.|||.||.||- .+++|||||..+|+++...
T Consensus 182 --~qp~mMV~ELaplGSLldrLrk--------a~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasp 248 (1039)
T KOG0199|consen 182 --DQPAMMVFELAPLGSLLDRLRK--------AKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASP 248 (1039)
T ss_pred --cchhhHHhhhcccchHHHHHhh--------ccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheeccc
Confidence 3667899999999999999974 24556778888999999999999999 7799999999999999999
Q ss_pred CCeEEeecccceecCCCCCcccc-cCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHH
Q 041757 171 MTARVGDFGLARFLPPTRTQTSS-IDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHK 248 (381)
Q Consensus 171 ~~~kl~Dfg~~~~~~~~~~~~~~-~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~ 248 (381)
..+||+|||+.+.+......... ....-...|.|||.+....|+.+||||+|||++|||+| |+.||- +-.....
T Consensus 249 rtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~----G~~g~qI 324 (1039)
T KOG0199|consen 249 RTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWV----GCRGIQI 324 (1039)
T ss_pred ceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCC----CCCHHHH
Confidence 99999999999988876544322 22335678999999999999999999999999999997 788874 1111111
Q ss_pred HHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 041757 249 FAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQS 323 (381)
Q Consensus 249 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~ 323 (381)
...+|.. .+..-+..|+.++++++..||..+|.+|||+..|.+.+-.
T Consensus 325 ----------L~~iD~~------------------erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 325 ----------LKNIDAG------------------ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred ----------HHhcccc------------------ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence 1111100 0111145799999999999999999999999999865543
No 257
>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3. Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac
Probab=100.00 E-value=5.2e-37 Score=279.61 Aligned_cols=248 Identities=21% Similarity=0.351 Sum_probs=185.0
Q ss_pred ccccceecCCCceEEEeccc----------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccC-Cc
Q 041757 38 MLEENLISAGTFGFSHLRRQ----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQG-ND 94 (381)
Q Consensus 38 ~~~~~~lG~G~fg~V~~~~~----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~-~~ 94 (381)
|...++||+|+||.||++.. ...+.+.+|++++++++||||+++++++....... ..
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 56678999999999986531 12446889999999999999999999875421111 12
Q ss_pred eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757 95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR 174 (381)
Q Consensus 95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k 174 (381)
..++++||+.+|+|.+++...... .....++...++.++.|++.||+||| +.+|+||||||+||+++.++.+|
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~----~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~k 153 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIG----EEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVC 153 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhccc----CCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEE
Confidence 347899999999999887421110 12345788999999999999999999 66999999999999999999999
Q ss_pred EeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHH
Q 041757 175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMA 253 (381)
Q Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~ 253 (381)
|+|||+++...............++..|++||.+....++.++||||||+++|+|++ |..||.... . .......
T Consensus 154 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~----~-~~~~~~~ 228 (273)
T cd05074 154 VADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE----N-SEIYNYL 228 (273)
T ss_pred ECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCC----H-HHHHHHH
Confidence 999999987654332222222345678999999988889999999999999999999 888865221 1 1111000
Q ss_pred hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 041757 254 LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSI 324 (381)
Q Consensus 254 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i 324 (381)
.. .... ..+...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 229 ~~------------~~~~---------------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 229 IK------------GNRL---------------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred Hc------------CCcC---------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 0000 00123456899999999999999999999999999876
No 258
>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k
Probab=100.00 E-value=6.2e-37 Score=275.62 Aligned_cols=232 Identities=24% Similarity=0.349 Sum_probs=180.1
Q ss_pred ceecCCCceEEEecccc-----------------cHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEccc
Q 041757 42 NLISAGTFGFSHLRRQG-----------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMH 104 (381)
Q Consensus 42 ~~lG~G~fg~V~~~~~~-----------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~~~ 104 (381)
++||.|+||.||.+... ....+.+|++++++++|+||+++++++ ......++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~v~e~~~ 75 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC-----VQKQPIYIVMELVP 75 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEE-----ecCCCeEEEEEcCC
Confidence 46999999999875421 346788999999999999999999985 44678899999999
Q ss_pred CCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccceec
Q 041757 105 NRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFL 184 (381)
Q Consensus 105 ~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~ 184 (381)
+++|.+++. .....+++..++.++.+++.||.||| ..+++||||||+||+++.++.+||+|||++...
T Consensus 76 ~~~l~~~l~---------~~~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~ 143 (251)
T cd05041 76 GGSLLTFLR---------KKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREE 143 (251)
T ss_pred CCcHHHHHH---------hcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccc
Confidence 999999985 22346788999999999999999999 669999999999999999999999999999765
Q ss_pred CCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchHHHHHh
Q 041757 185 PPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHVKDIVD 263 (381)
Q Consensus 185 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (381)
.............++..|+|||.+.+..++.++||||||+++|||++ |..||..... ... ...+.
T Consensus 144 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~-----~~~---------~~~~~ 209 (251)
T cd05041 144 EGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN-----QQT---------RERIE 209 (251)
T ss_pred cCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH-----HHH---------HHHHh
Confidence 43222211111234667999999988889999999999999999999 8888742211 000 01111
Q ss_pred hhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 041757 264 SILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQ 322 (381)
Q Consensus 264 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~ 322 (381)
..... ..+...+..+.+++.+||..+|.+|||+.++++.|+
T Consensus 210 ~~~~~------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 210 SGYRM------------------PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred cCCCC------------------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 00000 001234568999999999999999999999999886
No 259
>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of
Probab=100.00 E-value=7.9e-38 Score=293.21 Aligned_cols=224 Identities=21% Similarity=0.190 Sum_probs=168.6
Q ss_pred ecCCCceEEEecccc--------------------cHHHHHHHHHHHHcc---CCCcccceeeeeccccccCCceEEEEE
Q 041757 44 ISAGTFGFSHLRRQG--------------------AFKSFIAECKALRNI---RHRNLIKVLTACLGVDYQGNDFKALVY 100 (381)
Q Consensus 44 lG~G~fg~V~~~~~~--------------------~~~~~~~E~~~l~~l---~h~nIv~~~~~~~~~~~~~~~~~~lv~ 100 (381)
||+|+||+||+++.. ....+..|..++..+ .||||+++++++ ......++||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~-----~~~~~~~lv~ 75 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSF-----QTDSDLYLVT 75 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEE-----ecCCeEEEEE
Confidence 799999999876421 123345567777665 699999999984 5577899999
Q ss_pred EcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccc
Q 041757 101 EFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180 (381)
Q Consensus 101 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 180 (381)
||+++|+|..++ .....+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 76 e~~~~g~L~~~l----------~~~~~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~ 142 (330)
T cd05586 76 DYMSGGELFWHL----------QKEGRFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGL 142 (330)
T ss_pred cCCCCChHHHHH----------HhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCc
Confidence 999999999998 34567899999999999999999999 66999999999999999999999999999
Q ss_pred ceecCCCCCcccccCccCccceeCCCCcCCC-ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHH
Q 041757 181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVK 259 (381)
Q Consensus 181 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 259 (381)
++........ .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.... ....
T Consensus 143 a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~-----~~~~---------- 205 (330)
T cd05586 143 SKANLTDNKT--TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED-----TQQM---------- 205 (330)
T ss_pred CcCCCCCCCC--ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC-----HHHH----------
Confidence 8754332221 1225699999999998764 48999999999999999999999975211 1111
Q ss_pred HHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCC----HHHHHH
Q 041757 260 DIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMK----MTNVVH 319 (381)
Q Consensus 260 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs----~~~vl~ 319 (381)
........... . .......+.+++.+||+.||.+||+ +.++++
T Consensus 206 --~~~i~~~~~~~---------~------~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 206 --YRNIAFGKVRF---------P------KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred --HHHHHcCCCCC---------C------CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 11110000000 0 0123456788999999999999985 555544
No 260
>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development
Probab=100.00 E-value=7.3e-37 Score=277.79 Aligned_cols=236 Identities=19% Similarity=0.277 Sum_probs=179.3
Q ss_pred ccccccceecCCCceEEEeccc----------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN 93 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 93 (381)
.+|...++||+|+||.||++.. .....+.+|+.++++++||||+++++++.. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~ 78 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRD---RAE 78 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEc---CCC
Confidence 4788999999999999977631 123467889999999999999999998542 234
Q ss_pred ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757 94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA 173 (381)
Q Consensus 94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~ 173 (381)
...+++|||+++++|.+++. ....+++...+.++.|++.||.||| ..+++||||||+||+++.++.+
T Consensus 79 ~~~~l~~e~~~~~~L~~~l~----------~~~~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~ 145 (266)
T cd06651 79 KTLTIFMEYMPGGSVKDQLK----------AYGALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNV 145 (266)
T ss_pred CEEEEEEeCCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCE
Confidence 67899999999999999994 3445888999999999999999999 6699999999999999999999
Q ss_pred EEeecccceecCCCCC-cccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHH
Q 041757 174 RVGDFGLARFLPPTRT-QTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM 252 (381)
Q Consensus 174 kl~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~ 252 (381)
||+|||+++....... ........++..|+|||++.+..++.++|||||||++||+++|+.||... .........
T Consensus 146 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~----~~~~~~~~~ 221 (266)
T cd06651 146 KLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY----EAMAAIFKI 221 (266)
T ss_pred EEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcccc----chHHHHHHH
Confidence 9999999876543211 11111245788999999999888999999999999999999999998522 111111000
Q ss_pred HhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 253 ALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 253 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
.... ..+ ..+......+..++ +||..+|++||++.+|++
T Consensus 222 ---------~~~~--~~~----------------~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 222 ---------ATQP--TNP----------------QLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred ---------hcCC--CCC----------------CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 0000 000 01123344555565 788899999999999975
No 261
>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase. Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi
Probab=100.00 E-value=6.7e-37 Score=281.66 Aligned_cols=227 Identities=22% Similarity=0.242 Sum_probs=181.4
Q ss_pred ccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF 95 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~ 95 (381)
++|...+.||+|+||.||++.. ...+.+.+|++++++++||||+++++++ .....
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~ 75 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSF-----QDDSN 75 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCe
Confidence 4788899999999999987542 2345678899999999999999999994 45778
Q ss_pred EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757 96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV 175 (381)
Q Consensus 96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl 175 (381)
.++||||+++++|.+++. ....+++..+..++.|++.||.||| ..+++|+||+|+||+++.++.+||
T Consensus 76 ~~~v~e~~~~~~L~~~~~----------~~~~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl 142 (290)
T cd05580 76 LYLVMEYVPGGELFSHLR----------KSGRFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKI 142 (290)
T ss_pred EEEEEecCCCCCHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEE
Confidence 999999999999999994 4567899999999999999999999 679999999999999999999999
Q ss_pred eecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhh
Q 041757 176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALS 255 (381)
Q Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 255 (381)
+|||++....... ....+++.|+|||.+.+...+.++||||||+++|+|++|..||.... . ......
T Consensus 143 ~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~-~~~~~~--- 209 (290)
T cd05580 143 TDFGFAKRVKGRT-----YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN----P-IQIYEK--- 209 (290)
T ss_pred eeCCCccccCCCC-----CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC----H-HHHHHH---
Confidence 9999998765441 12458899999999988888999999999999999999999975221 1 110000
Q ss_pred chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHH
Q 041757 256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRM-----KMTNVV 318 (381)
Q Consensus 256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~~vl 318 (381)
+... .. ..+......+.+++.+||..||.+|| ++.+++
T Consensus 210 -----~~~~----~~----------------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 210 -----ILEG----KV----------------RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred -----HhcC----Cc----------------cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 0000 00 00123356788899999999999998 555655
No 262
>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti
Probab=100.00 E-value=2.6e-37 Score=282.81 Aligned_cols=237 Identities=22% Similarity=0.291 Sum_probs=184.5
Q ss_pred ccccccccceecCCCceEEEeccc-----------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757 34 VSRNMLEENLISAGTFGFSHLRRQ-----------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK 96 (381)
Q Consensus 34 ~~~~~~~~~~lG~G~fg~V~~~~~-----------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~ 96 (381)
..++|.+.+.||.|+||.||++.. ...+.+.+|++++++++||||+++++.+ ......
T Consensus 3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 77 (280)
T cd06611 3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAY-----FYENKL 77 (280)
T ss_pred chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEE-----ecCCeE
Confidence 457899999999999999987642 2345788999999999999999999995 447788
Q ss_pred EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757 97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG 176 (381)
Q Consensus 97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~ 176 (381)
++||||+++++|.+++. .....+++..++.++.|++.||.||| +.+|+|+||||+||+++.++.++|+
T Consensus 78 ~lv~e~~~~~~L~~~~~---------~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~ 145 (280)
T cd06611 78 WILIEFCDGGALDSIML---------ELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLA 145 (280)
T ss_pred EEEeeccCCCcHHHHHH---------HhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEc
Confidence 99999999999999985 23456899999999999999999999 6699999999999999999999999
Q ss_pred ecccceecCCCCCcccccCccCccceeCCCCcC-----CCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHH
Q 041757 177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGV-----GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAK 251 (381)
Q Consensus 177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~ 251 (381)
|||++.......... ....+++.|+|||++. ...++.++||||||+++|+|++|+.||.... .......
T Consensus 146 d~g~~~~~~~~~~~~--~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~----~~~~~~~ 219 (280)
T cd06611 146 DFGVSAKNKSTLQKR--DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN----PMRVLLK 219 (280)
T ss_pred cCccchhhccccccc--ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCC----HHHHHHH
Confidence 999887554332211 1245889999999874 3457889999999999999999999975321 1111100
Q ss_pred HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 252 MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 252 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
.....+.. ...+...+..+.+++.+||+.+|.+||++.++++
T Consensus 220 -------------~~~~~~~~-------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 220 -------------ILKSEPPT-------------LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred -------------HhcCCCCC-------------cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 00000000 0001234557889999999999999999999976
No 263
>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.
Probab=100.00 E-value=7.2e-37 Score=278.15 Aligned_cols=239 Identities=22% Similarity=0.364 Sum_probs=184.5
Q ss_pred cccccceecCCCceEEEecccc----------------------------cHHHHHHHHHHHHc-cCCCcccceeeeecc
Q 041757 37 NMLEENLISAGTFGFSHLRRQG----------------------------AFKSFIAECKALRN-IRHRNLIKVLTACLG 87 (381)
Q Consensus 37 ~~~~~~~lG~G~fg~V~~~~~~----------------------------~~~~~~~E~~~l~~-l~h~nIv~~~~~~~~ 87 (381)
+|...+.||+|+||.||++... ....+.+|+.++.+ ++||||+++++++.
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~- 79 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFL- 79 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEc-
Confidence 4788899999999999775421 22457788888875 78999999999954
Q ss_pred ccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeee
Q 041757 88 VDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLL 167 (381)
Q Consensus 88 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill 167 (381)
..+..++||||+++++|.+++.... .....+++..++.++.|++.||.|||+. .+++|+||+|+||++
T Consensus 80 ----~~~~~~lv~e~~~~~~l~~~l~~~~------~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~ 147 (269)
T cd08528 80 ----ENDRLYIVMDLIEGAPLGEHFNSLK------EKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIML 147 (269)
T ss_pred ----cCCeEEEEEecCCCCcHHHHHHHHH------hccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEE
Confidence 4778999999999999999884321 2345688999999999999999999942 479999999999999
Q ss_pred CCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHH
Q 041757 168 DDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLH 247 (381)
Q Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~ 247 (381)
+.++.+||+|||.+........ .....|+..|+|||++.+..++.++||||||+++|+|++|+.||... ...
T Consensus 148 ~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~-----~~~ 219 (269)
T cd08528 148 GEDDKVTITDFGLAKQKQPESK---LTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST-----NML 219 (269)
T ss_pred CCCCcEEEecccceeecccccc---cccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCccccc-----CHH
Confidence 9999999999999987654431 12245889999999999888999999999999999999999997521 111
Q ss_pred HHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 041757 248 KFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQ 322 (381)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~ 322 (381)
.... .+......... ....+..+.+++.+||+.||++||++.++.++++
T Consensus 220 ~~~~--------~~~~~~~~~~~------------------~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 220 SLAT--------KIVEAVYEPLP------------------EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred HHHH--------HHhhccCCcCC------------------cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 1110 11111000000 0123457889999999999999999999999875
No 264
>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter
Probab=100.00 E-value=1.1e-36 Score=278.42 Aligned_cols=233 Identities=20% Similarity=0.259 Sum_probs=185.5
Q ss_pred cccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757 35 SRNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK 96 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~ 96 (381)
...|...+.||.|+||.||.+.. .....+.+|+.+++++.|+||+++++.+. +....
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 77 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KGTKL 77 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----ECCEE
Confidence 35677889999999999987642 13456888999999999999999999954 47789
Q ss_pred EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757 97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG 176 (381)
Q Consensus 97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~ 176 (381)
++||||+++|+|.+++. ...+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+
T Consensus 78 ~lv~e~~~~~~L~~~i~-----------~~~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~ 143 (277)
T cd06640 78 WIIMEYLGGGSALDLLR-----------AGPFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLA 143 (277)
T ss_pred EEEEecCCCCcHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEc
Confidence 99999999999999984 235788899999999999999999 6699999999999999999999999
Q ss_pred ecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhc
Q 041757 177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSN 256 (381)
Q Consensus 177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~ 256 (381)
|||++.......... ....++..|+|||++.+..++.++|+||||+++|||++|..||....... ..
T Consensus 144 dfg~~~~~~~~~~~~--~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~----~~------- 210 (277)
T cd06640 144 DFGVAGQLTDTQIKR--NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR----VL------- 210 (277)
T ss_pred ccccceeccCCcccc--ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh----Hh-------
Confidence 999997765433221 12357889999999988889999999999999999999999975322110 00
Q ss_pred hHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041757 257 HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE 320 (381)
Q Consensus 257 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~ 320 (381)
..+.. ..+ ......++..+.+++.+||+.+|.+||++.+++..
T Consensus 211 ---~~~~~---~~~---------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 211 ---FLIPK---NNP---------------PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred ---hhhhc---CCC---------------CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 00000 000 01123466788999999999999999999999764
No 265
>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I
Probab=100.00 E-value=7.2e-37 Score=278.52 Aligned_cols=246 Identities=22% Similarity=0.247 Sum_probs=188.1
Q ss_pred hccccccccceecCCCceEEEeccc----------------ccHHHHHHHHHHHHcc-CCCcccceeeeeccccc-cCCc
Q 041757 33 DVSRNMLEENLISAGTFGFSHLRRQ----------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVDY-QGND 94 (381)
Q Consensus 33 ~~~~~~~~~~~lG~G~fg~V~~~~~----------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~-~~~~ 94 (381)
..+++|...+.||.|+||.||++.. ...+.+.+|+.+++++ .|+||+++++++..... ....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 3578999999999999999988652 1346788999999999 69999999999765222 2356
Q ss_pred eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757 95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR 174 (381)
Q Consensus 95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k 174 (381)
..++||||+++++|.+++.... .....+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~ 153 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLR------KKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVK 153 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHh------hcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEE
Confidence 7899999999999999985321 12467899999999999999999999 67999999999999999999999
Q ss_pred EeecccceecCCCCCcccccCccCccceeCCCCcCC-----CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHH
Q 041757 175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-----NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKF 249 (381)
Q Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~ 249 (381)
|+|||++.......... ....++..|+|||++.. ..++.++||||||+++|++++|..||..... ....
T Consensus 154 l~d~~~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~ 227 (275)
T cd06608 154 LVDFGVSAQLDSTLGRR--NTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP----MRAL 227 (275)
T ss_pred ECCCccceecccchhhh--cCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch----HHHH
Confidence 99999987654432211 12458899999998753 3467889999999999999999999852211 1111
Q ss_pred HHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 250 AKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 250 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
.. +.. ..... ..........+.+++.+||..||++|||+.++++
T Consensus 228 ~~---------~~~----~~~~~-------------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 228 FK---------IPR----NPPPT-------------LKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred HH---------hhc----cCCCC-------------CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 00 000 00000 0001235567889999999999999999999985
No 266
>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a
Probab=100.00 E-value=8.5e-37 Score=283.06 Aligned_cols=240 Identities=20% Similarity=0.201 Sum_probs=183.1
Q ss_pred ccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF 95 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~ 95 (381)
++|...+.||+|+||.||++.. ...+.+.+|+++++.++||||+++++.+ ...+.
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSF-----ETKRH 75 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ecCCE
Confidence 4688899999999999986541 1245677899999999999999999984 45778
Q ss_pred EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757 96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV 175 (381)
Q Consensus 96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl 175 (381)
.++||||+++++|.+++. ....+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||
T Consensus 76 ~~lv~e~~~g~~L~~~l~----------~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l 142 (305)
T cd05609 76 LCMVMEYVEGGDCATLLK----------NIGALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKL 142 (305)
T ss_pred EEEEEecCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEE
Confidence 999999999999999993 3456889999999999999999999 669999999999999999999999
Q ss_pred eecccceecCCCCC-------------cccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccC
Q 041757 176 GDFGLARFLPPTRT-------------QTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEG 242 (381)
Q Consensus 176 ~Dfg~~~~~~~~~~-------------~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~ 242 (381)
+|||+++....... ........++..|+|||.+.+..++.++||||||+++||+++|..||...
T Consensus 143 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~--- 219 (305)
T cd05609 143 TDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD--- 219 (305)
T ss_pred eeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---
Confidence 99999864211100 00111234788999999998888999999999999999999999997421
Q ss_pred CCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 041757 243 DMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQ 322 (381)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~ 322 (381)
.. ........... .. .+. .....+..+.+++.+||+.||++||++.++.+.|+
T Consensus 220 -~~-~~~~~~~~~~~--------~~-~~~----------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 220 -TP-EELFGQVISDD--------IE-WPE----------------GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred -CH-HHHHHHHHhcc--------cC-CCC----------------ccccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 11 11111100000 00 000 00134567899999999999999999876666665
Q ss_pred H
Q 041757 323 S 323 (381)
Q Consensus 323 ~ 323 (381)
.
T Consensus 273 ~ 273 (305)
T cd05609 273 H 273 (305)
T ss_pred C
Confidence 3
No 267
>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include
Probab=100.00 E-value=6.1e-37 Score=281.21 Aligned_cols=237 Identities=19% Similarity=0.240 Sum_probs=182.2
Q ss_pred ccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA 97 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~ 97 (381)
++|...+.||+|+||.||++.. .....+.+|+.++++++|+||+++++.+ ...+..+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~ 75 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF-----FIEGAVY 75 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhhe-----ecCCeEE
Confidence 3678889999999999977542 1245788999999999999999999984 4477899
Q ss_pred EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757 98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD 177 (381)
Q Consensus 98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D 177 (381)
+||||+++++|..++... .....+++..+..++.|++.||.|||+ +.+++||||||+||+++.++.+||+|
T Consensus 76 lv~e~~~~~~l~~~~~~~-------~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d 146 (286)
T cd06622 76 MCMEYMDAGSLDKLYAGG-------VATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCD 146 (286)
T ss_pred EEEeecCCCCHHHHHHhc-------cccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEee
Confidence 999999999999988421 113468999999999999999999994 24899999999999999999999999
Q ss_pred cccceecCCCCCcccccCccCccceeCCCCcCCCc------cCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHH
Q 041757 178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNE------VSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAK 251 (381)
Q Consensus 178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~------~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~ 251 (381)
||++......... ...++..|+|||.+.+.. ++.++|||||||++|+|++|..||..... .....
T Consensus 147 fg~~~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~--- 217 (286)
T cd06622 147 FGVSGNLVASLAK----TNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY--ANIFA--- 217 (286)
T ss_pred cCCcccccCCccc----cCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch--hhHHH---
Confidence 9998765433222 134788999999886543 58899999999999999999999853211 00000
Q ss_pred HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 252 MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 252 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
....+.. ..+. ..+..+..++.+++.+||+.+|++||++.++++
T Consensus 218 -----~~~~~~~----~~~~---------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 218 -----QLSAIVD----GDPP---------------TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred -----HHHHHhh----cCCC---------------CCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 0011111 0000 012346677889999999999999999999986
No 268
>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding
Probab=100.00 E-value=8.3e-37 Score=281.93 Aligned_cols=235 Identities=19% Similarity=0.244 Sum_probs=185.2
Q ss_pred ccccccccceecCCCceEEEecc-----------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757 34 VSRNMLEENLISAGTFGFSHLRR-----------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK 96 (381)
Q Consensus 34 ~~~~~~~~~~lG~G~fg~V~~~~-----------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~ 96 (381)
...+|...+.||.|+||.||++. ....+.+.+|+.+++.++||||+++++.+. ..+..
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~ 91 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL-----VGDEL 91 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEe-----cCceE
Confidence 34579999999999999998653 123567889999999999999999999954 47789
Q ss_pred EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757 97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG 176 (381)
Q Consensus 97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~ 176 (381)
++|+||+++++|..++. ...+++.++..++.|++.||.||| +.+++||||||+||+++.++.+||+
T Consensus 92 ~lv~e~~~~~~L~~~~~-----------~~~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~ 157 (296)
T cd06655 92 FVVMEYLAGGSLTDVVT-----------ETCMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLT 157 (296)
T ss_pred EEEEEecCCCcHHHHHH-----------hcCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEc
Confidence 99999999999999883 235889999999999999999999 6799999999999999999999999
Q ss_pred ecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhc
Q 041757 177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSN 256 (381)
Q Consensus 177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~ 256 (381)
|||++.......... ....++..|+|||.+.+..++.++|||||||++|++++|+.||.... ........
T Consensus 158 dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~----~~~~~~~~---- 227 (296)
T cd06655 158 DFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN----PLRALYLI---- 227 (296)
T ss_pred cCccchhcccccccC--CCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHH----
Confidence 999987654432221 12458889999999988889999999999999999999999975221 11111000
Q ss_pred hHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 257 HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 257 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
.. ...+. ...+...+..+.+++.+||..||.+|||+.+++.
T Consensus 228 -----~~---~~~~~--------------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 228 -----AT---NGTPE--------------LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred -----Hh---cCCcc--------------cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 00 00000 0001234557888999999999999999999985
No 269
>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte
Probab=100.00 E-value=8.8e-37 Score=278.04 Aligned_cols=238 Identities=20% Similarity=0.275 Sum_probs=182.1
Q ss_pred cccccceecCCCceEEEecccc---------------------------cHHHHHHHHHHHHccCCCcccceeeeecccc
Q 041757 37 NMLEENLISAGTFGFSHLRRQG---------------------------AFKSFIAECKALRNIRHRNLIKVLTACLGVD 89 (381)
Q Consensus 37 ~~~~~~~lG~G~fg~V~~~~~~---------------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 89 (381)
+|...+.||.|+||.||++... ..+.+.+|+.+++.++||||+++++++.
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--- 78 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFET--- 78 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEec---
Confidence 4778899999999999876310 1235778999999999999999999853
Q ss_pred ccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCC
Q 041757 90 YQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD 169 (381)
Q Consensus 90 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~ 169 (381)
..+..++||||+++++|.+++. ....+++..+..++.|++.||.||| +.+++|+||+|+||+++.
T Consensus 79 --~~~~~~lv~e~~~~~~L~~~l~----------~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~ 143 (272)
T cd06629 79 --TEEYLSIFLEYVPGGSIGSCLR----------TYGRFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDA 143 (272)
T ss_pred --cCCceEEEEecCCCCcHHHHHh----------hccCCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcC
Confidence 4678899999999999999994 3456888999999999999999999 669999999999999999
Q ss_pred CCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCc--cCcccchhhhhHHHHHHHhCCCCCCccccCCCcHH
Q 041757 170 DMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNE--VSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLH 247 (381)
Q Consensus 170 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~ 247 (381)
++.++|+|||+++...............++..|+|||++.... ++.++|+||||+++|++++|..||... ....
T Consensus 144 ~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~----~~~~ 219 (272)
T cd06629 144 DGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE----EAIA 219 (272)
T ss_pred CCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCc----chHH
Confidence 9999999999997654332222222345889999999887654 789999999999999999999997421 1111
Q ss_pred HHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 248 KFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
.... +......... .......++..+.+++.+||..+|++|||+.+|++
T Consensus 220 ~~~~---------~~~~~~~~~~--------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 220 AMFK---------LGNKRSAPPI--------------PPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred HHHH---------hhccccCCcC--------------CccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 1110 0000000000 00011235678899999999999999999999885
No 270
>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4. Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.
Probab=100.00 E-value=6.4e-37 Score=277.88 Aligned_cols=235 Identities=18% Similarity=0.250 Sum_probs=182.1
Q ss_pred cccccceecCCCceEEEeccc----------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757 37 NMLEENLISAGTFGFSHLRRQ----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND 94 (381)
Q Consensus 37 ~~~~~~~lG~G~fg~V~~~~~----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~ 94 (381)
+|..++.||.|+||.||++.. .....+.+|++++++++|+||+++++++. ...
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~ 75 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCL-----DDN 75 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEee-----cCC
Confidence 477889999999999987531 11356788999999999999999999954 467
Q ss_pred eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757 95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR 174 (381)
Q Consensus 95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k 174 (381)
..++||||+++++|.+++. ....+++..+..++.|++.||+||| ..+++|+||+|+||+++.++.++
T Consensus 76 ~~~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~ 142 (265)
T cd06631 76 TISIFMEFVPGGSISSILN----------RFGPLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIK 142 (265)
T ss_pred eEEEEEecCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEE
Confidence 8999999999999999993 3456788999999999999999999 66999999999999999999999
Q ss_pred EeecccceecCCCCC----cccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHH
Q 041757 175 VGDFGLARFLPPTRT----QTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFA 250 (381)
Q Consensus 175 l~Dfg~~~~~~~~~~----~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~ 250 (381)
|+|||++........ ........++..|+|||++.+..++.++||||||+++|++++|..||... .......
T Consensus 143 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~----~~~~~~~ 218 (265)
T cd06631 143 LIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASM----DRLAAMF 218 (265)
T ss_pred eccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccC----ChHHHHH
Confidence 999999876532111 11111245889999999999888999999999999999999999998522 1111110
Q ss_pred HHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 251 KMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 251 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
.. ... ....+ ..+......+.+++.+||+.+|.+||++.++++
T Consensus 219 ~~---------~~~-~~~~~----------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 219 YI---------GAH-RGLMP----------------RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred Hh---------hhc-cCCCC----------------CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00 000 00000 001234567889999999999999999999875
No 271
>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity
Probab=100.00 E-value=3.5e-37 Score=279.41 Aligned_cols=236 Identities=21% Similarity=0.292 Sum_probs=185.3
Q ss_pred ccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA 97 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~ 97 (381)
++|...+.||.|+||.||++.. ...+.+.+|++++++++||||+++++.+. .....+
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~ 75 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFY-----NNGDIS 75 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeee-----cCCEEE
Confidence 4677888999999999977542 23456889999999999999999999954 468899
Q ss_pred EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCC-CCceeeccCCCCeeeCCCCCeEEe
Q 041757 98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQ-PVTAHCVLKPSNVLLDDDMTARVG 176 (381)
Q Consensus 98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~-~~ivHrDlkp~Nill~~~~~~kl~ 176 (381)
+|+||+++++|.+++.. ....+++..+..++.|++.||.||| + .+++|+||||+||+++.++.++|+
T Consensus 76 lv~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~ 143 (265)
T cd06605 76 ICMEYMDGGSLDKILKE---------VQGRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLC 143 (265)
T ss_pred EEEEecCCCcHHHHHHH---------ccCCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEe
Confidence 99999999999999952 2267889999999999999999999 5 699999999999999999999999
Q ss_pred ecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhc
Q 041757 177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSN 256 (381)
Q Consensus 177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~ 256 (381)
|||.+.......... ..++..|+|||.+.+..++.++||||||+++|++++|..||...........
T Consensus 144 d~g~~~~~~~~~~~~----~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~--------- 210 (265)
T cd06605 144 DFGVSGQLVNSLAKT----FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIF--------- 210 (265)
T ss_pred ecccchhhHHHHhhc----ccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHH---------
Confidence 999987654322111 4588899999999988999999999999999999999999863322111111
Q ss_pred hHHHHHhhhhccCchhhhhcccchhhhhHHHHHH-HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 257 HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIR-ECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 257 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
+.+...+...... .+. .....+.+++.+||..||.+|||+.+++.
T Consensus 211 ---~~~~~~~~~~~~~---------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 211 ---ELLQYIVNEPPPR---------------LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred ---HHHHHHhcCCCCC---------------CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 1111111111000 011 25567899999999999999999999975
No 272
>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase. Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess
Probab=100.00 E-value=1.1e-36 Score=280.37 Aligned_cols=184 Identities=20% Similarity=0.335 Sum_probs=152.1
Q ss_pred ccccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757 34 VSRNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF 95 (381)
Q Consensus 34 ~~~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~ 95 (381)
++++|...+.||+|+||.||++.. .....+.+|+.+++.++|+||+++++++ .....
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~~~~ 77 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII-----HTKET 77 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEE-----ecCCe
Confidence 467899999999999999987531 1223678899999999999999999994 45678
Q ss_pred EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757 96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV 175 (381)
Q Consensus 96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl 175 (381)
.++||||+. ++|.+++. .....+++..+..++.|++.||.||| ..+|+|+||||+||+++.++.+||
T Consensus 78 ~~lv~e~~~-~~l~~~~~---------~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l 144 (291)
T cd07870 78 LTFVFEYMH-TDLAQYMI---------QHPGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKL 144 (291)
T ss_pred EEEEEeccc-CCHHHHHH---------hCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEE
Confidence 899999995 68877763 22345778888999999999999999 669999999999999999999999
Q ss_pred eecccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCC
Q 041757 176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSD 237 (381)
Q Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~ 237 (381)
+|||+++......... ....++..|+|||++.+ ..++.++||||||+++|+|++|..||.
T Consensus 145 ~Dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~ 205 (291)
T cd07870 145 ADFGLARAKSIPSQTY--SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFP 205 (291)
T ss_pred eccccccccCCCCCCC--CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 9999987654332211 12347889999999876 457889999999999999999999986
No 273
>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi
Probab=100.00 E-value=1.3e-36 Score=275.23 Aligned_cols=240 Identities=20% Similarity=0.269 Sum_probs=187.4
Q ss_pred cccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757 37 NMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA 97 (381)
Q Consensus 37 ~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~ 97 (381)
+|...+.||.|+||.||++.. ...+.+.+|+++++.++|+||+++++++.. ......+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~~~ 77 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIID---RSNQTLY 77 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeec---CCCCEEE
Confidence 477889999999999986531 234568889999999999999999997642 3456789
Q ss_pred EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCC--CCCceeeccCCCCeeeCCCCCeEE
Q 041757 98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDC--QPVTAHCVLKPSNVLLDDDMTARV 175 (381)
Q Consensus 98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--~~~ivHrDlkp~Nill~~~~~~kl 175 (381)
++|||+++++|.+++.... .....+++..++.++.|++.||.|||... ..+++|+||+|+||+++.++.+||
T Consensus 78 ~~~e~~~~~~L~~~l~~~~------~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl 151 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKCK------KERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKL 151 (265)
T ss_pred EEehhccCCCHHHHHHHHh------hcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEE
Confidence 9999999999999995321 23467899999999999999999999332 448999999999999999999999
Q ss_pred eecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhh
Q 041757 176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALS 255 (381)
Q Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 255 (381)
+|||++.......... ....++..|+|||++.+..++.++||||||+++|+|++|..||.... ...+...
T Consensus 152 ~d~g~~~~~~~~~~~~--~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~--- 221 (265)
T cd08217 152 GDFGLAKILGHDSSFA--KTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN-----QLQLASK--- 221 (265)
T ss_pred ecccccccccCCcccc--cccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC-----HHHHHHH---
Confidence 9999998765543211 12458999999999988889999999999999999999999975221 1111111
Q ss_pred chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
+..... ...+...+..+.+++.+||+.+|.+||++.+|++
T Consensus 222 ------~~~~~~------------------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 222 ------IKEGKF------------------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred ------HhcCCC------------------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 000000 0012345678899999999999999999999986
No 274
>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5. Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the
Probab=100.00 E-value=8.9e-37 Score=286.55 Aligned_cols=269 Identities=21% Similarity=0.239 Sum_probs=188.0
Q ss_pred ccccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757 34 VSRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND 94 (381)
Q Consensus 34 ~~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~ 94 (381)
+.++|...+.||.|+||.||++.. ...+.+.+|+.+|++++||||+++++++.... ....
T Consensus 3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~ 81 (334)
T cd07855 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFK 81 (334)
T ss_pred hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCc
Confidence 458899999999999999976541 23456788999999999999999999865321 2356
Q ss_pred eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757 95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR 174 (381)
Q Consensus 95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k 174 (381)
..++||||+. ++|.+++. ....+++..+..++.|++.||.||| ..+|+||||||+||+++.++.+|
T Consensus 82 ~~~lv~e~~~-~~l~~~~~----------~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~k 147 (334)
T cd07855 82 DVYVVMDLME-SDLHHIIH----------SDQPLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELR 147 (334)
T ss_pred eEEEEEehhh-hhHHHHhc----------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEE
Confidence 7899999995 69999983 4456899999999999999999999 66999999999999999999999
Q ss_pred EeecccceecCCCCCcc--cccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHH
Q 041757 175 VGDFGLARFLPPTRTQT--SSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAK 251 (381)
Q Consensus 175 l~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~ 251 (381)
|+|||++.......... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... .......
T Consensus 148 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~--~~~~~~~ 225 (334)
T cd07855 148 IGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV--HQLKLIL 225 (334)
T ss_pred ecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH--HHHHHHH
Confidence 99999997664432211 1112468899999998765 46899999999999999999999998532111 0001111
Q ss_pred HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 252 MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 252 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
........++............................+..+.++.+++.+||+.+|++|||+.+++.
T Consensus 226 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 226 SVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred HHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 11111111111110000000000000000000001112345678999999999999999999999887
No 275
>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases. Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki
Probab=100.00 E-value=6.7e-37 Score=276.52 Aligned_cols=222 Identities=22% Similarity=0.322 Sum_probs=172.2
Q ss_pred ceecCCCceEEEeccc--------------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757 42 NLISAGTFGFSHLRRQ--------------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF 95 (381)
Q Consensus 42 ~~lG~G~fg~V~~~~~--------------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~ 95 (381)
+.||+|+||.||++.. .....+.+|+.+++.++||||+++++++.. ..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR------DE 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec------CC
Confidence 4689999999975431 114578899999999999999999998642 45
Q ss_pred EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC----
Q 041757 96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM---- 171 (381)
Q Consensus 96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~---- 171 (381)
.++||||+++|+|.+++.. ....+++..+..++.|++.||.||| +.+|+||||||+||+++.++
T Consensus 75 ~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~ 142 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHR---------EKNNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEG 142 (259)
T ss_pred cEEEEEcCCCCcHHHHHHh---------hccCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccC
Confidence 6899999999999999952 2236889999999999999999999 67999999999999999887
Q ss_pred ---CeEEeecccceecCCCCCcccccCccCccceeCCCCcCCC--ccCcccchhhhhHHHHHHHh-CCCCCCccccCCCc
Q 041757 172 ---TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGN--EVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMN 245 (381)
Q Consensus 172 ---~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~ 245 (381)
.+||+|||++....... ...++..|+|||++.+. .++.++||||||+++|++++ |..||...... .
T Consensus 143 ~~~~~kl~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~--~ 214 (259)
T cd05037 143 YVPFIKLSDPGIPITVLSRE------ERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS--E 214 (259)
T ss_pred CceeEEeCCCCccccccccc------ccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch--h
Confidence 79999999998654411 13467789999998876 78999999999999999999 57776432110 0
Q ss_pred HHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 041757 246 LHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHEL 321 (381)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L 321 (381)
...... ..... + ......+.+++.+||..+|.+|||+.+|++.|
T Consensus 215 ~~~~~~-----------~~~~~--~-------------------~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 215 KERFYQ-----------DQHRL--P-------------------MPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred HHHHHh-----------cCCCC--C-------------------CCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 000000 00000 0 01115788999999999999999999999886
No 276
>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the
Probab=100.00 E-value=7.6e-37 Score=281.29 Aligned_cols=182 Identities=21% Similarity=0.313 Sum_probs=151.9
Q ss_pred ccccccceecCCCceEEEecccc------------------cHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757 36 RNMLEENLISAGTFGFSHLRRQG------------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA 97 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~~------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~ 97 (381)
++|...+.||.|+||.||++... ....+.+|++++++++|+||+++++++ ......+
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 79 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII-----HTKKTLT 79 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEE-----ecCCeEE
Confidence 67889999999999999876421 224567899999999999999999994 4577899
Q ss_pred EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757 98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD 177 (381)
Q Consensus 98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D 177 (381)
+||||+.+ +|.+++.. ....+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|
T Consensus 80 lv~e~~~~-~L~~~~~~---------~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~d 146 (291)
T cd07844 80 LVFEYLDT-DLKQYMDD---------CGGGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLAD 146 (291)
T ss_pred EEEecCCC-CHHHHHHh---------CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECc
Confidence 99999975 99998852 2346889999999999999999999 66999999999999999999999999
Q ss_pred cccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCC
Q 041757 178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSD 237 (381)
Q Consensus 178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~ 237 (381)
||+++......... ....++..|+|||++.+ ..++.++||||||+++|+|++|..||.
T Consensus 147 fg~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~ 205 (291)
T cd07844 147 FGLARAKSVPSKTY--SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFP 205 (291)
T ss_pred cccccccCCCCccc--cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 99987543222111 11246888999998875 458899999999999999999999985
No 277
>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants. Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati
Probab=100.00 E-value=7.9e-37 Score=287.23 Aligned_cols=273 Identities=21% Similarity=0.230 Sum_probs=189.7
Q ss_pred ccccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757 34 VSRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND 94 (381)
Q Consensus 34 ~~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~ 94 (381)
+.+.|...+.||+|+||+||.+.. .....+.+|+.+++.++|+||+++++++.........
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 467899999999999999987542 1234677899999999999999999986643223335
Q ss_pred eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757 95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR 174 (381)
Q Consensus 95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k 174 (381)
..++||||+. ++|.+++ .....+++..+..++.|++.||.||| +.+++||||||+||+++.++.+|
T Consensus 83 ~~~lv~e~~~-~~L~~~~----------~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~k 148 (337)
T cd07858 83 DVYIVYELMD-TDLHQII----------RSSQTLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLK 148 (337)
T ss_pred cEEEEEeCCC-CCHHHHH----------hcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEE
Confidence 6899999995 6899888 34567899999999999999999999 66999999999999999999999
Q ss_pred EeecccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH
Q 041757 175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA 253 (381)
Q Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~ 253 (381)
|+|||+++........ .....++..|+|||.+.. ..++.++|||||||++|+|++|+.||.... ...........
T Consensus 149 L~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--~~~~~~~~~~~ 224 (337)
T cd07858 149 ICDFGLARTTSEKGDF--MTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKD--YVHQLKLITEL 224 (337)
T ss_pred ECcCccccccCCCccc--ccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCC--hHHHHHHHHHH
Confidence 9999999876543211 112457889999998764 468999999999999999999999985321 00111111111
Q ss_pred hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH--HHHh
Q 041757 254 LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE--LQSI 324 (381)
Q Consensus 254 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~--L~~i 324 (381)
......+...........+.................+.++.++.+++.+||+.||++|||+.++++. +..+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 225 LGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 1100000000000000000000000000000011123456788999999999999999999999975 5444
No 278
>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha. Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype
Probab=100.00 E-value=6.9e-37 Score=286.45 Aligned_cols=183 Identities=19% Similarity=0.170 Sum_probs=146.4
Q ss_pred ccceecCC--CceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEE
Q 041757 40 EENLISAG--TFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKAL 98 (381)
Q Consensus 40 ~~~~lG~G--~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~l 98 (381)
..++||+| +||+||++.. ...+.+.+|+.+++.++||||+++++++. .++..++
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~-----~~~~~~l 76 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFI-----ADNELWV 76 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE-----ECCEEEE
Confidence 35789999 6788866541 12345667999999999999999999964 4678899
Q ss_pred EEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeec
Q 041757 99 VYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDF 178 (381)
Q Consensus 99 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df 178 (381)
||||+++|+|.+++.. .....+++..++.++.|++.||.||| +.+|+||||||+||+++.++.++++||
T Consensus 77 v~e~~~~~~l~~~~~~--------~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~ 145 (327)
T cd08227 77 VTSFMAYGSAKDLICT--------HFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGL 145 (327)
T ss_pred EEeccCCCcHHHHHHh--------hccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEccc
Confidence 9999999999999842 12345889999999999999999999 669999999999999999999999999
Q ss_pred ccceecCCCCCcc-----cccCccCccceeCCCCcCC--CccCcccchhhhhHHHHHHHhCCCCCCc
Q 041757 179 GLARFLPPTRTQT-----SSIDVKGSIGYIAPEYGVG--NEVSTIGDVYSYGILLLELMIREKPSDI 238 (381)
Q Consensus 179 g~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~l~~--~~~~~~sDiwSlG~il~el~tg~~Pf~~ 238 (381)
+.+.......... ......++..|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 146 RSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred chhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 8654332211100 0111346778999999876 4589999999999999999999999863
No 279
>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=1.8e-38 Score=318.66 Aligned_cols=237 Identities=23% Similarity=0.295 Sum_probs=187.4
Q ss_pred ccccccccceecCCCceEEEecc-------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757 34 VSRNMLEENLISAGTFGFSHLRR-------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND 94 (381)
Q Consensus 34 ~~~~~~~~~~lG~G~fg~V~~~~-------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~ 94 (381)
++-++..+.+||.|.||.||.+- ....+...+|..++..|+|||+|++||+- -+.+
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVE-----vHRe 1307 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVE-----VHRE 1307 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCcee-----ecHH
Confidence 35567778999999999998753 33456677899999999999999999994 4577
Q ss_pred eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757 95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR 174 (381)
Q Consensus 95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k 174 (381)
..+|.||||.+|+|.+.+ ...+..++.-...+..|++.|++||| +.|||||||||.||+++.+|.+|
T Consensus 1308 kv~IFMEyC~~GsLa~ll----------~~gri~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK 1374 (1509)
T KOG4645|consen 1308 KVYIFMEYCEGGSLASLL----------EHGRIEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIK 1374 (1509)
T ss_pred HHHHHHHHhccCcHHHHH----------HhcchhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEE
Confidence 889999999999999999 45666777777888999999999999 66999999999999999999999
Q ss_pred EeecccceecCCCCCc--ccccCccCccceeCCCCcCCCc---cCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHH
Q 041757 175 VGDFGLARFLPPTRTQ--TSSIDVKGSIGYIAPEYGVGNE---VSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKF 249 (381)
Q Consensus 175 l~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~---~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~ 249 (381)
++|||.|..+...... .......||+.|||||++.+.. ...++||||+|||+.||+||+.||... +.++.-+
T Consensus 1375 ~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~---dne~aIM 1451 (1509)
T KOG4645|consen 1375 YGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAEL---DNEWAIM 1451 (1509)
T ss_pred eecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhc---cchhHHH
Confidence 9999999987665211 1122467999999999988643 567899999999999999999998622 2222222
Q ss_pred HHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 250 AKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 250 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
...... .. +++|.....+-.+++.+|+..||.+|.++.|+++
T Consensus 1452 y~V~~g------------h~----------------Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1452 YHVAAG------------HK----------------PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred hHHhcc------------CC----------------CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 221111 11 1123445667778888999999999999887776
No 280
>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1. Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25
Probab=100.00 E-value=3.4e-37 Score=281.68 Aligned_cols=232 Identities=19% Similarity=0.233 Sum_probs=183.2
Q ss_pred ccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA 97 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~ 97 (381)
..|...+.||.|+||.||++.. ...+.+.+|++++++++||||+++++++ ......+
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 78 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY-----LKGTKLW 78 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhccc-----ccCCceE
Confidence 4577788899999999987631 1234688999999999999999999995 4477899
Q ss_pred EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757 98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD 177 (381)
Q Consensus 98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D 177 (381)
+||||+++++|.+++. ...+++..+..++.|++.|+.||| ..+++|+||+|+||+++.++.++|+|
T Consensus 79 lv~e~~~~~~L~~~~~-----------~~~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~d 144 (277)
T cd06642 79 IIMEYLGGGSALDLLK-----------PGPLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLAD 144 (277)
T ss_pred EEEEccCCCcHHHHhh-----------cCCCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEcc
Confidence 9999999999999883 245788999999999999999999 67999999999999999999999999
Q ss_pred cccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhch
Q 041757 178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH 257 (381)
Q Consensus 178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~ 257 (381)
||++.......... ....++..|+|||++.+..++.++||||||+++|||++|..||....... .. .
T Consensus 145 fg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~----~~-~------ 211 (277)
T cd06642 145 FGVAGQLTDTQIKR--NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR----VL-F------ 211 (277)
T ss_pred ccccccccCcchhh--hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh----HH-h------
Confidence 99987665432211 12357889999999998889999999999999999999999975322110 00 0
Q ss_pred HHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041757 258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE 320 (381)
Q Consensus 258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~ 320 (381)
.+.... .+ ......+..+.+++.+||+.+|++||++.++++.
T Consensus 212 ---~~~~~~--~~----------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 212 ---LIPKNS--PP----------------TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ---hhhcCC--CC----------------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 000000 00 0012345678899999999999999999999973
No 281
>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with
Probab=100.00 E-value=1.4e-36 Score=273.96 Aligned_cols=232 Identities=22% Similarity=0.358 Sum_probs=182.3
Q ss_pred cccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757 37 NMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA 97 (381)
Q Consensus 37 ~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~ 97 (381)
+|...+.||+|+||.||++.. ...+.+.+|+++++.++||||+++++.+ ...+..+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENF-----LEDKALM 75 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeE-----ecCCEEE
Confidence 477889999999999986431 2356788999999999999999999984 4577899
Q ss_pred EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCC-CCeEEe
Q 041757 98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDD-MTARVG 176 (381)
Q Consensus 98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~-~~~kl~ 176 (381)
+||||+++++|.+++.. .....+++..+..++.+++.||.||| +.+++|+||+|+||+++.+ +.+||+
T Consensus 76 lv~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~ 144 (256)
T cd08220 76 IVMEYAPGGTLAEYIQK--------RCNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIG 144 (256)
T ss_pred EEEecCCCCCHHHHHHH--------hcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEc
Confidence 99999999999999953 12345889999999999999999999 6699999999999999855 468999
Q ss_pred ecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhc
Q 041757 177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSN 256 (381)
Q Consensus 177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~ 256 (381)
|||.+.......... ...++..|+|||.+.+..++.++||||||+++|+|++|..||.... ........
T Consensus 145 d~~~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~-----~~~~~~~~--- 213 (256)
T cd08220 145 DFGISKILSSKSKAY---TVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN-----LPALVLKI--- 213 (256)
T ss_pred cCCCceecCCCcccc---ccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc-----hHHHHHHH---
Confidence 999998765443221 2458889999999998888999999999999999999999975221 11111100
Q ss_pred hHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 257 HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 257 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
...... ..+...+..+.+++.+||+.||.+|||+.+++.
T Consensus 214 -----~~~~~~-------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 214 -----MSGTFA-------------------PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred -----HhcCCC-------------------CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 000000 001234567889999999999999999999986
No 282
>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding
Probab=100.00 E-value=3.6e-37 Score=284.46 Aligned_cols=237 Identities=18% Similarity=0.209 Sum_probs=186.1
Q ss_pred hhccccccccceecCCCceEEEeccc-----------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757 32 LDVSRNMLEENLISAGTFGFSHLRRQ-----------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND 94 (381)
Q Consensus 32 ~~~~~~~~~~~~lG~G~fg~V~~~~~-----------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~ 94 (381)
-+..++|...+.||.|+||.||++.. ...+.+.+|+.+++.++|+||+++++++. ...
T Consensus 15 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~ 89 (297)
T cd06656 15 GDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGD 89 (297)
T ss_pred CChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCC
Confidence 34567899999999999999987642 23466788999999999999999999954 477
Q ss_pred eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757 95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR 174 (381)
Q Consensus 95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k 174 (381)
..++||||+++++|.+++. ...+++..+..++.|++.||.||| +.+++||||||+||+++.++.++
T Consensus 90 ~~~lv~e~~~~~~L~~~~~-----------~~~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~ 155 (297)
T cd06656 90 ELWVVMEYLAGGSLTDVVT-----------ETCMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVK 155 (297)
T ss_pred EEEEeecccCCCCHHHHHH-----------hCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEE
Confidence 8999999999999999983 234788899999999999999999 67999999999999999999999
Q ss_pred EeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHh
Q 041757 175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMAL 254 (381)
Q Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 254 (381)
|+|||++.......... ....+++.|+|||.+.+..++.++|||||||++|++++|..||....... .....
T Consensus 156 l~Dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~----~~~~~-- 227 (297)
T cd06656 156 LTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR----ALYLI-- 227 (297)
T ss_pred ECcCccceEccCCccCc--CcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcch----heeee--
Confidence 99999987654433221 12358889999999988889999999999999999999999985221100 00000
Q ss_pred hchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 255 SNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 255 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
.....+. ...+...+..+.+++.+||+.||++||++.++++
T Consensus 228 ----------~~~~~~~--------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 228 ----------ATNGTPE--------------LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred ----------ccCCCCC--------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000000 0001234556788999999999999999999987
No 283
>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=1.4e-37 Score=292.89 Aligned_cols=232 Identities=21% Similarity=0.280 Sum_probs=190.6
Q ss_pred ccccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757 34 VSRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND 94 (381)
Q Consensus 34 ~~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~ 94 (381)
-..+|.+.+.||+|.|+.|.++.. ...+.+.+|+++|+.|+|||||+++.+ .+...
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v-----~~t~~ 128 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSV-----IETEA 128 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeee-----eeecc
Confidence 457799999999999999977652 234568899999999999999999999 56788
Q ss_pred eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757 95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR 174 (381)
Q Consensus 95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k 174 (381)
.+|+||||+.+|.+.+++ .+...+.+..+..++.|+.+|++||| ++.|||||||++|||++.+..+|
T Consensus 129 ~lylV~eya~~ge~~~yl----------~~~gr~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnik 195 (596)
T KOG0586|consen 129 TLYLVMEYASGGELFDYL----------VKHGRMKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIK 195 (596)
T ss_pred eeEEEEEeccCchhHHHH----------HhcccchhhhhhhhhHHHHHHHHHHh---hcceeccccchhhccccccccee
Confidence 999999999999999999 56777888999999999999999999 77999999999999999999999
Q ss_pred EeecccceecCCCCCcccccCccCccceeCCCCcCCCcc-CcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH
Q 041757 175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEV-STIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA 253 (381)
Q Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~ 253 (381)
|+|||++..+....... .++|++.|.|||++.+..| ++.+|+||+|+++|.|+.|..||+...
T Consensus 196 IaDfgfS~~~~~~~~lq---t~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~------------- 259 (596)
T KOG0586|consen 196 IADFGFSTFFDYGLMLQ---TFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN------------- 259 (596)
T ss_pred eeccccceeeccccccc---ccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc-------------
Confidence 99999998887544333 3689999999999999776 688999999999999999999986221
Q ss_pred hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 254 LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 254 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
++++-.+.+.... .++.-...++.+++++++-.+|.+|+++.++.+
T Consensus 260 ----lk~Lr~rvl~gk~----------------rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 260 ----LKELRPRVLRGKY----------------RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred ----cccccchheeeee----------------cccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 1111111111111 112234456778888999999999999999876
No 284
>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning
Probab=100.00 E-value=1.6e-36 Score=278.54 Aligned_cols=260 Identities=19% Similarity=0.241 Sum_probs=185.9
Q ss_pred ccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK 96 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~ 96 (381)
++|...++||+|+||.||++.. ...+.+.+|++++++++|+||+++++++. ..+..
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~ 75 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFR-----RKGRL 75 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEE-----ECCEE
Confidence 3688899999999999987542 12357889999999999999999999954 46789
Q ss_pred EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757 97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG 176 (381)
Q Consensus 97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~ 176 (381)
++||||++++.+..+. .....+++..+..++.|++.||.||| ..+++|+||+|+||++++++.+||+
T Consensus 76 ~iv~e~~~~~~l~~~~----------~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~ 142 (288)
T cd07833 76 YLVFEYVERTLLELLE----------ASPGGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLC 142 (288)
T ss_pred EEEEecCCCCHHHHHH----------hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEE
Confidence 9999999987777665 34456899999999999999999999 6699999999999999999999999
Q ss_pred ecccceecCCCCCcccccCccCccceeCCCCcCCC-ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHH--H
Q 041757 177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM--A 253 (381)
Q Consensus 177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~--~ 253 (381)
|||++.......... .....++..|+|||++.+. .++.++||||||+++|+|++|..||.... ........ .
T Consensus 143 d~g~~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~----~~~~~~~~~~~ 217 (288)
T cd07833 143 DFGFARALRARPASP-LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDS----DIDQLYLIQKC 217 (288)
T ss_pred eeecccccCCCcccc-ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHH
Confidence 999988765543211 1224578899999999887 78999999999999999999999975221 11111110 0
Q ss_pred hhchHHHHHhhhhccCchhhh-hcccch-hhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 254 LSNHVKDIVDSILLNDDEKLV-VRGDQK-QTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 254 ~~~~~~~~~~~~l~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
........... ...+..... ...... ........+..++..+.+++.+||..+|++|||+.++++
T Consensus 218 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 218 LGPLPPSHQEL-FSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred hCCCCHHHhhh-cccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00000000000 000000000 000000 000011112234678999999999999999999999875
No 285
>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)
Probab=100.00 E-value=1.2e-36 Score=277.43 Aligned_cols=231 Identities=19% Similarity=0.210 Sum_probs=183.9
Q ss_pred ccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA 97 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~ 97 (381)
++|...+.||.|+||.||++.. .....+.+|+++++.++|+||+++++.+. +....+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFL-----KGSKLW 75 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEE-----ECCeEE
Confidence 4688889999999999987642 22456889999999999999999999854 467899
Q ss_pred EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757 98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD 177 (381)
Q Consensus 98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D 177 (381)
+|+||+++++|.+++. . ..+++..+..++.|++.||.||| +.+++|+||+|+||++++++.++|+|
T Consensus 76 ~v~e~~~~~~L~~~~~----------~-~~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d 141 (274)
T cd06609 76 IIMEYCGGGSCLDLLK----------P-GKLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLAD 141 (274)
T ss_pred EEEEeeCCCcHHHHHh----------h-cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcc
Confidence 9999999999999984 2 27899999999999999999999 67999999999999999999999999
Q ss_pred cccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhch
Q 041757 178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH 257 (381)
Q Consensus 178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~ 257 (381)
||+++........ .....++..|+|||++.+..++.++||||||+++|+|++|..||...... ...
T Consensus 142 ~g~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~-----~~~------- 207 (274)
T cd06609 142 FGVSGQLTSTMSK--RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM-----RVL------- 207 (274)
T ss_pred cccceeecccccc--cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH-----HHH-------
Confidence 9999877654221 11245788999999999888999999999999999999999998532110 000
Q ss_pred HHHHHhhhhccCchhhhhcccchhhhhHHHHHHH-HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRE-CVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
..+........ ... .+..+.+++.+||..||++|||+.++++
T Consensus 208 --~~~~~~~~~~~------------------~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 208 --FLIPKNNPPSL------------------EGNKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred --HHhhhcCCCCC------------------cccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 00000000000 011 4557888999999999999999999987
No 286
>smart00219 TyrKc Tyrosine kinase, catalytic domain. Phosphotransferases. Tyrosine-specific kinase subfamily.
Probab=100.00 E-value=2.4e-36 Score=272.50 Aligned_cols=234 Identities=25% Similarity=0.430 Sum_probs=182.5
Q ss_pred cccceecCCCceEEEecccc----------------------cHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757 39 LEENLISAGTFGFSHLRRQG----------------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK 96 (381)
Q Consensus 39 ~~~~~lG~G~fg~V~~~~~~----------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~ 96 (381)
...+.||.|+||.||.+... ..+.+..|+.++..++|+||+++++++. ..+..
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~ 76 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCT-----EEEPL 76 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEc-----CCCee
Confidence 45688999999999775321 3568889999999999999999999954 45789
Q ss_pred EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757 97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG 176 (381)
Q Consensus 97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~ 176 (381)
+++|||+++++|.+++... ....+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+
T Consensus 77 ~~i~e~~~~~~l~~~~~~~--------~~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~ 145 (258)
T smart00219 77 MIVMEYMEGGDLLDYLRKN--------RPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKIS 145 (258)
T ss_pred EEEEeccCCCCHHHHHHhh--------hhccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEc
Confidence 9999999999999999521 1122899999999999999999999 6799999999999999999999999
Q ss_pred ecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhh
Q 041757 177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALS 255 (381)
Q Consensus 177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~ 255 (381)
|||++............ ...++..|+|||.+.+..++.++||||||+++|+|++ |..||... ........
T Consensus 146 dfg~~~~~~~~~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~-----~~~~~~~~--- 216 (258)
T smart00219 146 DFGLSRDLYDDDYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM-----SNEEVLEY--- 216 (258)
T ss_pred ccCCceecccccccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHH---
Confidence 99999877654332221 1236789999999988889999999999999999998 78886521 11111110
Q ss_pred chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 041757 256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHEL 321 (381)
Q Consensus 256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L 321 (381)
+...... ..+...+.++.+++.+||..||++|||+.++++.|
T Consensus 217 -----~~~~~~~-------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 217 -----LKKGYRL-------------------PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -----HhcCCCC-------------------CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0000000 00123566789999999999999999999998764
No 287
>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]
Probab=100.00 E-value=8.4e-37 Score=278.89 Aligned_cols=260 Identities=23% Similarity=0.280 Sum_probs=194.2
Q ss_pred cccccceecCCCceEEEecc------------cccHHHHHHHHHHHHcc--CCCcccceeeeeccccccCCceEEEEEEc
Q 041757 37 NMLEENLISAGTFGFSHLRR------------QGAFKSFIAECKALRNI--RHRNLIKVLTACLGVDYQGNDFKALVYEF 102 (381)
Q Consensus 37 ~~~~~~~lG~G~fg~V~~~~------------~~~~~~~~~E~~~l~~l--~h~nIv~~~~~~~~~~~~~~~~~~lv~e~ 102 (381)
.....++||+|+||.||++. ...++.|.+|-+|.... +|+||++|++.-...+. ....++||+||
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~-~~~eywLVt~f 289 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTA-DRMEYWLVTEF 289 (534)
T ss_pred chhhHHHhhcCccceeehhhccCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCc-cccceeEEeee
Confidence 34445779999999998875 34678899999998854 79999999998433211 14478999999
Q ss_pred ccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCC------CCCceeeccCCCCeeeCCCCCeEEe
Q 041757 103 MHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDC------QPVTAHCVLKPSNVLLDDDMTARVG 176 (381)
Q Consensus 103 ~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~------~~~ivHrDlkp~Nill~~~~~~kl~ 176 (381)
.+.|+|.+||. ...++|....+++..+++||+|||++. ++.|+|||||..|||+.+++++.|+
T Consensus 290 h~kGsL~dyL~-----------~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIa 358 (534)
T KOG3653|consen 290 HPKGSLCDYLK-----------ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIA 358 (534)
T ss_pred ccCCcHHHHHH-----------hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEee
Confidence 99999999994 467999999999999999999999643 5679999999999999999999999
Q ss_pred ecccceecCCCCCcccccCccCccceeCCCCcCCCc-cC-----cccchhhhhHHHHHHHhCCCCC------------Cc
Q 041757 177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNE-VS-----TIGDVYSYGILLLELMIREKPS------------DI 238 (381)
Q Consensus 177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~-----~~sDiwSlG~il~el~tg~~Pf------------~~ 238 (381)
|||+|..+............+||.+|||||++.+.. +. .+.||||+|.|+|||+++-.-+ ..
T Consensus 359 DFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ 438 (534)
T KOG3653|consen 359 DFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEA 438 (534)
T ss_pred ccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhH
Confidence 999999888665555555578999999999988743 22 3579999999999999864433 21
Q ss_pred cccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 041757 239 MFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVV 318 (381)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl 318 (381)
.......+..+....+....+-.+.... + -...+..+.+.+.-||..||+.|.|+.-|.
T Consensus 439 evG~hPt~e~mq~~VV~kK~RP~~p~~W------------------~---~h~~~~~l~et~EeCWDhDaeARLTA~Cv~ 497 (534)
T KOG3653|consen 439 EVGNHPTLEEMQELVVRKKQRPKIPDAW------------------R---KHAGMAVLCETIEECWDHDAEARLTAGCVE 497 (534)
T ss_pred HhcCCCCHHHHHHHHHhhccCCCChhhh------------------h---cCccHHHHHHHHHHHcCCchhhhhhhHHHH
Confidence 1122222333222222111110000000 0 013456788889999999999999999999
Q ss_pred HHHHHhhhhcC
Q 041757 319 HELQSIKNTLL 329 (381)
Q Consensus 319 ~~L~~i~~~~~ 329 (381)
+++.++.....
T Consensus 498 eR~~~l~~~~~ 508 (534)
T KOG3653|consen 498 ERMAELMMLWE 508 (534)
T ss_pred HHHHHHhccCC
Confidence 99998876654
No 288
>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re
Probab=100.00 E-value=2.6e-36 Score=273.98 Aligned_cols=236 Identities=18% Similarity=0.226 Sum_probs=180.4
Q ss_pred ccccccceecCCCceEEEeccc----------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN 93 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 93 (381)
.+|...++||+|+||.||.+.. ...+.+.+|+.++++++||||+++++++.+ ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~ 78 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRD---PME 78 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEecc---CCC
Confidence 4788999999999999976531 123567889999999999999999998532 224
Q ss_pred ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757 94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA 173 (381)
Q Consensus 94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~ 173 (381)
...++||||+++++|.+++. ....+++..++.++.|++.||.||| +.+++|+||||+||+++.++.+
T Consensus 79 ~~~~~v~e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~ 145 (265)
T cd06652 79 RTLSIFMEHMPGGSIKDQLK----------SYGALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNV 145 (265)
T ss_pred ceEEEEEEecCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCE
Confidence 56789999999999999984 3455788889999999999999999 6699999999999999999999
Q ss_pred EEeecccceecCCCCCc-ccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHH
Q 041757 174 RVGDFGLARFLPPTRTQ-TSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM 252 (381)
Q Consensus 174 kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~ 252 (381)
+|+|||++......... .......++..|+|||++.+..++.++||||||+++|++++|+.||... .........
T Consensus 146 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~----~~~~~~~~~ 221 (265)
T cd06652 146 KLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEF----EAMAAIFKI 221 (265)
T ss_pred EECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCcc----chHHHHHHH
Confidence 99999998765432111 1111245889999999998888999999999999999999999997521 111111100
Q ss_pred HhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 253 ALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 253 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
.... ..+ ..+......+.+++.+||. +|.+||++++|++
T Consensus 222 ~~~~-----------~~~----------------~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 222 ATQP-----------TNP----------------VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred hcCC-----------CCC----------------CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 0000 000 0123445677888889984 9999999999875
No 289
>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express
Probab=100.00 E-value=5.2e-37 Score=282.76 Aligned_cols=234 Identities=19% Similarity=0.250 Sum_probs=181.3
Q ss_pred cccccccceecCCCceEEEeccc-----------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757 35 SRNMLEENLISAGTFGFSHLRRQ-----------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA 97 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~~-----------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~ 97 (381)
.+.|.....||.|+||.||++.. ...+.+.+|+.+++.++|+||+++++.+. ..+..+
T Consensus 21 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-----~~~~~~ 95 (292)
T cd06658 21 REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL-----VGDELW 95 (292)
T ss_pred HHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHhee-----cCCeEE
Confidence 45566667899999999987642 23456889999999999999999999853 467889
Q ss_pred EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757 98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD 177 (381)
Q Consensus 98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D 177 (381)
+||||+++++|.+++. ...+++..+..++.||+.||.||| +.+|+||||||+||+++.++.++|+|
T Consensus 96 lv~e~~~~~~L~~~~~-----------~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~d 161 (292)
T cd06658 96 VVMEFLEGGALTDIVT-----------HTRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSD 161 (292)
T ss_pred EEEeCCCCCcHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcc
Confidence 9999999999999883 235788999999999999999999 66999999999999999999999999
Q ss_pred cccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhch
Q 041757 178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH 257 (381)
Q Consensus 178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~ 257 (381)
||++.......... ....|+..|+|||.+.+..++.++||||||+++||+++|..||... ........
T Consensus 162 fg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~----~~~~~~~~------ 229 (292)
T cd06658 162 FGFCAQVSKEVPKR--KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNE----PPLQAMRR------ 229 (292)
T ss_pred CcchhhcccccccC--ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHH------
Confidence 99987554332211 1245889999999998888999999999999999999999997521 11111100
Q ss_pred HHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
+...+..... ........+.+++.+||..||.+|||+.++++
T Consensus 230 ----~~~~~~~~~~----------------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 271 (292)
T cd06658 230 ----IRDNLPPRVK----------------DSHKVSSVLRGFLDLMLVREPSQRATAQELLQ 271 (292)
T ss_pred ----HHhcCCCccc----------------cccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0000000000 01123456788899999999999999999997
No 290
>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex
Probab=100.00 E-value=2e-36 Score=277.37 Aligned_cols=258 Identities=20% Similarity=0.254 Sum_probs=181.2
Q ss_pred cccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757 37 NMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA 97 (381)
Q Consensus 37 ~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~ 97 (381)
+|+..+.||.|+||.||++.. .....+.+|++++++++||||+++++++ .+.+..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY 75 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhc-----ccCCcEE
Confidence 588889999999999988642 1225688999999999999999999994 4577899
Q ss_pred EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757 98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD 177 (381)
Q Consensus 98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D 177 (381)
+||||+. ++|.+++.. .....+++..+..++.|++.||+||| ..+++|+||+|+||+++.++.+||+|
T Consensus 76 ~v~e~~~-~~l~~~~~~--------~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~d 143 (284)
T cd07860 76 LVFEFLH-QDLKKFMDA--------SPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLAD 143 (284)
T ss_pred EEeeccc-cCHHHHHHh--------CCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEee
Confidence 9999996 689998853 22456889999999999999999999 66999999999999999999999999
Q ss_pred cccceecCCCCCcccccCccCccceeCCCCcCCCc-cCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH--h
Q 041757 178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNE-VSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA--L 254 (381)
Q Consensus 178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~--~ 254 (381)
||++.......... ....++..|+|||++.+.. ++.++||||||+++|+|+||+.||... .......... .
T Consensus 144 fg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~----~~~~~~~~~~~~~ 217 (284)
T cd07860 144 FGLARAFGVPVRTY--THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD----SEIDQLFRIFRTL 217 (284)
T ss_pred ccchhhcccCcccc--ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC----CHHHHHHHHHHHh
Confidence 99987654332211 1134688899999887644 588899999999999999999997522 1111111100 0
Q ss_pred hchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 255 SNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 255 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
.......... ....+.... ..............+.....+.+++.+||+.||.+|||+.+++.
T Consensus 218 ~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 218 GTPDEVVWPG-VTSLPDYKP-SFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred CCCChhhhhh-hhHHHHHHh-hcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0000000000 000000000 00000000011112234456789999999999999999999875
No 291
>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]
Probab=100.00 E-value=5.5e-37 Score=278.55 Aligned_cols=244 Identities=24% Similarity=0.299 Sum_probs=190.8
Q ss_pred cccccchhhhhcccc-ccccceecCCCceEEEecc--------------------cccHHHHHHHHHHHHccCCCcccce
Q 041757 23 VGKLKNLEILDVSRN-MLEENLISAGTFGFSHLRR--------------------QGAFKSFIAECKALRNIRHRNLIKV 81 (381)
Q Consensus 23 ~~~~~~l~~~~~~~~-~~~~~~lG~G~fg~V~~~~--------------------~~~~~~~~~E~~~l~~l~h~nIv~~ 81 (381)
+.+-++||...++.+ |+.-++||+||||.|+-.. .......++|-.+|.+++.+.||.+
T Consensus 171 FlQWK~lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVsl 250 (591)
T KOG0986|consen 171 FLQWKWLELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSL 250 (591)
T ss_pred HHHHHHHHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEE
Confidence 345567777666655 6777999999999994322 2344556789999999999999988
Q ss_pred eeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccC
Q 041757 82 LTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLK 161 (381)
Q Consensus 82 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlk 161 (381)
-.. +++.+.+++||..|.||||.-+|+. .....+++..++-++.+|+.||++|| ..+||.||||
T Consensus 251 aYA-----feTkd~LClVLtlMNGGDLkfHiyn--------~g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLK 314 (591)
T KOG0986|consen 251 AYA-----FETKDALCLVLTLMNGGDLKFHIYN--------HGNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLK 314 (591)
T ss_pred eee-----ecCCCceEEEEEeecCCceeEEeec--------cCCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCC
Confidence 666 6789999999999999999999864 23457999999999999999999999 5699999999
Q ss_pred CCCeeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCcccc
Q 041757 162 PSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFE 241 (381)
Q Consensus 162 p~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~ 241 (381)
|+|||+|+.|+++|+|+|+|..+........ .+||.+|||||++.+..|+...|.||+||++|||+.|+.||.....
T Consensus 315 PeNILLDd~GhvRISDLGLAvei~~g~~~~~---rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke 391 (591)
T KOG0986|consen 315 PENILLDDHGHVRISDLGLAVEIPEGKPIRG---RVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE 391 (591)
T ss_pred hhheeeccCCCeEeeccceEEecCCCCcccc---ccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh
Confidence 9999999999999999999998877665543 3699999999999999999999999999999999999999863221
Q ss_pred CCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCH
Q 041757 242 GDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKM 314 (381)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 314 (381)
.. -.+-++.+...++.+ .+....++..+|....|..||.+|.-.
T Consensus 392 Kv--------------k~eEvdrr~~~~~~e---------------y~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 392 KV--------------KREEVDRRTLEDPEE---------------YSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred hh--------------hHHHHHHHHhcchhh---------------cccccCHHHHHHHHHHHccCHHHhccC
Confidence 11 112233333333222 123444566666667778888877543
No 292
>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK
Probab=100.00 E-value=3.2e-36 Score=284.89 Aligned_cols=185 Identities=23% Similarity=0.231 Sum_probs=154.5
Q ss_pred ccccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeecccc-ccCC
Q 041757 34 VSRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVD-YQGN 93 (381)
Q Consensus 34 ~~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~-~~~~ 93 (381)
..++|...+.||+|+||.||++.. .....+.+|+.+++.++|+||+++++++.... ..+.
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 458899999999999999977641 12346778999999999999999999865311 1233
Q ss_pred ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757 94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA 173 (381)
Q Consensus 94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~ 173 (381)
...++||||+. ++|.+.+. . .++...+..++.|++.||.||| ..+++||||||+||+++.++.+
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~----------~--~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~ 157 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQ----------M--DLDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTL 157 (353)
T ss_pred CcEEEEEeccC-CCHHHHHh----------h--cCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCE
Confidence 56799999996 58888873 2 2788899999999999999999 6699999999999999999999
Q ss_pred EEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCC
Q 041757 174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSD 237 (381)
Q Consensus 174 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~ 237 (381)
||+|||+++........ ....++..|+|||.+.+..++.++|||||||++|+|++|+.||.
T Consensus 158 kL~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~ 218 (353)
T cd07850 158 KILDFGLARTAGTSFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFP 218 (353)
T ss_pred EEccCccceeCCCCCCC---CCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCC
Confidence 99999999876543321 12457889999999999999999999999999999999999975
No 293
>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase. Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea
Probab=100.00 E-value=3.5e-36 Score=275.95 Aligned_cols=258 Identities=20% Similarity=0.243 Sum_probs=184.7
Q ss_pred cccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757 37 NMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA 97 (381)
Q Consensus 37 ~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~ 97 (381)
+|...+.||.|+||.||++.. .....+.+|+.++++++||||+++++++ ......+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~ 75 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVF-----PHGSGFV 75 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCeeE
Confidence 478889999999999987641 1246788999999999999999999995 4477889
Q ss_pred EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757 98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD 177 (381)
Q Consensus 98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D 177 (381)
+||||+ +++|.+++.. ....+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|
T Consensus 76 ~v~e~~-~~~L~~~~~~---------~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~d 142 (286)
T cd07832 76 LVMEYM-PSDLSEVLRD---------EERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIAD 142 (286)
T ss_pred EEeccc-CCCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEee
Confidence 999999 9999999852 3356899999999999999999999 66999999999999999999999999
Q ss_pred cccceecCCCCCcccccCccCccceeCCCCcCCC-ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH--h
Q 041757 178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA--L 254 (381)
Q Consensus 178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~--~ 254 (381)
||++......... ......++..|+|||++.+. .++.++||||+|+++|||++|.+||.. ......+.... .
T Consensus 143 fg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~----~~~~~~~~~~~~~~ 217 (286)
T cd07832 143 FGLARLFSEEEPR-LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPG----ENDIEQLAIVFRTL 217 (286)
T ss_pred eeecccccCCCCC-ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCC----CCHHHHHHHHHHHc
Confidence 9999876544321 11124588999999988654 468999999999999999999877642 22211111110 0
Q ss_pred hchHHHHHhhhhc-cCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 255 SNHVKDIVDSILL-NDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 255 ~~~~~~~~~~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
............. ........ ............++....+.+++.+||..||.+|||+.++++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 218 GTPNEETWPGLTSLPDYNKITF--PESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred CCCChHHHhhccCcchhhcccC--CCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 0000000000000 00000000 000000011112344578999999999999999999999986
No 294
>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their
Probab=100.00 E-value=2.3e-36 Score=274.48 Aligned_cols=237 Identities=21% Similarity=0.310 Sum_probs=183.9
Q ss_pred cccccceecCCCceEEEeccc-----------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757 37 NMLEENLISAGTFGFSHLRRQ-----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN 93 (381)
Q Consensus 37 ~~~~~~~lG~G~fg~V~~~~~-----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 93 (381)
+|+.++.||+|+||.||.+.. ...+.+.+|++++++++|+||+++++++ ...
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~ 75 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGAT-----CED 75 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhcee-----ccC
Confidence 578889999999999987531 1246788999999999999999999994 457
Q ss_pred ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC-C
Q 041757 94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM-T 172 (381)
Q Consensus 94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~-~ 172 (381)
+..++||||+++++|.+++. ....+++..+..++.|++.||.||| +.+++|+||+|+||+++.++ .
T Consensus 76 ~~~~~v~e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~ 142 (268)
T cd06630 76 SHFNLFVEWMAGGSVSHLLS----------KYGAFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQR 142 (268)
T ss_pred CeEEEEEeccCCCcHHHHHH----------HhCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCE
Confidence 78999999999999999984 3456889999999999999999999 66999999999999998775 6
Q ss_pred eEEeecccceecCCCCCcc--cccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHH
Q 041757 173 ARVGDFGLARFLPPTRTQT--SSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFA 250 (381)
Q Consensus 173 ~kl~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~ 250 (381)
+||+|||.+.......... ......++..|+|||.+.+..++.++||||+|+++|++++|..||...... ......
T Consensus 143 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~ 220 (268)
T cd06630 143 LRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS--NHLALI 220 (268)
T ss_pred EEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc--chHHHH
Confidence 9999999987765432111 111245788999999998888999999999999999999999998522111 101100
Q ss_pred HHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 251 KMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 251 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
. ..... ...+ ..+.....++.+++.+||..+|.+|||+.++++
T Consensus 221 ~--------~~~~~--~~~~----------------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 221 F--------KIASA--TTAP----------------SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred H--------HHhcc--CCCC----------------CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 0 00000 0000 112345678889999999999999999999985
No 295
>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase. Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1
Probab=100.00 E-value=2.7e-36 Score=273.66 Aligned_cols=242 Identities=20% Similarity=0.232 Sum_probs=186.5
Q ss_pred ccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA 97 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~ 97 (381)
++|+..+.||.|+||+||.+.. ...+.+.+|+++++.++|+||+++++.+ ......+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 75 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF-----VVGDELW 75 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEE-----eeCCEEE
Confidence 4788999999999999976541 1356788999999999999999999985 4477899
Q ss_pred EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757 98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD 177 (381)
Q Consensus 98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D 177 (381)
+||||+++++|.+++.... ....+++..+..++.|++.||.||| +.+++|+||+|+||++++++.++|+|
T Consensus 76 iv~e~~~~~~l~~~~~~~~-------~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~d 145 (267)
T cd06610 76 LVMPYLSGGSLLDIMKSSY-------PRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIAD 145 (267)
T ss_pred EEEeccCCCcHHHHHHHhc-------ccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcc
Confidence 9999999999999995311 1246889999999999999999999 66999999999999999999999999
Q ss_pred cccceecCCCCCcc--cccCccCccceeCCCCcCCC-ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHh
Q 041757 178 FGLARFLPPTRTQT--SSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMAL 254 (381)
Q Consensus 178 fg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 254 (381)
||++.......... ......|+..|+|||++... .++.++|+||||+++|+|++|+.||...... ..+..
T Consensus 146 f~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~----~~~~~--- 218 (267)
T cd06610 146 FGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM----KVLML--- 218 (267)
T ss_pred cchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh----hhHHH---
Confidence 99987765543321 12224588999999998776 7899999999999999999999998633111 11100
Q ss_pred hchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 255 SNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 255 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
... ..+.... . .......+..+.+++.+||..||++|||+.++++
T Consensus 219 ------~~~----~~~~~~~--~--------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 219 ------TLQ----NDPPSLE--T--------GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred ------Hhc----CCCCCcC--C--------ccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000 0000000 0 0001245567889999999999999999999985
No 296
>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1. Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.
Probab=100.00 E-value=1.7e-36 Score=274.07 Aligned_cols=231 Identities=20% Similarity=0.282 Sum_probs=184.2
Q ss_pred cccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757 37 NMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK 96 (381)
Q Consensus 37 ~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~ 96 (381)
+|...++||.|+||.||++.. ...+.+.+|++++++++||||+++++. +.+....
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-----~~~~~~~ 75 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYS-----FQDEENM 75 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHh-----hcCCCeE
Confidence 588899999999999977642 235678899999999999999999998 4567889
Q ss_pred EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757 97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG 176 (381)
Q Consensus 97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~ 176 (381)
++|+||+.+++|.+++. ....+++..+..++.|++.||.||| ..+++|+||+|+||++++++.++|+
T Consensus 76 ~lv~e~~~~~~L~~~l~----------~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~ 142 (258)
T cd05578 76 YLVVDLLLGGDLRYHLS----------QKVKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHIT 142 (258)
T ss_pred EEEEeCCCCCCHHHHHH----------hcCCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEe
Confidence 99999999999999994 3457889999999999999999999 6699999999999999999999999
Q ss_pred ecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhc
Q 041757 177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSN 256 (381)
Q Consensus 177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~ 256 (381)
|||.+......... ....|+..|+|||.+....++.++|+||||+++|++++|..||...... ....+...
T Consensus 143 d~~~~~~~~~~~~~---~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~---- 213 (258)
T cd05578 143 DFNIATKVTPDTLT---TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT--IRDQIRAK---- 213 (258)
T ss_pred ecccccccCCCccc---cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc--HHHHHHHH----
Confidence 99998766543221 1245888999999998888999999999999999999999998633211 01111100
Q ss_pred hHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCH--HHHH
Q 041757 257 HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKM--TNVV 318 (381)
Q Consensus 257 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~--~~vl 318 (381)
... .. ...+...+..+.+++.+||+.||.+||++ .|++
T Consensus 214 -----~~~---~~----------------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 214 -----QET---AD----------------VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred -----hcc---cc----------------ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 000 00 01123455788999999999999999999 5544
No 297
>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of
Probab=100.00 E-value=3.9e-36 Score=272.16 Aligned_cols=235 Identities=23% Similarity=0.322 Sum_probs=188.5
Q ss_pred ccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA 97 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~ 97 (381)
++|...+.||.|+||.||++.. .....+.+|+..+.+++|+||+++++++. .....+
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFY-----KEGEIS 75 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-----cCCeEE
Confidence 4688889999999999977642 23577899999999999999999999954 468899
Q ss_pred EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCC-CCceeeccCCCCeeeCCCCCeEEe
Q 041757 98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQ-PVTAHCVLKPSNVLLDDDMTARVG 176 (381)
Q Consensus 98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~-~~ivHrDlkp~Nill~~~~~~kl~ 176 (381)
+||||+++++|.+++. ....+++..++.++.|++.|+.||| . .+++|+||+|+||+++.++.++|+
T Consensus 76 lv~e~~~~~~L~~~l~----------~~~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~ 142 (264)
T cd06623 76 IVLEYMDGGSLADLLK----------KVGKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIA 142 (264)
T ss_pred EEEEecCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEc
Confidence 9999999999999994 3467899999999999999999999 6 799999999999999999999999
Q ss_pred ecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhc
Q 041757 177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSN 256 (381)
Q Consensus 177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~ 256 (381)
|||.+.......... ....++..|+|||.+....++.++||||||+++|+|++|..||..... .....
T Consensus 143 df~~~~~~~~~~~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~--~~~~~-------- 210 (264)
T cd06623 143 DFGISKVLENTLDQC--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ--PSFFE-------- 210 (264)
T ss_pred cCccceecccCCCcc--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc--cCHHH--------
Confidence 999998765443322 124578899999999888899999999999999999999999853322 11111
Q ss_pred hHHHHHhhhhccCchhhhhcccchhhhhHHHHHHH-HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 257 HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRE-CVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 257 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
+.......... ..... .+..+.+++.+||+.+|++|||+.++++
T Consensus 211 ----~~~~~~~~~~~---------------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 211 ----LMQAICDGPPP---------------SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred ----HHHHHhcCCCC---------------CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 11111100000 00112 5678999999999999999999999987
No 298
>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins. Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily
Probab=100.00 E-value=7e-36 Score=277.16 Aligned_cols=234 Identities=24% Similarity=0.311 Sum_probs=180.9
Q ss_pred hhccccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeecccccc
Q 041757 32 LDVSRNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQ 91 (381)
Q Consensus 32 ~~~~~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 91 (381)
.+..+.|...++||+|+||.||++.. ...+.+.+|+++++.++||||++++++|.
T Consensus 11 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~----- 85 (307)
T cd06607 11 DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYL----- 85 (307)
T ss_pred CCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEE-----
Confidence 34567799999999999999987641 12356889999999999999999999965
Q ss_pred CCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC
Q 041757 92 GNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM 171 (381)
Q Consensus 92 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~ 171 (381)
.....++||||+. |+|.+++. .....+++..+..++.|++.||.||| ..+++||||+|+||+++.++
T Consensus 86 ~~~~~~lv~e~~~-g~l~~~~~---------~~~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~ 152 (307)
T cd06607 86 REHTAWLVMEYCL-GSASDILE---------VHKKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPG 152 (307)
T ss_pred eCCeEEEEHHhhC-CCHHHHHH---------HcccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCC
Confidence 3667899999996 57777764 22346899999999999999999999 66999999999999999999
Q ss_pred CeEEeecccceecCCCCCcccccCccCccceeCCCCcC---CCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHH
Q 041757 172 TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGV---GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHK 248 (381)
Q Consensus 172 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~ 248 (381)
.++|+|||++....... ...++..|+|||++. ...++.++||||||+++|||++|+.||.... ....
T Consensus 153 ~~kL~dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~----~~~~ 222 (307)
T cd06607 153 TVKLADFGSASLVSPAN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN----AMSA 222 (307)
T ss_pred CEEEeecCcceecCCCC------CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCcc----HHHH
Confidence 99999999987654322 134788999999874 3568899999999999999999999974221 1000
Q ss_pred HHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041757 249 FAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE 320 (381)
Q Consensus 249 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~ 320 (381)
... +.. ...+.. ....++..+.+++.+||+.||.+||++.+|+..
T Consensus 223 ~~~---------~~~---~~~~~~---------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 223 LYH---------IAQ---NDSPTL---------------SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred HHH---------Hhc---CCCCCC---------------CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000 000 000000 012355678999999999999999999999864
No 299
>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15. Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul
Probab=100.00 E-value=3.4e-36 Score=282.96 Aligned_cols=267 Identities=20% Similarity=0.254 Sum_probs=185.4
Q ss_pred ccccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHcc-CCCcccceeeeeccccccCC
Q 041757 34 VSRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGN 93 (381)
Q Consensus 34 ~~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~ 93 (381)
+.++|...++||+|+||.||++.. .....+.+|+.+++++ +||||+++++++.. .+.
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~---~~~ 81 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA---END 81 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeecc---CCC
Confidence 567899999999999999987531 1234567899999999 99999999998642 334
Q ss_pred ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757 94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA 173 (381)
Q Consensus 94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~ 173 (381)
...++||||++ ++|..++. .. .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~----------~~-~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~ 146 (337)
T cd07852 82 KDIYLVFEYME-TDLHAVIR----------AN-ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRV 146 (337)
T ss_pred ceEEEEecccc-cCHHHHHh----------cC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcE
Confidence 56899999997 59999884 22 6788889999999999999999 6799999999999999999999
Q ss_pred EEeecccceecCCCCCc---ccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHH
Q 041757 174 RVGDFGLARFLPPTRTQ---TSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKF 249 (381)
Q Consensus 174 kl~Dfg~~~~~~~~~~~---~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~ 249 (381)
||+|||++......... .......|+..|+|||++.+ ..++.++||||||+++|+|++|+.||....... .....
T Consensus 147 kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~-~~~~~ 225 (337)
T cd07852 147 KLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN-QLEKI 225 (337)
T ss_pred EEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH-HHHHH
Confidence 99999999866543321 12223568899999998765 457899999999999999999999975221110 01111
Q ss_pred HHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041757 250 AKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE 320 (381)
Q Consensus 250 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~ 320 (381)
.... .......+..+........................+..+.++.+++.+||+.||++|||+.++++.
T Consensus 226 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 226 IEVI-GPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHh-CCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000 000000000000000000000000000000111122356789999999999999999999999974
No 300
>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1. Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops
Probab=100.00 E-value=3.7e-36 Score=271.36 Aligned_cols=231 Identities=21% Similarity=0.260 Sum_probs=181.9
Q ss_pred cccccceecCCCceEEEeccc----------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757 37 NMLEENLISAGTFGFSHLRRQ----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND 94 (381)
Q Consensus 37 ~~~~~~~lG~G~fg~V~~~~~----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~ 94 (381)
+|...+.||+|+||.||++.. ...+.+.+|+.+++.++|+||+++++++ ....
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~ 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE-----REED 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE-----ecCC
Confidence 367788999999999977531 1346788999999999999999999985 4467
Q ss_pred eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757 95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR 174 (381)
Q Consensus 95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k 174 (381)
..++||||+++++|.+++. ....+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.+|
T Consensus 76 ~~~lv~e~~~~~~L~~~~~----------~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~k 142 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLK----------KYGSFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVK 142 (258)
T ss_pred eEEEEEEecCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEE
Confidence 8899999999999999994 3456889999999999999999999 66999999999999999999999
Q ss_pred EeecccceecCCCCCcccccCccCccceeCCCCcCCCc-cCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH
Q 041757 175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNE-VSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA 253 (381)
Q Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~ 253 (381)
|+|||++......... ....++..|+|||.+.... ++.++|+||||+++|++++|+.||.... .........
T Consensus 143 l~d~~~~~~~~~~~~~---~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~----~~~~~~~~~ 215 (258)
T cd06632 143 LADFGMAKQVVEFSFA---KSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE----GVAAVFKIG 215 (258)
T ss_pred EccCccceeccccccc---cccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc----HHHHHHHHH
Confidence 9999998776443311 1245889999999887766 8999999999999999999999985321 111100000
Q ss_pred hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 254 LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 254 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
.... . ...+......+.+++.+||+.+|.+||++.+++.
T Consensus 216 ~~~~--------~-------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 216 RSKE--------L-------------------PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred hccc--------C-------------------CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 0000 0 0011234567888999999999999999999975
No 301
>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin
Probab=100.00 E-value=1.9e-36 Score=282.03 Aligned_cols=237 Identities=22% Similarity=0.251 Sum_probs=183.2
Q ss_pred ccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF 95 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~ 95 (381)
++|...+.||+|+||.||++.. ...+.+.+|+++++.++|+||+++++.+ .....
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~ 75 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASF-----QTETY 75 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeee-----ecCCE
Confidence 4688889999999999987642 1345688899999999999999999994 45778
Q ss_pred EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757 96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV 175 (381)
Q Consensus 96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl 175 (381)
.++||||+.+++|.+++.. .....+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|
T Consensus 76 ~~lv~e~~~~~~L~~~~~~--------~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l 144 (316)
T cd05574 76 LCLVMDYCPGGELFRLLQR--------QPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIML 144 (316)
T ss_pred EEEEEEecCCCCHHHHHHh--------CCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEE
Confidence 9999999999999999852 22356899999999999999999999 669999999999999999999999
Q ss_pred eecccceecCCCCCc---------------------------ccccCccCccceeCCCCcCCCccCcccchhhhhHHHHH
Q 041757 176 GDFGLARFLPPTRTQ---------------------------TSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLE 228 (381)
Q Consensus 176 ~Dfg~~~~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~e 228 (381)
+|||++......... .......|+..|+|||++.+..++.++||||||+++|+
T Consensus 145 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~ 224 (316)
T cd05574 145 SDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYE 224 (316)
T ss_pred eecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHH
Confidence 999998755332110 01112457889999999998889999999999999999
Q ss_pred HHhCCCCCCccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCC
Q 041757 229 LMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESP 308 (381)
Q Consensus 229 l~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP 308 (381)
|++|..||..... ...+ ..+......... ....+..+.+++.+||+.||
T Consensus 225 l~~g~~pf~~~~~----~~~~---------~~~~~~~~~~~~------------------~~~~~~~~~~li~~~l~~~p 273 (316)
T cd05574 225 MLYGTTPFKGSNR----DETF---------SNILKKEVTFPG------------------SPPVSSSARDLIRKLLVKDP 273 (316)
T ss_pred HhhCCCCCCCCch----HHHH---------HHHhcCCccCCC------------------ccccCHHHHHHHHHHccCCH
Confidence 9999999852211 1111 111110000000 11246789999999999999
Q ss_pred CCCCC----HHHHHH
Q 041757 309 QDRMK----MTNVVH 319 (381)
Q Consensus 309 ~~RPs----~~~vl~ 319 (381)
++||| +.+++.
T Consensus 274 ~~R~s~~~~~~~ll~ 288 (316)
T cd05574 274 SKRLGSKRGAAEIKQ 288 (316)
T ss_pred hHCCCchhhHHHHHc
Confidence 99999 555554
No 302
>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1. Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the
Probab=100.00 E-value=3.5e-36 Score=277.22 Aligned_cols=264 Identities=21% Similarity=0.188 Sum_probs=182.5
Q ss_pred ccccccceecCCCceEEEecccc-------------------cHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757 36 RNMLEENLISAGTFGFSHLRRQG-------------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK 96 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~~-------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~ 96 (381)
++|...+.||.|+||.||++... ....+.+|+.++++++||||+++++++.. .+....
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~---~~~~~~ 81 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVG---SNLDKI 81 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEe---cCCCcE
Confidence 57888999999999999886521 12356789999999999999999998653 223789
Q ss_pred EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757 97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG 176 (381)
Q Consensus 97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~ 176 (381)
++||||+.+ +|.+++.. ....+++..++.++.|++.||+||| ..+++|+||||+||+++.++.+||+
T Consensus 82 ~lv~e~~~~-~L~~~~~~---------~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~ 148 (293)
T cd07843 82 YMVMEYVEH-DLKSLMET---------MKQPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKIC 148 (293)
T ss_pred EEEehhcCc-CHHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEe
Confidence 999999974 99998852 2346899999999999999999999 6699999999999999999999999
Q ss_pred ecccceecCCCCCcccccCccCccceeCCCCcCCC-ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhh
Q 041757 177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALS 255 (381)
Q Consensus 177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 255 (381)
|||++.......... ....++..|+|||.+.+. .++.++||||||+++|+|++|..||...... ............
T Consensus 149 d~g~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~-~~~~~~~~~~~~ 225 (293)
T cd07843 149 DFGLAREYGSPLKPY--TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI-DQLNKIFKLLGT 225 (293)
T ss_pred ecCceeeccCCcccc--ccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCC
Confidence 999998765542211 123478899999988764 4689999999999999999999998532110 011111110000
Q ss_pred chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHH-HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRE-CVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
. ..............................++.. ....+.+++.+||+.||++|||+.|+++
T Consensus 226 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 226 P-TEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred C-chHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0 0000000000000000000000000000001111 3567889999999999999999999985
No 303
>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]
Probab=100.00 E-value=1.2e-36 Score=263.24 Aligned_cols=246 Identities=17% Similarity=0.167 Sum_probs=189.8
Q ss_pred cccccccc-ceecCCCceEEEecccc------------cHHHHHHHHHHHHccC-CCcccceeeeeccccccCCceEEEE
Q 041757 34 VSRNMLEE-NLISAGTFGFSHLRRQG------------AFKSFIAECKALRNIR-HRNLIKVLTACLGVDYQGNDFKALV 99 (381)
Q Consensus 34 ~~~~~~~~-~~lG~G~fg~V~~~~~~------------~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~~~~~~lv 99 (381)
++++|.+. ++||-|-.|.|....+. ......+|+++.-..+ |||||++++++.. .+.+...+.+|
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~KARrEVeLHw~~s~h~~iV~IidVyeN-s~~~rkcLLiV 137 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSPKARREVELHWMASGHPHIVSIIDVYEN-SYQGRKCLLIV 137 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCHHHHhHhhhhhhhcCCCceEEeehhhhh-hccCceeeEee
Confidence 56777754 79999999999443211 2345678999877775 9999999999764 35667888999
Q ss_pred EEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCC---CCCeEEe
Q 041757 100 YEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD---DMTARVG 176 (381)
Q Consensus 100 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~---~~~~kl~ 176 (381)
||.|+||.|..-+.. .....+++.++..|+.||+.|+.||| +.+|.||||||+|+|... +..+||+
T Consensus 138 mE~meGGeLfsriq~--------~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLt 206 (400)
T KOG0604|consen 138 MECMEGGELFSRIQD--------RGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLT 206 (400)
T ss_pred eecccchHHHHHHHH--------cccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEec
Confidence 999999999999965 45677999999999999999999999 779999999999999965 4479999
Q ss_pred ecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhc
Q 041757 177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSN 256 (381)
Q Consensus 177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~ 256 (381)
|||+|+......... ..+-|+.|.|||++...+|+..+|+||+||++|-|++|.+||.+..... +++
T Consensus 207 DfGFAK~t~~~~~L~---TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a----------isp 273 (400)
T KOG0604|consen 207 DFGFAKETQEPGDLM---TPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA----------ISP 273 (400)
T ss_pred ccccccccCCCcccc---CCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc----------CCh
Confidence 999998765433322 3568999999999999999999999999999999999999997543321 122
Q ss_pred hHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 257 HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 257 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
.++.-+..---.-| .+-....+.+..++++..|..+|++|.|+.++++
T Consensus 274 gMk~rI~~gqy~FP---------------~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 274 GMKRRIRTGQYEFP---------------EPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred hHHhHhhccCccCC---------------ChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 22221111000000 0113456667788889999999999999999986
No 304
>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6. Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs
Probab=100.00 E-value=3.3e-36 Score=275.79 Aligned_cols=236 Identities=19% Similarity=0.273 Sum_probs=177.1
Q ss_pred ccccccceecCCCceEEEeccc------------------ccHHHHHHHHHH-HHccCCCcccceeeeeccccccCCceE
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKA-LRNIRHRNLIKVLTACLGVDYQGNDFK 96 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~-l~~l~h~nIv~~~~~~~~~~~~~~~~~ 96 (381)
++|...+.||+|+||.||++.. .....+..|+.+ ++.++||||+++++++. ..+..
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~-----~~~~~ 75 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALF-----REGDV 75 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEe-----cCCcE
Confidence 4788899999999999988642 123456667765 55668999999999954 46678
Q ss_pred EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCC-CceeeccCCCCeeeCCCCCeEE
Q 041757 97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQP-VTAHCVLKPSNVLLDDDMTARV 175 (381)
Q Consensus 97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~-~ivHrDlkp~Nill~~~~~~kl 175 (381)
++||||++ |+|.+++.... .....+++..++.++.|++.||.||| +. +++||||||+||+++.++.+||
T Consensus 76 ~lv~e~~~-~~l~~~l~~~~------~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl 145 (283)
T cd06617 76 WICMEVMD-TSLDKFYKKVY------DKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKL 145 (283)
T ss_pred EEEhhhhc-ccHHHHHHHhc------cCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEE
Confidence 99999996 68888875321 23356899999999999999999999 54 8999999999999999999999
Q ss_pred eecccceecCCCCCcccccCccCccceeCCCCcCC----CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHH
Q 041757 176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG----NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAK 251 (381)
Q Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~----~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~ 251 (381)
+|||++.......... ...++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.... .......
T Consensus 146 ~dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~- 218 (283)
T cd06617 146 CDFGISGYLVDSVAKT---IDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWK---TPFQQLK- 218 (283)
T ss_pred eecccccccccccccc---cccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccc---cCHHHHH-
Confidence 9999987654332211 1347889999998865 446889999999999999999999975211 1111111
Q ss_pred HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 252 MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 252 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
..........+ ....+.++.+++.+||..+|.+||++.++++
T Consensus 219 --------~~~~~~~~~~~------------------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 219 --------QVVEEPSPQLP------------------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred --------HHHhcCCCCCC------------------ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11110000000 0124567889999999999999999999986
No 305
>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i
Probab=100.00 E-value=2.5e-36 Score=278.89 Aligned_cols=234 Identities=18% Similarity=0.244 Sum_probs=181.5
Q ss_pred ccccccceecCCCceEEEeccc-----------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEE
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ-----------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKAL 98 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~-----------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~l 98 (381)
..|.....||+|+||.||++.. ...+.+.+|+.++..++||||+++++.+. ..+..++
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-----~~~~~~i 95 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL-----VGEELWV 95 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhhee-----eCCeEEE
Confidence 4455566899999999977631 23457889999999999999999999854 4678999
Q ss_pred EEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeec
Q 041757 99 VYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDF 178 (381)
Q Consensus 99 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df 178 (381)
||||+++++|..++. ...+++..++.++.|++.||.||| +.+++||||||+||+++.++.+||+||
T Consensus 96 v~e~~~~~~L~~~~~-----------~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~df 161 (297)
T cd06659 96 LMEFLQGGALTDIVS-----------QTRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDF 161 (297)
T ss_pred EEecCCCCCHHHHHh-----------hcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeec
Confidence 999999999999873 245789999999999999999999 669999999999999999999999999
Q ss_pred ccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchH
Q 041757 179 GLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHV 258 (381)
Q Consensus 179 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 258 (381)
|++.......... ....|+..|+|||++.+..++.++|||||||++|||++|+.||... .........
T Consensus 162 g~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~----~~~~~~~~~------ 229 (297)
T cd06659 162 GFCAQISKDVPKR--KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSD----SPVQAMKRL------ 229 (297)
T ss_pred hhHhhcccccccc--cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHH------
Confidence 9987554332211 1245889999999998888999999999999999999999997521 111111100
Q ss_pred HHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041757 259 KDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE 320 (381)
Q Consensus 259 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~ 320 (381)
........ ......+..+.+++.+||+.+|.+||++.++++.
T Consensus 230 ----~~~~~~~~----------------~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 230 ----RDSPPPKL----------------KNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred ----hccCCCCc----------------cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000000 0011234567889999999999999999999984
No 306
>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is
Probab=100.00 E-value=1.1e-35 Score=274.51 Aligned_cols=256 Identities=20% Similarity=0.245 Sum_probs=182.3
Q ss_pred cccccceecCCCceEEEecccc----------------------cHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757 37 NMLEENLISAGTFGFSHLRRQG----------------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND 94 (381)
Q Consensus 37 ~~~~~~~lG~G~fg~V~~~~~~----------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~ 94 (381)
+|...++||.|+||.||++... ....+..|++++++++|+||+++++++ .+..
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVF-----GHKS 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhhee-----ecCC
Confidence 4777889999999999876411 124567899999999999999999995 4477
Q ss_pred eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757 95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR 174 (381)
Q Consensus 95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k 174 (381)
..++||||+ +|+|.+++.. ....+++..++.++.|+++||.||| ..+++|+||+|+||+++.++.++
T Consensus 76 ~~~lv~e~~-~~~L~~~i~~---------~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~ 142 (298)
T cd07841 76 NINLVFEFM-ETDLEKVIKD---------KSIVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLK 142 (298)
T ss_pred EEEEEEccc-CCCHHHHHhc---------cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEE
Confidence 899999999 8999999942 2236899999999999999999999 66999999999999999999999
Q ss_pred EeecccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH
Q 041757 175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA 253 (381)
Q Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~ 253 (381)
|+|||++........... ...+++.|+|||.+.+ ..++.++|||||||++|||++|.+||.. ......+....
T Consensus 143 l~dfg~~~~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~----~~~~~~~~~~~ 216 (298)
T cd07841 143 LADFGLARSFGSPNRKMT--HQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPG----DSDIDQLGKIF 216 (298)
T ss_pred EccceeeeeccCCCcccc--ccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccC----CccHHHHHHHH
Confidence 999999987654322211 1346788999998765 4578999999999999999999777642 22222111110
Q ss_pred --hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 254 --LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 254 --~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
.............. .+.. .....................+.+++.+||+.||.+|||+.++++
T Consensus 217 ~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 217 EALGTPTEENWPGVTS-LPDY--VEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred HHcCCCchhhhhhccc-cccc--ccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 00000000000000 0000 000000000111122345678899999999999999999999998
No 307
>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1. Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U
Probab=100.00 E-value=8.8e-36 Score=279.00 Aligned_cols=262 Identities=20% Similarity=0.272 Sum_probs=184.6
Q ss_pred hhccccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccC
Q 041757 32 LDVSRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQG 92 (381)
Q Consensus 32 ~~~~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 92 (381)
...+++|...+.||.|+||.||++.. ...+.+.+|++++++++||||+++++++. ..
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~----~~ 81 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFI----SP 81 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEe----cC
Confidence 45788999999999999999987641 12457889999999999999999999863 23
Q ss_pred CceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCC
Q 041757 93 NDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT 172 (381)
Q Consensus 93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~ 172 (381)
....++||||+ +++|.+++. ...+++..+..++.|++.||.||| ..+++||||+|+||+++.++.
T Consensus 82 ~~~~~lv~e~~-~~~L~~~~~-----------~~~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~ 146 (328)
T cd07856 82 LEDIYFVTELL-GTDLHRLLT-----------SRPLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCD 146 (328)
T ss_pred CCcEEEEeehh-ccCHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCC
Confidence 55789999998 568988873 235778888899999999999999 679999999999999999999
Q ss_pred eEEeecccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHH
Q 041757 173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAK 251 (381)
Q Consensus 173 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~ 251 (381)
++|+|||.+....... ....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||..... ........
T Consensus 147 ~~l~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~--~~~~~~~~ 219 (328)
T cd07856 147 LKICDFGLARIQDPQM-----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDH--VNQFSIIT 219 (328)
T ss_pred EEeCccccccccCCCc-----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHH
Confidence 9999999987543221 12357889999998765 5689999999999999999999999853211 01111111
Q ss_pred HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 252 MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 252 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
........++............................+.....+.+++.+||+.+|++|||+.+++.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~ 287 (328)
T cd07856 220 DLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA 287 (328)
T ss_pred HHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 11111111111111110000000000000000001111234578899999999999999999999865
No 308
>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase. Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi
Probab=100.00 E-value=4e-36 Score=276.97 Aligned_cols=236 Identities=19% Similarity=0.224 Sum_probs=184.6
Q ss_pred ccccccccceecCCCceEEEecc-----------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757 34 VSRNMLEENLISAGTFGFSHLRR-----------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK 96 (381)
Q Consensus 34 ~~~~~~~~~~lG~G~fg~V~~~~-----------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~ 96 (381)
..++|...+.||.|+||.||++. ....+.+.+|+.+++.++||||+++++.+. ..+..
T Consensus 17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-----~~~~~ 91 (293)
T cd06647 17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL-----VGDEL 91 (293)
T ss_pred chhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheee-----eCCcE
Confidence 35789999999999999998763 123456888999999999999999999854 46788
Q ss_pred EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757 97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG 176 (381)
Q Consensus 97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~ 176 (381)
++|+||+++++|.+++. ...+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+
T Consensus 92 ~lv~e~~~~~~L~~~~~-----------~~~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~ 157 (293)
T cd06647 92 WVVMEYLAGGSLTDVVT-----------ETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLT 157 (293)
T ss_pred EEEEecCCCCcHHHHHh-----------hcCCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEc
Confidence 99999999999999984 234778889999999999999999 6799999999999999999999999
Q ss_pred ecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhc
Q 041757 177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSN 256 (381)
Q Consensus 177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~ 256 (381)
|||++.......... ....+++.|+|||.+....++.++||||||+++|++++|+.||....... .......
T Consensus 158 dfg~~~~~~~~~~~~--~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~----~~~~~~~-- 229 (293)
T cd06647 158 DFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR----ALYLIAT-- 229 (293)
T ss_pred cCcceeccccccccc--ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhh----heeehhc--
Confidence 999887654433221 12458889999999988889999999999999999999999986322111 0000000
Q ss_pred hHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041757 257 HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE 320 (381)
Q Consensus 257 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~ 320 (381)
...+. .......+..+.+++.+||..+|++||++.+++..
T Consensus 230 ----------~~~~~--------------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 230 ----------NGTPE--------------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred ----------CCCCC--------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 00012344568889999999999999999999964
No 309
>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]
Probab=100.00 E-value=2.9e-36 Score=287.74 Aligned_cols=272 Identities=20% Similarity=0.196 Sum_probs=190.4
Q ss_pred ccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeeeecccc-ccCCceE
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVD-YQGNDFK 96 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~-~~~~~~~ 96 (381)
..+...+.||+|+||.||..+. ...+...+|+++|++|+|+|||+++++-.+.. .......
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 5567788999999999988662 23566778999999999999999999833211 1114456
Q ss_pred EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCC----CCC
Q 041757 97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD----DMT 172 (381)
Q Consensus 97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~----~~~ 172 (381)
.+|||||.+|||...|..- .....+++.+.+.++.+++.||.||| ..+|+||||||.||++-. ...
T Consensus 93 vlvmEyC~gGsL~~~L~~P-------EN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~I 162 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSP-------ENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSI 162 (732)
T ss_pred eEEEeecCCCcHHHHhcCc-------ccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceE
Confidence 8999999999999999532 34567999999999999999999999 559999999999999832 236
Q ss_pred eEEeecccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHH
Q 041757 173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAK 251 (381)
Q Consensus 173 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~ 251 (381)
.||+|||.|+.+.++.... +.+||..|.+||+... ..|+..+|.|||||++|+++||..||........+.+....
T Consensus 163 yKLtDfG~Arel~d~s~~~---S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~ 239 (732)
T KOG4250|consen 163 YKLTDFGAARELDDNSLFT---SLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWH 239 (732)
T ss_pred EeeecccccccCCCCCeee---eecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhh
Confidence 7999999999887766333 4789999999999984 78999999999999999999999998644333222222111
Q ss_pred HHhhchHHHHH--hhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCC--CHHHHHHHHHHhhh
Q 041757 252 MALSNHVKDIV--DSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRM--KMTNVVHELQSIKN 326 (381)
Q Consensus 252 ~~~~~~~~~~~--~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP--s~~~vl~~L~~i~~ 326 (381)
.. ......+. ...-...|-...... +......+.....+..++..++..+|.+|- .+.+....+..|..
T Consensus 240 ~~-tkkp~~v~i~~~~~eNgpv~~s~~l-----P~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 240 II-TKKPSGVAIGAQEEENGPVEWSSTL-----PQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred hh-ccCCCceeEeeecccCCceeeeccC-----CCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 11 11100000 000000010000000 001111234444566666777788888888 77777777766655
No 310
>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int
Probab=100.00 E-value=1.1e-35 Score=271.76 Aligned_cols=232 Identities=20% Similarity=0.269 Sum_probs=182.9
Q ss_pred ccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA 97 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~ 97 (381)
.-|...+.||.|+||.||++.. ...+.+.+|+.++.+++||||+++++++ ..+...+
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~ 78 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY-----LKDTKLW 78 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEE-----EeCCeEE
Confidence 3477788999999999987531 1235688899999999999999999995 4477899
Q ss_pred EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757 98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD 177 (381)
Q Consensus 98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D 177 (381)
+||||+++++|.+++. ...+++..+..++.|++.|+.||| ..+++|+||+|+||+++.++.++|+|
T Consensus 79 lv~e~~~~~~l~~~i~-----------~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~d 144 (277)
T cd06641 79 IIMEYLGGGSALDLLE-----------PGPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLAD 144 (277)
T ss_pred EEEEeCCCCcHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEee
Confidence 9999999999999983 235789999999999999999999 67999999999999999999999999
Q ss_pred cccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhch
Q 041757 178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH 257 (381)
Q Consensus 178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~ 257 (381)
||++.......... ....++..|+|||.+.+..++.++|||||||++|++++|..||..... ......
T Consensus 145 fg~~~~~~~~~~~~--~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-----~~~~~~----- 212 (277)
T cd06641 145 FGVAGQLTDTQIKR--NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP-----MKVLFL----- 212 (277)
T ss_pred cccceecccchhhh--ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch-----HHHHHH-----
Confidence 99987665432211 123578899999999888889999999999999999999999752211 000000
Q ss_pred HHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041757 258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE 320 (381)
Q Consensus 258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~ 320 (381)
+.. .... ......+..+.+++.+||+.+|.+||++.++++.
T Consensus 213 ----~~~---~~~~---------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 213 ----IPK---NNPP---------------TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ----Hhc---CCCC---------------CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 000 0000 0012345678899999999999999999999983
No 311
>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.
Probab=100.00 E-value=5.2e-36 Score=270.35 Aligned_cols=233 Identities=21% Similarity=0.285 Sum_probs=182.1
Q ss_pred cccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757 37 NMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA 97 (381)
Q Consensus 37 ~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~ 97 (381)
+|...+.||+|+||.||++.. ...+.+.+|+.+++.++|+||+++++.+ ......+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~-----~~~~~~~ 75 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASF-----QENGRLF 75 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhhee-----ccCCeEE
Confidence 577889999999999987542 2345778999999999999999999985 4577899
Q ss_pred EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC-CeEEe
Q 041757 98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM-TARVG 176 (381)
Q Consensus 98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~-~~kl~ 176 (381)
+|+||+++++|.+++.. .....+++..+..++.|++.||.||| ..+++|+||||+||++++++ .+||+
T Consensus 76 lv~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~ 144 (257)
T cd08225 76 IVMEYCDGGDLMKRINR--------QRGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLG 144 (257)
T ss_pred EEEecCCCCcHHHHHHh--------ccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEec
Confidence 99999999999999853 22335789999999999999999999 66999999999999998875 46999
Q ss_pred ecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhc
Q 041757 177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSN 256 (381)
Q Consensus 177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~ 256 (381)
|||.+.......... ....|++.|+|||++.+..++.++|+||||+++|++++|..||.... .......
T Consensus 145 d~~~~~~~~~~~~~~--~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~---- 213 (257)
T cd08225 145 DFGIARQLNDSMELA--YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-----LHQLVLK---- 213 (257)
T ss_pred ccccchhccCCcccc--cccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHH----
Confidence 999987665433221 12358899999999988889999999999999999999999975221 1111111
Q ss_pred hHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 257 HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 257 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
........ .....+.++.+++.+||..+|++|||+.+++.
T Consensus 214 ----~~~~~~~~-------------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 214 ----ICQGYFAP-------------------ISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred ----HhcccCCC-------------------CCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 11100000 01133457889999999999999999999975
No 312
>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase. Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.
Probab=100.00 E-value=1.8e-35 Score=270.58 Aligned_cols=258 Identities=18% Similarity=0.193 Sum_probs=179.5
Q ss_pred ccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccC-CCcccceeeeeccccccCCceEEE
Q 041757 38 MLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIR-HRNLIKVLTACLGVDYQGNDFKAL 98 (381)
Q Consensus 38 ~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~~~~~~l 98 (381)
|...++||+|+||.||++.. .......+|+.++.++. |+||+++++++.+ ...+..++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~---~~~~~~~l 77 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFD---RKTGRLAL 77 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEec---CCCCcEEE
Confidence 56778999999999988642 11223457999999996 9999999999653 22367899
Q ss_pred EEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeec
Q 041757 99 VYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDF 178 (381)
Q Consensus 99 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df 178 (381)
||||+. |+|.+++. .....+++..++.++.|++.||.||| ..+++||||+|+||+++. +.+||+||
T Consensus 78 v~e~~~-~~l~~~l~---------~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~df 143 (282)
T cd07831 78 VFELMD-MNLYELIK---------GRKRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADF 143 (282)
T ss_pred EEecCC-ccHHHHHH---------hccCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEec
Confidence 999996 58888874 22356899999999999999999999 669999999999999999 99999999
Q ss_pred ccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhch
Q 041757 179 GLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH 257 (381)
Q Consensus 179 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~ 257 (381)
|+++......... ...++..|+|||++.. ..++.++|||||||++|||++|..||..... ..............
T Consensus 144 g~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~--~~~~~~~~~~~~~~ 218 (282)
T cd07831 144 GSCRGIYSKPPYT---EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE--LDQIAKIHDVLGTP 218 (282)
T ss_pred ccccccccCCCcC---CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH--HHHHHHHHHHcCCC
Confidence 9998765433222 1347889999997654 5578899999999999999999999753211 00111111111111
Q ss_pred HHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
...+... ....... ...................+..+.+++.+||+.+|++|||+.++++
T Consensus 219 ~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 219 DAEVLKK-FRKSRHM-NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred CHHHHHh-hcccccc-cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 1111100 0000000 0000000111112223456788999999999999999999999985
No 313
>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi
Probab=100.00 E-value=6.5e-36 Score=273.61 Aligned_cols=225 Identities=20% Similarity=0.235 Sum_probs=169.1
Q ss_pred eecCCCceEEEecccc--------------------cHHHHHHHHHHHHc---cCCCcccceeeeeccccccCCceEEEE
Q 041757 43 LISAGTFGFSHLRRQG--------------------AFKSFIAECKALRN---IRHRNLIKVLTACLGVDYQGNDFKALV 99 (381)
Q Consensus 43 ~lG~G~fg~V~~~~~~--------------------~~~~~~~E~~~l~~---l~h~nIv~~~~~~~~~~~~~~~~~~lv 99 (381)
+||+|+||.||++... ....+.+|..+++. ..||||+.+++.+ ...+..++|
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv 75 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAF-----HTPDKLCFI 75 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEE-----ecCCeEEEE
Confidence 4899999999875421 11234455544443 4699999999884 446788999
Q ss_pred EEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecc
Q 041757 100 YEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179 (381)
Q Consensus 100 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg 179 (381)
|||+++|+|.+++. ....+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||
T Consensus 76 ~e~~~~~~L~~~i~----------~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg 142 (279)
T cd05633 76 LDLMNGGDLHYHLS----------QHGVFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLG 142 (279)
T ss_pred EecCCCCCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCC
Confidence 99999999999983 3456899999999999999999999 6699999999999999999999999999
Q ss_pred cceecCCCCCcccccCccCccceeCCCCcC-CCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchH
Q 041757 180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGV-GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHV 258 (381)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 258 (381)
++......... ...|+..|+|||.+. +..++.++|||||||++|+|++|..||....... .........
T Consensus 143 ~~~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~---- 212 (279)
T cd05633 143 LACDFSKKKPH----ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEIDRMTL---- 212 (279)
T ss_pred cceeccccCcc----CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC--HHHHHHHhh----
Confidence 98755432221 235899999999886 4568999999999999999999999986332211 111100000
Q ss_pred HHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 041757 259 KDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRM-----KMTNVVH 319 (381)
Q Consensus 259 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~~vl~ 319 (381)
.... ..+...+.++.+++.+||..||.+|| |+.++++
T Consensus 213 --------~~~~----------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 254 (279)
T cd05633 213 --------TVNV----------------ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE 254 (279)
T ss_pred --------cCCc----------------CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence 0000 01234566888999999999999999 5888766
No 314
>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85. Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.
Probab=100.00 E-value=2.1e-35 Score=270.64 Aligned_cols=261 Identities=18% Similarity=0.212 Sum_probs=184.1
Q ss_pred cccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEE
Q 041757 37 NMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKAL 98 (381)
Q Consensus 37 ~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~l 98 (381)
+|+..++||.|+||.||++.. .....+.+|+.++++++|+||+++++++. ..+..++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 75 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIH-----TENKLML 75 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEe-----eCCcEEE
Confidence 588899999999999987652 12467788999999999999999999954 4678899
Q ss_pred EEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeec
Q 041757 99 VYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDF 178 (381)
Q Consensus 99 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df 178 (381)
||||+++ +|.+++... .....+++..+..++.|++.||.||| +.+++||||||+||++++++.++|+||
T Consensus 76 v~e~~~~-~l~~~~~~~-------~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~ 144 (284)
T cd07836 76 VFEYMDK-DLKKYMDTH-------GVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADF 144 (284)
T ss_pred EEecCCc-cHHHHHHhc-------CCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeec
Confidence 9999985 898888432 11246899999999999999999999 669999999999999999999999999
Q ss_pred ccceecCCCCCcccccCccCccceeCCCCcCCC-ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhch
Q 041757 179 GLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH 257 (381)
Q Consensus 179 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~ 257 (381)
|++.......... ....++..|+|||++.+. .++.++||||||+++|++++|+.||...... .......... ...
T Consensus 145 g~~~~~~~~~~~~--~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~-~~~~~~~~~~-~~~ 220 (284)
T cd07836 145 GLARAFGIPVNTF--SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE-DQLLKIFRIM-GTP 220 (284)
T ss_pred chhhhhcCCcccc--ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHh-CCC
Confidence 9997554332211 123478899999987663 5788999999999999999999997532211 0111111110 000
Q ss_pred HHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
..+....... .+. .................+..+..+.+++.+||+.||.+||++.++++
T Consensus 221 ~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 221 TESTWPGISQ-LPE-YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred ChhhHHHHhc-Cch-hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0011110000 000 00000000011112223345678899999999999999999999875
No 315
>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]
Probab=100.00 E-value=5.4e-36 Score=299.77 Aligned_cols=251 Identities=20% Similarity=0.324 Sum_probs=194.0
Q ss_pred ccccccceecCCCceEEEecc-------------------------cccHHHHHHHHHHHHccC-CCcccceeeeecccc
Q 041757 36 RNMLEENLISAGTFGFSHLRR-------------------------QGAFKSFIAECKALRNIR-HRNLIKVLTACLGVD 89 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~-------------------------~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~ 89 (381)
++....+.||+|.||.|+++. ....+.+..|+++|+.+. |+||+.++|+|..
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~-- 373 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ-- 373 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc--
Confidence 334556799999999996643 234678999999999995 9999999999864
Q ss_pred ccCCceEEEEEEcccCCCHHHhhccccCCcccccC-----C--CcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCC
Q 041757 90 YQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKR-----P--RNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKP 162 (381)
Q Consensus 90 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~-----~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp 162 (381)
....++|+||+..|+|.++++..+... .... . ..++..+.+.++.|||.|++||+ +.++|||||..
T Consensus 374 ---~~~~~~v~Ey~~~G~L~~~Lr~~r~~~-~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAa 446 (609)
T KOG0200|consen 374 ---DGPLYVIVEYAEHGDLLEFLRKKRVTE-SIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAA 446 (609)
T ss_pred ---CCceEEEEEeccCCcHHHHHHhccccc-cccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhh
Confidence 778899999999999999997544000 0001 1 24899999999999999999999 77999999999
Q ss_pred CCeeeCCCCCeEEeecccceecCCCCCcccccCc-cCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccc
Q 041757 163 SNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDV-KGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMF 240 (381)
Q Consensus 163 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~-~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~ 240 (381)
+|||+..+..+||+|||+++.............. .-+..|||||.+....|+.+||||||||+|||++| |..||...
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~- 525 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI- 525 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC-
Confidence 9999999999999999999976655444322110 12556999999999999999999999999999998 88886421
Q ss_pred cCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041757 241 EGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE 320 (381)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~ 320 (381)
.....+.. .+.. ..+...|..|..++.++|+.||+.+|++||++.++.+.
T Consensus 526 ---~~~~~l~~---------~l~~------------------G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~ 575 (609)
T KOG0200|consen 526 ---PPTEELLE---------FLKE------------------GNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEF 575 (609)
T ss_pred ---CcHHHHHH---------HHhc------------------CCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 10111111 1110 01112245788999999999999999999999999999
Q ss_pred HHHhhh
Q 041757 321 LQSIKN 326 (381)
Q Consensus 321 L~~i~~ 326 (381)
+.....
T Consensus 576 ~~~~l~ 581 (609)
T KOG0200|consen 576 FEKHLQ 581 (609)
T ss_pred HHHHHH
Confidence 998643
No 316
>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]
Probab=100.00 E-value=5.1e-36 Score=260.66 Aligned_cols=193 Identities=24% Similarity=0.292 Sum_probs=161.0
Q ss_pred hhccccccccceecCCCceEEEeccc-----------------------ccHHHHHHHHHHHHccCCCcccceeeeeccc
Q 041757 32 LDVSRNMLEENLISAGTFGFSHLRRQ-----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGV 88 (381)
Q Consensus 32 ~~~~~~~~~~~~lG~G~fg~V~~~~~-----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 88 (381)
++.-..|+....||+|+||.||++.. +.-.+..+|+.+++.++||||+.+..++..
T Consensus 20 ve~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~- 98 (438)
T KOG0666|consen 20 VEDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLS- 98 (438)
T ss_pred HHHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhc-
Confidence 34456788999999999999999731 122455689999999999999999999753
Q ss_pred cccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeC
Q 041757 89 DYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLD 168 (381)
Q Consensus 89 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~ 168 (381)
.+...++++||.+. ||.+.++-.+. .....++...+..|+.||+.|+.||| +.-|+||||||.|||+.
T Consensus 99 ---~d~~v~l~fdYAEh-DL~~II~fHr~-----~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvm 166 (438)
T KOG0666|consen 99 ---HDKKVWLLFDYAEH-DLWHIIKFHRA-----SKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVM 166 (438)
T ss_pred ---cCceEEEEehhhhh-hHHHHHHHhcc-----chhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEe
Confidence 37889999999976 99999865443 23357889999999999999999999 55899999999999998
Q ss_pred CC----CCeEEeecccceecCCCCCcc-cccCccCccceeCCCCcCCC-ccCcccchhhhhHHHHHHHhCCCCCC
Q 041757 169 DD----MTARVGDFGLARFLPPTRTQT-SSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLELMIREKPSD 237 (381)
Q Consensus 169 ~~----~~~kl~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~el~tg~~Pf~ 237 (381)
.+ |.+||+|||+++.+...-... ....++.|+.|+|||.+.+. .|+.+.||||.|||+.||+|-++.|.
T Consensus 167 gdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~ 241 (438)
T KOG0666|consen 167 GDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFK 241 (438)
T ss_pred ccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCcccc
Confidence 77 899999999999887654322 33346789999999998885 58999999999999999999988874
No 317
>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase. Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou
Probab=100.00 E-value=1.1e-35 Score=272.85 Aligned_cols=239 Identities=21% Similarity=0.241 Sum_probs=188.3
Q ss_pred hhccccccccceecCCCceEEEecccc----------------cHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757 32 LDVSRNMLEENLISAGTFGFSHLRRQG----------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF 95 (381)
Q Consensus 32 ~~~~~~~~~~~~lG~G~fg~V~~~~~~----------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~ 95 (381)
-+..++|...+.||.|+||.||.+... ..+.+.+|+++++.++|+||+++++.+. ....
T Consensus 15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~ 89 (286)
T cd06614 15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYL-----VGDE 89 (286)
T ss_pred CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEE-----ECCE
Confidence 456788999999999999999875432 2567889999999999999999999954 3678
Q ss_pred EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757 96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV 175 (381)
Q Consensus 96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl 175 (381)
.++|+||+++++|.+++.. ....+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|
T Consensus 90 ~~lv~e~~~~~~L~~~l~~---------~~~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l 157 (286)
T cd06614 90 LWVVMEYMDGGSLTDIITQ---------NFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKL 157 (286)
T ss_pred EEEEEeccCCCcHHHHHHH---------hccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEE
Confidence 9999999999999999952 1237899999999999999999999 679999999999999999999999
Q ss_pred eecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhh
Q 041757 176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALS 255 (381)
Q Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 255 (381)
+|||++.......... ....++..|+|||++.+..++.++||||||+++|+|++|..||... ........
T Consensus 158 ~d~~~~~~~~~~~~~~--~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~----~~~~~~~~---- 227 (286)
T cd06614 158 ADFGFAAQLTKEKSKR--NSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLRE----PPLRALFL---- 227 (286)
T ss_pred Cccchhhhhccchhhh--ccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCC----CHHHHHHH----
Confidence 9999987554332211 1234788999999998888999999999999999999999997521 11111100
Q ss_pred chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
+......... ....++..+.+++.+||+.+|.+|||+.++++
T Consensus 228 -----~~~~~~~~~~-----------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 228 -----ITTKGIPPLK-----------------NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred -----HHhcCCCCCc-----------------chhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 0000000000 01235567889999999999999999999986
No 318
>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the
Probab=100.00 E-value=2.3e-35 Score=274.54 Aligned_cols=192 Identities=21% Similarity=0.291 Sum_probs=153.7
Q ss_pred cccccceecCCCceEEEecccc----------------------cHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757 37 NMLEENLISAGTFGFSHLRRQG----------------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND 94 (381)
Q Consensus 37 ~~~~~~~lG~G~fg~V~~~~~~----------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~ 94 (381)
.|...++||+|+||.||++... ..+.+.+|+.++++++||||+++++++.. ....
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~ 77 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLE---HADK 77 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeC---CCCc
Confidence 3777889999999999876531 12567789999999999999999999753 2237
Q ss_pred eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCC----C
Q 041757 95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD----D 170 (381)
Q Consensus 95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~----~ 170 (381)
..++||||+++ +|.+++..... .....+++..++.++.|++.||.||| +.+|+||||||+||+++. +
T Consensus 78 ~~~lv~e~~~~-~l~~~~~~~~~-----~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~ 148 (316)
T cd07842 78 SVYLLFDYAEH-DLWQIIKFHRQ-----AKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPER 148 (316)
T ss_pred eEEEEEeCCCc-CHHHHHHhhcc-----CCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCcc
Confidence 89999999975 77777642211 12246889999999999999999999 679999999999999999 8
Q ss_pred CCeEEeecccceecCCCCC-cccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccc
Q 041757 171 MTARVGDFGLARFLPPTRT-QTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMF 240 (381)
Q Consensus 171 ~~~kl~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~ 240 (381)
+.+||+|||++........ ........++..|+|||++.+ ..++.++||||||+++|+|++|+.||....
T Consensus 149 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 220 (316)
T cd07842 149 GVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE 220 (316)
T ss_pred ceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence 9999999999987654332 111222457889999998766 457899999999999999999999986443
No 319
>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]
Probab=100.00 E-value=8.9e-37 Score=293.95 Aligned_cols=242 Identities=23% Similarity=0.361 Sum_probs=201.0
Q ss_pred ccccceecCCCceEEEecc----------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757 38 MLEENLISAGTFGFSHLRR----------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF 95 (381)
Q Consensus 38 ~~~~~~lG~G~fg~V~~~~----------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~ 95 (381)
.+..++||+|+||+||+.- ...-.+++.|+-+|.+++|||+++++++|.. +.
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~------s~ 771 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCML------ST 771 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhccc------ch
Confidence 4556899999999996632 2346789999999999999999999999863 33
Q ss_pred EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757 96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV 175 (381)
Q Consensus 96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl 175 (381)
..||++|++.|+|.++++ .....+.....+.|+.||++||.||| .+++|||||..+|+|+.....+||
T Consensus 772 ~qlvtq~mP~G~LlDyvr---------~hr~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvki 839 (1177)
T KOG1025|consen 772 LQLVTQLMPLGCLLDYVR---------EHRDNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKI 839 (1177)
T ss_pred HHHHHHhcccchHHHHHH---------HhhccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEE
Confidence 789999999999999997 35677888999999999999999999 779999999999999999999999
Q ss_pred eecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHh
Q 041757 176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMAL 254 (381)
Q Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~ 254 (381)
.|||+++...............-.+.|||-|.+....|+.++|||||||++||++| |..|+..+...
T Consensus 840 tdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~------------ 907 (1177)
T KOG1025|consen 840 TDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE------------ 907 (1177)
T ss_pred EecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH------------
Confidence 99999998877655444444556789999999999999999999999999999998 99997533211
Q ss_pred hchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhcC
Q 041757 255 SNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLL 329 (381)
Q Consensus 255 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~~~ 329 (381)
++.+++..- .+...++.|+.+++.++.+||..|+..||+++++.+.+.+..+.+.
T Consensus 908 --eI~dlle~g------------------eRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpq 962 (1177)
T KOG1025|consen 908 --EIPDLLEKG------------------ERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQ 962 (1177)
T ss_pred --HhhHHHhcc------------------ccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcc
Confidence 122332211 1123356899999999999999999999999999999998877543
No 320
>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase. Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun
Probab=100.00 E-value=1.8e-35 Score=271.59 Aligned_cols=233 Identities=18% Similarity=0.255 Sum_probs=181.9
Q ss_pred ccccccceecCCCceEEEeccc-----------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEE
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ-----------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKAL 98 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~-----------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~l 98 (381)
.+|...++||+|+||.||++.. ...+.+.+|+.+++.++||||+++++++ ...+..++
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~-----~~~~~~~~ 93 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSY-----LVGDELWV 93 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEE-----EcCCeEEE
Confidence 3566678999999999987642 1345688999999999999999999985 34678899
Q ss_pred EEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeec
Q 041757 99 VYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDF 178 (381)
Q Consensus 99 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df 178 (381)
|+||+++++|.+++. . ..+++..+..++.|++.||+||| +.+++||||+|+||+++.++.++|+||
T Consensus 94 v~e~~~~~~L~~~~~----------~-~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~ 159 (285)
T cd06648 94 VMEFLEGGALTDIVT----------H-TRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDF 159 (285)
T ss_pred EEeccCCCCHHHHHH----------h-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEccc
Confidence 999999999999984 2 45888999999999999999999 669999999999999999999999999
Q ss_pred ccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchH
Q 041757 179 GLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHV 258 (381)
Q Consensus 179 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 258 (381)
|.+.......... ....|+..|+|||.+.+..++.++||||||+++|+|++|+.||... ........
T Consensus 160 g~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~----~~~~~~~~------- 226 (285)
T cd06648 160 GFCAQVSKEVPRR--KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNE----PPLQAMKR------- 226 (285)
T ss_pred ccchhhccCCccc--ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCC----CHHHHHHH-------
Confidence 9887554332211 1245889999999998888999999999999999999999997521 11111100
Q ss_pred HHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 259 KDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 259 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
+ ......... .....+..+.+++.+||+.+|.+|||+.++++
T Consensus 227 --~-~~~~~~~~~----------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 227 --I-RDNLPPKLK----------------NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred --H-HhcCCCCCc----------------ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 0 000000000 01124567899999999999999999999986
No 321
>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4
Probab=100.00 E-value=2.1e-35 Score=267.46 Aligned_cols=236 Identities=22% Similarity=0.296 Sum_probs=182.9
Q ss_pred cccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757 37 NMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA 97 (381)
Q Consensus 37 ~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~ 97 (381)
+|...+.||+|+||.||.+.. ...+.+.+|+.+++.++|+||+++++.+ .+.+..+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~ 75 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVE-----VHREKVY 75 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeE-----ecCCEEE
Confidence 477889999999999977631 2467788999999999999999999984 4577899
Q ss_pred EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757 98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD 177 (381)
Q Consensus 98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D 177 (381)
+|+||+++++|.+++. ....+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.+||+|
T Consensus 76 lv~e~~~~~~L~~~~~----------~~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d 142 (264)
T cd06626 76 IFMEYCSGGTLEELLE----------HGRILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGD 142 (264)
T ss_pred EEEecCCCCcHHHHHh----------hcCCCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcc
Confidence 9999999999999994 3455788999999999999999999 66999999999999999999999999
Q ss_pred cccceecCCCCCcccc--cCccCccceeCCCCcCCCc---cCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHH
Q 041757 178 FGLARFLPPTRTQTSS--IDVKGSIGYIAPEYGVGNE---VSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM 252 (381)
Q Consensus 178 fg~~~~~~~~~~~~~~--~~~~gt~~y~aPE~l~~~~---~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~ 252 (381)
||++............ ....++..|+|||++.+.. ++.++||||||+++|++++|..||.... .........
T Consensus 143 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~---~~~~~~~~~ 219 (264)
T cd06626 143 FGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELD---NEFQIMFHV 219 (264)
T ss_pred cccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCc---chHHHHHHH
Confidence 9999876544322111 1245788999999988766 8899999999999999999999985221 111100000
Q ss_pred HhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 253 ALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 253 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
.... ....+. .......+.+++.+||+.+|.+|||+.+++.
T Consensus 220 -~~~~--------~~~~~~-----------------~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 220 -GAGH--------KPPIPD-----------------SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -hcCC--------CCCCCc-----------------ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000 000000 0123556788999999999999999999874
No 322
>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl
Probab=100.00 E-value=1.9e-35 Score=274.17 Aligned_cols=192 Identities=22% Similarity=0.313 Sum_probs=154.2
Q ss_pred hccccccccceecCCCceEEEecccc-------------------cHHHHHHHHHHHHccCCCcccceeeeeccccc---
Q 041757 33 DVSRNMLEENLISAGTFGFSHLRRQG-------------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDY--- 90 (381)
Q Consensus 33 ~~~~~~~~~~~lG~G~fg~V~~~~~~-------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~--- 90 (381)
+.-++|...++||+|+||.||++... ....+.+|++++++++||||++++++|.....
T Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (310)
T cd07865 9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYN 88 (310)
T ss_pred chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence 34567999999999999999876421 12356789999999999999999999765221
Q ss_pred cCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCC
Q 041757 91 QGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDD 170 (381)
Q Consensus 91 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~ 170 (381)
......++||||+.+ +|.+++. .....+++.+++.++.|++.||.||| ..+++|+||||+||+++.+
T Consensus 89 ~~~~~~~lv~e~~~~-~l~~~l~---------~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~ 155 (310)
T cd07865 89 RYKGSFYLVFEFCEH-DLAGLLS---------NKNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKD 155 (310)
T ss_pred CCCceEEEEEcCCCc-CHHHHHH---------hcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCC
Confidence 123567999999964 8888874 23346899999999999999999999 6699999999999999999
Q ss_pred CCeEEeecccceecCCCCCc--ccccCccCccceeCCCCcCCC-ccCcccchhhhhHHHHHHHhCCCCCC
Q 041757 171 MTARVGDFGLARFLPPTRTQ--TSSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLELMIREKPSD 237 (381)
Q Consensus 171 ~~~kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~el~tg~~Pf~ 237 (381)
+.+||+|||++......... .......++..|+|||.+.+. .++.++||||||+++|+|++|..||.
T Consensus 156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~ 225 (310)
T cd07865 156 GILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQ 225 (310)
T ss_pred CcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCC
Confidence 99999999999866443221 111123478889999987664 47889999999999999999999975
No 323
>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10. Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing
Probab=100.00 E-value=2e-35 Score=274.32 Aligned_cols=262 Identities=22% Similarity=0.219 Sum_probs=182.0
Q ss_pred cccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757 35 SRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF 95 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~ 95 (381)
.++|...+.||.|+||.||++.. .....+.+|+.++++++|+||+++++++.+ ...+.
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~ 82 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVG---KHLDS 82 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEec---CCCCe
Confidence 57899999999999999977642 112346789999999999999999999653 23356
Q ss_pred EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757 96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV 175 (381)
Q Consensus 96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl 175 (381)
.++||||+.+ +|.+++.. ....+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||
T Consensus 83 ~~lv~e~~~~-~l~~~l~~---------~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL 149 (309)
T cd07845 83 IFLVMEYCEQ-DLASLLDN---------MPTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKI 149 (309)
T ss_pred EEEEEecCCC-CHHHHHHh---------cccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEE
Confidence 8999999964 89888852 2356899999999999999999999 669999999999999999999999
Q ss_pred eecccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHH--H
Q 041757 176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAK--M 252 (381)
Q Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~--~ 252 (381)
+|||++.......... ....++..|+|||.+.+ ..++.++|||||||++|||++|..||... .....+.. .
T Consensus 150 ~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~----~~~~~~~~~~~ 223 (309)
T cd07845 150 ADFGLARTYGLPAKPM--TPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGK----SEIEQLDLIIQ 223 (309)
T ss_pred CccceeeecCCccCCC--CcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHH
Confidence 9999998765432111 11235788999998865 45789999999999999999999997522 11111111 0
Q ss_pred HhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 253 ALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 253 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
............... -+.........................+.+++.+||+.||++|||+.+++.
T Consensus 224 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 224 LLGTPNESIWPGFSD-LPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred hcCCCChhhchhhhc-ccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000000000000 000000000000000000001123567788999999999999999999986
No 324
>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent
Probab=100.00 E-value=1.4e-35 Score=270.85 Aligned_cols=230 Identities=19% Similarity=0.269 Sum_probs=180.4
Q ss_pred cccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccC---CCcccceeeeeccccccCCce
Q 041757 37 NMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIR---HRNLIKVLTACLGVDYQGNDF 95 (381)
Q Consensus 37 ~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~---h~nIv~~~~~~~~~~~~~~~~ 95 (381)
.|+..++||.|+||.||++.. ...+.+.+|+.++++++ |||++++++++. ....
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~-----~~~~ 76 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL-----KGPR 76 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee-----eCCE
Confidence 577788999999999987541 23457888999999996 999999999854 4678
Q ss_pred EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757 96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV 175 (381)
Q Consensus 96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl 175 (381)
.++||||+++++|.+++. . ..+++..++.++.|++.||.||| ..+++|+||+|+||+++.++.++|
T Consensus 77 ~~lv~e~~~~~~L~~~~~----------~-~~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l 142 (277)
T cd06917 77 LWIIMEYAEGGSVRTLMK----------A-GPIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKL 142 (277)
T ss_pred EEEEEecCCCCcHHHHHH----------c-cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEE
Confidence 899999999999999883 2 36889999999999999999999 669999999999999999999999
Q ss_pred eecccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHh
Q 041757 176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMAL 254 (381)
Q Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 254 (381)
+|||++.......... ....|+..|+|||.+.+ ..++.++||||||+++|+|++|..||..... .....
T Consensus 143 ~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-----~~~~~--- 212 (277)
T cd06917 143 CDFGVAALLNQNSSKR--STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA-----FRAMM--- 212 (277)
T ss_pred ccCCceeecCCCcccc--ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh-----hhhhh---
Confidence 9999998765543221 22458899999998765 4578999999999999999999999853211 00000
Q ss_pred hchHHHHHhhhhccCchhhhhcccchhhhhHHHHH-HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 255 SNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINII-RECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 255 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
.+... .+.. .. ...+.++.+++.+||+.||++||++.+++.
T Consensus 213 ------~~~~~---~~~~---------------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 213 ------LIPKS---KPPR---------------LEDNGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred ------ccccC---CCCC---------------CCcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 00000 0000 00 114557889999999999999999999986
No 325
>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and
Probab=100.00 E-value=1.8e-35 Score=277.23 Aligned_cols=274 Identities=20% Similarity=0.231 Sum_probs=190.5
Q ss_pred cccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757 37 NMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA 97 (381)
Q Consensus 37 ~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~ 97 (381)
+|...+.||.|+||.||++.. ...+.+.+|+.+++.++|+||+++++++...........+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 478889999999999987642 1345788999999999999999999996542222335789
Q ss_pred EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757 98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD 177 (381)
Q Consensus 98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D 177 (381)
+||||++ ++|.+++. ....+++..++.++.|++.||.||| +.+|+||||||+||+++.++.++|+|
T Consensus 81 lv~e~~~-~~l~~~l~----------~~~~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~d 146 (330)
T cd07834 81 IVTELME-TDLHKVIK----------SPQPLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICD 146 (330)
T ss_pred EEecchh-hhHHHHHh----------CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcc
Confidence 9999997 48999883 4457899999999999999999999 66999999999999999999999999
Q ss_pred cccceecCCCCCc-ccccCccCccceeCCCCcCCC-ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhh
Q 041757 178 FGLARFLPPTRTQ-TSSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALS 255 (381)
Q Consensus 178 fg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 255 (381)
||++......... .......++..|+|||++.+. .++.++||||||+++|+|++|..||....... .+... .....
T Consensus 147 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~-~~~~i-~~~~~ 224 (330)
T cd07834 147 FGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID-QLNLI-VEVLG 224 (330)
T ss_pred cCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH-HHHHH-HHhcC
Confidence 9999876554310 111124578899999999887 78999999999999999999999985332100 00000 00000
Q ss_pred chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH--HHHhhh
Q 041757 256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE--LQSIKN 326 (381)
Q Consensus 256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~--L~~i~~ 326 (381)
....+.............................+..+..+.+++.+||+.+|.+|||+.+++.. ++++..
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 225 TPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred CCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 00000000000000000000000000001111123356788999999999999999999999973 555443
No 326
>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase. Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm
Probab=100.00 E-value=3.2e-35 Score=270.91 Aligned_cols=266 Identities=17% Similarity=0.184 Sum_probs=182.7
Q ss_pred ccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccC-CCcccceeeeeccccccCCce
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIR-HRNLIKVLTACLGVDYQGNDF 95 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~~~~ 95 (381)
++|+..+.||+|+||.||++.. .....+.+|+.+++.+. ||||+++++++...+......
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4788999999999999988642 12356788999999995 699999999865422222334
Q ss_pred EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCC-CCCeE
Q 041757 96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD-DMTAR 174 (381)
Q Consensus 96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~-~~~~k 174 (381)
.++||||+++ +|.+++..... .....+++..++.++.||+.||.||| ..+++||||||+||+++. ++.+|
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~-----~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~k 151 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGR-----GPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLK 151 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcc-----cCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEE
Confidence 7999999985 89988853211 11346899999999999999999999 669999999999999998 88999
Q ss_pred EeecccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH
Q 041757 175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA 253 (381)
Q Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~ 253 (381)
|+|||+++......... ....+++.|+|||++.+ ..++.++||||||+++|+|++|..||.. ...........
T Consensus 152 l~dfg~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~----~~~~~~~~~~~ 225 (295)
T cd07837 152 IADLGLGRAFSIPVKSY--THEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPG----DSELQQLLHIF 225 (295)
T ss_pred EeecccceecCCCcccc--CCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCC----CCHHHHHHHHH
Confidence 99999987654322111 11346888999998765 4578999999999999999999999752 22222111110
Q ss_pred h--hchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 254 L--SNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 254 ~--~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
. ............. .... . ..............+.....+.+++.+||..||.+||++.+++.
T Consensus 226 ~~~~~~~~~~~~~~~~-~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 226 KLLGTPTEQVWPGVSK-LRDW-H-EFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred HHhCCCChhhCcchhh-ccch-h-hcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0 0000000000000 0000 0 00000001111112345677899999999999999999999875
No 327
>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1. Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co
Probab=100.00 E-value=2.2e-35 Score=276.85 Aligned_cols=266 Identities=18% Similarity=0.186 Sum_probs=181.3
Q ss_pred cccccceecCCCceEEEecccc---------------------cHHHHHHHHHHHHcc-CCCcccceeeeeccccccCCc
Q 041757 37 NMLEENLISAGTFGFSHLRRQG---------------------AFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGND 94 (381)
Q Consensus 37 ~~~~~~~lG~G~fg~V~~~~~~---------------------~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~~ 94 (381)
+|...+.||+|+||.||++... ..+.+.+|+.+++++ .||||+++++.+... .....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVF-PGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeec-cccCC
Confidence 4778899999999999776522 134678899999999 499999999875431 12345
Q ss_pred eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757 95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR 174 (381)
Q Consensus 95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k 174 (381)
..++++||+. ++|.+++. ....+++..++.++.|++.||.||| ..+++||||||+||+++.++.+|
T Consensus 80 ~~~~~~e~~~-~~L~~~l~----------~~~~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~k 145 (332)
T cd07857 80 ELYLYEELME-ADLHQIIR----------SGQPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELK 145 (332)
T ss_pred cEEEEEeccc-CCHHHHHh----------cCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEE
Confidence 6789999985 69999883 4556899999999999999999999 66999999999999999999999
Q ss_pred EeecccceecCCCCCc--ccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHH
Q 041757 175 VGDFGLARFLPPTRTQ--TSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAK 251 (381)
Q Consensus 175 l~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~ 251 (381)
|+|||+++........ .......|+..|+|||++.+ ..++.++||||||+++|++++|..||...... ..+.....
T Consensus 146 l~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~-~~~~~~~~ 224 (332)
T cd07857 146 ICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV-DQLNQILQ 224 (332)
T ss_pred eCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH-HHHHHHHH
Confidence 9999999866543221 11122468999999998765 56899999999999999999999997532110 00111111
Q ss_pred HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 252 MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 252 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
. ......+.+.................................+.+++.+||+.||.+|||+.+++.
T Consensus 225 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 225 V-LGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred H-hCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0 000001111110000000000000000000000111223567889999999999999999999874
No 328
>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional
Probab=100.00 E-value=1.8e-35 Score=268.98 Aligned_cols=233 Identities=19% Similarity=0.248 Sum_probs=175.6
Q ss_pred cccccccccee--cCCCceEEEecccc-----------cHHHH-HHHHHHHHcc-CCCcccceeeeeccccccCCceEEE
Q 041757 34 VSRNMLEENLI--SAGTFGFSHLRRQG-----------AFKSF-IAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKAL 98 (381)
Q Consensus 34 ~~~~~~~~~~l--G~G~fg~V~~~~~~-----------~~~~~-~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~~~~~l 98 (381)
..++|...+.+ |.|+||.||++... ....+ ..|+.....+ +||||+++++.+. ..+..++
T Consensus 12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~e~~~~~~~~~h~~iv~~~~~~~-----~~~~~~i 86 (267)
T PHA03390 12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAIEPMVHQLMKDNPNFIKLYYSVT-----TLKGHVL 86 (267)
T ss_pred HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchhhHHHHHHhhcCCCEEEEEEEEe-----cCCeeEE
Confidence 34566666665 99999999876521 11111 1234333333 6999999999954 4668999
Q ss_pred EEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC-CeEEee
Q 041757 99 VYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM-TARVGD 177 (381)
Q Consensus 99 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~-~~kl~D 177 (381)
||||+++++|.+++. ....+++..+..++.|++.||.||| +.+++||||||+||+++.++ .++|+|
T Consensus 87 v~e~~~~~~L~~~l~----------~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~d 153 (267)
T PHA03390 87 IMDYIKDGDLFDLLK----------KEGKLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCD 153 (267)
T ss_pred EEEcCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEec
Confidence 999999999999994 3447899999999999999999999 66999999999999999988 999999
Q ss_pred cccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhch
Q 041757 178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH 257 (381)
Q Consensus 178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~ 257 (381)
||++........ ..++..|+|||++.+..++.++||||||+++|+|++|..||............+....
T Consensus 154 fg~~~~~~~~~~------~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---- 223 (267)
T PHA03390 154 YGLCKIIGTPSC------YDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ---- 223 (267)
T ss_pred CccceecCCCcc------CCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh----
Confidence 999876643321 3488999999999988899999999999999999999999873332221111111110
Q ss_pred HHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCC-HHHHHH
Q 041757 258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMK-MTNVVH 319 (381)
Q Consensus 258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~~vl~ 319 (381)
.... ......+..+.+++.+||+.+|.+||+ ++++++
T Consensus 224 ---------~~~~----------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 224 ---------QKKL----------------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ---------cccC----------------CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 0000 011245667899999999999999996 588874
No 329
>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1. Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron
Probab=100.00 E-value=1.4e-35 Score=276.40 Aligned_cols=237 Identities=24% Similarity=0.299 Sum_probs=182.0
Q ss_pred ccccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757 34 VSRNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN 93 (381)
Q Consensus 34 ~~~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 93 (381)
....|...+.||+|+||.||++.. ...+.+.+|++++++++|||++++++++. ..
T Consensus 23 ~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~ 97 (317)
T cd06635 23 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYL-----RE 97 (317)
T ss_pred chhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-----eC
Confidence 445588899999999999977541 12356889999999999999999999964 36
Q ss_pred ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757 94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA 173 (381)
Q Consensus 94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~ 173 (381)
...++||||+. |+|.+.+. .....+++..+..++.|++.||.||| ..+++||||+|+||+++.++.+
T Consensus 98 ~~~~lv~e~~~-g~l~~~~~---------~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~ 164 (317)
T cd06635 98 HTAWLVMEYCL-GSASDLLE---------VHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQV 164 (317)
T ss_pred CeEEEEEeCCC-CCHHHHHH---------HhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCE
Confidence 67899999996 48877774 23456889999999999999999999 6699999999999999999999
Q ss_pred EEeecccceecCCCCCcccccCccCccceeCCCCcC---CCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHH
Q 041757 174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGV---GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFA 250 (381)
Q Consensus 174 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~ 250 (381)
+|+|||++....... ...++..|+|||++. ...++.++|||||||++|+|++|..||... ......
T Consensus 165 kl~dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~----~~~~~~- 233 (317)
T cd06635 165 KLADFGSASIASPAN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM----NAMSAL- 233 (317)
T ss_pred EEecCCCccccCCcc------cccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCc----cHHHHH-
Confidence 999999987543321 135888999999874 456889999999999999999999997521 111100
Q ss_pred HHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 041757 251 KMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIK 325 (381)
Q Consensus 251 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~ 325 (381)
..+......... ....+..+.+++.+||+.+|.+||++.++++.+-.+.
T Consensus 234 --------~~~~~~~~~~~~------------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 234 --------YHIAQNESPTLQ------------------SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred --------HHHHhccCCCCC------------------CccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 000100000000 1234557889999999999999999999998665443
No 330
>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase. Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi
Probab=100.00 E-value=2.3e-35 Score=267.15 Aligned_cols=226 Identities=22% Similarity=0.288 Sum_probs=176.5
Q ss_pred ecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEcc
Q 041757 44 ISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFM 103 (381)
Q Consensus 44 lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~~ 103 (381)
||.|+||.||++.. ...+.+.+|+.+++.++||||+++++.+ .+....++||||+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTF-----KDKKYIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeE-----EcCCccEEEEecC
Confidence 68999999877542 2335688999999999999999999984 4577899999999
Q ss_pred cCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccccee
Q 041757 104 HNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARF 183 (381)
Q Consensus 104 ~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~ 183 (381)
++++|.+++. +...+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++..
T Consensus 76 ~~~~L~~~l~----------~~~~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~ 142 (262)
T cd05572 76 LGGELWTILR----------DRGLFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKK 142 (262)
T ss_pred CCCcHHHHHh----------hcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccc
Confidence 9999999994 3455889999999999999999999 67999999999999999999999999999987
Q ss_pred cCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHHHHh
Q 041757 184 LPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVD 263 (381)
Q Consensus 184 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (381)
....... ....++..|+|||.+.+..++.++|+||||+++|++++|..||...... . . +...
T Consensus 143 ~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~-~------------~~~~ 204 (262)
T cd05572 143 LKSGQKT---WTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED--P-M------------EIYN 204 (262)
T ss_pred cCccccc---ccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC--H-H------------HHHH
Confidence 6544311 1245788999999988888999999999999999999999998633210 1 1 1111
Q ss_pred hhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 041757 264 SILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMK-----MTNVVH 319 (381)
Q Consensus 264 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~~vl~ 319 (381)
....... ....+...+..+.+++.+||+.||++||+ +.|+++
T Consensus 205 ~~~~~~~--------------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 205 DILKGNG--------------KLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHhccCC--------------CCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 1110000 00011233568999999999999999999 555554
No 331
>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po
Probab=100.00 E-value=4.3e-35 Score=268.63 Aligned_cols=262 Identities=20% Similarity=0.218 Sum_probs=182.1
Q ss_pred ccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEE
Q 041757 38 MLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKAL 98 (381)
Q Consensus 38 ~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~l 98 (381)
|...+.||.|+||.||++.. .....+.+|+++++.++|+|++++++++.. ......++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~~~l 77 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTS---KGKGSIYM 77 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEec---CCCCcEEE
Confidence 56778999999999988642 123568899999999999999999999643 11378999
Q ss_pred EEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeec
Q 041757 99 VYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDF 178 (381)
Q Consensus 99 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df 178 (381)
||||+++ +|.+++. .....+++..++.++.|++.||+||| ..+++|+||+|+||++++++.+||+||
T Consensus 78 v~e~~~~-~l~~~~~---------~~~~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~ 144 (287)
T cd07840 78 VFEYMDH-DLTGLLD---------SPEVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADF 144 (287)
T ss_pred Eeccccc-cHHHHHh---------ccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccc
Confidence 9999975 8998884 22357899999999999999999999 669999999999999999999999999
Q ss_pred ccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhch
Q 041757 179 GLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH 257 (381)
Q Consensus 179 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~ 257 (381)
|++.......... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ..............
T Consensus 145 g~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~-~~~~~~~~~~~~~~ 222 (287)
T cd07840 145 GLARPYTKRNSAD-YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL-EQLEKIFELCGSPT 222 (287)
T ss_pred cceeeccCCCccc-ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCc
Confidence 9998765543211 112346788999997765 45789999999999999999999997532211 00111111000000
Q ss_pred HHHHHhhhhccCchhhhhcccchhhhhHHHHHHH-HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRE-CVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
.... ...... ...................... ++..+.+++.+||..+|.+||++.++++
T Consensus 223 ~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 223 DENW-PGVSKL-PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhc-cccccc-hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000 000000 0000000000001111111222 3678999999999999999999999875
No 332
>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check
Probab=100.00 E-value=3.3e-35 Score=265.86 Aligned_cols=234 Identities=18% Similarity=0.245 Sum_probs=180.5
Q ss_pred cccccceecCCCceEEEeccc----------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757 37 NMLEENLISAGTFGFSHLRRQ----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND 94 (381)
Q Consensus 37 ~~~~~~~lG~G~fg~V~~~~~----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~ 94 (381)
.|...++||+|+||.||++.. .....+..|+.+++.++||||+++++++ ....
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASF-----LERD 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHH-----hcCC
Confidence 377889999999999986531 1223466799999999999999999985 4466
Q ss_pred eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757 95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR 174 (381)
Q Consensus 95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k 174 (381)
..++||||+++++|.+++.... .....+++..++.++.|++.||.||| +.+++|+||+|+||+++. +.++
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~ 145 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELK------HTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLK 145 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHh------hcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEe
Confidence 7899999999999999885321 23457899999999999999999999 669999999999999975 5699
Q ss_pred EeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHh
Q 041757 175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMAL 254 (381)
Q Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 254 (381)
|+|||++.......... ....|++.|+|||.+.+..++.++|+||||+++|+|++|..||... .. .....
T Consensus 146 l~d~g~~~~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~----~~-~~~~~--- 215 (260)
T cd08222 146 IGDFGVSRLLMGSCDLA--TTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ----NF-LSVVL--- 215 (260)
T ss_pred ecccCceeecCCCcccc--cCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc----cH-HHHHH---
Confidence 99999987764433221 1245788999999988888899999999999999999999997421 11 11111
Q ss_pred hchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 255 SNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 255 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
........ ..+..++.++.+++.+||..||++||++.++++
T Consensus 216 ---------~~~~~~~~---------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 216 ---------RIVEGPTP---------------SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred ---------HHHcCCCC---------------CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 00000000 012345668889999999999999999999986
No 333
>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase. Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines
Probab=100.00 E-value=2.5e-35 Score=270.88 Aligned_cols=239 Identities=21% Similarity=0.250 Sum_probs=182.3
Q ss_pred cccccceecCCCceEEEeccc------------------------ccHHHHHHHHHHHHcc-CCCcccceeeeecccccc
Q 041757 37 NMLEENLISAGTFGFSHLRRQ------------------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQ 91 (381)
Q Consensus 37 ~~~~~~~lG~G~fg~V~~~~~------------------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~ 91 (381)
+|...+.||+|+||.||++.. ...+.+.+|++++.++ +||||+++++. +.
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~-----~~ 75 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYA-----FQ 75 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhhee-----ee
Confidence 477889999999999987431 1224577899999999 59999999988 45
Q ss_pred CCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC
Q 041757 92 GNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM 171 (381)
Q Consensus 92 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~ 171 (381)
.....++||||+++|+|.+++. ....+++..+..++.|++.||.||| ..+++||||+|+||+++.++
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~~~----------~~~~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~ 142 (288)
T cd05583 76 TDTKLHLILDYVNGGELFTHLY----------QREHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEG 142 (288)
T ss_pred cCCEEEEEEecCCCCcHHHHHh----------hcCCcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCC
Confidence 5778899999999999999983 3456888999999999999999999 67999999999999999999
Q ss_pred CeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCc--cCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHH
Q 041757 172 TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNE--VSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKF 249 (381)
Q Consensus 172 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~ 249 (381)
.++|+|||++.......... .....|+..|+|||.+.+.. .+.++||||||+++|+|++|..||...... .....
T Consensus 143 ~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-~~~~~- 219 (288)
T cd05583 143 HVVLTDFGLSKEFLAEEEER-AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ-NSQSE- 219 (288)
T ss_pred CEEEEECccccccccccccc-cccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc-chHHH-
Confidence 99999999987654432211 11245889999999987654 788999999999999999999998522110 00111
Q ss_pred HHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 041757 250 AKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQS 323 (381)
Q Consensus 250 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~ 323 (381)
+........+. .+......+.+++.+||+.||++|||+.++.+.|+.
T Consensus 220 -----------~~~~~~~~~~~----------------~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 220 -----------ISRRILKSKPP----------------FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred -----------HHHHHHccCCC----------------CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 11111110000 012344578889999999999999999988776654
No 334
>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of
Probab=100.00 E-value=2.4e-35 Score=269.47 Aligned_cols=225 Identities=24% Similarity=0.260 Sum_probs=172.2
Q ss_pred ecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEcc
Q 041757 44 ISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFM 103 (381)
Q Consensus 44 lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~~ 103 (381)
||+|+||+||++.. .....+.+|+++++.++||||+++++++ ...+..++||||+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAF-----ETKDDLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEE-----ecCCeEEEEEecC
Confidence 69999999987531 1234567899999999999999999984 4577899999999
Q ss_pred cCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccccee
Q 041757 104 HNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARF 183 (381)
Q Consensus 104 ~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~ 183 (381)
++++|.+++.. .....+++..+..++.|++.||.||| ..+++||||+|+||+++.++.++|+|||.+..
T Consensus 76 ~~~~L~~~l~~--------~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~ 144 (277)
T cd05577 76 NGGDLKYHIYN--------VGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVE 144 (277)
T ss_pred CCCcHHHHHHH--------cCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhh
Confidence 99999999853 12246899999999999999999999 67999999999999999999999999999876
Q ss_pred cCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHHHHh
Q 041757 184 LPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVD 263 (381)
Q Consensus 184 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (381)
........ ...++..|+|||++.+..++.++||||||+++|+|++|+.||....... ..... ..
T Consensus 145 ~~~~~~~~---~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~------------~~ 208 (277)
T cd05577 145 LKGGKKIK---GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV-EKEEL------------KR 208 (277)
T ss_pred hccCCccc---cccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc-cHHHH------------Hh
Confidence 54322211 2347889999999988889999999999999999999999985322110 00110 00
Q ss_pred hhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 041757 264 SILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTN 316 (381)
Q Consensus 264 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~ 316 (381)
.... .+ ...+......+.+++.+||+.||.+||++.+
T Consensus 209 ~~~~-~~---------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 209 RTLE-MA---------------VEYPDKFSPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred cccc-cc---------------ccCCccCCHHHHHHHHHHccCChhHccCCCc
Confidence 0000 00 0011234567889999999999999994444
No 335
>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4. Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates
Probab=100.00 E-value=9e-36 Score=273.72 Aligned_cols=241 Identities=22% Similarity=0.246 Sum_probs=177.0
Q ss_pred ccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccC-CCcccceeeeeccccccCCceE
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIR-HRNLIKVLTACLGVDYQGNDFK 96 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~~~~~ 96 (381)
++|...++||+|+||.||.+.. .....+.+|+.++.++. |+||+++++++. .....
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~-----~~~~~ 78 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALF-----REGDC 78 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEe-----cCCcE
Confidence 4667778999999999976431 23456788999999996 999999999853 46778
Q ss_pred EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757 97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG 176 (381)
Q Consensus 97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~ 176 (381)
+++|||+.. ++.++...... .....+++..+..++.|++.||+|||+ ..+++||||||+||+++.++.+||+
T Consensus 79 ~~~~e~~~~-~l~~l~~~~~~-----~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~ 150 (288)
T cd06616 79 WICMELMDI-SLDKFYKYVYE-----VLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLC 150 (288)
T ss_pred EEEEecccC-CHHHHHHHHHH-----hhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEe
Confidence 999999864 66554321000 223568999999999999999999994 2489999999999999999999999
Q ss_pred ecccceecCCCCCcccccCccCccceeCCCCcCCC---ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH
Q 041757 177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGN---EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA 253 (381)
Q Consensus 177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~---~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~ 253 (381)
|||++.......... ...|+..|+|||++.+. .++.++|||||||++|+|++|+.||.... .....
T Consensus 151 dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~---~~~~~----- 219 (288)
T cd06616 151 DFGISGQLVDSIAKT---RDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN---SVFDQ----- 219 (288)
T ss_pred ecchhHHhccCCccc---cccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc---hHHHH-----
Confidence 999987654332221 13478899999998776 68999999999999999999999975221 00000
Q ss_pred hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 254 LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 254 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
+.......+... .......++.++.+++.+||+.||++|||+.+|++
T Consensus 220 --------~~~~~~~~~~~~-----------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 220 --------LTQVVKGDPPIL-----------SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred --------HhhhcCCCCCcC-----------CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000000000 00001235667899999999999999999999986
No 336
>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc
Probab=100.00 E-value=3.9e-35 Score=268.74 Aligned_cols=257 Identities=20% Similarity=0.256 Sum_probs=179.7
Q ss_pred ccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEE
Q 041757 38 MLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKAL 98 (381)
Q Consensus 38 ~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~l 98 (381)
|+..++||.|++|.||++.. ...+.+.+|+++++.++||||+++++++. +.+..++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~-----~~~~~~i 75 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVH-----SENKLYL 75 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheec-----cCCeEEE
Confidence 56778999999999987541 12356889999999999999999999954 4688999
Q ss_pred EEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeec
Q 041757 99 VYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDF 178 (381)
Q Consensus 99 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df 178 (381)
||||+. ++|.+++.. .....+++..++.++.|++.||+||| +.+++||||+|+||+++.++.++|+||
T Consensus 76 v~e~~~-~~l~~~~~~--------~~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df 143 (283)
T cd07835 76 VFEFLD-LDLKKYMDS--------SPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADF 143 (283)
T ss_pred EEeccC-cCHHHHHhh--------CCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeec
Confidence 999995 699999842 11246899999999999999999999 669999999999999999999999999
Q ss_pred ccceecCCCCCcccccCccCccceeCCCCcCCC-ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH--hh
Q 041757 179 GLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA--LS 255 (381)
Q Consensus 179 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~--~~ 255 (381)
|++.......... ....++..|+|||++.+. .++.++||||||+++|+|++|+.||... .......... ..
T Consensus 144 ~~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~----~~~~~~~~~~~~~~ 217 (283)
T cd07835 144 GLARAFGVPVRTY--THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGD----SEIDQLFRIFRTLG 217 (283)
T ss_pred ccccccCCCcccc--CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHHHhC
Confidence 9997654332111 113468899999987664 5788999999999999999999997522 1111111100 00
Q ss_pred chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
......... ....+.-... ................+..+.+++.+||+.||.+|||+.++++
T Consensus 218 ~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 218 TPDEDVWPG-VTSLPDYKPT-FPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred CCChHHhhh-hhhchhhhhh-cccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000000 0000000000 0000000001112234467889999999999999999999985
No 337
>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains. Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an
Probab=100.00 E-value=4.4e-35 Score=264.01 Aligned_cols=233 Identities=19% Similarity=0.230 Sum_probs=184.8
Q ss_pred cccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757 37 NMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA 97 (381)
Q Consensus 37 ~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~ 97 (381)
+|...++||.|+||.||++.. .....+.+|++++++++|+||+++++++ ......+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAF-----LDGNKLC 75 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhh-----ccCCEEE
Confidence 477889999999999987531 2245678899999999999999999985 4468899
Q ss_pred EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757 98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD 177 (381)
Q Consensus 98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D 177 (381)
+||||+++++|.+++.... .....+++..++.++.|++.||+||| +.+++|+||+|+||+++.++.+||+|
T Consensus 76 ~v~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d 146 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRK------KKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGD 146 (256)
T ss_pred EEehhcCCCCHHHHHHHHH------hhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEee
Confidence 9999999999999985321 12356889999999999999999999 67999999999999999999999999
Q ss_pred cccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhch
Q 041757 178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH 257 (381)
Q Consensus 178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~ 257 (381)
||++......... ...++..|+|||.+.+..++.++|+||||+++|++++|+.||.... ........
T Consensus 147 ~g~~~~~~~~~~~----~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~-----~~~~~~~~---- 213 (256)
T cd08530 147 LGISKVLKKNMAK----TQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS-----MQDLRYKV---- 213 (256)
T ss_pred ccchhhhccCCcc----cccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHH----
Confidence 9999876554211 1347889999999988889999999999999999999999975221 11111110
Q ss_pred HHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
..... ...+.....++.+++.+||+.+|++|||+.++++
T Consensus 214 --------~~~~~---------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 214 --------QRGKY---------------PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred --------hcCCC---------------CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000 0012245667899999999999999999999975
No 338
>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They
Probab=100.00 E-value=7.5e-35 Score=266.58 Aligned_cols=257 Identities=22% Similarity=0.253 Sum_probs=184.2
Q ss_pred ccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEE
Q 041757 38 MLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKAL 98 (381)
Q Consensus 38 ~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~l 98 (381)
|...+.||.|++|.||++.. .....+.+|+.++++++|+||+++++++ ......++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~ 75 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVF-----RHKGDLYL 75 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhh-----ccCCCEEE
Confidence 55678899999999977641 1245678899999999999999999995 44688999
Q ss_pred EEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeec
Q 041757 99 VYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDF 178 (381)
Q Consensus 99 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df 178 (381)
||||+++ +|.+++. .....+++..+..++.|++.||.||| ..+++|+||||+||+++.++.++|+||
T Consensus 76 v~e~~~~-~l~~~l~---------~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df 142 (283)
T cd05118 76 VFEFMDT-DLYKLIK---------DRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADF 142 (283)
T ss_pred EEeccCC-CHHHHHH---------hhcccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeee
Confidence 9999975 8888884 23357899999999999999999999 669999999999999999999999999
Q ss_pred ccceecCCCCCcccccCccCccceeCCCCcCCC-ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH--hh
Q 041757 179 GLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA--LS 255 (381)
Q Consensus 179 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~--~~ 255 (381)
|.+......... .....++..|+|||.+.+. .++.++||||||+++|++++|+.||... .....+.... ..
T Consensus 143 ~~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~----~~~~~~~~~~~~~~ 216 (283)
T cd05118 143 GLARSFGSPVRP--YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGK----SEIDQLFKIFRTLG 216 (283)
T ss_pred eeeEecCCCccc--ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHHHcC
Confidence 999876554311 1123478889999998776 7899999999999999999999997522 2221111110 00
Q ss_pred chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
................... ..............+..+.++.+++.+||+.||.+||++.+++.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 217 TPDPEVWPKFTSLARNYKF-SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred CCchHhcccchhhhhhhhh-hhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0000100000000000000 00000001112223456788999999999999999999999985
No 339
>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13
Probab=100.00 E-value=6.1e-35 Score=274.97 Aligned_cols=267 Identities=16% Similarity=0.182 Sum_probs=183.2
Q ss_pred ccccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeecccc-ccCC
Q 041757 34 VSRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVD-YQGN 93 (381)
Q Consensus 34 ~~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~-~~~~ 93 (381)
+.++|...+.||+|+||.||++.. .....+.+|+.+++.++||||+++++++.... ....
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 357899999999999999987541 12345788999999999999999999865321 1123
Q ss_pred ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757 94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA 173 (381)
Q Consensus 94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~ 173 (381)
...++|+||+.. +|..++ ...+++..+..++.|++.||+||| +.+++||||||+||+++.++.+
T Consensus 93 ~~~~lv~e~~~~-~l~~~~------------~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~ 156 (342)
T cd07879 93 QDFYLVMPYMQT-DLQKIM------------GHPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCEL 156 (342)
T ss_pred ceEEEEeccccc-CHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCE
Confidence 456999999964 777665 235788899999999999999999 6699999999999999999999
Q ss_pred EEeecccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHH
Q 041757 174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM 252 (381)
Q Consensus 174 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~ 252 (381)
||+|||+++...... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||... .....+...
T Consensus 157 kL~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~----~~~~~~~~~ 227 (342)
T cd07879 157 KILDFGLARHADAEM-----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK----DYLDQLTQI 227 (342)
T ss_pred EEeeCCCCcCCCCCC-----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHH
Confidence 999999987643322 12457889999998876 46889999999999999999999998522 111111110
Q ss_pred --HhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH--HHHhh
Q 041757 253 --ALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE--LQSIK 325 (381)
Q Consensus 253 --~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~--L~~i~ 325 (381)
........+.+..........................+.....+.+++.+||+.||.+||++.+++.. ++...
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 228 LKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred HHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 00011111111110000000000000000000001112345678899999999999999999999853 55543
No 340
>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]
Probab=100.00 E-value=4.3e-36 Score=300.28 Aligned_cols=241 Identities=20% Similarity=0.288 Sum_probs=174.3
Q ss_pred cccccccceecCCCceEEEecccc------------------cHHHHHHHHHHHHccCCCcccceeeeecc---------
Q 041757 35 SRNMLEENLISAGTFGFSHLRRQG------------------AFKSFIAECKALRNIRHRNLIKVLTACLG--------- 87 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~~~------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~--------- 87 (381)
..+|++.++||+||||.|++++.. ......+|+..|.+|+|||||++|..+++
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 467888999999999999887632 34557789999999999999999887543
Q ss_pred ---------------------------------------------cc----------------------c----------
Q 041757 88 ---------------------------------------------VD----------------------Y---------- 90 (381)
Q Consensus 88 ---------------------------------------------~~----------------------~---------- 90 (381)
.. .
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence 00 0
Q ss_pred --------------------cCC--------ceEEEEEEcccCCCHHHhhccccCCcccccCCCcc-cHHHHHHHHHHHH
Q 041757 91 --------------------QGN--------DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNL-NLLRRLNIAIDVA 141 (381)
Q Consensus 91 --------------------~~~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l-~~~~~~~i~~qi~ 141 (381)
..+ ..+||-||||+.-.|.+++.. .... .....++++++|+
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~----------N~~~~~~d~~wrLFreIl 707 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRR----------NHFNSQRDEAWRLFREIL 707 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHh----------cccchhhHHHHHHHHHHH
Confidence 001 356899999999888877742 1111 4677899999999
Q ss_pred HHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccceecCC----------------CCCcccccCccCccceeCC
Q 041757 142 SALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPP----------------TRTQTSSIDVKGSIGYIAP 205 (381)
Q Consensus 142 ~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~----------------~~~~~~~~~~~gt~~y~aP 205 (381)
+||.|+| ++|||||||||.||+++.+..|||+|||+|..... .......+..+||.-|+||
T Consensus 708 EGLaYIH---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAP 784 (1351)
T KOG1035|consen 708 EGLAYIH---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAP 784 (1351)
T ss_pred HHHHHHH---hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecH
Confidence 9999999 77999999999999999999999999999987220 0111123457799999999
Q ss_pred CCcCCC---ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhh
Q 041757 206 EYGVGN---EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQT 282 (381)
Q Consensus 206 E~l~~~---~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 282 (381)
|++.+. .|+.|+|+||+|||++||+. ||....+ -... +.++-+..+..+
T Consensus 785 Ell~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME----Ra~i--------L~~LR~g~iP~~------------- 836 (1351)
T KOG1035|consen 785 ELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSME----RASI--------LTNLRKGSIPEP------------- 836 (1351)
T ss_pred HHhcccccccccchhhhHHHHHHHHHHhc---cCCchHH----HHHH--------HHhcccCCCCCC-------------
Confidence 998875 49999999999999999984 4431111 1111 111111111000
Q ss_pred hhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 283 QAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 283 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
..+..+....-.+++.++++.||.+|||+.|+++
T Consensus 837 ---~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 837 ---ADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred ---cccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 0111233345567888999999999999999986
No 341
>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho
Probab=100.00 E-value=6.4e-35 Score=264.74 Aligned_cols=236 Identities=18% Similarity=0.222 Sum_probs=181.7
Q ss_pred ccccccceecCCCceEEEeccc----------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN 93 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 93 (381)
.+|...+.||+|+||.||++.. .....+.+|++++++++|+||+++++++.. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~---~~~ 78 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRD---PEE 78 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEc---CCC
Confidence 4788999999999999977641 123477889999999999999999998643 234
Q ss_pred ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757 94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA 173 (381)
Q Consensus 94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~ 173 (381)
...++||||+++++|.+++. ....+++..+..++.|++.||.||| +.+++|+||||+||+++.++.+
T Consensus 79 ~~~~~v~e~~~~~~L~~~~~----------~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~ 145 (264)
T cd06653 79 KKLSIFVEYMPGGSIKDQLK----------AYGALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNV 145 (264)
T ss_pred CEEEEEEEeCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCE
Confidence 56889999999999999984 3345788899999999999999999 6699999999999999999999
Q ss_pred EEeecccceecCCCCC-cccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHH
Q 041757 174 RVGDFGLARFLPPTRT-QTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM 252 (381)
Q Consensus 174 kl~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~ 252 (381)
+|+|||+++....... ........++..|+|||++.+..++.++|||||||++|++++|+.||... .........
T Consensus 146 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~----~~~~~~~~~ 221 (264)
T cd06653 146 KLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY----EAMAAIFKI 221 (264)
T ss_pred EECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc----CHHHHHHHH
Confidence 9999999986543211 11111245889999999998888999999999999999999999998522 111111110
Q ss_pred HhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 253 ALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 253 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
..... ....+......+.+++.+||. +|..||++.+++.
T Consensus 222 -------------~~~~~--------------~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 222 -------------ATQPT--------------KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred -------------HcCCC--------------CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 00000 001123455678999999999 5799999998765
No 342
>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK
Probab=100.00 E-value=6.2e-35 Score=262.93 Aligned_cols=237 Identities=21% Similarity=0.279 Sum_probs=186.5
Q ss_pred cccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757 37 NMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA 97 (381)
Q Consensus 37 ~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~ 97 (381)
+|...+.||+|+||.||.+.. ...+.+.+|+.++++++|+||+++++.+.. ......+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~~~ 77 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERD---EEKNTLN 77 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEec---CCCCeEE
Confidence 477789999999999977642 235678999999999999999999999643 1127889
Q ss_pred EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757 98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD 177 (381)
Q Consensus 98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D 177 (381)
+|+||+++++|.+++. ....+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|
T Consensus 78 lv~e~~~~~~L~~~~~----------~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d 144 (260)
T cd06606 78 IFLEYVSGGSLSSLLK----------KFGKLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLAD 144 (260)
T ss_pred EEEEecCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcc
Confidence 9999999999999994 3347899999999999999999999 66999999999999999999999999
Q ss_pred cccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhch
Q 041757 178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH 257 (381)
Q Consensus 178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~ 257 (381)
||.+................++..|+|||.+.+...+.++||||||+++|++++|..||.... ........
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~~~~~~~~----- 215 (260)
T cd06606 145 FGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG----NPMAALYK----- 215 (260)
T ss_pred cccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----chHHHHHh-----
Confidence 999987766543111122458899999999988889999999999999999999999986322 11110000
Q ss_pred HHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
+... .. ....+...+..+.+++.+||+.||.+||++.+++.
T Consensus 216 ---~~~~---~~---------------~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 216 ---IGSS---GE---------------PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred ---cccc---CC---------------CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 0000 00 00012234678999999999999999999999985
No 343
>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=4.3e-36 Score=262.54 Aligned_cols=182 Identities=27% Similarity=0.334 Sum_probs=159.2
Q ss_pred ccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF 95 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~ 95 (381)
++|...++||+|+||+|-+++. ..+..-+.|-++|+..+||.+..+-.. ++..+.
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYs-----FQt~dr 242 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYS-----FQTQDR 242 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhh-----hccCce
Confidence 6788889999999999965542 234455678899999999999887655 678999
Q ss_pred EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757 96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV 175 (381)
Q Consensus 96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl 175 (381)
++.||||..||.|.-+| .+...+++....-+..+|+.||.||| +.+||.||||.+|.|+|.+|++||
T Consensus 243 lCFVMeyanGGeLf~HL----------srer~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKi 309 (516)
T KOG0690|consen 243 LCFVMEYANGGELFFHL----------SRERVFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKI 309 (516)
T ss_pred EEEEEEEccCceEeeeh----------hhhhcccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEe
Confidence 99999999999999988 56778999999999999999999999 679999999999999999999999
Q ss_pred eecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCC
Q 041757 176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSD 237 (381)
Q Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~ 237 (381)
+|||+++.--.... ....++|||.|.|||++....|+.++|.|.+||++|||++|+.||.
T Consensus 310 tDFGLCKE~I~~g~--t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFy 369 (516)
T KOG0690|consen 310 TDFGLCKEEIKYGD--TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFY 369 (516)
T ss_pred eecccchhcccccc--eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccc
Confidence 99999985433222 2234899999999999999999999999999999999999999986
No 344
>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They
Probab=100.00 E-value=6.9e-35 Score=262.63 Aligned_cols=235 Identities=22% Similarity=0.319 Sum_probs=185.8
Q ss_pred cccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757 37 NMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA 97 (381)
Q Consensus 37 ~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~ 97 (381)
+|...+.||.|+||.||.+.. ...+.+.+|+++++.++|+|++++++.+. .....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~-----~~~~~~ 75 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFE-----EKGKLC 75 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEe-----cCCEEE
Confidence 577889999999999976542 24567889999999999999999999853 468899
Q ss_pred EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757 98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD 177 (381)
Q Consensus 98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D 177 (381)
+|+||+++++|.+++.... .....+++..+..++.+++.||.||| ..+++|+||+|+||+++.++.++|+|
T Consensus 76 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d 146 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQK------KEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGD 146 (258)
T ss_pred EEEEecCCCcHHHHHHHhh------ccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECC
Confidence 9999999999999995321 12467899999999999999999999 66999999999999999999999999
Q ss_pred cccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhch
Q 041757 178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH 257 (381)
Q Consensus 178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~ 257 (381)
||.+.......... ....|++.|+|||.+.+..++.++||||+|+++|+|++|..||.... ...
T Consensus 147 ~~~~~~~~~~~~~~--~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-----~~~--------- 210 (258)
T cd08215 147 FGISKVLSSTVDLA--KTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN-----LLE--------- 210 (258)
T ss_pred ccceeecccCccee--cceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc-----HHH---------
Confidence 99998765543111 12458889999999988889999999999999999999999975221 111
Q ss_pred HHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
+.......... ..+...+..+.+++.+||..+|++|||+.++++
T Consensus 211 ---~~~~~~~~~~~---------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 211 ---LALKILKGQYP---------------PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred ---HHHHHhcCCCC---------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 11111110000 001134567889999999999999999999986
No 345
>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12
Probab=100.00 E-value=6e-35 Score=275.10 Aligned_cols=264 Identities=18% Similarity=0.211 Sum_probs=184.3
Q ss_pred hhccccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeecccc-cc
Q 041757 32 LDVSRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVD-YQ 91 (381)
Q Consensus 32 ~~~~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~-~~ 91 (381)
-...++|...+.||+|+||.||++.. .....+.+|+.+|++++||||+++++++.... ..
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 34578899999999999999977531 12345788999999999999999999865311 11
Q ss_pred CCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC
Q 041757 92 GNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM 171 (381)
Q Consensus 92 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~ 171 (381)
.....++||||+ +++|.+++. ...+++..++.++.|++.||.||| ..+|+||||||+||+++.++
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~-----------~~~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~ 155 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMK-----------HEKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDC 155 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCC
Confidence 123568999999 779998873 245889999999999999999999 66999999999999999999
Q ss_pred CeEEeecccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHH
Q 041757 172 TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFA 250 (381)
Q Consensus 172 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~ 250 (381)
.++|+|||++........ ...+++.|+|||++.+ ..++.++||||||+++|++++|..||.... ......
T Consensus 156 ~~kl~dfg~~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~----~~~~~~ 226 (343)
T cd07880 156 ELKILDFGLARQTDSEMT-----GYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHD----HLDQLM 226 (343)
T ss_pred CEEEeecccccccccCcc-----ccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC----HHHHHH
Confidence 999999999976543221 2347889999998876 458899999999999999999999986321 111111
Q ss_pred HHH-h-hchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 251 KMA-L-SNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 251 ~~~-~-~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
... . .....++..................................+.+++.+|++.||.+|||+.+++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 227 EIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 100 0 00011111111000000000000000000011112345567889999999999999999999984
No 346
>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1. Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph
Probab=100.00 E-value=9e-35 Score=267.42 Aligned_cols=235 Identities=21% Similarity=0.261 Sum_probs=177.7
Q ss_pred cccccceecCCCceEEEeccc------------------------ccHHHHHHHHHHHHcc-CCCcccceeeeecccccc
Q 041757 37 NMLEENLISAGTFGFSHLRRQ------------------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQ 91 (381)
Q Consensus 37 ~~~~~~~lG~G~fg~V~~~~~------------------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~ 91 (381)
+|...+.||.|+||.||.+.. ...+.+.+|++++.++ +|+||+++++++ .
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~ 75 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-----Q 75 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe-----e
Confidence 578889999999999987542 1235577899999999 599999999884 4
Q ss_pred CCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC
Q 041757 92 GNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM 171 (381)
Q Consensus 92 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~ 171 (381)
.+...++||||+++++|.+++. ....+++..+..++.|++.||.||| +.+++||||+|+||+++.++
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~----------~~~~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~ 142 (290)
T cd05613 76 TDTKLHLILDYINGGELFTHLS----------QRERFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNG 142 (290)
T ss_pred cCCeEEEEEecCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCC
Confidence 5678899999999999999994 3456888899999999999999999 67999999999999999999
Q ss_pred CeEEeecccceecCCCCCcccccCccCccceeCCCCcCCC--ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHH
Q 041757 172 TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGN--EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKF 249 (381)
Q Consensus 172 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~ 249 (381)
.+||+|||++.......... .....|+..|+|||.+... .++.++||||||+++|+|++|..||...... ....
T Consensus 143 ~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-~~~~-- 218 (290)
T cd05613 143 HVVLTDFGLSKEFHEDEVER-AYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK-NSQA-- 218 (290)
T ss_pred CEEEeeCccceecccccccc-cccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc-ccHH--
Confidence 99999999997654432211 1124588999999998753 4678999999999999999999998522111 1111
Q ss_pred HHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 041757 250 AKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRM-----KMTNVVH 319 (381)
Q Consensus 250 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~~vl~ 319 (381)
++........+. .+......+.+++.+||+.||++|| ++.+++.
T Consensus 219 ----------~~~~~~~~~~~~----------------~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 219 ----------EISRRILKSEPP----------------YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ----------HHHHHhhccCCC----------------CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 111111111100 0123455778999999999999997 5555543
No 347
>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re
Probab=100.00 E-value=4e-35 Score=265.41 Aligned_cols=227 Identities=23% Similarity=0.307 Sum_probs=176.3
Q ss_pred ecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEcc
Q 041757 44 ISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFM 103 (381)
Q Consensus 44 lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~~ 103 (381)
||.|+||.||++.. ...+.+.+|++++++++||||+++++.+ ......++||||+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF-----QGKKNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhe-----ecCcEEEEEEecC
Confidence 68899999977652 2345788899999999999999999884 4578899999999
Q ss_pred cCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccccee
Q 041757 104 HNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARF 183 (381)
Q Consensus 104 ~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~ 183 (381)
++++|.+++. +...+++..+..++.|++.||.||| ..+++|+||+|+||+++.++.++|+|||++..
T Consensus 76 ~~~~L~~~l~----------~~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~ 142 (265)
T cd05579 76 PGGDLASLLE----------NVGSLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKV 142 (265)
T ss_pred CCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchh
Confidence 9999999994 3347899999999999999999999 66999999999999999999999999999876
Q ss_pred cCCCCCc------ccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhch
Q 041757 184 LPPTRTQ------TSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH 257 (381)
Q Consensus 184 ~~~~~~~------~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~ 257 (381)
....... .......++..|+|||.......+.++||||||+++|++++|..||.... ..
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-----~~---------- 207 (265)
T cd05579 143 GLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET-----PE---------- 207 (265)
T ss_pred cccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC-----HH----------
Confidence 5433211 11122457889999999988889999999999999999999999985221 01
Q ss_pred HHHHHhhhhccCchhhhhcccchhhhhHHHHHHH--HHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 041757 258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRE--CVISMVRIGVACSMESPQDRMKMTNVVHEL 321 (381)
Q Consensus 258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L 321 (381)
+........... .+.. .+..+.+++.+||+.+|.+|||+..+.+.|
T Consensus 208 --~~~~~~~~~~~~----------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 208 --EIFQNILNGKIE----------------WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred --HHHHHHhcCCcC----------------CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 111111100000 0111 256789999999999999999995555444
No 348
>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein. Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc
Probab=100.00 E-value=1.1e-34 Score=269.89 Aligned_cols=240 Identities=18% Similarity=0.191 Sum_probs=167.3
Q ss_pred cHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHH
Q 041757 59 AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAI 138 (381)
Q Consensus 59 ~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~ 138 (381)
..+.+.+|+++++.++|+||+++++++ ...+..+++|||+++|+|.+++.. .....+++..+..++.
T Consensus 42 ~~~~~~~Ei~~l~~l~h~~i~~~~~~~-----~~~~~~~~~~e~~~~~~l~~~l~~--------~~~~~~~~~~~~~~~~ 108 (314)
T cd08216 42 DLKLLQQEIITSRQLQHPNILPYVTSF-----IVDSELYVVSPLMAYGSCEDLLKT--------HFPEGLPELAIAFILK 108 (314)
T ss_pred HHHHHHHHHHHHHhcCCcchhhhhhee-----ecCCeEEEEEeccCCCCHHHHHHH--------hcccCCCHHHHHHHHH
Confidence 456889999999999999999999984 457788999999999999999953 1234578899999999
Q ss_pred HHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccceecCCCCCc-----ccccCccCccceeCCCCcCC--C
Q 041757 139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQ-----TSSIDVKGSIGYIAPEYGVG--N 211 (381)
Q Consensus 139 qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~--~ 211 (381)
|++.||.||| +.+|+||||||+||+++.++.+||+|||.+......... .......++..|+|||++.. .
T Consensus 109 ~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 185 (314)
T cd08216 109 DVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQ 185 (314)
T ss_pred HHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCC
Confidence 9999999999 669999999999999999999999999988755432211 11112347788999999876 3
Q ss_pred ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHHHHhhhhccCchh-hh-----hcccchhhhhH
Q 041757 212 EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEK-LV-----VRGDQKQTQAK 285 (381)
Q Consensus 212 ~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~-~~-----~~~~~~~~~~~ 285 (381)
.++.++|||||||++|||++|..||...... ...... .......+++......... .. ...........
T Consensus 186 ~~~~~~Diws~G~il~el~~g~~pf~~~~~~----~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (314)
T cd08216 186 GYNEKSDIYSVGITACELANGHVPFKDMPAT----QMLLEK-VRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVD 260 (314)
T ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHH-HhccCccccccCchhhhcCCcCcccccccccchhhhhh
Confidence 5889999999999999999999998632111 111110 0100000000000000000 00 00000000000
Q ss_pred HHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 286 INIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 286 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
.........++.+++.+||..||++|||+.++++
T Consensus 261 ~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 261 HPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred cchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 1112334567889999999999999999999986
No 349
>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo
Probab=100.00 E-value=4.6e-35 Score=269.74 Aligned_cols=229 Identities=19% Similarity=0.246 Sum_probs=177.6
Q ss_pred ccceecCCCceEEEeccc-----------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEc
Q 041757 40 EENLISAGTFGFSHLRRQ-----------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEF 102 (381)
Q Consensus 40 ~~~~lG~G~fg~V~~~~~-----------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~ 102 (381)
...+||+|+||.||.+.. .....+.+|+.+++.++|+||+++++.+ ...+..++||||
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~ 98 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY-----LVGDELWVVMEF 98 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEE-----EeCCEEEEEEec
Confidence 346799999999977532 2345688899999999999999999985 447789999999
Q ss_pred ccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccce
Q 041757 103 MHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR 182 (381)
Q Consensus 103 ~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~ 182 (381)
+++++|.+++. ...+++..+..++.|++.||+||| ..+++|+||+|+||+++.++.++|+|||++.
T Consensus 99 ~~~~~L~~~~~-----------~~~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~ 164 (292)
T cd06657 99 LEGGALTDIVT-----------HTRMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCA 164 (292)
T ss_pred CCCCcHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccce
Confidence 99999999873 235788999999999999999999 6699999999999999999999999999987
Q ss_pred ecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHHHH
Q 041757 183 FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIV 262 (381)
Q Consensus 183 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (381)
......... ....++..|+|||.+.+..++.++||||||+++|+|++|..||... ...... . .+
T Consensus 165 ~~~~~~~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~----~~~~~~-~---------~~ 228 (292)
T cd06657 165 QVSKEVPRR--KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE----PPLKAM-K---------MI 228 (292)
T ss_pred ecccccccc--cccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC----CHHHHH-H---------HH
Confidence 654332111 1245889999999998888899999999999999999999997521 111110 0 00
Q ss_pred hhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 263 DSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 263 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
...+.... ......+..+.+++.+||..||.+||++.++++
T Consensus 229 ~~~~~~~~----------------~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 229 RDNLPPKL----------------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HhhCCccc----------------CCcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 00000000 001134456788899999999999999999987
No 350
>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely
Probab=100.00 E-value=9.6e-35 Score=268.65 Aligned_cols=269 Identities=19% Similarity=0.207 Sum_probs=183.0
Q ss_pred ccccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeecccc-----
Q 041757 34 VSRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVD----- 89 (381)
Q Consensus 34 ~~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~----- 89 (381)
..++|...++||+|+||.||++.. .....+.+|+++++.++||||+++++++....
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 357899999999999999977542 12246778999999999999999999875421
Q ss_pred ccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCC
Q 041757 90 YQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD 169 (381)
Q Consensus 90 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~ 169 (381)
.......++|+||+++ ++..++. .....+++..++.++.|++.||+||| ..+|+|+||||+||++++
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~---------~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~ 151 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLE---------SGLVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNN 151 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHh---------cCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECC
Confidence 1123478999999976 7777764 23456899999999999999999999 669999999999999999
Q ss_pred CCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHH
Q 041757 170 DMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHK 248 (381)
Q Consensus 170 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~ 248 (381)
++.+||+|||++........... ....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||..... ...+..
T Consensus 152 ~~~~kl~dfg~~~~~~~~~~~~~-~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~-~~~~~~ 229 (302)
T cd07864 152 KGQIKLADFGLARLYNSEESRPY-TNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE-LAQLEL 229 (302)
T ss_pred CCcEEeCcccccccccCCccccc-ccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHH
Confidence 99999999999987654332111 11236788999998765 3578899999999999999999999852210 001111
Q ss_pred HHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 249 FAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 249 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
+... ............... +......................+..+.+++.+||+.||.+|||+.+++.
T Consensus 230 ~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 230 ISRL-CGSPCPAVWPDVIKL-PYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred HHHH-hCCCChhhccccccc-ccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1111 000000000000000 00000000000000000111124567899999999999999999999875
No 351
>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta. Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig
Probab=100.00 E-value=9.3e-35 Score=272.18 Aligned_cols=265 Identities=18% Similarity=0.194 Sum_probs=178.3
Q ss_pred ceecCC--CceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEE
Q 041757 42 NLISAG--TFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVY 100 (381)
Q Consensus 42 ~~lG~G--~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~ 100 (381)
..||+| +||+||++.. ...+.+.+|+.+++.++||||+++++++ ...+..++||
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~-----~~~~~~~~v~ 78 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVF-----TTGSWLWVIS 78 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeE-----ecCCceEEEE
Confidence 456666 8899977642 1246788999999999999999999995 4477889999
Q ss_pred EcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccc
Q 041757 101 EFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180 (381)
Q Consensus 101 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 180 (381)
||+.+++|.+++... ....+++..+..++.|++.||+||| +.+++||||||+||+++.++.++++||+.
T Consensus 79 e~~~~~~l~~~l~~~--------~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~ 147 (328)
T cd08226 79 PFMAYGSANSLLKTY--------FPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSH 147 (328)
T ss_pred ecccCCCHHHHHHhh--------cccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHH
Confidence 999999999998531 2345888999999999999999999 66999999999999999999999999986
Q ss_pred ceecCCCCCcc-----cccCccCccceeCCCCcCCC--ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH
Q 041757 181 ARFLPPTRTQT-----SSIDVKGSIGYIAPEYGVGN--EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA 253 (381)
Q Consensus 181 ~~~~~~~~~~~-----~~~~~~gt~~y~aPE~l~~~--~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~ 253 (381)
+.......... ......++..|+|||++.+. .++.++|||||||++|+|++|..||....... ......
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~----~~~~~~ 223 (328)
T cd08226 148 LYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ----MLLQKL 223 (328)
T ss_pred HhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH----HHHHHh
Confidence 54332211110 00012246679999998763 47899999999999999999999986332111 110000
Q ss_pred hhch------------HHHHHhhhhccC---chhhhh---cccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHH
Q 041757 254 LSNH------------VKDIVDSILLND---DEKLVV---RGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMT 315 (381)
Q Consensus 254 ~~~~------------~~~~~~~~l~~~---~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 315 (381)
.... ............ ...... ................+...+.+++.+||+.||++|||+.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~ 303 (328)
T cd08226 224 KGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSAS 303 (328)
T ss_pred cCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHH
Confidence 0000 000000000000 000000 0000000011122345677899999999999999999999
Q ss_pred HHHH--HHHHhhh
Q 041757 316 NVVH--ELQSIKN 326 (381)
Q Consensus 316 ~vl~--~L~~i~~ 326 (381)
++++ .+..+.+
T Consensus 304 e~l~~~~~~~~~~ 316 (328)
T cd08226 304 SLLSHAFFKQVKE 316 (328)
T ss_pred HHhhCHHHHHHHH
Confidence 9984 4444443
No 352
>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili
Probab=100.00 E-value=2e-34 Score=263.90 Aligned_cols=258 Identities=21% Similarity=0.224 Sum_probs=179.3
Q ss_pred ccccceecCCCceEEEecccc------------------cHHHHHHHHHHHHccC-CCcccceeeeeccccccCCceEEE
Q 041757 38 MLEENLISAGTFGFSHLRRQG------------------AFKSFIAECKALRNIR-HRNLIKVLTACLGVDYQGNDFKAL 98 (381)
Q Consensus 38 ~~~~~~lG~G~fg~V~~~~~~------------------~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~~~~~~l 98 (381)
|...+.||.|+||+||++... ......+|+..+.+++ |+||+++++++. ..+..++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~-----~~~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFR-----ENDELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhh-----cCCcEEE
Confidence 567789999999999876521 1123457999999999 999999999954 4788999
Q ss_pred EEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeec
Q 041757 99 VYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDF 178 (381)
Q Consensus 99 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df 178 (381)
||||+ +|+|.+++.. .....+++..+..++.|++.+|.||| +.+++|+||+|+||+++.++.++|+||
T Consensus 76 v~e~~-~~~l~~~~~~--------~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~ 143 (283)
T cd07830 76 VFEYM-EGNLYQLMKD--------RKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADF 143 (283)
T ss_pred EEecC-CCCHHHHHHh--------cccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeec
Confidence 99999 8899998852 12347899999999999999999999 669999999999999999999999999
Q ss_pred ccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhch
Q 041757 179 GLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH 257 (381)
Q Consensus 179 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~ 257 (381)
|++.......... ...++..|+|||++.. ..++.++||||||+++|+|++|+.||......+ .............
T Consensus 144 ~~~~~~~~~~~~~---~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~-~~~~~~~~~~~~~ 219 (283)
T cd07830 144 GLAREIRSRPPYT---DYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEID-QLYKICSVLGTPT 219 (283)
T ss_pred ccceeccCCCCcC---CCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHH-HHHHHHHhcCCCC
Confidence 9998765433222 2357889999998754 457899999999999999999999975321110 0000000000000
Q ss_pred HHHHHhhh-hccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 258 VKDIVDSI-LLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 258 ~~~~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
.....+.. +........ ..................+.+++.+||+.||++|||+.|++.
T Consensus 220 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 220 KQDWPEGYKLASKLGFRF---PQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred hhhhhhHhhhhccccccc---cccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 00000000 000000000 000000001111122567899999999999999999999875
No 353
>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK
Probab=100.00 E-value=5.6e-35 Score=275.31 Aligned_cols=265 Identities=17% Similarity=0.203 Sum_probs=184.4
Q ss_pred hhhccccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccc-
Q 041757 31 ILDVSRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDY- 90 (381)
Q Consensus 31 ~~~~~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~- 90 (381)
+....++|...+.||+|+||.||++.. ...+.+.+|+.++++++||||+++++++...+.
T Consensus 10 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07851 10 VWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSL 89 (343)
T ss_pred eecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccc
Confidence 335678899999999999999987642 123456789999999999999999987543111
Q ss_pred cCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCC
Q 041757 91 QGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDD 170 (381)
Q Consensus 91 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~ 170 (381)
......++|+||+ +++|.+++. ...+++..+..++.|++.||.||| +.+|+||||||+||+++.+
T Consensus 90 ~~~~~~~lv~e~~-~~~L~~~~~-----------~~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~ 154 (343)
T cd07851 90 EDFQDVYLVTHLM-GADLNNIVK-----------CQKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNED 154 (343)
T ss_pred cccccEEEEEecC-CCCHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCC
Confidence 1223489999999 669999883 246899999999999999999999 6699999999999999999
Q ss_pred CCeEEeecccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHH
Q 041757 171 MTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKF 249 (381)
Q Consensus 171 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~ 249 (381)
+.++|+|||++....... ....++..|+|||.+.+ ..++.++||||||+++|++++|+.||... .....+
T Consensus 155 ~~~kL~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~----~~~~~~ 225 (343)
T cd07851 155 CELKILDFGLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGS----DHIDQL 225 (343)
T ss_pred CCEEEccccccccccccc-----cCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCC----ChHHHH
Confidence 999999999997654331 12457889999998765 46789999999999999999999997522 111111
Q ss_pred HH--HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 250 AK--MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 250 ~~--~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
.. .........+..................................+.+++.+||+.||.+|||+.+|++
T Consensus 226 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 226 KRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 10 00000011111111000000000000000000001111234678999999999999999999999875
No 354
>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases. Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core
Probab=100.00 E-value=1.3e-34 Score=259.73 Aligned_cols=233 Identities=23% Similarity=0.290 Sum_probs=183.5
Q ss_pred cccccceecCCCceEEEecccc-----------------cHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEE
Q 041757 37 NMLEENLISAGTFGFSHLRRQG-----------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALV 99 (381)
Q Consensus 37 ~~~~~~~lG~G~fg~V~~~~~~-----------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv 99 (381)
+|...+.||+|+||.||.+... ..+.+.+|++++++++|+||+++++.+. .....+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~l~ 75 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL-----KKDELWIV 75 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEe-----cCCeEEEE
Confidence 4677889999999999776421 4467889999999999999999999853 46788999
Q ss_pred EEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecc
Q 041757 100 YEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179 (381)
Q Consensus 100 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg 179 (381)
+||+++++|.+++.. ....+++..+..++.|++.||.+|| ..+++|+||+|+||+++.++.++|+|||
T Consensus 76 ~e~~~~~~L~~~~~~---------~~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~ 143 (253)
T cd05122 76 MEFCSGGSLKDLLKS---------TNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFG 143 (253)
T ss_pred EecCCCCcHHHHHhh---------cCCCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecc
Confidence 999999999999852 2257899999999999999999999 6799999999999999999999999999
Q ss_pred cceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHH
Q 041757 180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVK 259 (381)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 259 (381)
.+........ .....++..|+|||.+.+..++.++||||||+++|++++|+.||.... ........ ....
T Consensus 144 ~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~~~~~~~~-~~~~-- 213 (253)
T cd05122 144 LSAQLSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELP----PMKALFKI-ATNG-- 213 (253)
T ss_pred cccccccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCc----hHHHHHHH-HhcC--
Confidence 9887655432 112458899999999988888999999999999999999999975221 10000000 0000
Q ss_pred HHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 260 DIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 260 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
....+. ....+..+.+++.+||..||.+|||+.++++
T Consensus 214 ------~~~~~~-----------------~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 214 ------PPGLRN-----------------PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred ------CCCcCc-----------------ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000000 1122567899999999999999999999975
No 355
>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co
Probab=100.00 E-value=9e-35 Score=265.91 Aligned_cols=225 Identities=20% Similarity=0.217 Sum_probs=169.3
Q ss_pred eecCCCceEEEecccc--------------------cHHHHHHHHH---HHHccCCCcccceeeeeccccccCCceEEEE
Q 041757 43 LISAGTFGFSHLRRQG--------------------AFKSFIAECK---ALRNIRHRNLIKVLTACLGVDYQGNDFKALV 99 (381)
Q Consensus 43 ~lG~G~fg~V~~~~~~--------------------~~~~~~~E~~---~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv 99 (381)
+||+|+||.||++... ....+..|.. .++...||||+++++++ ...+..++|
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~~v 75 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----HTPDKLSFI 75 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeee-----ecCCEEEEE
Confidence 4899999999875421 1112344443 34445799999999884 457789999
Q ss_pred EEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecc
Q 041757 100 YEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179 (381)
Q Consensus 100 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg 179 (381)
|||+++|+|..++. ....+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||
T Consensus 76 ~e~~~g~~L~~~l~----------~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg 142 (278)
T cd05606 76 LDLMNGGDLHYHLS----------QHGVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLG 142 (278)
T ss_pred EecCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCc
Confidence 99999999999883 4457899999999999999999999 6699999999999999999999999999
Q ss_pred cceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchH
Q 041757 180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHV 258 (381)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 258 (381)
++......... ...|+..|+|||++.+ ..++.++||||+|+++|+|++|+.||........ ......
T Consensus 143 ~~~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~--~~~~~~------ 210 (278)
T cd05606 143 LACDFSKKKPH----ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRM------ 210 (278)
T ss_pred CccccCccCCc----CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch--HHHHHH------
Confidence 98765432221 2458999999999875 4689999999999999999999999863311111 000000
Q ss_pred HHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 041757 259 KDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRM-----KMTNVVH 319 (381)
Q Consensus 259 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~~vl~ 319 (381)
.....+ ..+...+..+.+++.+|+..+|.+|| ++.++++
T Consensus 211 ------~~~~~~----------------~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 211 ------TLTMAV----------------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred ------hhccCC----------------CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 000000 00123456788999999999999999 8888875
No 356
>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do
Probab=100.00 E-value=4.5e-35 Score=264.99 Aligned_cols=227 Identities=20% Similarity=0.247 Sum_probs=171.2
Q ss_pred ceecCCCceEEEecccc--------------------cHHHHHHHHHHHH-ccCCCcccceeeeeccccccCCceEEEEE
Q 041757 42 NLISAGTFGFSHLRRQG--------------------AFKSFIAECKALR-NIRHRNLIKVLTACLGVDYQGNDFKALVY 100 (381)
Q Consensus 42 ~~lG~G~fg~V~~~~~~--------------------~~~~~~~E~~~l~-~l~h~nIv~~~~~~~~~~~~~~~~~~lv~ 100 (381)
+.||.|+||.||++... ....+..|..++. ..+|+||+++++++ ...+..++||
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF-----QSKDYLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeE-----EcCCeEEEEE
Confidence 56999999999876421 1123344555444 45799999999995 4477899999
Q ss_pred EcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccc
Q 041757 101 EFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180 (381)
Q Consensus 101 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 180 (381)
||+++++|.+++. ....+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||+
T Consensus 77 e~~~~~~L~~~l~----------~~~~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~ 143 (260)
T cd05611 77 EYLNGGDCASLIK----------TLGGLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGL 143 (260)
T ss_pred eccCCCCHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeeccc
Confidence 9999999999993 3456889999999999999999999 66999999999999999999999999999
Q ss_pred ceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHH
Q 041757 181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKD 260 (381)
Q Consensus 181 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 260 (381)
+....... ...++..|+|||.+.+..++.++||||||+++|++++|..||..... ..... .
T Consensus 144 ~~~~~~~~------~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~--------~ 204 (260)
T cd05611 144 SRNGLENK------KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP-----DAVFD--------N 204 (260)
T ss_pred ceeccccc------cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH-----HHHHH--------H
Confidence 87643311 24578899999999888889999999999999999999999852211 11100 0
Q ss_pred HHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 041757 261 IVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHEL 321 (381)
Q Consensus 261 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L 321 (381)
+......... .....++..+.+++.+||+.||++||++.++.+.|
T Consensus 205 ~~~~~~~~~~----------------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 205 ILSRRINWPE----------------EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred HHhcccCCCC----------------cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 0000000000 01124567889999999999999999886665543
No 357
>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1. Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto
Probab=100.00 E-value=6.1e-35 Score=266.63 Aligned_cols=233 Identities=22% Similarity=0.327 Sum_probs=183.8
Q ss_pred ccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccC-CCcccceeeeeccccccCCc
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIR-HRNLIKVLTACLGVDYQGND 94 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~~~ 94 (381)
++|...+.||.|+||.||.+.. ...+.+.+|+.+++++. |+||+++++++ ...+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF-----QDEE 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh-----cCCc
Confidence 4688899999999999987542 12356788999999998 99999999984 4577
Q ss_pred eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757 95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR 174 (381)
Q Consensus 95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k 174 (381)
..++||||+++++|.+++. ....+++..+..++.|++.||.||| ..+++|+||+|+||+++.++.++
T Consensus 76 ~~~lv~e~~~~~~L~~~l~----------~~~~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~ 142 (280)
T cd05581 76 NLYFVLEYAPNGELLQYIR----------KYGSLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIK 142 (280)
T ss_pred eEEEEEcCCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEE
Confidence 8999999999999999994 4457999999999999999999999 66999999999999999999999
Q ss_pred EeecccceecCCCCCc------------------ccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCC
Q 041757 175 VGDFGLARFLPPTRTQ------------------TSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPS 236 (381)
Q Consensus 175 l~Dfg~~~~~~~~~~~------------------~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf 236 (381)
|+|||++......... .......++..|+|||+.....++.++||||||++++++++|..||
T Consensus 143 l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~ 222 (280)
T cd05581 143 ITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPF 222 (280)
T ss_pred ecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCC
Confidence 9999998876543321 1112245788999999988888999999999999999999999997
Q ss_pred CccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCH--
Q 041757 237 DIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKM-- 314 (381)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~-- 314 (381)
.... ....+ ...... .. ..+...+..+.+++.+||+.+|.+|||+
T Consensus 223 ~~~~----~~~~~---------~~~~~~----~~----------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~ 269 (280)
T cd05581 223 RGSN----EYLTF---------QKILKL----EY----------------SFPPNFPPDAKDLIEKLLVLDPQDRLGVNE 269 (280)
T ss_pred CCcc----HHHHH---------HHHHhc----CC----------------CCCCccCHHHHHHHHHHhcCCHhhCCCccc
Confidence 6221 11100 011000 00 0012345678899999999999999999
Q ss_pred --HHHHH
Q 041757 315 --TNVVH 319 (381)
Q Consensus 315 --~~vl~ 319 (381)
.++++
T Consensus 270 ~~~~ll~ 276 (280)
T cd05581 270 GYDELKA 276 (280)
T ss_pred CHHHHhc
Confidence 66653
No 358
>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2. Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin
Probab=100.00 E-value=5.3e-35 Score=271.43 Aligned_cols=233 Identities=23% Similarity=0.293 Sum_probs=178.7
Q ss_pred ccccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757 34 VSRNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN 93 (381)
Q Consensus 34 ~~~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 93 (381)
..+.|...+.||+|+||.||++.. ...+.+.+|+++++.++|+|++++++++. ..
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 87 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL-----RE 87 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEE-----cC
Confidence 445578889999999999986541 12346788999999999999999999964 36
Q ss_pred ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757 94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA 173 (381)
Q Consensus 94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~ 173 (381)
...++||||+. |+|.+++. .....+++..+..++.|++.||.||| ..+++||||+|+||+++.++.+
T Consensus 88 ~~~~lv~e~~~-~~l~~~~~---------~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~ 154 (308)
T cd06634 88 HTAWLVMEYCL-GSASDLLE---------VHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLV 154 (308)
T ss_pred CeeEEEEEccC-CCHHHHHH---------HcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcE
Confidence 78899999996 58887774 23345789999999999999999999 6699999999999999999999
Q ss_pred EEeecccceecCCCCCcccccCccCccceeCCCCcC---CCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHH
Q 041757 174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGV---GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFA 250 (381)
Q Consensus 174 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~ 250 (381)
+|+|||++....... ...++..|+|||++. ...++.++|||||||++|+|++|..||.... .....
T Consensus 155 kl~dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~~~~- 223 (308)
T cd06634 155 KLGDFGSASIMAPAN------XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN----AMSAL- 223 (308)
T ss_pred EECCcccceeecCcc------cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcccc----HHHHH-
Confidence 999999987654322 134788999999874 3467889999999999999999999974221 00000
Q ss_pred HHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 041757 251 KMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHEL 321 (381)
Q Consensus 251 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L 321 (381)
..+..... ... ........+.+++.+||..+|.+||++.++++.-
T Consensus 224 --------~~~~~~~~-~~~-----------------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 224 --------YHIAQNES-PAL-----------------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred --------HHHhhcCC-CCc-----------------CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 00000000 000 0123456788999999999999999999999753
No 359
>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both
Probab=100.00 E-value=4.4e-34 Score=262.01 Aligned_cols=261 Identities=20% Similarity=0.223 Sum_probs=181.7
Q ss_pred ccccceecCCCceEEEecccc-------------------cHHHHHHHHHHHHcc---CCCcccceeeeeccccccCCce
Q 041757 38 MLEENLISAGTFGFSHLRRQG-------------------AFKSFIAECKALRNI---RHRNLIKVLTACLGVDYQGNDF 95 (381)
Q Consensus 38 ~~~~~~lG~G~fg~V~~~~~~-------------------~~~~~~~E~~~l~~l---~h~nIv~~~~~~~~~~~~~~~~ 95 (381)
|+..++||.|+||.||++... ....+.+|+.+++++ .|+||+++++++...+......
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567889999999999776521 123566788887766 5999999999976533223345
Q ss_pred EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757 96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV 175 (381)
Q Consensus 96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl 175 (381)
.+++|||+.+ +|.+++.. .....+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.+||
T Consensus 81 ~~l~~e~~~~-~l~~~l~~--------~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l 148 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSK--------CPKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKI 148 (287)
T ss_pred eEEEehhccc-CHHHHHHH--------ccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEE
Confidence 8999999974 89988852 12235899999999999999999999 669999999999999999999999
Q ss_pred eecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhh
Q 041757 176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALS 255 (381)
Q Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 255 (381)
+|||++.......... ...++..|+|||++.+..++.++||||||+++|+|++|..||...... ..+..+......
T Consensus 149 ~dfg~~~~~~~~~~~~---~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~-~~~~~~~~~~~~ 224 (287)
T cd07838 149 ADFGLARIYSFEMALT---SVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA-DQLDKIFDVIGL 224 (287)
T ss_pred eccCcceeccCCcccc---cccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH-HHHHHHHHHcCC
Confidence 9999998765433221 134788999999999888999999999999999999999997532211 111111110000
Q ss_pred chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
......... ........ ............+.....+.+++.+||+.||.+||++.+++.
T Consensus 225 ~~~~~~~~~---~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 225 PSEEEWPRN---VSLPRSSF--PSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CChHhcCCC---cccchhhc--ccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 000000000 00000000 000001112223345678889999999999999999999874
No 360
>PLN00009 cyclin-dependent kinase A; Provisional
Probab=100.00 E-value=1.4e-34 Score=266.67 Aligned_cols=258 Identities=19% Similarity=0.232 Sum_probs=178.5
Q ss_pred ccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK 96 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~ 96 (381)
++|...+.||+|+||.||++.. ...+.+.+|++++++++||||+++++++ ......
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 76 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVV-----HSEKRL 76 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEE-----ecCCeE
Confidence 4688899999999999988642 1235678899999999999999999995 457789
Q ss_pred EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCC-CCCeEE
Q 041757 97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD-DMTARV 175 (381)
Q Consensus 97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~-~~~~kl 175 (381)
++||||++ ++|.+++.. .....+++..+..++.||+.||+||| ..+++||||+|+||+++. ++.+||
T Consensus 77 ~lv~e~~~-~~l~~~~~~--------~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl 144 (294)
T PLN00009 77 YLVFEYLD-LDLKKHMDS--------SPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKL 144 (294)
T ss_pred EEEEeccc-ccHHHHHHh--------CCCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEE
Confidence 99999996 588887742 12334578888899999999999999 669999999999999985 557999
Q ss_pred eecccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH-
Q 041757 176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA- 253 (381)
Q Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~- 253 (381)
+|||++.......... ....+++.|+|||++.+ ..++.++||||||+++|+|++|..||.... .........
T Consensus 145 ~dfg~~~~~~~~~~~~--~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~----~~~~~~~~~~ 218 (294)
T PLN00009 145 ADFGLARAFGIPVRTF--THEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDS----EIDELFKIFR 218 (294)
T ss_pred cccccccccCCCcccc--ccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHH
Confidence 9999997654322111 12347889999998866 457899999999999999999999975321 111111100
Q ss_pred -hhchHHHHHhhhhc-cCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 254 -LSNHVKDIVDSILL-NDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 254 -~~~~~~~~~~~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
.............. .+... ... ...........+.....+.+++.+|++.+|++||++.++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 219 ILGTPNEETWPGVTSLPDYKS-AFP--KWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred HhCCCChhhccccccchhhhh-hcc--cCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000000000000 00000 000 00000000111234567889999999999999999999986
No 361
>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins. Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic
Probab=100.00 E-value=1.4e-34 Score=268.49 Aligned_cols=268 Identities=18% Similarity=0.174 Sum_probs=182.9
Q ss_pred cccccccceecCCCceEEEecccc-------------------cHHHHHHHHHHHHccCCCcccceeeeeccccc---cC
Q 041757 35 SRNMLEENLISAGTFGFSHLRRQG-------------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDY---QG 92 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~~~-------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~---~~ 92 (381)
.++|...++||.|+||.||++... ....+.+|+++++.++||||+++++++..... ..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 578999999999999999886521 12457889999999999999999998654211 23
Q ss_pred CceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCC
Q 041757 93 NDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT 172 (381)
Q Consensus 93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~ 172 (381)
....++||||+.+ +|...+. .....+++..+..++.|+++||.||| +.+++|+||||+||++++++.
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~---------~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~ 153 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLE---------NPSVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGI 153 (311)
T ss_pred CceEEEEEecCCc-CHHHHHh---------ccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCC
Confidence 4567999999965 7777774 23456899999999999999999999 679999999999999999999
Q ss_pred eEEeecccceecCCCCCccc---------ccCccCccceeCCCCcCCC-ccCcccchhhhhHHHHHHHhCCCCCCccccC
Q 041757 173 ARVGDFGLARFLPPTRTQTS---------SIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLELMIREKPSDIMFEG 242 (381)
Q Consensus 173 ~kl~Dfg~~~~~~~~~~~~~---------~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~ 242 (381)
++|+|||+++.......... .....+++.|+|||.+.+. .++.++||||||+++|||++|+.||......
T Consensus 154 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~ 233 (311)
T cd07866 154 LKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI 233 (311)
T ss_pred EEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99999999976544322111 1123568889999987653 5789999999999999999999997522111
Q ss_pred CCcHHHHHHHHhhchHHHHHhhh-hccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 243 DMNLHKFAKMALSNHVKDIVDSI-LLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
...................... +........ ..................+.+++.+||+.||.+|||+.+++.
T Consensus 234 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 234 -DQLHLIFKLCGTPTEETWPGWRSLPGCEGVHS---FTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred -HHHHHHHHHhCCCChhhchhhhhccccccccc---CCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 0011111100000000000000 000000000 000000001111223367889999999999999999999875
No 362
>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast
Probab=100.00 E-value=1.8e-34 Score=259.55 Aligned_cols=231 Identities=23% Similarity=0.324 Sum_probs=184.2
Q ss_pred cccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757 37 NMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA 97 (381)
Q Consensus 37 ~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~ 97 (381)
+|...+.||+|+||.||.+.. .....+.+|++++++++|+|++++++++ .+....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 75 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSI-----ETSDSLY 75 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEE-----EeCCEEE
Confidence 477889999999999987531 2456789999999999999999999985 3467899
Q ss_pred EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757 98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD 177 (381)
Q Consensus 98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D 177 (381)
+||||+++++|.+++. ....+++..+..++.|++.||.||| +.+++||||+|+||+++.++.++|+|
T Consensus 76 ~v~e~~~~~~L~~~~~----------~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d 142 (254)
T cd06627 76 IILEYAENGSLRQIIK----------KFGPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLAD 142 (254)
T ss_pred EEEecCCCCcHHHHHH----------hccCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEec
Confidence 9999999999999983 3467899999999999999999999 66999999999999999999999999
Q ss_pred cccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhch
Q 041757 178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH 257 (381)
Q Consensus 178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~ 257 (381)
||.+......... .....++..|+|||.+.+..++.++||||||+++|+|++|..||.... ........
T Consensus 143 ~~~~~~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~----~~~~~~~~----- 211 (254)
T cd06627 143 FGVATKLNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN----PMAALFRI----- 211 (254)
T ss_pred cccceecCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc----HHHHHHHH-----
Confidence 9999876554332 112458899999999888778999999999999999999999975221 11111000
Q ss_pred HHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
... ..+ ..+...+..+.+++.+||..+|++|||+.+++.
T Consensus 212 ----~~~---~~~----------------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 212 ----VQD---DHP----------------PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred ----hcc---CCC----------------CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 000 000 001234567889999999999999999999874
No 363
>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14
Probab=100.00 E-value=1.4e-34 Score=272.71 Aligned_cols=270 Identities=17% Similarity=0.188 Sum_probs=184.5
Q ss_pred hhhhhccccccccceecCCCceEEEecccc-------------------cHHHHHHHHHHHHccCCCcccceeeeecccc
Q 041757 29 LEILDVSRNMLEENLISAGTFGFSHLRRQG-------------------AFKSFIAECKALRNIRHRNLIKVLTACLGVD 89 (381)
Q Consensus 29 l~~~~~~~~~~~~~~lG~G~fg~V~~~~~~-------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 89 (381)
-++..+.++|...+.||+|+||.||++... ..+.+.+|+.++++++||||+++++++....
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 344557899999999999999999775311 1356778999999999999999999865311
Q ss_pred -ccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeC
Q 041757 90 -YQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLD 168 (381)
Q Consensus 90 -~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~ 168 (381)
.......+++++++ +++|.+++. ...+++..+..++.|++.||.||| +.+|+||||||+||+++
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~-----------~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~ 154 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVK-----------CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVN 154 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEc
Confidence 12334578888887 789988873 235889999999999999999999 66999999999999999
Q ss_pred CCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHH
Q 041757 169 DDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLH 247 (381)
Q Consensus 169 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~ 247 (381)
.++.+||+|||++....... ....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||..... ...+.
T Consensus 155 ~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~-~~~~~ 228 (345)
T cd07877 155 EDCELKILDFGLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH-IDQLK 228 (345)
T ss_pred CCCCEEEecccccccccccc-----cccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHH
Confidence 99999999999987643321 12457889999998766 5688999999999999999999999752211 01111
Q ss_pred HHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041757 248 KFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE 320 (381)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~ 320 (381)
..... .......+..................................+.+++.+|++.||.+||++.+++..
T Consensus 229 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 229 LILRL-VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHHH-hCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 11111 0111111111100000000000000000000000001234578899999999999999999999864
No 364
>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=4.2e-35 Score=291.17 Aligned_cols=184 Identities=25% Similarity=0.313 Sum_probs=162.6
Q ss_pred cccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757 35 SRNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND 94 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~ 94 (381)
.++|.+.++||+|+||.|.+++. ....-|..|-.+|..-+.+-|+.++.. |+++.
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyA-----FQD~~ 148 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYA-----FQDER 148 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHH-----hcCcc
Confidence 47899999999999999977653 234567789999999999999999877 78899
Q ss_pred eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757 95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR 174 (381)
Q Consensus 95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k 174 (381)
++|+|||||+||||..++. +...+++..+.-++..|..||.-|| +.|+|||||||+|||+|..|++|
T Consensus 149 ~LYlVMdY~pGGDlltLlS----------k~~~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHik 215 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLS----------KFDRLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIK 215 (1317)
T ss_pred ceEEEEecccCchHHHHHh----------hcCCChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEe
Confidence 9999999999999999994 4458999999999999999999999 88999999999999999999999
Q ss_pred EeecccceecCCCCCcccccCccCccceeCCCCcCC-----CccCcccchhhhhHHHHHHHhCCCCCC
Q 041757 175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-----NEVSTIGDVYSYGILLLELMIREKPSD 237 (381)
Q Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~sDiwSlG~il~el~tg~~Pf~ 237 (381)
|+|||.+-.+..++.-.... .+|||-|.+||++.. +.|+..+|.||+||++|||+.|..||.
T Consensus 216 LADFGsClkm~~dG~V~s~~-aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY 282 (1317)
T KOG0612|consen 216 LADFGSCLKMDADGTVRSSV-AVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY 282 (1317)
T ss_pred eccchhHHhcCCCCcEEecc-ccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch
Confidence 99999998887665544443 679999999998863 568999999999999999999999975
No 365
>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3. Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co
Probab=100.00 E-value=3e-34 Score=266.95 Aligned_cols=229 Identities=24% Similarity=0.292 Sum_probs=175.6
Q ss_pred ccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757 36 RNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF 95 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~ 95 (381)
+-|...++||+|+||.||++.. ...+.+.+|+++++.++|||++++++++. +...
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~ 95 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYL-----KEHT 95 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEE-----eCCE
Confidence 3366778899999999988641 12356788999999999999999999954 4678
Q ss_pred EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757 96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV 175 (381)
Q Consensus 96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl 175 (381)
.++||||+. |+|.+++. .....+++..++.++.|++.||.||| ..+++|+||+|+||+++.++.+||
T Consensus 96 ~~lv~e~~~-~~l~~~l~---------~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL 162 (313)
T cd06633 96 AWLVMEYCL-GSASDLLE---------VHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKL 162 (313)
T ss_pred EEEEEecCC-CCHHHHHH---------hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEE
Confidence 899999996 57887774 23456889999999999999999999 669999999999999999999999
Q ss_pred eecccceecCCCCCcccccCccCccceeCCCCcC---CCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHH
Q 041757 176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGV---GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM 252 (381)
Q Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~ 252 (381)
+|||++...... ....|+..|+|||++. ...++.++|||||||++|+|++|..||.... ........
T Consensus 163 ~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~----~~~~~~~~ 232 (313)
T cd06633 163 ADFGSASKSSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN----AMSALYHI 232 (313)
T ss_pred eecCCCcccCCC------CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHH
Confidence 999988643221 1245889999999874 3568889999999999999999999974221 11111100
Q ss_pred HhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 253 ALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 253 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
. .. ..+.. .....+..+.+++.+||+.+|.+||++.+++.
T Consensus 233 ~---------~~---~~~~~---------------~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 233 A---------QN---DSPTL---------------QSNEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred H---------hc---CCCCC---------------CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 00 00000 00123456888999999999999999999985
No 366
>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6. Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi
Probab=100.00 E-value=1.5e-34 Score=272.37 Aligned_cols=266 Identities=18% Similarity=0.231 Sum_probs=180.8
Q ss_pred ccccccccceecCCCceEEEeccc-----------------ccHHHHHHHHHHHHccCCCcccceeeeecccc-------
Q 041757 34 VSRNMLEENLISAGTFGFSHLRRQ-----------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVD------- 89 (381)
Q Consensus 34 ~~~~~~~~~~lG~G~fg~V~~~~~-----------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~------- 89 (381)
...+|...+.||.|+||.||++.. ...+.+.+|++++++++||||+++++++....
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 457899999999999999987642 23467889999999999999999998754311
Q ss_pred --ccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeee
Q 041757 90 --YQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLL 167 (381)
Q Consensus 90 --~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill 167 (381)
.......++||||+. ++|.+++. ...+++..++.++.||+.||.||| ..+++||||||+||++
T Consensus 83 ~~~~~~~~~~lv~e~~~-~~L~~~~~-----------~~~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili 147 (342)
T cd07854 83 GSLTELNSVYIVQEYME-TDLANVLE-----------QGPLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFI 147 (342)
T ss_pred ccccccceEEEEeeccc-ccHHHHHH-----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEE
Confidence 111245799999997 59988873 235889999999999999999999 6699999999999999
Q ss_pred CC-CCCeEEeecccceecCCCCCcc-cccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCC
Q 041757 168 DD-DMTARVGDFGLARFLPPTRTQT-SSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDM 244 (381)
Q Consensus 168 ~~-~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~ 244 (381)
+. ++.+||+|||.+.......... ......++..|+|||.+.. ..++.++|||||||++|+|++|+.||.....
T Consensus 148 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~--- 224 (342)
T cd07854 148 NTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHE--- 224 (342)
T ss_pred cCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCH---
Confidence 74 5578999999998654322111 1111347889999997654 5688899999999999999999999853221
Q ss_pred cHHHHHHHHhh--chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 245 NLHKFAKMALS--NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 245 ~~~~~~~~~~~--~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
.......... ....+.........+........ ...............++.+++.+||..||.+|||+.+++.
T Consensus 225 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 225 -LEQMQLILESVPVVREEDRNELLNVIPSFVRNDGG-EPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred -HHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhccc-ccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 1111110000 00000000000000000000000 0000000111234567889999999999999999999985
No 367
>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the
Probab=100.00 E-value=7.3e-34 Score=259.90 Aligned_cols=256 Identities=21% Similarity=0.272 Sum_probs=180.8
Q ss_pred ccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEE
Q 041757 38 MLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKAL 98 (381)
Q Consensus 38 ~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~l 98 (381)
|...+.||+|+||.||.+.. ...+.+.+|+.+++.++|+||+++++++ ......++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~~ 75 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVI-----HTERKLYL 75 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhh-----hcCCceEE
Confidence 45678899999999977542 1235678899999999999999999995 44678999
Q ss_pred EEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeec
Q 041757 99 VYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDF 178 (381)
Q Consensus 99 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df 178 (381)
||||++ ++|.+++.. ....+++..+..++.|++.||.||| ..+++||||+|+||++++++.++|+||
T Consensus 76 v~e~~~-~~l~~~i~~---------~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~ 142 (282)
T cd07829 76 VFEYCD-MDLKKYLDK---------RPGPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADF 142 (282)
T ss_pred EecCcC-cCHHHHHHh---------hccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecC
Confidence 999997 599999952 2256899999999999999999999 669999999999999999999999999
Q ss_pred ccceecCCCCCcccccCccCccceeCCCCcCCC-ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHH--Hhh
Q 041757 179 GLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM--ALS 255 (381)
Q Consensus 179 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~--~~~ 255 (381)
|.+........... ...++..|+|||.+.+. .++.++||||||+++||+++|..||.... ....+... ...
T Consensus 143 g~~~~~~~~~~~~~--~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~----~~~~~~~~~~~~~ 216 (282)
T cd07829 143 GLARAFGIPLRTYT--HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDS----EIDQLFKIFQILG 216 (282)
T ss_pred CcccccCCCccccC--ccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCcc----HHHHHHHHHHHhC
Confidence 99986654332111 13467789999988766 78999999999999999999999975321 11111110 000
Q ss_pred chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
.................... ............+.....+.+++.+||..||++||++.+++.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 217 TPTEESWPGVTKLPDYKPTF--PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred CCcHHHHHhhcccccccccc--cccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00000000000000000000 000000001111233668999999999999999999999975
No 368
>PTZ00024 cyclin-dependent protein kinase; Provisional
Probab=100.00 E-value=3.7e-34 Score=268.87 Aligned_cols=259 Identities=19% Similarity=0.244 Sum_probs=181.3
Q ss_pred ccccccc-cceecCCCceEEEecccc---------------c----------------HHHHHHHHHHHHccCCCcccce
Q 041757 34 VSRNMLE-ENLISAGTFGFSHLRRQG---------------A----------------FKSFIAECKALRNIRHRNLIKV 81 (381)
Q Consensus 34 ~~~~~~~-~~~lG~G~fg~V~~~~~~---------------~----------------~~~~~~E~~~l~~l~h~nIv~~ 81 (381)
+.++|.. .+.||.|+||.||++... . ...+.+|++++++++|+||+++
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 85 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL 85 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence 4566764 578999999999886411 0 1147789999999999999999
Q ss_pred eeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccC
Q 041757 82 LTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLK 161 (381)
Q Consensus 82 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlk 161 (381)
++++ ...+..++||||+. |+|.+++. ....+++.....++.|++.||.||| +.+++|+||+
T Consensus 86 ~~~~-----~~~~~~~lv~e~~~-~~l~~~l~----------~~~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~ 146 (335)
T PTZ00024 86 VDVY-----VEGDFINLVMDIMA-SDLKKVVD----------RKIRLTESQVKCILLQILNGLNVLH---KWYFMHRDLS 146 (335)
T ss_pred eEEE-----ecCCcEEEEEeccc-cCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccc
Confidence 9995 44778999999996 69999983 4556899999999999999999999 6799999999
Q ss_pred CCCeeeCCCCCeEEeecccceecCCCCC------------cccccCccCccceeCCCCcCCC-ccCcccchhhhhHHHHH
Q 041757 162 PSNVLLDDDMTARVGDFGLARFLPPTRT------------QTSSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLE 228 (381)
Q Consensus 162 p~Nill~~~~~~kl~Dfg~~~~~~~~~~------------~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~e 228 (381)
|+||+++.++.++|+|||++........ ........++..|+|||++.+. .++.++|||||||++|+
T Consensus 147 ~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~e 226 (335)
T PTZ00024 147 PANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAE 226 (335)
T ss_pred HHHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHH
Confidence 9999999999999999999986652110 0111123467889999998764 46899999999999999
Q ss_pred HHhCCCCCCccccCCCcHHHHHHH--Hhh-chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccC
Q 041757 229 LMIREKPSDIMFEGDMNLHKFAKM--ALS-NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSM 305 (381)
Q Consensus 229 l~tg~~Pf~~~~~~~~~~~~~~~~--~~~-~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~ 305 (381)
|++|..||.... ....+... ... .....+.......... ....................+.+++.+||+
T Consensus 227 l~tg~~p~~~~~----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 298 (335)
T PTZ00024 227 LLTGKPLFPGEN----EIDQLGRIFELLGTPNEDNWPQAKKLPLYT----EFTPRKPKDLKTIFPNASDDAIDLLQSLLK 298 (335)
T ss_pred HHhCCCCCCCCC----HHHHHHHHHHHhCCCchhhCcchhhccccc----ccCcCCcccHHHhCcCCChHHHHHHHHHcC
Confidence 999999975221 11111100 000 0000000000000000 000000011111122345678899999999
Q ss_pred CCCCCCCCHHHHHH
Q 041757 306 ESPQDRMKMTNVVH 319 (381)
Q Consensus 306 ~dP~~RPs~~~vl~ 319 (381)
.+|++|||+.+++.
T Consensus 299 ~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 299 LNPLERISAKEALK 312 (335)
T ss_pred CCchhccCHHHHhc
Confidence 99999999999986
No 369
>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=2.9e-35 Score=266.65 Aligned_cols=244 Identities=20% Similarity=0.271 Sum_probs=187.6
Q ss_pred ccccccccceecCCCceEEEecc------------------------cccHHHHHHHHHHHHccCCCcccceeeeecccc
Q 041757 34 VSRNMLEENLISAGTFGFSHLRR------------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVD 89 (381)
Q Consensus 34 ~~~~~~~~~~lG~G~fg~V~~~~------------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 89 (381)
+.+.|....+||+|||+.||++- ....+...+|.++.+.|.||.||++|+++.
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfs--- 537 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFS--- 537 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeee---
Confidence 46778889999999999996642 234566778999999999999999999964
Q ss_pred ccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCC
Q 041757 90 YQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD 169 (381)
Q Consensus 90 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~ 169 (381)
-+.+.++-|+|||+|.+|+-+| +....+++.++..|+.||+.||.||.+- +.+|||-||||.|||+.+
T Consensus 538 -lDtdsFCTVLEYceGNDLDFYL----------KQhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~ 605 (775)
T KOG1151|consen 538 -LDTDSFCTVLEYCEGNDLDFYL----------KQHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVN 605 (775)
T ss_pred -eccccceeeeeecCCCchhHHH----------HhhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEec
Confidence 3566789999999999999999 5678899999999999999999999976 889999999999999954
Q ss_pred ---CCCeEEeecccceecCCCCCccc-----ccCccCccceeCCCCcCC----CccCcccchhhhhHHHHHHHhCCCCCC
Q 041757 170 ---DMTARVGDFGLARFLPPTRTQTS-----SIDVKGSIGYIAPEYGVG----NEVSTIGDVYSYGILLLELMIREKPSD 237 (381)
Q Consensus 170 ---~~~~kl~Dfg~~~~~~~~~~~~~-----~~~~~gt~~y~aPE~l~~----~~~~~~sDiwSlG~il~el~tg~~Pf~ 237 (381)
.|.+||+|||+++++..+..... .....||.+|.+||.+.- ...+.|+||||+|||+|.++.|+.||.
T Consensus 606 GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFG 685 (775)
T KOG1151|consen 606 GTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFG 685 (775)
T ss_pred CcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCC
Confidence 46899999999999987655422 223669999999997653 247899999999999999999999986
Q ss_pred ccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHH
Q 041757 238 IMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNV 317 (381)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v 317 (381)
...... .+... .-+++..-..-|.+ +....+...++++||++.-++|....++
T Consensus 686 hnqsQQ----dILqe------NTIlkAtEVqFP~K-----------------PvVsseAkaFIRRCLaYRKeDR~DV~qL 738 (775)
T KOG1151|consen 686 HNQSQQ----DILQE------NTILKATEVQFPPK-----------------PVVSSEAKAFIRRCLAYRKEDRIDVQQL 738 (775)
T ss_pred CchhHH----HHHhh------hchhcceeccCCCC-----------------CccCHHHHHHHHHHHHhhhhhhhhHHHH
Confidence 332211 11110 00111110111111 2344567788889999999999887776
Q ss_pred HH
Q 041757 318 VH 319 (381)
Q Consensus 318 l~ 319 (381)
..
T Consensus 739 A~ 740 (775)
T KOG1151|consen 739 AC 740 (775)
T ss_pred cc
Confidence 53
No 370
>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7. Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it
Probab=100.00 E-value=3.1e-34 Score=264.74 Aligned_cols=237 Identities=19% Similarity=0.227 Sum_probs=176.8
Q ss_pred cccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccC-CCcccceeeeeccccccCCce
Q 041757 35 SRNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIR-HRNLIKVLTACLGVDYQGNDF 95 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~~~~ 95 (381)
-++|...+.||+|+||.||++.. .....+.+|+.++.+.. ||||+++++++. ....
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~ 88 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFI-----TDSD 88 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeee-----cCCe
Confidence 46788899999999999977542 12345667887777775 999999999964 4678
Q ss_pred EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757 96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV 175 (381)
Q Consensus 96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl 175 (381)
.++||||+. ++|.+++. .....+++..+..++.|++.||.|||+. .+|+||||+|+||++++++.+||
T Consensus 89 ~~~v~e~~~-~~l~~l~~---------~~~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL 156 (296)
T cd06618 89 VFICMELMS-TCLDKLLK---------RIQGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKL 156 (296)
T ss_pred EEEEeeccC-cCHHHHHH---------HhcCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEE
Confidence 999999985 47777764 2234688999999999999999999931 48999999999999999999999
Q ss_pred eecccceecCCCCCcccccCccCccceeCCCCcCCCc----cCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHH
Q 041757 176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNE----VSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAK 251 (381)
Q Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~----~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~ 251 (381)
+|||++..+....... ...++..|+|||++.+.. ++.++||||||+++|+|++|+.||..... .....
T Consensus 157 ~dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~-- 228 (296)
T cd06618 157 CDFGISGRLVDSKAKT---RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT---EFEVL-- 228 (296)
T ss_pred CccccchhccCCCccc---CCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh---HHHHH--
Confidence 9999987654432221 134788999999987654 78899999999999999999999752111 11110
Q ss_pred HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041757 252 MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE 320 (381)
Q Consensus 252 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~ 320 (381)
...+.......+. ...++.++.+++.+||+.||.+||++.+++..
T Consensus 229 -------~~~~~~~~~~~~~-----------------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 229 -------TKILQEEPPSLPP-----------------NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred -------HHHhcCCCCCCCC-----------------CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0111100000000 01245578999999999999999999999863
No 371
>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]
Probab=100.00 E-value=1.9e-34 Score=232.71 Aligned_cols=259 Identities=20% Similarity=0.257 Sum_probs=184.5
Q ss_pred ccccccceecCCCceEEEecc-------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757 36 RNMLEENLISAGTFGFSHLRR-------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK 96 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~-------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~ 96 (381)
.+|...++||+|+||+|++++ ++...+.++|+-+|+.++|.|||+++++ ...++..
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dv-----lhsdkkl 76 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV-----LHSDKKL 76 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhh-----hccCcee
Confidence 357778999999999997765 2345678999999999999999999999 5668889
Q ss_pred EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757 97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG 176 (381)
Q Consensus 97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~ 176 (381)
.+|+|||.. +|..+.. ...+.++.+.+..++.|+++||.|+| +.++.||||||+|.+|+.+|.+|++
T Consensus 77 tlvfe~cdq-dlkkyfd---------slng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkla 143 (292)
T KOG0662|consen 77 TLVFEFCDQ-DLKKYFD---------SLNGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLA 143 (292)
T ss_pred EEeHHHhhH-HHHHHHH---------hcCCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEec
Confidence 999999955 9999886 45677899999999999999999999 6699999999999999999999999
Q ss_pred ecccceecCCCCCcccccCccCccceeCCCCcCCCc-cCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHh-
Q 041757 177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNE-VSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMAL- 254 (381)
Q Consensus 177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~- 254 (381)
|||+++-+..+...... .+.|..|++|.++.+.. |++..|+||-||++.|+.....| .|++.....+..+...
T Consensus 144 dfglarafgipvrcysa--evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrp---lfpg~dvddqlkrif~~ 218 (292)
T KOG0662|consen 144 DFGLARAFGIPVRCYSA--EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP---LFPGNDVDDQLKRIFRL 218 (292)
T ss_pred ccchhhhcCCceEeeec--eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCC---CCCCCcHHHHHHHHHHH
Confidence 99999987765433322 35799999999988854 88999999999999999875555 2444433333322211
Q ss_pred -hchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 255 -SNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 255 -~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
....++-...+-. -++-...... .....-.++.+.....=.+++...+.-+|..|.+++..++
T Consensus 219 lg~p~ed~wps~t~-lpdyk~yp~y-pattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 219 LGTPTEDQWPSMTK-LPDYKPYPIY-PATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred hCCCccccCCcccc-CCCCcccCCc-cccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 0000110000000 0000000000 0011111222333333455666777889999999988764
No 372
>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]
Probab=100.00 E-value=1.7e-34 Score=257.70 Aligned_cols=261 Identities=18% Similarity=0.195 Sum_probs=186.9
Q ss_pred cccccccceecCCCceEEEecc----------------cccHHHHHHHHHHHHccC--CCc----ccceeeeeccccccC
Q 041757 35 SRNMLEENLISAGTFGFSHLRR----------------QGAFKSFIAECKALRNIR--HRN----LIKVLTACLGVDYQG 92 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~----------------~~~~~~~~~E~~~l~~l~--h~n----Iv~~~~~~~~~~~~~ 92 (381)
++.|.+...+|+|+||.|-... ....+..+-|+++|+++. -|+ +|.+.++ ++-
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~w-----Fdy 162 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDW-----FDY 162 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehh-----hhc
Confidence 7789999999999999994322 123344556999999994 232 6777777 556
Q ss_pred CceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCC---
Q 041757 93 NDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD--- 169 (381)
Q Consensus 93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~--- 169 (381)
.++.+||+|.+ |-|+.++|.. +...+++...+..++.|++++++||| +.+++|-||||+|||+.+
T Consensus 163 rghiCivfell-G~S~~dFlk~--------N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~ 230 (415)
T KOG0671|consen 163 RGHICIVFELL-GLSTFDFLKE--------NNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEY 230 (415)
T ss_pred cCceEEEEecc-ChhHHHHhcc--------CCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccce
Confidence 88999999988 6699999964 45667899999999999999999999 669999999999999832
Q ss_pred -----------------CCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhC
Q 041757 170 -----------------DMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIR 232 (381)
Q Consensus 170 -----------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg 232 (381)
+..++|+|||.|....+... ..+.|..|+|||++.+-.++.++||||+||||+|+++|
T Consensus 231 ~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~hs-----~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG 305 (415)
T KOG0671|consen 231 FKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHHS-----TIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTG 305 (415)
T ss_pred EEEeccCCccceeccCCCcceEEEecCCcceeccCcc-----eeeeccccCCchheeccCcCCccCceeeeeEEEEeecc
Confidence 23589999999987655442 25689999999999999999999999999999999999
Q ss_pred CCCCCccccCCCcHHHHHHHHhhchHHHHHhhhh--------ccCchhhhhc-------ccchhhhhHHHHHHHHHHHHH
Q 041757 233 EKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSIL--------LNDDEKLVVR-------GDQKQTQAKINIIRECVISMV 297 (381)
Q Consensus 233 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l--------~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~l~ 297 (381)
...|... ++.....++...+.+-....+.+.- ..++...... ..................++.
T Consensus 306 ~~LFqtH--en~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~Lf 383 (415)
T KOG0671|consen 306 ETLFQTH--ENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLF 383 (415)
T ss_pred ceecccC--CcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHH
Confidence 9987522 1222223333333332222222210 1111000000 001111111122345566899
Q ss_pred HHHHhccCCCCCCCCCHHHHHH
Q 041757 298 RIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 298 ~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
+|+.+||..||.+|+|+.|++.
T Consensus 384 DLl~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 384 DLLRRMLEFDPARRITLREALS 405 (415)
T ss_pred HHHHHHHccCccccccHHHHhc
Confidence 9999999999999999999885
No 373
>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the
Probab=100.00 E-value=8.3e-34 Score=254.90 Aligned_cols=220 Identities=25% Similarity=0.311 Sum_probs=174.1
Q ss_pred ecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEcc
Q 041757 44 ISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFM 103 (381)
Q Consensus 44 lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~~ 103 (381)
||.|+||.||.+.. .....+.+|+.++++++|+||+++++. +......++||||+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-----~~~~~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYA-----FQTEEKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHH-----eecCCeeEEEEecC
Confidence 68999999976542 134478899999999999999999988 45688899999999
Q ss_pred cCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccccee
Q 041757 104 HNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARF 183 (381)
Q Consensus 104 ~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~ 183 (381)
++++|.+++. ....+++..+..++.|++.||.||| ..+++|+||+|+||+++.++.++|+|||.+..
T Consensus 76 ~~~~L~~~l~----------~~~~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~ 142 (250)
T cd05123 76 PGGELFSHLS----------KEGRFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKE 142 (250)
T ss_pred CCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCccee
Confidence 9999999994 3446899999999999999999999 66999999999999999999999999999987
Q ss_pred cCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHHHHh
Q 041757 184 LPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVD 263 (381)
Q Consensus 184 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (381)
....... .....++..|+|||...+...+.++|+||||+++|++++|..||..... ... ..
T Consensus 143 ~~~~~~~--~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----~~~------------~~ 203 (250)
T cd05123 143 LSSEGSR--TNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-----KEI------------YE 203 (250)
T ss_pred cccCCCc--ccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHH------------HH
Confidence 6543211 1124578899999999888889999999999999999999999852211 111 11
Q ss_pred hhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 041757 264 SILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTN 316 (381)
Q Consensus 264 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~ 316 (381)
....... ..+...+..+.+++.+||..||++||++.+
T Consensus 204 ~~~~~~~----------------~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 204 KILKDPL----------------RFPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHhcCCC----------------CCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 1100000 011233567889999999999999999954
No 374
>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=7.5e-34 Score=276.25 Aligned_cols=244 Identities=20% Similarity=0.223 Sum_probs=198.6
Q ss_pred hccccccccceecCCCceEEEeccc----------------ccHHHHHHHHHHHHccC-CCcccceeeeeccccccCCce
Q 041757 33 DVSRNMLEENLISAGTFGFSHLRRQ----------------GAFKSFIAECKALRNIR-HRNLIKVLTACLGVDYQGNDF 95 (381)
Q Consensus 33 ~~~~~~~~~~~lG~G~fg~V~~~~~----------------~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~~~~ 95 (381)
+.++-|.+.++||.|.+|.||+++. ...++...|.++|+.+. |||++.+||++.-.+....+.
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq 95 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ 95 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence 4678899999999999999988762 34566778999999885 999999999998766678899
Q ss_pred EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757 96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV 175 (381)
Q Consensus 96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl 175 (381)
+|||||||.+|+..++++.. ...++.+..+..|++.++.|+.+|| ...++|||+|-.|||++.++.+||
T Consensus 96 LWLVMEfC~gGSVTDLVKn~--------~g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 96 LWLVMEFCGGGSVTDLVKNT--------KGNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred EEEEeeccCCccHHHHHhhh--------cccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEE
Confidence 99999999999999999642 3678999999999999999999999 558999999999999999999999
Q ss_pred eecccceecCCCCCcccccCccCccceeCCCCcCCC-----ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHH
Q 041757 176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGN-----EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFA 250 (381)
Q Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~ 250 (381)
+|||.+..++........ ..||+.|||||++.-. .|+..+|+||||++..||.-|.+|+..+.+.
T Consensus 165 vDFGvSaQldsT~grRnT--~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm-------- 234 (953)
T KOG0587|consen 165 VDFGVSAQLDSTVGRRNT--FIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM-------- 234 (953)
T ss_pred eeeeeeeeeecccccccC--cCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh--------
Confidence 999999988776554433 6799999999998643 4788999999999999999999996533221
Q ss_pred HHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 251 KMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 251 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
+.++.- .++++-....+..-.+++.+++..|+..|.+.||++.++++
T Consensus 235 --------raLF~I--------------pRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 235 --------RALFLI--------------PRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred --------hhhccC--------------CCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 011100 00111111124567788999999999999999999999875
No 375
>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=7.4e-35 Score=246.67 Aligned_cols=268 Identities=18% Similarity=0.243 Sum_probs=186.6
Q ss_pred ccccccccceecCCCceEEEecccc-------------------cHHHHHHHHHHHHccCCCcccceeeeecccc---cc
Q 041757 34 VSRNMLEENLISAGTFGFSHLRRQG-------------------AFKSFIAECKALRNIRHRNLIKVLTACLGVD---YQ 91 (381)
Q Consensus 34 ~~~~~~~~~~lG~G~fg~V~~~~~~-------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~---~~ 91 (381)
....|....+||+|.||.|++++.. .-...++|+++|..|+|+|++.++.+|.... ..
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence 3456777899999999999776532 2234568999999999999999999987521 22
Q ss_pred CCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC
Q 041757 92 GNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM 171 (381)
Q Consensus 92 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~ 171 (381)
.....|+|+.+|+. +|..+|. +...+++..++..++.++.+||.|+| ...|+|||+||+|+||+.++
T Consensus 95 ~r~t~ylVf~~ceh-DLaGlLs---------n~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dg 161 (376)
T KOG0669|consen 95 DRATFYLVFDFCEH-DLAGLLS---------NRKVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDG 161 (376)
T ss_pred ccceeeeeHHHhhh-hHHHHhc---------CccccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCc
Confidence 34568999999976 9999995 45578999999999999999999999 55899999999999999999
Q ss_pred CeEEeecccceecCCCCC--cccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHH
Q 041757 172 TARVGDFGLARFLPPTRT--QTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHK 248 (381)
Q Consensus 172 ~~kl~Dfg~~~~~~~~~~--~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~ 248 (381)
.+||+|||+++.+..... ....+..+.|..|++||.+.+ ..|+++.|||.-||++.||++|.+.+. ++.....
T Consensus 162 ilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimq----gnteqqq 237 (376)
T KOG0669|consen 162 ILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQ----GNTEQQQ 237 (376)
T ss_pred eEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCcccc----CChHHHH
Confidence 999999999976543321 222233456999999998887 568999999999999999999999854 3333222
Q ss_pred HH--HHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHH------HHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041757 249 FA--KMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECV------ISMVRIGVACSMESPQDRMKMTNVVHE 320 (381)
Q Consensus 249 ~~--~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~l~~l~~~cl~~dP~~RPs~~~vl~~ 320 (381)
+. ........++....+-...--..+.... -..+......+.. +...+|+..++..||.+|+++++++..
T Consensus 238 l~~Is~LcGs~tkevWP~~d~lpL~~sie~eP--l~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 238 LHLISQLCGSITKEVWPNVDNLPLYQSIELEP--LPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred HHHHHHHhccCCcccCCCcccchHHHhccCCC--CCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 21 1111111111111000000000000000 0000111112222 267788889999999999999999863
No 376
>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]
Probab=100.00 E-value=4.7e-36 Score=255.68 Aligned_cols=243 Identities=23% Similarity=0.274 Sum_probs=179.8
Q ss_pred ccccccceecCCCceEEEecc------------------cccHHHHHHHHHHHHcc-CCCcccceeeeeccccccCCceE
Q 041757 36 RNMLEENLISAGTFGFSHLRR------------------QGAFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFK 96 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~------------------~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~~~~ 96 (381)
++.+....||.|+||+|++.. +...++++.|.+...+- +.||||++||.++. ++..
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~-----EGdc 138 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS-----EGDC 138 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc-----CCce
Confidence 445566889999999994421 34567888899876665 58999999999753 6778
Q ss_pred EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757 97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG 176 (381)
Q Consensus 97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~ 176 (381)
|+.||+|.- ||+.+.... .......+++...-.|......||.||-+ ...|||||+||+|||++..|.+||+
T Consensus 139 WiCMELMd~-SlDklYk~v-----y~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLC 210 (361)
T KOG1006|consen 139 WICMELMDI-SLDKLYKRV-----YSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLC 210 (361)
T ss_pred eeeHHHHhh-hHHHHHHHH-----HHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeee
Confidence 999999954 776654211 11345678888888899999999999986 4589999999999999999999999
Q ss_pred ecccceecCCCCCcccccCccCccceeCCCCcCC--CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHh
Q 041757 177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG--NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMAL 254 (381)
Q Consensus 177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 254 (381)
|||.+..+..+-..+. -.|...|||||.+.. ..|+.+|||||||++|||+.||..|+..-. ..++++..
T Consensus 211 DFGIcGqLv~SiAkT~---daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~---svfeql~~--- 281 (361)
T KOG1006|consen 211 DFGICGQLVDSIAKTV---DAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD---SVFEQLCQ--- 281 (361)
T ss_pred cccchHhHHHHHHhhh---ccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH---HHHHHHHH---
Confidence 9999987765543333 348999999998764 358999999999999999999999964110 01111111
Q ss_pred hchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041757 255 SNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE 320 (381)
Q Consensus 255 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~ 320 (381)
....++........ ..+....+..++..|+..|-.+||+..++.+.
T Consensus 282 ----------Vv~gdpp~l~~~~~----------~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 282 ----------VVIGDPPILLFDKE----------CVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ----------HHcCCCCeecCccc----------ccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 11112211111000 12456789999999999999999999998763
No 377
>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]
Probab=100.00 E-value=4.7e-34 Score=270.44 Aligned_cols=228 Identities=19% Similarity=0.183 Sum_probs=178.2
Q ss_pred ccccccccceecCCCceEEEecccc-------------cHHHHHHHHHHHHcc-CCCcccceeeeeccccccCCceEEEE
Q 041757 34 VSRNMLEENLISAGTFGFSHLRRQG-------------AFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALV 99 (381)
Q Consensus 34 ~~~~~~~~~~lG~G~fg~V~~~~~~-------------~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~~~~~lv 99 (381)
.+..|.....+|.|+||.|...... ......+|+.++... +||||+++.++ +.+..+.|+|
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v-----~~~~~~~~~v 394 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDV-----YEDGKEIYLV 394 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeecce-----ecCCceeeee
Confidence 4677888888999999999554311 122345678777766 59999999999 5668899999
Q ss_pred EEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeee-CCCCCeEEeec
Q 041757 100 YEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLL-DDDMTARVGDF 178 (381)
Q Consensus 100 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill-~~~~~~kl~Df 178 (381)
||++.++-|.+-+. ...... ..+..|+.+|+.|+.||| .+|+|||||||+|||+ ++.+.++|+||
T Consensus 395 ~e~l~g~ell~ri~----------~~~~~~-~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyF 460 (612)
T KOG0603|consen 395 MELLDGGELLRRIR----------SKPEFC-SEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYF 460 (612)
T ss_pred ehhccccHHHHHHH----------hcchhH-HHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEe
Confidence 99999998887773 233333 778889999999999999 6799999999999999 68899999999
Q ss_pred ccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchH
Q 041757 179 GLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHV 258 (381)
Q Consensus 179 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 258 (381)
|.++..... ..+.+-|..|.|||++....|+.++||||||++||+|++|+.||.....+ ..+...
T Consensus 461 G~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~----~ei~~~------ 525 (612)
T KOG0603|consen 461 GFWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG----IEIHTR------ 525 (612)
T ss_pred chhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch----HHHHHh------
Confidence 999877655 11234688999999999999999999999999999999999998644333 111111
Q ss_pred HHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 259 KDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 259 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
+..... ....+....+|+..||+.||.+||++.++..
T Consensus 526 ------i~~~~~------------------s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 526 ------IQMPKF------------------SECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred ------hcCCcc------------------ccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 111100 1245567788889999999999999999975
No 378
>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=7e-34 Score=255.67 Aligned_cols=183 Identities=21% Similarity=0.274 Sum_probs=154.3
Q ss_pred cccccccceecCCCceEEEecccccH--------------------HHHHHHHHHHHccC-CCcccceeeeeccccccCC
Q 041757 35 SRNMLEENLISAGTFGFSHLRRQGAF--------------------KSFIAECKALRNIR-HRNLIKVLTACLGVDYQGN 93 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~~~~~--------------------~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~~ 93 (381)
..+|....+||+|+||.|-++..... +--+.|-++|.-.. -|.+++++.+ +++-
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHSc-----FQTm 422 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSC-----FQTM 422 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHH-----hhhh
Confidence 35677789999999999977764332 33344767776664 6778888877 6778
Q ss_pred ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757 94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA 173 (381)
Q Consensus 94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~ 173 (381)
+.+|.||||+.||+|.-.+ ..-+.+.+..+.-++.+|+-||-+|| +++|+.||||.+|||++.+|++
T Consensus 423 DRLyFVMEyvnGGDLMyhi----------QQ~GkFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHi 489 (683)
T KOG0696|consen 423 DRLYFVMEYVNGGDLMYHI----------QQVGKFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHI 489 (683)
T ss_pred hheeeEEEEecCchhhhHH----------HHhcccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCce
Confidence 8999999999999999988 45667888889999999999999999 7799999999999999999999
Q ss_pred EEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCC
Q 041757 174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSD 237 (381)
Q Consensus 174 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~ 237 (381)
||+|||+++.---.... ...++||+-|+|||++...+|+..+|.|||||+||||+.|++||+
T Consensus 490 Ki~DFGmcKEni~~~~T--TkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFd 551 (683)
T KOG0696|consen 490 KIADFGMCKENIFDGVT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 551 (683)
T ss_pred EeeecccccccccCCcc--eeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCC
Confidence 99999999754333322 224789999999999999999999999999999999999999976
No 379
>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=9.4e-34 Score=247.34 Aligned_cols=247 Identities=18% Similarity=0.235 Sum_probs=180.9
Q ss_pred cceecCCCceEEEecc-----------------cccHHHHHHHHHHHHccC-CCcccceeeeeccccccCCceEEEEEEc
Q 041757 41 ENLISAGTFGFSHLRR-----------------QGAFKSFIAECKALRNIR-HRNLIKVLTACLGVDYQGNDFKALVYEF 102 (381)
Q Consensus 41 ~~~lG~G~fg~V~~~~-----------------~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~~~~~~lv~e~ 102 (381)
.+.||+|+|+.|.... .....+..+|++++.+.+ |+||++++++ ++++...|||||-
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLief-----FEdd~~FYLVfEK 157 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEF-----FEDDTRFYLVFEK 157 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHH-----hcccceEEEEEec
Confidence 4789999999993322 235678999999999996 9999999999 6778999999999
Q ss_pred ccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC---CeEEeecc
Q 041757 103 MHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM---TARVGDFG 179 (381)
Q Consensus 103 ~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~---~~kl~Dfg 179 (381)
|.||+|..+| .+...+++.++.++..+|+.||.||| .+||.||||||+|||..... -+||+||.
T Consensus 158 m~GGplLshI----------~~~~~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDfD 224 (463)
T KOG0607|consen 158 MRGGPLLSHI----------QKRKHFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDFD 224 (463)
T ss_pred ccCchHHHHH----------HHhhhccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeeccc
Confidence 9999999999 45678999999999999999999999 77999999999999996554 57999998
Q ss_pred cceecCCCCC-----cccccCccCccceeCCCCcC-----CCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHH
Q 041757 180 LARFLPPTRT-----QTSSIDVKGSIGYIAPEYGV-----GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKF 249 (381)
Q Consensus 180 ~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~ 249 (381)
+..-+..... .......+|+..|||||+.. ...|+.++|.||||||+|-|++|.+||..+-..+..+..-
T Consensus 225 LgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrG 304 (463)
T KOG0607|consen 225 LGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRG 304 (463)
T ss_pred cccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCC
Confidence 8765443222 11223467999999999743 2458999999999999999999999987554433322110
Q ss_pred HHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 250 AKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 250 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
. ....-...++..+.....+- ...-......+..+++...+..|+.+|-++.++++
T Consensus 305 e--~Cr~CQ~~LFesIQEGkYeF------------PdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 305 E--VCRVCQNKLFESIQEGKYEF------------PDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred C--ccHHHHHHHHHHHhccCCcC------------ChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 0 00001222333222221110 00011234455666677777789999988888876
No 380
>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481
Probab=100.00 E-value=3e-33 Score=283.82 Aligned_cols=129 Identities=26% Similarity=0.338 Sum_probs=113.9
Q ss_pred ccccccceecCCCceEEEecccc--------------------cHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757 36 RNMLEENLISAGTFGFSHLRRQG--------------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF 95 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~~--------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~ 95 (381)
++|.+.++||+|+||.||++... ....+.+|+.++..++||||+++++++ .....
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~~ 78 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL-----QSANN 78 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEE-----EECCE
Confidence 67889999999999999876421 136788899999999999999999884 44778
Q ss_pred EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757 96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV 175 (381)
Q Consensus 96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl 175 (381)
.++||||+.+++|.+++. ....+++..++.++.||+.||.||| ..+|+||||||+|||++.++.+||
T Consensus 79 ~~lVmEy~~g~~L~~li~----------~~~~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL 145 (669)
T cd05610 79 VYLVMEYLIGGDVKSLLH----------IYGYFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKL 145 (669)
T ss_pred EEEEEeCCCCCCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEE
Confidence 999999999999999994 3456788899999999999999999 669999999999999999999999
Q ss_pred eecccce
Q 041757 176 GDFGLAR 182 (381)
Q Consensus 176 ~Dfg~~~ 182 (381)
+|||+++
T Consensus 146 ~DFGls~ 152 (669)
T cd05610 146 TDFGLSK 152 (669)
T ss_pred EeCCCCc
Confidence 9999886
No 381
>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]
Probab=100.00 E-value=1.6e-34 Score=247.24 Aligned_cols=232 Identities=19% Similarity=0.242 Sum_probs=175.2
Q ss_pred cccceecCCCceEEEecc------------------cccHHHHHHHHHHHHccC-CCcccceeeeeccccccCCceEEEE
Q 041757 39 LEENLISAGTFGFSHLRR------------------QGAFKSFIAECKALRNIR-HRNLIKVLTACLGVDYQGNDFKALV 99 (381)
Q Consensus 39 ~~~~~lG~G~fg~V~~~~------------------~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~~~~~~lv 99 (381)
.....||.|+-|.|++.+ ....++.+..++++..-. .|.||+-+|+|+ .+...++.
T Consensus 95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi-----~n~dV~Ic 169 (391)
T KOG0983|consen 95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFI-----TNTDVFIC 169 (391)
T ss_pred hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEe-----eCchHHHH
Confidence 345679999999996643 224456667777766654 899999999965 36678899
Q ss_pred EEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecc
Q 041757 100 YEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179 (381)
Q Consensus 100 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg 179 (381)
||.|.. -++.++. .-...+++..+-.+...+++||.||.+ +++|+|||+||+|||+|..|.+||+|||
T Consensus 170 MelMs~-C~ekLlk---------rik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFG 237 (391)
T KOG0983|consen 170 MELMST-CAEKLLK---------RIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFG 237 (391)
T ss_pred HHHHHH-HHHHHHH---------HhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeeccc
Confidence 998843 5666664 234568999999999999999999975 5699999999999999999999999999
Q ss_pred cceecCCCCCcccccCccCccceeCCCCcCC---CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhc
Q 041757 180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGVG---NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSN 256 (381)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~ 256 (381)
.+..+.++...+. ..|.+.|||||.+.- ..|+.++||||||++++||.||+.||..- +..+..+.
T Consensus 238 IsGrlvdSkAhtr---sAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c---~tdFe~lt------ 305 (391)
T KOG0983|consen 238 ISGRLVDSKAHTR---SAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGC---KTDFEVLT------ 305 (391)
T ss_pred ccceeeccccccc---ccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCC---CccHHHHH------
Confidence 9988776654443 359999999998764 46899999999999999999999997521 12222211
Q ss_pred hHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 257 HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 257 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
+.+...|.... -.......+.+++..||..|+.+||...++++
T Consensus 306 -------kvln~ePP~L~-------------~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 306 -------KVLNEEPPLLP-------------GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred -------HHHhcCCCCCC-------------cccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 11111110000 00125567888999999999999999999886
No 382
>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=3.2e-34 Score=263.66 Aligned_cols=226 Identities=20% Similarity=0.300 Sum_probs=185.0
Q ss_pred ccccccceecCCCceEEEecc--------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757 36 RNMLEENLISAGTFGFSHLRR--------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF 95 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~--------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~ 95 (381)
.+++....||-||||.|.+++ ....+....|-.+|...+.|.||++|.. +.+..+
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrT-----frd~ky 494 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRT-----FRDSKY 494 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHH-----hccchh
Confidence 345556779999999996643 3345667789999999999999999998 677999
Q ss_pred EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757 96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV 175 (381)
Q Consensus 96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl 175 (381)
.|+.||-|-||.|-..| ...+.++...+.-++..+.+|++||| .++||.|||||+|.+++.+|.+||
T Consensus 495 vYmLmEaClGGElWTiL----------rdRg~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KL 561 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTIL----------RDRGSFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKL 561 (732)
T ss_pred hhhhHHhhcCchhhhhh----------hhcCCcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEE
Confidence 99999999999999999 46778888999999999999999999 779999999999999999999999
Q ss_pred eecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhh
Q 041757 176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALS 255 (381)
Q Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 255 (381)
.|||+|+.+......- .++||+.|.|||++.....+.++|.||||+++|||++|.+||. +...+..+-.....
T Consensus 562 VDFGFAKki~~g~KTw---TFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs----~~dpmktYn~ILkG 634 (732)
T KOG0614|consen 562 VDFGFAKKIGSGRKTW---TFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFS----GVDPMKTYNLILKG 634 (732)
T ss_pred eehhhHHHhccCCcee---eecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCC----CCchHHHHHHHHhh
Confidence 9999999887665433 3789999999999999999999999999999999999999975 22222221111100
Q ss_pred chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCC
Q 041757 256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMK 313 (381)
Q Consensus 256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs 313 (381)
++ ...+|........+++++.+..+|.+|.-
T Consensus 635 ------id---------------------~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 635 ------ID---------------------KIEFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred ------hh---------------------hhhcccccchhHHHHHHHHHhcCcHhhhc
Confidence 01 11224456677888899999999999976
No 383
>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]
Probab=100.00 E-value=2e-34 Score=265.97 Aligned_cols=178 Identities=24% Similarity=0.368 Sum_probs=155.8
Q ss_pred ccceecCCCceEEEecc-------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEE
Q 041757 40 EENLISAGTFGFSHLRR-------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVY 100 (381)
Q Consensus 40 ~~~~lG~G~fg~V~~~~-------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~ 100 (381)
..++||.|.||+||-++ ......+.+|+.||+++.||.||.+-.. +++.+..++||
T Consensus 568 ~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M-----~ET~ervFVVM 642 (888)
T KOG4236|consen 568 ADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECM-----FETPERVFVVM 642 (888)
T ss_pred hHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEe-----ecCCceEEEEe
Confidence 36899999999997654 2345778899999999999999999888 56789999999
Q ss_pred EcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC---CeEEee
Q 041757 101 EFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM---TARVGD 177 (381)
Q Consensus 101 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~---~~kl~D 177 (381)
|-+.| |..+.+.. ...+++++....-++.||+.||.||| .++|+|+||||+|||+.+.. .+||+|
T Consensus 643 EKl~G-DMLEMILS--------sEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCD 710 (888)
T KOG4236|consen 643 EKLHG-DMLEMILS--------SEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCD 710 (888)
T ss_pred hhhcc-hHHHHHHH--------hhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeecc
Confidence 99955 66666643 45678999999999999999999999 77999999999999996543 799999
Q ss_pred cccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCC
Q 041757 178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSD 237 (381)
Q Consensus 178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~ 237 (381)
||+|+++.+...... ++||+.|.|||++....|+..-|+||.||++|.-++|..||.
T Consensus 711 FGfARiIgEksFRrs---VVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFN 767 (888)
T KOG4236|consen 711 FGFARIIGEKSFRRS---VVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFN 767 (888)
T ss_pred ccceeecchhhhhhh---hcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCC
Confidence 999999988766554 679999999999999999999999999999999999999975
No 384
>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins. Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha
Probab=100.00 E-value=3.9e-33 Score=249.10 Aligned_cols=210 Identities=19% Similarity=0.113 Sum_probs=161.7
Q ss_pred CCceEEEecccc------------cHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEcccCCCHHHhhcc
Q 041757 47 GTFGFSHLRRQG------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYP 114 (381)
Q Consensus 47 G~fg~V~~~~~~------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 114 (381)
|.||.||++... ....+.+|...+....||||+++++++ ......++||||+++|+|.+++.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~- 77 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSEYSRERLTIIPHCVPNMVCLHKYI-----VSEDSVFLVLQHAEGGKLWSHIS- 77 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhhhhhHHHHHHhcCCCceeehhhhe-----ecCCeEEEEEecCCCCCHHHHHH-
Confidence 778888775531 112345666666677899999999984 45778999999999999999984
Q ss_pred ccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccceecCCCCCccccc
Q 041757 115 ISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSI 194 (381)
Q Consensus 115 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 194 (381)
....+++..+..++.|++.||.||| +.+++||||||+||+++.++.++++|||.+........
T Consensus 78 ---------~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~----- 140 (237)
T cd05576 78 ---------KFLNIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCD----- 140 (237)
T ss_pred ---------HhcCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhccccccc-----
Confidence 3345899999999999999999999 67999999999999999999999999998765543221
Q ss_pred CccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhh
Q 041757 195 DVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLV 274 (381)
Q Consensus 195 ~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 274 (381)
...++..|+|||.+.+..++.++||||+|+++||+++|..||....... .....
T Consensus 141 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-------------------~~~~~------- 194 (237)
T cd05576 141 GEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-------------------NTHTT------- 194 (237)
T ss_pred cCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-------------------ccccc-------
Confidence 1335778999999988889999999999999999999998864211000 00000
Q ss_pred hcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 041757 275 VRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTN 316 (381)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~ 316 (381)
...+......+.+++.+||+.||.+||++.+
T Consensus 195 -----------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 195 -----------LNIPEWVSEEARSLLQQLLQFNPTERLGAGV 225 (237)
T ss_pred -----------cCCcccCCHHHHHHHHHHccCCHHHhcCCCc
Confidence 0011234557888999999999999999743
No 385
>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]
Probab=100.00 E-value=1.5e-32 Score=245.60 Aligned_cols=252 Identities=20% Similarity=0.265 Sum_probs=197.9
Q ss_pred ccccccceecCCCceEEEecc-----------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccC
Q 041757 36 RNMLEENLISAGTFGFSHLRR-----------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQG 92 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~-----------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 92 (381)
.++....++-+|+||.||.+- +-++..++.|.-.+..+.|||+.++.++++. +
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie----~ 359 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE----D 359 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEee----c
Confidence 346777889999999997751 2345667788889999999999999999863 5
Q ss_pred CceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCC
Q 041757 93 NDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT 172 (381)
Q Consensus 93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~ 172 (381)
....++++.++.-|+|..||..-+..+ .+....++..+...++.|++.|++||| ..++||.||..+|++|++.-.
T Consensus 360 ~~~P~V~y~~~~~gNLK~FL~~Cr~~~--~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~Lq 434 (563)
T KOG1024|consen 360 YATPFVLYPATGVGNLKSFLQICRGDD--PSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQLQ 434 (563)
T ss_pred cCcceEEEeccCcchHHHHHHHhccCC--CccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhhee
Confidence 677889999999999999996222111 134566888899999999999999999 669999999999999999999
Q ss_pred eEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHH
Q 041757 173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAK 251 (381)
Q Consensus 173 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~ 251 (381)
+||+|=.+++.+-........-+...+..||+||.+....|+.++|||||||++|||+| |+.|+...- ++ .
T Consensus 435 VkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeID----Pf-E--- 506 (563)
T KOG1024|consen 435 VKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEID----PF-E--- 506 (563)
T ss_pred EEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccC----HH-H---
Confidence 99999999987765544332222346889999999999999999999999999999998 899964221 11 1
Q ss_pred HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhc
Q 041757 252 MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTL 328 (381)
Q Consensus 252 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~~ 328 (381)
+...+.. ..+...|.+|++++..+|..||..+|++||++.|+...|.+....+
T Consensus 507 ------m~~ylkd------------------GyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql 559 (563)
T KOG1024|consen 507 ------MEHYLKD------------------GYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL 559 (563)
T ss_pred ------HHHHHhc------------------cceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence 1111110 0112224589999999999999999999999999999998876543
No 386
>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=3.4e-32 Score=249.48 Aligned_cols=138 Identities=23% Similarity=0.333 Sum_probs=118.0
Q ss_pred CCccccccccccccccchhhhhccccccccceecCCCceEEEeccc----------------ccHHHHHHHHHHHHccC-
Q 041757 12 GNKLTGSLHIEVGKLKNLEILDVSRNMLEENLISAGTFGFSHLRRQ----------------GAFKSFIAECKALRNIR- 74 (381)
Q Consensus 12 ~n~~~g~~~~~~~~~~~l~~~~~~~~~~~~~~lG~G~fg~V~~~~~----------------~~~~~~~~E~~~l~~l~- 74 (381)
.+.-.|.+|..||...+ ...|-+.++||.|-|++||++.. ...+..+.||++|++++
T Consensus 60 dY~kGGYHpV~IGD~F~------~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~ 133 (590)
T KOG1290|consen 60 DYRKGGYHPVRIGDVFN------GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVRE 133 (590)
T ss_pred hhhcCCCceeecccccc------CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHh
Confidence 45678999999998886 78999999999999999999763 23456678999999984
Q ss_pred ----C---CcccceeeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHh
Q 041757 75 ----H---RNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYL 147 (381)
Q Consensus 75 ----h---~nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~L 147 (381)
| .+||++++.|... ..++.++++|+|++ |-+|..+|.. ...+.++...+..|+.|++.||.||
T Consensus 134 ~Dp~~~~~~~VV~LlD~Fkhs-GpNG~HVCMVfEvL-GdnLLklI~~--------s~YrGlpl~~VK~I~~qvL~GLdYL 203 (590)
T KOG1290|consen 134 GDPNDPGKKCVVQLLDHFKHS-GPNGQHVCMVFEVL-GDNLLKLIKY--------SNYRGLPLSCVKEICRQVLTGLDYL 203 (590)
T ss_pred cCCCCCCCceeeeeeccceec-CCCCcEEEEEehhh-hhHHHHHHHH--------hCCCCCcHHHHHHHHHHHHHHHHHH
Confidence 2 3699999997653 45788999999999 7799999964 4567899999999999999999999
Q ss_pred hcCCCCCceeeccCCCCeee
Q 041757 148 HHDCQPVTAHCVLKPSNVLL 167 (381)
Q Consensus 148 H~~~~~~ivHrDlkp~Nill 167 (381)
|+.+ +|||-||||+|||+
T Consensus 204 H~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 204 HREC--GIIHTDLKPENVLL 221 (590)
T ss_pred HHhc--CccccCCCcceeee
Confidence 9876 99999999999998
No 387
>PLN03225 Serine/threonine-protein kinase SNT7; Provisional
Probab=99.98 E-value=4.5e-32 Score=269.05 Aligned_cols=267 Identities=14% Similarity=0.095 Sum_probs=161.3
Q ss_pred ccccccccceecCCCceEEEecccccH--------------HHHHHHHHHHHcc---CCCcccceeeeecccc-ccCCce
Q 041757 34 VSRNMLEENLISAGTFGFSHLRRQGAF--------------KSFIAECKALRNI---RHRNLIKVLTACLGVD-YQGNDF 95 (381)
Q Consensus 34 ~~~~~~~~~~lG~G~fg~V~~~~~~~~--------------~~~~~E~~~l~~l---~h~nIv~~~~~~~~~~-~~~~~~ 95 (381)
..++|...++||+|+||.||++..... ..-..|..+..++ .+.+++.++..+.... ......
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCADFVYGFLEPVSSKKEDE 209 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHHHHHhhchhhHHHHHHhhhcccccccCCc
Confidence 467899999999999999998753211 1111233333333 2333433332221111 134677
Q ss_pred EEEEEEcccCCCHHHhhccccCCc----------ccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCe
Q 041757 96 KALVYEFMHNRSLKEWLYPISKED----------ETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNV 165 (381)
Q Consensus 96 ~~lv~e~~~~g~L~~~l~~~~~~~----------~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Ni 165 (381)
.++||||+.+++|.+++....... .............+..++.|++.||.||| +.+|+||||||+||
T Consensus 210 ~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLKP~NI 286 (566)
T PLN03225 210 YWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVKPQNI 286 (566)
T ss_pred eEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCCHHHE
Confidence 899999999999999985321000 00000111223456689999999999999 66999999999999
Q ss_pred eeCC-CCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCC----------------------ccCcccchhhh
Q 041757 166 LLDD-DMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGN----------------------EVSTIGDVYSY 222 (381)
Q Consensus 166 ll~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----------------------~~~~~sDiwSl 222 (381)
|++. ++.+||+|||+++.+....... .....+++.|+|||.+... .++.++|||||
T Consensus 287 Ll~~~~~~~KL~DFGlA~~l~~~~~~~-~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl 365 (566)
T PLN03225 287 IFSEGSGSFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 365 (566)
T ss_pred EEeCCCCcEEEEeCCCccccccccccC-CcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence 9985 5799999999998654432221 1235689999999965322 23456799999
Q ss_pred hHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhc--hHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHH
Q 041757 223 GILLLELMIREKPSDIMFEGDMNLHKFAKMALSN--HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIG 300 (381)
Q Consensus 223 G~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 300 (381)
||++|||+++..|++ .....+....... ....+... ..... ...................+|+
T Consensus 366 GviL~el~~~~~~~~------~~~~~~~~~l~~~~~~~~~~~~~-~~~~~--------~~~~~~~~~~~d~~~~~~~dLi 430 (566)
T PLN03225 366 GLIFLQMAFPNLRSD------SNLIQFNRQLKRNDYDLVAWRKL-VEPRA--------SPDLRRGFEVLDLDGGAGWELL 430 (566)
T ss_pred HHHHHHHHhCcCCCc------hHHHHHHHHHHhcCCcHHHHHHh-hcccc--------chhhhhhhhhccccchHHHHHH
Confidence 999999999776643 1122221111100 01111000 00000 0000000011112233456899
Q ss_pred HhccCCCCCCCCCHHHHHH
Q 041757 301 VACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 301 ~~cl~~dP~~RPs~~~vl~ 319 (381)
.+|++.||.+|||+.++++
T Consensus 431 ~~mL~~dP~kR~ta~e~L~ 449 (566)
T PLN03225 431 KSMMRFKGRQRISAKAALA 449 (566)
T ss_pred HHHccCCcccCCCHHHHhC
Confidence 9999999999999999987
No 388
>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]
Probab=99.98 E-value=3.4e-32 Score=256.03 Aligned_cols=190 Identities=21% Similarity=0.295 Sum_probs=160.9
Q ss_pred cccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757 37 NMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK 96 (381)
Q Consensus 37 ~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~ 96 (381)
.|..++-||-|+||.|-++++ ..+.....|-.||..-+++-||++|.. |++.+.+
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyyS-----FQDkdnL 704 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYS-----FQDKDNL 704 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEE-----eccCCce
Confidence 367789999999999966552 234456679999999999999999988 6789999
Q ss_pred EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757 97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG 176 (381)
Q Consensus 97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~ 176 (381)
|+||+|++|||+..+| -+.+.+.+..++-++.++..|+++.| ..|+|||||||+|||||.+|++||+
T Consensus 705 YFVMdYIPGGDmMSLL----------IrmgIFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLT 771 (1034)
T KOG0608|consen 705 YFVMDYIPGGDMMSLL----------IRMGIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLT 771 (1034)
T ss_pred EEEEeccCCccHHHHH----------HHhccCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeee
Confidence 9999999999999999 56778899999999999999999999 8899999999999999999999999
Q ss_pred ecccceecCC---CCCc-------------------------------------ccccCccCccceeCCCCcCCCccCcc
Q 041757 177 DFGLARFLPP---TRTQ-------------------------------------TSSIDVKGSIGYIAPEYGVGNEVSTI 216 (381)
Q Consensus 177 Dfg~~~~~~~---~~~~-------------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~ 216 (381)
|||++.-+.- ..+. ...-..+||+.|+|||++....|+..
T Consensus 772 DFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~ 851 (1034)
T KOG0608|consen 772 DFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQL 851 (1034)
T ss_pred eccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcccc
Confidence 9999853320 0000 00013569999999999999999999
Q ss_pred cchhhhhHHHHHHHhCCCCCCccccCCC
Q 041757 217 GDVYSYGILLLELMIREKPSDIMFEGDM 244 (381)
Q Consensus 217 sDiwSlG~il~el~tg~~Pf~~~~~~~~ 244 (381)
+|.||.|||||||+.|+.||.....++.
T Consensus 852 cdwws~gvil~em~~g~~pf~~~tp~~t 879 (1034)
T KOG0608|consen 852 CDWWSVGVILYEMLVGQPPFLADTPGET 879 (1034)
T ss_pred chhhHhhHHHHHHhhCCCCccCCCCCcc
Confidence 9999999999999999999976655553
No 389
>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=99.97 E-value=5.7e-32 Score=237.69 Aligned_cols=184 Identities=24% Similarity=0.320 Sum_probs=158.9
Q ss_pred ccccccceecCCCceEEEecc--------------------cccHHHHHHHHHHHHcc-CCCcccceeeeeccccccCCc
Q 041757 36 RNMLEENLISAGTFGFSHLRR--------------------QGAFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGND 94 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~--------------------~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~~ 94 (381)
.+|...++||+|+|++|.+++ ...+.....|-.+..+- +||.+|.++.+ ++++.
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhsc-----fqtes 324 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSC-----FQTES 324 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhh-----hcccc
Confidence 568888999999999995443 12334445576777766 59999999988 67899
Q ss_pred eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757 95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR 174 (381)
Q Consensus 95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k 174 (381)
.+++|.||.+||+|.-++ .+...++++.+.-+..+|+.||.||| +.|||.||||.+|+|++..|.+|
T Consensus 325 rlffvieyv~ggdlmfhm----------qrqrklpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghik 391 (593)
T KOG0695|consen 325 RLFFVIEYVNGGDLMFHM----------QRQRKLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIK 391 (593)
T ss_pred eEEEEEEEecCcceeeeh----------hhhhcCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCcee
Confidence 999999999999998888 56778999999999999999999999 66999999999999999999999
Q ss_pred EeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCcc
Q 041757 175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIM 239 (381)
Q Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~ 239 (381)
|+|+|+++.--.+...+. .++||+.|.|||.+.+..|+..+|.|++||+++||+.|+.||+..
T Consensus 392 ltdygmcke~l~~gd~ts--tfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdiv 454 (593)
T KOG0695|consen 392 LTDYGMCKEGLGPGDTTS--TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIV 454 (593)
T ss_pred ecccchhhcCCCCCcccc--cccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCccee
Confidence 999999986554444433 378999999999999999999999999999999999999999744
No 390
>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]
Probab=99.97 E-value=7.1e-32 Score=225.64 Aligned_cols=261 Identities=20% Similarity=0.247 Sum_probs=193.5
Q ss_pred ccccccccceecCCCceEEEecc--------------cccHHHHHHHHHHHHccC-CCcccceeeeeccccccCCceEEE
Q 041757 34 VSRNMLEENLISAGTFGFSHLRR--------------QGAFKSFIAECKALRNIR-HRNLIKVLTACLGVDYQGNDFKAL 98 (381)
Q Consensus 34 ~~~~~~~~~~lG~G~fg~V~~~~--------------~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~~~~~~l 98 (381)
..++|++.+++|+|.|+.|+.+. ....+...+|+++|..|. ||||++++++..+ .......|
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~D---p~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKD---PESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcC---ccccCchh
Confidence 35789999999999999995543 234677889999999998 9999999999664 34566789
Q ss_pred EEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCC-CCeEEee
Q 041757 99 VYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDD-MTARVGD 177 (381)
Q Consensus 99 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~-~~~kl~D 177 (381)
|+||..+.+...+. ..++..++..++.+++.||.|+| ++||.|||+||.|++||.. -.++|+|
T Consensus 113 iFE~v~n~Dfk~ly-------------~tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlID 176 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY-------------PTLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLID 176 (338)
T ss_pred HhhhhccccHHHHh-------------hhhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeee
Confidence 99999998877654 45777889999999999999999 8899999999999999864 4789999
Q ss_pred cccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH---
Q 041757 178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA--- 253 (381)
Q Consensus 178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~--- 253 (381)
+|+|........... .+.+..|--||.+.. ..|+..-|+|||||++..|+..+.|| |.+..+..++++..
T Consensus 177 WGLAEFYHp~~eYnV---RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepF---FhG~dN~DQLVkIakVL 250 (338)
T KOG0668|consen 177 WGLAEFYHPGKEYNV---RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF---FHGHDNYDQLVKIAKVL 250 (338)
T ss_pred cchHhhcCCCceeee---eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcc---cCCCCCHHHHHHHHHHh
Confidence 999988766654433 346778889998876 45788899999999999999999997 67777766665544
Q ss_pred hhchHHHHHhhhh-ccCchhhhhcccc-hh--hhhHHHHHH-HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 254 LSNHVKDIVDSIL-LNDDEKLVVRGDQ-KQ--TQAKINIIR-ECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 254 ~~~~~~~~~~~~l-~~~~~~~~~~~~~-~~--~~~~~~~~~-~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
....+...+++.- ..++.-....... +. ......-.. -..++.++++.+.|..|-.+|||+.|.+.
T Consensus 251 Gt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 251 GTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred ChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 3344444444322 1122111100000 00 000000011 12367889999999999999999999875
No 391
>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]
Probab=99.97 E-value=2e-32 Score=225.54 Aligned_cols=187 Identities=23% Similarity=0.332 Sum_probs=153.4
Q ss_pred cccccccceecCCCceEEEecc------------------cccHHHHHHHHHHHHcc-CCCcccceeeeeccccccCCce
Q 041757 35 SRNMLEENLISAGTFGFSHLRR------------------QGAFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDF 95 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~------------------~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~~~ 95 (381)
.++...+..||+|+||.|.+.+ ....++.++|+.+..+. ..|.+|.+||. .-....
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa-----~~regd 119 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGA-----LFREGD 119 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehh-----hhcccc
Confidence 3455567889999999983321 34556778888887766 59999999998 445778
Q ss_pred EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757 96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV 175 (381)
Q Consensus 96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl 175 (381)
.|+.||.|.. ||+.+-... ......+++.-+-+|+..+.+||.|||+ +..++|||+||+|||++.+|++|+
T Consensus 120 vwIcME~M~t-Sldkfy~~v------~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKi 190 (282)
T KOG0984|consen 120 VWICMELMDT-SLDKFYRKV------LKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKI 190 (282)
T ss_pred EEEeHHHhhh-hHHHHHHHH------HhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEE
Confidence 9999999955 888776432 2567889999999999999999999997 458999999999999999999999
Q ss_pred eecccceecCCCCCcccccCccCccceeCCCCcCC----CccCcccchhhhhHHHHHHHhCCCCCCc
Q 041757 176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG----NEVSTIGDVYSYGILLLELMIREKPSDI 238 (381)
Q Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~----~~~~~~sDiwSlG~il~el~tg~~Pf~~ 238 (381)
+|||.+..+.++...+.. .|.-.|||||.+.. ..|+.+|||||||+++.||.+++.||+.
T Consensus 191 CDFGIsG~L~dSiAkt~d---aGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 191 CDFGISGYLVDSIAKTMD---AGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred cccccceeehhhhHHHHh---cCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 999999888766544422 38889999998653 4699999999999999999999999763
No 392
>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]
Probab=99.97 E-value=1.9e-32 Score=265.41 Aligned_cols=235 Identities=23% Similarity=0.307 Sum_probs=174.9
Q ss_pred ccccceecCCCceEE-----EecccccHHH--------HHHHHHHHHccC-CCcccceeeeeccccccCCceEEEEEEcc
Q 041757 38 MLEENLISAGTFGFS-----HLRRQGAFKS--------FIAECKALRNIR-HRNLIKVLTACLGVDYQGNDFKALVYEFM 103 (381)
Q Consensus 38 ~~~~~~lG~G~fg~V-----~~~~~~~~~~--------~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~~~~~~lv~e~~ 103 (381)
|...+++|.|+-|+| |-.+.-++++ ..+|+..|+.-+ |||||++|+. ..+..+.||..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~-----E~d~qF~YIalELC 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCS-----EQDRQFLYIALELC 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeCCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEee-----ccCCceEEEEehHh
Confidence 556788999999987 3344444444 357999999885 9999999998 67899999999999
Q ss_pred cCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCC---C--CCeEEeec
Q 041757 104 HNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD---D--MTARVGDF 178 (381)
Q Consensus 104 ~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~---~--~~~kl~Df 178 (381)
.. +|.+++.... . ..........+.++.|+++||++|| +.+||||||||+||||+. + .+++|+||
T Consensus 586 ~~-sL~dlie~~~-~-----d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDf 655 (903)
T KOG1027|consen 586 AC-SLQDLIESSG-L-----DVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDF 655 (903)
T ss_pred hh-hHHHHHhccc-c-----chhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEeccc
Confidence 55 9999996420 0 0011111455778899999999999 679999999999999975 2 47899999
Q ss_pred ccceecCCCCCc-ccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhC-CCCCCccccCCCcHHHHHHHHhhc
Q 041757 179 GLARFLPPTRTQ-TSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIR-EKPSDIMFEGDMNLHKFAKMALSN 256 (381)
Q Consensus 179 g~~~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg-~~Pf~~~~~~~~~~~~~~~~~~~~ 256 (381)
|+++.+..+... .......||-+|+|||++....-+.++||+|+||++|++++| .+||......+.++.. ..
T Consensus 656 glsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~------~~ 729 (903)
T KOG1027|consen 656 GLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILT------GN 729 (903)
T ss_pred ccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhc------Cc
Confidence 999988766432 223446799999999999998888899999999999999885 9998754433222111 00
Q ss_pred hHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 257 HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 257 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
. .+.. +. + ..++ ...+|+.+|++++|..||++.+|+.
T Consensus 730 ~--~L~~--L~--~------------------~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 730 Y--TLVH--LE--P------------------LPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred c--ceee--ec--c------------------CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 0 0000 00 0 0122 6788889999999999999999974
No 393
>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain. Phosphotransferases. Serine or threonine-specific kinase subfamily.
Probab=99.97 E-value=1.6e-30 Score=231.59 Aligned_cols=210 Identities=26% Similarity=0.328 Sum_probs=166.2
Q ss_pred HHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHH
Q 041757 60 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAID 139 (381)
Q Consensus 60 ~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~q 139 (381)
.+.+.+|++.+++++|+||+++++.+. .....++++||+++++|.+++. ....++...++.++.+
T Consensus 31 ~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~l~~e~~~~~~L~~~~~----------~~~~~~~~~~~~~~~~ 95 (244)
T smart00220 31 RERILREISILKKLKHPNIVRLYDVFE-----DEDKLYLVMEYCDGGDLFDLLK----------KRGRLSEDEARFYARQ 95 (244)
T ss_pred HHHHHHHHHHHHhCCCCcHHHHHhhee-----eCCEEEEEEeCCCCCCHHHHHH----------hccCCCHHHHHHHHHH
Confidence 688999999999999999999999964 3578899999999999999984 2233889999999999
Q ss_pred HHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccch
Q 041757 140 VASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDV 219 (381)
Q Consensus 140 i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDi 219 (381)
++.++.+|| ..+++|+||+|+||+++.++.++|+|||.+.......... ...++..|+|||.+.+..++.++||
T Consensus 96 l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~---~~~~~~~~~~pE~~~~~~~~~~~Di 169 (244)
T smart00220 96 ILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLT---TFVGTPEYMAPEVLLGKGYGKAVDV 169 (244)
T ss_pred HHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccc---cccCCcCCCCHHHHccCCCCchhhH
Confidence 999999999 6699999999999999999999999999998766543111 2457889999999988888999999
Q ss_pred hhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHH
Q 041757 220 YSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRI 299 (381)
Q Consensus 220 wSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 299 (381)
||||+++|++++|..||... ..... +.+......... .......+..+.++
T Consensus 170 ~slG~~l~~l~~~~~p~~~~----~~~~~------------~~~~~~~~~~~~-------------~~~~~~~~~~~~~~ 220 (244)
T smart00220 170 WSLGVILYELLTGKPPFPGD----DQLLE------------LFKKIGKPKPPF-------------PPPEWKISPEAKDL 220 (244)
T ss_pred HHHHHHHHHHHhCCCCCCCC----CcHHH------------HHHHHhccCCCC-------------ccccccCCHHHHHH
Confidence 99999999999999997532 11111 111111000000 00000155688999
Q ss_pred HHhccCCCCCCCCCHHHHHH
Q 041757 300 GVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 300 ~~~cl~~dP~~RPs~~~vl~ 319 (381)
+.+||..+|++||++.++++
T Consensus 221 i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 221 IRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHccCCchhccCHHHHhh
Confidence 99999999999999999986
No 394
>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]
Probab=99.97 E-value=2.1e-31 Score=227.91 Aligned_cols=262 Identities=18% Similarity=0.231 Sum_probs=196.8
Q ss_pred CCccccccccccccccchhhhhccccccccceecCCCceEEEeccc----------------ccHHHHHHHHHHHHccC-
Q 041757 12 GNKLTGSLHIEVGKLKNLEILDVSRNMLEENLISAGTFGFSHLRRQ----------------GAFKSFIAECKALRNIR- 74 (381)
Q Consensus 12 ~n~~~g~~~~~~~~~~~l~~~~~~~~~~~~~~lG~G~fg~V~~~~~----------------~~~~~~~~E~~~l~~l~- 74 (381)
+++..|.++.- ....|+.++..+.|.+.+.||+|.||.+.++++ ...++|.+|...--.|.
T Consensus 2 ~k~~~g~ih~I--~~~el~kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~ 79 (378)
T KOG1345|consen 2 DKNDGGQIHLI--PMEELKKVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSP 79 (378)
T ss_pred CCCCCCccccc--ccccccccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeecc
Confidence 35556664432 233466677889999999999999999977652 35688999988777775
Q ss_pred CCcccceeeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCC
Q 041757 75 HRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPV 154 (381)
Q Consensus 75 h~nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ 154 (381)
|.||+.-|++. +++.+..+++|||++.|||..-+. ...+.+.....++.|+++|+.||| +++
T Consensus 80 H~hIi~tY~va----Fqt~d~YvF~qE~aP~gdL~snv~-----------~~GigE~~~K~v~~ql~SAi~fMH---skn 141 (378)
T KOG1345|consen 80 HQHIIDTYEVA----FQTSDAYVFVQEFAPRGDLRSNVE-----------AAGIGEANTKKVFAQLLSAIEFMH---SKN 141 (378)
T ss_pred chhhhHHHHHH----hhcCceEEEeeccCccchhhhhcC-----------cccccHHHHHHHHHHHHHHHHHhh---ccc
Confidence 99999998885 567889999999999999998873 356788888999999999999999 789
Q ss_pred ceeeccCCCCeeeC--CCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCC---C--ccCcccchhhhhHHHH
Q 041757 155 TAHCVLKPSNVLLD--DDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG---N--EVSTIGDVYSYGILLL 227 (381)
Q Consensus 155 ivHrDlkp~Nill~--~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~--~~~~~sDiwSlG~il~ 227 (381)
+||||||.+||||- +..++||+|||..+..+..... ..-+..|.+||.... . ...+.+|||.||+++|
T Consensus 142 lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~~-----~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f 216 (378)
T KOG1345|consen 142 LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVKY-----LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFF 216 (378)
T ss_pred hhhcccccceEEEecCCccEEEeeecccccccCceehh-----hhhhcccCCcHHHhhccccceEecccccchheeeeee
Confidence 99999999999993 2348999999998765443322 224667899996543 2 2467789999999999
Q ss_pred HHHhCCCCCCccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCC
Q 041757 228 ELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMES 307 (381)
Q Consensus 228 el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~d 307 (381)
.++||..||......+..+..|.....+... ..|.+ .......+.++..+-+..+
T Consensus 217 ~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~---------~~P~~----------------F~~fs~~a~r~Fkk~lt~~ 271 (378)
T KOG1345|consen 217 YCLTGKFPWQKASIMDKPYWEWEQWLKRKNP---------ALPKK----------------FNPFSEKALRLFKKSLTPR 271 (378)
T ss_pred eeecCCCcchhhhccCchHHHHHHHhcccCc---------cCchh----------------hcccCHHHHHHHHHhcCCc
Confidence 9999999998777777776666554332221 11111 2234456677777889999
Q ss_pred CCCCCCHHHHHHHHHH
Q 041757 308 PQDRMKMTNVVHELQS 323 (381)
Q Consensus 308 P~~RPs~~~vl~~L~~ 323 (381)
|++|-...++.++...
T Consensus 272 ~~drcki~~~kk~rk~ 287 (378)
T KOG1345|consen 272 FKDRCKIWTAKKMRKC 287 (378)
T ss_pred ccccchhHHHHHHHHH
Confidence 9999666666655543
No 395
>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]
Probab=99.97 E-value=2.5e-32 Score=233.87 Aligned_cols=185 Identities=23% Similarity=0.310 Sum_probs=151.7
Q ss_pred ccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEE
Q 041757 38 MLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKAL 98 (381)
Q Consensus 38 ~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~l 98 (381)
.+-.+-||.|+||.||-+.. ...+++.+|+++|..++|.|++..++........--...|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 44568899999999985431 24577889999999999999999998843221122234578
Q ss_pred EEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeec
Q 041757 99 VYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDF 178 (381)
Q Consensus 99 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df 178 (381)
++|+|.. +|...+ ..+..++...+.-++.||++||.||| +.+|.||||||.|.|++.+..+||+||
T Consensus 135 ~TELmQS-DLHKII----------VSPQ~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDF 200 (449)
T KOG0664|consen 135 LTELMQS-DLHKII----------VSPQALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDF 200 (449)
T ss_pred HHHHHHh-hhhhee----------ccCCCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEeccc
Confidence 9998854 898888 67888999999999999999999999 779999999999999999999999999
Q ss_pred ccceecCCCCCcccccCccCccceeCCCCcCCC-ccCcccchhhhhHHHHHHHhCCCCCC
Q 041757 179 GLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLELMIREKPSD 237 (381)
Q Consensus 179 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~el~tg~~Pf~ 237 (381)
|+++.......... +..+.|-.|+|||.+.+. .|+.+.||||.||++.|++-++..|.
T Consensus 201 GLARvee~d~~~hM-TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQ 259 (449)
T KOG0664|consen 201 GLARTWDQRDRLNM-THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQ 259 (449)
T ss_pred ccccccchhhhhhh-HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhh
Confidence 99987655443322 224568899999999885 58999999999999999998888765
No 396
>PLN03224 probable serine/threonine protein kinase; Provisional
Probab=99.97 E-value=2.4e-30 Score=250.97 Aligned_cols=262 Identities=16% Similarity=0.147 Sum_probs=169.2
Q ss_pred ccccccccceecCCCceEEEeccc---------------------------------ccHHHH--------------HHH
Q 041757 34 VSRNMLEENLISAGTFGFSHLRRQ---------------------------------GAFKSF--------------IAE 66 (381)
Q Consensus 34 ~~~~~~~~~~lG~G~fg~V~~~~~---------------------------------~~~~~~--------------~~E 66 (381)
..++|.+.++||+|+||+||++.. ...+.| ..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999986521 011223 346
Q ss_pred HHHHHccCCCcc-----cceeeeecccc---ccCCceEEEEEEcccCCCHHHhhccccCCc--------------ccccC
Q 041757 67 CKALRNIRHRNL-----IKVLTACLGVD---YQGNDFKALVYEFMHNRSLKEWLYPISKED--------------ETYKR 124 (381)
Q Consensus 67 ~~~l~~l~h~nI-----v~~~~~~~~~~---~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~--------------~~~~~ 124 (381)
+.++.+++|.++ ++++++|.... .......+|||||+++++|.++++...... .....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 677777776654 66777765311 112456899999999999999996421100 00011
Q ss_pred CCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccceecCCCCCcccccCccCccceeC
Q 041757 125 PRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIA 204 (381)
Q Consensus 125 ~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~a 204 (381)
...+++..+..++.|++.||.||| ..+|+||||||+||+++.++.+||+|||++............ ...+++.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~-~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPL-YGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCcc-ccCCCcceeC
Confidence 234567788999999999999999 669999999999999999999999999999765433221111 1235789999
Q ss_pred CCCcCCCc--------------------c--CcccchhhhhHHHHHHHhCCC-CCCccccCCCcHHHHHHHHhhchHHHH
Q 041757 205 PEYGVGNE--------------------V--STIGDVYSYGILLLELMIREK-PSDIMFEGDMNLHKFAKMALSNHVKDI 261 (381)
Q Consensus 205 PE~l~~~~--------------------~--~~~sDiwSlG~il~el~tg~~-Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (381)
||.+.... + ..+.||||+||++|+|++|.. ||.....-...+. .........
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~-----~~~~~~~~~ 453 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELR-----QYDNDLNRW 453 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHh-----hccchHHHH
Confidence 99875422 1 124699999999999999875 6532110000000 000111000
Q ss_pred HhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCC---CCCCCHHHHHH
Q 041757 262 VDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESP---QDRMKMTNVVH 319 (381)
Q Consensus 262 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP---~~RPs~~~vl~ 319 (381)
. ....... .............+++.+++..+| .+|+|+.|+++
T Consensus 454 r-~~~~~~~--------------~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 454 R-MYKGQKY--------------DFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred H-hhcccCC--------------CcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 0 0000000 000122345678888889999766 68999999985
No 397
>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]
Probab=99.97 E-value=3.4e-31 Score=247.10 Aligned_cols=181 Identities=22% Similarity=0.359 Sum_probs=157.1
Q ss_pred ccccccceecCCCceEEEeccccc----------------HHHHH---------HHHHHHHccC---CCcccceeeeecc
Q 041757 36 RNMLEENLISAGTFGFSHLRRQGA----------------FKSFI---------AECKALRNIR---HRNLIKVLTACLG 87 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~~~~----------------~~~~~---------~E~~~l~~l~---h~nIv~~~~~~~~ 87 (381)
.+|...+.+|.|+||.|+++.... ...++ .|++||..|+ |+||++++++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf--- 637 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF--- 637 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe---
Confidence 458889999999999997764221 11122 3999999997 9999999999
Q ss_pred ccccCCceEEEEEEc-ccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCee
Q 041757 88 VDYQGNDFKALVYEF-MHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVL 166 (381)
Q Consensus 88 ~~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nil 166 (381)
++++++.||+||- -++.+|.+++ .....+++.++..|+.|++.|+++|| +.+|||||||-+|++
T Consensus 638 --FEddd~yyl~te~hg~gIDLFd~I----------E~kp~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvi 702 (772)
T KOG1152|consen 638 --FEDDDYYYLETEVHGEGIDLFDFI----------EFKPRMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVI 702 (772)
T ss_pred --eecCCeeEEEecCCCCCcchhhhh----------hccCccchHHHHHHHHHHHhcccccc---ccCceecccccccEE
Confidence 6789999999996 4567999999 56788999999999999999999999 779999999999999
Q ss_pred eCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCcc-CcccchhhhhHHHHHHHhCCCCCCc
Q 041757 167 LDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEV-STIGDVYSYGILLLELMIREKPSDI 238 (381)
Q Consensus 167 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDiwSlG~il~el~tg~~Pf~~ 238 (381)
++.+|.+||+|||.+.......... ++||..|.|||++.+..| +..-|||++|++||.++....||.+
T Consensus 703 vd~~g~~klidfgsaa~~ksgpfd~----f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 703 VDSNGFVKLIDFGSAAYTKSGPFDV----FVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred EecCCeEEEeeccchhhhcCCCcce----eeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 9999999999999998877766554 679999999999999887 4567999999999999999999753
No 398
>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]
Probab=99.96 E-value=2.6e-30 Score=226.05 Aligned_cols=240 Identities=19% Similarity=0.199 Sum_probs=171.4
Q ss_pred cccHHHHHHHHHHHHccCCCcccceeeeecccc-ccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHH
Q 041757 57 QGAFKSFIAECKALRNIRHRNLIKVLTACLGVD-YQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLN 135 (381)
Q Consensus 57 ~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~-~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~ 135 (381)
....++..+|..++..+.|+||++++.++.-.. .+.....|+|||||. ++|.+++. -.++-..+..
T Consensus 56 ~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~-~nl~~vi~------------~elDH~tis~ 122 (369)
T KOG0665|consen 56 QTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMD-ANLCQVIL------------MELDHETISY 122 (369)
T ss_pred CccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhh-hHHHHHHH------------HhcchHHHHH
Confidence 345577789999999999999999999976311 223456799999995 49998883 3467788899
Q ss_pred HHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCc
Q 041757 136 IAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVST 215 (381)
Q Consensus 136 i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ 215 (381)
++.|++.|+.||| +.+|+||||||+||++..+..+||.|||+++..... ...+.++.|..|.|||++.+..|..
T Consensus 123 i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke 196 (369)
T KOG0665|consen 123 ILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKE 196 (369)
T ss_pred HHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhcccCcc---cccCchhheeeccCchheeccCCcc
Confidence 9999999999999 779999999999999999999999999999865544 2223467899999999999988999
Q ss_pred ccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhh--chHHHHHhhh-------hccCchhhh--hcccchhh--
Q 041757 216 IGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALS--NHVKDIVDSI-------LLNDDEKLV--VRGDQKQT-- 282 (381)
Q Consensus 216 ~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~-------l~~~~~~~~--~~~~~~~~-- 282 (381)
.+||||+||++.||++|..-| .+...+.+|.+..-. ..-..+.+.+ ....+.-.. +.......
T Consensus 197 ~vdiwSvGci~gEli~~~Vlf----~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f 272 (369)
T KOG0665|consen 197 NVDIWSVGCIMGELILGTVLF----PGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLF 272 (369)
T ss_pred cchhhhhhhHHHHHhhceEEe----cCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccc
Confidence 999999999999999999885 466666666554311 1111111111 111110000 00000000
Q ss_pred hhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 283 QAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 283 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
.......+.......+++.+||-.||++|.|+.+++.
T Consensus 273 ~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 273 PVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred cccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 0000001123345677888999999999999999886
No 399
>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]
Probab=99.95 E-value=1.2e-28 Score=223.05 Aligned_cols=265 Identities=21% Similarity=0.239 Sum_probs=189.2
Q ss_pred ccccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccC-CCcccceeeeeccccccCCc
Q 041757 34 VSRNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIR-HRNLIKVLTACLGVDYQGND 94 (381)
Q Consensus 34 ~~~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~~~ 94 (381)
+.+.|...++||.|+|++||++.. ....+..+|+++|..+. +.||+++.++ +..++
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~-----~rnnd 108 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGC-----FRNND 108 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhh-----hccCC
Confidence 457789999999999999977542 23466788999999996 9999999999 67899
Q ss_pred eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCC-CCCe
Q 041757 95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD-DMTA 173 (381)
Q Consensus 95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~-~~~~ 173 (381)
...+||||++.-+..++.. .++..++..++..++.||.++| ..|||||||||+|+|.+. .++-
T Consensus 109 ~v~ivlp~~~H~~f~~l~~-------------~l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg 172 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYR-------------SLSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRG 172 (418)
T ss_pred eeEEEecccCccCHHHHHh-------------cCCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCc
Confidence 9999999999988888873 3668889999999999999999 779999999999999975 4577
Q ss_pred EEeecccceecCCCC------------------------------------------CcccccCccCccceeCCCCcCC-
Q 041757 174 RVGDFGLARFLPPTR------------------------------------------TQTSSIDVKGSIGYIAPEYGVG- 210 (381)
Q Consensus 174 kl~Dfg~~~~~~~~~------------------------------------------~~~~~~~~~gt~~y~aPE~l~~- 210 (381)
.|+|||+|....... .........||++|+|||++..
T Consensus 173 ~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~ 252 (418)
T KOG1167|consen 173 VLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRC 252 (418)
T ss_pred eEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhc
Confidence 899999987221100 0000113559999999999876
Q ss_pred CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHH---HHhh--hhcc-----Cchhhhhcccc-
Q 041757 211 NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKD---IVDS--ILLN-----DDEKLVVRGDQ- 279 (381)
Q Consensus 211 ~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~---~~~~--~l~~-----~~~~~~~~~~~- 279 (381)
...++++||||.|||+.-+++++.||-....+-..+..++.......++. +.+. .... .++........
T Consensus 253 ~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~ 332 (418)
T KOG1167|consen 253 PRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLH 332 (418)
T ss_pred cCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccC
Confidence 45689999999999999999999998655544444544444433333222 1111 0000 00000000000
Q ss_pred -------hhh-hhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 280 -------KQT-QAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 280 -------~~~-~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
.+. ..........+..+++++.+|++.||.+|.|+++.+.
T Consensus 333 ~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 333 IESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred hhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 000 1111122233448899999999999999999999885
No 400
>PLN00181 protein SPA1-RELATED; Provisional
Probab=99.95 E-value=8.1e-29 Score=257.15 Aligned_cols=203 Identities=18% Similarity=0.218 Sum_probs=140.3
Q ss_pred HHccCC-Ccccceeeeeccc--cccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHH
Q 041757 70 LRNIRH-RNLIKVLTACLGV--DYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNY 146 (381)
Q Consensus 70 l~~l~h-~nIv~~~~~~~~~--~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~ 146 (381)
.+.++| +||++++++|... +......++.+|||+ +++|.++|. .....+++.+++.++.||+.||.|
T Consensus 26 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~---------~~~~~~~~~~~~~i~~qi~~al~~ 95 (793)
T PLN00181 26 SKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLD---------NPDRSVDAFECFHVFRQIVEIVNA 95 (793)
T ss_pred cchhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHh---------cccccccHHHHHHHHHHHHHHHHH
Confidence 445667 6888888886321 112234567888987 669999995 234568999999999999999999
Q ss_pred hhcCCCCCceeeccCCCCeeeCC-------------------CCCeEEeecccceecCCCCC--------------cccc
Q 041757 147 LHHDCQPVTAHCVLKPSNVLLDD-------------------DMTARVGDFGLARFLPPTRT--------------QTSS 193 (381)
Q Consensus 147 LH~~~~~~ivHrDlkp~Nill~~-------------------~~~~kl~Dfg~~~~~~~~~~--------------~~~~ 193 (381)
|| +.+|+||||||+|||++. ++.+|++|||+++....... ....
T Consensus 96 lH---~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (793)
T PLN00181 96 AH---SQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQ 172 (793)
T ss_pred HH---hCCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccc
Confidence 99 679999999999999954 34566667776654221000 0000
Q ss_pred cCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhh
Q 041757 194 IDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKL 273 (381)
Q Consensus 194 ~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 273 (381)
....||+.|||||++.+..++.++|||||||+||||++|..|+.... .. ...+....+ .+.
T Consensus 173 ~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~---~~------------~~~~~~~~~--~~~-- 233 (793)
T PLN00181 173 ILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS---RT------------MSSLRHRVL--PPQ-- 233 (793)
T ss_pred cccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH---HH------------HHHHHHhhc--Chh--
Confidence 11357889999999999999999999999999999999988853110 00 000000000 000
Q ss_pred hhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 274 VVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
..........++.+||+.||.+||++.++++
T Consensus 234 ---------------~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 234 ---------------ILLNWPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred ---------------hhhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 0112234567788999999999999999975
No 401
>smart00750 KIND kinase non-catalytic C-lobe domain. It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features
Probab=99.95 E-value=6.6e-28 Score=205.17 Aligned_cols=169 Identities=23% Similarity=0.267 Sum_probs=125.9
Q ss_pred CCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccceecC
Q 041757 106 RSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLP 185 (381)
Q Consensus 106 g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~ 185 (381)
|+|.+++. .....+++..++.++.|++.||.|||+. + ||+||+++.++.+|+ ||+++...
T Consensus 1 GsL~~~l~---------~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~ 60 (176)
T smart00750 1 VSLADILE---------VRGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKT 60 (176)
T ss_pred CcHHHHHH---------HhCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeec
Confidence 68999885 2345699999999999999999999944 4 999999999999999 99998764
Q ss_pred CCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHHHHhhh
Q 041757 186 PTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSI 265 (381)
Q Consensus 186 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (381)
... ..||+.|+|||++.+..++.++|||||||++|||++|+.||........ ....++...
T Consensus 61 ~~~-------~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~------------~~~~~~~~~ 121 (176)
T smart00750 61 PEQ-------SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA------------ILEILLNGM 121 (176)
T ss_pred ccc-------CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH------------HHHHHHHHh
Confidence 422 2488999999999999999999999999999999999999753221111 111111111
Q ss_pred hccCchhhhhcccchhhhhHHHHHHHHH--HHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 041757 266 LLNDDEKLVVRGDQKQTQAKINIIRECV--ISMVRIGVACSMESPQDRMKMTNVVHELQSIKN 326 (381)
Q Consensus 266 l~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~ 326 (381)
....+.. ........ ..+.+++.+||..||.+|||+.++++.+..+..
T Consensus 122 ~~~~~~~-------------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 122 PADDPRD-------------RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred ccCCccc-------------cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 1111000 00011222 268999999999999999999999998876643
No 402
>cd00180 PKc Catalytic domain of Protein Kinases. Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which
Probab=99.95 E-value=3e-27 Score=205.31 Aligned_cols=194 Identities=27% Similarity=0.453 Sum_probs=162.9
Q ss_pred ecCCCceEEEecccc------------------cHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEcccC
Q 041757 44 ISAGTFGFSHLRRQG------------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHN 105 (381)
Q Consensus 44 lG~G~fg~V~~~~~~------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~~~~ 105 (381)
||.|++|.||++... ..+.+.+|++.++.++|++|+++++++. .....++++||+.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFE-----DENHLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeee-----cCCeEEEEEecCCC
Confidence 688888888775421 1367999999999999999999999953 45788999999999
Q ss_pred CCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCC-CCCeEEeecccceec
Q 041757 106 RSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD-DMTARVGDFGLARFL 184 (381)
Q Consensus 106 g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~-~~~~kl~Dfg~~~~~ 184 (381)
++|.+++.. ....++...+..++.+++.++.+|| ..+++|+||+|.||+++. ++.++|+|||.+...
T Consensus 76 ~~l~~~~~~---------~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~ 143 (215)
T cd00180 76 GSLKDLLKE---------NEGKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLL 143 (215)
T ss_pred CcHHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEc
Confidence 999999842 1146889999999999999999999 669999999999999999 899999999999876
Q ss_pred CCCCCcccccCccCccceeCCCCcCCC-ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHHHHh
Q 041757 185 PPTRTQTSSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVD 263 (381)
Q Consensus 185 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (381)
..... ......+...|++||.+... .++.++|+|++|++++++
T Consensus 144 ~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------- 187 (215)
T cd00180 144 TSDKS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------- 187 (215)
T ss_pred cCCcc--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------
Confidence 55431 11113478889999998877 788999999999999997
Q ss_pred hhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041757 264 SILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE 320 (381)
Q Consensus 264 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~ 320 (381)
..+.+++..|+..||.+||++.++++.
T Consensus 188 ------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ------------------------------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 156778889999999999999999864
No 403
>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]
Probab=99.95 E-value=5.1e-29 Score=236.12 Aligned_cols=239 Identities=20% Similarity=0.286 Sum_probs=184.0
Q ss_pred hccccccccceecCCCceEEEecccc-----------------cHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757 33 DVSRNMLEENLISAGTFGFSHLRRQG-----------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF 95 (381)
Q Consensus 33 ~~~~~~~~~~~lG~G~fg~V~~~~~~-----------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~ 95 (381)
...++|....++|.|+||.||+++.. .++-...|+-+++..+|||||.++|.+ .....
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsy-----lr~dk 86 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSY-----LRRDK 86 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhh-----hhhcC
Confidence 45788999999999999999998742 344556799999999999999999994 45778
Q ss_pred EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757 96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV 175 (381)
Q Consensus 96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl 175 (381)
.|+.||||.+|+|.+.-+ -...+++.++...++..+.||.||| +++=+|||||-.||++++.|.+|+
T Consensus 87 lwicMEycgggslQdiy~----------~TgplselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvkl 153 (829)
T KOG0576|consen 87 LWICMEYCGGGSLQDIYH----------VTGPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKL 153 (829)
T ss_pred cEEEEEecCCCcccceee----------ecccchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceee
Confidence 899999999999999773 4678999999999999999999999 778899999999999999999999
Q ss_pred eecccceecCCCCCcccccCccCccceeCCCCcC---CCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHH
Q 041757 176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGV---GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM 252 (381)
Q Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~ 252 (381)
+|||.+..+........ .+.||+.|||||+.. ...|...+|||++|+...|+-.-++|- |.-. .......+
T Consensus 154 aDfgvsaqitati~Krk--sfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqppl---fdlh-pmr~l~Lm 227 (829)
T KOG0576|consen 154 ADFGVSAQITATIAKRK--SFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPL---FDLH-PMRALFLM 227 (829)
T ss_pred cccCchhhhhhhhhhhh--cccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcc---cccc-hHHHHHHh
Confidence 99999877665433332 367999999999753 456899999999999999998877772 2211 11111111
Q ss_pred HhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 253 ALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 253 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
..+. +++.-..++ ..-...+.++++.|+..+|.+|||++.++.
T Consensus 228 TkS~-----~qpp~lkDk-------------------~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 228 TKSG-----FQPPTLKDK-------------------TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred hccC-----CCCCcccCC-------------------ccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 1000 010000011 123446778888999999999999987764
No 404
>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]
Probab=99.95 E-value=4e-28 Score=224.17 Aligned_cols=184 Identities=22% Similarity=0.248 Sum_probs=152.9
Q ss_pred ccccccccceecCCCceEEEeccc----------------ccHHHHHHHHHHHHccCC------Ccccceeeeecccccc
Q 041757 34 VSRNMLEENLISAGTFGFSHLRRQ----------------GAFKSFIAECKALRNIRH------RNLIKVLTACLGVDYQ 91 (381)
Q Consensus 34 ~~~~~~~~~~lG~G~fg~V~~~~~----------------~~~~~~~~E~~~l~~l~h------~nIv~~~~~~~~~~~~ 91 (381)
+...|.+....|+|-||+|..+.. ...+.=++|+++|++|.. -|.++++-. |.
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~-----F~ 504 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRH-----FK 504 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHH-----hh
Confidence 456788888999999999965542 234556789999999952 378888888 45
Q ss_pred CCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC
Q 041757 92 GNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM 171 (381)
Q Consensus 92 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~ 171 (381)
..+++|||+|-+. -+|.++|+.. .....|....+..++.|+..||..|- .-+|+|+||||+|||+++..
T Consensus 505 hknHLClVFE~Ls-lNLRevLKKy-------G~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k 573 (752)
T KOG0670|consen 505 HKNHLCLVFEPLS-LNLREVLKKY-------GRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESK 573 (752)
T ss_pred hcceeEEEehhhh-chHHHHHHHh-------CcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCc
Confidence 6899999999884 4999999654 24556888899999999999999999 66999999999999998754
Q ss_pred -CeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCC
Q 041757 172 -TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSD 237 (381)
Q Consensus 172 -~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~ 237 (381)
.+||||||.|..+....... +..+..|.|||++.+..|+...|+||.||+||||.||+..|.
T Consensus 574 ~iLKLCDfGSA~~~~eneitP----YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFp 636 (752)
T KOG0670|consen 574 NILKLCDFGSASFASENEITP----YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFP 636 (752)
T ss_pred ceeeeccCccccccccccccH----HHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecC
Confidence 68999999998776654333 335778999999999999999999999999999999998864
No 405
>smart00221 STYKc Protein kinase; unclassified specificity. Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.
Probab=99.94 E-value=1.6e-26 Score=203.70 Aligned_cols=181 Identities=29% Similarity=0.405 Sum_probs=152.7
Q ss_pred ccccceecCCCceEEEecccc------------------cHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEE
Q 041757 38 MLEENLISAGTFGFSHLRRQG------------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALV 99 (381)
Q Consensus 38 ~~~~~~lG~G~fg~V~~~~~~------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv 99 (381)
|...+.||.|+||.||++... ..+.+.+|++.+.+++|+|++++++.+. .....+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~-----~~~~~~~v 75 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFE-----DPEPLYLV 75 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeee-----cCCceEEE
Confidence 456788999999999776421 4678889999999999999999999853 45788999
Q ss_pred EEcccCCCHHHhhccccCCcccccCCCc-ccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeec
Q 041757 100 YEFMHNRSLKEWLYPISKEDETYKRPRN-LNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDF 178 (381)
Q Consensus 100 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~-l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df 178 (381)
+||+++++|.+++. .... +++..+..++.+++.++.+|| ..+++|+|++|+||+++.++.++|+||
T Consensus 76 ~e~~~~~~L~~~~~----------~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~ 142 (225)
T smart00221 76 MEYCEGGDLFDYLR----------KKGGKLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADF 142 (225)
T ss_pred EeccCCCCHHHHHH----------hcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeC
Confidence 99999999999994 2233 788999999999999999999 669999999999999999999999999
Q ss_pred ccceecCCCCCcccccCccCccceeCCCCc-CCCccCcccchhhhhHHHHHHHhCCCCCC
Q 041757 179 GLARFLPPTRTQTSSIDVKGSIGYIAPEYG-VGNEVSTIGDVYSYGILLLELMIREKPSD 237 (381)
Q Consensus 179 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~l-~~~~~~~~sDiwSlG~il~el~tg~~Pf~ 237 (381)
|.+......... ......++..|++||.+ ....++.++||||||+++++|++|+.||.
T Consensus 143 g~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 143 GLARFIHRDLAA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred ceeeEecCcccc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 999877654311 11124578889999998 66678889999999999999999999985
No 406
>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]
Probab=99.92 E-value=8.2e-24 Score=197.23 Aligned_cols=248 Identities=21% Similarity=0.218 Sum_probs=183.5
Q ss_pred cccccceecCCCceEEEeccccc------------------HHHHHHHHHHHHccCC----CcccceeeeeccccccCCc
Q 041757 37 NMLEENLISAGTFGFSHLRRQGA------------------FKSFIAECKALRNIRH----RNLIKVLTACLGVDYQGND 94 (381)
Q Consensus 37 ~~~~~~~lG~G~fg~V~~~~~~~------------------~~~~~~E~~~l~~l~h----~nIv~~~~~~~~~~~~~~~ 94 (381)
+|.+.++||+|+||.||++.... ...+..|+.++..+.. +++..+++... ....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~~~ 94 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----STED 94 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc----CCCc
Confidence 89999999999999998876321 1157789999999973 58888888731 3577
Q ss_pred eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCC----
Q 041757 95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDD---- 170 (381)
Q Consensus 95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~---- 170 (381)
+.++||+.+ |.+|.++... .....++..+++.++.|++.+|.+|| +.|++||||||+|+++...
T Consensus 95 ~~~iVM~l~-G~sL~dl~~~--------~~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~ 162 (322)
T KOG1164|consen 95 FNFIVMSLL-GPSLEDLRKR--------NPPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSE 162 (322)
T ss_pred eeEEEEecc-CccHHHHHHh--------CCCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcc
Confidence 899999988 7899998742 22478999999999999999999999 7799999999999999765
Q ss_pred -CCeEEeecccce--ecCCCCC------cccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCcccc
Q 041757 171 -MTARVGDFGLAR--FLPPTRT------QTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFE 241 (381)
Q Consensus 171 -~~~kl~Dfg~~~--~~~~~~~------~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~ 241 (381)
..+.|.|||+++ ....... ........||..|+++.+..+...+.+.|+||++.++.+++.|..||.....
T Consensus 163 ~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~ 242 (322)
T KOG1164|consen 163 VRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEM 242 (322)
T ss_pred cceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccc
Confidence 368999999998 3222211 1112235699999999999999999999999999999999999999853322
Q ss_pred CCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 041757 242 GDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHEL 321 (381)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L 321 (381)
... ...+...... ..... .....+..+.++...+-..+..++|....+...+
T Consensus 243 ~~~-~~~~~~~~~~----~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l 294 (322)
T KOG1164|consen 243 TDL-KSKFEKDPRK----LLTDR-----------------------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELL 294 (322)
T ss_pred cch-HHHHHHHhhh----hcccc-----------------------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHH
Confidence 211 1111110000 00000 0112334555555566668999999999999999
Q ss_pred HHhhhhc
Q 041757 322 QSIKNTL 328 (381)
Q Consensus 322 ~~i~~~~ 328 (381)
+......
T Consensus 295 ~~~~~~~ 301 (322)
T KOG1164|consen 295 KDVFDSE 301 (322)
T ss_pred HHHHHhc
Confidence 8887665
No 407
>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]
Probab=99.91 E-value=3.2e-25 Score=219.79 Aligned_cols=238 Identities=19% Similarity=0.222 Sum_probs=177.0
Q ss_pred cccceecCCCceEEEeccc------ccH-----------------HHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757 39 LEENLISAGTFGFSHLRRQ------GAF-----------------KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF 95 (381)
Q Consensus 39 ~~~~~lG~G~fg~V~~~~~------~~~-----------------~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~ 95 (381)
....++|.|++|.|+.... ... ..+..|+-+-..|.|+|++..+..+.+ ...
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~-----~~~ 395 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQE-----IDG 395 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhh-----ccc
Confidence 4568999999995533210 001 113446666667899999887777543 223
Q ss_pred EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757 96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV 175 (381)
Q Consensus 96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl 175 (381)
..-+||||++ ||..++ .....++..++..++.|++.|++|+| ..||.|||+|++|+++..++.+||
T Consensus 396 ~~~~mE~~~~-Dlf~~~----------~~~~~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki 461 (601)
T KOG0590|consen 396 ILQSMEYCPY-DLFSLV----------MSNGKLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKI 461 (601)
T ss_pred chhhhhcccH-HHHHHH----------hcccccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEE
Confidence 3334999999 999999 34457889999999999999999999 779999999999999999999999
Q ss_pred eecccceecCCCCCc--ccccCccCccceeCCCCcCCCccCcc-cchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHH
Q 041757 176 GDFGLARFLPPTRTQ--TSSIDVKGSIGYIAPEYGVGNEVSTI-GDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM 252 (381)
Q Consensus 176 ~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~-sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~ 252 (381)
+|||.+....-.... ......+|+-.|+|||++.+..|.+. .||||.|+++..|.+|+.||......+..+ ...
T Consensus 462 ~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~---~~~ 538 (601)
T KOG0590|consen 462 IDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF---KTN 538 (601)
T ss_pred eecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch---hhh
Confidence 999998776554443 44445789999999999999998755 699999999999999999997555444332 000
Q ss_pred HhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 253 ALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 253 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
..... .........+....+.....++.++++.||.+|.|+.+|++
T Consensus 539 ~~~~~---------------------~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 539 NYSDQ---------------------RNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ccccc---------------------cccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 00000 00011112234566778888999999999999999999986
No 408
>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]
Probab=99.91 E-value=1.8e-23 Score=184.17 Aligned_cols=266 Identities=15% Similarity=0.173 Sum_probs=202.7
Q ss_pred hccccccccceecCCCceEEEecc---------------cccHHHHHHHHHHHHccC-CCcccceeeeeccccccCCceE
Q 041757 33 DVSRNMLEENLISAGTFGFSHLRR---------------QGAFKSFIAECKALRNIR-HRNLIKVLTACLGVDYQGNDFK 96 (381)
Q Consensus 33 ~~~~~~~~~~~lG~G~fg~V~~~~---------------~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~~~~~ 96 (381)
.+.-+|.++++||+|+||..+..+ +....++..|.+..+.|. .++|..+|-+ .+.+.+.
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYF-----GqeG~~N 99 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYF-----GQEGKYN 99 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeee-----ccccchh
Confidence 346689999999999999985543 445678888999999996 7899998877 5668888
Q ss_pred EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC-----
Q 041757 97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM----- 171 (381)
Q Consensus 97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~----- 171 (381)
.||+|++ |.+|++++. -..+.++..+++.++.|++.-++|+| .+.+|.|||||+|+||...+
T Consensus 100 iLVidLL-GPSLEDLFD---------~CgR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n 166 (449)
T KOG1165|consen 100 ILVIDLL-GPSLEDLFD---------LCGRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDAN 166 (449)
T ss_pred hhhhhhh-CcCHHHHHH---------HhcCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCc
Confidence 9999988 889999885 56788999999999999999999999 77999999999999997544
Q ss_pred CeEEeecccceecCCCCCc-----ccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcH
Q 041757 172 TARVGDFGLARFLPPTRTQ-----TSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNL 246 (381)
Q Consensus 172 ~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~ 246 (381)
.+.++|||+|+.+.+.... ....+..||.+||+-....+.+.+.+.|+=|+|-++.+.+-|..||..... +.+-
T Consensus 167 ~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA-~tnK 245 (449)
T KOG1165|consen 167 VIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA-DTNK 245 (449)
T ss_pred eEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC-cchH
Confidence 5889999999987664321 122235699999999999999999999999999999999999999974432 2222
Q ss_pred HHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 041757 247 HKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKN 326 (381)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~ 326 (381)
..+.+..-.. +......+....|.++..-+...-..+-.+-|...-+...+..+..
T Consensus 246 ~kYeKIGe~K------------------------r~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvld 301 (449)
T KOG1165|consen 246 EKYEKIGETK------------------------RSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLD 301 (449)
T ss_pred HHHHHhcccc------------------------ccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence 2222221111 1111122233455566666666667788999999999888888877
Q ss_pred hcCCCCCcccccccc
Q 041757 327 TLLGPKNLATCKAVI 341 (381)
Q Consensus 327 ~~~~~~~~~~~~~~~ 341 (381)
......+-..+|..+
T Consensus 302 r~g~t~Dg~yDW~~l 316 (449)
T KOG1165|consen 302 RLGETDDGEYDWMGL 316 (449)
T ss_pred hcCCccccccccccc
Confidence 766555555555443
No 409
>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]
Probab=99.91 E-value=4.8e-24 Score=180.10 Aligned_cols=270 Identities=19% Similarity=0.196 Sum_probs=209.4
Q ss_pred chhhhhccccccccceecCCCceEEEecc---------------cccHHHHHHHHHHHHccCC-Ccccceeeeecccccc
Q 041757 28 NLEILDVSRNMLEENLISAGTFGFSHLRR---------------QGAFKSFIAECKALRNIRH-RNLIKVLTACLGVDYQ 91 (381)
Q Consensus 28 ~l~~~~~~~~~~~~~~lG~G~fg~V~~~~---------------~~~~~~~~~E~~~l~~l~h-~nIv~~~~~~~~~~~~ 91 (381)
.++.+...++|...++||.|+||.+|++. ......+..|.++...|++ ..|..+..+ ..
T Consensus 7 s~~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y-----~~ 81 (341)
T KOG1163|consen 7 SLEELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHY-----GT 81 (341)
T ss_pred chhhheeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhh-----cc
Confidence 34555667899999999999999998764 2234667889999999985 556666655 34
Q ss_pred CCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCC-
Q 041757 92 GNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDD- 170 (381)
Q Consensus 92 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~- 170 (381)
+..+..+||+++ |.+|.+++. -....++..+++.++-|++.-++|+| .+++|||||||+|+|..-+
T Consensus 82 e~~ynvlVMdLL-GPsLEdLfn---------fC~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgr 148 (341)
T KOG1163|consen 82 EKDYNVLVMDLL-GPSLEDLFN---------FCSRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGR 148 (341)
T ss_pred ccccceeeeecc-CccHHHHHH---------HHhhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeecccc
Confidence 577889999988 889999885 45678999999999999999999999 6699999999999998543
Q ss_pred --CCeEEeecccceecCCCCC-----cccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCC
Q 041757 171 --MTARVGDFGLARFLPPTRT-----QTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD 243 (381)
Q Consensus 171 --~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~ 243 (381)
..+.++|||+|+.+.+... ........||.+|.+-....+.+.+.+.|+=|+|.+|.+.--|..||.......
T Consensus 149 h~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~t 228 (341)
T KOG1163|consen 149 HCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAAT 228 (341)
T ss_pred ccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhh
Confidence 3678999999997765322 222334679999999998888888999999999999999999999997554322
Q ss_pred --CcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 041757 244 --MNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHEL 321 (381)
Q Consensus 244 --~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L 321 (381)
...+.+.....+..+..+ ....|.++.-.+..|-..--++-|...-+.+.+
T Consensus 229 k~QKyEkI~EkK~s~~ie~L---------------------------C~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlF 281 (341)
T KOG1163|consen 229 KKQKYEKISEKKMSTPIEVL---------------------------CKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLF 281 (341)
T ss_pred HHHHHHHHHHhhcCCCHHHH---------------------------hCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHH
Confidence 112222222222222222 235566788888899999999999999999999
Q ss_pred HHhhhhcCCCCCccccccccC
Q 041757 322 QSIKNTLLGPKNLATCKAVIG 342 (381)
Q Consensus 322 ~~i~~~~~~~~~~~~~~~~~~ 342 (381)
.-+...+....+...+|+.+.
T Consensus 282 riLfr~ln~~~d~iyDW~~lk 302 (341)
T KOG1163|consen 282 RILFRTLNHQYDYIYDWTMLK 302 (341)
T ss_pred HHHHhhccccCCeEeeHHHHH
Confidence 999998888888888887765
No 410
>PRK09188 serine/threonine protein kinase; Provisional
Probab=99.90 E-value=1.5e-23 Score=195.59 Aligned_cols=152 Identities=21% Similarity=0.147 Sum_probs=116.8
Q ss_pred hhccccccccceecCCCceEEEecccc-----------------------cHHHHHHHHHHHHccCCCcccceeeeeccc
Q 041757 32 LDVSRNMLEENLISAGTFGFSHLRRQG-----------------------AFKSFIAECKALRNIRHRNLIKVLTACLGV 88 (381)
Q Consensus 32 ~~~~~~~~~~~~lG~G~fg~V~~~~~~-----------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 88 (381)
....++|...++||+|+||+||++... ..+.|.+|+++|++++|+||+..+..
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---- 89 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---- 89 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----
Confidence 345788999999999999999876310 13458899999999999999863322
Q ss_pred cccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeecc-CCCCeee
Q 041757 89 DYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVL-KPSNVLL 167 (381)
Q Consensus 89 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDl-kp~Nill 167 (381)
....++||||++|++|.. +. ... ...++.+++.||.||| +.+|+|||| ||+|||+
T Consensus 90 ----~~~~~LVmE~~~G~~L~~-~~----------~~~------~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv 145 (365)
T PRK09188 90 ----TGKDGLVRGWTEGVPLHL-AR----------PHG------DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLM 145 (365)
T ss_pred ----cCCcEEEEEccCCCCHHH-hC----------ccc------hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEE
Confidence 124699999999999963 21 111 1457889999999999 679999999 9999999
Q ss_pred CCCCCeEEeecccceecCCCCCccc------ccCccCccceeCCCCcCCC
Q 041757 168 DDDMTARVGDFGLARFLPPTRTQTS------SIDVKGSIGYIAPEYGVGN 211 (381)
Q Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~~~~~------~~~~~gt~~y~aPE~l~~~ 211 (381)
+.++.+||+|||+++.+........ .....+++.|+|||++...
T Consensus 146 ~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 146 GPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 9999999999999997765432111 1235678889999988753
No 411
>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]
Probab=99.88 E-value=3.1e-23 Score=197.01 Aligned_cols=221 Identities=24% Similarity=0.359 Sum_probs=162.7
Q ss_pred HHccCCCcccceeeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhc
Q 041757 70 LRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHH 149 (381)
Q Consensus 70 l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~ 149 (381)
|+.+.|.|+.+++|.++. ....++|.+||..|+|.+.+. .....+++.....+..+|+.||+|||.
T Consensus 1 l~~l~h~n~~~f~g~~~~-----~~~~~~i~~~c~rGsl~D~i~---------~~~~~~d~~F~~s~~rdi~~Gl~ylh~ 66 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVD-----GPEMIVIWEYCSRGSLLDILS---------NEDIKLDYFFILSFIRDISKGLAYLHN 66 (484)
T ss_pred CcccchhhhhhheeeEec-----CCceEEEEeeecCccHHhHHh---------ccccCccHHHHHHHHHHHHHHHHHHhc
Confidence 467899999999999865 478899999999999999996 456778999999999999999999995
Q ss_pred CCCCCceeeccCCCCeeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCc-------cCcccchhhh
Q 041757 150 DCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNE-------VSTIGDVYSY 222 (381)
Q Consensus 150 ~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-------~~~~sDiwSl 222 (381)
. + ...|+.+++.|++++..+.+||+|||+.................-..-|.|||.+.+.. .+.++|||||
T Consensus 67 s-~-i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~ 144 (484)
T KOG1023|consen 67 S-P-IGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSF 144 (484)
T ss_pred C-c-ceeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehH
Confidence 4 2 23999999999999999999999999987764311111111122456799999988642 3667999999
Q ss_pred hHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHh
Q 041757 223 GILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVA 302 (381)
Q Consensus 223 G~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 302 (381)
|++++|+++++.||+........ ......... .....+.+ .... ..+....+..++..
T Consensus 145 ~ii~~ei~~r~~~~~~~~~~~~~-~eii~~~~~-~~~~~~rP-------------------~i~~-~~e~~~~l~~l~~~ 202 (484)
T KOG1023|consen 145 GIIMYEILFRSGPFDLRNLVEDP-DEIILRVKK-GGSNPFRP-------------------SIEL-LNELPPELLLLVAR 202 (484)
T ss_pred HHHHHHHHhccCccccccccCCh-HHHHHHHHh-cCCCCcCc-------------------chhh-hhhcchHHHHHHHH
Confidence 99999999999999754433332 111111000 00000000 0000 01344578999999
Q ss_pred ccCCCCCCCCCHHHHHHHHHHhhhhc
Q 041757 303 CSMESPQDRMKMTNVVHELQSIKNTL 328 (381)
Q Consensus 303 cl~~dP~~RPs~~~vl~~L~~i~~~~ 328 (381)
||..+|.+||++.+|...++.+....
T Consensus 203 cw~e~P~~rPs~~~i~~~~~~~~~~~ 228 (484)
T KOG1023|consen 203 CWEEIPEKRPSIEQIRSKLLTINKGG 228 (484)
T ss_pred hcccChhhCccHHHHHhhhhhhcccc
Confidence 99999999999999999998886654
No 412
>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]
Probab=99.88 E-value=1.6e-21 Score=180.59 Aligned_cols=247 Identities=25% Similarity=0.328 Sum_probs=179.7
Q ss_pred ccccceecCCCceEEEecccc-----------------cHHHHHHHHHHHHccCCC-cccceeeeeccccccCCceEEEE
Q 041757 38 MLEENLISAGTFGFSHLRRQG-----------------AFKSFIAECKALRNIRHR-NLIKVLTACLGVDYQGNDFKALV 99 (381)
Q Consensus 38 ~~~~~~lG~G~fg~V~~~~~~-----------------~~~~~~~E~~~l~~l~h~-nIv~~~~~~~~~~~~~~~~~~lv 99 (381)
|...+.||.|+||.||.+... ....+.+|+.++..+.|+ +|+++++.+ ......+++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~~~ 76 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFF-----QDEGSLYLV 76 (384)
T ss_pred ceeEEeecCCCCeEEEEEEeccEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEE-----ecCCEEEEE
Confidence 667788999999999776421 367789999999999988 799999995 335558999
Q ss_pred EEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC-CeEEeec
Q 041757 100 YEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM-TARVGDF 178 (381)
Q Consensus 100 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~-~~kl~Df 178 (381)
++++.++++.+++.... .. ..+.......++.|++.++.|+| ..+++|||+||+||+++..+ .++++||
T Consensus 77 ~~~~~~~~l~~~~~~~~------~~-~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~df 146 (384)
T COG0515 77 MEYVDGGSLEDLLKKIG------RK-GPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDF 146 (384)
T ss_pred EecCCCCcHHHHHHhcc------cc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEecc
Confidence 99999999997774210 00 37899999999999999999999 66899999999999999988 7999999
Q ss_pred ccceecCCCCCcc----cccCccCccceeCCCCcCC---CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHH
Q 041757 179 GLARFLPPTRTQT----SSIDVKGSIGYIAPEYGVG---NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAK 251 (381)
Q Consensus 179 g~~~~~~~~~~~~----~~~~~~gt~~y~aPE~l~~---~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~ 251 (381)
|.++......... ......|+..|+|||.+.+ ..++...|+||+|++++++++|..||...... .......
T Consensus 147 g~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~-~~~~~~~- 224 (384)
T COG0515 147 GLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS-SATSQTL- 224 (384)
T ss_pred CcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc-ccHHHHH-
Confidence 9998665543321 2234679999999999887 57889999999999999999999996422211 0001100
Q ss_pred HHhhchHHHHHhhhhcc-CchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041757 252 MALSNHVKDIVDSILLN-DDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE 320 (381)
Q Consensus 252 ~~~~~~~~~~~~~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~ 320 (381)
+.+...... .... .. ..........+.+++..|+..+|..|.+..+....
T Consensus 225 --------~~~~~~~~~~~~~~----~~-------~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 225 --------KIILELPTPSLASP----LS-------PSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred --------HHHHhcCCcccccc----cC-------ccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 001000000 0000 00 00001223567788889999999999999887764
No 413
>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]
Probab=99.87 E-value=7.1e-23 Score=175.95 Aligned_cols=213 Identities=24% Similarity=0.345 Sum_probs=160.2
Q ss_pred cHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHH
Q 041757 59 AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAI 138 (381)
Q Consensus 59 ~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~ 138 (381)
.-+.|..|.-.|+-+.||||+.+++.|.. .....++..||+.|+|..+|+.. ..-.++..++.+++.
T Consensus 230 isrdfneefp~lrifshpnilpvlgacns-----ppnlv~isq~mp~gslynvlhe~--------t~vvvd~sqav~fal 296 (448)
T KOG0195|consen 230 ISRDFNEEFPALRIFSHPNILPVLGACNS-----PPNLVIISQYMPFGSLYNVLHEQ--------TSVVVDHSQAVRFAL 296 (448)
T ss_pred hcchhhhhCcceeeecCCchhhhhhhccC-----CCCceEeeeeccchHHHHHHhcC--------ccEEEecchHHHHHH
Confidence 34568889999999999999999999754 67789999999999999999863 345577889999999
Q ss_pred HHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe--ecccceecCCCCCcccccCccCccceeCCCCcCCCcc---
Q 041757 139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG--DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEV--- 213 (381)
Q Consensus 139 qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~--Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~--- 213 (381)
++++|++|||+. ..-|.---|....+++|++.+.+|+ |--++.. .....-.+.||+||.+...+-
T Consensus 297 diargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsfq---------e~gr~y~pawmspealqrkped~n 366 (448)
T KOG0195|consen 297 DIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ---------EVGRAYSPAWMSPEALQRKPEDLN 366 (448)
T ss_pred HHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeeee---------ccccccCcccCCHHHHhcCchhcc
Confidence 999999999976 3444445689999999999877764 3222211 111234788999999887543
Q ss_pred CcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHH
Q 041757 214 STIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECV 293 (381)
Q Consensus 214 ~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (381)
-.++|+|||.+++||+.|+..||......+.... . -+.. .+..+++...
T Consensus 367 ~raadmwsfaillwel~trevpfadlspmecgmk----i--------aleg-------------------lrv~ippgis 415 (448)
T KOG0195|consen 367 IRAADMWSFAILLWELNTREVPFADLSPMECGMK----I--------ALEG-------------------LRVHIPPGIS 415 (448)
T ss_pred hhhhhHHHHHHHHHHhhccccccccCCchhhhhh----h--------hhcc-------------------ccccCCCCcc
Confidence 3568999999999999999999864433222111 0 0111 0112245667
Q ss_pred HHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 041757 294 ISMVRIGVACSMESPQDRMKMTNVVHELQSIK 325 (381)
Q Consensus 294 ~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~ 325 (381)
..+.+|+.-|...||.+||.+..|+-.|++..
T Consensus 416 ~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 416 RHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred HHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 78899999999999999999999998888753
No 414
>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional
Probab=99.84 E-value=2.7e-21 Score=168.21 Aligned_cols=162 Identities=12% Similarity=0.105 Sum_probs=121.6
Q ss_pred hccccccccceecCCCceEEEeccc------------------ccHHH------HHHHHHHHHccCCCcccceeeeeccc
Q 041757 33 DVSRNMLEENLISAGTFGFSHLRRQ------------------GAFKS------FIAECKALRNIRHRNLIKVLTACLGV 88 (381)
Q Consensus 33 ~~~~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~------~~~E~~~l~~l~h~nIv~~~~~~~~~ 88 (381)
.+.++|+..++||.|+||.|++... ....+ +.+|++.+.++.|++|..+.+++...
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 3689999999999999999987542 11222 57899999999999999998885531
Q ss_pred cc---cCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCe
Q 041757 89 DY---QGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNV 165 (381)
Q Consensus 89 ~~---~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Ni 165 (381)
.. ......+|||||++|.+|.++.. +++ ....+++.++..+| ..|++|||+||+||
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------------~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Ni 166 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE--------------ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNF 166 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh--------------ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHE
Confidence 11 11345789999999999988741 122 24569999999999 66999999999999
Q ss_pred eeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHH
Q 041757 166 LLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230 (381)
Q Consensus 166 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~ 230 (381)
+++.++ ++|+|||............ .++....|..++||||||+++.-..
T Consensus 167 li~~~g-i~liDfg~~~~~~e~~a~d--------------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 167 IVSKNG-LRIIDLSGKRCTAQRKAKD--------------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEeCCC-EEEEECCCcccccchhhHH--------------HHHHHhHhcccccccceeEeehHHH
Confidence 999888 9999999886543221110 0233445678899999999986543
No 415
>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]
Probab=99.83 E-value=2.2e-21 Score=184.65 Aligned_cols=169 Identities=25% Similarity=0.272 Sum_probs=144.1
Q ss_pred eecCCCceEEEecc----------------------cccHHHHHHHHHHHHccC-CCcccceeeeeccccccCCceEEEE
Q 041757 43 LISAGTFGFSHLRR----------------------QGAFKSFIAECKALRNIR-HRNLIKVLTACLGVDYQGNDFKALV 99 (381)
Q Consensus 43 ~lG~G~fg~V~~~~----------------------~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~~~~~~lv 99 (381)
++|.|.||.|.+++ .........|..++...+ ||.+|++... ++.....+++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhya-----fqt~~kl~l~ 75 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYA-----FQTDGKLYLI 75 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeee-----eccccchhHh
Confidence 47899999995543 112225566888999997 9999999888 5678889999
Q ss_pred EEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecc
Q 041757 100 YEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179 (381)
Q Consensus 100 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg 179 (381)
++|..+|+|...+ .....+++.....+...++-+++++| +.+++|||+|++||+++.+|.+++.|||
T Consensus 76 ld~~rgg~lft~l----------~~~~~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfg 142 (612)
T KOG0603|consen 76 LDFLRGGDLFTRL----------SKEVMFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFG 142 (612)
T ss_pred hhhcccchhhhcc----------ccCCchHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCch
Confidence 9999999999888 56677888888889999999999999 7799999999999999999999999999
Q ss_pred cceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCC
Q 041757 180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSD 237 (381)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~ 237 (381)
+++..-..... +||..|||||++. .....+|.||||++++||+||..||.
T Consensus 143 lske~v~~~~~------cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~ 192 (612)
T KOG0603|consen 143 LSKEAVKEKIA------CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFG 192 (612)
T ss_pred hhhHhHhhhhc------ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCc
Confidence 99865443322 6899999999987 56788999999999999999999986
No 416
>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]
Probab=99.82 E-value=6.4e-20 Score=165.48 Aligned_cols=202 Identities=21% Similarity=0.245 Sum_probs=142.3
Q ss_pred CCCcccceeeeecc----------------------ccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHH
Q 041757 74 RHRNLIKVLTACLG----------------------VDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLL 131 (381)
Q Consensus 74 ~h~nIv~~~~~~~~----------------------~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~ 131 (381)
+|||||++.+.|.+ .........|+||.-++. +|.+++. ....+..
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~-----------~~~~s~r 341 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLW-----------TRHRSYR 341 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHh-----------cCCCchH
Confidence 59999999998875 112346678999998865 9999984 3445667
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeee--CCCC--CeEEeecccceecCCC----CCcccccCccCcccee
Q 041757 132 RRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLL--DDDM--TARVGDFGLARFLPPT----RTQTSSIDVKGSIGYI 203 (381)
Q Consensus 132 ~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill--~~~~--~~kl~Dfg~~~~~~~~----~~~~~~~~~~gt~~y~ 203 (381)
...-++.|+++|+.||| ++||.|||+|.+|||+ ++++ .+.|+|||++---+.. .........-|.-.-|
T Consensus 342 ~~~~~laQlLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lm 418 (598)
T KOG4158|consen 342 TGRVILAQLLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLM 418 (598)
T ss_pred HHHHHHHHHHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceec
Confidence 77889999999999999 6699999999999999 3343 5689999987533321 1112222344788899
Q ss_pred CCCCcCCCc------cCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcc
Q 041757 204 APEYGVGNE------VSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRG 277 (381)
Q Consensus 204 aPE~l~~~~------~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 277 (381)
|||+....+ .-.|+|.|+.|.+.||++....||...-+.......+....
T Consensus 419 APEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~q------------------------ 474 (598)
T KOG4158|consen 419 APEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQ------------------------ 474 (598)
T ss_pred chhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhh------------------------
Confidence 999876432 23679999999999999999999864211111111111110
Q ss_pred cchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 041757 278 DQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHEL 321 (381)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L 321 (381)
.+.++..++..+.+++...++.||++|++..=..+.|
T Consensus 475 -------LPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 475 -------LPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred -------CCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHH
Confidence 0112345677788888899999999999976555444
No 417
>PRK12274 serine/threonine protein kinase; Provisional
Probab=99.82 E-value=8.2e-20 Score=155.72 Aligned_cols=174 Identities=21% Similarity=0.113 Sum_probs=125.0
Q ss_pred cccceecCCCceEEEecccc-------------------cHHHHHHHHHHHHccC-CCcccceeeeeccccccCCceEEE
Q 041757 39 LEENLISAGTFGFSHLRRQG-------------------AFKSFIAECKALRNIR-HRNLIKVLTACLGVDYQGNDFKAL 98 (381)
Q Consensus 39 ~~~~~lG~G~fg~V~~~~~~-------------------~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~~~~~~l 98 (381)
.....|++|+||+|+++... ....+.+|+++|++|. |++|.+++++ . ..++
T Consensus 5 ~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~--------~-~~~l 75 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW--------D-GRHL 75 (218)
T ss_pred ccceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE--------c-CEEE
Confidence 45678999999999876522 1225789999999996 5889998886 1 2589
Q ss_pred EEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeecc-CCCCeeeCCCCCeEEee
Q 041757 99 VYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVL-KPSNVLLDDDMTARVGD 177 (381)
Q Consensus 99 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDl-kp~Nill~~~~~~kl~D 177 (381)
+|||+.|.+|.+.+. . ....++.|++.+|.++| ..||+|||| ||+|||++.++.++|+|
T Consensus 76 vmeyI~G~~L~~~~~----------~-------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LID 135 (218)
T PRK12274 76 DRSYLAGAAMYQRPP----------R-------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVID 135 (218)
T ss_pred EEeeecCccHHhhhh----------h-------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEE
Confidence 999999999875441 1 11347789999999999 669999999 79999999999999999
Q ss_pred cccceecCCCCCc----c-c------ccCccCccceeCCCCcCC-CccC-cccchhhhhHHHHHHHhCCCCCCcccc
Q 041757 178 FGLARFLPPTRTQ----T-S------SIDVKGSIGYIAPEYGVG-NEVS-TIGDVYSYGILLLELMIREKPSDIMFE 241 (381)
Q Consensus 178 fg~~~~~~~~~~~----~-~------~~~~~gt~~y~aPE~l~~-~~~~-~~sDiwSlG~il~el~tg~~Pf~~~~~ 241 (381)
||++......... . . ......++.|++|+.-.- ...+ ...+.++-|.-+|.++||..|+....+
T Consensus 136 FG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 136 FQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred CCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 9999865443210 0 0 000114555666653221 1223 345778999999999999999654433
No 418
>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]
Probab=99.82 E-value=1.2e-20 Score=188.58 Aligned_cols=255 Identities=18% Similarity=0.194 Sum_probs=170.1
Q ss_pred cCCccccccccccccccchhhhhccccccccceecCCCceEEEecc----------------cccHHHHH---HHHHHHH
Q 041757 11 SGNKLTGSLHIEVGKLKNLEILDVSRNMLEENLISAGTFGFSHLRR----------------QGAFKSFI---AECKALR 71 (381)
Q Consensus 11 ~~n~~~g~~~~~~~~~~~l~~~~~~~~~~~~~~lG~G~fg~V~~~~----------------~~~~~~~~---~E~~~l~ 71 (381)
.+|+++| |.++.....+- -+...++...+.||.+.|=+|.+++ .-....|. +|++ ..
T Consensus 1 MGnqls~--~sQi~~~e~yf-sd~~~e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~ 76 (1431)
T KOG1240|consen 1 MGNQLSL--PSQISPVEVYF-SDLSVECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FA 76 (1431)
T ss_pred CCccccc--ccccchHHHHh-hcCccceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HH
Confidence 3788887 44432222110 1112256667888988887663322 11234444 4444 45
Q ss_pred ccCCCcccceeeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCC
Q 041757 72 NIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDC 151 (381)
Q Consensus 72 ~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ 151 (381)
.++|||.+.+..+ .....-.|||-+|... +|.+.+ ....-+...+..-|+.|++.||.-+|
T Consensus 77 l~~~pn~lPfqk~-----~~t~kAAylvRqyvkh-nLyDRl----------STRPFL~~iEKkWiaFQLL~al~qcH--- 137 (1431)
T KOG1240|consen 77 LMKAPNCLPFQKV-----LVTDKAAYLVRQYVKH-NLYDRL----------STRPFLVLIEKKWIAFQLLKALSQCH--- 137 (1431)
T ss_pred hhcCCcccchHHH-----HHhhHHHHHHHHHHhh-hhhhhh----------ccchHHHHHHHHHHHHHHHHHHHHHH---
Confidence 5689999998877 4557778899999855 999988 45566788889999999999999999
Q ss_pred CCCceeeccCCCCeeeCCCCCeEEeecccceecCCCCCccccc-----CccCccceeCCCCcCC----------Cc-cCc
Q 041757 152 QPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSI-----DVKGSIGYIAPEYGVG----------NE-VST 215 (381)
Q Consensus 152 ~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~-----~~~gt~~y~aPE~l~~----------~~-~~~ 215 (381)
..||+|+|||.+||||+.-..+.|+||...+..--+....... ....-..|.|||.+.. .. .++
T Consensus 138 ~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~p 217 (1431)
T KOG1240|consen 138 KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTP 217 (1431)
T ss_pred HcCccccccccceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccCh
Confidence 7799999999999999998899999998776543222221111 0112346999997543 12 567
Q ss_pred ccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHH
Q 041757 216 IGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVI 294 (381)
Q Consensus 216 ~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (381)
+-||||+||++.|+++ |++||. +.++....... .+.....++.. ...
T Consensus 218 aMDIFS~GCViaELf~Eg~PlF~--------LSQL~aYr~~~--~~~~e~~Le~I----------------------ed~ 265 (1431)
T KOG1240|consen 218 AMDIFSAGCVIAELFLEGRPLFT--------LSQLLAYRSGN--ADDPEQLLEKI----------------------EDV 265 (1431)
T ss_pred hhhhhhhhHHHHHHHhcCCCccc--------HHHHHhHhccC--ccCHHHHHHhC----------------------cCc
Confidence 8899999999999987 688875 11111111110 11111111111 112
Q ss_pred HHHHHHHhccCCCCCCCCCHHHHHHH
Q 041757 295 SMVRIGVACSMESPQDRMKMTNVVHE 320 (381)
Q Consensus 295 ~l~~l~~~cl~~dP~~RPs~~~vl~~ 320 (381)
.+..++..|++.||++|.++++.++.
T Consensus 266 ~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 266 SLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred cHHHHHHHHHccCchhccCHHHHHHh
Confidence 67788889999999999999999986
No 419
>PRK10345 hypothetical protein; Provisional
Probab=99.79 E-value=6.7e-19 Score=152.66 Aligned_cols=125 Identities=16% Similarity=0.147 Sum_probs=94.4
Q ss_pred cccceecCCCceEEEecc--------------cccHHHHHHHHHHHHcc-----CCCcccceeeeeccccccCCce-EEE
Q 041757 39 LEENLISAGTFGFSHLRR--------------QGAFKSFIAECKALRNI-----RHRNLIKVLTACLGVDYQGNDF-KAL 98 (381)
Q Consensus 39 ~~~~~lG~G~fg~V~~~~--------------~~~~~~~~~E~~~l~~l-----~h~nIv~~~~~~~~~~~~~~~~-~~l 98 (381)
...++||+|+||.||... ....+.+.+|+++++.+ .||||+++++++.+ ...... ..+
T Consensus 5 ~~~~~LG~G~~~~Vy~hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et--~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYAHPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVET--DCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEECCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEe--CCCCeEEEEE
Confidence 456789999999997632 11456789999999999 57999999999643 111134 337
Q ss_pred EEEc--ccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHH-HHhhcCCCCCceeeccCCCCeeeCC----CC
Q 041757 99 VYEF--MHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASAL-NYLHHDCQPVTAHCVLKPSNVLLDD----DM 171 (381)
Q Consensus 99 v~e~--~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l-~~LH~~~~~~ivHrDlkp~Nill~~----~~ 171 (381)
|||| +.+|+|.+++. . ..+++. ..++.+++.++ +||| +.+|+||||||+|||++. ++
T Consensus 83 I~e~~G~~~~tL~~~l~----------~-~~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~ 146 (210)
T PRK10345 83 IADFDGKPSITLTEFAE----------Q-CRYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEV 146 (210)
T ss_pred EecCCCCcchhHHHHHH----------c-ccccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCC
Confidence 8999 66899999994 2 234444 35678888888 9999 669999999999999974 34
Q ss_pred CeEEeecccc
Q 041757 172 TARVGDFGLA 181 (381)
Q Consensus 172 ~~kl~Dfg~~ 181 (381)
.++|+||+.+
T Consensus 147 ~~~LiDg~G~ 156 (210)
T PRK10345 147 IPVVCDNIGE 156 (210)
T ss_pred cEEEEECCCC
Confidence 8999995433
No 420
>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c
Probab=99.79 E-value=3.2e-19 Score=153.15 Aligned_cols=99 Identities=15% Similarity=0.108 Sum_probs=78.5
Q ss_pred HHHHHHHccCCCcccceeeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHH
Q 041757 65 AECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASAL 144 (381)
Q Consensus 65 ~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l 144 (381)
+|++++.++.++++.....+. . . ..+|||||++++++..... ....++...+..++.|++.+|
T Consensus 68 ~E~~~l~~l~~~~v~~p~~~~-----~-~-~~~iVmE~i~g~~l~~~~~----------~~~~~~~~~~~~i~~qi~~~L 130 (190)
T cd05147 68 KEMRNLKRLVTAGIPCPEPIL-----L-K-SHVLVMEFIGDDGWAAPRL----------KDAPLSESKARELYLQVIQIM 130 (190)
T ss_pred HHHHHHHHHHHCCCCCCcEEE-----e-c-CCEEEEEEeCCCCCcchhh----------hcCCCCHHHHHHHHHHHHHHH
Confidence 499999999888774433321 1 1 2389999999887765531 234688899999999999999
Q ss_pred HHh-hcCCCCCceeeccCCCCeeeCCCCCeEEeecccceec
Q 041757 145 NYL-HHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFL 184 (381)
Q Consensus 145 ~~L-H~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~ 184 (381)
.++ | ..+|+||||||+||+++ ++.++|+|||+|...
T Consensus 131 ~~l~H---~~giiHrDlkP~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 131 RILYQ---DCRLVHADLSEYNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred HHHHH---hCCcccCCCCHHHEEEE-CCcEEEEEccccccC
Confidence 999 6 55999999999999998 478999999998754
No 421
>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro
Probab=99.77 E-value=2.2e-18 Score=148.29 Aligned_cols=102 Identities=19% Similarity=0.099 Sum_probs=80.6
Q ss_pred HHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHH
Q 041757 64 IAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASA 143 (381)
Q Consensus 64 ~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~ 143 (381)
.+|.+.+.++.|++|.....+.. . ..++||||++++++..... ....++......++.|++.+
T Consensus 67 ~~E~~~l~~l~~~~i~~p~~~~~------~-~~~lVmE~~~g~~~~~~~l----------~~~~~~~~~~~~i~~~l~~~ 129 (190)
T cd05145 67 EKEFRNLKRLYEAGVPVPEPILL------K-KNVLVMEFIGDDGSPAPRL----------KDVPLEEEEAEELYEQVVEQ 129 (190)
T ss_pred HHHHHHHHHHHhCCCCCceEEEe------c-CCEEEEEEecCCCchhhhh----------hhccCCHHHHHHHHHHHHHH
Confidence 57899999999998754444321 1 2489999999886544321 23456788899999999999
Q ss_pred HHHhhcCCC-CCceeeccCCCCeeeCCCCCeEEeecccceecCC
Q 041757 144 LNYLHHDCQ-PVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPP 186 (381)
Q Consensus 144 l~~LH~~~~-~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~ 186 (381)
+.++| . .||+||||||+||+++ ++.++|+|||++.....
T Consensus 130 l~~lH---~~~givHrDlkP~NIll~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 130 MRRLY---QEAGLVHGDLSEYNILYH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred HHHHH---HhCCEecCCCChhhEEEE-CCCEEEEEcccceecCC
Confidence 99999 5 6999999999999998 78999999999976543
No 422
>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]
Probab=99.76 E-value=1.1e-19 Score=170.10 Aligned_cols=126 Identities=29% Similarity=0.477 Sum_probs=106.6
Q ss_pred CceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCC
Q 041757 93 NDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT 172 (381)
Q Consensus 93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~ 172 (381)
..+.||.|++|...+|.+||... ......++...+.++.|++.|+.| ++.+|||+||.||+...+..
T Consensus 328 ~~~lyI~Mn~c~~~tledWl~rr-------~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q 394 (516)
T KOG1033|consen 328 KVYLYIQMNLCEKETLEDWLRRR-------RTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQ 394 (516)
T ss_pred ccchhhhhhhhhhhhHHHHhhCC-------CcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchh
Confidence 34678999999999999999532 233456677889999999999999 38999999999999999999
Q ss_pred eEEeecccceecCCCC----CcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh
Q 041757 173 ARVGDFGLARFLPPTR----TQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI 231 (381)
Q Consensus 173 ~kl~Dfg~~~~~~~~~----~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t 231 (381)
+||.|||+........ .....+..+||..||+||.+.+..|+.++||||||++++|+++
T Consensus 395 ~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 395 LKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred hhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 9999999987766554 1223334679999999999999999999999999999999986
No 423
>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=99.75 E-value=2.4e-18 Score=174.71 Aligned_cols=183 Identities=14% Similarity=0.127 Sum_probs=141.8
Q ss_pred cccccccceecCCCceEEEecccccHHH-------------HHHHHHHHHccC---CCcccceeeeeccccccCCceEEE
Q 041757 35 SRNMLEENLISAGTFGFSHLRRQGAFKS-------------FIAECKALRNIR---HRNLIKVLTACLGVDYQGNDFKAL 98 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~-------------~~~E~~~l~~l~---h~nIv~~~~~~~~~~~~~~~~~~l 98 (381)
...|.+.+.||+|+||+||.+....-+. |.-=.+++.+|+ -+-|..+....+ ..+-.+|
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~-----~~~~S~l 771 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHV-----FQNASVL 771 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHc-----cCCccee
Confidence 4568899999999999999987544111 111224455554 233444444422 2455689
Q ss_pred EEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCC-------CC
Q 041757 99 VYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD-------DM 171 (381)
Q Consensus 99 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~-------~~ 171 (381)
|+||.+.|+|.+++ +....+++..++.+..|++.-++.|| ..+|||+||||+|+||.. ..
T Consensus 772 v~ey~~~Gtlld~~----------N~~~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~ 838 (974)
T KOG1166|consen 772 VSEYSPYGTLLDLI----------NTNKVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSK 838 (974)
T ss_pred eeeccccccHHHhh----------ccCCCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCccc
Confidence 99999999999999 56778999999999999999999999 779999999999999943 33
Q ss_pred CeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCC
Q 041757 172 TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235 (381)
Q Consensus 172 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~P 235 (381)
-++|+|||.+-.+.--.....-...++|-.+-++|+..+..++...|-|.|+.+++.|+.|+..
T Consensus 839 ~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 839 GLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred ceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 6899999998765543333333346688899999999999999999999999999999998764
No 424
>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A.
Probab=99.74 E-value=8.2e-19 Score=157.23 Aligned_cols=227 Identities=17% Similarity=0.190 Sum_probs=136.6
Q ss_pred ccccccceecCCCceEEEecc--------------------cccHHHHHHHHHHHHccCC---C-------cccceeeee
Q 041757 36 RNMLEENLISAGTFGFSHLRR--------------------QGAFKSFIAECKALRNIRH---R-------NLIKVLTAC 85 (381)
Q Consensus 36 ~~~~~~~~lG~G~fg~V~~~~--------------------~~~~~~~~~E~~~l~~l~h---~-------nIv~~~~~~ 85 (381)
.....++.||.|+|+.|+.+. ...++.+.+|.-....+.+ | .++--++..
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 455677899999999997754 2356777777755555433 1 111111111
Q ss_pred cc---cc-c---cCCc-----eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCC
Q 041757 86 LG---VD-Y---QGND-----FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQP 153 (381)
Q Consensus 86 ~~---~~-~---~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ 153 (381)
.- .. . .... ..+++|+-+ .+||.+++....... .....+.....+.+..|+++.+++|| ..
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~---~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~ 164 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRA---QTHSPLAFAARLSLTVQMIRLVANLH---SY 164 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHT---TTSHHHHHHHHHHHHHHHHHHHHHHH---HT
T ss_pred EEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcc---cccchhHHHHHHHHHHHHHHHHHHHh---hc
Confidence 10 00 0 1111 236788877 458988864221110 11233555566777899999999999 66
Q ss_pred CceeeccCCCCeeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCC--------CccCcccchhhhhHH
Q 041757 154 VTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG--------NEVSTIGDVYSYGIL 225 (381)
Q Consensus 154 ~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~~~~sDiwSlG~i 225 (381)
|+||+||+|+|++++.+|.+.|+||+.....+..... ...+..|.+||.... ..++.+.|.|++|++
T Consensus 165 GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ 239 (288)
T PF14531_consen 165 GLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGIT 239 (288)
T ss_dssp TEEEST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHH
T ss_pred ceEecccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHH
Confidence 9999999999999999999999999987765443221 124577899996533 247888999999999
Q ss_pred HHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccC
Q 041757 226 LLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSM 305 (381)
Q Consensus 226 l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~ 305 (381)
+|.|.++..||+.......... .+.. ..+.+..+..|+..+|+
T Consensus 240 ly~lWC~~lPf~~~~~~~~~~~-------------~f~~------------------------C~~~Pe~v~~LI~~lL~ 282 (288)
T PF14531_consen 240 LYSLWCGRLPFGLSSPEADPEW-------------DFSR------------------------CRDMPEPVQFLIRGLLQ 282 (288)
T ss_dssp HHHHHHSS-STCCCGGGSTSGG-------------GGTT------------------------SS---HHHHHHHHHHT-
T ss_pred HHHHHHccCCCCCCCccccccc-------------cchh------------------------cCCcCHHHHHHHHHHcc
Confidence 9999999999875433221110 0000 12566778888889999
Q ss_pred CCCCCC
Q 041757 306 ESPQDR 311 (381)
Q Consensus 306 ~dP~~R 311 (381)
.||.+|
T Consensus 283 ~~~~~R 288 (288)
T PF14531_consen 283 RNPEDR 288 (288)
T ss_dssp SSGGGS
T ss_pred CCcccC
Confidence 999987
No 425
>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]
Probab=99.73 E-value=2e-18 Score=172.45 Aligned_cols=164 Identities=26% Similarity=0.319 Sum_probs=118.4
Q ss_pred ccccccccceecCCCceEEEeccccc-HHHHHHHHHHHHccCCCcccce-eeeeccccccCCceEEEEEEcccCCCHHHh
Q 041757 34 VSRNMLEENLISAGTFGFSHLRRQGA-FKSFIAECKALRNIRHRNLIKV-LTACLGVDYQGNDFKALVYEFMHNRSLKEW 111 (381)
Q Consensus 34 ~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~~~~E~~~l~~l~h~nIv~~-~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~ 111 (381)
...+|..++.|..|+||.||++++.. .++|.. +++-.|+|-= +.. + .+..+.| ||-...
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~------kiNkq~lilRnilt-----~--a~npfvv------gDc~tl 141 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAM------KINKQNLILRNILT-----F--AGNPFVV------GDCATL 141 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhh------cccccchhhhcccc-----c--cCCccee------chhhhh
Confidence 35789999999999999999997653 344432 3333333211 111 1 1122333 566666
Q ss_pred hccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccceecCCCCC--
Q 041757 112 LYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRT-- 189 (381)
Q Consensus 112 l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 189 (381)
+ +..+.++.. .+.+++||| ..+|+|||+||+|.+|..-|++|+.|||+++.......
T Consensus 142 l----------k~~g~lPvd--------mvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 142 L----------KNIGPLPVD--------MVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred c----------ccCCCCcch--------hhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 6 233333322 278999999 66999999999999999999999999999875432111
Q ss_pred -----------cccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCC
Q 041757 190 -----------QTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSD 237 (381)
Q Consensus 190 -----------~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~ 237 (381)
......++||+.|.|||++....|+..+|+|++|+++||.+.|..||.
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpff 259 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFF 259 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeecc
Confidence 112234689999999999999999999999999999999999999974
No 426
>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated
Probab=99.70 E-value=7.7e-17 Score=160.33 Aligned_cols=122 Identities=21% Similarity=0.260 Sum_probs=100.0
Q ss_pred cccccccceecCCCceEEEeccc-----------------------ccHHHHHHHHHHHHccCCCcccceeeeecccccc
Q 041757 35 SRNMLEENLISAGTFGFSHLRRQ-----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQ 91 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~~-----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 91 (381)
...|...++||+|+||+||++.. ...+++.+|++++..++|++++....++.
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~----- 406 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDV----- 406 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEE-----
Confidence 44556789999999999987220 01246788999999999999988766643
Q ss_pred CCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC
Q 041757 92 GNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM 171 (381)
Q Consensus 92 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~ 171 (381)
.....++||||+++++|.+++. ....++.+++.+|.+|| +.+++||||||+||++ .++
T Consensus 407 ~~~~~~lv~E~~~g~~L~~~l~------------------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~ 464 (535)
T PRK09605 407 DPEEKTIVMEYIGGKDLKDVLE------------------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDD 464 (535)
T ss_pred eCCCCEEEEEecCCCcHHHHHH------------------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECC
Confidence 2445689999999999999882 34678999999999999 6799999999999999 577
Q ss_pred CeEEeeccccee
Q 041757 172 TARVGDFGLARF 183 (381)
Q Consensus 172 ~~kl~Dfg~~~~ 183 (381)
.++|+|||+++.
T Consensus 465 ~~~liDFGla~~ 476 (535)
T PRK09605 465 RLYLIDFGLGKY 476 (535)
T ss_pred cEEEEeCccccc
Confidence 899999999864
No 427
>PRK14879 serine/threonine protein kinase; Provisional
Probab=99.67 E-value=2.7e-16 Score=137.69 Aligned_cols=119 Identities=20% Similarity=0.241 Sum_probs=96.8
Q ss_pred ceecCCCceEEEecccc-----------------------cHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEE
Q 041757 42 NLISAGTFGFSHLRRQG-----------------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKAL 98 (381)
Q Consensus 42 ~~lG~G~fg~V~~~~~~-----------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~l 98 (381)
+.||+|++|.||++... ....+.+|++++..+.|+||.....++. .....++
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~-----~~~~~~l 76 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFV-----DPENFII 76 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEE-----eCCCCEE
Confidence 57999999999876310 1235778999999999999877666643 2456789
Q ss_pred EEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeec
Q 041757 99 VYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDF 178 (381)
Q Consensus 99 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df 178 (381)
||||++|++|.+++.. .. . ....++.+++.+|.++| ..+++|+|++|.||+++ ++.++|+||
T Consensus 77 v~e~~~G~~L~~~~~~----------~~---~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf 138 (211)
T PRK14879 77 VMEYIEGEPLKDLINS----------NG---M-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDF 138 (211)
T ss_pred EEEEeCCcCHHHHHHh----------cc---H-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEEC
Confidence 9999999999999842 11 1 77889999999999999 77999999999999999 788999999
Q ss_pred cccee
Q 041757 179 GLARF 183 (381)
Q Consensus 179 g~~~~ 183 (381)
|.+..
T Consensus 139 ~~a~~ 143 (211)
T PRK14879 139 GLAEF 143 (211)
T ss_pred CcccC
Confidence 98753
No 428
>smart00090 RIO RIO-like kinase.
Probab=99.67 E-value=2.9e-16 Score=139.44 Aligned_cols=125 Identities=16% Similarity=0.046 Sum_probs=96.1
Q ss_pred cccccceecCCCceEEEecc-cc-------------c----------------------------HHHHHHHHHHHHccC
Q 041757 37 NMLEENLISAGTFGFSHLRR-QG-------------A----------------------------FKSFIAECKALRNIR 74 (381)
Q Consensus 37 ~~~~~~~lG~G~fg~V~~~~-~~-------------~----------------------------~~~~~~E~~~l~~l~ 74 (381)
.|.+.+.||+|+||.||.+. .. . ...+.+|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48889999999999998875 10 0 012467999999997
Q ss_pred CCc--ccceeeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCC
Q 041757 75 HRN--LIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQ 152 (381)
Q Consensus 75 h~n--Iv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ 152 (381)
+.+ +.++++. . ..++||||+++++|..... ....+....+..++.|++.++.+|| .
T Consensus 109 ~~~i~~p~~~~~--------~-~~~lV~E~~~g~~L~~~~~----------~~~~~~~~~~~~i~~qi~~~l~~LH---~ 166 (237)
T smart00090 109 EAGVPVPKPIAW--------R-RNVLVMEFIGGDGLPAPRL----------KDVEPEEEEEFELYDDILEEMRKLY---K 166 (237)
T ss_pred hcCCCCCeeeEe--------c-CceEEEEEecCCccccccc----------ccCCcchHHHHHHHHHHHHHHHHHH---h
Confidence 533 3344433 1 2489999999988876542 2234556667899999999999999 6
Q ss_pred CC-ceeeccCCCCeeeCCCCCeEEeecccceec
Q 041757 153 PV-TAHCVLKPSNVLLDDDMTARVGDFGLARFL 184 (381)
Q Consensus 153 ~~-ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~ 184 (381)
.+ ++||||||+||+++ ++.++|+|||.+...
T Consensus 167 ~g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 167 EGELVHGDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred cCCEEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 68 99999999999999 789999999998643
No 429
>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]
Probab=99.64 E-value=1.7e-17 Score=164.92 Aligned_cols=242 Identities=21% Similarity=0.213 Sum_probs=177.4
Q ss_pred cccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccC-CCcccceeeeeccccccCC
Q 041757 35 SRNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIR-HRNLIKVLTACLGVDYQGN 93 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~~ 93 (381)
...|...+-||+|+|+.|..... ........|..+-..+. |+|++++++. ....
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~-----~~~~ 93 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEP-----SSSP 93 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCc-----cCCC
Confidence 45677777899999999944321 12233344788888887 9999999999 5668
Q ss_pred ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC-C
Q 041757 94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM-T 172 (381)
Q Consensus 94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~-~ 172 (381)
...+++++|..++++.+.+.. ......+...+-.++.|+..++.|+|. ..++.|||+||+|.+++..+ .
T Consensus 94 ~~~~~~~~~s~g~~~f~~i~~--------~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~ 163 (601)
T KOG0590|consen 94 RSYLLSLSYSDGGSLFSKISH--------PDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSA 163 (601)
T ss_pred cccccccCccccccccccccc--------CCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCc
Confidence 889999999999999888720 222256667788899999999999993 23899999999999999999 9
Q ss_pred eEEeecccceecCC-CCCcccccCccC-ccceeCCCCcCCC-ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHH
Q 041757 173 ARVGDFGLARFLPP-TRTQTSSIDVKG-SIGYIAPEYGVGN-EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKF 249 (381)
Q Consensus 173 ~kl~Dfg~~~~~~~-~~~~~~~~~~~g-t~~y~aPE~l~~~-~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~ 249 (381)
.+++|||+|..+.. ..........+| ++.|+|||...+. ......|+||.|+++.-+++|..||......+..+..+
T Consensus 164 l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~ 243 (601)
T KOG0590|consen 164 LKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSW 243 (601)
T ss_pred ccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceee
Confidence 99999999987766 444434444668 9999999998884 45677899999999999999999987554444322222
Q ss_pred HHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757 250 AKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319 (381)
Q Consensus 250 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~ 319 (381)
...... .... ..........+++.+++..+|..|.+.+++..
T Consensus 244 ~~~~~~----------~~~~------------------~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 244 KSNKGR----------FTQL------------------PWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred cccccc----------cccC------------------ccccCChhhhhcccccccCCchhccccccccc
Confidence 211100 0000 01133345667777888899999999887754
No 430
>TIGR03724 arch_bud32 Kae1-associated kinase Bud32. Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.
Probab=99.64 E-value=5.1e-16 Score=134.64 Aligned_cols=115 Identities=21% Similarity=0.288 Sum_probs=90.6
Q ss_pred eecCCCceEEEecccc-----------------------cHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEE
Q 041757 43 LISAGTFGFSHLRRQG-----------------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALV 99 (381)
Q Consensus 43 ~lG~G~fg~V~~~~~~-----------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv 99 (381)
.||+|+||.||++... ...++.+|++++..+.|+++.....++. .....++|
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~-----~~~~~~lv 75 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDV-----DPDNKTIV 75 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEE-----ECCCCEEE
Confidence 4899999999876510 1255678999999999887554444422 24456899
Q ss_pred EEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecc
Q 041757 100 YEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179 (381)
Q Consensus 100 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg 179 (381)
|||++|++|.+++.. ... .++.+++.+|.+|| ..+++|+|++|.||+++ ++.++++|||
T Consensus 76 ~e~~~g~~l~~~~~~----------~~~-------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg 134 (199)
T TIGR03724 76 MEYIEGKPLKDVIEE----------GND-------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFG 134 (199)
T ss_pred EEEECCccHHHHHhh----------cHH-------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECC
Confidence 999999999998731 111 78899999999999 67999999999999999 7899999999
Q ss_pred ccee
Q 041757 180 LARF 183 (381)
Q Consensus 180 ~~~~ 183 (381)
+++.
T Consensus 135 ~a~~ 138 (199)
T TIGR03724 135 LGKY 138 (199)
T ss_pred CCcC
Confidence 8754
No 431
>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom
Probab=99.62 E-value=2e-15 Score=130.81 Aligned_cols=121 Identities=17% Similarity=0.052 Sum_probs=94.2
Q ss_pred cccccceecCCCceEEEecccc--------------------------------------cHHHHHHHHHHHHccCCCc-
Q 041757 37 NMLEENLISAGTFGFSHLRRQG--------------------------------------AFKSFIAECKALRNIRHRN- 77 (381)
Q Consensus 37 ~~~~~~~lG~G~fg~V~~~~~~--------------------------------------~~~~~~~E~~~l~~l~h~n- 77 (381)
.|...+.||.|+||.||.+... ....+.+|+.++..+.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 4788899999999999876431 0113567899999998774
Q ss_pred -ccceeeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCce
Q 041757 78 -LIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTA 156 (381)
Q Consensus 78 -Iv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iv 156 (381)
+...++. ...++||||+++++|..... . .....++.+++.++.++| ..+++
T Consensus 96 ~v~~~~~~---------~~~~lv~e~~~g~~L~~~~~----------~------~~~~~~~~~i~~~l~~lh---~~gi~ 147 (198)
T cd05144 96 PVPKPIDW---------NRHAVVMEYIDGVELYRVRV----------L------EDPEEVLDEILEEIVKAY---KHGII 147 (198)
T ss_pred CCCceeec---------CCceEEEEEeCCcchhhccc----------c------ccHHHHHHHHHHHHHHHH---HCCCC
Confidence 4444332 23489999999999976541 0 234678899999999999 67999
Q ss_pred eeccCCCCeeeCCCCCeEEeecccceecC
Q 041757 157 HCVLKPSNVLLDDDMTARVGDFGLARFLP 185 (381)
Q Consensus 157 HrDlkp~Nill~~~~~~kl~Dfg~~~~~~ 185 (381)
||||||+||+++.++.++|+|||.+....
T Consensus 148 H~Dl~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 148 HGDLSEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred cCCCCcccEEEcCCCcEEEEECCccccCC
Confidence 99999999999999999999999986443
No 432
>KOG1266 consensus Protein kinase [Signal transduction mechanisms]
Probab=99.55 E-value=5.5e-15 Score=130.90 Aligned_cols=160 Identities=23% Similarity=0.346 Sum_probs=122.4
Q ss_pred HHHHccCCCcccceeeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHh
Q 041757 68 KALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYL 147 (381)
Q Consensus 68 ~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~L 147 (381)
..|-++-|.|||+++.++.+..+++.....++.||+..|+|..+|++.. +....+......+|+.||+.||.||
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~------~~~~a~~~~~wkkw~tqIlsal~yL 192 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTK------KNQKALFQKAWKKWCTQILSALSYL 192 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHH------HhhhhhhHHHHHHHHHHHHhhhhhh
Confidence 3455667999999999987766667778899999999999999996543 4556788888899999999999999
Q ss_pred hcCCCCCceeeccCCCCeeeCCCCCeEEeecccceecCC--CCCcccccCccCccceeCCCCcCCCccCcccchhhhhHH
Q 041757 148 HHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPP--TRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGIL 225 (381)
Q Consensus 148 H~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~i 225 (381)
|+- ...|+|+++.-+.|++..++.+|+.--........ ...........+-++|.|||+-.....+.++|||+||..
T Consensus 193 hs~-~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmc 271 (458)
T KOG1266|consen 193 HSC-DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMC 271 (458)
T ss_pred hcc-CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHH
Confidence 987 88999999999999999998888753211110000 000000111236788999998777778889999999999
Q ss_pred HHHHHhCCC
Q 041757 226 LLELMIREK 234 (381)
Q Consensus 226 l~el~tg~~ 234 (381)
..||..+..
T Consensus 272 AlemailEi 280 (458)
T KOG1266|consen 272 ALEMAILEI 280 (458)
T ss_pred HHHHHHhee
Confidence 999987754
No 433
>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed
Probab=99.51 E-value=8.9e-14 Score=123.72 Aligned_cols=104 Identities=19% Similarity=0.141 Sum_probs=79.0
Q ss_pred HHHHHHHHHHHccCCCcc--cceeeeeccccccCCceEEEEEEcccC-CCHHHhhccccCCcccccCCCcccHHHHHHHH
Q 041757 61 KSFIAECKALRNIRHRNL--IKVLTACLGVDYQGNDFKALVYEFMHN-RSLKEWLYPISKEDETYKRPRNLNLLRRLNIA 137 (381)
Q Consensus 61 ~~~~~E~~~l~~l~h~nI--v~~~~~~~~~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~ 137 (381)
..+.+|++++.+|.|++| +..+++.... .......++||||+++ .+|.+++.. ..++.. .+
T Consensus 85 ~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~-~~~~~~~~lV~e~l~G~~~L~~~l~~-----------~~l~~~----~~ 148 (239)
T PRK01723 85 TRAFAEFRLLAQLYEAGLPVPRPIAARVVR-HGLFYRADILIERIEGARDLVALLQE-----------APLSEE----QW 148 (239)
T ss_pred hHHHHHHHHHHHHHhCCCCCceeEeeeeee-cCcceeeeEEEEecCCCCCHHHHHhc-----------CCCCHH----HH
Confidence 457789999999998875 6666663321 0111123599999997 699988831 234433 35
Q ss_pred HHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccccee
Q 041757 138 IDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARF 183 (381)
Q Consensus 138 ~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~ 183 (381)
.+++.+|.+|| ..||+||||||.|||++.++.++|+|||.+..
T Consensus 149 ~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 149 QAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred HHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 78999999999 67999999999999999888999999998864
No 434
>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family. The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves
Probab=99.47 E-value=3.1e-13 Score=111.10 Aligned_cols=122 Identities=23% Similarity=0.247 Sum_probs=96.6
Q ss_pred ccceecCCCceEEEeccc-----------cc--HHHHHHHHHHHHccCC--CcccceeeeeccccccCCceEEEEEEccc
Q 041757 40 EENLISAGTFGFSHLRRQ-----------GA--FKSFIAECKALRNIRH--RNLIKVLTACLGVDYQGNDFKALVYEFMH 104 (381)
Q Consensus 40 ~~~~lG~G~fg~V~~~~~-----------~~--~~~~~~E~~~l~~l~h--~nIv~~~~~~~~~~~~~~~~~~lv~e~~~ 104 (381)
+.+.||.|.++.||.... .. ...+.+|+.++..++| .++.+++++. ...+..+++|||++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~-----~~~~~~~~v~e~~~ 76 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASG-----ESDGWSYLLMEWIE 76 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEc-----CCCCccEEEEEecC
Confidence 346799999999976542 11 2478999999999976 5888888873 33567899999998
Q ss_pred CCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccccee
Q 041757 105 NRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARF 183 (381)
Q Consensus 105 ~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~ 183 (381)
++++..+ +......++.+++.++.++|.....+++|+|++|+||+++..+.++++|||.+..
T Consensus 77 g~~~~~~-----------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 77 GETLDEV-----------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred CeecccC-----------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 8766532 3455677889999999999954235799999999999999988999999998853
No 435
>cd05119 RIO RIO kinase family, catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct
Probab=99.46 E-value=2.3e-13 Score=116.72 Aligned_cols=75 Identities=20% Similarity=0.130 Sum_probs=58.0
Q ss_pred EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCC-CCceeeccCCCCeeeCCCCCeE
Q 041757 96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQ-PVTAHCVLKPSNVLLDDDMTAR 174 (381)
Q Consensus 96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~-~~ivHrDlkp~Nill~~~~~~k 174 (381)
.++||||++++++..... .. .... ..+..++.+++.++.++| . .+|+||||||+||+++ ++.++
T Consensus 90 ~~lv~e~~~g~~~~~~~l---------~~-~~~~-~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili~-~~~~~ 154 (187)
T cd05119 90 HVLVMEFIGGDGIPAPRL---------KD-VRLL-EDPEELYDQILELMRKLY---REAGLVHGDLSEYNILVD-DGKVY 154 (187)
T ss_pred CEEEEEEeCCCCccChhh---------hh-hhhc-ccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEEE-CCcEE
Confidence 589999999965432110 00 0011 567889999999999999 5 6999999999999999 88999
Q ss_pred EeecccceecC
Q 041757 175 VGDFGLARFLP 185 (381)
Q Consensus 175 l~Dfg~~~~~~ 185 (381)
|+|||.+....
T Consensus 155 liDfg~a~~~~ 165 (187)
T cd05119 155 IIDVPQAVEID 165 (187)
T ss_pred EEECccccccc
Confidence 99999986543
No 436
>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]
Probab=99.35 E-value=1.7e-12 Score=124.19 Aligned_cols=180 Identities=23% Similarity=0.236 Sum_probs=141.6
Q ss_pred ccccceecC--CCceEEEecccc---------------------cHHHHHHHHHHHHccC-CCcccceeeeeccccccCC
Q 041757 38 MLEENLISA--GTFGFSHLRRQG---------------------AFKSFIAECKALRNIR-HRNLIKVLTACLGVDYQGN 93 (381)
Q Consensus 38 ~~~~~~lG~--G~fg~V~~~~~~---------------------~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~~ 93 (381)
|-..+-+|. |.+|.||..+.. ...+=.+|+...+.++ |+|.++.+.. +++.
T Consensus 116 ~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~-----~e~~ 190 (524)
T KOG0601|consen 116 FPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPA-----WEGS 190 (524)
T ss_pred cccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcc-----cccC
Confidence 445678999 999999776531 1122345777777775 9999997777 6778
Q ss_pred ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHH----HHHHhhcCCCCCceeeccCCCCeeeCC
Q 041757 94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVAS----ALNYLHHDCQPVTAHCVLKPSNVLLDD 169 (381)
Q Consensus 94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~----~l~~LH~~~~~~ivHrDlkp~Nill~~ 169 (381)
+..++-+|+|. .+|.++.+ .....++...++..+.+... ||.++| ..+++|-|+||+||++..
T Consensus 191 ~~lfiqtE~~~-~sl~~~~~---------~~~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~ 257 (524)
T KOG0601|consen 191 GILFIQTELCG-ESLQSYCH---------TPCNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTS 257 (524)
T ss_pred Ccceeeecccc-chhHHhhh---------cccccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheeccc
Confidence 89999999995 68888875 33445788888899999999 999999 669999999999999999
Q ss_pred C-CCeEEeecccceecCCCCCcccc---cCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCC
Q 041757 170 D-MTARVGDFGLARFLPPTRTQTSS---IDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPS 236 (381)
Q Consensus 170 ~-~~~kl~Dfg~~~~~~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf 236 (381)
+ ..++++|||+...+......... ....|...|++||.+.+ -++..+||||+|.++.+..++..++
T Consensus 258 ~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~ 327 (524)
T KOG0601|consen 258 DWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLP 327 (524)
T ss_pred ccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccc
Confidence 8 78999999999887765422211 11247788999998765 6788999999999999999887764
No 437
>KOG1243 consensus Protein kinase [General function prediction only]
Probab=99.29 E-value=3.2e-11 Score=116.81 Aligned_cols=167 Identities=18% Similarity=0.157 Sum_probs=122.8
Q ss_pred ceecCCCceEEEecccc---cHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEcccCCCHHHhhccccCC
Q 041757 42 NLISAGTFGFSHLRRQG---AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKE 118 (381)
Q Consensus 42 ~~lG~G~fg~V~~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~ 118 (381)
..-..|++-.|+..+.. ......+-++.|+.++||||++++.. ++..+..|||+|-+. .|..++..
T Consensus 32 t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t-----~e~~~~~ylvTErV~--Pl~~~lk~---- 100 (690)
T KOG1243|consen 32 TRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDT-----TEEEGTLYLVTERVR--PLETVLKE---- 100 (690)
T ss_pred ceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhh-----hcccCceEEEeeccc--cHHHHHHH----
Confidence 45666777777554432 24567788999999999999999998 566789999999873 67777742
Q ss_pred cccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccceecCCCCCcccccCccC
Q 041757 119 DETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKG 198 (381)
Q Consensus 119 ~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g 198 (381)
+....+...+.||+.||.|||+++ +++|++|..+.|+++..|..||++|.++........... ...-
T Consensus 101 ---------l~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~--~~~~ 167 (690)
T KOG1243|consen 101 ---------LGKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAK--SLYL 167 (690)
T ss_pred ---------hHHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccc--cchh
Confidence 335666777889999999999755 999999999999999999999999998765433221000 0111
Q ss_pred ccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCC
Q 041757 199 SIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREK 234 (381)
Q Consensus 199 t~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~ 234 (381)
-..|..|+.+.... -..|.|-||++++|++.|..
T Consensus 168 ~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng~~ 201 (690)
T KOG1243|consen 168 IESFDDPEEIDPSE--WSIDSWGLGCLIEELFNGSL 201 (690)
T ss_pred hhcccChhhcCccc--cchhhhhHHHHHHHHhCccc
Confidence 22355666443322 34599999999999999933
No 438
>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]
Probab=99.16 E-value=2.1e-11 Score=116.80 Aligned_cols=179 Identities=20% Similarity=0.158 Sum_probs=132.4
Q ss_pred cccccccceecCCCceEEEecccc--------------------cHHHHHHHHHHHHccC-CCcccceeeeeccccccCC
Q 041757 35 SRNMLEENLISAGTFGFSHLRRQG--------------------AFKSFIAECKALRNIR-HRNLIKVLTACLGVDYQGN 93 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~~~--------------------~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~~ 93 (381)
..+|.....||.|.|+.|+.+... ....-..|+-+...+. |.++++++.. +...
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~-----W~~~ 338 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSS-----WSQL 338 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCC-----cccc
Confidence 456888899999999988553211 1111234666666664 8899988777 3445
Q ss_pred ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCC-CC
Q 041757 94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDD-MT 172 (381)
Q Consensus 94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~-~~ 172 (381)
...++-.|||.++++.... .....+.+...+++..|++.++.++| ++.++|+|+||+||++..+ +.
T Consensus 339 r~~~ip~e~~~~~s~~l~~----------~~~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~ 405 (524)
T KOG0601|consen 339 RQGYIPLEFCEGGSSSLRS----------VTSQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFF 405 (524)
T ss_pred ccccCchhhhcCcchhhhh----------HHHHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhh
Confidence 6677999999999987766 23456778888999999999999999 8899999999999999886 78
Q ss_pred eEEeecccceecCCCCCcccccCccCccce-eCCCCcCCCccCcccchhhhhHHHHHHHhCCCC
Q 041757 173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGY-IAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235 (381)
Q Consensus 173 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y-~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~P 235 (381)
.++.|||.+..+.-..... ...+..| .++.......+..+.|++|||..+.+..++..-
T Consensus 406 ~~~~~~~~~t~~~~~~~~~----~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l 465 (524)
T KOG0601|consen 406 SKLGDFGCWTRLAFSSGVF----HHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL 465 (524)
T ss_pred hhccccccccccceecccc----cccccccccchhhccccccccccccccccccccccccCccc
Confidence 8999999986532221111 1123334 355556667788999999999999999888654
No 439
>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]
Probab=99.12 E-value=3.2e-11 Score=121.74 Aligned_cols=186 Identities=18% Similarity=0.217 Sum_probs=131.4
Q ss_pred cccccccceecCCCceEEEecccccHH-----HHHHHH---------------HHHHccCCCcccceeeeeccccccCCc
Q 041757 35 SRNMLEENLISAGTFGFSHLRRQGAFK-----SFIAEC---------------KALRNIRHRNLIKVLTACLGVDYQGND 94 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~~~~~~-----~~~~E~---------------~~l~~l~h~nIv~~~~~~~~~~~~~~~ 94 (381)
-+.+.+.+-+-+|.||.+..++...-. ....++ .++-.-.||-++....- +.-..
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s-----~~~rs 877 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPS-----FPCRS 877 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCC-----CCCCC
Confidence 456777778889999988665532211 122222 22222233444443322 23466
Q ss_pred eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757 95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR 174 (381)
Q Consensus 95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k 174 (381)
..+||++|+.+++|...|+. ....+..-+......+..++++|| ...++|||++|.|+++..++..+
T Consensus 878 P~~L~~~~~~~~~~~Skl~~----------~~~~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~ 944 (1205)
T KOG0606|consen 878 PLPLVGHYLNGGDLPSKLHN----------SGCLSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRP 944 (1205)
T ss_pred CcchhhHHhccCCchhhhhc----------CCCcccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcc
Confidence 78999999999999999853 334455555666778889999999 55799999999999999999999
Q ss_pred EeecccceecCCC-------------------------CCc----ccccCccCccceeCCCCcCCCccCcccchhhhhHH
Q 041757 175 VGDFGLARFLPPT-------------------------RTQ----TSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGIL 225 (381)
Q Consensus 175 l~Dfg~~~~~~~~-------------------------~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~i 225 (381)
+.|||.......- ... .......||+.|.+||.+.+......+|+|++|++
T Consensus 945 l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~ 1024 (1205)
T KOG0606|consen 945 LTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVC 1024 (1205)
T ss_pred cCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhh
Confidence 9999833222110 000 11223568999999999999999999999999999
Q ss_pred HHHHHhCCCCCCc
Q 041757 226 LLELMIREKPSDI 238 (381)
Q Consensus 226 l~el~tg~~Pf~~ 238 (381)
++|.++|.+||..
T Consensus 1025 l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen 1025 LFEVLTGIPPFNA 1037 (1205)
T ss_pred hhhhhcCCCCCCC
Confidence 9999999999863
No 440
>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase. This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.
Probab=99.12 E-value=2.6e-10 Score=110.28 Aligned_cols=104 Identities=19% Similarity=0.202 Sum_probs=69.2
Q ss_pred HHHHHHHHHccC----CCcccceeeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHH
Q 041757 63 FIAECKALRNIR----HRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAI 138 (381)
Q Consensus 63 ~~~E~~~l~~l~----h~nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~ 138 (381)
|.+|++.+.++. |.+-+.+-.++.+ .....+|||||++|++|.++... .....+ ...++.
T Consensus 200 f~~Ea~n~~~~~~~~~~~~~v~vP~v~~~----~~~~~vLvmE~i~G~~L~~~~~~---------~~~~~~---~~~ia~ 263 (437)
T TIGR01982 200 LRREAANASELGENFKNDPGVYVPEVYWD----RTSERVLTMEWIDGIPLSDIAAL---------DEAGLD---RKALAE 263 (437)
T ss_pred HHHHHHHHHHHHHhcCCCCCEEeCCEehh----hcCCceEEEEeECCcccccHHHH---------HhcCCC---HHHHHH
Confidence 444666665552 3333333333322 13346899999999999887631 011111 234555
Q ss_pred HHHH-HHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccceecC
Q 041757 139 DVAS-ALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLP 185 (381)
Q Consensus 139 qi~~-~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~ 185 (381)
.++. .+..+| ..|++|+|+||.||+++.++.++++|||++..+.
T Consensus 264 ~~~~~~l~ql~---~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 264 NLARSFLNQVL---RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHHHHHHHHH---hCCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 5555 467788 5599999999999999999999999999987654
No 441
>cd05151 ChoK Choline Kinase (ChoK). The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph
Probab=99.06 E-value=3.3e-10 Score=95.35 Aligned_cols=96 Identities=22% Similarity=0.155 Sum_probs=68.9
Q ss_pred HHHHHHHHHHHccCCCccc-ceeeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHH
Q 041757 61 KSFIAECKALRNIRHRNLI-KVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAID 139 (381)
Q Consensus 61 ~~~~~E~~~l~~l~h~nIv-~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~q 139 (381)
..+.+|+.++..+.+.+++ +++... ....++||||++|.++.... .....++.+
T Consensus 37 ~~~~~E~~~l~~l~~~~~~P~~~~~~-------~~~~~lv~e~i~G~~l~~~~------------------~~~~~~~~~ 91 (170)
T cd05151 37 INRENEAENSKLAAEAGIGPKLYYFD-------PETGVLITEFIEGSELLTED------------------FSDPENLEK 91 (170)
T ss_pred cCHHHHHHHHHHHHHhCCCCceEEEe-------CCCCeEEEEecCCCcccccc------------------ccCHHHHHH
Confidence 3467899999999765544 444441 22347999999998775421 011235678
Q ss_pred HHHHHHHhhcCC--CCCceeeccCCCCeeeCCCCCeEEeecccce
Q 041757 140 VASALNYLHHDC--QPVTAHCVLKPSNVLLDDDMTARVGDFGLAR 182 (381)
Q Consensus 140 i~~~l~~LH~~~--~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~ 182 (381)
++.+|+.||... ..+++|+|++|.||+++ ++.++++|||.+.
T Consensus 92 l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 92 IAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred HHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 999999999441 12359999999999998 5689999999874
No 442
>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.
Probab=99.04 E-value=9.7e-10 Score=93.88 Aligned_cols=99 Identities=18% Similarity=0.094 Sum_probs=73.2
Q ss_pred HHHHHHHHccC--CCcccceeeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHH
Q 041757 64 IAECKALRNIR--HRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVA 141 (381)
Q Consensus 64 ~~E~~~l~~l~--h~nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~ 141 (381)
.+|++.|+++. .-++.+.+++ ...+|||||+.+..+..-. -+...++......+..+++
T Consensus 74 ~kE~r~L~rl~~~Gv~vP~pi~~---------~~~~lvME~Ig~~~~~~~~----------Lkd~~~~~~~~~~i~~~i~ 134 (197)
T cd05146 74 EKEMHNLKRMQKAGIPCPEVVVL---------KKHVLVMSFIGDDQVPAPK----------LKDAKLNDEEMKNAYYQVL 134 (197)
T ss_pred HHHHHHHHHHHHcCCCCCeEEEe---------cCCEEEEEEcCCCCccchh----------hhccccCHHHHHHHHHHHH
Confidence 48999999996 3466666654 2358999999765442211 0112344556677889999
Q ss_pred HHHHHh-hcCCCCCceeeccCCCCeeeCCCCCeEEeecccceecC
Q 041757 142 SALNYL-HHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLP 185 (381)
Q Consensus 142 ~~l~~L-H~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~ 185 (381)
.+|..| | ..++||+||++.||+++ ++.+.|+|||.+....
T Consensus 135 ~~l~~l~H---~~glVHGDLs~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 135 SMMKQLYK---ECNLVHADLSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HHHHHHHH---hCCeecCCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence 999999 7 56999999999999997 4679999999887553
No 443
>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]
Probab=99.04 E-value=1.1e-09 Score=90.59 Aligned_cols=96 Identities=24% Similarity=0.284 Sum_probs=75.4
Q ss_pred cHHHHHHHHHHHHccCCC--cccceeeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHH
Q 041757 59 AFKSFIAECKALRNIRHR--NLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNI 136 (381)
Q Consensus 59 ~~~~~~~E~~~l~~l~h~--nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i 136 (381)
...+..+|++++.++.-- +...++++ +.....|+|||.+|..|.+.+.. . ...+
T Consensus 42 rr~Rt~~Earil~~a~~~GV~~P~v~dv-------D~~~~~I~me~I~G~~lkd~l~~----------~-------~~~~ 97 (204)
T COG3642 42 RRERTRREARILAKAREAGVPVPIVYDV-------DPDNGLIVMEYIEGELLKDALEE----------A-------RPDL 97 (204)
T ss_pred HHHHHHHHHHHHHHHHHcCCCCCeEEEE-------cCCCCEEEEEEeCChhHHHHHHh----------c-------chHH
Confidence 356678899999998643 44445554 35556899999999999988842 1 2456
Q ss_pred HHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccce
Q 041757 137 AIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR 182 (381)
Q Consensus 137 ~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~ 182 (381)
+..+-.-+.-|| ..+|+|+||.++||++.++. +.++|||++.
T Consensus 98 ~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~ 139 (204)
T COG3642 98 LREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGE 139 (204)
T ss_pred HHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCccc
Confidence 777888889999 66999999999999998764 9999999986
No 444
>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]
Probab=98.95 E-value=5.5e-09 Score=86.23 Aligned_cols=125 Identities=20% Similarity=0.203 Sum_probs=88.0
Q ss_pred ccceecCCCceEEEecc-----------------------cccHHHHHHHHHHHHccCCCcc--cceeeeeccccccCCc
Q 041757 40 EENLISAGTFGFSHLRR-----------------------QGAFKSFIAECKALRNIRHRNL--IKVLTACLGVDYQGND 94 (381)
Q Consensus 40 ~~~~lG~G~fg~V~~~~-----------------------~~~~~~~~~E~~~l~~l~h~nI--v~~~~~~~~~~~~~~~ 94 (381)
....|-+|+-+.|+... +-..++..+|+++|.++.--.| .+++.+ +..
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~-------D~~ 83 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFI-------DTY 83 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEE-------ecC
Confidence 55678888888774432 2245677889999999864333 223322 244
Q ss_pred eEEEEEEcccC-CCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC--
Q 041757 95 FKALVYEFMHN-RSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM-- 171 (381)
Q Consensus 95 ~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~-- 171 (381)
...|+|||.+| .++.+++.... ...........++..|-+.+.-|| ..+|+|+||..+||++..++
T Consensus 84 ~~~i~ME~~~g~~~vk~~i~~~~--------~~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~ 152 (229)
T KOG3087|consen 84 GGQIYMEFIDGASTVKDFILSTM--------EDESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQ 152 (229)
T ss_pred CCeEEEEeccchhHHHHHHHHHc--------cCcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCc
Confidence 45799999977 47888874321 222233333678889999999999 66999999999999997655
Q ss_pred -CeEEeecccce
Q 041757 172 -TARVGDFGLAR 182 (381)
Q Consensus 172 -~~kl~Dfg~~~ 182 (381)
.+.++|||++.
T Consensus 153 ~~~~lIdfgls~ 164 (229)
T KOG3087|consen 153 ITPILIDFGLSS 164 (229)
T ss_pred CceEEEeecchh
Confidence 45899999985
No 445
>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed
Probab=98.95 E-value=1.2e-09 Score=107.03 Aligned_cols=80 Identities=16% Similarity=0.045 Sum_probs=56.0
Q ss_pred CceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC-
Q 041757 93 NDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM- 171 (381)
Q Consensus 93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~- 171 (381)
....+|||||+.|+++.++-.-.. .......+....+..++.|+.. | |++|+|+||.||+++.++
T Consensus 233 st~~VLvmE~i~G~~l~d~~~l~~----~g~d~~~la~~~v~~~~~Qif~-----~-----GffHaDpHPGNIlv~~~g~ 298 (537)
T PRK04750 233 CSETVMVMERMYGIPVSDVAALRA----AGTDMKLLAERGVEVFFTQVFR-----D-----GFFHADMHPGNIFVSYDPP 298 (537)
T ss_pred CCCceEEEeeecCccHHhHHHHHh----cCCCHHHHHHHHHHHHHHHHHh-----C-----CeeeCCCChHHeEEecCCC
Confidence 345689999999999987521000 0011123444455555555542 3 999999999999999887
Q ss_pred ---CeEEeecccceecCC
Q 041757 172 ---TARVGDFGLARFLPP 186 (381)
Q Consensus 172 ---~~kl~Dfg~~~~~~~ 186 (381)
.++++|||++..+..
T Consensus 299 ~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 299 ENPRYIALDFGIVGSLNK 316 (537)
T ss_pred CCCeEEEEecceEEECCH
Confidence 999999999987765
No 446
>KOG2137 consensus Protein kinase [Signal transduction mechanisms]
Probab=98.84 E-value=1.1e-09 Score=106.74 Aligned_cols=152 Identities=13% Similarity=0.172 Sum_probs=100.9
Q ss_pred HHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccceecCCCCCccc-------ccCccCccceeCCCCc
Q 041757 136 IAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTS-------SIDVKGSIGYIAPEYG 208 (381)
Q Consensus 136 i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~-------~~~~~gt~~y~aPE~l 208 (381)
-+.+.+.|+.|+|+. .++||++|.|++|.++..+.+||+.|+++........... ..-..-...|.|||++
T Consensus 104 nl~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~ 181 (700)
T KOG2137|consen 104 NLGNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYL 181 (700)
T ss_pred hhhcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhh
Confidence 345566999999974 4899999999999999999999999998876554211110 0012245679999999
Q ss_pred CCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHH
Q 041757 209 VGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKIN 287 (381)
Q Consensus 209 ~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 287 (381)
.+...+.++|+||+|+++|.+.. |+..+. .......+.......+.....
T Consensus 182 ~~~~~~~~sd~fSlG~li~~i~~~gk~i~~----a~~~~~~~~~~~~~~~~~~~~------------------------- 232 (700)
T KOG2137|consen 182 LGTTNTPASDVFSLGVLIYTIYNGGKSIIA----ANGGLLSYSFSRNLLNAGAFG------------------------- 232 (700)
T ss_pred ccccccccccceeeeeEEEEEecCCcchhh----ccCCcchhhhhhccccccccc-------------------------
Confidence 99888999999999999999984 444432 111111111111111100000
Q ss_pred HHHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 041757 288 IIRECVISMVRIGVACSMESPQDRMKMTNVV 318 (381)
Q Consensus 288 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl 318 (381)
...+.+.++.+-+.+.+..++.-||++.++.
T Consensus 233 ~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 233 YSNNLPSELRESLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred ccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence 0135566777777788889999999766654
No 447
>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]
Probab=98.81 E-value=2.2e-07 Score=86.06 Aligned_cols=265 Identities=12% Similarity=0.054 Sum_probs=155.6
Q ss_pred ccceecCCCceEEEecccc-----------cHHHHHHHHHHHHcc-CCCcccceeeeecc-c-cccCCceEEEEEEcccC
Q 041757 40 EENLISAGTFGFSHLRRQG-----------AFKSFIAECKALRNI-RHRNLIKVLTACLG-V-DYQGNDFKALVYEFMHN 105 (381)
Q Consensus 40 ~~~~lG~G~fg~V~~~~~~-----------~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~-~-~~~~~~~~~lv~e~~~~ 105 (381)
.++-||+|+-+.+|-..+. -...--+.+..|... .||-+-.-+.+-.. + .........+.|+.+++
T Consensus 15 ~gr~LgqGgea~ly~l~e~~d~VAKIYh~Pppa~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~v~g 94 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEVRDQVAKIYHAPPPAAQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPKVSG 94 (637)
T ss_pred CCccccCCccceeeecchhhchhheeecCCCchHHHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecccCCC
Confidence 4577999999988654311 001111223334433 46654331111110 0 01233446788888876
Q ss_pred C-CHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccceec
Q 041757 106 R-SLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFL 184 (381)
Q Consensus 106 g-~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~ 184 (381)
. .+..++..... ........|...++.++.++.+.+-|| ..|.+-+|+.++|+|+++++.+.|.|=.....-
T Consensus 95 ~~pI~~~y~p~tR----Rqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 95 KEPIHMIYSPATR----RQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred ccchhhhcCchhh----cccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcccceeec
Confidence 4 33333322111 123455789999999999999999999 668999999999999999999999874433222
Q ss_pred CCCCCcccccCccCccceeCCCCcC-----CCccCcccchhhhhHHHHHHHhC-CCCCCccccCC---CcHHHHHHHHhh
Q 041757 185 PPTRTQTSSIDVKGSIGYIAPEYGV-----GNEVSTIGDVYSYGILLLELMIR-EKPSDIMFEGD---MNLHKFAKMALS 255 (381)
Q Consensus 185 ~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDiwSlG~il~el~tg-~~Pf~~~~~~~---~~~~~~~~~~~~ 255 (381)
..+.... ..+|...|.+||.-. +-.-+...|-|.||+++++++.| ++||....... ...+.
T Consensus 168 ~ng~~~~---cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~------- 237 (637)
T COG4248 168 ANGTLHL---CPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET------- 237 (637)
T ss_pred cCCceEe---cccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh-------
Confidence 2222221 246889999999643 34456778999999999999876 99987553221 11110
Q ss_pred chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCC--CCCCCCCHHHHHHHHHHhhhhcC
Q 041757 256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSME--SPQDRMKMTNVVHELQSIKNTLL 329 (381)
Q Consensus 256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~--dP~~RPs~~~vl~~L~~i~~~~~ 329 (381)
++........++. .....+.-+.......+.++..+..+|+.. ++.-|||++.-+..|..+..++.
T Consensus 238 ----~Ia~g~f~ya~~~----~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~ 305 (637)
T COG4248 238 ----DIAHGRFAYASDQ----RRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLK 305 (637)
T ss_pred ----hhhcceeeechhc----cCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhh
Confidence 1111111111100 000000001111234455677777788875 46789999999888888776553
No 448
>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.
Probab=98.78 E-value=3e-08 Score=84.38 Aligned_cols=102 Identities=20% Similarity=0.181 Sum_probs=67.5
Q ss_pred cHHHHHHHHHHHHccCCC--cccceeeeeccccccCCceEEEEEEccc--CCCHHHhhccccCCcccccCCCcccHHHHH
Q 041757 59 AFKSFIAECKALRNIRHR--NLIKVLTACLGVDYQGNDFKALVYEFMH--NRSLKEWLYPISKEDETYKRPRNLNLLRRL 134 (381)
Q Consensus 59 ~~~~~~~E~~~l~~l~h~--nIv~~~~~~~~~~~~~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~ 134 (381)
......+|.+.|.++..- ++.+++++ . ...|||||++ |..+..+.. ..++.....
T Consensus 51 ~~~~~~~E~~~L~~l~~~Gv~vP~p~~~--------~-~~~ivME~I~~~G~~~~~l~~------------~~~~~~~~~ 109 (188)
T PF01163_consen 51 IREWAKKEFRNLKRLYEAGVPVPKPYDY--------N-RNVIVMEYIGEDGVPLPRLKD------------VDLSPEEPK 109 (188)
T ss_dssp HHHHHHHHHHHHHHCCCTT-SS--EEEE--------E-TTEEEEE--EETTEEGGCHHH------------CGGGGSTHH
T ss_pred HHHHHHHHHHHHHHHHHCCccCCcEEEE--------e-CCEEEEEecCCCccchhhHHh------------ccccchhHH
Confidence 345677899999999755 56777765 1 2379999998 655544331 111233456
Q ss_pred HHHHHHHHHHHH-hhcCCCCCceeeccCCCCeeeCCCCCeEEeecccceecC
Q 041757 135 NIAIDVASALNY-LHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLP 185 (381)
Q Consensus 135 ~i~~qi~~~l~~-LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~ 185 (381)
.++.+++..+.. +| ..|++|+||.+.||+++++ .+.|+|||.+....
T Consensus 110 ~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 110 ELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYIIDFGQAVDSS 157 (188)
T ss_dssp HHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE--GTTEEETT
T ss_pred HHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEEEecCcceecC
Confidence 677788885555 57 6699999999999999887 89999999886543
No 449
>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional
Probab=98.76 E-value=4.2e-08 Score=88.43 Aligned_cols=110 Identities=14% Similarity=0.062 Sum_probs=79.3
Q ss_pred HHHHHHHHHHccCCCcc--cceeeeeccccccCCceEEEEEEcccCC-CHHHhhccccCCcccccCCCcccHHHHHHHHH
Q 041757 62 SFIAECKALRNIRHRNL--IKVLTACLGVDYQGNDFKALVYEFMHNR-SLKEWLYPISKEDETYKRPRNLNLLRRLNIAI 138 (381)
Q Consensus 62 ~~~~E~~~l~~l~h~nI--v~~~~~~~~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~ 138 (381)
.+.+|...+.+|...+| ...+++............+||||++++- +|.+++... .....+......++.
T Consensus 74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~--------~~~~~~~~~~~~ll~ 145 (268)
T PRK15123 74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADW--------ATNPPDPRLKRMLIK 145 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhh--------cccCCCHHHHHHHHH
Confidence 47899999998854333 3334442210011134578999999886 899987321 123345667778999
Q ss_pred HHHHHHHHhhcCCCCCceeeccCCCCeeeCC-------CCCeEEeecccce
Q 041757 139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDD-------DMTARVGDFGLAR 182 (381)
Q Consensus 139 qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~-------~~~~kl~Dfg~~~ 182 (381)
+++..+.-|| ..||+|+|+++.|||++. +..+.++||+.+.
T Consensus 146 ~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 146 RVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred HHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 9999999999 679999999999999975 4678999999875
No 450
>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins. This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain
Probab=98.75 E-value=6.7e-08 Score=84.83 Aligned_cols=110 Identities=26% Similarity=0.276 Sum_probs=77.7
Q ss_pred HHHHHHHHHHHHccCCC--cccceeeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHH
Q 041757 60 FKSFIAECKALRNIRHR--NLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIA 137 (381)
Q Consensus 60 ~~~~~~E~~~l~~l~h~--nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~ 137 (381)
...+.+|+++++.+.+. ++.+++.+.... ...+..++||||++|.++.+.+. . ..++......++
T Consensus 39 ~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~--~~~~~~~~v~e~i~G~~l~~~~~----------~-~~~~~~~~~~i~ 105 (223)
T cd05154 39 AHDVAREYRVLRALAGTGVPVPKVLALCEDP--SVLGTPFYVMERVDGRVLRDRLL----------R-PELSPEERRALA 105 (223)
T ss_pred cccHHHHHHHHHHhhCCCCCCCCEEEECCCC--CccCCceEEEEEeCCEecCCCCC----------C-CCCCHHHHHHHH
Confidence 45788999999999753 456677763220 01135689999999988876541 0 235555666667
Q ss_pred HHHHHHHHHhhcC-----------------------------------------------------CCCCceeeccCCCC
Q 041757 138 IDVASALNYLHHD-----------------------------------------------------CQPVTAHCVLKPSN 164 (381)
Q Consensus 138 ~qi~~~l~~LH~~-----------------------------------------------------~~~~ivHrDlkp~N 164 (381)
.+++..|..||+- ....++|+|++|.|
T Consensus 106 ~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~N 185 (223)
T cd05154 106 RALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGN 185 (223)
T ss_pred HHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCccc
Confidence 7777777777631 12467999999999
Q ss_pred eeeCC--CCCeEEeecccce
Q 041757 165 VLLDD--DMTARVGDFGLAR 182 (381)
Q Consensus 165 ill~~--~~~~kl~Dfg~~~ 182 (381)
|+++. ++.+.|+||+.+.
T Consensus 186 il~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 186 VLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred EEEcCCCCcEEEEEeccccc
Confidence 99998 5668999998875
No 451
>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]
Probab=98.75 E-value=3e-07 Score=87.21 Aligned_cols=148 Identities=18% Similarity=0.209 Sum_probs=111.0
Q ss_pred HHHHHHHccCCCcccceeeeeccccccCCceEEEEEEcccC-CCHHHhhccccCCc-----ccccCCCcccHHHHHHHHH
Q 041757 65 AECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHN-RSLKEWLYPISKED-----ETYKRPRNLNLLRRLNIAI 138 (381)
Q Consensus 65 ~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~-----~~~~~~~~l~~~~~~~i~~ 138 (381)
.-++.++++.|+|||++.+++....+ ....+++|++|+++ ++|.++-....... .....+...++...|.++.
T Consensus 322 ~lve~wkkl~h~NvV~frevf~t~tF-~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~ 400 (655)
T KOG3741|consen 322 SLVEAWKKLCHTNVVPFREVFLTYTF-GDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYIS 400 (655)
T ss_pred HHHHHHHHhccCceeehhhhhhhhcc-CcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHH
Confidence 45788999999999999999874333 35667899999887 68877754322211 2223456788999999999
Q ss_pred HHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccc
Q 041757 139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGD 218 (381)
Q Consensus 139 qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sD 218 (381)
|+..||.++| +.|+.-+-|.|.+|+++++.+++|+..|....+..+.. |-+. --.+-|
T Consensus 401 QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~~----------------~~le---~~Qq~D 458 (655)
T KOG3741|consen 401 QLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDPT----------------EPLE---SQQQND 458 (655)
T ss_pred HHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeecCCCC----------------cchh---HHhhhh
Confidence 9999999999 66888899999999999998899988777655443331 0011 123458
Q ss_pred hhhhhHHHHHHHhCCCC
Q 041757 219 VYSYGILLLELMIREKP 235 (381)
Q Consensus 219 iwSlG~il~el~tg~~P 235 (381)
.=.||.++..|.||..-
T Consensus 459 ~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 459 LRDLGLLLLALATGTEN 475 (655)
T ss_pred HHHHHHHHHHHhhcccc
Confidence 88999999999999543
No 452
>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane
Probab=98.70 E-value=8.5e-08 Score=83.46 Aligned_cols=111 Identities=22% Similarity=0.198 Sum_probs=83.4
Q ss_pred cHHHHHHHHHHHHccCCC--cccceeeeeccccccCCceEEEEEEcccCC-CHHHhhccccCCcccccCCCcccHHHHHH
Q 041757 59 AFKSFIAECKALRNIRHR--NLIKVLTACLGVDYQGNDFKALVYEFMHNR-SLKEWLYPISKEDETYKRPRNLNLLRRLN 135 (381)
Q Consensus 59 ~~~~~~~E~~~l~~l~h~--nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~l~~~~~~~ 135 (381)
....+.+|...+..|..- .+.+.+++...... .....++|+|++++. +|.+++. .....+......
T Consensus 54 ~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~-~~~~s~lite~l~~~~~L~~~~~----------~~~~~~~~~~~~ 122 (206)
T PF06293_consen 54 RRSRAKREWRNLQRLREAGIPTPEPVAYGERRKG-GGYRSYLITEALPGAQDLRDLLQ----------QWEQLDPSQRRE 122 (206)
T ss_pred cchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCC-CceeEEEEEEeCCCcccHHHHHH----------hhcccchhhHHH
Confidence 445788899988888533 34455555332111 124568999999884 8999984 222366677888
Q ss_pred HHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC---CeEEeeccccee
Q 041757 136 IAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM---TARVGDFGLARF 183 (381)
Q Consensus 136 i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~---~~kl~Dfg~~~~ 183 (381)
++.+++..++-|| ..||+|+|+++.|||++.+. .+.++||+-++.
T Consensus 123 ll~~l~~~i~~lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 123 LLRALARLIAKLH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHHHHHHHHH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999999999999 66999999999999998887 889999998764
No 453
>PRK09902 hypothetical protein; Provisional
Probab=98.57 E-value=6.8e-07 Score=76.73 Aligned_cols=112 Identities=16% Similarity=0.143 Sum_probs=82.2
Q ss_pred cHHHHHHHHHHHHccCCC--cccceeeeeccccccCCceEEEEEEcccC-CCHHHhhccccCCcccccCCCcccHHHHHH
Q 041757 59 AFKSFIAECKALRNIRHR--NLIKVLTACLGVDYQGNDFKALVYEFMHN-RSLKEWLYPISKEDETYKRPRNLNLLRRLN 135 (381)
Q Consensus 59 ~~~~~~~E~~~l~~l~h~--nIv~~~~~~~~~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~ 135 (381)
....|.+|+..+.+|..- .+.+....... .....-..+||+|-+.+ .||.+++.. ......+......
T Consensus 62 g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~-k~~~~~rA~LVTe~L~g~~~L~~~l~~--------~~~~~~~~~~k~~ 132 (216)
T PRK09902 62 GRPTIVREVAVIKELERAGVIVPKIVFGEAV-KIEGEWRALLVTEDMAGFISIADWYAQ--------HAVSPYSDEVRQA 132 (216)
T ss_pred CchHHHHHHHHHHHHHHcCCCCCccceeeee-ccCCceEEEEEEEeCCCCccHHHHHhc--------CCcCCcchHHHHH
Confidence 467899999999999632 34444422111 11224456899997754 689998842 1123557777889
Q ss_pred HHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCC--eEEeecccce
Q 041757 136 IAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT--ARVGDFGLAR 182 (381)
Q Consensus 136 i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~--~kl~Dfg~~~ 182 (381)
++.+++..++-|| ..|+.|+|+.+.||+++.++. ++++||.-++
T Consensus 133 il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 133 MLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred HHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 9999999999999 779999999999999986666 9999998664
No 454
>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]
Probab=98.45 E-value=8.1e-07 Score=78.25 Aligned_cols=118 Identities=17% Similarity=0.077 Sum_probs=84.6
Q ss_pred ccccceecCCCceEEEeccc--------------------------------------ccHHHHHHHHHHHHccCCC--c
Q 041757 38 MLEENLISAGTFGFSHLRRQ--------------------------------------GAFKSFIAECKALRNIRHR--N 77 (381)
Q Consensus 38 ~~~~~~lG~G~fg~V~~~~~--------------------------------------~~~~~~~~E~~~l~~l~h~--n 77 (381)
..+++.||-|.-|.||.+.. -......+|.++|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 44578899999999866431 1234556799999999754 7
Q ss_pred ccceeeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCcee
Q 041757 78 LIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAH 157 (381)
Q Consensus 78 Iv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH 157 (381)
|.+.+++ +...+||||.+|-.|...- ++....-.++..|+.-+.-.- ..|+||
T Consensus 173 VP~P~~~---------nRHaVvMe~ieG~eL~~~r---------------~~~en~~~il~~il~~~~~~~---~~GiVH 225 (304)
T COG0478 173 VPKPIAW---------NRHAVVMEYIEGVELYRLR---------------LDVENPDEILDKILEEVRKAY---RRGIVH 225 (304)
T ss_pred CCCcccc---------ccceeeeehcccceeeccc---------------CcccCHHHHHHHHHHHHHHHH---HcCccc
Confidence 7776665 3458999999886654322 123334445555556555555 348999
Q ss_pred eccCCCCeeeCCCCCeEEeecccce
Q 041757 158 CVLKPSNVLLDDDMTARVGDFGLAR 182 (381)
Q Consensus 158 rDlkp~Nill~~~~~~kl~Dfg~~~ 182 (381)
+|+.+=||+++++|.+.++||-.+.
T Consensus 226 GDlSefNIlV~~dg~~~vIDwPQ~v 250 (304)
T COG0478 226 GDLSEFNILVTEDGDIVVIDWPQAV 250 (304)
T ss_pred cCCchheEEEecCCCEEEEeCcccc
Confidence 9999999999999999999997654
No 455
>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]
Probab=98.36 E-value=1.3e-07 Score=91.65 Aligned_cols=170 Identities=18% Similarity=0.139 Sum_probs=123.8
Q ss_pred cceecCCCceEEEecccccH-----------HHHHHHHHHHHccCCCc-ccceeeeeccccccCCceEEEEEEcccCC-C
Q 041757 41 ENLISAGTFGFSHLRRQGAF-----------KSFIAECKALRNIRHRN-LIKVLTACLGVDYQGNDFKALVYEFMHNR-S 107 (381)
Q Consensus 41 ~~~lG~G~fg~V~~~~~~~~-----------~~~~~E~~~l~~l~h~n-Iv~~~~~~~~~~~~~~~~~~lv~e~~~~g-~ 107 (381)
-+-+++|+++++++.+.... ....-++++|.+++||| .+..++- .+.+...+++|+++.++ +
T Consensus 247 fh~fvK~altknpKkRptaeklL~h~fvs~~l~~rl~~eLLdK~n~P~~~v~~~~d-----~~~E~~~~i~~~i~s~~rs 321 (829)
T KOG0576|consen 247 FHNFVKGALTKNPKKRPTAEKLLQHPFVSQTLSRRLAIELLDKVNNPNPVVRYLED-----YDGEDYLWIPMRICSTGRS 321 (829)
T ss_pred HHHHHHHHhcCCCccCCChhhheeceeeccchhhHHHHHHHHHccCCCCccccccc-----CCcccccchhhhhhcCCcc
Confidence 35578888888877664322 23345889999999999 5555544 56688899999999887 3
Q ss_pred HHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccceecCCC
Q 041757 108 LKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPT 187 (381)
Q Consensus 108 L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 187 (381)
...... .....+...+...+.+.-.++++++|+ ..=+||| ||+..+ +..+..||+....+...
T Consensus 322 ~~~~~~---------~se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~ 384 (829)
T KOG0576|consen 322 SALEMT---------VSEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRT 384 (829)
T ss_pred ccccCC---------hhhHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCcc
Confidence 322221 223345555566677788889999994 3458888 777665 57899999988776655
Q ss_pred CCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCC
Q 041757 188 RTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235 (381)
Q Consensus 188 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~P 235 (381)
.. .....+++.|+|||+...+.+....|+||+|+-..++.-|.+|
T Consensus 385 ~~---~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pP 429 (829)
T KOG0576|consen 385 MK---PRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPP 429 (829)
T ss_pred cc---cccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCC
Confidence 42 2225689999999999999999999999999877777777666
No 456
>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY). The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process
Probab=98.33 E-value=4.9e-06 Score=71.77 Aligned_cols=127 Identities=17% Similarity=0.186 Sum_probs=79.5
Q ss_pred ccccccccceecCCCceEEEecc------------------cccHHH------HHHHHHHHHccCC---Ccccceeeeec
Q 041757 34 VSRNMLEENLISAGTFGFSHLRR------------------QGAFKS------FIAECKALRNIRH---RNLIKVLTACL 86 (381)
Q Consensus 34 ~~~~~~~~~~lG~G~fg~V~~~~------------------~~~~~~------~~~E~~~l~~l~h---~nIv~~~~~~~ 86 (381)
.+++|...+++-......|.+.. +..... ..+++..+.++.. .....++.+..
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 57788888888888888773321 011111 1234444444432 23333333322
Q ss_pred cccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCee
Q 041757 87 GVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVL 166 (381)
Q Consensus 87 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nil 166 (381)
-..+.-....+++|||++|..|.++.. +++ .+...+..++.-|| ..|++|+|..|.|++
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~--------------i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFl 167 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED--------------IDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFL 167 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh--------------cCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEE
Confidence 211222345578999999988876541 222 24456778899999 669999999999999
Q ss_pred eCCCCCeEEeecccce
Q 041757 167 LDDDMTARVGDFGLAR 182 (381)
Q Consensus 167 l~~~~~~kl~Dfg~~~ 182 (381)
++++ .++++||+..+
T Consensus 168 v~~~-~i~iID~~~k~ 182 (229)
T PF06176_consen 168 VSNN-GIRIIDTQGKR 182 (229)
T ss_pred EECC-cEEEEECcccc
Confidence 9865 49999998764
No 457
>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C). Proteins in this uncharacterised family are described as transmembrane proteins.
Probab=98.28 E-value=4e-05 Score=65.45 Aligned_cols=105 Identities=21% Similarity=0.205 Sum_probs=80.9
Q ss_pred HHHHHHHHccCC-CcccceeeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHH
Q 041757 64 IAECKALRNIRH-RNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVAS 142 (381)
Q Consensus 64 ~~E~~~l~~l~h-~nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~ 142 (381)
..|.-+|+.+.+ +++.+++|.|- .++|.||...+++...-... ..-...+|..+.+|+.++++
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG---------~~~v~E~~~~~~~~~~~~~l-------~~~~~~~w~~R~~iA~~lL~ 70 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG---------RFYVVEYVGAGSLYGIYRPL-------SQFLQSPWEQRAKIALQLLE 70 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC---------CEEEEEeecCcccccccccc-------ccccccCHHHHHHHHHHHHH
Confidence 358889999975 69999999983 26899999877654210000 12234689999999999999
Q ss_pred HHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccceec
Q 041757 143 ALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFL 184 (381)
Q Consensus 143 ~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~ 184 (381)
.+.++++.....+.-+|++|+|+.+++++++|++|...+...
T Consensus 71 ~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 71 LLEELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred HHHHHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 999999763345666999999999999999999999876543
No 458
>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172. This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.
Probab=98.04 E-value=5.1e-05 Score=66.93 Aligned_cols=61 Identities=15% Similarity=0.117 Sum_probs=40.3
Q ss_pred ceecCCCceEEEecc-----------cccHHHHHHHHHHHHccCCCc--ccceeeeeccccccCCceEEEEEEcccCCC
Q 041757 42 NLISAGTFGFSHLRR-----------QGAFKSFIAECKALRNIRHRN--LIKVLTACLGVDYQGNDFKALVYEFMHNRS 107 (381)
Q Consensus 42 ~~lG~G~fg~V~~~~-----------~~~~~~~~~E~~~l~~l~h~n--Iv~~~~~~~~~~~~~~~~~~lv~e~~~~g~ 107 (381)
..||.|..+.||... ........+|.+++..+..-+ +.+.++++ ...+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~-----~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTHKTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLV-----EDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEecCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEE-----ecCCeeeeeeeecCCcc
Confidence 456777777766521 112456788999999986433 45666663 33555688999999864
No 459
>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]
Probab=97.98 E-value=1.6e-05 Score=82.43 Aligned_cols=200 Identities=21% Similarity=0.195 Sum_probs=133.7
Q ss_pred HHHHHHHHHHccCCCcccceeeeeccccccCCc-eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHH
Q 041757 62 SFIAECKALRNIRHRNLIKVLTACLGVDYQGND-FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDV 140 (381)
Q Consensus 62 ~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi 140 (381)
....|...+.++.|+|++.++.+.... ...+ ...+..|+|..-++...+ ..-..++....+.+..++
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~--~~~g~~~~v~~~~~s~~~~~~~~----------q~v~~i~~~~~r~~~~~~ 295 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLER--LFRGIVLDVLQEICSKVELRSLL----------QSVGSIPLETLRILHQKL 295 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehh--hcchHHHHHHHhhcCccchHHHH----------hhccccCHHHHHHHHHHH
Confidence 334567778888999999999985531 1112 223456788888888888 456778889999999999
Q ss_pred HHHHHHhhcCCCCCceeeccCCC---CeeeCCCCCeEEe--ecccceecCCCCCcccccCccCccceeCCCCcCCCccCc
Q 041757 141 ASALNYLHHDCQPVTAHCVLKPS---NVLLDDDMTARVG--DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVST 215 (381)
Q Consensus 141 ~~~l~~LH~~~~~~ivHrDlkp~---Nill~~~~~~kl~--Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ 215 (381)
..||.|+|+. ...|.-+..+ +-..+..+.+.++ ||+.++........... .-+..|.++|......+..
T Consensus 296 ~~GL~~~h~~---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~---~~~~~~~~~e~~~~~~~~~ 369 (1351)
T KOG1035|consen 296 LEGLAYLHSL---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSD---LLAEIRNADEDLKENTAKK 369 (1351)
T ss_pred hhhHHHHHHh---ccceeEEecccccccccCccceeecchhhhcccccCCCcccchhh---cCccccccccccccccchh
Confidence 9999999944 4445444444 3344555566666 88888776654433322 2455677888777665544
Q ss_pred c--cchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHH
Q 041757 216 I--GDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECV 293 (381)
Q Consensus 216 ~--sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (381)
+ .|+|.+|.....+..|..+-. . ......+++ ....
T Consensus 370 ~r~~dL~~lgll~~~~~~~~~i~~----~------------~~~~~~~l~--------------------------~~~~ 407 (1351)
T KOG1035|consen 370 SRLTDLWCLGLLLLQLSQGEDISE----K------------SAVPVSLLD--------------------------VLST 407 (1351)
T ss_pred hhhhHHHHHHHHHhhhhhcCcccc----c------------ccchhhhhc--------------------------cccc
Confidence 4 699999999999988876621 0 000011111 1111
Q ss_pred HHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 041757 294 ISMVRIGVACSMESPQDRMKMTNVVHEL 321 (381)
Q Consensus 294 ~~l~~l~~~cl~~dP~~RPs~~~vl~~L 321 (381)
..+.....+|+..++++|+++.+++...
T Consensus 408 ~~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 408 SELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred hhhhhhhhhhcchhhhhccchhhhhhch
Confidence 1456667799999999999999998754
No 460
>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]
Probab=97.87 E-value=3.6e-05 Score=75.29 Aligned_cols=80 Identities=16% Similarity=0.177 Sum_probs=59.2
Q ss_pred CceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeC----
Q 041757 93 NDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLD---- 168 (381)
Q Consensus 93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~---- 168 (381)
.....|+||||+|..+.+.-. -....++...+..-+.++..-+-+-| |++|+|-+|.||+++
T Consensus 274 st~RVLtME~~~G~~i~Dl~~---------i~~~gi~~~~i~~~l~~~~~~qIf~~-----GffHaDPHPGNilv~~~~~ 339 (538)
T KOG1235|consen 274 STKRVLTMEYVDGIKINDLDA---------IDKRGISPHDILNKLVEAYLEQIFKT-----GFFHADPHPGNILVRPNPE 339 (538)
T ss_pred CcceEEEEEecCCccCCCHHH---------HHHcCCCHHHHHHHHHHHHHHHHHhc-----CCccCCCCCCcEEEecCCC
Confidence 446789999999987776632 23445666666666666555555556 899999999999998
Q ss_pred CCCCeEEeecccceecCC
Q 041757 169 DDMTARVGDFGLARFLPP 186 (381)
Q Consensus 169 ~~~~~kl~Dfg~~~~~~~ 186 (381)
.++.+.+.|||+...+..
T Consensus 340 ~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 340 GDEEIVLLDHGLYAVISH 357 (538)
T ss_pred CCccEEEEcccccccccH
Confidence 366899999999876543
No 461
>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP. PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].
Probab=97.79 E-value=0.00035 Score=60.03 Aligned_cols=99 Identities=15% Similarity=0.178 Sum_probs=67.8
Q ss_pred cHHHHHHHHHHHHccC------CCcccceeeeeccccccCCceEEEEEEcccC------CCHHHhhccccCCcccccCCC
Q 041757 59 AFKSFIAECKALRNIR------HRNLIKVLTACLGVDYQGNDFKALVYEFMHN------RSLKEWLYPISKEDETYKRPR 126 (381)
Q Consensus 59 ~~~~~~~E~~~l~~l~------h~nIv~~~~~~~~~~~~~~~~~~lv~e~~~~------g~L~~~l~~~~~~~~~~~~~~ 126 (381)
..+++.+|+.....+. +.+|.+++|+ .+++.-..+|+|...+ .+|.+++. ..
T Consensus 54 ~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~-----veT~~G~Glv~e~I~d~dG~~s~TL~~~l~-----------~~ 117 (199)
T PF10707_consen 54 RYRQNRRELRYYKQLSLRRGVDWSHIPRFYGF-----VETNLGLGLVVELIRDADGNISPTLEDYLK-----------EG 117 (199)
T ss_pred hhHHHHHHHHHHHHHhhccCCcccccccEeEE-----EecCCceEEEEEEEECCCCCcCccHHHHHH-----------cC
Confidence 3677888888877776 7889999999 5667778899998643 35666662 23
Q ss_pred cccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC----CeEEee-ccc
Q 041757 127 NLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM----TARVGD-FGL 180 (381)
Q Consensus 127 ~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~----~~kl~D-fg~ 180 (381)
.++. .....+.+.. .||- ..+|+.+|++|.||++.... .+.|+| ||.
T Consensus 118 ~~~~-~~~~~L~~f~---~~l~---~~~Iv~~dl~~~NIv~~~~~~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 118 GLTE-ELRQALDEFK---RYLL---DHHIVIRDLNPHNIVVQRRDSGEFRLVLIDGLGE 169 (199)
T ss_pred CccH-HHHHHHHHHH---HHHH---HcCCeecCCCcccEEEEecCCCceEEEEEeCCCC
Confidence 3444 4444444444 4444 44799999999999995332 577777 443
No 462
>COG0661 AarF Predicted unusual protein kinase [General function prediction only]
Probab=97.75 E-value=9e-05 Score=72.71 Aligned_cols=106 Identities=14% Similarity=0.169 Sum_probs=68.5
Q ss_pred HHHHHHHHHccC----CCcccceeeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHH
Q 041757 63 FIAECKALRNIR----HRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAI 138 (381)
Q Consensus 63 ~~~E~~~l~~l~----h~nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~ 138 (381)
+.+|...+.+++ +..=+.+=.++ ++-.....|+|||++|-.+.+... .+...++...+...+.
T Consensus 208 y~~EA~n~~~~~~nf~~~~~v~VP~V~----we~t~~~VLtmE~i~Gi~i~d~~~---------l~~~g~d~k~ia~~~~ 274 (517)
T COG0661 208 YRREAANAERFRENFKDDPDVYVPKVY----WEYTTRRVLTMEWIDGIKISDIAA---------LKSAGIDRKELAELLV 274 (517)
T ss_pred HHHHHHHHHHHHHHcCCCCCeEeceee----hhccCCcEEEEEeeCCEecccHHH---------HHhcCCCHHHHHHHHH
Confidence 345777777663 22222233332 223455689999999988888742 1123344334333333
Q ss_pred HHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccceecCC
Q 041757 139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPP 186 (381)
Q Consensus 139 qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~ 186 (381)
++.--.-+-| |++|.|.+|.||+++.++.+.+.|||+...+..
T Consensus 275 ~~f~~q~~~d-----gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 275 RAFLRQLLRD-----GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHHHHHHHhc-----CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 3333333445 999999999999999999999999999887654
No 463
>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]
Probab=97.62 E-value=0.00048 Score=60.39 Aligned_cols=99 Identities=20% Similarity=0.182 Sum_probs=69.7
Q ss_pred HHHHHHHHccC--CCcccceeeeeccccccCCceEEEEEEcccCCCH-HHhhccccCCcccccCCCcccHHHHHHHHHHH
Q 041757 64 IAECKALRNIR--HRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSL-KEWLYPISKEDETYKRPRNLNLLRRLNIAIDV 140 (381)
Q Consensus 64 ~~E~~~l~~l~--h~nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L-~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi 140 (381)
.+|+..|.++. +-.+.+-+++ ....|||||+..... .-.| +.-.+...+...+..++
T Consensus 116 ~kEf~NL~R~~eAGVrvP~Pi~~---------~~nVLvMEfIg~~g~pAP~L-----------kDv~~e~~e~~~~~~~~ 175 (268)
T COG1718 116 RKEFRNLKRAYEAGVRVPEPIAF---------RNNVLVMEFIGDDGLPAPRL-----------KDVPLELEEAEGLYEDV 175 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCceee---------cCCeEEEEeccCCCCCCCCc-----------ccCCcCchhHHHHHHHH
Confidence 45888888884 4455555555 234799999855311 1111 12223333677888889
Q ss_pred HHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccceecC
Q 041757 141 ASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLP 185 (381)
Q Consensus 141 ~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~ 185 (381)
+..+.-|.. ..++||+||..=|||+. ++.+.|+|||.|....
T Consensus 176 v~~~~~l~~--~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 176 VEYMRRLYK--EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred HHHHHHHHH--hcCcccccchhhheEEE-CCeEEEEECccccccC
Confidence 999998884 25999999999999999 7799999999886544
No 464
>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members. The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista
Probab=97.59 E-value=0.00064 Score=60.38 Aligned_cols=31 Identities=39% Similarity=0.493 Sum_probs=26.4
Q ss_pred CCCceeeccCCCCeeeCCCCCeEEeecccce
Q 041757 152 QPVTAHCVLKPSNVLLDDDMTARVGDFGLAR 182 (381)
Q Consensus 152 ~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~ 182 (381)
...++|+|+.+.||+++++....|+||+.+.
T Consensus 163 ~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 163 PPVWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred CceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 4569999999999999877666799999764
No 465
>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH). The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio
Probab=97.57 E-value=0.00049 Score=61.42 Aligned_cols=31 Identities=19% Similarity=0.157 Sum_probs=27.0
Q ss_pred CCCceeeccCCCCeeeCCCCCeEEeecccce
Q 041757 152 QPVTAHCVLKPSNVLLDDDMTARVGDFGLAR 182 (381)
Q Consensus 152 ~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~ 182 (381)
...++|+|+.|.|||++++..+.|+||+.+.
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 4569999999999999987778899998764
No 466
>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily.; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....
Probab=97.55 E-value=0.00033 Score=61.65 Aligned_cols=67 Identities=21% Similarity=0.221 Sum_probs=43.5
Q ss_pred ceecCCCceEEEeccc-------------ccHHHHHHHHHHHHccCCC--cccceeeeeccccccCCceEEEEEEcccCC
Q 041757 42 NLISAGTFGFSHLRRQ-------------GAFKSFIAECKALRNIRHR--NLIKVLTACLGVDYQGNDFKALVYEFMHNR 106 (381)
Q Consensus 42 ~~lG~G~fg~V~~~~~-------------~~~~~~~~E~~~l~~l~h~--nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g 106 (381)
+.|+.|..+.||.... .....+.+|..+++.+... .+.+++..+.. .......+++|+++++.
T Consensus 3 ~~l~~G~~n~~~~v~~~~~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~--~~~~~~~~~~~~~i~g~ 80 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDDGRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTS--DEFNGFPYLLMEYIPGR 80 (239)
T ss_dssp EEEEESSSSEEEEEEETTSEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEE--TEETSEEEEEEEEESSE
T ss_pred ccCCCCCeeeEEEEEECCcEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeeccc--ccccccceEEEEEeccc
Confidence 4567777776655432 2346788899999988633 35566664322 23344579999999998
Q ss_pred CHHH
Q 041757 107 SLKE 110 (381)
Q Consensus 107 ~L~~ 110 (381)
++..
T Consensus 81 ~~~~ 84 (239)
T PF01636_consen 81 PLDD 84 (239)
T ss_dssp EHHH
T ss_pred cccc
Confidence 8877
No 467
>PLN02876 acyl-CoA dehydrogenase
Probab=97.53 E-value=0.00088 Score=70.53 Aligned_cols=46 Identities=20% Similarity=0.330 Sum_probs=33.4
Q ss_pred HHHHHHHHHHHccC-CCcc--cceeeeeccccccCCceEEEEEEcccCCCH
Q 041757 61 KSFIAECKALRNIR-HRNL--IKVLTACLGVDYQGNDFKALVYEFMHNRSL 108 (381)
Q Consensus 61 ~~~~~E~~~l~~l~-h~nI--v~~~~~~~~~~~~~~~~~~lv~e~~~~g~L 108 (381)
..+.+|+++|+.+. |.+| .+++.+|.+. ...+..|+||||++|..+
T Consensus 83 ~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~--~v~G~~flVME~v~G~~~ 131 (822)
T PLN02876 83 HAVEREYQVLRALGEHTDVPVPKVYCLCTDA--SVIGTAFYIMEYLEGRIF 131 (822)
T ss_pred HHHHHHHHHHHHHhhcCCCCCCcEEEEecCC--CcCCCceEEEEecCCccc
Confidence 56889999999996 6665 7777776431 122456899999988653
No 468
>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]
Probab=97.44 E-value=0.00055 Score=56.85 Aligned_cols=122 Identities=18% Similarity=0.128 Sum_probs=79.4
Q ss_pred hhccccccccceecCCCceEEEecc-------------cccHHHHHHHHHHHHccCCCccc-ceeeeeccccccCCceEE
Q 041757 32 LDVSRNMLEENLISAGTFGFSHLRR-------------QGAFKSFIAECKALRNIRHRNLI-KVLTACLGVDYQGNDFKA 97 (381)
Q Consensus 32 ~~~~~~~~~~~~lG~G~fg~V~~~~-------------~~~~~~~~~E~~~l~~l~h~nIv-~~~~~~~~~~~~~~~~~~ 97 (381)
......-...+.||+|++|.||+.. ......+..|+++|..+.-.++. ++|.+. ..+
T Consensus 18 ~~~~~~~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg---------~~~ 88 (201)
T COG2112 18 EEGKYELRVEKELAKGTTSVVYLGEWRGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYG---------EDF 88 (201)
T ss_pred eccchhhhhhhhhhcccccEEEEeeccCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEec---------hhh
Confidence 3344555667899999999998843 34577899999999999876664 345541 234
Q ss_pred EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccC-CCCeeeCCCCCeEEe
Q 041757 98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLK-PSNVLLDDDMTARVG 176 (381)
Q Consensus 98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlk-p~Nill~~~~~~kl~ 176 (381)
+.|||..|.+|.++-.. .+...+. .+++.---|- ..||-|..|. |..+++.++..+-|+
T Consensus 89 i~me~i~G~~L~~~~~~-------------~~rk~l~----~vlE~a~~LD---~~GI~H~El~~~~k~vlv~~~~~~iI 148 (201)
T COG2112 89 IRMEYIDGRPLGKLEIG-------------GDRKHLL----RVLEKAYKLD---RLGIEHGELSRPWKNVLVNDRDVYII 148 (201)
T ss_pred hhhhhhcCcchhhhhhc-------------ccHHHHH----HHHHHHHHHH---HhccchhhhcCCceeEEecCCcEEEE
Confidence 66999999898876521 0222222 2333322222 3467777764 444555555589999
Q ss_pred ecccce
Q 041757 177 DFGLAR 182 (381)
Q Consensus 177 Dfg~~~ 182 (381)
||..|.
T Consensus 149 DFd~At 154 (201)
T COG2112 149 DFDSAT 154 (201)
T ss_pred Eccchh
Confidence 998876
No 469
>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]
Probab=97.29 E-value=2.9e-05 Score=82.61 Aligned_cols=165 Identities=10% Similarity=-0.067 Sum_probs=114.0
Q ss_pred HHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHH
Q 041757 61 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDV 140 (381)
Q Consensus 61 ~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi 140 (381)
+-.+.|...++...|+++...+.-.. ......-+.+++|+.+|++.+.+-... .+...+...-+.....+.
T Consensus 1274 emll~e~de~~~~~h~~~~~~p~rI~---ps~s~ee~~r~~~~~~g~~f~iIikg~------ee~~~ld~~~v~~~~kvs 1344 (2724)
T KOG1826|consen 1274 EMLLSERDELREAKHYLTEVDPLRIP---PSESTEEYIRSLYVEFGKLFSIIIKGL------EESPDLDRSPVHLRHKVS 1344 (2724)
T ss_pred HhhhhhhhhhhhhhceeeecccccCC---CCCChHHHHHHHHHHHhHHHHHHHhcc------ccCCcchhchHHHHHHHH
Confidence 33445666666778999887665422 345666789999999999999985433 122223333333333333
Q ss_pred HHHHHHhhcC--CCCCceeeccCCCCeeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccc
Q 041757 141 ASALNYLHHD--CQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGD 218 (381)
Q Consensus 141 ~~~l~~LH~~--~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sD 218 (381)
..+..-+|+. .....+|+++|+-|.+|..+..+|++++|+.++........ ....+++.|++|+......++.++|
T Consensus 1345 vl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~--Gl~l~sp~~v~qli~N~ik~t~rsd 1422 (2724)
T KOG1826|consen 1345 VLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFF--GLELCSPIYVLQLIKNEIKFTKRSD 1422 (2724)
T ss_pred HhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCchHhhh--hhhhCCHHHHHHHHHHHHhhhhHHH
Confidence 5555555532 23457899999999999999999999999998433222211 1245788899999888888888899
Q ss_pred hhhhhHHHHHHHhCCCCC
Q 041757 219 VYSYGILLLELMIREKPS 236 (381)
Q Consensus 219 iwSlG~il~el~tg~~Pf 236 (381)
+|+.|+-+|+..-|..+|
T Consensus 1423 ilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1423 ILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred HHHHHHHHHHHhcccHHH
Confidence 999999999987777664
No 470
>PRK10593 hypothetical protein; Provisional
Probab=96.94 E-value=0.011 Score=54.45 Aligned_cols=67 Identities=13% Similarity=-0.027 Sum_probs=45.8
Q ss_pred ccceecCCCceEEEecc------------cc-cHHHHHHHHHHHHccCC---CcccceeeeeccccccCCceEEEEEEcc
Q 041757 40 EENLISAGTFGFSHLRR------------QG-AFKSFIAECKALRNIRH---RNLIKVLTACLGVDYQGNDFKALVYEFM 103 (381)
Q Consensus 40 ~~~~lG~G~fg~V~~~~------------~~-~~~~~~~E~~~l~~l~h---~nIv~~~~~~~~~~~~~~~~~~lv~e~~ 103 (381)
..+-||.|..+.||... .. ....+.+|.+.|+.|.- -.+.+++++|.. ....+..+||||++
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~~~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~--~~~~g~~~LVmE~i 95 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQGNPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTH--EQSPGPDVLLLERL 95 (297)
T ss_pred eeeecCCccceeEEEEEcCCCCEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEecc--CCcCCCeEEEEecc
Confidence 34567788877775521 11 23578899999999953 367888887542 12345679999999
Q ss_pred cCCCH
Q 041757 104 HNRSL 108 (381)
Q Consensus 104 ~~g~L 108 (381)
+++++
T Consensus 96 ~G~~~ 100 (297)
T PRK10593 96 RGVSV 100 (297)
T ss_pred CCEec
Confidence 98765
No 471
>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]
Probab=96.82 E-value=0.0078 Score=58.16 Aligned_cols=48 Identities=23% Similarity=0.325 Sum_probs=36.5
Q ss_pred HHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEcccCCCHHHhhc
Q 041757 61 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLY 113 (381)
Q Consensus 61 ~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~ 113 (381)
.....-...++.+.|+|...++++... ......+|||++ +-+|++.+.
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~----~~~r~IVV~e~~-~~Sled~~~ 74 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRG----KHERVIVVMEHY-TMSLEDILK 74 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecC----ccceEEEEehhh-ccchHHHHH
Confidence 344556778899999999999988542 234478999999 559999884
No 472
>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]
Probab=96.65 E-value=0.0053 Score=56.05 Aligned_cols=117 Identities=14% Similarity=0.035 Sum_probs=76.9
Q ss_pred ccccceecCCCceEEEecccc--------------------------------------cHHHHHHHHHHHHccC-C-Cc
Q 041757 38 MLEENLISAGTFGFSHLRRQG--------------------------------------AFKSFIAECKALRNIR-H-RN 77 (381)
Q Consensus 38 ~~~~~~lG~G~fg~V~~~~~~--------------------------------------~~~~~~~E~~~l~~l~-h-~n 77 (381)
++.++.||-|.-+.||.+-.. ..-...+|...|+.|. | --
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 567788888888888664311 1122346888888885 3 23
Q ss_pred ccceeeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCcee
Q 041757 78 LIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAH 157 (381)
Q Consensus 78 Iv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH 157 (381)
|.+.+++ +..++|||++.+-.|.+.-+ .-+...+..-+..++ .-|- ..|+||
T Consensus 174 VPkpiD~---------~RH~Vvmelv~g~Pl~~v~~-------------v~d~~~ly~~lm~~I---v~la---~~GlIH 225 (465)
T KOG2268|consen 174 VPKPIDH---------NRHCVVMELVDGYPLRQVRH-------------VEDPPTLYDDLMGLI---VRLA---NHGLIH 225 (465)
T ss_pred CCCcccc---------cceeeHHHhhcccceeeeee-------------cCChHHHHHHHHHHH---HHHH---HcCcee
Confidence 4444444 45689999999988866542 112223333233322 3333 449999
Q ss_pred eccCCCCeeeCCCCCeEEeecccce
Q 041757 158 CVLKPSNVLLDDDMTARVGDFGLAR 182 (381)
Q Consensus 158 rDlkp~Nill~~~~~~kl~Dfg~~~ 182 (381)
+|..-=||++++++.++++||-...
T Consensus 226 gDFNEFNimv~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 226 GDFNEFNIMVKDDDKIVVIDFPQMV 250 (465)
T ss_pred cccchheeEEecCCCEEEeechHhh
Confidence 9999999999999999999997654
No 473
>PRK09550 mtnK methylthioribose kinase; Reviewed
Probab=96.55 E-value=0.02 Score=54.77 Aligned_cols=30 Identities=17% Similarity=0.221 Sum_probs=25.9
Q ss_pred CCCceeeccCCCCeeeCCCCCeEEeecccce
Q 041757 152 QPVTAHCVLKPSNVLLDDDMTARVGDFGLAR 182 (381)
Q Consensus 152 ~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~ 182 (381)
...++|+|+.+.||++..+ .++++||.++.
T Consensus 222 ~~~l~HgDl~~gni~~~~~-~~~viD~E~a~ 251 (401)
T PRK09550 222 AEALLHGDLHTGSIFVTEE-ETKVIDPEFAF 251 (401)
T ss_pred CCceeeccCCcccEEeeCC-CcEEEeccccc
Confidence 5579999999999999776 58999998764
No 474
>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2
Probab=96.44 E-value=0.032 Score=47.83 Aligned_cols=116 Identities=19% Similarity=0.274 Sum_probs=78.7
Q ss_pred cccccccceecCCCc-eEEEeccc------------------------------------ccHHHHHHHHHHHHccC---
Q 041757 35 SRNMLEENLISAGTF-GFSHLRRQ------------------------------------GAFKSFIAECKALRNIR--- 74 (381)
Q Consensus 35 ~~~~~~~~~lG~G~f-g~V~~~~~------------------------------------~~~~~~~~E~~~l~~l~--- 74 (381)
+.+++..+.||.|.- |.|++++- .....|..|.+...+|+
T Consensus 36 ~~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 36 GDDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CCcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 378889999999999 99955430 12345788999888885
Q ss_pred CCcc--cceeeeeccc-------------cccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHH
Q 041757 75 HRNL--IKVLTACLGV-------------DYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAID 139 (381)
Q Consensus 75 h~nI--v~~~~~~~~~-------------~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~q 139 (381)
+.++ |+.+|+..=. .........||-||.+... .++ .+-+.+
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------------~~~----~~~~~~ 172 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------------PLQ----IRDIPQ 172 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------------ccc----hhHHHH
Confidence 4566 8888885310 0011223356777664422 122 233567
Q ss_pred HHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccc
Q 041757 140 VASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLA 181 (381)
Q Consensus 140 i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~ 181 (381)
+.+-+..+| ..||+-+|+++.|.. .-||+|||.+
T Consensus 173 ~~~dl~~~~---k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 173 MLRDLKILH---KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHHHHH---HCCeeeccCcccccc-----CCEEEecccC
Confidence 777888999 779999999999987 3489999864
No 475
>TIGR02721 ycfN_thiK thiamine kinase. Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.
Probab=96.31 E-value=0.0091 Score=53.67 Aligned_cols=29 Identities=14% Similarity=0.164 Sum_probs=25.4
Q ss_pred CCceeeccCCCCeeeCCCCCeEEeecccce
Q 041757 153 PVTAHCVLKPSNVLLDDDMTARVGDFGLAR 182 (381)
Q Consensus 153 ~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~ 182 (381)
..++|+|+.|.||++++++ +.|+||..+.
T Consensus 146 ~~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 146 LAPLHMDVHAYNLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred CeeecCCCCcCcEEEeCCC-CEEEeccccC
Confidence 4689999999999999876 7899998774
No 476
>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length. The function of this family is unknown.
Probab=96.07 E-value=0.024 Score=49.03 Aligned_cols=124 Identities=11% Similarity=0.088 Sum_probs=78.4
Q ss_pred cHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHH
Q 041757 59 AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAI 138 (381)
Q Consensus 59 ~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~ 138 (381)
...-|.++.+++.++. .|+++.. .+.-...++.|.|-. ...... .++.
T Consensus 101 ~~~~y~nky~v~Armh--GilrL~N-------Dn~~~yGvIlE~Cy~-------------------~~i~~~----N~i~ 148 (308)
T PF07387_consen 101 NDALYFNKYRVFARMH--GILRLKN-------DNNYKYGVILERCYK-------------------IKINFS----NFIT 148 (308)
T ss_pred chhhhhhhhhHHHHhh--heeEeec-------CCCceeEEEEeeccC-------------------cccchh----HHHH
Confidence 3455677888888775 3555442 234556789999833 111111 1122
Q ss_pred HHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccc
Q 041757 139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGD 218 (381)
Q Consensus 139 qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sD 218 (381)
-=+.+|.-.|+. ..+.+|+|..|+||+-|..|.+||.|=+.-. ..+.-|.--| ....+.++.
T Consensus 149 agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll--------------~~~V~~vN~~---Y~~lT~~aE 210 (308)
T PF07387_consen 149 AGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLL--------------ENQVNMVNIE---YESLTQEAE 210 (308)
T ss_pred HhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhh--------------hheeeEEeee---ccccChHHH
Confidence 225678888976 7799999999999999999999999976431 0222233312 123466777
Q ss_pred hhhhhHHHHHHHhC
Q 041757 219 VYSYGILLLELMIR 232 (381)
Q Consensus 219 iwSlG~il~el~tg 232 (381)
+-+|-.-+.++...
T Consensus 211 ~~~fv~s~l~~v~~ 224 (308)
T PF07387_consen 211 VKVFVKSCLKLVEK 224 (308)
T ss_pred HHHHHHHHHHHHHH
Confidence 77777777776653
No 477
>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]
Probab=95.67 E-value=0.057 Score=49.86 Aligned_cols=32 Identities=31% Similarity=0.515 Sum_probs=28.5
Q ss_pred CCCceeeccCCCCeeeCCCCCeEEeeccccee
Q 041757 152 QPVTAHCVLKPSNVLLDDDMTARVGDFGLARF 183 (381)
Q Consensus 152 ~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~ 183 (381)
...++|+|+.+.|++++....+-+.||+++..
T Consensus 197 ~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 197 PPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred CceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 35699999999999999988899999999864
No 478
>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]
Probab=95.36 E-value=0.069 Score=49.76 Aligned_cols=74 Identities=19% Similarity=0.184 Sum_probs=54.5
Q ss_pred CCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC
Q 041757 92 GNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM 171 (381)
Q Consensus 92 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~ 171 (381)
...+.|++|++- |+++.- ...-.+.++..++.+.+.-+.-+-. .-..-|||+.-.||||+ .|
T Consensus 297 e~~y~yl~~kdh-gt~is~--------------ik~~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~G 358 (488)
T COG5072 297 ETLYLYLHFKDH-GTPISI--------------IKADRSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EG 358 (488)
T ss_pred CceEEEEEEecC-Cceeee--------------eecccHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cC
Confidence 345556777754 445432 2234567788888887777776653 44788999999999999 89
Q ss_pred CeEEeeccccee
Q 041757 172 TARVGDFGLARF 183 (381)
Q Consensus 172 ~~kl~Dfg~~~~ 183 (381)
.+.|+||-+++.
T Consensus 359 nvtLIDfklsRl 370 (488)
T COG5072 359 NVTLIDFKLSRL 370 (488)
T ss_pred ceEEEEeeeeec
Confidence 999999999983
No 479
>PLN02756 S-methyl-5-thioribose kinase
Probab=94.57 E-value=0.42 Score=45.79 Aligned_cols=30 Identities=23% Similarity=0.207 Sum_probs=24.9
Q ss_pred CCCceeeccCCCCeeeCCCCCeEEeecccce
Q 041757 152 QPVTAHCVLKPSNVLLDDDMTARVGDFGLAR 182 (381)
Q Consensus 152 ~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~ 182 (381)
....+|+||.|.||+++.++ .+++|..++.
T Consensus 229 ~~~L~HGDl~~g~i~~~~~~-~~~id~ef~~ 258 (418)
T PLN02756 229 AQALVHGDLHTGSVMVTPDS-TQVIDPEFAF 258 (418)
T ss_pred ccceeecCCCCCcEEEcCCC-ceEecchhhc
Confidence 56799999999999998875 8888876653
No 480
>PRK05231 homoserine kinase; Provisional
Probab=93.95 E-value=0.1 Score=48.53 Aligned_cols=31 Identities=29% Similarity=0.238 Sum_probs=26.7
Q ss_pred CCCceeeccCCCCeeeCCCCCeEEeecccce
Q 041757 152 QPVTAHCVLKPSNVLLDDDMTARVGDFGLAR 182 (381)
Q Consensus 152 ~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~ 182 (381)
..++||+|+.|.||+++++....|+||+.+.
T Consensus 186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred CcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 5689999999999999876666899998774
No 481
>PF00560 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape []. LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. ; GO: 0005515 protein binding; PDB: 4ECO_B 2A0Z_A 3ULU_A 1ZIW_A 3ULV_A 1DCE_C 1LTX_A 3J0A_B 3A79_B 4FCG_A ....
Probab=93.89 E-value=0.035 Score=29.15 Aligned_cols=21 Identities=48% Similarity=0.589 Sum_probs=17.0
Q ss_pred eEeEEccCCccccccccccccc
Q 041757 5 LIALDVSGNKLTGSLHIEVGKL 26 (381)
Q Consensus 5 ~~~l~~~~n~~~g~~~~~~~~~ 26 (381)
|+.|||++|+++ .+|..++++
T Consensus 2 L~~Ldls~n~l~-~ip~~~~~l 22 (22)
T PF00560_consen 2 LEYLDLSGNNLT-SIPSSFSNL 22 (22)
T ss_dssp ESEEEETSSEES-EEGTTTTT-
T ss_pred ccEEECCCCcCE-eCChhhcCC
Confidence 567999999999 889887653
No 482
>PHA03111 Ser/Thr kinase; Provisional
Probab=93.83 E-value=0.077 Score=48.75 Aligned_cols=38 Identities=21% Similarity=0.031 Sum_probs=26.4
Q ss_pred HHHHHHHHHHHHHHHHhhcCC-CCCceeeccCCCCeeeC
Q 041757 131 LRRLNIAIDVASALNYLHHDC-QPVTAHCVLKPSNVLLD 168 (381)
Q Consensus 131 ~~~~~i~~qi~~~l~~LH~~~-~~~ivHrDlkp~Nill~ 168 (381)
+-+.-++.|++--.-.+.+.. ..+.+|-||||+|||+-
T Consensus 279 ~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiF 317 (444)
T PHA03111 279 EYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIF 317 (444)
T ss_pred HHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEe
Confidence 445667778776553443322 45799999999999994
No 483
>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]
Probab=93.79 E-value=0.38 Score=42.12 Aligned_cols=48 Identities=23% Similarity=0.334 Sum_probs=36.9
Q ss_pred cccHHHHHHHHHHHHccCC---CcccceeeeeccccccCCceEEEEEEcccCCCHH
Q 041757 57 QGAFKSFIAECKALRNIRH---RNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLK 109 (381)
Q Consensus 57 ~~~~~~~~~E~~~l~~l~h---~nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~ 109 (381)
......|..|+.-|..|.- -++.+++.+ .....+.|+||||++-|.+.
T Consensus 49 ~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~-----G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 49 REQLSMFTAEADGLELLARSNTITVPKVIAV-----GASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred hhhHHHHHHHHHHHHHHHhcCCccccceEEe-----cCCCCeeEEEEeeccCCCCC
Confidence 4455778899998888853 456677776 56688999999999987776
No 484
>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes. The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer
Probab=93.66 E-value=0.14 Score=47.16 Aligned_cols=31 Identities=29% Similarity=0.267 Sum_probs=27.3
Q ss_pred CCCceeeccCCCCeeeCCC----CCeEEeecccce
Q 041757 152 QPVTAHCVLKPSNVLLDDD----MTARVGDFGLAR 182 (381)
Q Consensus 152 ~~~ivHrDlkp~Nill~~~----~~~kl~Dfg~~~ 182 (381)
...++|+|+.+.||+++.+ +.+.++||..|.
T Consensus 178 ~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 178 PVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred CceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 5689999999999999874 789999998774
No 485
>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly. ; GO: 0004672 protein kinase activity, 0005524 ATP binding
Probab=93.22 E-value=0.1 Score=48.25 Aligned_cols=55 Identities=20% Similarity=0.158 Sum_probs=34.6
Q ss_pred HHHHHHHHHHHHHHHHhhcCC-CCCceeeccCCCCeeeCC------------------CCCeEEeecccceecC
Q 041757 131 LRRLNIAIDVASALNYLHHDC-QPVTAHCVLKPSNVLLDD------------------DMTARVGDFGLARFLP 185 (381)
Q Consensus 131 ~~~~~i~~qi~~~l~~LH~~~-~~~ivHrDlkp~Nill~~------------------~~~~kl~Dfg~~~~~~ 185 (381)
+-+.-++.|++--.--..+.. ..+.+|-||||+|||+-+ ...++|.||.+++...
T Consensus 275 ~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~~ 348 (434)
T PF05445_consen 275 EYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVAN 348 (434)
T ss_pred HHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhcc
Confidence 345556667654322133221 457999999999999932 2346778888876543
No 486
>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo
Probab=93.12 E-value=0.14 Score=45.25 Aligned_cols=31 Identities=19% Similarity=0.282 Sum_probs=26.9
Q ss_pred CCCceeeccCCCCeeeCC-CCCeEEeecccce
Q 041757 152 QPVTAHCVLKPSNVLLDD-DMTARVGDFGLAR 182 (381)
Q Consensus 152 ~~~ivHrDlkp~Nill~~-~~~~kl~Dfg~~~ 182 (381)
...++|+|+.+.||++++ ++.+.++||..|.
T Consensus 169 ~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 169 PIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred CEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 457999999999999997 5789999998764
No 487
>TIGR00938 thrB_alt homoserine kinase, Neisseria type. Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.
Probab=92.89 E-value=0.2 Score=46.36 Aligned_cols=31 Identities=39% Similarity=0.387 Sum_probs=27.4
Q ss_pred CCCceeeccCCCCeeeCCCCCeEEeecccce
Q 041757 152 QPVTAHCVLKPSNVLLDDDMTARVGDFGLAR 182 (381)
Q Consensus 152 ~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~ 182 (381)
..+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 5689999999999999988777899998763
No 488
>cd05153 HomoserineK_II Homoserine Kinase, type II. Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.
Probab=92.59 E-value=0.079 Score=48.61 Aligned_cols=31 Identities=35% Similarity=0.292 Sum_probs=27.2
Q ss_pred CCCceeeccCCCCeeeCCCCCeEEeecccce
Q 041757 152 QPVTAHCVLKPSNVLLDDDMTARVGDFGLAR 182 (381)
Q Consensus 152 ~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~ 182 (381)
..+++|+|+.|.||+++++..+.|+||+.+.
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 4579999999999999988777899998764
No 489
>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]
Probab=92.56 E-value=0.25 Score=46.11 Aligned_cols=144 Identities=21% Similarity=0.227 Sum_probs=75.7
Q ss_pred cccccccceecCCCceEEEecccc-cHHHHHHHHHHHHccCCCcc------cceeeeeccccccCCceEEEEEEcccCCC
Q 041757 35 SRNMLEENLISAGTFGFSHLRRQG-AFKSFIAECKALRNIRHRNL------IKVLTACLGVDYQGNDFKALVYEFMHNRS 107 (381)
Q Consensus 35 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~~~~E~~~l~~l~h~nI------v~~~~~~~~~~~~~~~~~~lv~e~~~~g~ 107 (381)
+.+|.. ....|.+ .++..+.. .......|...|..|.-.+| ...=|-... ......+.+-+.+|++|..
T Consensus 39 N~~f~~--~~~~g~~-iLki~~~~~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~-~~~~~~r~a~lf~~l~G~~ 114 (331)
T COG2334 39 NSNFRV--QTEDGRY-ILKIYRPGWTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLE-ALSGGPRPAALFEYLPGRP 114 (331)
T ss_pred CceEEE--EecCCCe-EEEEecCCCCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhh-hccCCceeEEEEEecCCcC
Confidence 444544 3667777 66665554 66777889999998842222 111111111 0111247788999999988
Q ss_pred HHH-hh--------------ccccCCcc--cccCCCcccHH-------------HHHHHHHHHHHHHHHhh----cCCCC
Q 041757 108 LKE-WL--------------YPISKEDE--TYKRPRNLNLL-------------RRLNIAIDVASALNYLH----HDCQP 153 (381)
Q Consensus 108 L~~-~l--------------~~~~~~~~--~~~~~~~l~~~-------------~~~~i~~qi~~~l~~LH----~~~~~ 153 (381)
+.. .- +.....-. .........|. .......++...+..+. .....
T Consensus 115 ~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp~ 194 (331)
T COG2334 115 LERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLPA 194 (331)
T ss_pred cCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCCc
Confidence 873 11 10000000 00000011111 00112223333333333 22233
Q ss_pred C---ceeeccCCCCeeeCCCCC-eEEeecccce
Q 041757 154 V---TAHCVLKPSNVLLDDDMT-ARVGDFGLAR 182 (381)
Q Consensus 154 ~---ivHrDlkp~Nill~~~~~-~kl~Dfg~~~ 182 (381)
. +||+|+.|.||+++.+.. +.++||+-+.
T Consensus 195 ~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 195 LGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred ccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 3 999999999999998874 8899999774
No 490
>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B ....
Probab=92.33 E-value=0.071 Score=33.56 Aligned_cols=33 Identities=45% Similarity=0.591 Sum_probs=27.6
Q ss_pred eEeEEccCCccccccccccccccchhhhhccccc
Q 041757 5 LIALDVSGNKLTGSLHIEVGKLKNLEILDVSRNM 38 (381)
Q Consensus 5 ~~~l~~~~n~~~g~~~~~~~~~~~l~~~~~~~~~ 38 (381)
|+.|++++|+++ .+|.+++++++|+.++++++.
T Consensus 3 L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~ 35 (44)
T PF12799_consen 3 LEELDLSNNQIT-DLPPELSNLPNLETLNLSNNP 35 (44)
T ss_dssp -SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSC
T ss_pred ceEEEccCCCCc-ccCchHhCCCCCCEEEecCCC
Confidence 567999999999 678889999999999988774
No 491
>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]
Probab=92.26 E-value=0.48 Score=44.46 Aligned_cols=102 Identities=17% Similarity=0.177 Sum_probs=70.4
Q ss_pred HHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHH
Q 041757 63 FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVAS 142 (381)
Q Consensus 63 ~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~ 142 (381)
..+|++.|.+|+...|.-.--.. -....|||+|+..- .|-.+. -+...++...+..+-.+++.
T Consensus 213 AEKE~RNLkRl~~aGIP~PePIl-------Lk~hVLVM~FlGrd---gw~aPk-------LKd~~ls~~ka~~~Y~~~v~ 275 (520)
T KOG2270|consen 213 AEKEMRNLKRLNNAGIPCPEPIL-------LKNHVLVMEFLGRD---GWAAPK-------LKDASLSTSKARELYQQCVR 275 (520)
T ss_pred HHHHHHHHHHHHhcCCCCCCcee-------eecceEeeeeccCC---CCcCcc-------cccccCChHHHHHHHHHHHH
Confidence 34688999998766653222111 12347999999532 121110 23455677778888889999
Q ss_pred HHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccceec
Q 041757 143 ALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFL 184 (381)
Q Consensus 143 ~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~ 184 (381)
-+.-|...+ ++||.||.-=|+|+.+ |.+.|+|-+.+...
T Consensus 276 ~MR~lY~~c--~LVHADLSEfN~Lyhd-G~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 276 IMRRLYQKC--RLVHADLSEFNLLYHD-GKLYIIDVSQSVEH 314 (520)
T ss_pred HHHHHHHHh--ceeccchhhhhheEEC-CEEEEEEccccccC
Confidence 999998655 8999999999999864 58999998877543
No 492
>PRK10271 thiK thiamine kinase; Provisional
Probab=92.24 E-value=0.1 Score=44.31 Aligned_cols=29 Identities=17% Similarity=0.167 Sum_probs=25.3
Q ss_pred CCceeeccCCCCeeeCCCCCeEEeecccce
Q 041757 153 PVTAHCVLKPSNVLLDDDMTARVGDFGLAR 182 (381)
Q Consensus 153 ~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~ 182 (381)
...+|+|+.|.|+++++++ ++|+||+.+.
T Consensus 77 ~~p~H~D~~~~N~~~~~~~-~~lIDwe~a~ 105 (188)
T PRK10271 77 LAPLHMDVHAGNLVHSASG-LRLIDWEYAG 105 (188)
T ss_pred eeeecCCCCCccEEEECCC-EEEEeCCccc
Confidence 4579999999999998877 8899999874
No 493
>TIGR02906 spore_CotS spore coat protein, CotS family. Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.
Probab=91.67 E-value=0.34 Score=44.68 Aligned_cols=30 Identities=27% Similarity=0.183 Sum_probs=25.7
Q ss_pred CCCceeeccCCCCeeeCCCCCeEEeecccce
Q 041757 152 QPVTAHCVLKPSNVLLDDDMTARVGDFGLAR 182 (381)
Q Consensus 152 ~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~ 182 (381)
..+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 458999999999999987 578899998653
No 494
>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]
Probab=90.79 E-value=0.44 Score=43.14 Aligned_cols=46 Identities=28% Similarity=0.303 Sum_probs=33.9
Q ss_pred HHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccce
Q 041757 136 IAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR 182 (381)
Q Consensus 136 i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~ 182 (381)
.+..+-.++.-.+.. ...++|+|+.|.|++.++.+.++|+||.-|.
T Consensus 137 ~~~~l~~~l~~~~~~-~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg 182 (269)
T COG0510 137 KLKELRRALEEVPKD-DLVPCHNDLNPGNLLLTDKGGLFLIDWEYAG 182 (269)
T ss_pred HHHHHHHHhhhcCCC-ceeeecCCCCccceEEcCCCcEEEEecccCC
Confidence 334444445555532 2469999999999999998999999998764
No 495
>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2.7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....
Probab=90.58 E-value=0.17 Score=44.00 Aligned_cols=30 Identities=33% Similarity=0.483 Sum_probs=21.3
Q ss_pred CCceeeccCCCCeee-CCCCCeEEeecccce
Q 041757 153 PVTAHCVLKPSNVLL-DDDMTARVGDFGLAR 182 (381)
Q Consensus 153 ~~ivHrDlkp~Nill-~~~~~~kl~Dfg~~~ 182 (381)
..++|.|+.|.||++ +.++.++++||..|.
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 468999999999999 788899999998774
No 496
>PTZ00384 choline kinase; Provisional
Probab=90.57 E-value=1.1 Score=42.92 Aligned_cols=28 Identities=25% Similarity=0.140 Sum_probs=23.7
Q ss_pred CCceeeccCCCCeeeCCCCCeEEeecccc
Q 041757 153 PVTAHCVLKPSNVLLDDDMTARVGDFGLA 181 (381)
Q Consensus 153 ~~ivHrDlkp~Nill~~~~~~kl~Dfg~~ 181 (381)
...+|.|+-+.||+.+++ .+.++||..|
T Consensus 227 ~VfCHNDL~~gNIL~~~~-~l~lID~EYA 254 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFNQ-GIYFIDFDFA 254 (383)
T ss_pred eeeeeccCCcccEEecCC-CEEEEEeccc
Confidence 578999999999997654 6999999765
No 497
>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []. Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.
Probab=90.31 E-value=0.73 Score=42.16 Aligned_cols=44 Identities=20% Similarity=0.231 Sum_probs=26.1
Q ss_pred ccHHHHHHHHHHHHccC---CCcccceeeeeccccccCCceEEEEEEcccCC
Q 041757 58 GAFKSFIAECKALRNIR---HRNLIKVLTACLGVDYQGNDFKALVYEFMHNR 106 (381)
Q Consensus 58 ~~~~~~~~E~~~l~~l~---h~nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g 106 (381)
.....|..|.+-|+.|. --.+.+++++. ...+..+|||||++.+
T Consensus 51 ~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G-----~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 51 SGRDMFEGEAEGLKALAEANPIRVPKVIAWG-----EYDDDAFLLLEFLEMG 97 (288)
T ss_dssp GGCCHHHHHHHHHHHHCHTTTSBS--EEEEE-----E-SSCCEEEEE-----
T ss_pred hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEE-----eecCCceEEEEeecCC
Confidence 34567899999999994 33567778773 2344559999999776
No 498
>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported
Probab=89.80 E-value=0.23 Score=45.26 Aligned_cols=30 Identities=30% Similarity=0.498 Sum_probs=25.2
Q ss_pred CCceeeccCCCCeeeCCCCC-eEEeecccce
Q 041757 153 PVTAHCVLKPSNVLLDDDMT-ARVGDFGLAR 182 (381)
Q Consensus 153 ~~ivHrDlkp~Nill~~~~~-~kl~Dfg~~~ 182 (381)
..++|+|++|.||++++++. ..|+||+.+.
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~ 215 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAK 215 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence 46899999999999987554 5699999874
No 499
>smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain. subfamily of choline kinases
Probab=89.79 E-value=0.25 Score=42.47 Aligned_cols=31 Identities=26% Similarity=0.275 Sum_probs=25.7
Q ss_pred CCCceeeccCCCCeeeCCCC-----CeEEeecccce
Q 041757 152 QPVTAHCVLKPSNVLLDDDM-----TARVGDFGLAR 182 (381)
Q Consensus 152 ~~~ivHrDlkp~Nill~~~~-----~~kl~Dfg~~~ 182 (381)
...++|+|+.+.||++..++ .+.++||..++
T Consensus 119 ~~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~ 154 (196)
T smart00587 119 FNVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH 154 (196)
T ss_pred ceEEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence 45799999999999997543 58999998774
No 500
>TIGR02904 spore_ysxE spore coat protein YsxE. Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.
Probab=89.50 E-value=0.5 Score=43.70 Aligned_cols=31 Identities=26% Similarity=0.247 Sum_probs=27.9
Q ss_pred CCCceeeccCCCCeeeCCCCCeEEeecccce
Q 041757 152 QPVTAHCVLKPSNVLLDDDMTARVGDFGLAR 182 (381)
Q Consensus 152 ~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~ 182 (381)
..+++|+|+.++|+++++++.+.++||..+.
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 5589999999999999998899999998774
Done!